Citrus Sinensis ID: 007625
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 595 | 2.2.26 [Sep-21-2011] | |||||||
| Q8W4S5 | 614 | Probable LRR receptor-lik | yes | no | 0.978 | 0.947 | 0.699 | 0.0 | |
| C0LGX1 | 607 | Probable LRR receptor-lik | no | no | 0.968 | 0.948 | 0.560 | 0.0 | |
| C0LGT1 | 613 | Probable LRR receptor-lik | no | no | 0.942 | 0.915 | 0.555 | 0.0 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.968 | 0.921 | 0.468 | 1e-145 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.904 | 0.874 | 0.493 | 1e-144 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.917 | 0.859 | 0.453 | 1e-138 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.957 | 0.901 | 0.443 | 1e-137 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.889 | 0.834 | 0.479 | 1e-136 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.936 | 0.873 | 0.440 | 1e-133 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.880 | 0.845 | 0.462 | 1e-133 |
| >sp|Q8W4S5|Y5371_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g63710 OS=Arabidopsis thaliana GN=At5g63710 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 833 bits (2151), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/586 (69%), Positives = 493/586 (84%), Gaps = 4/586 (0%)
Query: 13 LMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVT 72
L+ + + + F+ S+ +PD+EG AL+++ +LND+ + W FVSPC+SWS+VT
Sbjct: 30 LILQCFMALAFVGITSSTTQPDIEGGALLQLRDSLNDSSNRL-KWTRDFVSPCYSWSYVT 88
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
CR +V++L L S+GF+G +SP+ITKLKFL +LELQ+N LSG LPD LG+M +LQ+LNL+
Sbjct: 89 CRGQSVVALNLASSGFTGTLSPAITKLKFLVTLELQNNSLSGALPDSLGNMVNLQTLNLS 148
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCM 192
N FSGSIPA+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+GT LICG SL QPC
Sbjct: 149 VNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPCS 208
Query: 193 SRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCK 252
S PV++S+ KLR + +ASC A ++L LGA+ + ++R+ K+D+FFDVAGEDD K
Sbjct: 209 SSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRK 268
Query: 253 VSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE 312
+S QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGE
Sbjct: 269 ISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGE 328
Query: 313 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 372
AAFQRE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWP
Sbjct: 329 AAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWP 388
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
TRKRVAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD LTHV
Sbjct: 389 TRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHV 448
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492
TTQ+RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLDH
Sbjct: 449 TTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDH 508
Query: 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE-DL 551
I+KLLRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG L
Sbjct: 509 IKKLLREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGL 568
Query: 552 AERWAEWEELEEVRQQEVSLLPHQFA-WG-EDSSIDQEAIQLSNAR 595
AE+W EWE+LEEVR +E LLP A W E++++DQE+I+LS AR
Sbjct: 569 AEKWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 656 bits (1692), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/607 (56%), Positives = 428/607 (70%), Gaps = 31/607 (5%)
Query: 18 LILVIFLNFGH--SSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRN 75
L+++ L F SS PD +G+AL + +L + Q +DWN + V PC +WS V C +
Sbjct: 3 LLIITALVFSSLWSSVSPDAQGDALFALRSSLRASPEQLSDWNQNQVDPC-TWSQVICDD 61
Query: 76 G-NVISLTLG-------------------------SNGFSGKISPSITKLKFLASLELQD 109
+V S+TL NG G I SI L L SL+L+D
Sbjct: 62 KKHVTSVTLSYMNFSSGTLSSGIGILTTLKTLTLKGNGIMGGIPESIGNLSSLTSLDLED 121
Query: 110 NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
N L+ +P LG++ +LQ L L+ N +GSIP + + LS L ++ L SNNL+G IP LF
Sbjct: 122 NHLTDRIPSTLGNLKNLQFLTLSRNNLNGSIPDSLTGLSKLINILLDSNNLSGEIPQSLF 181
Query: 170 SVATFNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFAC 229
+ +NFT +L CG + QPC++ SP +S K I+ S A +LL F C
Sbjct: 182 KIPKYNFTANNLSCGGTFPQPCVTESSPSGDSSSRKTGIIAGVVSGIAVILLGFFFFFFC 241
Query: 230 RYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYK 289
+ K + K DVF DVAGE D +++ QLRRF+ RELQLATD FSE N++GQGGFGKVYK
Sbjct: 242 K-DKHKGYKRDVFVDVAGEVDRRIAFGQLRRFAWRELQLATDEFSEKNVLGQGGFGKVYK 300
Query: 290 GVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349
G+LSD TKVAVKRL D+ PGG+ AFQREV +ISVA+H+NLL+LIG+CTT +ER+LVYPF
Sbjct: 301 GLLSDGTKVAVKRLTDFERPGGDEAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPF 360
Query: 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 409
MQNLSVAY LR++KPG+ LDW RK++A G A GLEYLHE CNPKIIHRD+KAAN+LLD
Sbjct: 361 MQNLSVAYCLREIKPGDPVLDWFRRKQIALGAARGLEYLHEHCNPKIIHRDVKAANVLLD 420
Query: 410 DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 469
++FEAV+ DFGLAKLVD + T+VTTQ+RGTMGHIAPE +STGKSSEKTDVFGYGI LLEL
Sbjct: 421 EDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPECISTGKSSEKTDVFGYGIMLLEL 480
Query: 470 VTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLC 528
VTGQRAIDFSRLEEE+DVLLLDH++KL RE RL DIVD+ L+ Y +EVE M+QVALLC
Sbjct: 481 VTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLEDIVDKKLDEDYIKEEVEMMIQVALLC 540
Query: 529 TQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEA 588
TQ+ PE+RP M++VV+ML+GE LAERW EW+ LE RQ+E L +F WGEDS +Q+A
Sbjct: 541 TQAAPEERPAMSEVVRMLEGEGLAERWEEWQNLEVTRQEEFQRLQRRFDWGEDSINNQDA 600
Query: 589 IQLSNAR 595
I+LS R
Sbjct: 601 IELSGGR 607
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 649 bits (1674), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/589 (55%), Positives = 418/589 (70%), Gaps = 28/589 (4%)
Query: 33 PDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGN-VISLTLGSNGFSGK 91
PD +G+AL + +L Q +DWN + V+PC +WS V C + N V SLTL FSG
Sbjct: 27 PDAQGDALFALRISLRALPNQLSDWNQNQVNPC-TWSQVICDDKNFVTSLTLSDMNFSGT 85
Query: 92 ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151
+S + L+ L +L L+ N ++G +P+ G++T L SL+L +N+ +G IP+T L L+
Sbjct: 86 LSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPSTIGNLKKLQ 145
Query: 152 HLDLSSNNLTG------------------------RIPMQLFSVATFNFTGTHLICGSSL 187
L LS N L G +IP LF + +NFT +L CG
Sbjct: 146 FLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTSNNLNCGGRQ 205
Query: 188 EQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAG 247
PC+S + +S+ K I+ + VL + C+ + + + DVF DVAG
Sbjct: 206 PHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCK-DRHKGYRRDVFVDVAG 264
Query: 248 EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY 307
E D +++ QL+RF+ RELQLATDNFSE N++GQGGFGKVYKGVL DNTKVAVKRL D+
Sbjct: 265 EVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFE 324
Query: 308 SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK 367
SPGG+AAFQREV +ISVA+H+NLL+LIG+CTT +ER+LVYPFMQNLS+A+RLR++K G+
Sbjct: 325 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDP 384
Query: 368 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427
LDW TRKR+A G A G EYLHE CNPKIIHRD+KAAN+LLD++FEAV+ DFGLAKLVD
Sbjct: 385 VLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 444
Query: 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 487
+ T+VTTQ+RGTMGHIAPEYLSTGKSSE+TDVFGYGI LLELVTGQRAIDFSRLEEE+DV
Sbjct: 445 RRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 504
Query: 488 LLLDHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
LLLDH++KL RE RL IVD+NL+ Y +EVE M+QVALLCTQ +PEDRP M++VV+ML
Sbjct: 505 LLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRML 564
Query: 547 QGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 595
+GE LAERW EW+ +E R+ E L +F WGEDS +Q+AI+LS R
Sbjct: 565 EGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 514 bits (1325), Expect = e-145, Method: Compositional matrix adjust.
Identities = 289/617 (46%), Positives = 394/617 (63%), Gaps = 41/617 (6%)
Query: 18 LILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGN 77
L L++ N ++EG+AL + L D + W+ V+PC +W HVTC N N
Sbjct: 11 LSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPC-TWFHVTCNNEN 69
Query: 78 -VISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
VI + LG+ SG + P + LK L LEL N+++G +P LG++T+L SL+L N F
Sbjct: 70 SVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSF 129
Query: 137 SGSIPATWSQLSNLKHL------------------------DLSSNNLTGRIPMQ-LFSV 171
SG IP + +LS L+ L DLS+N L+G +P FS+
Sbjct: 130 SGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSL 189
Query: 172 AT-FNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACR 230
T +F +CG PC P + V + G ++ G
Sbjct: 190 FTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAA 249
Query: 231 YQKL----------RKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIG 280
R+ D+FFDV E+D +V L QL+RFS RELQ+A+D FS NI+G
Sbjct: 250 LLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILG 309
Query: 281 QGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340
+GGFGKVYKG L+D T VAVKRL++ +PGGE FQ EV +IS+A+H+NLL+L G+C T
Sbjct: 310 RGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 369
Query: 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 400
+ER+LVYP+M N SVA LR+ P + LDWPTRKR+A G+A GL YLH+ C+PKIIHRD
Sbjct: 370 TERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRD 429
Query: 401 LKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVF 460
+KAANILLD+ FEAV+ DFGLAKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVF
Sbjct: 430 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 489
Query: 461 GYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVE 519
GYGI LLEL+TGQRA D +RL ++DV+LLD ++ LL+E +L +VD +L T Y+ +E+E
Sbjct: 490 GYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELE 549
Query: 520 TMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFA-W 578
++QVALLCTQ +P +RP M++VV+ML+G+ LAE+W EW+++E +R +E+ L P+ + W
Sbjct: 550 QVIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILR-EEIDLSPNPNSDW 608
Query: 579 GEDSSIDQEAIQLSNAR 595
DS+ + A++LS R
Sbjct: 609 ILDSTYNLHAVELSGPR 625
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 511 bits (1316), Expect = e-144, Method: Compositional matrix adjust.
Identities = 288/584 (49%), Positives = 382/584 (65%), Gaps = 46/584 (7%)
Query: 17 WLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNG 76
WLILV+ L S + EG+AL + +L D + W+ V+PC +W HVTC +
Sbjct: 12 WLILVLDLVLRVSG---NAEGDALSALKNSLADPNKVLQSWDATLVTPC-TWFHVTCNSD 67
Query: 77 N-VISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N V + LG+ SG++ + +L L LEL N+++GT+P+ LG++T L SL+L N
Sbjct: 68 NSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNN 127
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN--------FTGTHLICGS-S 186
SG IP+T +L L+ L L++N+L+G IP L +V T TG + GS S
Sbjct: 128 LSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFS 187
Query: 187 LEQPCMSRPSPPVSTSRTKL----------------------RIVVASASCGAFVLLSLG 224
L P+S + TKL RI A A A L
Sbjct: 188 L--------FTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLF 239
Query: 225 ALFACRYQKLRKLK-HDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGG 283
A+ A R+ K D FFDV E+D +V L QL+RFS RELQ+A+DNFS NI+G+GG
Sbjct: 240 AVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGG 299
Query: 284 FGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343
FGKVYKG L+D T VAVKRL++ + GGE FQ EV +IS+A+H+NLL+L G+C T +ER
Sbjct: 300 FGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 359
Query: 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 403
+LVYP+M N SVA LR+ + LDWP R+R+A G+A GL YLH+ C+PKIIHRD+KA
Sbjct: 360 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 419
Query: 404 ANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 463
ANILLD+ FEAV+ DFGLAKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG
Sbjct: 420 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 479
Query: 464 ITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-TYDSKEVETMV 522
+ LLEL+TGQRA D +RL ++DV+LLD ++ LL+E +L +VD +L Y +EVE ++
Sbjct: 480 VMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLI 539
Query: 523 QVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQ 566
QVALLCTQS+P +RP M++VV+ML+G+ LAERW EW++ E RQ
Sbjct: 540 QVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ 583
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 493 bits (1269), Expect = e-138, Method: Compositional matrix adjust.
Identities = 273/602 (45%), Positives = 377/602 (62%), Gaps = 56/602 (9%)
Query: 39 ALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITK 98
ALI + +L D HG +W+D V PC SW+ +TC +G VI L S SG +S SI
Sbjct: 45 ALIGIKSSLTDPHGVLMNWDDTAVDPC-SWNMITCSDGFVIRLEAPSQNLSGTLSSSIGN 103
Query: 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158
L L ++ LQ+N ++G +P +G + L++L+L+ N F+G IP T S NL++L +++N
Sbjct: 104 LTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSKNLQYLRVNNN 163
Query: 159 NLTGRIPMQLFSVA----------------------TFNFTGTHLICGSSLEQPCMSRPS 196
+LTG IP L ++ TFN G IC + E+ C
Sbjct: 164 SLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKTFNVMGNSQICPTGTEKDCNGTQP 223
Query: 197 PPVS--------------TSRTKLRIVVA-SASCGAFVLLSLGALFACRYQKLRKLKHDV 241
P+S T K+ +V S +C +++ G L + + R K +
Sbjct: 224 KPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLL---WWRRRHNKQVL 280
Query: 242 FFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK 301
FFD+ ++ ++ L LRRF+ +ELQ AT NFS N++G+GGFG VYKG L D + +AVK
Sbjct: 281 FFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAVK 340
Query: 302 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 361
RL+D + GGE FQ E+ +IS+A+H+NLL+L G+CTTSSER+LVYP+M N SVA RL+
Sbjct: 341 RLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLK- 399
Query: 362 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421
KP LDW TRKR+A G GL YLHEQC+PKIIHRD+KAANILLDD FEAV+ DFGL
Sbjct: 400 AKPV---LDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFGL 456
Query: 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481
AKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TG RA++F +
Sbjct: 457 AKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKA 516
Query: 482 EEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMA 540
+ +LD ++KL +E +L IVD++L + YD EVE MVQVALLCTQ P RP M+
Sbjct: 517 ANQRGA-ILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKMS 575
Query: 541 QVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGE-------DSSIDQEAIQLSN 593
+VV+ML+G+ L E+W + E + P++F+ E DSS+ +A++LS
Sbjct: 576 EVVRMLEGDGLVEKWEASSQRAETNRSYSK--PNEFSSSERYSDLTDDSSVLVQAMELSG 633
Query: 594 AR 595
R
Sbjct: 634 PR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1258), Expect = e-137, Method: Compositional matrix adjust.
Identities = 279/629 (44%), Positives = 390/629 (62%), Gaps = 59/629 (9%)
Query: 17 WLILVIFLNFGHSSREP---DVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTC 73
+L+ V F + ++ P + E AL+ V LND + +W+ + V PC SW V+C
Sbjct: 13 FLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPC-SWRMVSC 71
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLAN 133
+G V SL L S SG +SP I L +L S+ LQ+N ++G +P+ +G + LQSL+L+N
Sbjct: 72 TDGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSN 131
Query: 134 NKFSGSIPATW------------------------SQLSNLKHLDLSSNNLTGRIPMQLF 169
N F+G IPA+ S++ L +D+S NNL+G +P
Sbjct: 132 NSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPK--V 189
Query: 170 SVATFNFTGTHLICGSSLEQPCMSRPSPPV--------STSRTKLRIVVASASCGAFVLL 221
S TF G LICG C + P P S +RT V + +
Sbjct: 190 SARTFKVIGNALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHHVALAFAASFSAAF 249
Query: 222 ----SLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESN 277
+ G RY++ ++ +FFDV + D +VSL L+R++ +EL+ AT++F+ N
Sbjct: 250 FVFFTSGMFLWWRYRRNKQ----IFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKN 305
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
I+G+GG+G VYKG L+D T VAVKRL+D GGE FQ EV IS+A+H+NLL+L G+C
Sbjct: 306 ILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFC 365
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
+++ ERILVYP+M N SVA RL+D GE LDW RK++A GTA GL YLHEQC+PKII
Sbjct: 366 SSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKII 425
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRD+KAANILLD++FEAV+ DFGLAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKT
Sbjct: 426 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 485
Query: 458 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-TYDSK 516
DVFG+GI LLEL+TGQ+A+DF R ++ V +LD ++KL +E +L ++D++LN +D
Sbjct: 486 DVFGFGILLLELITGQKALDFGRSAHQKGV-MLDWVKKLHQEGKLKQLIDKDLNDKFDRV 544
Query: 517 EVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQF 576
E+E +VQVALLCTQ P RP M++V+KML+G+ LAERW E + Q L P
Sbjct: 545 ELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERW-EATQNGTGEHQPPPLPPGMV 603
Query: 577 A----------WGEDSSIDQEAIQLSNAR 595
+ + ++SS+ EAI+LS R
Sbjct: 604 SSSPRVRYYSDYIQESSLVVEAIELSGPR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 485 bits (1249), Expect = e-136, Method: Compositional matrix adjust.
Identities = 275/573 (47%), Positives = 371/573 (64%), Gaps = 44/573 (7%)
Query: 18 LILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGN 77
L+L F+ SS + E EALI + L+D HG F +W++ V PC SW+ ++C + N
Sbjct: 16 LLLCFFVTCSLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPC-SWTMISCSSDN 74
Query: 78 -VISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
VI L S SG +S SI L L + LQ+N++SG +P + S+ LQ+L+L+NN+F
Sbjct: 75 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNRF 134
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL----------------------FSVATF 174
SG IP + +QLSNL++L L++N+L+G P L F TF
Sbjct: 135 SGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKFPARTF 194
Query: 175 NFTGTHLICGSSLEQPCM-SRPSPPVSTS-------RTKLRIVVASASCG--AFVLLSLG 224
N G LIC +SL + C S + P+S S RT + V S G V+LSLG
Sbjct: 195 NVAGNPLICKNSLPEICSGSISASPLSVSLRSSSGRRTNILAVALGVSLGFAVSVILSLG 254
Query: 225 ALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGF 284
F +K R+L D +++ + L LR F+ REL +ATD FS +I+G GGF
Sbjct: 255 --FIWYRKKQRRLTMLRISD--KQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGF 310
Query: 285 GKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344
G VY+G D T VAVKRL+D G + F+ E+ +IS+A+H+NLL+LIGYC +SSER+
Sbjct: 311 GNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERL 370
Query: 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA 404
LVYP+M N SVA RL+ KP LDW TRK++A G A GL YLHEQC+PKIIHRD+KAA
Sbjct: 371 LVYPYMSNGSVASRLKA-KPA---LDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAA 426
Query: 405 NILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGI 464
NILLD+ FEAV+ DFGLAKL++ + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI
Sbjct: 427 NILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 486
Query: 465 TLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQ 523
LLEL+TG RA++F + ++ +L+ +RKL +E ++ ++VDR L TYD EV M+Q
Sbjct: 487 LLLELITGMRALEFGKSVSQKGA-MLEWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQ 545
Query: 524 VALLCTQSTPEDRPPMAQVVKMLQGEDLAERWA 556
VALLCTQ P RP M++VV+ML+G+ LAERWA
Sbjct: 546 VALLCTQFLPAHRPKMSEVVQMLEGDGLAERWA 578
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 477 bits (1227), Expect = e-133, Method: Compositional matrix adjust.
Identities = 271/615 (44%), Positives = 386/615 (62%), Gaps = 58/615 (9%)
Query: 29 SSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGN-VISLTLGSNG 87
S + + E +AL+++ +L+D HG +W+ V PC SW+ VTC + N VI L S
Sbjct: 34 SPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVDPC-SWTMVTCSSENFVIGLGTPSQN 92
Query: 88 FSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQL 147
SG +SPSIT L L + LQ+N++ G +P +G +T L++L+L++N F G IP + L
Sbjct: 93 LSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYL 152
Query: 148 SNLKHLDLSSNNLTGRIPMQL----------------------FSVATFNFTGTHLICGS 185
+L++L L++N+L+G P+ L F+ TF+ G LIC +
Sbjct: 153 QSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVPRFAAKTFSIVGNPLICPT 212
Query: 186 SLEQPCMSRPSPPVST-------------SRTKLRIVVASASCG--AFVLLSLGALFACR 230
E C P+S SR + +S G + + +++G R
Sbjct: 213 GTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWWR 272
Query: 231 YQKLRKLKHDVFFDVA-GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYK 289
++ + FFDV G +VSL LRRF RELQ+AT+NFS N++G+GG+G VYK
Sbjct: 273 ----QRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYK 328
Query: 290 GVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349
G+L D+T VAVKRL+D + GGE FQ EV +IS+A+H+NLL+L G+C T +E++LVYP+
Sbjct: 329 GILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPY 388
Query: 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 409
M N SVA R++ KP LDW RKR+A G A GL YLHEQC+PKIIHRD+KAANILLD
Sbjct: 389 MSNGSVASRMKA-KPV---LDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLD 444
Query: 410 DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 469
D EAV+ DFGLAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL
Sbjct: 445 DYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 504
Query: 470 VTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL---NTYDSKEVETMVQVAL 526
VTGQRA +F + ++ V +LD ++K+ +E +L +VD+ L +YD E++ MV+VAL
Sbjct: 505 VTGQRAFEFGKAANQKGV-MLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVAL 563
Query: 527 LCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEV-----RQQEVSLLPHQFA-WGE 580
LCTQ P RP M++VV+ML+G+ LAE+W + + V R E+ +++ +
Sbjct: 564 LCTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTD 623
Query: 581 DSSIDQEAIQLSNAR 595
DSS+ +A++LS R
Sbjct: 624 DSSLLVQAMELSGPR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 476 bits (1226), Expect = e-133, Method: Compositional matrix adjust.
Identities = 259/560 (46%), Positives = 362/560 (64%), Gaps = 36/560 (6%)
Query: 34 DVEGEALIEVLKAL---NDTHGQFTDWNDHFVSPCFSWSHVTCRNGN-VISLTLGSNGFS 89
+ EG+AL ++ +L + + W+ V+PC +W HVTC N V + LG+ S
Sbjct: 30 NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPC-TWFHVTCNPENKVTRVDLGNAKLS 88
Query: 90 GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSN 149
GK+ P + +L L LEL N+++G +P+ LG + L SL+L N SG IP++ +L
Sbjct: 89 GKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGK 148
Query: 150 LKHLDLSSNNLTGRIPM-------QLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVSTS 202
L+ L L++N+L+G IPM Q+ ++ +G + GS + P + S
Sbjct: 149 LRFLRLNNNSLSGEIPMTLTSVQLQVLDISNNRLSGDIPVNGSF----SLFTPISFANNS 204
Query: 203 RTKL------------------RIVVASASCGAFVLLSLGALFACRYQK-LRKLKHDVFF 243
T L ++ A A A L A+ A + LR+ D FF
Sbjct: 205 LTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHFF 264
Query: 244 DVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRL 303
DV E+D +V L QL+RF+ REL +ATDNFS N++G+GGFGKVYKG L+D VAVKRL
Sbjct: 265 DVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRL 324
Query: 304 QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK 363
++ + GGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 325 KEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 384
Query: 364 PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423
G LDWP RK +A G+A GL YLH+ C+ KIIHRD+KAANILLD+ FEAV+ DFGLAK
Sbjct: 385 EGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAK 444
Query: 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 483
L++ +HVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQ+A D +RL
Sbjct: 445 LMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLAN 504
Query: 484 EEDVLLLDHIRKLLREDRLNDIVDRNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQV 542
++D++LLD ++++L+E +L +VD L Y EVE ++Q+ALLCTQS+ +RP M++V
Sbjct: 505 DDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEV 564
Query: 543 VKMLQGEDLAERWAEWEELE 562
V+ML+G+ LAERW EW++ E
Sbjct: 565 VRMLEGDGLAERWEEWQKEE 584
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 595 | ||||||
| 359480667 | 621 | PREDICTED: probable LRR receptor-like se | 0.996 | 0.954 | 0.763 | 0.0 | |
| 255568877 | 598 | ATP binding protein, putative [Ricinus c | 0.996 | 0.991 | 0.722 | 0.0 | |
| 356512884 | 596 | PREDICTED: probable LRR receptor-like se | 0.984 | 0.983 | 0.727 | 0.0 | |
| 356527105 | 595 | PREDICTED: probable LRR receptor-like se | 0.984 | 0.984 | 0.721 | 0.0 | |
| 224126743 | 595 | predicted protein [Populus trichocarpa] | 0.998 | 0.998 | 0.736 | 0.0 | |
| 224060473 | 594 | predicted protein [Populus trichocarpa] | 0.998 | 1.0 | 0.731 | 0.0 | |
| 357520193 | 597 | Plasma membrane receptor-like kinase [Me | 0.986 | 0.983 | 0.706 | 0.0 | |
| 297793957 | 614 | hypothetical protein ARALYDRAFT_496559 [ | 0.994 | 0.964 | 0.69 | 0.0 | |
| 10177052 | 579 | receptor-like protein kinase [Arabidopsi | 0.961 | 0.987 | 0.710 | 0.0 | |
| 18424740 | 614 | Leucine-rich repeat protein kinase famil | 0.978 | 0.947 | 0.699 | 0.0 |
| >gi|359480667|ref|XP_002272767.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g63710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 919 bits (2376), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/596 (76%), Positives = 512/596 (85%), Gaps = 3/596 (0%)
Query: 2 FGALHKCC--PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWND 59
FG L CC P L+ WLIL + L F +SS PDVEGEAL++ LK LND++ + TDWND
Sbjct: 27 FGLL-SCCLVPLKLILSWLILFVMLRFSYSSNGPDVEGEALVDFLKTLNDSNNRITDWND 85
Query: 60 HFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDF 119
HFVSPCFSWS+VTCRNGNVISL+L S GFSG +SPSITKLKFLASL+L+DN+LSG LPD+
Sbjct: 86 HFVSPCFSWSNVTCRNGNVISLSLASKGFSGTLSPSITKLKFLASLDLKDNNLSGALPDY 145
Query: 120 LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGT 179
L SM +LQ+L+LA N FSGSIP++W QLSN+KHLDLSSN+LTGRIP QLFSV TFNFTG
Sbjct: 146 LSSMINLQNLDLARNNFSGSIPSSWGQLSNIKHLDLSSNDLTGRIPEQLFSVPTFNFTGN 205
Query: 180 HLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKH 239
L CGSSL+QPC S + PVST ++KLR+V A C AF+LLSLGA+FA RY K+K
Sbjct: 206 RLTCGSSLQQPCASGSTIPVSTKKSKLRVVTPVAICAAFILLSLGAIFAYRYCYAHKIKR 265
Query: 240 DVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVA 299
DVF DV GED+CK+S Q+RRFS ELQLATD FSESNIIGQGGFGKVY+GVL + TKVA
Sbjct: 266 DVFHDVTGEDECKISFGQVRRFSWHELQLATDEFSESNIIGQGGFGKVYRGVLPNGTKVA 325
Query: 300 VKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRL 359
VKRL DY++PGGEAAFQREV LISVA+HKNLL+LIG+CTT +ERILVYPFMQNLSVAYRL
Sbjct: 326 VKRLSDYHNPGGEAAFQREVQLISVAVHKNLLRLIGFCTTFNERILVYPFMQNLSVAYRL 385
Query: 360 RDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419
RDLKPGE+GLDWPTR++VAFG A+GLEYLHE CNPKIIHRDLKAANILLDD+FE VL DF
Sbjct: 386 RDLKPGERGLDWPTRRKVAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDDFEPVLGDF 445
Query: 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479
GLAKL+D KLTHVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS
Sbjct: 446 GLAKLLDTKLTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 505
Query: 480 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 539
RLEEEEDVLLLDHIRKL RE RL+ IVDRNL T+D+KEVET+VQVALLCTQS+PEDRP M
Sbjct: 506 RLEEEEDVLLLDHIRKLQREKRLDAIVDRNLKTFDAKEVETIVQVALLCTQSSPEDRPKM 565
Query: 540 AQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 595
A+VV MLQGE LA RW EWE LEEVR Q SLL HQF W ++S+ DQEAIQLS AR
Sbjct: 566 AEVVSMLQGEGLAARWVEWERLEEVRNQHFSLLSHQFPWADESTHDQEAIQLSKAR 621
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568877|ref|XP_002525409.1| ATP binding protein, putative [Ricinus communis] gi|223535300|gb|EEF36976.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2319), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/595 (72%), Positives = 506/595 (85%), Gaps = 2/595 (0%)
Query: 1 MFGALHKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDH 60
MFGA P L+ LIL+ FL G+ S++PD+EGEALI++L ALND++ + DWN +
Sbjct: 6 MFGAASIWHPLKLVISCLILLNFLCVGYPSKDPDLEGEALIQLLSALNDSNHRVEDWNYY 65
Query: 61 FVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL 120
VSPCFSWSH+TCRNGNVISL+L +NGFSG +SP+ITKL+FL +LELQ+N+LSG LPD+L
Sbjct: 66 LVSPCFSWSHITCRNGNVISLSLAANGFSGTLSPAITKLRFLVNLELQNNNLSGPLPDYL 125
Query: 121 GSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTH 180
GS+THL++LNLA+NKF GSIP W +L NLKHLD+SSNNLTGR+P Q FSV FNFT T
Sbjct: 126 GSLTHLENLNLASNKFHGSIPIAWGKLFNLKHLDISSNNLTGRVPKQFFSVPEFNFTETS 185
Query: 181 LICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHD 240
L CGS LE+PC+S+ PVS ++++L I+V +ASCGAF+L LG FA R+ +LR+LK+D
Sbjct: 186 LTCGSRLEEPCVSKSPSPVSPNKSRLSIIVIAASCGAFILFLLG--FAYRHHRLRRLKND 243
Query: 241 VFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAV 300
VF DVAGEDD K+SL Q++RFS RE+QLATDNFS+SNIIGQGGFGKVYKGVLSDNTKVAV
Sbjct: 244 VFVDVAGEDDRKISLGQIKRFSWREIQLATDNFSDSNIIGQGGFGKVYKGVLSDNTKVAV 303
Query: 301 KRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 360
KRL D Y PGGEAAF REV +ISVA+H+NLL+LIG+CTTSSERILVYP+MQNLSVA+ LR
Sbjct: 304 KRLSDCYIPGGEAAFHREVQIISVAVHRNLLRLIGFCTTSSERILVYPYMQNLSVAFHLR 363
Query: 361 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420
+LKPGE GLDW TR+RVAFG A+GLEYLHE CNPKIIHRDLKAANILLDDNFEAVL DFG
Sbjct: 364 ELKPGETGLDWQTRRRVAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDNFEAVLGDFG 423
Query: 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
LA+LVD KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG+TLLELV G+RAID SR
Sbjct: 424 LARLVDTKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGVTLLELVNGKRAIDLSR 483
Query: 481 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 540
L EEEDVLLLDH +KLLRE+RL+DIVD NL TYD KEVET+V+VALLCTQS+PE RP M+
Sbjct: 484 LAEEEDVLLLDHAKKLLRENRLDDIVDGNLKTYDRKEVETLVKVALLCTQSSPECRPRMS 543
Query: 541 QVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 595
+VVK+L G L ERW EWE LE+ R Q+ SL+ Q+ W EDS++DQEAI LS AR
Sbjct: 544 EVVKLLHGVGLTERWIEWERLEDARNQDFSLMSCQYLWAEDSTVDQEAIHLSKAR 598
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356512884|ref|XP_003525144.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g63710-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2312), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/587 (72%), Positives = 498/587 (84%), Gaps = 1/587 (0%)
Query: 10 PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWS 69
P ++T+WLI + L G + ++PDVEGEAL++VL LND++ Q TDW+ VSPCFSWS
Sbjct: 10 PLKILTRWLIFLTILQVGCAIKDPDVEGEALLDVLHFLNDSNKQITDWDSFLVSPCFSWS 69
Query: 70 HVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSL 129
HVTCRNG+VISL L S GFSG +SPSITKLK+L+SLELQ+N+LSG LPD++ ++T LQ L
Sbjct: 70 HVTCRNGHVISLALASVGFSGTLSPSITKLKYLSSLELQNNNLSGPLPDYISNLTELQYL 129
Query: 130 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQ 189
NLA+N F+GSIPA W +L NLKHLDLSSN LTG IPMQLFSV FNF+ THL CG EQ
Sbjct: 130 NLADNSFNGSIPANWGELPNLKHLDLSSNGLTGSIPMQLFSVPLFNFSDTHLQCGPGFEQ 189
Query: 190 PCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHD-VFFDVAGE 248
C S+ P S ++KL +V ASCGAF LL LGA+F R+ + K D VF DV+GE
Sbjct: 190 SCASKSENPASAHKSKLAKIVRYASCGAFALLCLGAIFTYRHHRKHWRKSDDVFVDVSGE 249
Query: 249 DDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS 308
D+ K+ QLRRFS RELQLAT NFSE N+IGQGGFGKVYKGVLSDNTKVAVKRL DY++
Sbjct: 250 DESKIFFGQLRRFSWRELQLATKNFSEGNVIGQGGFGKVYKGVLSDNTKVAVKRLIDYHN 309
Query: 309 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 368
PGGEAAF+REV LISVA+H+NLL+LIG+CTT++ERILVYPFM+NLSVAYRLRDLKPGEKG
Sbjct: 310 PGGEAAFEREVQLISVAVHRNLLRLIGFCTTTTERILVYPFMENLSVAYRLRDLKPGEKG 369
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
LDWPTRKRVAFGTA+GLEYLHEQCNPKIIHRDLKAANILLDD FEAVL DFGLAKLVDA+
Sbjct: 370 LDWPTRKRVAFGTAHGLEYLHEQCNPKIIHRDLKAANILLDDEFEAVLGDFGLAKLVDAR 429
Query: 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
+THVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG+RAID SRLEE+EDVL
Sbjct: 430 MTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGERAIDLSRLEEDEDVL 489
Query: 489 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548
L+D+++KLLRE RL DIVDRNL +YD KEVET++QVALLCTQ PEDRP M++VVKMLQG
Sbjct: 490 LIDYVKKLLREKRLEDIVDRNLESYDPKEVETILQVALLCTQGYPEDRPTMSEVVKMLQG 549
Query: 549 EDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 595
LA+RWA+W++LEE R QE SL+ HQF W ++S++DQEAIQLS AR
Sbjct: 550 VGLADRWADWQQLEEARNQEFSLMTHQFVWNDESTLDQEAIQLSRAR 596
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356527105|ref|XP_003532154.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g63710-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2306), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/586 (72%), Positives = 496/586 (84%)
Query: 10 PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWS 69
P ++T+WLI + L + ++PDVEGEAL+++L LND++ Q TDW+ VSPCFSWS
Sbjct: 10 PLKILTRWLIFLTILQVSCAIKDPDVEGEALLDLLHFLNDSNKQITDWDSFLVSPCFSWS 69
Query: 70 HVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSL 129
HVTCRNG+VISL L S GFSG +SPSI KLK+L+SLELQ+N+LSG LPD++ ++T LQ L
Sbjct: 70 HVTCRNGHVISLALASVGFSGTLSPSIIKLKYLSSLELQNNNLSGPLPDYISNLTELQYL 129
Query: 130 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQ 189
NLA+N F+GSIPA W ++ NLKHLDLSSN LTG IP QLFSV FNFT T L CG EQ
Sbjct: 130 NLADNNFNGSIPAKWGEVPNLKHLDLSSNGLTGSIPKQLFSVPLFNFTDTQLQCGPGFEQ 189
Query: 190 PCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGED 249
PC S+ P S ++KL +V ASCGAF LL LGA+F R + + K DVF DV+GED
Sbjct: 190 PCASKSENPASAHKSKLAKIVRYASCGAFALLCLGAIFTYRQHQKHRRKIDVFVDVSGED 249
Query: 250 DCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP 309
+ K+S QLRRFS RELQLAT NFSE N+IGQGGFGKVYKGVLSDNTKVAVKRL DY++P
Sbjct: 250 ERKISFGQLRRFSWRELQLATKNFSEGNVIGQGGFGKVYKGVLSDNTKVAVKRLIDYHNP 309
Query: 310 GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL 369
GGEAAF+REV LISVA+H+NLL+LIG+CTT++ERILVYPFM+NLSVAYRLRDLKPGEKGL
Sbjct: 310 GGEAAFEREVQLISVAVHRNLLRLIGFCTTTTERILVYPFMENLSVAYRLRDLKPGEKGL 369
Query: 370 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
DWPTRKRVAFGTA+GLEYLHEQCNPKIIHRDLKAANILLDD FEAVL DFGLAKLVDA++
Sbjct: 370 DWPTRKRVAFGTAHGLEYLHEQCNPKIIHRDLKAANILLDDEFEAVLGDFGLAKLVDARM 429
Query: 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489
THVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG+RA+D SRLEE+EDVLL
Sbjct: 430 THVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGERALDLSRLEEDEDVLL 489
Query: 490 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549
+D+++KLLRE RL DIVDRNL +YD KEVET++QVALLCTQ PEDRP M++VVKMLQG
Sbjct: 490 IDYVKKLLREKRLEDIVDRNLESYDPKEVETILQVALLCTQGYPEDRPTMSEVVKMLQGV 549
Query: 550 DLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 595
LA+RWA+W++LEE R QE SL+ HQF W ++S++DQEAIQLS AR
Sbjct: 550 GLADRWADWQQLEEARNQEFSLMTHQFVWNDESTLDQEAIQLSRAR 595
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126743|ref|XP_002329462.1| predicted protein [Populus trichocarpa] gi|222870142|gb|EEF07273.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2266), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/596 (73%), Positives = 505/596 (84%), Gaps = 2/596 (0%)
Query: 1 MFGALHKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDH 60
MFG P L+ LIL+ FL S++EPD EG AL ++L ALND++ Q +W+ +
Sbjct: 1 MFGVFSLWNPLKLVINCLILLNFLKITISTKEPDTEGNALRDLLLALNDSNRQI-NWDTN 59
Query: 61 FVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL 120
VSPCFSW+HV CRNG+V SL+L S GFSG +SP+I KL+FL +LELQ+N LSG LPD+L
Sbjct: 60 LVSPCFSWTHVICRNGHVESLSLNSLGFSGTLSPAIMKLEFLVTLELQNNSLSGPLPDYL 119
Query: 121 GSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTH 180
G+M HLQ+LNLA+NKFSGSIP TW QLSNLK+LDLSSNNLTGRIP +LFSVA FNFT TH
Sbjct: 120 GNMVHLQNLNLASNKFSGSIPTTWGQLSNLKNLDLSSNNLTGRIPGKLFSVAMFNFTATH 179
Query: 181 LICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHD 240
L CG SLE+PC+S VSTS+++L+++ SASCGAF+LL L A+ A RY + K K+D
Sbjct: 180 LACGLSLEEPCISGSPLRVSTSKSRLKVIATSASCGAFILLILVAVLAYRYHQFHKEKND 239
Query: 241 VFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAV 300
+F DVAGEDD K++ QLRRFS RELQLATDNFSESNIIGQGG GKVYKG+LSDN KVAV
Sbjct: 240 IFVDVAGEDDRKITFGQLRRFSWRELQLATDNFSESNIIGQGGCGKVYKGILSDNMKVAV 299
Query: 301 KRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 360
KRL DYYSPGGEAAFQREV LISVA HKNLL+L+G+CTTSSERILVYP+MQNLSVAYRLR
Sbjct: 300 KRLADYYSPGGEAAFQREVQLISVAFHKNLLKLVGFCTTSSERILVYPYMQNLSVAYRLR 359
Query: 361 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420
+LKPGEKGLDWPTRK++AFG A+GLEYLHE CNPKIIHRDLKAANILLDDNFEAVL DFG
Sbjct: 360 ELKPGEKGLDWPTRKKIAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDNFEAVLGDFG 419
Query: 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
LAKLVD K THVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID SR
Sbjct: 420 LAKLVDTKFTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDLSR 479
Query: 481 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 540
LEEEE+VLLLDHI+KLLRE+RL+DIVD NL TYD KEVET+VQVALLCT S+PE RP M
Sbjct: 480 LEEEEEVLLLDHIKKLLRENRLDDIVDGNLKTYDRKEVETIVQVALLCTNSSPEGRPKME 539
Query: 541 QVVKMLQGEDLAERWAEWEELEEVRQQEVS-LLPHQFAWGEDSSIDQEAIQLSNAR 595
+VVKML+G LAERWA+WE+LE+ Q+++ L+ Q+ W EDSSIDQEAIQLS AR
Sbjct: 540 EVVKMLRGIGLAERWAKWEQLEDAMNQDLAVLMSQQYIWAEDSSIDQEAIQLSRAR 595
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224060473|ref|XP_002300217.1| predicted protein [Populus trichocarpa] gi|222847475|gb|EEE85022.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 870 bits (2248), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/595 (73%), Positives = 504/595 (84%), Gaps = 1/595 (0%)
Query: 1 MFGALHKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDH 60
MFG P L+ L+L+ FL +SS+EPD EG AL ++L ALND++GQ DW+ +
Sbjct: 1 MFGVFSIRNPLKLVINCLVLLNFLQIINSSKEPDTEGGALRDLLLALNDSNGQI-DWDPN 59
Query: 61 FVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL 120
VSPC+SW++V C+NG+V+ L+L S G SG +SP+ITKLKFL SLEL++N+LSG+LPD+L
Sbjct: 60 LVSPCYSWTNVYCKNGHVVFLSLNSLGLSGTLSPAITKLKFLVSLELRNNNLSGSLPDYL 119
Query: 121 GSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTH 180
G+M L++LNLA+NKFSGSIP TW QLSNLK LD+SSNNLTGRIP +LFSVATFNFT T+
Sbjct: 120 GNMVQLKNLNLASNKFSGSIPDTWDQLSNLKFLDVSSNNLTGRIPDKLFSVATFNFTATY 179
Query: 181 LICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHD 240
+ CG S E+PC+SR PVST + +L+++ ASASCGAF LL L + A RYQ+ K K+D
Sbjct: 180 IACGLSFEEPCLSRSPLPVSTRKLRLKVIAASASCGAFGLLILLVVLAYRYQQFHKEKND 239
Query: 241 VFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAV 300
+F DV+GEDD K+S QLRRFS RELQLATDNFSESNIIGQGGFGKVYKG++SDN KVAV
Sbjct: 240 IFVDVSGEDDRKISFGQLRRFSWRELQLATDNFSESNIIGQGGFGKVYKGIISDNMKVAV 299
Query: 301 KRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 360
KRL+DYYSPGG+AAF REV LISVA HKNLL+LIG+CTTSSERILVYP+MQNLSVAY LR
Sbjct: 300 KRLEDYYSPGGKAAFLREVQLISVAAHKNLLRLIGFCTTSSERILVYPYMQNLSVAYHLR 359
Query: 361 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420
DLKPGEKGLDWPTRKR+AFG A+GLEYLHE CNPKIIHRDLKAANILLDDNFE VL DFG
Sbjct: 360 DLKPGEKGLDWPTRKRIAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDNFEPVLGDFG 419
Query: 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
LAKLVD K TH+TTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID SR
Sbjct: 420 LAKLVDTKFTHITTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDLSR 479
Query: 481 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 540
LEEEEDVLLLD+I+KLLRE+RL+D+VD NL TYD KEVET+VQVALLCTQS+PE RP MA
Sbjct: 480 LEEEEDVLLLDYIKKLLRENRLDDVVDGNLETYDRKEVETIVQVALLCTQSSPEGRPTMA 539
Query: 541 QVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 595
VVKMLQG LAERWA+ E+ + R QE SL+ Q+ W EDSSIDQEAIQLS AR
Sbjct: 540 GVVKMLQGIGLAERWAKREQHGDARNQEFSLMSQQYIWSEDSSIDQEAIQLSKAR 594
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357520193|ref|XP_003630385.1| Plasma membrane receptor-like kinase [Medicago truncatula] gi|194441092|gb|ACF70844.1| plasma membrane receptor-like kinase [Medicago truncatula] gi|355524407|gb|AET04861.1| Plasma membrane receptor-like kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 869 bits (2246), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/589 (70%), Positives = 499/589 (84%), Gaps = 2/589 (0%)
Query: 9 CPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSW 68
P ++ +W I ++ L + ++PD+EGEAL+++L LND++ Q DW+ H VSPCFSW
Sbjct: 9 APFKILMRWFIFLVVLKLSSAIKDPDIEGEALLDLLNYLNDSNNQIQDWDSHLVSPCFSW 68
Query: 69 SHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128
SHVTCRNG+VISLTL S GFSG +SPSIT+LK+L +LELQ+N+LSG +PD++ ++T LQ
Sbjct: 69 SHVTCRNGHVISLTLASIGFSGTLSPSITRLKYLVNLELQNNNLSGPIPDYISNLTDLQY 128
Query: 129 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLE 188
LNLANN F+GSIP +W QLS+LK++DLSSN LTG IP QLFSV FNF+ T L CGSS +
Sbjct: 129 LNLANNNFNGSIPVSWGQLSSLKNVDLSSNGLTGTIPTQLFSVPMFNFSDTPLDCGSSFD 188
Query: 189 QPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGE 248
QPC+S+ P ST+++KL + ASCGAFVLL LGA+F R+ + + K DVF DV GE
Sbjct: 189 QPCVSKSDHPASTNKSKLAKAMPYASCGAFVLLCLGAIFTYRHHQKIRHKSDVFVDVLGE 248
Query: 249 DDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS 308
D+ K+S QLRRFS RELQLAT +FSESN+IGQGGFGKVYKGVLSDNTK+AVKRL DY++
Sbjct: 249 DESKISFGQLRRFSLRELQLATKSFSESNVIGQGGFGKVYKGVLSDNTKIAVKRLTDYHN 308
Query: 309 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 368
PGGEAAF+REV LISVA+H+NLL+LIG+CTTS+ERILVYPFM+NLSVAY+LRDLK EKG
Sbjct: 309 PGGEAAFEREVDLISVAVHRNLLRLIGFCTTSTERILVYPFMENLSVAYQLRDLKSDEKG 368
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
LDWPTRKRVAFGTA+GLEYLHEQCNPKIIHRDLKAANILLDD FE VL DFGLAKLVDA+
Sbjct: 369 LDWPTRKRVAFGTAHGLEYLHEQCNPKIIHRDLKAANILLDDEFEPVLGDFGLAKLVDAR 428
Query: 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
+THVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL+TGQRAID SRLEEEEDVL
Sbjct: 429 MTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELITGQRAIDLSRLEEEEDVL 488
Query: 489 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548
L+DH++ L+RE+RL DIVD NL TYD KE ET++QVALLCTQ PEDRP M++VVKMLQG
Sbjct: 489 LIDHVKNLIRENRLEDIVDNNLETYDPKEAETILQVALLCTQGYPEDRPTMSEVVKMLQG 548
Query: 549 EDLAERWAEWEELEEVRQQEV--SLLPHQFAWGEDSSIDQEAIQLSNAR 595
LA+RWA+W++LEE R QE+ SL+ HQF W ++S++DQEAIQLS AR
Sbjct: 549 VGLADRWADWKQLEEARNQEIELSLMTHQFPWSDESTLDQEAIQLSRAR 597
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793957|ref|XP_002864863.1| hypothetical protein ARALYDRAFT_496559 [Arabidopsis lyrata subsp. lyrata] gi|297310698|gb|EFH41122.1| hypothetical protein ARALYDRAFT_496559 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 835 bits (2157), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/600 (69%), Positives = 498/600 (83%), Gaps = 8/600 (1%)
Query: 3 GALHKCC----PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWN 58
G +H+ C L+ + + + F+ S+ +PD+EG AL+++ +LND+ + W
Sbjct: 16 GFIHRNCFRWNNQKLILQCFMALAFVGVTSSTTQPDIEGGALLQLRDSLNDSSNRL-KWT 74
Query: 59 DHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD 118
FVSPC+SWS+VTCR +V++L L SNGF+G +SP+ITKLKFL +LELQ+N LSG LP+
Sbjct: 75 RDFVSPCYSWSYVTCRGQSVVALNLASNGFTGTLSPAITKLKFLVTLELQNNSLSGALPE 134
Query: 119 FLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 178
LG+M +LQ+LNL+ N FSGSIPA+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+G
Sbjct: 135 SLGNMVNLQTLNLSMNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSG 194
Query: 179 THLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLK 238
T LICG SL QPC S PV++S+ KLR + +ASC A ++L LGA+ + ++R+ K
Sbjct: 195 TQLICGKSLNQPCSSSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRQTK 254
Query: 239 HDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV 298
+D+FFDVAGEDD K+S QLRRFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKV
Sbjct: 255 YDIFFDVAGEDDRKISFGQLRRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKV 314
Query: 299 AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYR 358
AVKRL DY+SPGGEAAFQRE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYR
Sbjct: 315 AVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYR 374
Query: 359 LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418
LRDLK GE+GLDWPTRKRVAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL D
Sbjct: 375 LRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGD 434
Query: 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478
FGLAKLVD LTHVTTQ+RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDF
Sbjct: 435 FGLAKLVDTSLTHVTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDF 494
Query: 479 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 538
SRLEEEE++LLLDHI+KLLRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP
Sbjct: 495 SRLEEEENILLLDHIKKLLREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPA 554
Query: 539 MAQVVKMLQGE-DLAERWAEWEELEEVRQQEVSLLPHQFA-WG-EDSSIDQEAIQLSNAR 595
M++VVKMLQG LAE+W EWE+LEEVR +E LLP A W E++++DQE+I+LS AR
Sbjct: 555 MSEVVKMLQGTGGLAEKWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSAAR 614
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10177052|dbj|BAB10464.1| receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 834 bits (2155), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/576 (71%), Positives = 488/576 (84%), Gaps = 4/576 (0%)
Query: 23 FLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLT 82
F+ S+ +PD+EG AL+++ +LND+ + W FVSPC+SWS+VTCR +V++L
Sbjct: 5 FVGITSSTTQPDIEGGALLQLRDSLNDSSNRL-KWTRDFVSPCYSWSYVTCRGQSVVALN 63
Query: 83 LGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 142
L S+GF+G +SP+ITKLKFL +LELQ+N LSG LPD LG+M +LQ+LNL+ N FSGSIPA
Sbjct: 64 LASSGFTGTLSPAITKLKFLVTLELQNNSLSGALPDSLGNMVNLQTLNLSVNSFSGSIPA 123
Query: 143 TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVSTS 202
+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+GT LICG SL QPC S PV++S
Sbjct: 124 SWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPCSSSSRLPVTSS 183
Query: 203 RTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFS 262
+ KLR + +ASC A ++L LGA+ + ++R+ K+D+FFDVAGEDD K+S QL+RFS
Sbjct: 184 KKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRKISFGQLKRFS 243
Query: 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLI 322
RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGEAAFQRE+ LI
Sbjct: 244 LREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGEAAFQREIQLI 303
Query: 323 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
SVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWPTRKRVAFG+A
Sbjct: 304 SVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWPTRKRVAFGSA 363
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442
+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD LTHVTTQ+RGTMGH
Sbjct: 364 HGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHVTTQVRGTMGH 423
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502
IAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLDHI+KLLRE RL
Sbjct: 424 IAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDHIKKLLREQRL 483
Query: 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE-DLAERWAEWEEL 561
DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG LAE+W EWE+L
Sbjct: 484 RDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGLAEKWTEWEQL 543
Query: 562 EEVRQQEVSLLPHQFA-WG-EDSSIDQEAIQLSNAR 595
EEVR +E LLP A W E++++DQE+I+LS AR
Sbjct: 544 EEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 579
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18424740|ref|NP_568977.1| Leucine-rich repeat protein kinase family protein [Arabidopsis thaliana] gi|75331406|sp|Q8W4S5.1|Y5371_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At5g63710; Flags: Precursor gi|16974577|gb|AAL31184.1| AT5g63710/MBK5_19 [Arabidopsis thaliana] gi|22655394|gb|AAM98289.1| At5g63710/MBK5_19 [Arabidopsis thaliana] gi|224589745|gb|ACN59404.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332010405|gb|AED97788.1| Leucine-rich repeat protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2151), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/586 (69%), Positives = 493/586 (84%), Gaps = 4/586 (0%)
Query: 13 LMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVT 72
L+ + + + F+ S+ +PD+EG AL+++ +LND+ + W FVSPC+SWS+VT
Sbjct: 30 LILQCFMALAFVGITSSTTQPDIEGGALLQLRDSLNDSSNRL-KWTRDFVSPCYSWSYVT 88
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
CR +V++L L S+GF+G +SP+ITKLKFL +LELQ+N LSG LPD LG+M +LQ+LNL+
Sbjct: 89 CRGQSVVALNLASSGFTGTLSPAITKLKFLVTLELQNNSLSGALPDSLGNMVNLQTLNLS 148
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCM 192
N FSGSIPA+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+GT LICG SL QPC
Sbjct: 149 VNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPCS 208
Query: 193 SRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCK 252
S PV++S+ KLR + +ASC A ++L LGA+ + ++R+ K+D+FFDVAGEDD K
Sbjct: 209 SSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRK 268
Query: 253 VSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE 312
+S QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGE
Sbjct: 269 ISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGE 328
Query: 313 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 372
AAFQRE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWP
Sbjct: 329 AAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWP 388
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
TRKRVAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD LTHV
Sbjct: 389 TRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHV 448
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492
TTQ+RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLDH
Sbjct: 449 TTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDH 508
Query: 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE-DL 551
I+KLLRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG L
Sbjct: 509 IKKLLREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGL 568
Query: 552 AERWAEWEELEEVRQQEVSLLPHQFA-WG-EDSSIDQEAIQLSNAR 595
AE+W EWE+LEEVR +E LLP A W E++++DQE+I+LS AR
Sbjct: 569 AEKWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 614
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 595 | ||||||
| TAIR|locus:2160644 | 614 | AT5G63710 [Arabidopsis thalian | 0.978 | 0.947 | 0.655 | 4.4e-203 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.870 | 0.845 | 0.555 | 6.2e-149 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.867 | 0.825 | 0.469 | 3e-117 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.887 | 0.878 | 0.451 | 1.8e-112 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.867 | 0.821 | 0.461 | 3.6e-112 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.788 | 0.742 | 0.475 | 2.6e-109 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.776 | 0.728 | 0.489 | 7e-109 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.786 | 0.754 | 0.482 | 9e-109 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.781 | 0.717 | 0.485 | 2.7e-107 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.776 | 0.724 | 0.481 | 5.1e-106 |
| TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1965 (696.8 bits), Expect = 4.4e-203, P = 4.4e-203
Identities = 384/586 (65%), Positives = 460/586 (78%)
Query: 13 LMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVT 72
L+ + + + F+ S+ +PD+EG AL+++ +LND+ + W FVSPC+SWS+VT
Sbjct: 30 LILQCFMALAFVGITSSTTQPDIEGGALLQLRDSLNDSSNRLK-WTRDFVSPCYSWSYVT 88
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
CR +V++L L S+GF+G +SP+ITKLKFL +LELQ+N LSG LPD LG+M +LQ+LNL+
Sbjct: 89 CRGQSVVALNLASSGFTGTLSPAITKLKFLVTLELQNNSLSGALPDSLGNMVNLQTLNLS 148
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCM 192
N FSGSIPA+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+GT LICG SL QPC
Sbjct: 149 VNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPCS 208
Query: 193 XXXXXXXXXXXXKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCK 252
KLR + +ASC A ++L LGA+ + ++R+ K+D+FFDVAGEDD K
Sbjct: 209 SSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRK 268
Query: 253 VSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE 312
+S QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGE
Sbjct: 269 ISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGE 328
Query: 313 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 372
AAFQRE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWP
Sbjct: 329 AAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWP 388
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
TRKRVAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD LTHV
Sbjct: 389 TRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHV 448
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXH 492
TTQ+RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSR H
Sbjct: 449 TTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDH 508
Query: 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDXX 552
I+KLLRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG
Sbjct: 509 IKKLLREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGL 568
Query: 553 XXXXXXXXXXXXXXXXXSLL-PHQFA-WGED-SSIDQEAIQLSNAR 595
+LL P A W E+ +++DQE+I+LS AR
Sbjct: 569 AEKWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 614
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1454 (516.9 bits), Expect = 6.2e-149, P = 6.2e-149
Identities = 289/520 (55%), Positives = 366/520 (70%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ +LTL NG +G+I L L SL+L+DN L+G +P +G++ LQ L L+ NK
Sbjct: 95 NLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPSTIGNLKKLQFLTLSRNKL 154
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMXXXX 196
+G+IP + + L NL +L L SN+L+G+IP LF + +NFT +L CG PC+
Sbjct: 155 NGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTSNNLNCGGRQPHPCVSAVA 214
Query: 197 XXXXXXXXKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLT 256
K I+ + VL + C+ + + + DVF DVAGE D +++
Sbjct: 215 HSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCK-DRHKGYRRDVFVDVAGEVDRRIAFG 273
Query: 257 QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ 316
QL+RF+ RELQLATDNFSE N++GQGGFGKVYKGVL DNTKVAVKRL D+ SPGG+AAFQ
Sbjct: 274 QLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQ 333
Query: 317 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR 376
REV +ISVA+H+NLL+LIG+CTT +ER+LVYPFMQNLS+A+RLR++K G+ LDW TRKR
Sbjct: 334 REVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKR 393
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
+A G A G EYLHE CNPKIIHRD+KAAN+LLD++FEAV+ DFGLAKLVD + T+VTTQ+
Sbjct: 394 IALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQV 453
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKL 496
RGTMGHIAPEYLSTGKSSE+TDVFGYGI LLELVTGQRAIDFSR H++KL
Sbjct: 454 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 513
Query: 497 LREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDXXXXX 555
RE RL IVD+NL+ Y +EVE M+QVALLCTQ +PEDRP M++VV+ML+GE
Sbjct: 514 EREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAERW 573
Query: 556 XXXXXXXXXXXXXXSLLPHQFAWGEDSSIDQEAIQLSNAR 595
L +F WGEDS +Q+AI+LS R
Sbjct: 574 EEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1155 (411.6 bits), Expect = 3.0e-117, P = 3.0e-117
Identities = 251/535 (46%), Positives = 341/535 (63%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L SN +G I ++ L L SL+L N SG +P+ LG ++ L+ L L NN
Sbjct: 94 NLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESLGKLSKLRFLRLNNNSL 153
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-LFSVAT-FNFTGTHLICGSSLEQPC--- 191
+GSIP + + ++ L+ LDLS+N L+G +P FS+ T +F +CG PC
Sbjct: 154 TGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSHPCPGS 213
Query: 192 ---------MXXXXXXXXXXXXKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVF 242
+ + + GA +L + A+ +++ + L D+F
Sbjct: 214 PPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAALLFAAPAIAFAWWRRRKPL--DIF 271
Query: 243 FDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKR 302
FDV E+D +V L QL+RFS RELQ+A+D FS NI+G+GGFGKVYKG L+D T VAVKR
Sbjct: 272 FDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKR 331
Query: 303 LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL 362
L++ +PGGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 332 LKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 391
Query: 363 KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422
P + LDWPTRKR+A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEAV+ DFGLA
Sbjct: 392 PPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 451
Query: 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXX 482
KL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYGI LLEL+TGQRA D +R
Sbjct: 452 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA 511
Query: 483 XXXXXXXXXHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQ 541
++ LL+E +L +VD +L T Y+ +E+E ++QVALLCTQ +P +RP M++
Sbjct: 512 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSE 571
Query: 542 VVKMLQGEDXXXXXXXXXXXXXXXXXXXSLLPHQFA-WGEDSSIDQEAIQLSNAR 595
VV+ML+G D L P+ + W DS+ + A++LS R
Sbjct: 572 VVRMLEG-DGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVELSGPR 625
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1110 (395.8 bits), Expect = 1.8e-112, P = 1.8e-112
Identities = 247/547 (45%), Positives = 343/547 (62%)
Query: 17 WLILVIFLNFGHSSREPDVEGEALIEVLKALND---THGQFTDWNDHFVSPCFSWSHVTC 73
WLIL FL+F S + +ALI + +L+ T+ WN V+PC SW HVTC
Sbjct: 11 WLIL--FLDFV-SRVTGKTQVDALIALRSSLSSGDHTNNILQSWNATHVTPC-SWFHVTC 66
Query: 74 RNGNVIS-LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
N ++ L LGS SG++ P + +L L LEL +N+++G +P+ LG + L SL+L
Sbjct: 67 NTENSVTRLDLGSANLSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLF 126
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL-------FSVATFNFTGTHLICGS 185
N SG IP++ +L L+ L L +N+L+G IP L ++ +G + GS
Sbjct: 127 ANNISGPIPSSLGKLGKLRFLRLYNNSLSGEIPRSLTALPLDVLDISNNRLSGDIPVNGS 186
Query: 186 SLEQPCMXXXXXXXXXXXXKLRIVVASASCGAFVLLSLGA--LFACRYQKLRKLKHDVFF 243
+ M + S V ++ GA LFA + RKL+ F
Sbjct: 187 FSQFTSMSFANNKLRPRPASPSPSPSGTSAAIVVGVAAGAALLFALAWWLRRKLQGH-FL 245
Query: 244 DVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRL 303
DV E+D +V L Q +RFS REL +AT+ FS+ N++G+G FG +YKG L+D+T VAVKRL
Sbjct: 246 DVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRL 305
Query: 304 QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK 363
+ + GGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 306 NEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 365
Query: 364 PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423
G LDWP RK +A G+A GL YLH+ C+ KIIH D+KAANILLD+ FEAV+ DFGLAK
Sbjct: 366 EGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAK 425
Query: 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXX 483
L++ +HVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQ+A D +R
Sbjct: 426 LMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLAN 485
Query: 484 XXXXXXXXHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQV 542
++++L+E +L +VD L Y EVE ++Q+ALLCTQS+ +RP M++V
Sbjct: 486 DDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEV 545
Query: 543 VKMLQGE 549
V+ML+G+
Sbjct: 546 VRMLEGD 552
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1107 (394.7 bits), Expect = 3.6e-112, P = 3.6e-112
Identities = 247/535 (46%), Positives = 332/535 (62%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L SN +G + + L L SL+L N +G +PD LG + L+ L L NN
Sbjct: 97 NLQYLELYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKLRFLRLNNNSL 156
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-LFSVAT-FNFTGTHLICGSSLEQPCMXX 194
+G IP + + + L+ LDLS+N L+G +P FS+ T +F +CG +PC
Sbjct: 157 TGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSRPCPGS 216
Query: 195 XXXX------------XXXXXXKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVF 242
+ + GA +L + AL A + + RK + F
Sbjct: 217 PPFSPPPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPAL-AFAWWRRRK-PQEFF 274
Query: 243 FDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKR 302
FDV E+D +V L QL+RFS RELQ+ATD+FS NI+G+GGFGKVYKG L+D T VAVKR
Sbjct: 275 FDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKR 334
Query: 303 LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL 362
L++ +PGGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 335 LKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 394
Query: 363 KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422
P + L W R+++A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEAV+ DFGLA
Sbjct: 395 PPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 454
Query: 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXX 482
+L+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYGI LLEL+TGQRA D +R
Sbjct: 455 RLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLA 514
Query: 483 XXXXXXXXXHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQ 541
++ LL+E +L +VD +L + Y EVE ++QVALLCTQS+P +RP M++
Sbjct: 515 NDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSE 574
Query: 542 VVKMLQGEDXXXXXXXXXXXXXXXXXXXSLLPHQFA-WGEDSSIDQEAIQLSNAR 595
VV+ML+G D L H + W DS+ + A++LS R
Sbjct: 575 VVRMLEG-DGLAEKWDEWQKVEVLRQEVELSSHPTSDWILDSTDNLHAMELSGPR 628
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1080 (385.2 bits), Expect = 2.6e-109, P = 2.6e-109
Identities = 234/492 (47%), Positives = 324/492 (65%)
Query: 74 RNGNVI---SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLN 130
R GN+ S+ L +N +G I +I +L+ L SL+L +N +G +P LG + +L L
Sbjct: 93 RIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIPASLGELKNLNYLR 152
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICG------ 184
L NN G+ P + S++ L +D+S NNL+G +P S TF G LICG
Sbjct: 153 LNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPK--VSARTFKVIGNALICGPKAVSN 210
Query: 185 -SSLEQPCMXXXX----XXXXXXXXKLRIV-VASASCGAFVLLSLGALFACRYQKLRKLK 238
S++ +P + + AS S FV + G RY++ ++
Sbjct: 211 CSAVPEPLTLPQDGPDESGTRTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYRRNKQ-- 268
Query: 239 HDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV 298
+FFDV + D +VSL L+R++ +EL+ AT++F+ NI+G+GG+G VYKG L+D T V
Sbjct: 269 --IFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLV 326
Query: 299 AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYR 358
AVKRL+D GGE FQ EV IS+A+H+NLL+L G+C+++ ERILVYP+M N SVA R
Sbjct: 327 AVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASR 386
Query: 359 LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418
L+D GE LDW RK++A GTA GL YLHEQC+PKIIHRD+KAANILLD++FEAV+ D
Sbjct: 387 LKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 446
Query: 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478
FGLAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TGQ+A+DF
Sbjct: 447 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDF 506
Query: 479 SRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRP 537
R ++KL +E +L ++D++LN +D E+E +VQVALLCTQ P RP
Sbjct: 507 GRSAHQKGVMLDW-VKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRP 565
Query: 538 PMAQVVKMLQGE 549
M++V+KML+G+
Sbjct: 566 KMSEVMKMLEGD 577
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1076 (383.8 bits), Expect = 7.0e-109, P = 7.0e-109
Identities = 237/484 (48%), Positives = 312/484 (64%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ ++L +N SGKI P I L L +L+L +N SG +P + +++LQ L L NN
Sbjct: 99 NLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNRFSGEIPGSVNQLSNLQYLRLNNNSL 158
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPC----- 191
SG PA+ SQ+ +L LDLS NNL G +P F TFN G LIC +SL + C
Sbjct: 159 SGPFPASLSQIPHLSFLDLSYNNLRGPVPK--FPARTFNVAGNPLICKNSLPEICSGSIS 216
Query: 192 ---MXXXXXXXXXXXXKLRIVVASASCG--AFVLLSLGALFACRYQKLRKLKHDVFFDVA 246
+ + V S G V+LSLG F +K R+L D
Sbjct: 217 ASPLSVSLRSSSGRRTNILAVALGVSLGFAVSVILSLG--FIWYRKKQRRLTMLRISDK- 273
Query: 247 GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY 306
+++ + L LR F+ REL +ATD FS +I+G GGFG VY+G D T VAVKRL+D
Sbjct: 274 -QEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDV 332
Query: 307 YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE 366
G + F+ E+ +IS+A+H+NLL+LIGYC +SSER+LVYP+M N SVA RL+ KP
Sbjct: 333 NGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLK-AKPA- 390
Query: 367 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
LDW TRK++A G A GL YLHEQC+PKIIHRD+KAANILLD+ FEAV+ DFGLAKL++
Sbjct: 391 --LDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLN 448
Query: 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXX 486
+ +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TG RA++F +
Sbjct: 449 HEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKG 508
Query: 487 XXXXXHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545
+RKL +E ++ ++VDR L T YD EV M+QVALLCTQ P RP M++VV+M
Sbjct: 509 AMLEW-VRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQM 567
Query: 546 LQGE 549
L+G+
Sbjct: 568 LEGD 571
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1075 (383.5 bits), Expect = 9.0e-109, P = 9.0e-109
Identities = 230/477 (48%), Positives = 313/477 (65%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L SN +G+I + L L SL+L N +SG +P LG + L+ L L NN
Sbjct: 100 NLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKLRFLRLNNNSL 159
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-LFSVAT-FNFTGTHLICGSSLEQPCMXX 194
SG IP T + + L+ LD+S+N L+G IP+ FS+ T +F L E P
Sbjct: 160 SGEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANNSLT--DLPEPPPTST 216
Query: 195 XXXXXXXXXXKLRIVVASA-SCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKV 253
++ +A + GA +L ++ A+ + LR+ D FFDV E+D +V
Sbjct: 217 SPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWW--LRRKPQDHFFDVPAEEDPEV 274
Query: 254 SLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA 313
L QL+RF+ REL +ATDNFS N++G+GGFGKVYKG L+D VAVKRL++ + GGE
Sbjct: 275 HLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGEL 334
Query: 314 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+ G LDWP
Sbjct: 335 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPK 394
Query: 374 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433
RK +A G+A GL YLH+ C+ KIIHRD+KAANILLD+ FEAV+ DFGLAKL++ +HVT
Sbjct: 395 RKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVT 454
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHI 493
T +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQ+A D +R +
Sbjct: 455 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWV 514
Query: 494 RKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549
+++L+E +L +VD L Y EVE ++Q+ALLCTQS+ +RP M++VV+ML+G+
Sbjct: 515 KEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGD 571
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1061 (378.5 bits), Expect = 2.7e-107, P = 2.7e-107
Identities = 234/482 (48%), Positives = 308/482 (63%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ ++L +N SGKI P + L L +L+L +N SG +P + ++ LQ L L NN
Sbjct: 102 NLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRFSGDIPVSIDQLSSLQYLRLNNNSL 161
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMXXXX 196
SG PA+ SQ+ +L LDLS NNL+G +P F TFN G LIC S+ + C
Sbjct: 162 SGPFPASLSQIPHLSFLDLSYNNLSGPVPK--FPARTFNVAGNPLICRSNPPEICSGSIN 219
Query: 197 XX-------XXXXXXKLRIVVA-SASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGE 248
R+ +A S S G+ V+L L C Y+K ++ + + E
Sbjct: 220 ASPLSVSLSSSSGRRSNRLAIALSVSLGSVVILVLALGSFCWYRKKQRRLLILNLNDKQE 279
Query: 249 DDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS 308
+ + L LR F+ REL + TD FS NI+G GGFG VY+G L D T VAVKRL+D
Sbjct: 280 EGLQ-GLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDING 338
Query: 309 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 368
G++ F+ E+ +IS+A+HKNLL+LIGYC TS ER+LVYP+M N SVA +L+ KP
Sbjct: 339 TSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKS-KPA--- 394
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
LDW RKR+A G A GL YLHEQC+PKIIHRD+KAANILLD+ FEAV+ DFGLAKL++
Sbjct: 395 LDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHA 454
Query: 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXX 488
+HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TG RA++F +
Sbjct: 455 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGAM 514
Query: 489 XXXHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+RKL E ++ +++DR L T YD EV M+QVALLCTQ P RP M++VV ML+
Sbjct: 515 LEW-VRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLMLE 573
Query: 548 GE 549
G+
Sbjct: 574 GD 575
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1049 (374.3 bits), Expect = 5.1e-106, P = 5.1e-106
Identities = 237/492 (48%), Positives = 312/492 (63%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ + L +N GKI I +L L +L+L DN G +P +G + LQ L L NN
Sbjct: 106 NLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQYLRLNNNSL 165
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMXXXX 196
SG P + S ++ L LDLS NNL+G +P F+ TF+ G LIC + E C
Sbjct: 166 SGVFPLSLSNMTQLAFLDLSYNNLSGPVPR--FAAKTFSIVGNPLICPTGTEPDCNGTTL 223
Query: 197 X--------------XXXXXXXKLRIVVASASCGAFVLLSLGA-LFACRYQKLRKLKHDV 241
K+ I V S S G L+ + LF Q+ + +
Sbjct: 224 IPMSMNLNQTGVPLYAGGSRNHKMAIAVGS-SVGTVSLIFIAVGLFLWWRQRHNQ---NT 279
Query: 242 FFDVA-GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAV 300
FFDV G +VSL LRRF RELQ+AT+NFS N++G+GG+G VYKG+L D+T VAV
Sbjct: 280 FFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAV 339
Query: 301 KRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 360
KRL+D + GGE FQ EV +IS+A+H+NLL+L G+C T +E++LVYP+M N SVA R++
Sbjct: 340 KRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVASRMK 399
Query: 361 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420
KP LDW RKR+A G A GL YLHEQC+PKIIHRD+KAANILLDD EAV+ DFG
Sbjct: 400 -AKPV---LDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFG 455
Query: 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
LAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLELVTGQRA +F +
Sbjct: 456 LAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGK 515
Query: 481 XXXXXXXXXXXHIRKLLREDRLNDIVDRNL---NTYDSKEVETMVQVALLCTQSTPEDRP 537
++K+ +E +L +VD+ L +YD E++ MV+VALLCTQ P RP
Sbjct: 516 AANQKGVMLDW-VKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRP 574
Query: 538 PMAQVVKMLQGE 549
M++VV+ML+G+
Sbjct: 575 KMSEVVRMLEGD 586
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8W4S5 | Y5371_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6996 | 0.9781 | 0.9478 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 595 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-23 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 5e-47
Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 34/278 (12%)
Query: 278 IIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FG+VYKG L +VAVK L++ S F RE ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L+G CT ++V +M + LR +P K L A A G+EYL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK- 122
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYL 448
IHRDL A N L+ +N + DFGL++ + + IR APE L
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM----APESL 176
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508
GK + K+DV+ +G+ L E+ F+ EE + + + L++
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEI--------FTLGEEPYPGMSNAEVLEYLKKGYRLPKPP- 227
Query: 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
E + ++ L C PEDRP +++V++L
Sbjct: 228 ----NCPPE---LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-46
Identities = 81/280 (28%), Positives = 127/280 (45%), Gaps = 40/280 (14%)
Query: 279 IGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
+G+G FG+VYKG L TKVAVK L++ S F E ++ H N+++L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
+G CT +V +M + LR L ++A A G+EYL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGHIAPEYL 448
+HRDL A N L+ +N + DFGL++ + + I+ APE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APESL 176
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507
GK + K+DV+ +G+ L E+ T G+ + + EE + LL+ +L R +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGE--QPYPGMSNEEVLELLEDGYRLPRPE------- 227
Query: 508 RNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKML 546
E+ E M+Q C PEDRP +++V+ L
Sbjct: 228 -----NCPDELYELMLQ----CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-46
Identities = 71/195 (36%), Positives = 98/195 (50%), Gaps = 12/195 (6%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G+GGFG VY KVA+K ++ S RE+ ++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 338 TTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
+ LV + + S L+D LK E L R+ GLEYLH I
Sbjct: 61 EDENHLYLVMEYCEGGS----LKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 397 IHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGKSS 454
IHRDLK NILLD DN + L DFGL+KL+ + + I GT ++APE L G S
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 455 EKTDVFGYGITLLEL 469
EK+D++ G+ L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 8e-46
Identities = 76/279 (27%), Positives = 123/279 (44%), Gaps = 37/279 (13%)
Query: 278 IIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FG+VYKG L +VAVK L++ S F RE ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L+G CT +V +M+ + LR +P L A A G+EYL +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLESK- 121
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APEY 447
IHRDL A N L+ +N + DFGL++ + + R G + APE
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDL-----YDDDYYRKRGGKLPIRWMAPES 174
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507
L GK + K+DV+ +G+ L E+ F+ E+ + + + + L+
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEI--------FTLGEQPYPGMSNEEVLEYLKNGYRLPQPP 226
Query: 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
E + + L C PEDRP +++V++L
Sbjct: 227 -----NCPPE---LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 6e-45
Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 41/287 (14%)
Query: 277 NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FG+VYKG L T+VAVK L++ S F +E ++ H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 333 LIGYCTTSSERILVYPFMQN---LSV--AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
L+G CT LV +M+ L R P + L A A G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---A 444
L + K +HRDL A N L+ ++ + DFGL++ V + G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK---LLRED 500
PE L G + K+DV+ +G+ L E+ T G A + L EE +L+++RK L + +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLG--ATPYPGLSNEE---VLEYLRKGYRLPKPE 230
Query: 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
D + Y+ + L C Q PEDRP +++V+ L+
Sbjct: 231 YCPDEL------YE---------LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 9e-43
Identities = 67/199 (33%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G G FG VYK VAVK L+ + +RE+ ++ H N+++LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
LV + + + L L K++A GLEYLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SS 454
IIHRDLK NILLD+N + DFGLAK + + +TT GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177
Query: 455 EKTDVFGYGITLLELVTGQ 473
K DV+ G+ L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 1e-42
Identities = 141/513 (27%), Positives = 232/513 (45%), Gaps = 75/513 (14%)
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLAN 133
+ + +L L N FSG + + L L L+L +N LSG +PD L S L SL+L++
Sbjct: 473 GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSV--------------ATFNFTGT 179
N+ SG IPA++S++ L LDLS N L+G IP L +V + TG
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592
Query: 180 HLICGSSL----EQPCMSRPS---PPVS-TSRTKLRIVVASASCGAFVLLSLGALFACRY 231
L +S C + PP +T + + GAF++L+L A F +
Sbjct: 593 FLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVA-FGFVF 651
Query: 232 QKLRK---LKHDVFFDVAGED--------DCKVSLTQLRRFSCRELQLATDNFSESNIIG 280
+ R LK V ED D KVS + + ++ + E N+I
Sbjct: 652 IRGRNNLELKR-----VENEDGTWELQFFDSKVS----KSITINDILSSL---KEENVIS 699
Query: 281 QGGFGKVYKGVLSDN-TKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G YKG N + VK + D S P E A ++ H N+++LIG C
Sbjct: 700 RGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ------HPNIVKLIGLCR 753
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
+ L++ +++ +++ LR L W R+++A G A L +LH +C+P ++
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTD 458
+L I++D E L L L+ + ++APE T +EK+D
Sbjct: 807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSD 860
Query: 459 VFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD----RNLNTYD 514
++G+G+ L+EL+TG+ D E +++ R + L+ +D +++
Sbjct: 861 IYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 515 SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
++ VE M +AL CT + P RP V+K L+
Sbjct: 918 NEIVEVM-NLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 1e-39
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G+G FGKVY VA+K ++ RE+ ++ H N+++L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ LV + + + L+ L + LEYLH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLHSK---G 117
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 455
I+HRDLK NILLD++ L DFGLA+ +D +TT + GT ++APE L +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 456 KTDVFGYGITLLELVTGQ 473
D++ G+ L EL+TG+
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 16/224 (7%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEA-AFQREVHLISVAIHKN 329
++ ++G+G FG VY + D + +AVK ++ E A +RE+ ++S H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 330 LLQLIGYCTTSSERILVYPFMQNL---SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
+++ G E+ + F++ + S++ L+ L P ++ GL
Sbjct: 61 IVRYYG-SERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYTRQILEGLA 115
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAP 445
YLH I+HRD+K ANIL+D + L DFG AK + D + T +RGT +AP
Sbjct: 116 YLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489
E + + D++ G T++E+ TG+ +S L L
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP--WSELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (302), Expect = 7e-30
Identities = 72/278 (25%), Positives = 110/278 (39%), Gaps = 23/278 (8%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA--FQREVH-LISVAIHKNLLQLIG 335
+G+G FG+VY D VA+K L + F RE+ L S+ N+++L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ LV ++ S+ L + L + LEYLH +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 396 IIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIR-----GTMGHIAPEYL- 448
IIHRD+K NILLD D L DFGLAKL+ + + GT G++APE L
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 449 --STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506
S +S +D++ GITL EL+TG + + L I +L + +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-QTLKIILELPTPSLASPLS 240
Query: 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
N + P++R + +
Sbjct: 241 PSNPELISKA----ASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 67/198 (33%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 279 IGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG+GGFG+VYK +VA+K + S + E+ ++ H N+++ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 338 TTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
E +V F S L+D LK + L V GLEYLH I
Sbjct: 67 LKKDELWIVMEFCSGGS----LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GI 119
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 455
IHRD+KAANILL + E L DFGL+ L D K + GT +APE ++
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPYDY 176
Query: 456 KTDVFGYGITLLELVTGQ 473
K D++ GIT +EL G+
Sbjct: 177 KADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 78/270 (28%), Positives = 118/270 (43%), Gaps = 30/270 (11%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHKNLLQLIGYC 337
IG+G FG V G KVAVK L+D A AF E +++ H NL+QL+G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDD---STAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
+ +V +M S+ LR G + + A G+EYL E+ +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRDL A N+L+ ++ A + DFGLAK ++ T APE L K S K+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKS 180
Query: 458 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKE 517
DV+ +GI L E+ + R + R+ ++ ++ H+ K R + E
Sbjct: 181 DVWSFGILLWEIYSFGRV-PYPRIPLKD---VVPHVEKGYRMEAPEGCPP---------E 227
Query: 518 VETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
V +V C + P RP Q+ + L
Sbjct: 228 V---YKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 67/199 (33%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V+ G + TKVAVK L+ PG AF +E ++ H L+QL
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK----PGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
C+ +V +M S+ L+ K L P +A A G+ YL +
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NY 124
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTGK 452
IHRDL A NIL+ +N + DFGLA+L+ D + I+ T APE + G+
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGR 180
Query: 453 SSEKTDVFGYGITLLELVT 471
+ K+DV+ +GI L E+VT
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLL 331
F+ +G G FG+V++G+ + +VA+K L D + FQ+EV + HK+L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLI 65
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L C+ ++ M+ S+ LR P + L + +A A G+ YL EQ
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTT-QIRGTMGHIAPEYL 448
IHRDL A NIL+ ++ + DFGLA+L+ D L+ + T APE
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAA 176
Query: 449 STGKSSEKTDVFGYGITLLELVT 471
S G S K+DV+ +GI L E+ T
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKN 329
N+ ++IG+G FG VYKG+ L VA+K++ + +E+ L+ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+++ IG TS ++ + +N S LR + + GL YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGS----LRQIIKKFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
EQ +IHRD+KAANIL + L DFG+A ++ ++ + GT +APE +
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIE 172
Query: 450 TGKSSEKTDVFGYGITLLELVTGQ 473
+S +D++ G T++EL+TG
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 261 FSCRELQLATDNFSESNIIGQGGFGKVYKG---VLSDNT--KVAVKRLQDYYSPGGEAAF 315
F R L+ +G+G FGKV L DNT +VAVK L + F
Sbjct: 1 FEKRHLKF-------IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF 53
Query: 316 QREVHLISVAIHKNLLQLIGYCTTSSERI--LVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
+RE+ ++ H+N+++ G C R L+ ++ + S+ L+ + ++
Sbjct: 54 EREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKR 110
Query: 374 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433
+ G++YL Q + IHRDL A NIL++ + DFGLAK++ +
Sbjct: 111 LLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY 167
Query: 434 TQIRGT--MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ G + APE L T K S +DV+ +G+TL EL T
Sbjct: 168 VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
IG+G FG VYKGVL NT+VAVK + P + F +E ++ H N+++LIG C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG--TAYGLEYLHEQCNPKI 396
+V + S+ LR +K +K + A G+EYL +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR-----KKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APEYLSTG 451
IHRDL A N L+ +N + DFG+++ + + V+ + I APE L+ G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS----DGLKQIPIKWTAPEALNYG 170
Query: 452 KSSEKTDVFGYGITLLELVTG 472
+ + ++DV+ YGI L E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+IG G FG+V +G L K VA+K L+ S F E ++ H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L G T S +++ +M+N S+ LR+ + + G A G++YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGHIAPEY 447
+HRDL A NIL++ N + DFGL++ ++ TT+ IR T APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 448 LSTGKSSEKTDVFGYGITLLELVT-GQR 474
++ K + +DV+ +GI + E+++ G+R
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (250), Expect = 2e-23
Identities = 77/279 (27%), Positives = 125/279 (44%), Gaps = 43/279 (15%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G FGKVY SD +K + S EV ++ H N+ I Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---IKY 64
Query: 337 CTTSSERILVYPFMQ-----NLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEY 387
+ E+ + M+ +LS + + + P E+ LDW + L+Y
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKY 118
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LH + KI+HRD+K NI L N L DFG++K++ + + T + GT +++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE- 173
Query: 448 LSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506
L K + K+D++ G L EL T + + L E L K+L+
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----L----ALKILKGQY----- 220
Query: 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545
+ + S E+ +V +LL Q PE+RP +AQ+++
Sbjct: 221 -PPIPSQYSSELRNLVS-SLL--QKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V++G+ ++ T VAVK L+ PG F E ++ H L+QL
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK----PGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
CT +V M+ S+ L+ + L P +A A G+ YL Q
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEAQ---NY 124
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 456
IHRDL A N+L+ +N + DFGLA+++ + + + APE + S K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 457 TDVFGYGITLLELVT 471
+DV+ +GI L E+VT
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 81/282 (28%), Positives = 132/282 (46%), Gaps = 36/282 (12%)
Query: 277 NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+IG+G FG VY G L D+ AVK L F +E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 333 LIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAYGLEYL 388
L+G C + ++V P+M++ + +R PT K + FG A G+EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN------PTVKDLIGFGLQVAKGMEYL 114
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK---LTHVTTQIRGTMGHIAP 445
+ K +HRDL A N +LD++F + DFGLA+ + K H T + + +A
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505
E L T K + K+DV+ +G+ L EL+T + A + ++ + + L R+LL+ + D
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD- 229
Query: 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ +V L C PE RP +++V ++
Sbjct: 230 --------------PLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-23
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 36 EGEALIEVLKALNDTHGQFT-----DWN-DHFVSPCFSWSHVTCRNGNVIS------LTL 83
E + L+E + AL WN D V WS C+ + L L
Sbjct: 366 ESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGL 425
Query: 84 GSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT 143
+ G G I I+KL+ L S+ L N + G +P LGS+T L+ L+L+ N F+GSIP +
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 144 WSQLSNLKHLDLSSNNLTGRIPM----QLFSVATFNFTGTHLICGSSLEQPCMSRPSPPV 199
QL++L+ L+L+ N+L+GR+P +L A+FNFT +CG + C P V
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC--GPHLSV 543
Query: 200 STSRTKLRIVVASASCGAFVLLSLGALFACR 230
+I +A AF+ L + A+ +
Sbjct: 544 GA-----KIGIAFGVSVAFLFLVICAMCWWK 569
|
Length = 623 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 70/221 (31%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 276 SNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQ---REVHLISVAIHKN 329
N IG G FGKVY V L +AVK R+QD + E+ ++ + H N
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD----NDPKTIKEIADEMKVLELLKHPN 60
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
L + Y R VY FM+ S L +L + LD + GL YLH
Sbjct: 61 L---VKYYGVEVHREKVYIFMEYCSGG-TLEELLEHGRILDEHVIRVYTLQLLEGLAYLH 116
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG---HIAPE 446
I+HRD+K ANI LD N L DFG A + T + +++ G ++APE
Sbjct: 117 SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 447 YLSTGKSSEK---TDVFGYGITLLELVTGQRAIDFSRLEEE 484
++ GK D++ G +LE+ TG+R +S L+ E
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP--WSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 73/200 (36%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V+ G + NTKVAVK L+ PG +F E ++ H L+QL Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK----PGTMSPESFLEEAQIMKKLRHDKLVQL--Y 67
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGE-KGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
S E I +V +M S+ L LK GE + L P +A A G+ Y+ E+ N
Sbjct: 68 AVVSEEPIYIVTEYMSKGSL---LDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMN- 122
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 454
IHRDL++ANIL+ D + DFGLA+L++ + + APE G+ +
Sbjct: 123 -YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 455 EKTDVFGYGITLLELVTGQR 474
K+DV+ +GI L ELVT R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 36/277 (12%)
Query: 279 IGQGGFGKVYKGV-LSDNTK---VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 334
+G G FG V KGV L + K VAVK L+ + G+ F RE +++ H +++LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 335 GYCTTSSERILVYPFM--QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
G C P M L+ L + + K +A A G+ YL +
Sbjct: 63 GVC-------KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK- 114
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT--MGHIAPEYLST 450
+HRDL A N+LL + +A + DFG+++ + A + G + APE ++
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 451 GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509
GK S K+DV+ YG+TL E + G + + ++ E + +L+ +L R +
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP--YGEMKGAEVIAMLESGERLPRPEECPQ----- 225
Query: 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
Y + L C + PEDRP +++
Sbjct: 226 -EIYS---------IMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 83/278 (29%), Positives = 127/278 (45%), Gaps = 43/278 (15%)
Query: 279 IGQGGFGKVYKGVLSDNTK-VAVKR--LQDYYSPGGEAAFQ--REVHLISVAIHKNLLQL 333
+G G FG VY+G+ D+ AVK L D G EA Q +E+ L+S H N++Q
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 334 IGYCTTSSERILVY-PFMQNLSVAYRLRDLKPGEKGLDWP-----TRKRVAFGTAYGLEY 387
+G + + ++ + S+A L+ P TR+ + GLEY
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILL-----GLEY 117
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LH++ +HRD+K ANIL+D N L DFG+AK V +G+ +APE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEV 172
Query: 448 L-STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506
+ G D++ G T+LE+ TG+ +S+LE V K+ R L I
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK--PPWSQLEGVAAVF------KIGRSKELPPIP 224
Query: 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
D + S E + + L C Q P RP A++++
Sbjct: 225 D-----HLSDEAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 6e-22
Identities = 82/269 (30%), Positives = 131/269 (48%), Gaps = 44/269 (16%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G G FG+V+ G + +TKVA+K L Q SP AF E +L+ H L++L Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRL--YA 68
Query: 338 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV--AFGTAYGLEYLHEQCNP 394
+ E I ++ +M+N S L D +G+ K + A A G+ ++ E+ N
Sbjct: 69 VVTQEPIYIITEYMENGS----LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI-ERKN- 122
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAPEYL 448
IHRDL+AANIL+ + + DFGLA+L+ + T + I+ T APE +
Sbjct: 123 -YIHRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWT----APEAI 175
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508
+ G + K+DV+ +GI L E+VT R I + + E + L+ ++ R D
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGR-IPYPGMTNPEVIQNLERGYRMPRPDNCP----- 229
Query: 509 NLNTYDSKEVETMVQVALLCTQSTPEDRP 537
E + ++ LC + PE+RP
Sbjct: 230 ----------EELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 279 IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV+ G D VAVK L++ S F+RE L++ H+N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----------RVAFGTA 382
G CT I+V+ +M++ + LR P L P ++A A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442
G+ YL Q +HRDL N L+ + + DFG+++ V TT GH
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVGGH 183
Query: 443 -------IAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ PE + K + ++DV+ +G+ L E+ T
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 26/224 (11%)
Query: 278 IIGQGGFGKVYKGV---LSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
++G G FG VYKGV + K VA+K L++ SP E ++++ H ++++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG----LDWPTRKRVAFGTAYGLEYL 388
L+G C +S L+ M + +R+ K G L+W + A G+ YL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQ------IAKGMSYL 125
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---AP 445
E+ +++HRDL A N+L+ + DFGLAKL+D G I A
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMAL 180
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 488
E + + K+DV+ YG+T+ EL+T G + + E D+L
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 3e-21
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 6 HKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPC 65
+ CP + + + FLNF E E E L+ ++ND ++WN C
Sbjct: 6 PQHCPYLIFMLFFL---FLNFSMLHAE---ELELLLSFKSSINDPLKYLSNWNSS-ADVC 58
Query: 66 FSWSHVTCRNGN-VISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD------ 118
W +TC N + V+S+ L SGKIS +I +L ++ ++ L +N LSG +PD
Sbjct: 59 -LWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 119 ----FL-------------GSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
+L GS+ +L++L+L+NN SG IP S+LK LDL N L
Sbjct: 118 SSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177
Query: 162 GRIPMQLFSVATFNF 176
G+IP L ++ + F
Sbjct: 178 GKIPNSLTNLTSLEF 192
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 82/274 (29%), Positives = 119/274 (43%), Gaps = 23/274 (8%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+IG G VY + L +N KVA+KR+ ++EV +S H N+++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
E LV P++ S+ ++ P GLD V GLEYLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---G 122
Query: 396 IIHRDLKAANILLDDNFEAVLCDFG----LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
IHRD+KA NILL ++ + DFG LA D T GT +APE +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT-FVGTPCWMAPEVMEQV 181
Query: 452 KS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510
K D++ +GIT +EL TG A +S+ + VL+L L+ D + +
Sbjct: 182 HGYDFKADIWSFGITAIELATG--AAPYSKYPPMK-VLML-----TLQNDPPSLETGADY 233
Query: 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
Y SK M+ LC Q P RP +++K
Sbjct: 234 KKY-SKSFRKMIS---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 277 NIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPG----GEAAFQREVHLISVAIHKNLL 331
+ +G G +G+VY+GV + VAVK L++ EAA +E+ H NL+
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLV 65
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
QL+G CT ++ FM ++ LR+ + ++ +A + +EYL ++
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEY 447
IHRDL A N L+ +N + DFGL++L+ D H + I+ T APE
Sbjct: 124 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APES 176
Query: 448 LSTGKSSEKTDVFGYGITLLELVT 471
L+ K S K+DV+ +G+ L E+ T
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 61/210 (29%), Positives = 113/210 (53%), Gaps = 17/210 (8%)
Query: 274 SESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
++ +IG G FG+V++G+L VA+K L+ Y+ F E ++ H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEY 387
+++L G T +++ +M+N ++ LRD GE + + + V G A G++Y
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGE----FSSYQLVGMLRGIAAGMKY 122
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAP 445
L + +HRDL A NIL++ N E + DFGL++++ D + T+ T+ + + AP
Sbjct: 123 LSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
E ++ K + +DV+ +GI + E+++ G+R
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-20
Identities = 81/264 (30%), Positives = 126/264 (47%), Gaps = 34/264 (12%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 336
+GQG FG+V+ G + T+VA+K L+ PG AF +E ++ H+ L+QL Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 67
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 393
S E I +V +M S L D GE G L P +A A G+ Y+ E+ N
Sbjct: 68 AVVSEEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 122
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 453
+HRDL+AANIL+ +N + DFGLA+L++ + + APE G+
Sbjct: 123 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 454 SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 513
+ K+DV+ +GI L EL T R + + + E +LD + + R
Sbjct: 181 TIKSDVWSFGILLTELTTKGR-VPYPGMVNRE---VLDQVERGYRM------------PC 224
Query: 514 DSKEVETMVQVALLCTQSTPEDRP 537
+ E++ + C + PE+RP
Sbjct: 225 PPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 70/289 (24%), Positives = 124/289 (42%), Gaps = 46/289 (15%)
Query: 279 IGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-- 330
+GQG FG VY+G+ T+VA+K + + S F L ++ K
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF-----LNEASVMKEFNC 68
Query: 331 ---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK---GLDWPTRKRV---AFGT 381
++L+G +T ++V M + LR +P + GL PT ++ A
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441
A G+ YL + K +HRDL A N ++ ++ + DFG+ + D T + +
Sbjct: 129 ADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLL 183
Query: 442 HI---APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498
+ APE L G + K+DV+ +G+ L E+ T L E+ + L
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------LAEQP-------YQGLSN 227
Query: 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
E+ L ++D + ++++ +C Q P+ RP ++V L+
Sbjct: 228 EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 72/273 (26%), Positives = 127/273 (46%), Gaps = 32/273 (11%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V+ + +TKVAVK ++ PG + AF E +++ H L++L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK----PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCNP 394
T I+ FM S L D ++G P K + F A G+ ++ ++
Sbjct: 70 VTKEPIYIIT-EFMAKGS----LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--- 121
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 454
IHRDL+AANIL+ + + DFGLA++++ + + APE ++ G +
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 455 EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD 514
K+DV+ +GI L+E+VT R I + + E + L+ ++ R +
Sbjct: 182 IKSDVWSFGILLMEIVTYGR-IPYPGMSNPEVIRALERGYRMPRPENCP----------- 229
Query: 515 SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
E + + + C ++ PE+RP + +L
Sbjct: 230 ----EELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 75/200 (37%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 336
+GQG FG+V+ G + TKVA+K L+ PG AF +E ++ H L+ L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK----PGTMMPEAFLQEAQIMKKLRHDKLVPL--Y 67
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGE-KGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
S E I +V FM S+ L LK G+ K L P +A A G+ Y+ E+ N
Sbjct: 68 AVVSEEPIYIVTEFMGKGSL---LDFLKEGDGKYLKLPQLVDMAAQIADGMAYI-ERMN- 122
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 454
IHRDL+AANIL+ DN + DFGLA+L++ + + APE G+ +
Sbjct: 123 -YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 455 EKTDVFGYGITLLELVTGQR 474
K+DV+ +GI L ELVT R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 6/191 (3%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
++G+G FG+V+KG L D T VAVK ++ + F E ++ H N+++LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
T +R +Y M+ + L L+ + L + A A G+ YL + I
Sbjct: 62 T---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRDL A N L+ +N + DFG+++ D + + + + APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 458 DVFGYGITLLE 468
DV+ YGI L E
Sbjct: 176 DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 279 IGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG+G FG+V+ G L +DNT VAVK ++ P +A F +E ++ H N+++LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
T +V +Q LR P L ++ A G+EYL + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGP---RLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APEYLSTGK 452
HRDL A N L+ + + DFG+++ + + T G M I APE L+ G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST----GGMKQIPVKWTAPEALNYGR 172
Query: 453 SSEKTDVFGYGITLLE 468
S ++DV+ +GI L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 38/275 (13%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
IG G FG V+ G + KVA+K +++ E F E ++ H L+QL G CT
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
S LV+ FM++ ++ LR ++G T + G+ YL +I
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLR----AQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 456
HRDL A N L+ +N + DFG+ + V D + T +T + + +PE S K S K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSK 181
Query: 457 TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT---- 512
+DV+ +G+ + E+ FS K E+R N V +N
Sbjct: 182 SDVWSFGVLMWEV--------FSE-------------GKTPYENRSNSEVVETINAGFRL 220
Query: 513 YDSKEVETMV-QVALLCTQSTPEDRPPMAQVVKML 546
Y + V ++ C + PEDRP + ++ L
Sbjct: 221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 67/202 (33%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIHKNLLQLIGY 336
IG+G FG+VYK + N VA+K + D E Q+E+ +S + + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
S+ ++ + S DL KPG LD + GLEYLHE+
Sbjct: 68 FLKGSKLWIIMEYCGGGSC----LDLLKPG--KLDETYIAFILREVLLGLEYLHEE---G 118
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-----GTMGHIAPEYLST 450
IHRD+KAANILL + + L DFG V +LT T + GT +APE +
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFG----VSGQLTS--TMSKRNTFVGTPFWMAPEVIKQ 172
Query: 451 GKSSEKTDVFGYGITLLELVTG 472
EK D++ GIT +EL G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 278 IIGQGGFGKVYKGVLS--DNT--KVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQ 332
I+G+G FG V +G LS D + KVAVK ++ D ++ F E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 333 LIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYG 384
LIG C +S +++ PFM++ + L + G P + + F A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-RGTMGHI 443
+EYL N IHRDL A N +L ++ + DFGL+K + + + +I + + I
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRE-DR 501
A E L+ + K+DV+ +G+T+ E+ T GQ + +E E I LR +R
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENHE-------IYDYLRHGNR 233
Query: 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
L D YD M C ++ P+DRP ++ ++L+
Sbjct: 234 LKQPEDCLDELYDL-----MYS----CWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLI 334
IG+G +G+VYK VA+K+++ + G RE+ L+ H N+++L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 335 GYCT--TSSERILVYPFMQNLSVAYRLRDL-----KPGEKGLDWPTRKRVAFGTAYGLEY 387
T +V+ +M + DL P K K GL+Y
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH--------DLTGLLDSPEVK-FTESQIKCYMKQLLEGLQY 115
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LH I+HRD+K +NIL++++ L DFGLA+ + + T T+ + PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 448 L--STGKSSEKTDVFGYGITLLELVTG 472
L +T + + D++ G L EL G
Sbjct: 173 LLGAT-RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 75/280 (26%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 273 FSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIH-- 327
+ +IG+G +G VY+G V + VA+K + + +P + + QREV L+S
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRV-VALKII-NLDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 328 -KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
N+ + G ++ + + SV ++ EK + R+ L+
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIRE-----VLVALK 115
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
Y+H+ +IHRD+KAANIL+ + LCDFG+A L++ + +T + GT +APE
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPE 171
Query: 447 YLSTGKSSE-KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505
++ GK + K D++ GIT+ E+ TG +S ++ ++L+ + RL D
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPP--YSDVDAFRAMMLIPKSKP----PRLED- 224
Query: 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545
N Y SK + V C P++R +++K
Sbjct: 225 -----NGY-SKLLREFVA---ACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA-----AFQREVHLISVAIH 327
+++ ++G+G +G VY G+ + +AVK+++ S A Q EV L+ H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
N++Q +G C + + F+ S++ L P L P + G+ Y
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAY 117
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK---LVDAKLTH--VTTQIRGTMGH 442
LH C ++HRD+K N++L N L DFG A+ V TH + + GT
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+APE ++ K+D++ G T+ E+ TG+
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 45/213 (21%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLI-------------S 323
+G+G +G VYK + VA+K + +E+ ++ S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTA 382
+ +L ++ YC S + D+ K K L + + T
Sbjct: 67 YFKNTDLWIVMEYCGAGS-----------------VSDIMKITNKTLTEEEIAAILYQTL 109
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GT 439
GLEYLH K IHRD+KA NILL++ +A L DFG V +LT + GT
Sbjct: 110 KGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG----VSGQLTDTMAKRNTVIGT 162
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
+APE + + K D++ GIT +E+ G
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 362 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421
LK + + ++A GL YLHE+ KIIHRD+K +NIL++ + LCDFG+
Sbjct: 90 LKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGV 147
Query: 422 A-KLVDAK-LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479
+ +LV++ T V GT ++APE + S K+D++ G++L+EL TG+
Sbjct: 148 SGQLVNSLAKTFV-----GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202
Query: 480 RLEEEEDVLLLDHI 493
+ LL +I
Sbjct: 203 NDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 318
E+ L+ F E +G+G FGKVYKG L T VA+K L++ P + F++E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 319 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV-AYRLR-----------DLKPGE 366
L+S H N++ L+G CT +++ ++ + + + +R + +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 367 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV- 425
LD +A A G+EYL +HRDL A N L+ + + DFGL++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 469
A V ++ + + PE + GK + ++D++ +G+ L E+
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 15/197 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V+ G +++TKVAVK L+ PG + AF E +L+ H L++L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCNP 394
T ++ +M S L D ++G K + F A G+ Y+ +
Sbjct: 70 VTKEEPIYIITEYMAKGS----LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--- 122
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 454
IHRDL+AAN+L+ ++ + DFGLA++++ + + APE ++ G +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 455 EKTDVFGYGITLLELVT 471
K+DV+ +GI L E+VT
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G +G VYK VA+K++ + S G RE+ L+ H N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 337 CTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ LV+ FM +L Y+L +K ++GL K + GL + H
Sbjct: 67 FRHKGDLYLVFEFMDTDL---YKL--IKDRQRGLPESLIKSYLYQLLQGLAFCHSH---G 118
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-S 454
I+HRDLK N+L++ L DFGLA+ + + T + T + APE L K S
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYS 177
Query: 455 EKTDVFGYGITLLELVTGQ 473
D++ G EL++ +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 78/283 (27%), Positives = 132/283 (46%), Gaps = 34/283 (12%)
Query: 279 IGQGGFGKVYKGVLSDNT---KVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 334
+G+G FG V +G L+ + KVAVK ++ E F E + H N+++LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 335 GYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLE 386
G C + E +++ PFM++ + L + G+ PT+ V F T A G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-RGTMGHIAP 445
YL + IHRDL A N +L++N + DFGL+K + + +I + + IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504
E L+ + K+DV+ +G+T+ E+ T GQ + +E E + D++R+ R + D
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP--YPGVENSE---IYDYLRQGNRLKQPPD 238
Query: 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+D + + C P+DRP + L+
Sbjct: 239 CLD------------GLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 30/271 (11%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G FG V+ G VA+K +++ E F E ++ H NL+QL G CT
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE--GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
+V +M N + LR+ + G+ G +W + +EYL IH
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLD--MCSDVCEAMEYLESNG---FIH 123
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYLSTGKSSE 455
RDL A N L+ ++ + DFGLA+ V L T +GT + PE + S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 456 KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 515
K+DV+ +G+ + E+ + + + + R E +++ + R R
Sbjct: 181 KSDVWSFGVLMWEVFSEGK-MPYERFSNSE---VVESVSAGYRLYR---------PKLAP 227
Query: 516 KEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
EV T + C PEDRP +++ L
Sbjct: 228 TEVYT---IMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 79/298 (26%), Positives = 133/298 (44%), Gaps = 57/298 (19%)
Query: 278 IIGQGGFGKVYKG--VLSDNTK----VAVKRLQDYYSPGGEAAFQREV-HLIS------- 323
+G+G FG+V K V DN VAVK L+D A ++++ L+S
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-------DATEKDLSDLVSEMEMMKM 71
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE----KGLDWPTRKRV-- 377
+ HKN++ L+G CT +V + + ++ LR +P P + +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 378 ------AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLT 430
A+ A G+E+L + K IHRDL A N+L+ ++ + DFGLA+ +
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 489
TT R + +APE L + ++DV+ +G+ L E+ T G +EE
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------ 242
Query: 490 LDHIRKLLRE-DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
+ KLL+E R+ ++ N ++E+ ++ C P RP Q+V+ L
Sbjct: 243 ---LFKLLKEGYRM----EKPQNC--TQELYHLM---RDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 77/290 (26%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 278 IIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKNLLQL 333
++G+G +G V K + + VA+K+ S + + RE+ ++ H+NL+ L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
I LV+ F+ + L DL+ GLD ++ F G+E+ H +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTV----LDDLEKYPNGLDESRVRKYLFQILRGIEFCH---S 118
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGK 452
IIHRD+K NIL+ + LCDFG A+ + A V T T + APE L K
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYTDYVATRWYRAPELLVGDTK 177
Query: 453 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE--DRLNDIVDRN- 509
D++ G + E++TG+ + D+ L HI K L R +I +N
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGE-----PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 510 ----LNTYDSKEVETM-----------VQVALLCTQSTPEDRPPMAQVVK 544
+ + KE+E + + +A C + P+DRP +Q++
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEA-------AFQREVHLISVAIHK 328
+IG G FG VY G+ S +AVK+++ S + A RE+ L+ H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 329 NLLQLIGYCTTSSERILVY-PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
N++Q +G + ++ + ++ ++ SVA L + E+ L + GL Y
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFVRQILKGLNY 121
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGH 442
LH N IIHRD+K ANIL+D+ + DFG++K ++A T ++G++
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
+APE + + K D++ G ++E++TG
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 6e-18
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 279 IGQGGFGKVY--KGVLSDNT---KVAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV + + KV K+ + E +++S H +++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVK 57
Query: 333 LIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLEYL 388
L Y + E++ LV + + L E +R F A LEYL
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSK----EGRFS---EERARFYAAEIVLALEYL 109
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H II+RDLK NILLD + L DFGLAK + ++ + T GT ++APE L
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVL 165
Query: 449 STGKSSEKTDVFGYGITLLELVTGQ 473
+ D + G+ L E++TG+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 75/276 (27%), Positives = 112/276 (40%), Gaps = 31/276 (11%)
Query: 279 IGQGGFGKVYKG----VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 334
+G G FG V +G VAVK L+ F +E ++ H+NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
G T ++V S+ RLR G + T A A G+ YL +
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESK--- 116
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLSTGK 452
+ IHRDL A NILL + + + DFGL + + H + ++ APE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 453 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512
S +DV+ +G+TL E+ F+ EE L I K +D+
Sbjct: 177 FSHASDVWMFGVTLWEM--------FTYGEEPWAGLSGSQILKK---------IDKEGER 219
Query: 513 YDSKEV--ETMVQVALLCTQSTPEDRPPMAQVVKML 546
+ E + + V L C P DRP A + + L
Sbjct: 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 77/275 (28%), Positives = 110/275 (40%), Gaps = 64/275 (23%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+F +IG+G FGKV D K+ A+K Y + Q+ V SV N
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMK----YMNK------QKCVEKGSVRNVLNE 50
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVA-------YRLRDLKPGEKG-LDWPTRKRVAFGT- 381
+++ E L +PF+ NL + Y + DL G G L + ++V F
Sbjct: 51 RRIL------QE--LNHPFLVNLWYSFQDEENMYLVVDLLLG--GDLRYHLSQKVKFSEE 100
Query: 382 ---------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
LEYLH + IIHRD+K NILLD+ + DF +A V +
Sbjct: 101 QVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TL 155
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL---- 488
TT GT G++APE L S D + G+T E + G+R + +
Sbjct: 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE 215
Query: 489 -------------LLDHIRKLLRED---RLNDIVD 507
+D I KLL D RL D +
Sbjct: 216 TADVLYPATWSTEAIDAINKLLERDPQKRLGDNLK 250
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIH 327
T F +IG+G +GKVYK ++ ++ D E + E + L + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNH 62
Query: 328 KNLLQLIGYCTTSSERI------LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 381
N+ G + LV SV ++ L+ K L + T
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441
GL YLHE K+IHRD+K NILL N E L DFG++ +D+ L T I GT
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPY 178
Query: 442 HIAPEYLSTGKSSEKT-----DVFGYGITLLELVTGQ 473
+APE ++ + + + DV+ GIT +EL G+
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 81/285 (28%), Positives = 129/285 (45%), Gaps = 46/285 (16%)
Query: 278 IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
+IG G FG+V +G L K VA+K L+ Y+ F E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 391
G T S +++ FM+N ++ LR G+ + + V G A G++YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLR-QNDGQ----FTVIQLVGMLRGIAAGMKYLSEM 125
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--------TQIRGTMGHI 443
+HRDL A NIL++ N + DFGL++ ++ + T IR T
Sbjct: 126 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT---- 178
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAI-DFSRLEEEEDVLLLDHIRKLLREDR 501
APE ++ K + +DV+ YGI + E+++ G+R D S +DV I + ++ R
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----NQDV-----INAIEQDYR 229
Query: 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
L +D + Q+ L C Q RP Q+V L
Sbjct: 230 LPPPMDCP---------TALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IIG+G FG V +G + KVAVK ++ D + AF E +++ HKNL++L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 337 CTTSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
+ I V M NL R R G + + + A G+EYL +
Sbjct: 68 ILHNGLYI-VMELMSKGNLVNFLRTR----GRALVSVIQLLQFSLDVAEGMEYLESK--- 119
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 454
K++HRDL A NIL+ ++ A + DFGLA++ + + ++ T APE L K S
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFS 175
Query: 455 EKTDVFGYGITLLELVTGQRA 475
K+DV+ YG+ L E+ + RA
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 54/299 (18%)
Query: 279 IGQGGFGKVYK----GVLS--DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
IGQG FG+V++ G+L T VAVK L++ S +A FQRE L++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------------GEKGLDWPTR 374
L+G C L++ +M + LR P L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 375 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 434
+A A G+ YL E+ K +HRDL N L+ +N + DFGL++ + + + +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 435 Q-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489
+ IR + PE + + + ++DV+ YG+ L E+ + + EE +
Sbjct: 190 ENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE----V 241
Query: 490 LDHIRKLLREDRLNDIVDRN-LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ ++R D N L+ D+ +E + + LC P DRP A + ++LQ
Sbjct: 242 IYYVR------------DGNVLSCPDNCPLE-LYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 279 IGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G+GGFG+V + K+ A K+L + GE E ++ + + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSLA 59
Query: 336 YC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLEYLHEQ 391
Y T + LV M + Y + ++ GE G R F A GLE+LH++
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEA---RAIFYAAQIICGLEHLHQR 114
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
+I++RDLK N+LLDD+ + D GLA V+ K GT G++APE L
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 452 KSSEKTDVFGYGITLLELVTGQ 473
D F G TL E++ G+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+ E + +G+G G V K L + + A+K + +P + RE+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 330 LLQLIGYCT---TSSERILV-YPFMQNLSVAY---RLRDLKPGEKGLDWPTRKRVAFGTA 382
+++ G +SS I + Y +L Y + R + GEK L ++A
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVL 115
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMG 441
GL YLH + KIIHRD+K +NILL + LCDFG++ +LV++ T GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSF 168
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
++APE + S +DV+ G+TLLE+
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 278 IIGQGGFGKVYKGVLSDNTKV-AVKRLQ---------DYYSPGGEAAFQREVHLISVAIH 327
+IG+G +G+VY + ++ AVK+++ D A + E+ + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
N++Q +G+ TT + ++ S+ LR G + + GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGR--FEEQLVRFFTEQVLEGLAY 123
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPE 446
LH + I+HRDLKA N+L+D + + DFG++K D + ++G++ +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 447 YLSTGKS--SEKTDVFGYGITLLELVTGQRAIDFSRLE 482
+ + S K D++ G +LE+ G+R +S E
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--WSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-17
Identities = 43/94 (45%), Positives = 56/94 (59%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ISL L N SG+I + +L+ L L L N+ +G +P L S+ LQ L L +NKF
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
SG IP + +NL LDLS+NNLTG IP L S
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
|
Length = 968 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 279 IGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAA---FQREVHLISVAIHKNLLQLI 334
+G+G +G V K + VA+K+ ++ S E REV ++ H+N++ L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 335 GYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
LV+ ++ + L L L+ GL + + + Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTL-----LELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH-- 119
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL----S 449
IIHRD+K NIL+ ++ LCDFG A+ + A+ T T + APE L +
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 450 TGKSSEKTDVFGYGITLLELVTGQ 473
GK DV+ G + EL+ G+
Sbjct: 179 YGKP---VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 62/221 (28%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 323
E + D E ++G+G +G VY LS ++A+K + + S + E+ L S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHS 60
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNL---SVAYRLRD----LKPGEKGLDWPTRKR 376
H+N++Q +G SE FM+ + S++ LR LK E+ + + T++
Sbjct: 61 YLKHRNIVQYLGSD---SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKLVDAKLTHVTT 434
+ GL+YLH+ +I+HRD+K N+L+ + + V+ DFG +K + A + T
Sbjct: 118 LE-----GLKYLHDN---QIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRL-AGINPCTE 167
Query: 435 QIRGTMGHIAPEYLSTGKS--SEKTDVFGYGITLLELVTGQ 473
GT+ ++APE + G D++ G T++E+ TG+
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 61/200 (30%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G FGKVYK + A ++ S F E+ ++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
++ ++ F ++ + +L E+GL P + V L +LH K+IH
Sbjct: 73 YENKLWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYLSTGKSS 454
RDLKA NILL + + L DFG V AK T Q R GT +APE ++
Sbjct: 127 RDLKAGNILLTLDGDVKLADFG----VSAKNKS-TLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 455 E-----KTDVFGYGITLLEL 469
+ K D++ GITL+EL
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGE---AAFQREVHLISVAI 326
N+ ++GQG FG+VY D + +AVK++ D SP + A + E+ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 327 HKNLLQLIGYCTTSSERILVY-PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
H+ ++Q G C E + ++ +M SV +L+ + + TRK G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TRK-YTRQILEGV 117
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHI 443
EYLH I+HRD+K ANIL D L DFG +K + + T + GT +
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVT 471
+PE +S K DV+ G T++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 40/221 (18%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIHK 328
+++ IG G +G VYK ++ VA+K ++ PG + Q+E+ ++ H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 329 NLLQLIG-------------YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 375
N++ G YC S L Y++ E + + R+
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGS-----------LQDIYQVTRGPLSELQIAYVCRE 109
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
T GL YLHE IHRD+K ANILL ++ + L DFG++ + A + +
Sbjct: 110 -----TLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161
Query: 436 IRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQ 473
I GT +APE G K D++ GIT +EL Q
Sbjct: 162 I-GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 3e-16
Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 39/213 (18%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVAIHKNLLQ 332
+G+G +G VYK VA+K+++ G RE+ L+ H N+++
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKHPNIVK 62
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L+ T + LV+ + L+ L L K + + GL Y H
Sbjct: 63 LLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGTMGHIAPE 446
+I+HRDLK NIL++ + L DFGLA+ TH VT R APE
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR------APE 168
Query: 447 YL------STGKSSEKTDVFGYGITLLELVTGQ 473
L ST D++ G E++TG+
Sbjct: 169 ILLGSKHYSTA-----VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 71/287 (24%), Positives = 122/287 (42%), Gaps = 31/287 (10%)
Query: 272 NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA 325
N E +G+G FG+V+ T V VK LQ ++ F+RE+ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP---TRKRVAFGT- 381
HKN+++L+G C + ++ + + LR K ++ L P T+++VA T
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 382 -AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
A G+++L N + +HRDL A N L+ E + L+K V + +
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500
+APE + S K+DV+ +G+ + E+ T Q + F L +EE
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDEE--------------- 226
Query: 501 RLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
LN + L + ++ C P+DRP +++V L
Sbjct: 227 VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 71/297 (23%), Positives = 127/297 (42%), Gaps = 46/297 (15%)
Query: 278 IIGQGGFGKVYKGV------LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
+G+G FGKV K + T VAVK L++ S E +L+ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLR--------------------DLKPGEKGLDW 371
+L G C+ +L+ + + S+ LR P E+ L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431
A+ + G++YL E K++HRDL A N+L+ + + + DFGL++ V + ++
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 432 VT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 490
V ++ R + +A E L + ++DV+ +G+ L E+VT + + E LL
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-LGGNPYPGIAPERLFNLL 242
Query: 491 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
++ R + + E M + L C + P+ RP A + K L+
Sbjct: 243 KTGYRMERPENCS---------------EEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 19/213 (8%)
Query: 268 LATDNFSESNIIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREVHLI 322
L F + ++G G FG VYKG+ + K VA+K L++ SP E +++
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 323 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
+ + ++ +L+G C TS+ +++ + PF L +D + L+W +
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 117
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 438
A G+ YL E+ +++HRDL A N+L+ + DFGLAKL+ D K H +
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KV 173
Query: 439 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ +A E + + ++DV+ YG+T+ EL+T
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLL 331
F++ IG+G FG+V+KG+ + KV ++ D E Q+E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+ G ++ ++ M+ L L L+PG LD + GL+YLH +
Sbjct: 66 KYYGSYLKDTK---LWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 120
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 450
K IHRD+KAAN+LL ++ E L DFG+A +L D ++ GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQ 175
Query: 451 GKSSEKTDVFGYGITLLELVTGQ 473
K D++ GIT +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 65/203 (32%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 279 IGQGGFGKVY------KGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+GGFG+V G L K+ KRL+ G E A + L V H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKV--HSRFIV 56
Query: 333 LIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLEYL 388
+ Y T ++ LV M + Y + ++ G P R F TA GLE+L
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEP---RACFYTAQIISGLEHL 113
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEY 447
H++ +II+RDLK N+LLD++ + D GLA +L D + T GT G +APE
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPEL 168
Query: 448 LSTGKSSEKTDVFGYGITLLELV 470
L + D F G+TL E++
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 278 IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
+IG G FG+V G L K VA+K L+ Y+ F E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 391
G T S ++V +M+N S+ LR + + + V G A G++YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLR-----KHDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLS 449
+HRDL A NIL++ N + DFGL++++ D + + T + + APE ++
Sbjct: 126 ---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 450 TGKSSEKTDVFGYGITLLELVT-GQRAI-DFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507
K + +DV+ YGI + E+++ G+R + S +DV I+ + RL +D
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMS----NQDV-----IKAIEEGYRLPAPMD 233
Query: 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
+ Q+ L C Q +RP Q+V +L
Sbjct: 234 CPAALH---------QLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 279 IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
+G+G FG V L DNT VAVK+LQ + + F+RE+ ++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-HSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 334 IGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
G C ++ R LV ++ S LRD L+ + LD A G+EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGS----LRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYL 448
+ + +HRDL NIL++ + DFGL K++ D + V + APE L
Sbjct: 127 K---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 449 STGKSSEKTDVFGYGITLLELVT 471
+ K S +DV+ +G+ L EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 8e-16
Identities = 70/281 (24%), Positives = 110/281 (39%), Gaps = 65/281 (23%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRL----------QDYYSPGGEAAFQREV 319
D+F IIG+G F V N + A+K L Y ++EV
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY------VKIEKEV 54
Query: 320 HLISVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 377
L + H +++L Y T E L V + N + +R LD +
Sbjct: 55 -LTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFY 107
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
A LEYLH + IIHRDLK NILLD + + DFG AK++D + + +
Sbjct: 108 AAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 438 -------------------GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID- 477
GT +++PE L+ + + +D++ G + +++TG+
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
Query: 478 ------FSRLEEEE-------DVLLLDHIRKLLR---EDRL 502
F ++ + E D I KLL +DRL
Sbjct: 225 SNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLL 331
F++ IG+G FG+VYKG+ + +V ++ D E Q+E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+ G ++ ++ M+ L L LKPG L+ + GL+YLH +
Sbjct: 66 RYYGSYLKGTK---LWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSE 120
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 450
+ IHRD+KAAN+LL + + L DFG+A +L D ++ T GT +APE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175
Query: 451 GKSSEKTDVFGYGITLLELVTGQ 473
K D++ GIT +EL G+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG-Y 336
+GQG G VYK A+K++ RE+ + +++ G +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
I +V +M S+A L+ + E L +A GL+YLH +
Sbjct: 69 Y--KEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGLDYLHTK--R 119
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 454
IIHRD+K +N+L++ E + DFG++K+++ L T + GT+ +++PE + S
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYS 178
Query: 455 EKTDVFGYGITLLELVTGQ 473
D++ G+TLLE G+
Sbjct: 179 YAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 32/273 (11%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G FG V G VA+K +++ E F E ++ H+ L+QL G CT
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
+V +M N + LR+ K + G+ YL + + IH
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTGKSS 454
RDL A N L+DD + DFGL++ V D + V ++ +R + PE L K S
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLLYSKFS 179
Query: 455 EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD 514
K+DV+ +G+ + E+ + + + + R E V + +L R +
Sbjct: 180 SKSDVWAFGVLMWEVYSLGK-MPYERFNNSETVEKVSQGLRLYRPHLAS----------- 227
Query: 515 SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
E + + C E+RP Q++ ++
Sbjct: 228 ----EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 26/224 (11%)
Query: 278 IIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREV-HLISVAI--HKN 329
++G G FG V+KG+ D+ K VA+K +QD G FQ H++++ H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAY 70
Query: 330 LLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
+++L+G C +S +++ + P L + RD ++ L+W + A G+ Y
Sbjct: 71 IVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYY 124
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAP 445
L E ++HR+L A NILL + + DFG+A L+ D K + ++ + + +A
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK-KYFYSEHKTPIKWMAL 180
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 488
E + G+ + ++DV+ YG+T+ E+++ G R E D+L
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 335
+G G FG VY VA+K++ + +YS E REV L + H N+++L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 336 YCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
+ E V+ +M NL + R KP + + + GL ++H+
Sbjct: 66 VFRENDELYFVFEYMEGNLYQLMKDRKGKP----FSESVIRSIIYQILQGLAHIHKH--- 118
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL--STGK 452
HRDLK N+L+ + DFGLA+ + ++ + T + T + APE L ST
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILLRSTSY 176
Query: 453 SSEKTDVFGYGITLLELVTGQ 473
SS D++ G + EL T +
Sbjct: 177 SS-PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 58/226 (25%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REVHLISVAI 326
IG G +G V V KVA+K++ + F RE+ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISN--------VFDDLIDAKRILREIKLLRHLR 57
Query: 327 HKNLLQLI-----GYCTTSSERILVYPFMQ-NL-SVAYRLRDLKPGEKGLDWPTRKRVAF 379
H+N++ L+ ++ +V M+ +L V + L T + +
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQY 107
Query: 380 GTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK------L 429
Y GL+YLH N +IHRDLK +NIL++ N + +CDFGLA+ VD L
Sbjct: 108 FL-YQILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 430 T-HVTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTG 472
T +V T+ R APE LS+ + ++ D++ G EL+T
Sbjct: 164 TEYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 50/126 (39%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L LG N GKI S+T L L L L N L G +P LG M L+ + L N SG I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 141 PATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVS 200
P L++L HLDL NNLTG IP L ++ + L Q +S P PP
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL--------FLYQNKLSGPIPPSI 280
Query: 201 TSRTKL 206
S KL
Sbjct: 281 FSLQKL 286
|
Length = 968 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 20/175 (11%)
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 434
++A GL YL+ +I+HRD+K +NIL++ + LCDFG++ +L+++ +
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IAD 160
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494
GT +++PE + GK + K+DV+ GI+++EL G+ FS D D
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS----NIDDDGQDDPM 216
Query: 495 KLLREDRLNDIVDR---NLNTYD-SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545
+L D L IV L + D +++ V LL P +RP Q+ M
Sbjct: 217 GIL--DLLQQIVQEPPPRLPSSDFPEDLRDFVDACLL---KDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 78/307 (25%), Positives = 125/307 (40%), Gaps = 58/307 (18%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLS----DNTK--VAVKRLQDYYSPGGEAAFQREVH 320
++ D+ + +G G FG+VY+G+ D + VAVK L + S E+ F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 321 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR---- 376
++S H+N+++LIG R ++ M + LR+ +P + P+
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRP---RPERPSSLTMKDL 118
Query: 377 --VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKLVDAKLTH 431
A A G +YL E IHRD+ A N LL A + DFG+A+ D
Sbjct: 119 LFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRAS 173
Query: 432 VTTQIRGTMGHIA---PEYLSTGKSSEKTDVFGYGITLLELV-------TGQRAIDFSRL 481
+ M I PE G + KTDV+ +G+ L E+ G+
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT------- 226
Query: 482 EEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMV-QVALLCTQSTPEDRPPMA 540
++V+ + RL+ K V ++ C Q TPEDRP A
Sbjct: 227 --NQEVMEF-----VTGGGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFA 269
Query: 541 QVVKMLQ 547
+++ +Q
Sbjct: 270 TILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 279 IGQGGFGKVYKGVLSDNT-------KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
+G+GGFG+V V NT K+ KRL+ GE E ++ ++
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLK---KKSGEKMALLEKEILEKVNSPFIV 56
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLEYL 388
L + + LV M + Y + ++ GE+GL+ +RV +A G+ +L
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEM---ERVIHYSAQITCGILHL 111
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H I++RD+K N+LLDD L D GLA V+ K TQ GT G++APE L
Sbjct: 112 HSM---DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEIL 166
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAI-DFSRLEEEEDVL 488
S D F G ++ E+V G+ D +E++
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-15
Identities = 38/88 (43%), Positives = 52/88 (59%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L L N SG I PSI L+ L SL+L DN LSG +P+ + + +L+ L+L +N F+G I
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324
Query: 141 PATWSQLSNLKHLDLSSNNLTGRIPMQL 168
P + L L+ L L SN +G IP L
Sbjct: 325 PVALTSLPRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 52/301 (17%)
Query: 277 NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 332
++IG+G FG+V K + + A+KR+++Y S F E+ L + H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA------------FG 380
L+G C L + + ++ LR + E + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
A G++YL ++ + IHRDL A NIL+ +N+ A + DFGL++ + ++ TM
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 182
Query: 441 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEEEEDVLLLDHI 493
G + A E L+ + +DV+ YG+ L E+V+ G + E E
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-------- 234
Query: 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE 553
KL + RL ++ LN D + + M Q C + P +RP AQ++ L L E
Sbjct: 235 -KLPQGYRL----EKPLNC-DDEVYDLMRQ----CWREKPYERPSFAQILVSL-NRMLEE 283
Query: 554 R 554
R
Sbjct: 284 R 284
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 20/221 (9%)
Query: 278 IIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
++G G FG VYKG+ + VA+K L + P F E +++ H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 333 LIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
L+G C + + +++ + P L + +D + L+W + A G+ YL E
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM--GHIAPEYL 448
+ +++HRDL A N+L+ + DFGLA+L++ G M +A E +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD-GGKMPIKWMALECI 183
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 488
K + ++DV+ YG+T+ EL+T G + D E D+L
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 72/296 (24%), Positives = 129/296 (43%), Gaps = 41/296 (13%)
Query: 279 IGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+GQG FG VY+G D T+VAVK + + S F E ++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK---GLDWPTRK---RVAFGTAYGLE 386
L+G + ++V M + + LR L+P + G PT + ++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG----- 441
YL+ + K +HRDL A N ++ +F + DFG+ + + +G G
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501
+APE L G + +D++ +G+ L E+ + L E+ + L E
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQP-------YQGLSNEQV 230
Query: 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAE 557
L ++D E + + +C Q P+ RP ++V +L+ +DL + E
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK-DDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 24/226 (10%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTK-VAVKRLQDYYSPGGEAAFQREV 319
EL L+ F E +G+ FGK+YKG L D+ + VA+K L+D +P FQ+E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 320 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP--------GEKG--- 368
L++ H N++ L+G T +++ ++ + L P E G
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 369 --LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LV 425
LD +A A G+EYL +H+DL A NIL+ + + D GL++ +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
A V + + + PE + GK S +D++ +G+ L E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 22/232 (9%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTKV-AVKR--LQDYYSPGGEAAFQREVHLISVAIHK 328
+F N IG+G FG V+K V + +V A+K+ L E A E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLE 386
+I Y + ++ + M+ L L ++G P + R GL
Sbjct: 60 ---YIIRYYESFLDKGKLNIVMEYAENG-DLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
+LH + KI+HRD+K+ N+ LD + D G+AKL+ T+ I GT +++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-TNFANTIVGTPYYLSPE 171
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498
+EK+DV+ G+ L E TG+ D + L I K++R
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGAL----ILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 279 IGQGGFGKV----YKGVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV Y +D T VAVK L+ + +++E++++ H+N+++
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
G C+ + L M+ + + LRD P K L+ A G+ YLH Q
Sbjct: 71 YKGCCSEQGGKGLQL-IMEYVPLG-SLRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYL 448
IHRDL A N+LLD++ + DFGLAK V H ++R + A E L
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRVREDGDSPVFWYAVECL 182
Query: 449 STGKSSEKTDVFGYGITLLELVT 471
K S +DV+ +G+TL EL+T
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 26/224 (11%)
Query: 278 IIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
++G G FG VYKG+ +N K VA+K L++ SP E ++++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 333 LIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
L+G C TS+ +++ + P+ L +D + L+W + A G+ YL E
Sbjct: 74 LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----AP 445
+++HRDL A N+L+ + DFGLA+L+D T+ G + A
Sbjct: 128 V---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID----ETEYHADGGKVPIKWMAL 180
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 488
E + + + ++DV+ YG+T+ EL+T G + D E D+L
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 52/299 (17%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNT-----KVAVKRLQDYYSPGGEAAFQREVHLISVA 325
D + S+++ +G FG+++ G+L D +V VK ++D+ S +E L+
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 326 IHKNLLQLIGYCTTSSERILV-YPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGT- 381
H+N+L ++ C E V YP+M NL + + L T++ V
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 382 -AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
A G+ YLH +IH+D+ A N ++D+ + + D L++ + H +
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-------CL 175
Query: 441 GH--------IAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRA---IDFSRLEEEEDVL 488
G +A E L + S +DV+ +G+ L EL+T GQ ID E
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID----PFEMAAY 231
Query: 489 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
L D R + + +N D + V C PE+RP +Q+V+ L
Sbjct: 232 LKDGYR-----------LAQPINCPDE-----LFAVMACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 33/176 (18%)
Query: 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKR-LQDYYSPGGEAAFQREVHLISVAI 326
++ +G+G FG+VYK + VA+K+ L G RE+ ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 327 HKNLLQLIGYCTTSSERI--------LVYPFM--------QNLSVAYRLRDLKPGEKGLD 370
H N++ LI ++ +V P+M +N SV +K L
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL- 124
Query: 371 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
G+ YLHE I+HRD+KAANIL+D+ + DFGLA+ D
Sbjct: 125 -----------LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 51/293 (17%)
Query: 277 NIIGQGGFGKVYKGVL-SDNTKV--AVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 332
++IG+G FG+V + ++ D K+ A+K L+++ S F E+ L + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 333 LIGYCTTSSE---RILVYPFMQNLSVAYRLRDLKPG-----EKG----LDWPTRKRVAFG 380
L+G C I P+ L + R L+ E G L + A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
A G++YL E+ + IHRDL A N+L+ +N + + DFGL++ + ++ TM
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKKTM 177
Query: 441 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEEEEDVLLLDHI 493
G + A E L+ + K+DV+ +G+ L E+V+ G + E E
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE-------- 229
Query: 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
KL + R+ RN D + E M Q C + P +RPP AQ+ L
Sbjct: 230 -KLPQGYRMEK--PRNC---DDEVYELMRQ----CWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 18/216 (8%)
Query: 273 FSESNIIGQGGFGKVYKGVL--SDNT--KVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
F+ ++G+G FG V + L D + KVAVK L+ D +S F RE + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 328 KNLLQLIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF-- 379
N+++LIG S + +++ PFM++ + L + GE+ P + V F
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRG 438
A G+EYL + IHRDL A N +L++N + DFGL+ K+ +
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 439 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQ 473
+ +A E L+ + +DV+ +G+T+ E++T GQ
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 70/294 (23%), Positives = 125/294 (42%), Gaps = 52/294 (17%)
Query: 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA-----AFQREVHLISVA 325
+ + +G G F Y+ + T +AVK++ + E A ++E+ L++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
H ++++++G S L +M SV++ L ++ + +++ GL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGL 116
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLT---HVTTQIRGTMG 441
YLHE +IIHRD+K AN+L+D + + + DFG A + AK T Q+ GT+
Sbjct: 117 SYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR-----------AIDFSRLEEEEDVLLL 490
+APE L + DV+ G ++E+ T + A+ F +
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233
Query: 491 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
+H+ LR+ V L C + PEDRPP +++K
Sbjct: 234 EHLSPGLRD------------------------VTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 329
NF + IG+G +G VYK + VA+K+++ D + G + RE+ L+ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 330 LLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
+++L+ T ++ LV+ F+ Q+L + D P G+ P K F GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASPLS-GIPLPLIKSYLFQLLQGLAFC 116
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H +++HRDLK N+L++ L DFGLA+ + T ++ T+ + APE L
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 172
Query: 449 STGK-SSEKTDVFGYGITLLELVTGQRAI 476
K S D++ G E+VT +RA+
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 43/102 (42%), Positives = 57/102 (55%), Gaps = 13/102 (12%)
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVD--AKLTHVT 433
+A T L YL E KIIHRD+K +NILLD N LCDFG++ +LVD AK
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----- 164
Query: 434 TQIRGTMGHIAPEYLSTGKSSE---KTDVFGYGITLLELVTG 472
T+ G ++APE + ++DV+ GITL E+ TG
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 12/206 (5%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
+ + IG+G G+VYK + +VA+K++ E E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIIN-EILIMKDCKHP 75
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ E +V +M S+ + ++ P V GLEYL
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVDAKLTHVTTQIRGTMGHIAPEY 447
H Q +IHRD+K+ NILL + L DFG A+L K + + GT +APE
Sbjct: 133 HSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEV 187
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQ 473
+ K D++ GI +E+ G+
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 51/293 (17%)
Query: 277 NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 332
++IG+G FG+V K + + A+KR+++Y S F E+ L + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 333 LIGYCTTSSE---RILVYPFMQNLSVAYRLRDLKPG-----EKG----LDWPTRKRVAFG 380
L+G C I P L + R L+ L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
A G++YL ++ + IHRDL A NIL+ +N+ A + DFGL++ + ++ TM
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 170
Query: 441 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEEEEDVLLLDHI 493
G + A E L+ + +DV+ YG+ L E+V+ G + E E
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-------- 222
Query: 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
KL + RL N D + + M Q C + P +RP AQ++ L
Sbjct: 223 -KLPQGYRLEK--PLNC---DDEVYDLMRQ----CWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 39/94 (41%), Positives = 56/94 (59%), Gaps = 10/94 (10%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHI 443
L YL E+ +IHRD+K +NILLD + LCDFG++ +LVD+K T+ G ++
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYM 181
Query: 444 APEYLSTGKSSEK----TDVFGYGITLLELVTGQ 473
APE + + K DV+ GI+L+EL TGQ
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G FGKVYK + +A ++ D S + E+ +++ H N+++L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
+ ++ F +V + +L E+ L P + V T L YLHE KIIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYLSTGKSS 454
RDLKA NIL + + L DFG V AK T T Q R GT +APE + S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFG----VSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 455 E-----KTDVFGYGITLLEL 469
+ K DV+ GITL+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-13
Identities = 47/116 (40%), Positives = 61/116 (52%), Gaps = 14/116 (12%)
Query: 83 LGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 142
LG N SG+I I L L L+L N+L+G +P LG++ +LQ L L NK SG IP
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 143 TWSQLSNLKHLDLSSNNLTGRIP-----------MQLFSVATFNFTGTHLICGSSL 187
+ L L LDLS N+L+G IP + LFS NFTG + +SL
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN---NFTGKIPVALTSL 331
|
Length = 968 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 78/303 (25%), Positives = 135/303 (44%), Gaps = 43/303 (14%)
Query: 267 QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 318
+ + D + +G+G FG+V G+ D K VAVK L+D + + E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 319 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------G 365
+ ++ + HKN++ L+G CT ++ + ++ LR +P
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 366 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425
++ + + + A G+EYL Q K IHRDL A N+L+ +N + DFGLA+ V
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 426 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE 483
+ TT R + +APE L + ++DV+ +G+ + E+ T G +EE
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
Query: 484 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 543
+ KLL+E +D+ N + E+ M++ C + P RP Q+V
Sbjct: 248 ---------LFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAIPSHRPTFKQLV 290
Query: 544 KML 546
+ L
Sbjct: 291 EDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 270 TDNFSESNIIGQGGFGKV--YKGVLSDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAI 326
T+ + + +G G FG V + L+ VA+K++ +S P RE+ L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H+N++ L + E I + + RL +P EK + + GL+
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLH-RLLTSRPLEKQF----IQYFLYQILRGLK 122
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAP 445
Y+H + ++HRDLK +NIL+++N + +CDFGLA++ D ++T +V+T+ + AP
Sbjct: 123 YVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAP 174
Query: 446 EYLST-GKSSEKTDVFGYGITLLELVTGQ 473
E + T K + D++ G E++ G+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 69/298 (23%), Positives = 131/298 (43%), Gaps = 40/298 (13%)
Query: 267 QLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQREVH 320
++A + + S +GQG FG VY KGV+ D T+VA+K + + S F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 321 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRV 377
++ ++++L+G + +++ M + LR L+P P+ K++
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 378 ---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 434
A A G+ YL+ K +HRDL A N ++ ++F + DFG+ + +
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDY 174
Query: 435 QIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489
+G G ++PE L G + +DV+ +G+ L E+ T E+ +
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------LAEQPYQGMS 226
Query: 490 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + + + E L D D N D + ++ +C Q P+ RP +++ ++
Sbjct: 227 NEQVLRFVMEGGLLDKPD---NCPD-----MLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 28/270 (10%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G FG V+ G KVA+K + + E F E ++ H L+QL G CT
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
+V FM+N + LR + G+ D + G+EYL E+ + IH
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKD--MLLSMCQDVCEGMEYL-ERNS--FIH 123
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
RDL A N L+ + DFG+ + V D + T ++ + + PE + K S K+
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 458 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSK- 516
DV+ +G+ + E+ T + E++ + + + + R RL Y K
Sbjct: 183 DVWSFGVLMWEVFTEGKM----PFEKKSN---YEVVEMISRGFRL----------YRPKL 225
Query: 517 EVETMVQVALLCTQSTPEDRPPMAQVVKML 546
T+ +V C PE RP A++++ +
Sbjct: 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 279 IGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKN 329
+G+G FG+V + G+ VAVK L+D + A E+ L+ + HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRV 377
++ L+G CT ++ + ++ LR +P E+ L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQI 436
A+ A G+EYL + + IHRDL A N+L+ ++ + DFGLA+ V D T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
R + +APE L + ++DV+ +GI + E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 278 IIGQGGFGKV----YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
IG+G FG V Y+G KVAVK +++ AF E +++ H NL+QL
Sbjct: 13 TIGKGEFGDVMLGDYRG-----NKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQL 64
Query: 334 IGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
+G + +V +M S+ LR G L + + +EYL
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEAN- 121
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 452
+HRDL A N+L+ ++ A + DFGL K + ++ T APE L K
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKK 175
Query: 453 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 487
S K+DV+ +GI L E+ + R + + R+ ++ V
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR-VPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 33/88 (37%), Positives = 49/88 (55%), Gaps = 1/88 (1%)
Query: 83 LGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 142
L N FSG++ TKL + L++ +N+L G + M LQ L+LA NKF G +P
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD 470
Query: 143 TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L++LDLS N +G +P +L S
Sbjct: 471 S-FGSKRLENLDLSRNQFSGAVPRKLGS 497
|
Length = 968 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 59/282 (20%), Positives = 111/282 (39%), Gaps = 47/282 (16%)
Query: 278 IIGQGGFGK--VYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLI 334
++G+G FG+ +Y+ D++ V K + S E+ ++S+ H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKGLDWPTRKRVA--FGTAYG 384
+ FM + ++ + G +KG + + F
Sbjct: 66 NH------------FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
+ Y+H+ I+HRD+K NI L L DFG++K++ ++ + T + GT +++
Sbjct: 114 VSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMS 169
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504
PE K + K+D++ G L EL+T +R D + +
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----------------LVVK 212
Query: 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
IV N S ++ + Q PE RP +V+
Sbjct: 213 IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGE---AAFQREVHLISVAI 326
N+ ++GQG FG+VY +D + +AVK++Q D SP A + E+ L+ +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H+ ++Q G ER L FM+ ++D L ++ G+
Sbjct: 63 HERIVQYYGCLRDPMERTLSI-FME-HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIA 444
YLH I+HRD+K ANIL D L DFG +K + T + GT ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVT 471
PE +S K D++ G T++E++T
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 27/262 (10%)
Query: 298 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 357
VAVK L+ S F +EV ++S N+ +L+G CT ++ +M+N +
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 358 RLRDLKPGEKGLDWPTRKRVAFGT--------AYGLEYLHEQCNPKIIHRDLKAANILLD 409
L+ GL K ++F T A G+ YL E N +HRDL N L+
Sbjct: 109 FLQKHVAETSGLAC-NSKSLSFSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVG 164
Query: 410 DNFEAVLCDFGLAKLVDAKLTHVTTQIRG-TMGHI---APEYLSTGKSSEKTDVFGYGIT 465
N+ + DFG+++ + + +++G I A E + GK + K+DV+ +G+T
Sbjct: 165 KNYTIKIADFGMSRNLYSS---DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221
Query: 466 LLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVA 525
L E++T R + L +++ ++++ R+D + R N + + ++
Sbjct: 222 LWEILTLCREQPYEHLTDQQ---VIENAGHFFRDDGRQIYLPRPPNC-----PKDIYELM 273
Query: 526 LLCTQSTPEDRPPMAQVVKMLQ 547
L C + EDRP ++ LQ
Sbjct: 274 LECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 30/192 (15%)
Query: 273 FSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA----AFQREVHL---ISV 324
+ E IG+G +G VYK L+ VA+K+++ P E + RE+ L +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 325 AIHKNLLQLIGYCTTS-SERI----LVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVA 378
H N+++L+ C ++R LV+ + Q+L+ K + GL T K +
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLS----KCPKPGLPPETIKDLM 113
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD--AKLTHVTTQI 436
G+++LH I+HRDLK NIL+ + + + DFGLA++ LT V
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-- 168
Query: 437 RGTMGHIAPEYL 448
T+ + APE L
Sbjct: 169 --TLWYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLL 331
F++ IG+G FG+V+KG+ + +V ++ D E Q+E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+ G ++ ++ M+ L L L+ G D + GL+YLH +
Sbjct: 66 KYYGSYLKGTK---LWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLHSE 120
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 450
K IHRD+KAAN+LL + + L DFG+A +L D ++ T GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 175
Query: 451 GKSSEKTDVFGYGITLLELVTGQ 473
K D++ GIT +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 60/223 (26%), Positives = 89/223 (39%), Gaps = 47/223 (21%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQR---EVHLISVAIHKNLLQ 332
IG+G FG V K SD + K + Y E Q+ EV+++ H N+++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 333 LIGYCTTSSERIL------VYPFM---------QNLSVAYRLRDLKPGEKGLDWPTRKRV 377
+RI+ +Y M Q + + R E R+
Sbjct: 64 YY-------DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW------RI 110
Query: 378 AFGTAYGLEYLH--EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-----AKLT 430
L H ++HRDLK ANI LD N L DFGLAK++ AK T
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK-T 169
Query: 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+V GT +++PE L+ EK+D++ G + EL
Sbjct: 170 YV-----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 56/299 (18%)
Query: 271 DNFSESNIIGQGGFGKVYKGV---LSDN---TKVAVKRLQDYYSPGGEAAFQREVHLIS- 323
+N S +G G FGKV + LS + KVAVK L+ A E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT-- 381
+ H+N++ L+G CT +++ + DL L++ RKR +F T
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYC-------CYGDL------LNFLRRKRESFLTLE 141
Query: 382 ---------AYGLEYL-HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431
A G+ +L + C IHRDL A N+LL +CDFGLA+ + +
Sbjct: 142 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197
Query: 432 VTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR-LEEEEDVLL 489
V R + +APE + + ++DV+ YGI L E+ FS + +
Sbjct: 198 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI--------FSLGSNPYPGMPV 249
Query: 490 LDHIRKLLRED-RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
KL++E R+ + E+ +++ C + P RP Q+V+++
Sbjct: 250 DSKFYKLIKEGYRMAQPE------HAPAEIYDIMKT---CWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREV 319
CR + F + N IG+G +G VY+ + + + VA+K+++ D G + RE+
Sbjct: 2 RCRSVT----EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREI 57
Query: 320 HLISVAIHKNLLQLIGYCTTSS-ERI-LVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKR 376
L+ H N+++L + I LV + Q+L+ L D P K
Sbjct: 58 TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLA---SLLDNMP--TPFSESQVKC 112
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
+ GL+YLHE IIHRDLK +N+LL D + DFGLA+ +T ++
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 437 RGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 473
T+ + APE L + D++ G L EL+ +
Sbjct: 170 V-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L + +N G+I+ + L L L N G LPD GS L++L+L+ N+FSG++
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAV 491
Query: 141 PATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
P LS L L LS N L+G IP +L S
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSS 521
|
Length = 968 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 50/226 (22%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVH--------- 320
D + + +G G +G+V + KVA+K+L P FQ +H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL---SRP-----FQSAIHAKRTYRELR 66
Query: 321 LISVAIHKNLLQLIGYCTTSSER------ILVYPFM-QNLSVAYRLRDLKPGEKGLDWPT 373
L+ H+N++ L+ T +S LV M +L+ + + L +
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL----------S 116
Query: 374 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
+ F Y GL+Y+H + IIHRDLK +NI ++++ E + DFGLA+ D ++
Sbjct: 117 DDHIQF-LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM 172
Query: 430 T-HVTTQIRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 473
T +V T + APE L+ ++ D++ G + EL+TG+
Sbjct: 173 TGYV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 279 IGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 329
+G+G FG+V G+ D VAVK L+D + + E+ ++ + HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW-------PTRK------- 375
++ L+G CT ++ + ++ LR +P G+D+ P +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRP--PGMDYSFDTCKLPEEQLTFKDLV 137
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTT 434
A+ A G+EYL Q K IHRDL A N+L+ ++ + DFGLA+ V + TT
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
R + +APE L + ++DV+ +G+ L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 17/206 (8%)
Query: 279 IGQGGFGKVYKG---VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
IG G FGKV G +V VK L+ +P + F +EV H N+LQ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP-TRKRVAFGTAYGLEYLHEQCNP 394
C S +LV F + LR + + +R+A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT--QIRGTMGHIAPEY----- 447
IH DL N L + + D+GLA L + T + +APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 448 --LSTGKSSEKTDVFGYGITLLELVT 471
L ++K++++ G+T+ EL T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 12/209 (5%)
Query: 279 IGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G+G + VYKG L+DN VA+K ++ + G REV L+ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
T LV+ ++ Y L ++ K F GL Y H + K+
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQY----LDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGKSSE 455
+HRDLK N+L+++ E L DFGLA+ + ++ T+ + P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 456 KTDVFGYGITLLELVTGQRAIDFSRLEEE 484
+ D++G G E+ TG+ S +EE+
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 47/141 (33%), Positives = 59/141 (41%), Gaps = 28/141 (19%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVD-----AKLTHVTTQI 436
LEYLH + IIHRDLK NIL+D N L DFGL+K LV +I
Sbjct: 105 ALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-----------------QRAIDFS 479
GT +IAPE + S+ D + G L E + G I++
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221
Query: 480 RLEEEEDVLLLDHIRKLLRED 500
E D +D I KLL D
Sbjct: 222 EDVEVSDE-AIDLISKLLVPD 241
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 279 IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV+ D VAVK L++ S FQRE L++V H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLD-----------WPTRKRVAFGT 381
G CT ++V+ +M++ + LR P K L +A
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTM 440
A G+ YL + +HRDL N L+ + DFG+++ + V + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ PE + K + ++D++ +G+ L E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 82/334 (24%), Positives = 134/334 (40%), Gaps = 84/334 (25%)
Query: 279 IGQGGFGKVYKGVLSDNTK------VAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLL 331
+G+G FGKV + K VAVK L++ + A E+ LI + H N++
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 332 QLIGYCTTSSERILV---YPFMQNLS----------VAYRLRDL-------KPGEKG-LD 370
L+G CT ++V Y NLS YR + K G+K LD
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 371 ------------WPTRKRV-------------------------AFGTAYGLEYLHEQCN 393
+ K + +F A G+E+L +
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR-- 192
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGK 452
K IHRDL A NILL +N +CDFGLA+ + +V R + +APE +
Sbjct: 193 -KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251
Query: 453 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512
+ ++DV+ +G+ L E+ + A + ++ +E+ R+L R+
Sbjct: 252 YTTQSDVWSFGVLLWEIFS-LGASPYPGVQIDEEF-----CRRLKEGTRMRA-------- 297
Query: 513 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
+ + L C + PEDRP +++V++L
Sbjct: 298 -PEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 39/104 (37%), Positives = 61/104 (58%), Gaps = 14/104 (13%)
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVD--AKLTHV 432
++A LEYLH + +IHRD+K +N+L++ N + LCDFG++ LVD AK
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---- 160
Query: 433 TTQIRGTMGHIAPEYLSTGKSSE----KTDVFGYGITLLELVTG 472
T G ++APE ++ + + K+DV+ GIT++EL TG
Sbjct: 161 -TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 65/220 (29%), Positives = 90/220 (40%), Gaps = 52/220 (23%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQ---REVHLISVAIHK 328
F++ IG G FG VY + VA+K++ Y +Q +EV + H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 329 NLLQLIG-------------YCTTSSERIL-VY--PFMQNLSVAYRLRDLKPGEKGLDWP 372
N ++ G YC S+ IL V+ P +Q + +A
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP-LQEVEIA---------------- 118
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
+ G GL YLH IHRD+KA NILL + L DFG A LV + V
Sbjct: 119 ---AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV 172
Query: 433 TTQIRGTMGHIAPEY---LSTGKSSEKTDVFGYGITLLEL 469
GT +APE + G+ K DV+ GIT +EL
Sbjct: 173 -----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-13
Identities = 36/99 (36%), Positives = 56/99 (56%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ +L L +N SG+I I L L+L N L G +P+ L ++T L+ L LA+N+
Sbjct: 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQL 200
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN 175
G IP Q+ +LK + L NNL+G IP ++ + + N
Sbjct: 201 VGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239
|
Length = 968 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 80/309 (25%), Positives = 139/309 (44%), Gaps = 55/309 (17%)
Query: 267 QLATDNFSESNIIGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 318
++ D +G+G FG+V G+ + TKVAVK L+ + + E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 319 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW---PTR 374
+ ++ + HKN++ L+G CT ++ + ++ LR +P G+++ PT+
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP--PGMEYCYNPTQ 131
Query: 375 KRV-----------AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423
A+ A G+EYL + K IHRDL A N+L+ ++ + DFGLA+
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 188
Query: 424 LVDAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 477
+ H+ TT R + +APE L + ++DV+ +G+ L E+ T G
Sbjct: 189 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244
Query: 478 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 537
+EE + KLL+E +D+ N + E+ M++ C + P RP
Sbjct: 245 GVPVEE---------LFKLLKEGHR---MDKPSNC--TNELYMMMRD---CWHAVPSQRP 287
Query: 538 PMAQVVKML 546
Q+V+ L
Sbjct: 288 TFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 7e-13
Identities = 57/190 (30%), Positives = 79/190 (41%), Gaps = 43/190 (22%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQ--REVHLISVAIHKNLLQL 333
+G+G + VYK VA+K +L + F RE+ L+ H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---------- 383
+ S LV+ FM+ DL EK + K + A
Sbjct: 68 LDVFGHKSNINLVFEFMET--------DL---EKVIK---DKSIVLTPADIKSYMLMTLR 113
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRG 438
GLEYLH I+HRDLK N+L+ + L DFGLA+ + K+TH VT R
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR- 169
Query: 439 TMGHIAPEYL 448
APE L
Sbjct: 170 -----APELL 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 277 NIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
N +G G FG+VY+G +D +VAVK L+ + + F +E HL+S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK---PGEKGLDWPTRKRVAFGTAYGLE 386
+++L+G C + + ++ M+ + LRD + G L + A G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAV-----LCDFGLAK-LVDAKLTHVTTQIRGTM 440
YL + IHRDL A N L+ + + DFGLA+ + + + +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+APE L GK + ++DV+ +G+ + E++T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-13
Identities = 41/91 (45%), Positives = 53/91 (58%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L L N +G I S+ LK L L L N LSG +P + S+ L SL+L++N SG I
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 141 PATWSQLSNLKHLDLSSNNLTGRIPMQLFSV 171
P QL NL+ L L SNN TG+IP+ L S+
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
|
Length = 968 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
TD + IG+G +GKVYK D + AVK L E + + L S+ H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-LQSLPNHP 79
Query: 329 NLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
N+++ G + + + LV SV ++ L + LD + +G
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVDAKLTHVTTQIRGTMGH 442
GL++LH N +IIHRD+K NILL L DFG+ A+L +L T+ GT
Sbjct: 140 GLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFW 194
Query: 443 IAPEYLSTGKSSE-----KTDVFGYGITLLELVTG 472
+APE ++ + + + DV+ GIT +EL G
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 279 IGQGGFGKVYKG-VLSD--NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
IG G FGKV G V S +V VK L+ S + F E H NLLQ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEK-GLDWPTRKRVAFGTAYGLEYLHEQCNP 394
CT + +LV F + LR + E D T +R+A A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKS 453
IH DL N LL + + D+GL+ + +VT Q+ + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 454 -------SEKTDVFGYGITLLEL 469
+++++V+ G+T+ EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 12/220 (5%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
D++ + +G+G + VYKG N K VA+K ++ G RE L+ H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
++ L T LV+ ++ Y D PG GL K F GL Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPG--GLHPENVKLFLFQLLRGLSYIH 120
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YL 448
++ I+HRDLK N+L+ D E L DFGLA+ + +H + T+ + P+ L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
+ + S D++G G +E++ G A F +++ +D L
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAA--FPGMKDIQDQL 214
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 75/281 (26%), Positives = 111/281 (39%), Gaps = 41/281 (14%)
Query: 272 NFSESNIIGQGGFGKVYK-GVLSDNTKVAVKR--LQDYYSPGGEAAFQREVHLISVAIHK 328
+F +G+G +G VYK LSDN A+K L E A E+ +++ H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59
Query: 329 NLLQLIGYCTTSSE-RILV----YPFMQNLSVAYRLRDL--KPGEKGLDWPTRKRVAFGT 381
N+ I Y + L Y +LS A R K + W R+
Sbjct: 60 NI---ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQL 112
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441
GL+ LHEQ KI+HRDLK+ANILL N + D G++K+ K TQI GT
Sbjct: 113 LRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKTQI-GTPH 166
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501
++APE S K+D++ G L E+ T + +++ LR
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------------LRYKV 213
Query: 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQV 542
Y + + Q P+ RP ++
Sbjct: 214 QRGKYPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-12
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 278 IIGQGGFGKVYKG---VLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQ 332
+IG+GG G+VY V S +VA+K++++ S P + F RE + + IH ++
Sbjct: 9 LIGKGGMGEVYLAYDPVCS--RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 333 LIGYCTTSSERILVY---PFMQNLSVAYRLRDL-------KPGEKGLDWPTRKRVAFGTA 382
+ C S+ VY P+++ ++ L+ + K + +
Sbjct: 67 VYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK-------------- 428
+EY+H + ++HRDLK NILL E V+ D+G A +
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 429 LTHVTT---QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
T +I GT ++APE L +SE TD++ G+ L +++T
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 279 IGQGGFGKVYKGVLSDNTKV--AVK--RLQDYYSPGGEAAFQ---REVHLISVAIHKNLL 331
+G+G +G VYK VL T V A+K RL+ E+ F E+ ++ A+ ++
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLEL-----DESKFNQIIMELDILHKAVSPYIV 62
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
G + +M S+ +L +G+ +R+ + GL++L E+
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
N IIHRD+K N+L++ N + LCDFG++ + A L T I G ++APE + +G
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--KTNI-GCQSYMAPERIKSG 176
Query: 452 KSSE------KTDVFGYGITLLELVTG 472
++ ++DV+ G+++LE+ G
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
NF + +G+G + VYKG + VA+K + G + RE+ L+ H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-----GEKG-LDWPTRKRVAFGTAYG 384
++L T ++ +LV+ +M DLK G +G LD T K + G
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDK--------DLKKYMDTHGVRGALDPNTVKSFTYQLLKG 112
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
+ + HE +++HRDLK N+L++ E L DFGLA+ + + ++ T+ + A
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRA 168
Query: 445 PEYLSTGKS-SEKTDVFGYGITLLELVTG 472
P+ L ++ S D++ G + E++TG
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G FGKVYK + +A ++ + S + E+ +++ H +++L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
+ ++ F +V + +L ++GL P + + L+YLH KIIH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIH 133
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYL--STGK 452
RDLKA N+LL + + L DFG V AK T Q R GT +APE + T K
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFG----VSAKNVK-TLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 453 SSE---KTDVFGYGITLLEL 469
+ K D++ GITL+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGE---AAFQREVHLISVAI 326
N+ ++GQG FG+VY D + +A K++Q D SP +A + E+ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H+ ++Q G +E+ L FM+ + ++D L ++ G+
Sbjct: 63 HERIVQYYGCLRDRAEKTLTI-FMEYMP-GGSVKDQLKAYGALTESVTRKYTRQILEGMS 120
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIA 444
YLH I+HRD+K ANIL D L DFG +K + T + GT ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVT 471
PE +S K DV+ G T++E++T
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 272 NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHK 328
+ IG+G FGK+Y K SD+ +K + P E A ++EV L++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD----LKPGEKGLDWPTRKRVAFGTAYG 384
N++ + +V + + R+ L ++ L W + + G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLG 113
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L+++H++ KI+HRD+K+ NI L N A L DFG+A+ ++ + T + GT ++
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYL 169
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVT 471
+PE + KTD++ G L EL T
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 62/236 (26%), Positives = 110/236 (46%), Gaps = 27/236 (11%)
Query: 273 FSESNIIGQGGFGKV------YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI 326
F + ++G+GGFG+V G + K+ KR++ GE+ E ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK---KRKGESMALNEKQILEKVN 58
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY--- 383
+ ++ L T LV M + + + + GE G + R F A
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFE---EGRAVFYAAEICC 113
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GLE LH++ +I++RDLK NILLDD+ + D GLA V T + ++ GT+G++
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 168
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499
APE + + + D + G L E++ GQ S ++ + + + + +L++E
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQ-----SPFQQRKKKIKREEVERLVKE 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 279 IGQGGFGKVYKG------VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV+ D VAVK L+D + FQRE L++ H+++++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 71
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP--------------GEKGLDWPTRKRVA 378
G C I+V+ +M++ + LR P GE GL +A
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--QMLHIA 129
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 438
A G+ YL Q +HRDL N L+ N + DFG+++ V +T
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDV------YSTDYYR 180
Query: 439 TMGH-------IAPEYLSTGKSSEKTDVFGYGITLLELVT 471
GH + PE + K + ++DV+ +G+ L E+ T
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 5e-12
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
F ++G G +G+VYKG ++A ++ D E Q L + H+N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 333 LIGYCTTSS------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
G + + LV F SV +++ K +W + GL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLS 125
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
+LH+ K+IHRD+K N+LL +N E L DFG++ +D + T I GT +APE
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 181
Query: 447 YLSTGKSSE-----KTDVFGYGITLLELVTG 472
++ ++ + K+D++ GIT +E+ G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 279 IGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G+G + V+KG L++N VA+K ++ + G REV L+ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
T LV+ ++ + Y L + K F GL Y H++ KI
Sbjct: 72 IHTERCLTLVFEYLDSDLKQY----LDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGKSSE 455
+HRDLK N+L+++ E L DFGLA+ + ++ T+ + P+ L + + S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 456 KTDVFGYGITLLELVTGQRAIDFSRLEEE 484
D++G G L E+ TG+ S ++EE
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKN 329
F + ++G+GGFG+V + K+ A KRL+ GE+ E ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLE 386
++ L T LV M + + + ++ G G + +R F A GLE
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFE---EERALFYAAEILCGLE 116
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIR---GTMGH 442
LH + ++RDLK NILLDD + D GLA K+ + + IR GT+G+
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES------IRGRVGTVGY 167
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+APE L+ + + D +G G + E++ GQ
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 279 IGQGGFGKVY------KGVLSDNT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+G+G FGKV +G DNT +VAVK L+ A ++E+ ++ H+N+
Sbjct: 12 LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 331 LQLIGYCTTSSER--ILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGLEY 387
++ G CT L+ F+ + S L++ P K ++ + + A G++Y
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGS----LKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAP 445
L + + +HRDL A N+L++ + + DFGL K + D + V + + AP
Sbjct: 125 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT 471
E L K +DV+ +G+TL EL+T
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 70/216 (32%), Positives = 96/216 (44%), Gaps = 45/216 (20%)
Query: 279 IGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREV-HLISVAIHKNLLQLIGY 336
IG+G FG+VY+ D ++ A+K L E ++EV H I +N+L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVAHTIG---ERNILV---- 48
Query: 337 CTTSSERILVYPFM-------QNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTA 382
T E PF+ Q S Y + D G + L W +K R F A
Sbjct: 49 RTLLDES----PFIVGLKFSFQTDSDLYLVTDYMSGGE-LFWHLQKEGRFSEDRAKFYIA 103
Query: 383 ---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIR 437
LE+LH+ I++RDLK NILLD LCDFGL+K L D K T+
Sbjct: 104 ELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--- 157
Query: 438 GTMGHIAPEYLSTGKSSEK-TDVFGYGITLLELVTG 472
GT ++APE L K K D + G+ + E+ G
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G +G V+K + + VA+KR++ D G ++ RE+ L+ HKN+++L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 337 CTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ + LV+ + Q+L + D G+ +D K F GL + H
Sbjct: 68 LHSDKKLTLVFEYCDQDLK---KYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAK 423
++HRDLK N+L++ N E L DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 279 IGQGGFGKVYK-GVLSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVAIHKNLLQL 333
IG+G G V+K VA+K++ E RE+ + H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
+ S +LV +M + ++ LRD E+ L K G+ Y+H
Sbjct: 65 LDVFPHGSGFVLVMEYMPS-DLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN-- 118
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGK 452
I+HRDLK AN+L+ + + DFGLA+L + + + T + APE L K
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 453 SSEKTDVFGYGITLLELVTGQ 473
D++ G EL+ G
Sbjct: 178 YDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 65/280 (23%), Positives = 126/280 (45%), Gaps = 37/280 (13%)
Query: 272 NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+ + ++G+G FG V+ + +D V +K++ + + A Q E ++ + H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVA----YRLRDLKPGEKGLDWPTRKRVAFGTAYG 384
N+++ ++V + ++A R L + L + + +A
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------ 113
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L ++H I+HRDLK NILLD + V + DFG++K++ +K T + GT +I
Sbjct: 114 LHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYI 168
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503
+PE ++K+D++ G L EL + +RA + + L L+L K++
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVL----KIMS-GTFA 219
Query: 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 543
I DR S ++ ++ L P RP ++Q++
Sbjct: 220 PISDRY-----SPDLRQLILSML---NLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 279 IGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G+G + V+KG L++N VA+K ++ + G REV L+ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKG----LDWPTRKRVAFGTAYGLEYLHEQC 392
T LV+ ++ +DLK + K + GL Y H +
Sbjct: 73 VHTDKSLTLVFEYLD--------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR- 123
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTG 451
K++HRDLK N+L+++ E L DFGLA+ + ++ T+ + P+ L +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 452 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484
+ S + D++G G E+ +G+ S +E+E
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 279 IGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G +G V+K + + VA+K+ ++ P + RE+ ++ H NL+ LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
+ LV+ + + +V L +L+ +G+ K++ + T + + H+
Sbjct: 69 FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NC 121
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGKSSE 455
IHRD+K NIL+ + LCDFG A+++ T + T + APE L +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGP 180
Query: 456 KTDVFGYGITLLELVTGQ 473
DV+ G EL+TGQ
Sbjct: 181 PVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL 331
F ++G G +G+VYKG ++A ++ D + E + E++++ + H+N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 332 QLIGYCTTSS------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
G S + LV F SV +++ K DW + GL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 445
+LH K+IHRD+K N+LL +N E L DFG++ +D + T I GT +AP
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190
Query: 446 EYLSTGKSSEKT-----DVFGYGITLLELVTG 472
E ++ ++ + T D++ GIT +E+ G
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 63/238 (26%), Positives = 109/238 (45%), Gaps = 27/238 (11%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKN 329
F ++G+GGFG+V + K+ A K+L+ GEA E ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLE 386
++ L T LV M + + + ++ G G D +R F A GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFD---EQRAIFYAAELCCGLE 116
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMGHI 443
L + +I++RDLK NILLDD + D GLA + T +R GT+G++
Sbjct: 117 DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYM 168
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501
APE ++ K + D +G G + E++ GQ S + ++ + + + + ++ED+
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQ-----SPFRKRKERVKREEVDRRVKEDQ 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 279 IGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV+ D VAVK L+D S F RE L++ H+++++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVK 71
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL---DWPTR------KRVAFGTAY 383
G C I+V+ +M++ + LR P + + P +A A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH- 442
G+ YL Q +HRDL N L+ +N + DFG+++ V +T GH
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDV------YSTDYYRVGGHT 182
Query: 443 ------IAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ PE + K + ++DV+ G+ L E+ T
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 279 IGQGGFGKVYKGVLSDNTK--VAVKRLQDYYSPGG-------EAAFQREVHLISVAIHKN 329
IG+G +GKV+K N VA+KR++ G E A R + H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE---HPN 65
Query: 330 LLQLIGYCTTS-----SERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
+++L CT S ++ LV+ + Q+L+ K E G+ T K + F
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD----KVPEPGVPTETIKDMMFQLLR 121
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GL++LH +++HRDLK NIL+ + + L DFGLA++ ++ T + T+ +
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 176
Query: 444 APEYLSTGKSSEKTDVFGYGITLLEL 469
APE L + D++ G E+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 35/102 (34%), Positives = 61/102 (59%), Gaps = 7/102 (6%)
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 434
+V+ GL YL E+ +I+HRD+K +NIL++ E LCDFG++ +L+D+ +
Sbjct: 107 KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476
GT +++PE L S ++D++ G++L+EL G+ I
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 61/277 (22%), Positives = 118/277 (42%), Gaps = 21/277 (7%)
Query: 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAIHK 328
NF IG+G F +VY+ L D VA+K++Q D A +E+ L+ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N+++ +E +V ++ ++ K ++ + T + LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H + +++HRD+K AN+ + L D GL + +K T + + GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508
+ K+D++ G L E+ Q ++ ++ L ++ D
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----------NLYSLCKKIEQCDYPPL 228
Query: 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545
+ Y S+E+ +V +C PE RP + V +
Sbjct: 229 PSDHY-SEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 53/172 (30%), Positives = 80/172 (46%), Gaps = 35/172 (20%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKR-LQDYYSPGGEAAFQREVHLISVAIH 327
+ + IGQG FG+V+K TK VA+K+ L + G RE+ ++ + H
Sbjct: 12 SKYEKLAKIGQGTFGEVFK-ARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH 70
Query: 328 KNLLQLIGYCTTSSER--------ILVYPF--------MQNLSVAYRLRDLKPGEKGLDW 371
+N++ LI C T + LV+ F + N +V + L ++K K L
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML-- 128
Query: 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423
GL Y+H KI+HRD+KAANIL+ + L DFGLA+
Sbjct: 129 ----------LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 33/102 (32%), Positives = 60/102 (58%), Gaps = 7/102 (6%)
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 434
+++ GL YL E KI+HRD+K +NIL++ E LCDFG++ +L+D+ +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476
GT +++PE L + ++D++ G++L+E+ G+ I
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 76/274 (27%), Positives = 111/274 (40%), Gaps = 38/274 (13%)
Query: 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKNLLQLI 334
IG G FG VY S N VAVK++ Y +Q +EV + H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
G LV + L A L L+ +K L + G GL YLH
Sbjct: 88 GCYLKEHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY---LSTG 451
+IHRD+KA NILL + + L DFG A + V GT +APE + G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 452 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 511
+ K DV+ GIT +EL E + + ++ + L I +
Sbjct: 196 QYDGKVDVWSLGITCIELA-----------ERKPPLFNMNAMSALYH------IAQNDSP 238
Query: 512 TYDSKE-VETMVQVALLCTQSTPEDRPPMAQVVK 544
T S E ++ C Q P++RP A++++
Sbjct: 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-11
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 27/203 (13%)
Query: 297 KVAVKRLQDYYSPGGE---AAFQREVHLISVAIHKNLLQLIGYCTTSSERIL-VYPFMQN 352
+VA+K L+ +P E A F+RE L + H N++ L+ + V+ ++
Sbjct: 5 EVAIKLLRTD-APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 353 LSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL- 408
++ L L GE G R+ L H Q I+HRDLK NI++
Sbjct: 64 RTLREVLAADGALPAGETG-------RLMLQVLDALACAHNQ---GIVHRDLKPQNIMVS 113
Query: 409 --DDNFEAVLCDFGLAKL------VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVF 460
A + DFG+ L D TT++ GT + APE L + +D++
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 461 GYGITLLELVTGQRAIDFSRLEE 483
+G+ LE +TGQR + + + E
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 34/231 (14%)
Query: 279 IGQGGFGKVYKGV--LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G+G + VYKG L+ VA+K ++ + G RE L+ H N++ L
Sbjct: 13 LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHE 390
T LV+ ++ DLK G GL + F GL Y H+
Sbjct: 72 IHTKKTLTLVFEYLD--------TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--THVTTQIRGTMGHIAPEYL 448
+ +++HRDLK N+L+ + E L DFGLA+ AK + + T+ + P+ L
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPPDVL 175
Query: 449 --STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 497
ST S+ D++G G E+ TG+ S E++ L I ++L
Sbjct: 176 LGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVEDQ----LHKIFRVL 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 45/211 (21%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKNLLQLIG- 335
+G G +G VYK L AVK ++ PG + + Q+E+ ++ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 336 ------------YCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 381
YC S + + V + L +AY R+ T
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE-------------------T 115
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441
GL YLH + +HRD+K ANILL DN + L DFG+A + A + + I GT
Sbjct: 116 LQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPY 171
Query: 442 HIAPEYLSTGKS---SEKTDVFGYGITLLEL 469
+APE + K+ ++ D++ GIT +EL
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKN 329
F ++G+GGFG+V + K+ A K+L+ GEA E ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLE 386
++ L T LV M + + + ++ G D +R F A GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP--GFD---EERAVFYAAEITCGLE 116
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
LH + +I++RDLK NILLDD + D GLA V+ GT+G++APE
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPE 171
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ + + D +G G + E++ G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 48/203 (23%), Positives = 93/203 (45%), Gaps = 7/203 (3%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAI 326
NF IG+G F VYK + L D VA+K++Q + +E+ L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H N+++ + ++E +V ++ ++ K ++ + T + LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
++H + +I+HRD+K AN+ + L D GL + +K T + + GT +++PE
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 447 YLSTGKSSEKTDVFGYGITLLEL 469
+ + K+D++ G L E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 38/225 (16%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISVA 325
+L D+F + + +G G G V+K + P G ++ +HL I A
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVS---------------HKPSGLIMARKLIHLEIKPA 45
Query: 326 IHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------- 375
I + LQ++ C + F + ++ + + G LD +K
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 103
Query: 376 ---RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTH 431
+V+ GL YL E+ KI+HRD+K +NIL++ E LCDFG++ +L+D+
Sbjct: 104 ILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157
Query: 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476
+ GT +++PE L S ++D++ G++L+E+ G+ I
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEA------AFQREVHLISV 324
N+ ++G+G FG+VY +D + +AVK++ + P + A + E+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVP--FDPDSQETSKEVNALECEIQLLKN 60
Query: 325 AIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
H ++Q G E+ L +M S+ +L+ L +R
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQIL 116
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTM 440
G+ YLH I+HRD+K ANIL D L DFG +K + T + GT
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
++PE +S K DV+ T++E++T
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 53/161 (32%), Positives = 80/161 (49%), Gaps = 22/161 (13%)
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPE 446
+H + +IHRD+K+ANILL N L DFG +K+ A ++ V GT ++APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL--REDRLND 504
S+K D+F G+ L EL+T +R D +EE + K L R D L
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV--------MHKTLAGRYDPLPP 267
Query: 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545
+ S E++ +V ALL S P+ RP ++++ M
Sbjct: 268 SI--------SPEMQEIVT-ALLS--SDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 32/230 (13%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 318
E+ L+T F E +G+ FGKVYKG L VA+K L+D F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 319 VHLISVAIHKNLLQLIGYCTTSS--ERILVYPFMQNLSVAYRLR----------DLKPGE 366
+ S H N++ L+G T I Y +L +R D K +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 367 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
L+ + A G+E+L ++H+DL N+L+ D + D GL + V
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 427 AK-----LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
A + + IR ++PE + GK S +D++ YG+ L E+ +
Sbjct: 176 AADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 279 IGQGGFGKVYKGVLSDNTK---VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G G FG V KGV K VA+K L++ RE ++ + ++++IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA---FGTAYGLEYLHEQC 392
C +E +++ + ++ L G+K D T V + G++YL +
Sbjct: 63 VC--EAEALML---VMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK- 114
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT--MGHIAPEYLST 450
+HRDL A N+LL + A + DFGL+K + A ++ + G + APE ++
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 451 GKSSEKTDVFGYGITLLELVT-GQR 474
K S ++DV+ YGIT+ E + GQ+
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
L++LH+ II+RD+K NILLD VL DFGL+K A+ GT+ ++A
Sbjct: 118 LDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 445 PEYLSTGKS--SEKTDVFGYGITLLELVTG 472
PE + G + D + G+ EL+TG
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 279 IGQGGFGKVYKGVLSDN--TKVAVKRLQDYYSPGGEAAFQR---------EVHLISVAI- 326
+G G FG VYK +N +A+K + + G+ +R EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 327 HKNLLQLIGYCTTSSERILVYPFM---QNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGT 381
H N+++ Y T E +Y M + + LK EK + + +
Sbjct: 68 HPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLK--EKKQRFTEERIWNIFVQM 122
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA--KLVDAKLTHVTTQIRGT 439
L YLH++ +I+HRDL NI+L ++ + + DFGLA K ++KLT V GT
Sbjct: 123 VLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV----GT 176
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ + PE + EK DV+ +G L ++ T Q
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 9e-11
Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 17/210 (8%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLI 322
++ ++ + IG+G FG VY+GV ++ VAVK ++ SP F +E +++
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 323 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAF 379
H ++++LIG T + I+ + P + LR L+ + LD + ++
Sbjct: 62 RQFDHPHIVKLIGVITENPVWIVMELAPLGE-------LRSYLQVNKYSLDLASLILYSY 114
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 439
+ L YL + + +HRD+ A N+L+ L DFGL++ ++ + + ++ +
Sbjct: 115 QLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLEL 469
+ +APE ++ + + +DV+ +G+ + E+
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G +G VYKG VA+K+++ + G + RE+ L+ H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHE 390
S L++ F+ DLK P + +D K + G+ + H
Sbjct: 68 LMQESRLYLIFEFLS--------MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-S 449
+ +++HRDLK N+L+D+ L DFGLA+ + T ++ T+ + APE L
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLG 175
Query: 450 TGKSSEKTDVFGYGITLLELVT 471
+ + S D++ G E+ T
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 85/336 (25%), Positives = 141/336 (41%), Gaps = 75/336 (22%)
Query: 278 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
++G+G FGKV+ L N A+K A +++V L+ +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIK------------ALKKDVVLMDDDVE--------- 40
Query: 337 CTTSSERILV----YPFMQNLSVAYRLRD--------LKPGE--------KGLDWPTRKR 376
CT +R+L +PF+ +L ++ ++ L G+ D P
Sbjct: 41 CTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF 100
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK---LVDAKLTHVT 433
A GL++LH + I++RDLK NILLD + + DFG+ K L DAK T
Sbjct: 101 YAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK----T 153
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 493
GT +IAPE L K + D + +G+ L E++ GQ F +EEE
Sbjct: 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP--FHGHDEEE-------- 203
Query: 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE 553
L + R+++ T ++K++ + V PE R + ++ +
Sbjct: 204 --LFQSIRMDNPCYPRWLTREAKDILVKLFV------REPERRLGVKGDIR----QHPFF 251
Query: 554 RWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAI 589
R +W LEE R+ E P + + S+ D+E +
Sbjct: 252 REIDWSALEE-REIEPPFKPKVKSANDCSNFDKEFL 286
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIG 335
+G G +G V + KVA+K+L + + A+ RE+ L+ H+N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLLD 81
Query: 336 YCTTSS------ERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
T++ + LV P+MQ +L ++ E + + + + GL+Y+
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQY-----LVYQMLCGLKYI 133
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEY 447
H IIHRDLK N+ ++++ E + DFGLA+ DA++T +V T+ + APE
Sbjct: 134 HSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEV 185
Query: 448 -LSTGKSSEKTDVFGYGITLLELVTGQ 473
L+ ++ D++ G + E++TG+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVHLISVAIHKN--LLQ 332
IIG+GGFG+VY +D K+ + D GE E ++S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 333 LIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLEYL 388
+ Y + +++ + M + Y L + G+ + + F A GLE++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVF--SEAEMRFYAAEIILGLEHM 113
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H N +++RDLK ANILLD++ + D GLA K H + GT G++APE L
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 449 STGKSSEKT-DVFGYGITLLELVTGQ 473
G + + + D F G L +L+ G
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 37/88 (42%), Positives = 47/88 (53%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L L SN F+GKI ++T L L L+L N SG +P LG +L L+L+ N +G I
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372
Query: 141 PATWSQLSNLKHLDLSSNNLTGRIPMQL 168
P NL L L SN+L G IP L
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 37/113 (32%), Positives = 60/113 (53%), Gaps = 8/113 (7%)
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLAN 133
++ N+ L L +N +G+I + L L L N L G +P LG+ L+ + L +
Sbjct: 354 KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRI--------PMQLFSVATFNFTG 178
N FSG +P+ +++L + LD+S+NNL GRI +Q+ S+A F G
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG 466
|
Length = 968 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVA 325
D + + +G G +G V + KVA+K+L Y P F RE+ L+
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL---YRPFQSELFAKRAYRELRLLKHM 71
Query: 326 IHKNLLQLIGYCT--TSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 379
H+N++ L+ T S +R LV PFM + ++ K E + + + +
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQF-----LVY 125
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 439
GL+Y+H IIHRDLK N+ ++++ E + DFGLA+ D+++T T
Sbjct: 126 QMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----T 178
Query: 440 MGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 473
+ APE L+ ++ D++ G + E++TG+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 8/99 (8%)
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 434
R+A GL YL + KI+HRD+K +N+L++ + LCDFG++ +LV++ +
Sbjct: 99 RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAK 151
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT ++APE +S + +DV+ GI+ +EL G+
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 59/220 (26%), Positives = 89/220 (40%), Gaps = 58/220 (26%)
Query: 279 IGQGGFGKVYK-GVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G GGFG+V V S N A+K + ++ H++ +++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV-------------KKRHIVETGQQEHIFS----- 42
Query: 338 TTSSER----ILVYPFMQNLSVAYR-------LRDLKPG--------EKGL--DWPTRKR 376
E+ +PF+ L ++ L + G ++GL ++ R
Sbjct: 43 ----EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-- 96
Query: 377 VAFGTAY---GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHV 432
F A EYLH + II+RDLK N+LLD N L DFG AK L + T
Sbjct: 97 --FYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
GT ++APE + D + GI L EL+TG
Sbjct: 152 ---FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 57/269 (21%), Positives = 115/269 (42%), Gaps = 35/269 (13%)
Query: 298 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN----- 352
VAVK L+ + F +EV ++S N+++L+G C ++ +M+N
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 353 -LSVAYRLRDLKPGEKG---------LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLK 402
LS + + G + + + VA A G++YL + +HRDL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 403 AANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG--HIAPEYLSTGKSSEKTDVF 460
N L+ +N + DFG+++ + A + Q R + +A E + GK + +DV+
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAG-DYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 461 GYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV-- 518
+G+TL E++ + + L +E+ ++++ + R D+ Y +
Sbjct: 225 AFGVTLWEILMLCKEQPYGELTDEQ---VIENAGEFFR--------DQGRQVYLFRPPPC 273
Query: 519 -ETMVQVALLCTQSTPEDRPPMAQVVKML 546
+ + ++ L C +RP + + L
Sbjct: 274 PQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHK-NLLQ 332
IIG+GGFG+VY +D K+ + D G A + L V+ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 333 LIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLEYL 388
+ Y + +++ + M + Y L + G+ + K + F GLE++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQHGVF--SEKEMRFYATEIILGLEHM 113
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H N +++RDLK ANILLD++ + D GLA K H + GT G++APE L
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 449 STGKSSEKT-DVFGYGITLLELVTGQ 473
G + + + D F G L +L+ G
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 47/236 (19%)
Query: 278 IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI-----SVAIHKNLL 331
++G+G FGKV L + A+K A +++V L + + +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIK------------ALKKDVVLEDDDVECTMVERRVL 49
Query: 332 QLIG--------YCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 381
L +CT ++ L V ++ + + ++ ++ R F
Sbjct: 50 ALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE-------ARARFYA 102
Query: 382 A---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 438
A GL++LH++ II+RDLK N+LLD + + DFG+ K + + G
Sbjct: 103 AEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCG 158
Query: 439 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494
T +IAPE L K +E D + +G+ L E++ GQ F +E+E L D I
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP--FHGEDEDE---LFDSIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 65/204 (31%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 273 FSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHK 328
FS+ IG G FG VY + ++ VA+K++ Y +Q +EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N +Q G LV + L A L L+ +K L V G GL YL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY- 447
H + +IHRD+KA NILL + L DFG A ++ V GT +APE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 448 --LSTGKSSEKTDVFGYGITLLEL 469
+ G+ K DV+ GIT +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHK 328
++F IG G +G VYK ++ A+K ++ PG + A Q+E+ ++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ G + + F S L+D+ L V+ T GL YL
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRETLQGLYYL 122
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H + +HRD+K ANILL DN L DFG++ + A + + I GT +APE
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVA 178
Query: 449 ST---GKSSEKTDVFGYGITLLEL 469
+ G ++ D++ GIT +EL
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 47/205 (22%), Positives = 95/205 (46%), Gaps = 7/205 (3%)
Query: 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ--REVHLISVAIHK 328
NF IG+G F +VY+ L D VA+K++Q + +A +E+ L+ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N+++ + +E +V ++ ++ K ++ + T + +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H + +++HRD+K AN+ + L D GL + +K T + + GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 449 STGKSSEKTDVFGYGITLLELVTGQ 473
+ K+D++ G L E+ Q
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 60/203 (29%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKN 329
F++ IG G FG VY +V + Y +Q +EV + H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
++ G LV + L A L L+ +K L + G GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY-- 447
+IHRD+KA NILL + + L DFG A + + V GT +APE
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVIL 194
Query: 448 -LSTGKSSEKTDVFGYGITLLEL 469
+ G+ K DV+ GIT +EL
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 68/277 (24%), Positives = 116/277 (41%), Gaps = 44/277 (15%)
Query: 279 IGQGGFGKVYKGVLS---DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLI 334
+G G FG V KG+ VAVK L+ D P + RE +++ + ++++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP---TRKRV---AFGTAYGLEYL 388
G C ++ + L +L P K L T K + + G++YL
Sbjct: 63 GICEA-----------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT--MGHIAPE 446
E +HRDL A N+LL A + DFGL+K + A + + G + APE
Sbjct: 112 EET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
Query: 447 YLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505
++ K S K+DV+ +G+ + E + GQ+ + ++ E +++ +R+
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKP--YKGMKGNEVTQMIE------SGERMECP 220
Query: 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQV 542
YD + LC ++RP A V
Sbjct: 221 QRCPPEMYD---------LMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 279 IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G+G + VYKG+ N + VA+K + G RE L+ H N++ L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
T V+ +M Y ++ PG GL + F GL Y+H Q I+
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQ--HPG--GLHPYNVRLFMFQLLRGLAYIHGQ---HIL 125
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL--STGKSSE 455
HRDLK N+L+ E L DFGLA+ ++++ T+ + P+ L +T SS
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 456 KTDVFGYGITLLELVTGQ 473
D++G G +E++ GQ
Sbjct: 185 -LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 38/124 (30%), Positives = 60/124 (48%), Gaps = 11/124 (8%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMG 441
GL YLH Q +IIHRD+K NI ++D + + D G A+ +V + GT+
Sbjct: 169 GLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA----GTVE 221
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI--DFSRLEEEEDVLLLDHIRKLLRE 499
APE L+ K + K D++ GI L E++ I D EE H+ K++
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST 281
Query: 500 DRLN 503
+++
Sbjct: 282 LKVH 285
|
Length = 357 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 327
+D + IG+G +GKV+K VL+ + +K AVK L + E + + L +++ H
Sbjct: 17 SDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDH 74
Query: 328 KNLLQLIGY-----CTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGT 381
N+++ G + LV SV ++ LK GE+ ++ P +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPIIAYILHEA 133
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVDAKLTHVTTQIRGTM 440
GL++LH K IHRD+K NILL L DFG+ A+L +L T+ GT
Sbjct: 134 LMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTP 188
Query: 441 GHIAPEYLSTGKS-----SEKTDVFGYGITLLELVTG 472
+APE ++ + + DV+ GIT +EL G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 14/213 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHL---ISVA 325
D + + IG+G +GKVYK + K VA+K+ + G RE+ L +S +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSV---AYRLRDLKPGEKGLDWPTRKRVAFGTA 382
I+ L + + + + +Y + L + + + + L T K +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 441
G+ + H+ ++HRDLK N+L+D + + D GL + + T +I T+
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLW 176
Query: 442 HIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
+ APE L S D++ G E+ Q
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G +G VYK VA+K+++ + G + RE+ L+ H N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKP-----GEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+ ++ LV+ F+ DLK GLD P K + G+ Y H
Sbjct: 67 VHSENKLYLVFEFLD--------LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL---TH--VTTQIRGTMGHIAPE 446
+++HRDLK N+L+D L DFGLA+ + TH VT R APE
Sbjct: 119 ---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYR------APE 169
Query: 447 YLSTGKS-SEKTDVFGYGITLLELVTGQ 473
L + S D++ G E+V +
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-GTMGH 442
GL++LHE+ II+RDLK N+LLD + DFG+ K + L VTT GT +
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDY 162
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 487
IAPE LS D + G+ L E++ GQ + ++E+++
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 46/197 (23%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 298 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN--LSV 355
VAVK L+ + F +E+ ++S + N+++L+G C + ++ +M+N L+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 356 AYRLRDLKPG-EKGLDWPTRKR-----VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 409
R+++ + P+ +A A G++YL + +HRDL N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 410 DNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLE 468
+++ + DFG+++ L + + + +A E + GK + +DV+ +G+TL E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 469 LVTGQRAIDFSRLEEEE 485
+ T + +S L +E+
Sbjct: 224 MFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
LE+LH+ II+RD+K NILLD N VL DFGL+K GT+ ++
Sbjct: 117 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 444 APEYLSTGKS--SEKTDVFGYGITLLELVTG 472
AP+ + G + D + G+ + EL+TG
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 36/88 (40%), Positives = 48/88 (54%), Gaps = 4/88 (4%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
LE LH+ +I+RDLK NILLD LCDFGL KL + K T GT ++A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLA 161
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTG 472
PE L ++ D + G+ L E++TG
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQ-------DYYSPGGEAAFQREVHLISVAIHKNLL 331
+G+G FG VY ++ D VA +RL+ +P +E L+S H ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+ ++ + + + +L +LK K L G+ Y+H++
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
+I+HRDLKA NI L +N + DFG+++L+ TT GT +++PE L
Sbjct: 126 ---RILHRDLKAKNIFLKNNLLKI-GDFGVSRLLMGSCDLATT-FTGTPYYMSPEALKHQ 180
Query: 452 KSSEKTDVFGYGITLLEL 469
K+D++ G L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 28/169 (16%)
Query: 279 IGQGGFGKVYKGVL---SDNTKVAVKRLQ---DYYSPGGEAAFQREVHLISVAIHKNLLQ 332
IG+G +G+VYK D + A+K+ + + Y+ G + RE+ L+ H+N++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-GISQSACREIALLRELKHENVVS 66
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDL--------KPGEKGLDWPTRKRVAFGTAYG 384
L+ +++ VY L Y DL + + K + + G
Sbjct: 67 LVEVFLEHADK-SVY-----LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 385 LEYLHEQCNPKIIHRDLKAANILL--DDNFEAV--LCDFGLAKLVDAKL 429
+ YLH ++HRDLK ANIL+ + V + D GLA+L +A L
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 436
+F A G+E+L + K IHRDL A NILL +N +CDFGLA+ + +V
Sbjct: 185 SFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK 495
R + +APE + + ++DV+ +G+ L E+ + G +++EE R+
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRR 294
Query: 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
L R+ Y + E M Q L C P RP +++V+ L
Sbjct: 295 LKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 278 IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
I+G G FG++ +G L +K VA+ L+ S F E + H N+++L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
G T + ++V +M N ++ LR E L + G A G++YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM-- 126
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI--APEYLSTG 451
+H+ L A +L++ + + F +L + K + T + G + APE +
Sbjct: 127 -GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 452 KSSEKTDVFGYGITLLELVT-GQR 474
S +DV+ +GI + E+++ G+R
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 62/244 (25%), Positives = 94/244 (38%), Gaps = 40/244 (16%)
Query: 244 DVAGEDDCKVSLTQLRRFSCRELQLATDNFS----ESNIIGQ---GGFGKVYKGVL---S 293
D +++ T + + C E ++D S + NI+ G G+V+
Sbjct: 59 DYDADEESLSPQTDVCQEPC-ETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDE 117
Query: 294 DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353
KV VK + +PG E + + H+ ++ LI S +V P +
Sbjct: 118 QRKKVIVKAVTGGKTPGREIDILKTIS------HRAIINLIHAYRWKSTVCMVMPKYKCD 171
Query: 354 SVAY-------RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406
Y L ++ L L YLH + IIHRD+K NI
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRL------------LEALAYLHGR---GIIHRDVKTENI 216
Query: 407 LLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGIT 465
LD+ AVL DFG A KL T GT+ +PE L+ KTD++ G+
Sbjct: 217 FLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLV 276
Query: 466 LLEL 469
L E+
Sbjct: 277 LFEM 280
|
Length = 392 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 8/91 (8%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
G+E LH++ IIHRD+K N+L+D L DFGL++ + GT ++
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYL 160
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
APE + + +D + G + E + G
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 20/178 (11%)
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 436
+F A G+E+L + K IHRDL A NILL +N +CDFGLA+ + +V
Sbjct: 180 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 496
R + +APE + + ++DV+ +G+ L E+ + A + ++ E+
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-LGASPYPGVQINEEFC-------- 287
Query: 497 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 554
RL D + E+ ++ L C Q P++RP + +V++L G+ L E
Sbjct: 288 ---QRLKDGTRMRAPENATPEIY---RIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 57/261 (21%), Positives = 120/261 (45%), Gaps = 25/261 (9%)
Query: 298 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 357
VAVK L++ + F +E+ ++S N+++L+ C TS ++ +M+N +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 358 RLRDLKPGEKGLD-------WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 410
L +P E + T +A A G++YL + +HRDL N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 411 NFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 469
N+ + DFG+++ L + + + ++ E + GK + +DV+ +G+TL E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 470 VTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV---ETMVQVAL 526
+T + +S+L +E+ ++++ + R D+ Y K +++ ++ L
Sbjct: 226 LTLCKEQPYSQLSDEQ---VIENTGEFFR--------DQGRQVYLPKPALCPDSLYKLML 274
Query: 527 LCTQSTPEDRPPMAQVVKMLQ 547
C + ++RP ++ L
Sbjct: 275 SCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLIG 335
+IG+G +G V + KVA+K++ D + +A RE+ L+ + H +++++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 336 YCTTSSERILVYPFMQNLSVAYRL--RDLKPGEKGLDWPTRKRVAF---GTAYGLEYLHE 390
S R +++ V + L DL K D T + F L+Y+H
Sbjct: 67 IMLPPSRREF-----KDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH- 120
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGHIAPEYL 448
+ HRDLK NIL + + + +CDFGLA+ D T T + APE
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 449 ST--GKSSEKTDVFGYGITLLELVTGQ 473
+ K + D++ G E++TG+
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 279 IGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLI-SVAIHKNLLQLIG- 335
IG+G F +V K A+K ++ ++ + RE+ + ++ H N+L+LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 336 -YCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
+ + LV+ M NL Y L +K ++ L K + L+++H +
Sbjct: 67 LFDRKTGRLALVFELMDMNL---YEL--IKGRKRPLPEKRVKSYMYQLLKSLDHMH-RNG 120
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGK 452
I HRD+K NIL+ D+ L DFG + + +K + T+ T + APE L+ G
Sbjct: 121 --IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGY 175
Query: 453 SSEKTDVFGYGITLLELVT 471
K D++ G E+++
Sbjct: 176 YGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 279 IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQ----REVHLI---SVAIHKNL 330
IG G +G VYK + VA+K ++ E REV L+ H N+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 331 LQLIGYCTTS--SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
++L+ C TS V +++ R K GL T K + GL++L
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H C I+HRDLK NIL+ + L DFGLA++ ++ T + T+ + APE L
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVL 179
Query: 449 STGKSSEKTDVFGYGITLLEL 469
+ D++ G E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 52/228 (22%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAF----QREVHLISVA 325
+ + IG+G +G V KVA+K++ SP F RE+ ++
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKILRRF 60
Query: 326 IHKNLLQLIGYCTTSS-----ERILVYPFM----------QNLS---VAYRLRDLKPGEK 367
H+N++ ++ S + +V M Q+LS + Y L
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL-------- 112
Query: 368 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427
+ GL+Y+H N ++HRDLK +N+LL+ N + +CDFGLA++ D
Sbjct: 113 -----------YQILRGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158
Query: 428 KLTH--VTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 472
+ H T+ T + APE + K K D++ G L E+++
Sbjct: 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 63/259 (24%), Positives = 108/259 (41%), Gaps = 60/259 (23%)
Query: 263 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ----R 317
CR + D + + N I +G +G VY+ VA+K+L+ E F R
Sbjct: 1 CRSV----DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEG-FPITSLR 53
Query: 318 EVHLISVAIHKNLLQL--IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 375
E++++ H N++ + + + + +V ++++ DLK
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH--------DLK------SLMETM 99
Query: 376 RVAFGTA----------YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425
+ F + G+ +LH+ I+HRDLK +N+LL++ +CDFGLA+
Sbjct: 100 KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY 156
Query: 426 DAKLTHVTTQIRGTMGHIAPE-YLSTGKSSEKTDV------FGYGITLLELVTGQRAIDF 478
+ L TQ+ T+ + APE L + S D+ F +T L G+ ID
Sbjct: 157 GSPLKPY-TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID- 214
Query: 479 SRLEEEEDVLLLDHIRKLL 497
L+ I KLL
Sbjct: 215 ----------QLNKIFKLL 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 66/213 (30%), Positives = 91/213 (42%), Gaps = 40/213 (18%)
Query: 278 IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQR--EVHLI---SVAIHKNLL 331
+IG+G FGKV + K AVK LQ +A ++ + H++ +V + KN+
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQK------KAILKKKEQKHIMAERNVLL-KNVK 54
Query: 332 Q--LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG---------EKGLDWPTRKRVAFG 380
L+G L Y F Q Y + D G E+ P + A
Sbjct: 55 HPFLVG---------LHYSF-QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE 104
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGT 439
A L YLH II+RDLK NILLD VL DFGL K ++ T T+ GT
Sbjct: 105 IASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGT 159
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
++APE L D + G L E++ G
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 48/200 (24%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 278 IIGQGGFGK--VYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
++G+G FG+ + + V SD K A+K ++ S ++E L++ H N++
Sbjct: 7 VVGEGSFGRALLVQHVNSDQ-KYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+V + + +++ + P + L W + G++++HE+
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK 119
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
+++HRD+K+ NI L N + L DFG A+L+ + + T + GT ++ PE
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 452 KSSEKTDVFGYGITLLELVT 471
+ K+D++ G L EL T
Sbjct: 176 PYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IGQG G VY + ++ +VA+K++ P E E+ ++ H N++ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
E +V ++ S L D+ E +D V LE+LH ++I
Sbjct: 86 LVGDELWVVMEYLAGGS----LTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRD+K+ NILL + L DFG + + + +T + GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 458 DVFGYGITLLELVTGQ 473
D++ GI +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 61/200 (30%), Positives = 85/200 (42%), Gaps = 14/200 (7%)
Query: 278 IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQ 332
+IG+G FGKV + K AVK LQ +R V L +V H L+
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVG 60
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L T+ + V F+ + + L+ E+ P + A A L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLH--- 113
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 452
+ I++RDLK NILLD VL DFGL K + TT GT ++APE +
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 453 SSEKTDVFGYGITLLELVTG 472
D + G L E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 7e-09
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 42/219 (19%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREV-HLISVAIHK 328
D+F +G G FG+V + K A+K L + ++V H+++ K
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-----SKAKIVKLKQVEHVLN---EK 52
Query: 329 NLLQLIG--YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY--- 383
+LQ I + L F + ++ Y + + PG + RK F
Sbjct: 53 RILQSIRHPFLVN-----LYGSFQDDSNL-YLVMEYVPGGELFSH-LRKSGRFPEPVARF 105
Query: 384 -------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
LEYLH + I++RDLK N+LLD + + DFG AK V + T +
Sbjct: 106 YAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTL 158
Query: 437 RGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTG 472
GT ++APE + + GK+ D + GI + E++ G
Sbjct: 159 CGTPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 62/201 (30%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 278 IIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQ 332
+IG+G FGKV SD + AVK LQ +R V L ++ H L+
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVG 60
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L T+ + V ++ + + L+ E+ P + A A + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL- 115
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPEYLSTG 451
II+RDLK NILLD VL DFGL K V+ + T T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 452 KSSEKTDVFGYGITLLELVTG 472
D + G L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 10/109 (9%)
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-GTM 440
+ GL +LH + II+RDLK N++LD + DFG+ K + + VTT+ GT
Sbjct: 111 SVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTP 165
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489
+IAPE ++ + D + YG+ L E++ GQ D E+ED L
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD----GEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 53/220 (24%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
++GQG FGKV+ V+++ G A Q ++ + V + K L++
Sbjct: 3 VLGQGSFGKVF----------LVRKIT------GPDAGQ--LYAMKV-LKKATLKVRDRV 43
Query: 338 TTSSER-ILV---YPFMQNLSVAYRLRDLKPGE--------KGLDWPTR--KRVAFGT-- 381
T ER IL +PF+ L A++ G+ +G D TR K V F
Sbjct: 44 RTKMERDILAEVNHPFIVKLHYAFQ----TEGKLYLILDFLRGGDLFTRLSKEVMFTEED 99
Query: 382 --------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHV 432
A L++LH + II+RDLK NILLD+ L DFGL+K +D +
Sbjct: 100 VKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
GT+ ++APE ++ ++ D + +G+ + E++TG
Sbjct: 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 9e-09
Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 278 IIGQGGFGKV----YKGVLSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKNLLQ 332
++G+G +G+V ++ +D + +K+L + E A ++E L+S H N++
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 333 LI-GYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEY 387
+ +V F + + ++L++ K P + ++W + A L+Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQY 117
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LHE+ I+HRDLK N+ L + D G+A++++ + +T I GT +++PE
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPEL 173
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQRAID 477
S + K+DV+ G + E+ T + A +
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 43/127 (33%), Positives = 63/127 (49%), Gaps = 11/127 (8%)
Query: 373 TRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
+ R F A GL+YLHE KI++RDLK N+LLD + DFGL K
Sbjct: 99 SEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGF 154
Query: 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE--DV 487
T+ GT +APE L+ + D +G G+ + E++ G+ F +EEE D
Sbjct: 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP--FPGDDEEEVFDS 212
Query: 488 LLLDHIR 494
++ D +R
Sbjct: 213 IVNDEVR 219
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGH 442
LE+LH+Q II+RDLK NILLD L DFGL K + + +TH GT+ +
Sbjct: 113 LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEY 166
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+APE L + D + G + +++TG
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 44/226 (19%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
D F IG+G +G+VYK D VA+K+++ D G RE+ ++ H+
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 329 NLLQLIGYCTTSSERI----------LVYPFMQNLSVAYRLRDLKPG--EKGLDWPTRKR 376
N++ L T + + LV+ +M + DL G E GL
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH--------DLM-GLLESGL------- 110
Query: 377 VAFGTAY----------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
V F + GL Y H +HRD+K +NILL++ + L DFGLA+L +
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 427 AKLTHVTTQIRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVT 471
++ + T T+ + PE L + DV+ G L EL T
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 2e-08
Identities = 21/59 (35%), Positives = 33/59 (55%)
Query: 102 LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNL 160
L SL+L +N L+ + +L+ L+L+ N + P +S L +L+ LDLS NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 67/261 (25%), Positives = 106/261 (40%), Gaps = 54/261 (20%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKRLQ--DYYSPGGEAAFQREVHLISVAI 326
D+ +G G FG+V+ V ++ A+K + + E E ++
Sbjct: 1 DDLERIKTVGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW-PTRKRVAFGTA--Y 383
H +++L + T +R L Y L + PG + + R + T Y
Sbjct: 60 HPFIIRL--FWTEHDQRFL-----------YMLMEYVPGGELFSYLRNSGRFSNSTGLFY 106
Query: 384 G------LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
LEYLH + +I++RDLK NILLD L DFG AK KL T +
Sbjct: 107 ASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLC 159
Query: 438 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-----------------QRAIDFSR 480
GT ++APE + + ++ D + GI + E++ G ++F R
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR 219
Query: 481 LEEEEDVLLLDHIRKLLREDR 501
D+ D I+KLL DR
Sbjct: 220 ---HLDLYAKDLIKKLLVVDR 237
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IGQG G VY + ++ +VA+K++ P E E+ ++ + N++ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
E +V ++ S L D+ E +D V L++LH ++I
Sbjct: 86 LVGDELWVVMEYLAGGS----LTDVVT-ETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRD+K+ NILL + L DFG + + + +T + GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 458 DVFGYGITLLELVTGQ 473
D++ GI +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
LE+LH+ I++RD+K NILLD VL DFGL+K ++ T GT+ ++A
Sbjct: 118 LEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 445 PEYL-STGKSSEKTDVFGYGITLLELVTG 472
PE + G + D + GI + EL+TG
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 42/119 (35%), Positives = 60/119 (50%), Gaps = 21/119 (17%)
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGT 439
A GL +LH + II+RDLK N++LD + DFG+ K + K T GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GT 164
Query: 440 MGHIAPE---YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL---LLDH 492
+IAPE Y GKS D + +G+ L E++ GQ D E+ED L +++H
Sbjct: 165 PDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFD----GEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 49/216 (22%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 267 QLATDNFSE---SNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI 322
A + SE N IG G G VYK + ++ A+K + + RE+ ++
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126
Query: 323 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
H N+++ + E ++ FM S+ G D VA
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------GTHIADEQFLADVARQIL 178
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442
G+ YLH + I+HRD+K +N+L++ + DFG+++++ + + + GT+ +
Sbjct: 179 SGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAY 234
Query: 443 IAPEYLSTGKSSEK-----TDVFGYGITLLELVTGQ 473
++PE ++T + D++ G+++LE G+
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 60/200 (30%), Positives = 86/200 (43%), Gaps = 14/200 (7%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQ 332
+IG+G FGKV ++ AVK LQ +R V L +V H L+
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVG 60
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L T+ + V ++ + Y L+ E+ P + A A L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLH--- 113
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 452
+ I++RDLK NILLD VL DFGL K + + T+ GT ++APE L
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 453 SSEKTDVFGYGITLLELVTG 472
D + G L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 278 IIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLI 334
++G+G FGKV L ++ ++ AVK L+ E ++S+A + L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 335 GYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
C + +R+ V F+ + + ++ + D + A L +LH++
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-- 115
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
II+RDLK N+LLD L DFG+ K + + K T+ GT +IAPE L
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---TSTFCGTPDYIAPEILQEM 171
Query: 452 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
D + G+ L E++ G + E E+D+
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT---TQIRGTM 440
GL+Y+H +IHRDLK +N+L++++ E + DFG+A+ + + T T+ T
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 441 GHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQRAI 476
+ APE LS + + D++ G E++ G+R +
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDY--YSPGGEAAFQREVH 320
R+LQ+ +++ +IG+G FG+V + KV A+K L + A F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 321 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
+++ A ++QL +C ++ L Y M+ + DL D P K F
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYL-YMVMEYMPGG----DLVNLMSNYDVP-EKWAKFY 147
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGT 439
TA + L + +IHRD+K N+LLD + L DFG K+ + + T + GT
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GT 206
Query: 440 MGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 472
+I+PE L + G + D + G+ L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 7/87 (8%)
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 445
EYLH + II+RDLK N+LLD+ + DFG AK K+ T + GT ++AP
Sbjct: 132 EYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLAP 184
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTG 472
E + + + D + G+ L E + G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 279 IGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLIGY 336
IG+G +G V S+ N KVA+K++ + + +A RE+ L+ H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 337 CTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+VY M L + + L + + GL+Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELMDT-----DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH-- 125
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
+ ++HRDLK +N+LL+ N + +CDFGLA+ K +T + T + APE L
Sbjct: 126 -SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLN- 182
Query: 452 KSSEKT---DVFGYGITLLELVTGQ 473
SE T DV+ G EL+ +
Sbjct: 183 -CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IGQG G V+ + ++ +VA+K++ P E E+ ++ + N++ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLDSF 85
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
E +V ++ S L D+ E +D V LE+LH ++I
Sbjct: 86 LVGDELFVVMEYLAGGS----LTDVVT-ETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRD+K+ N+LL + L DFG + + + +T + GT +APE ++ K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 458 DVFGYGITLLELVTGQ 473
D++ GI +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 9/115 (7%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GL+YLH + I+HRD+K N+L++ N +CDFGLA++ + + TQ T +
Sbjct: 115 GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171
Query: 444 APEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 497
APE L + + D++ G EL+ R I F + + + LD I LL
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELL--GRRILF---QAQSPIQQLDLITDLL 221
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 50/219 (22%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY- 336
++G+G FGKV +A + D EV+ I V +LQ
Sbjct: 2 VLGKGSFGKVM---------LAELKGTD------------EVYAIKVLKKDVILQDDDVD 40
Query: 337 CTTSSERILV----YPFMQNLSVAYRLRD--------LKPGE--------KGLDWPTRKR 376
CT + +RIL +PF+ L ++ +D + G+ + D P +
Sbjct: 41 CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF 100
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTT 434
A L +LH +I+RDLK NILLD L DFG+ K +++ TT
Sbjct: 101 YAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT---TT 154
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT +IAPE L + D + G+ + E++ GQ
Sbjct: 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 279 IGQGGFGKVYKGVL----SDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQL 333
IG+G FGK +L D + +K + SP ++EV ++S H N++Q
Sbjct: 8 IGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63
Query: 334 IGYCTTSSERILVYPFMQNLS-------VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
Y + E +Y M + + L P ++ LDW + L+
Sbjct: 64 --YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALK 115
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
++H++ KI+HRD+K+ NI L + L DFG+A+++++ + T I GT +++PE
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPE 171
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQRAID 477
+ K+D++ G L E+ T + A +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 51/238 (21%)
Query: 278 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
++G+G FGKV L AVK A +++V LI +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVK------------ALKKDVVLIDDDVE--------- 40
Query: 337 CTTSSERILVY----PFMQNLSVAYRLRD--------LKPGEKGLDWPTRKRVAF--GTA 382
CT +R+L PF+ +L ++ ++ L G+ + R T
Sbjct: 41 CTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF 100
Query: 383 Y------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
Y GL++LH + II+RDLK N++LD + + DFG+ K +T
Sbjct: 101 YAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-F 156
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494
GT +IAPE L K + D + +G+ L E++ GQ F +E+E L + IR
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP--FHGDDEDE---LFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 45/252 (17%)
Query: 248 EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNT-KVAVKR-LQD 305
ED+ K+ + R + +L NIIG G FG VY+ + D + KVA+K+ LQD
Sbjct: 50 EDEEKMIDNDINRSPNKSYKLG-------NIIGNGSFGVVYEAICIDTSEKVAIKKVLQD 102
Query: 306 -YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER-----ILVYPFMQNL--SVAY 357
Y RE+ ++ H N++ L Y T + I + M+ + +V
Sbjct: 103 PQYK-------NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHK 155
Query: 358 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-L 416
++ L K ++ L Y+H + I HRDLK N+L+D N + L
Sbjct: 156 YMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKL 212
Query: 417 CDFGLAKLVDA---KLTHVTTQIRGTMGHIAPEYLSTGKSSEKT--DVFGYGITLLELV- 470
CDFG AK + A ++++ ++ + APE L G ++ T D++ G + E++
Sbjct: 213 CDFGSAKNLLAGQRSVSYICSRF-----YRAPE-LMLGATNYTTHIDLWSLGCIIAEMIL 266
Query: 471 -----TGQRAID 477
+GQ ++D
Sbjct: 267 GYPIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 38/165 (23%)
Query: 279 IGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAAFQ---------REV-HLISVA 325
+G+G +G V+K + D VA+K++ D AF+ RE+ L +
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFD--------AFRNATDAQRTFREIMFLQELG 64
Query: 326 IHKNLLQLIGYCTTSSER--ILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKR-VAFGT 381
H N+++L+ +++ LV+ +M+ +L R + KR + +
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR--------ANILEDVHKRYIMYQL 116
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
L+Y+H +IHRDLK +NILL+ + L DFGLA+ +
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 10/109 (9%)
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-GTM 440
A GL +LH + II+RDLK N++LD + DFG+ K + VTT+ GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489
+IAPE ++ + D + +G+ L E++ GQ + E+ED L
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQ--DYYSPGGEAAFQREVH 320
+L++ ++F +IG+G FG+V + +V A+K L + A F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 321 LISVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 378
+++ A + ++QL + ++ L V +M + + + EK W
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---W-----AR 145
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK-LTHVTTQIR 437
F TA + L + IHRD+K N+LLD + L DFG +DA + T +
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV- 204
Query: 438 GTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 472
GT +I+PE L + G + D + G+ L E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IGQG G VY + ++ +VA++++ P E E+ ++ + N++ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
E +V ++ S L D+ E +D V LE+LH ++I
Sbjct: 87 LVGDELWVVMEYLAGGS----LTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRD+K+ NILL + L DFG + + + + + GT +APE ++ K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 458 DVFGYGITLLELVTGQ 473
D++ GI +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
DNF + IG+G G V + + K VAVK++ E F EV ++ H+N
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 78
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
++++ E +V F++ ++ + + E+ + V L LH
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLH 133
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
Q +IHRD+K+ +ILL + L DFG V ++ + + GT +APE +S
Sbjct: 134 AQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELIS 189
Query: 450 TGKSSEKTDVFGYGITLLELVTGQ 473
+ D++ GI ++E+V G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 264 RELQLATDNFSESNIIGQGGFGKV----YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 319
R+ ++ ++F+ +G G FG+V YK D VA+KR + + Q++V
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEK-----SKIIKQKQV 75
Query: 320 -------HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK--PGEKGLD 370
+++ H + L G S LV F+ LR K P + G
Sbjct: 76 DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF 135
Query: 371 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+ + + F EYL + I++RDLK N+LLD + + DFG AK+VD +
Sbjct: 136 YAAQIVLIF------EYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184
Query: 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
T + GT +IAPE L + D + GI + E++ G
Sbjct: 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
L YLH +++RDLK N++LD + + DFGL K GT ++A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
PE L D +G G+ + E++ G+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 56/239 (23%), Positives = 105/239 (43%), Gaps = 34/239 (14%)
Query: 279 IGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+GQG F K++KG+ + T+V +K L + E+ F+ ++S HK+L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFE-AASMMSQLSHKHL 61
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK-GLDWPTRKRVAFGTAYGLEYLH 389
+ G C E I+V +++ S+ L+ K + W + VA A+ L +L
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLK--KNKNLINISW--KLEVAKQLAWALHFLE 117
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH----IAP 445
++ + H ++ A N+LL + + KL D ++ +T + + + P
Sbjct: 118 DK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLERIPWVPP 173
Query: 446 EYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL-REDRL 502
E + ++ S D + +G TL E+ +G ++ + LD +KL EDR
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGG----------DKPLSALDSQKKLQFYEDRH 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 67/285 (23%), Positives = 105/285 (36%), Gaps = 35/285 (12%)
Query: 280 GQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+ K NT VAVK++ D S Q+E+ H N+L +
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
SE +V P M S L+ P +GL + L+Y+H + IH
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIH---SKGFIH 124
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLVD------AKLTHVTTQIRGTMGHIAPEYLSTGK 452
R +KA++ILL + + VL + + + + ++PE L
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184
Query: 453 S--SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL---------LLDHIRKLLREDR 501
+EK+D++ GIT EL G + F + + +L LLD L ED
Sbjct: 185 QGYNEKSDIYSVGITACELANGH--VPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242
Query: 502 LNDIVDRNLNTYDSKEVETMV---------QVALLCTQSTPEDRP 537
++ N + + V+ Q LC Q PE RP
Sbjct: 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 281 QGGFGKVY--------------KGVLSDNTKV--AVKRLQDYYSPGGEAAFQREVHLISV 324
G FGK++ +GV S N + + G AA Q E ++++
Sbjct: 158 AGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILAL 217
Query: 325 AI--HKNLLQLIGYCTTSSERILVYP---FMQNLSVAYRL------RDLKPGEKGLDWPT 373
H+N+L++ E IL +M + L ++ L T
Sbjct: 218 GRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQT 269
Query: 374 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433
R + +EY+H++ K+IHRD+K NI L+ + + VL DFG A + +
Sbjct: 270 R-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
GT+ +PE L+ E TD++ G+ LL++++
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 36/173 (20%)
Query: 318 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 377
E H++ H +++QL G T + L+ P + Y L ++ +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCY-LAA------------KRNI 179
Query: 378 AF--------GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAK 428
A ++YLHE +IIHRD+KA NI ++ + L DFG A VD
Sbjct: 180 AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD-- 234
Query: 429 LTHVTTQIR-----GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476
+ GT+ APE L+ D++ GI L E+ T ++
Sbjct: 235 ----INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 35/121 (28%), Positives = 58/121 (47%), Gaps = 4/121 (3%)
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441
+ L YLHE+ II+RDLK N+LLD L D+G+ K + T+ GT
Sbjct: 106 SLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPN 161
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501
+IAPE L D + G+ + E++ G+ D + D D++ +++ E +
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 221
Query: 502 L 502
+
Sbjct: 222 I 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 55/227 (24%), Positives = 86/227 (37%), Gaps = 40/227 (17%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY-YSPGGEAAFQ------------REVHLI 322
+G+G +GKV K VA+K+++ S Q RE+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 323 SVAIHKNLLQLIG-YCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
+ H+N++ L+ Y + I LV M A L+ + + L K +
Sbjct: 75 NEIKHENIMGLVDVYV--EGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQ 127
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-------------KLVDA 427
GL LH +HRDL ANI ++ + DFGLA K
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 428 KLTHVTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 473
+ T T+ + APE L K D++ G EL+TG+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 8/113 (7%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMG 441
L+YLH + KI++RDLK N++LD + + DFGL K + DA GT
Sbjct: 107 ALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TMKTFCGTPE 160
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494
++APE L D +G G+ + E++ G+ E+ +++L++ I+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 11/141 (7%)
Query: 335 GYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----RVAFGTAYGLEYLH 389
G+ + S+ + + P + S + +D + E WP R + A G+++L
Sbjct: 172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTED--SWPLDLDDLLRFSSQVAQGMDFLA 229
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYL 448
+ IHRD+ A N+LL D A +CDFGLA+ + +V R + +APE +
Sbjct: 230 SK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 286
Query: 449 STGKSSEKTDVFGYGITLLEL 469
+ ++DV+ YGI L E+
Sbjct: 287 FDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAI 326
+ F ++G+G +G V K + VA+K+ +D S E + RE+ ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKD--SEENEEVKETTLRELKMLRTLK 58
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQN--LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 384
+N+++L + LV+ +++ L + + + P EK + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK------VRSYIYQLIKA 112
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
+ + H+ I+HRD+K N+L+ N LCDFG A+ + T+ T + +
Sbjct: 113 IHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
PE L + D++ G L EL GQ
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 12/204 (5%)
Query: 278 IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAA--FQREVHLISVAIHKNLLQLI 334
+IG+G + KV L N ++ A+K ++ E Q E H+ A L +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 335 GYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
C T+S LV ++ + + ++ ++ L + A L +LHE+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER-- 115
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 453
II+RDLK N+LLD + L D+G+ K T+ GT +IAPE L +
Sbjct: 116 -GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 454 SEKTDVFGYGITLLELVTGQRAID 477
D + G+ + E++ G+ D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 279 IGQGGFGKVYKGVLSDNTKVA---VKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
IG G FGKV + +T VA VK L+ S + F ++ + H N+LQ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR-------KRVAFGTAYGLEYL 388
C + +LV+ + + L DLK W R +R+A A G+ ++
Sbjct: 63 QCVEAIPYLLVFEYCE-------LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 442
H+ +H DL N L + + D+G+ K ++ T+ +R
Sbjct: 116 HKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 443 IAPEY---LSTGKSSEKTDVFGYGITLLEL 469
+ E+ L T + ++ ++V+ G+TL EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 11/196 (5%)
Query: 279 IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG+G G V K VAVK++ E F EV ++ H+N++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSY 88
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
E +V F++ ++ + + E+ + V L YLH Q +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQ---GVI 140
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRD+K+ +ILL + L DFG V ++ + + GT +APE +S +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 458 DVFGYGITLLELVTGQ 473
D++ GI ++E++ G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMG 441
L +LH Q +IHRD+K+ +ILL + L DFG A+++ + + GT
Sbjct: 128 LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC----AQVSKEVPRRKSLVGTPY 180
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+APE +S + D++ GI ++E+V G+
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G G +G V KVAVK+L + + S RE+ L+ H+N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTAYGLEYLH 389
T ++ ++N + Y + +L + + L + + + GL+Y+H
Sbjct: 83 FTPATS-------IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YL 448
+ IIHRDLK +N+ ++++ E + DFGLA+ D ++T T + APE L
Sbjct: 136 ---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV----ATRWYRAPEIML 188
Query: 449 STGKSSEKTDVFGYGITLLELVTGQ 473
+ ++ D++ G + EL+ G+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHI 443
L+ +H + ++HRDLK+ANI L L DFG +K D+ V + GT ++
Sbjct: 182 LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
APE + S+K D++ G+ L EL+T R
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSD---NTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI 326
D + + IG+G +G VYK D N +A+K+++ + G + RE+ L+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ 59
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG-EKGLDWPTRKRVAFGTAY-- 383
H N+++L SE+ L F Y DLK + D+ R+ Y
Sbjct: 60 HGNIVRL--QDVVHSEKRLYLVF------EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQI 111
Query: 384 --GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTM 440
G+ Y H +++HRDLK N+L+D A+ L DFGLA+ + T ++ T+
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TL 167
Query: 441 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVT 471
+ APE L + S D++ G E+V
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 279 IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLI 334
IG G G V Y VL N VA+K+L + A RE+ L+ HKN++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 335 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
T + E VY M+ NL ++ LD + + G+++
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 134
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LH + IIHRDLK +NI++ + + DFGLA+ A + + T T + APE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189
Query: 448 LSTGKSSEKTDVFGYGITLLELV 470
+ E D++ G + E+V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 35/115 (30%), Positives = 58/115 (50%), Gaps = 14/115 (12%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGH 442
LEYLH + +++RD+K N++LD + + DFGL K ++ T GT +
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI---DFSRLEEEEDVLLLDHIR 494
+APE L D +G G+ + E++ G+ D RL E ++L++ IR
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 34/86 (39%), Positives = 51/86 (59%), Gaps = 4/86 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKF-LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ SL L +N + I P I LK L L+L DN + +LP L ++ +L++L+L+ N
Sbjct: 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
S +P S LSNL +LDLS N ++
Sbjct: 175 LS-DLPKLLSNLSNLNNLDLSGNKIS 199
|
Length = 394 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 3/111 (2%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L+YLH + N +++RDLK N++LD + + DFGL K K GT ++
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494
APE L D +G G+ + E++ G+ E+ +++L++ IR
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 214
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 279 IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLI 334
IG G G V + VL N VAVK+L + A RE+ L+ HKN++ L+
Sbjct: 29 IGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGE---KGLDWPTRKRVAFGTAYGLEYLHEQ 391
T Q++ + L D + LD + + G+++LH
Sbjct: 87 NVFTPQKS----LEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH-- 140
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
+ IIHRDLK +NI++ + + DFGLA+ A + T T + APE +
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGM 197
Query: 452 KSSEKTDVFGYGITLLELVTG 472
E D++ G + ELV G
Sbjct: 198 GYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GL+Y+H + IIHRDLK +N+ ++++ E + DFGLA+ D ++T T +
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 184
Query: 444 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE L+ ++ D++ G + EL+TG+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 33/178 (18%)
Query: 314 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
A Q EV L H N++ TT S ++ PFM S L+ P +G+
Sbjct: 45 ALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP--EGMSEAL 102
Query: 374 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433
+ FG GL YLH+ IHR++KA++IL+ + GL L + L+H+
Sbjct: 103 IGNILFGALRGLNYLHQN---GYIHRNIKASHILISGD--------GLVSL--SGLSHLY 149
Query: 434 TQIRGTMGH----------------IAPEYLSTGKS--SEKTDVFGYGITLLELVTGQ 473
+ +R ++PE L + K+D++ GIT EL TG+
Sbjct: 150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 27/175 (15%)
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 436
++ A G+ +L + IHRDL A NILL +CDFGLA+ + +V
Sbjct: 220 SYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD-HIRK 495
R + +APE + + ++DV+ YGI L E+ FS + +D K
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEI--------FSLGSSPYPGMPVDSKFYK 328
Query: 496 LLRED-RLNDIVDRNLNTYDSKEVE--TMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+++E R+ S E M + C + P RP Q+V++++
Sbjct: 329 MIKEGYRM-----------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G+G +G VYK D L+ G + RE+ L+ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 339 TSSER--ILVYPFMQN--LSVAYRLRDLKPGEKGLDWPTR--KRVAFGTAYGLEYLHEQC 392
+ S+R L++ + ++ + R K +K + P K + + G+ YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 393 NPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 446
++HRDLK ANIL+ + + D G A+L ++ L + + T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 447 YLSTGKSSEKT-DVFGYGITLLELVTGQ 473
L + K D++ G EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 35/122 (28%), Positives = 66/122 (54%), Gaps = 8/122 (6%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTH--VTTQIRGTM 440
GL+Y+H + ++HRDLK AN+ ++ ++ + DFGLA++VD +H ++ T
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 441 GHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499
+ +P LS ++ D++ G E++TG+ + E E+ L+L+ + + E
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH-ELEQMQLILESVPVVREE 241
Query: 500 DR 501
DR
Sbjct: 242 DR 243
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 4/115 (3%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
L +LHE+ II+RDLK N+LLD L D+G+ K + T+ GT +IA
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIA 164
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499
PE L D + G+ + E++ G+ D + + D D++ +++ E
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 279 IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLI 334
IG G G V Y +L N VA+K+L + A RE+ L+ HKN++ L+
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
T Q++ + L D + + LD + + G+++LH
Sbjct: 90 NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 143
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
+ IIHRDLK +NI++ + + DFGLA+ A + + T T + APE +
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 452 KSSEKTDVFGYGITLLELVTGQ 473
E D++ G + E++ G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 15/98 (15%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-------KLVDAKLTHVTTQI 436
GL+Y+H + ++HRDLK N+L++ + E +CDFGLA +T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-- 171
Query: 437 RGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 473
T + APE LS ++ DV+ G L EL+ +
Sbjct: 172 --TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 3/86 (3%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
N+ L L N + + L L +L+L NDLS LP L ++++L +L+L+ N
Sbjct: 139 KSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN 196
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNL 160
K S +P LS L+ LDLS+N++
Sbjct: 197 KIS-DLPPEIELLSALEELDLSNNSI 221
|
Length = 394 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 37/109 (33%), Positives = 49/109 (44%), Gaps = 23/109 (21%)
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT------ 434
T LEYLH N I+HRDLK N+L+ L DFGL+K+ L +TT
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGH 163
Query: 435 -----------QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
Q+ GT +IAPE + + D + GI L E + G
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 72/290 (24%), Positives = 111/290 (38%), Gaps = 56/290 (19%)
Query: 279 IGQGGFGKVYKGVLSDN-----------TKVAVKRLQDYYSPGGEA--AFQREVHLISVA 325
+GQG F +YKGVL V +K L AF L+S
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
HK+L++L G C E I+V +++ + L + L W + VA A L
Sbjct: 59 SHKHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASAL 114
Query: 386 EYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDA--KLTHVTTQIR-GT 439
YL ++ K++H ++ NIL+ N V KL D +T ++ + R
Sbjct: 115 HYLEDK---KLVHGNVCGKNILVARYGLNEGYVPF----IKLSDPGIPITVLSREERVER 167
Query: 440 MGHIAPEYLSTGKSS--EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 497
+ IAPE + G++S D + +G TLLE+ S EE + L K
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEI--------CSN--GEEPLSTLSSSEKER 217
Query: 498 REDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKML 546
+ L D E+ + Q C P RP +++ L
Sbjct: 218 FYQDQH-----RLPMPDCAELANLINQ----CWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L YLH Q +IHRD+K+ +ILL + L DFG + + + + GT +
Sbjct: 129 ALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWM 184
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE +S + D++ GI ++E+V G+
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G+G +G VYK D L+ G + RE+ L+ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 339 TSSER--ILVYPFMQN--LSVAYRLRDLKPGEKGLDWP--TRKRVAFGTAYGLEYLHEQC 392
+ ++R L++ + ++ + R K +K + P K + + G+ YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 393 NPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 446
++HRDLK ANIL+ + + D G A+L ++ L + + T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 447 YLSTGKSSEKT-DVFGYGITLLELVTGQ 473
L + K D++ G EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 36/211 (17%)
Query: 279 IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQL 333
IG G G V Y V VA+K+L + A A+ RE+ L+ + HKN++ L
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGL 80
Query: 334 IGYCT------TSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
+ T + LV M NL ++ LD + + G++
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--------LDHERMSYLLYQMLCGIK 132
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH----VTTQIRGTMGH 442
+LH + IIHRDLK +NI++ + + DFGLA+ VT R
Sbjct: 133 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR----- 184
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE + E D++ G + E++ G
Sbjct: 185 -APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 30/109 (27%), Positives = 48/109 (44%), Gaps = 9/109 (8%)
Query: 366 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKL 424
E L K++ L LH IIH D+K N+L D + + LCD+GL K+
Sbjct: 103 EGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ + GT+ + +PE + D + G+ EL+TG+
Sbjct: 160 IGTPSCY-----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 4e-05
Identities = 17/38 (44%), Positives = 27/38 (71%), Gaps = 2/38 (5%)
Query: 124 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
T+L++L+L+NN+ + +P S L NL+ LDLS N +T
Sbjct: 1 TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 51/241 (21%), Positives = 96/241 (39%), Gaps = 50/241 (20%)
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW-------PTRKRVA--------- 378
GY S + Y MQ++ + D++ + P R R
Sbjct: 177 GYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPAL 236
Query: 379 ---------FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
+ A G+E+L + +HRDL A N+L+ + +CDFGLA+ +
Sbjct: 237 SYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS 293
Query: 430 THVTTQIRGT----MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485
+++ +G+ + +APE + + +DV+ +GI L E+ T + L E
Sbjct: 294 NYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT-LGGTPYPELPMNE 349
Query: 486 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545
+ I++ R + + S E+ ++Q C + E RP +Q+V +
Sbjct: 350 --QFYNAIKRGYRMAK---------PAHASDEIYEIMQ---KCWEEKFEIRPDFSQLVHL 395
Query: 546 L 546
+
Sbjct: 396 V 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 17/217 (7%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDY--YSPGGEAAFQREVH 320
R+L++ +++ +IG+G FG+V KV A+K L + A F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 321 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
+++ A ++QL +V +M + + + EK + T + V
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV--- 152
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGT 439
L+ +H IHRD+K N+LLD + L DFG K+ + T + GT
Sbjct: 153 --LALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 206
Query: 440 MGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 472
+I+PE L + G + D + G+ L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 9e-05
Identities = 25/62 (40%), Positives = 37/62 (59%), Gaps = 7/62 (11%)
Query: 125 HLQSLNLANNKFSGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLF----SVATFNFTGT 179
+L+SL+L+NN+ + IP L NLK LDLS NNLT I + F S+ + + +G
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGN 58
Query: 180 HL 181
+L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 22/215 (10%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHK 328
++F +IG+G FG+V L + KV ++ + + E A RE + V
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 329 NLLQLIGYCTTSSERILV----YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 384
+ + Y + + Y L++ + D P + + +A + +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG-LAKLVDAKLTHVTTQIRGTMGHI 443
L Y +HRD+K NIL+D N L DFG KL++ + + GT +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 444 APEYLST-----GKSSEKTDVFGYGITLLELVTGQ 473
+PE L GK + D + G+ + E++ G+
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 42/160 (26%), Positives = 66/160 (41%), Gaps = 8/160 (5%)
Query: 310 GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL 369
G A+ E L+ H +L L+ LV P ++ Y L+P L
Sbjct: 202 GWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRP----L 257
Query: 370 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-AK 428
VA ++Y+H + IIHRD+K N+L++ + L DFG A +
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314
Query: 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLE 468
T I GT+ APE L+ + D++ G+ + E
Sbjct: 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 438
+ A G+E+L + +HRDL A N+LL +CDFGLA+ + +V+ +G
Sbjct: 244 YQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KG 297
Query: 439 T----MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ + +APE + + +DV+ YGI L E+ +
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 6/83 (7%)
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 456
+HRD+K N+L+D L DFG A + A + GT +IAPE L+T K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 457 T------DVFGYGITLLELVTGQ 473
D + G+ E++ G+
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 20/56 (35%), Positives = 29/56 (51%), Gaps = 4/56 (7%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 439
LEYLH I++RDLK NILL ++ +L DF L+K D + ++
Sbjct: 115 ALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE-PPPVSKALRK 166
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----G 451
+HRD+K N+LLD N L DFG ++ T ++ GT +I+PE L G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 452 KSSEKTDVFGYGITLLELVTGQ 473
K + D + G+ + E++ G+
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 31/109 (28%), Positives = 46/109 (42%), Gaps = 6/109 (5%)
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 455
IHRDLK N L+D + L DFGL+K + V G+ ++APE L
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAPEVLRGKGYDF 177
Query: 456 KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504
D + G L E + G S E + L + ++ L+ +D
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK--YWKETLQRPVYDD 224
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-----STG 451
+HRD+K N+LLD N L DFG + A T + GT +I+PE L G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 452 KSSEKTDVFGYGITLLELVTGQ 473
+ + D + G+ + E++ G+
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 36.5 bits (85), Expect = 0.001
Identities = 15/39 (38%), Positives = 21/39 (53%), Gaps = 2/39 (5%)
Query: 36 EGEALIEVLKALN-DTHGQFTDWNDHFVSPCFSWSHVTC 73
+ +AL+ +LN D G + WN PC SW+ VTC
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPC-SWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 20/43 (46%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424
A L+YLH IIHRDLK N+L+ + L DFGL+K+
Sbjct: 114 ALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 30/86 (34%), Positives = 55/86 (63%), Gaps = 4/86 (4%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L +N ++ S++ LK L+ LEL +N LP+ +G++++L++L+L+NN+ S
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNN-KLEDLPESIGNLSNLETLDLSNNQ--IS 268
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIP 165
++ L+NL+ LDLS N+L+ +P
Sbjct: 269 SISSLGSLTNLRELDLSGNSLSNALP 294
|
Length = 394 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 47/240 (19%), Positives = 105/240 (43%), Gaps = 20/240 (8%)
Query: 287 VYKGVLSDNTKVAVKRLQDYYSPGGEA---AFQREVHLISVAIHKNLLQLIGYCTTSSER 343
+YKG+ +N +V ++ + + G + + E+ + N+L++ G+ +
Sbjct: 36 IYKGIF-NNKEVIIRTFK-KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 403
+ + LR++ EK L + T+ +A GL L++ N +++L +
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 404 ANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFG 461
+ L+ +N++ + GL K+ L+ + M + + + L+ + + K D++
Sbjct: 152 VSFLVTENYKLKIICHGLEKI----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYS 207
Query: 462 YGITLLELVTGQRAIDFSRLEEEE--DVLLLDHIRKLLRED---RLNDIVDRNLNTYDSK 516
G+ L E+ TG+ I F L +E D+++ + L D + IV+ + K
Sbjct: 208 LGVVLWEIFTGK--IPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIK 265
|
Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 595 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.07 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.95 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.88 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.88 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.85 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.84 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.84 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.83 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.77 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.73 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.7 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.7 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.69 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.67 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.62 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.47 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.42 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.41 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.39 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.38 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.37 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.35 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.35 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.35 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.34 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.32 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.3 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.28 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.24 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.2 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.19 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.15 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.12 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.1 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.09 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.07 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=526.19 Aligned_cols=448 Identities=28% Similarity=0.464 Sum_probs=308.5
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+++|.+|..+.++++|+.|+|++|+++|.+|..++++++|++|+|++|+++|.+|..+.++++|+.|+|+
T Consensus 476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 555 (968)
T PLN00113 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555 (968)
T ss_pred cceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence 57778888888887777777777778888888887777777777777777777777777777777777777777777777
Q ss_pred CCcCCccCchhhh---ccccccccccccccCCCCCC---------------CCCCCCC---CC-CCCccc-ceeeEeeec
Q 007625 157 SNNLTGRIPMQLF---SVATFNFTGTHLICGSSLEQ---------------PCMSRPS---PP-VSTSRT-KLRIVVASA 213 (595)
Q Consensus 157 ~N~l~g~ip~~l~---~l~~l~~~~n~~~~~~~~~~---------------~c~~~~~---~~-~~~~~~-~~~~iv~~~ 213 (595)
+|+++|.+|..+. ++..+++++|++.+..|... -|...++ ++ ....+. ...++++++
T Consensus 556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~ 635 (968)
T PLN00113 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCT 635 (968)
T ss_pred CCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHH
Confidence 7777777776553 35566666666554333111 1211100 00 001111 222223222
Q ss_pred ccccceeeehhhhhhhhhhhcccccccccccccCCCCccc-ccccccccCHHHHHHHhcCCCcCCeeeeccceEEEEEEe
Q 007625 214 SCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKV-SLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVL 292 (595)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~ 292 (595)
++++++++++++++++++++++.+........+.-.... .......++.+++ ...|...++||+|+||.||+|+.
T Consensus 636 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~ 711 (968)
T PLN00113 636 -LGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKS 711 (968)
T ss_pred -HHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEE
Confidence 222222222222222222222111110000000000000 0001112333333 34677889999999999999996
Q ss_pred -CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCH
Q 007625 293 -SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW 371 (595)
Q Consensus 293 -~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 371 (595)
.++..||+|++..... ....|++.+++++||||++++++|.+.+..++||||+++|+|.++++. ++|
T Consensus 712 ~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~ 779 (968)
T PLN00113 712 IKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSW 779 (968)
T ss_pred CCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCH
Confidence 5789999999864322 113468889999999999999999999999999999999999999963 789
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeecccccccccCccccCCC
Q 007625 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451 (595)
Q Consensus 372 ~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 451 (595)
.++.+++.|+|.||+|||..+.++|+||||||+||+++.++.+++. ||........ ....||+.|+|||++.+.
T Consensus 780 ~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~ 853 (968)
T PLN00113 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETK 853 (968)
T ss_pred HHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCC
Confidence 9999999999999999997766799999999999999999888875 6655433211 123578999999999999
Q ss_pred CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC---CCHHHHHHHHHHHHHc
Q 007625 452 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT---YDSKEVETMVQVALLC 528 (595)
Q Consensus 452 ~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~l~~l~~~c 528 (595)
.++.++|||||||++|||+||+.||+.... ......+|.+..........++|+.+.. ...++..++.+++.+|
T Consensus 854 ~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C 930 (968)
T PLN00113 854 DITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHC 930 (968)
T ss_pred CCCcccchhhHHHHHHHHHhCCCCCCcccC---CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhh
Confidence 999999999999999999999999864322 2234566666555444455556655432 3556777899999999
Q ss_pred ccCCCCCCCCHHHHHHHhhcC
Q 007625 529 TQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 529 l~~dP~~RPs~~evl~~L~~~ 549 (595)
|+.||++||+|+||+++|+..
T Consensus 931 l~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 931 TATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CcCCchhCcCHHHHHHHHHHh
Confidence 999999999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-55 Score=446.53 Aligned_cols=287 Identities=52% Similarity=0.851 Sum_probs=252.6
Q ss_pred cccccCHHHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccce
Q 007625 257 QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336 (595)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 336 (595)
..+.|+++++..+|++|...+.||+|+||.||+|.+++|..||||++....... ..+|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567799999999999999999999999999999999999999999887544332 5669999999999999999999999
Q ss_pred eecCC-ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEE
Q 007625 337 CTTSS-ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 337 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 415 (595)
|.+.+ +.++|||||++|+|.++|+..... .++|.+|.+|+.++|+||+|||+.+.|.||||||||+|||+|+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99999 499999999999999999974432 899999999999999999999999998999999999999999999999
Q ss_pred EeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 416 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 416 l~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
|+|||+++..............||.+|+|||++..+..++|+|||||||+++|++||+.+.+.... .....+.+|+..
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHHHH
Confidence 999999976554111111111799999999999999999999999999999999999999886542 223348999998
Q ss_pred HhccccccccccccCC--CCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 496 LLREDRLNDIVDRNLN--TYDS-KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~--~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
....+.+.+++|+.+. .+.. .+...+..++.+|++.+|.+||+|.||+++|+.
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 8888899999999986 3554 688889999999999999999999999999954
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=372.34 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=215.8
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC-ceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 349 (595)
+.+..+.||+|..|+|||++++ +++.+|+|++.....+...+++.+|+++++..+||+||.++|.|..+. ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3444789999999999999975 788999999976667777899999999999999999999999999998 49999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|++|+|.+.+... ..+++...-+|+.++++||.|||+ . +||||||||+|||++..|++||+|||.++.+...
T Consensus 160 MDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999863 569999999999999999999996 5 8999999999999999999999999999977654
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
...+..||..|||||.+.+..|+.++||||||+.++|+.+|+.|+............+.. .+++.
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~------------~Iv~~ 297 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC------------AIVDE 297 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH------------HHhcC
Confidence 445677999999999999999999999999999999999999999865221122222222 23444
Q ss_pred cCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 509 NLNTYDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 509 ~l~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..+..+.. ...++.+++..|+++||.+||+++|++++
T Consensus 298 ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 298 PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 44444554 77899999999999999999999999764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=387.96 Aligned_cols=254 Identities=31% Similarity=0.455 Sum_probs=210.0
Q ss_pred CCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCC-ceEEEEEec
Q 007625 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERILVYPFM 350 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 350 (595)
+...+.||+|+||+||+|.++....||||++.... .......|.+|+.++.+++|||||+++|+|.++. ..++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456699999999999999655559999997532 3333679999999999999999999999999988 799999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-cEEcCCCCCCEEEcCCC-cEEEeeccccccccCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK-IIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK 428 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~~~~~ 428 (595)
++|+|..+++.. ....+++..+.+++.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999874 356799999999999999999999999 6 99999999999999997 9999999999876543
Q ss_pred CcceeecccccccccCccccC--CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLS--TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
. ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||...... ..+.......
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--------~~~~~v~~~~------ 262 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--------QVASAVVVGG------ 262 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcC------
Confidence 2 2233367999999999999 568999999999999999999999999864431 1111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+..+..+...+..++.+||..||++||++.+|+..|+.
T Consensus 263 --~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~ 302 (362)
T KOG0192|consen 263 --LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES 302 (362)
T ss_pred --CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence 1112233366788899999999999999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=383.40 Aligned_cols=256 Identities=30% Similarity=0.441 Sum_probs=218.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
.+.+...+.||+|-||.||.|.++....||+|.++.. .....+|.+|+++|++++|+|||+++++|..++..++||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 3334457899999999999999988889999999864 34567899999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
|+.|+|.++|+. .....+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+...++.
T Consensus 283 m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 283 MPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred cccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 999999999997 3356789999999999999999999999 99999999999999999999999999999766655
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+...... +.+....+..++
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------ev~~~le~GyRl------ 423 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------EVLELLERGYRL------ 423 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--------HHHHHHhccCcC------
Confidence 555555556789999999999999999999999999999999 77887654432 223322222222
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..|..++.++.++|..||..+|++|||++.+...|++.
T Consensus 424 ---p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 424 ---PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred ---CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 23667888999999999999999999999998888764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=354.14 Aligned_cols=259 Identities=23% Similarity=0.335 Sum_probs=215.8
Q ss_pred cCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEec-cCCCchhHHHHHHHHHHHHhcCCCCCccccc-eeecCCc-eEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIG-YCTTSSE-RILV 346 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 346 (595)
.+|++.++||+|.||+||++. ..+|..||.|.++ ...+....++...|+.+|++++|||||++++ .+..+.+ .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 356778999999999999999 5689999999987 3345566788999999999999999999998 4455555 7899
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP-KIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||..|+|...+..+++..+.+++.+.++++.|++.||.++|...+. -|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999999988889999999999999999999999994221 3999999999999999999999999999988
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.... ......+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.+... .+.-+++ ..+
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------~~L~~KI-~qg----- 243 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------LSLCKKI-EQG----- 243 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--------HHHHHHH-HcC-----
Confidence 7543 334557899999999999999999999999999999999999999987642 1222211 111
Q ss_pred ccccCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 506 VDRNLNTYD-SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 506 ~d~~l~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
..+..+ ..++.++..++..|+..||+.||+...+++.+.
T Consensus 244 ---d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 ---DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ---CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 222233 667889999999999999999999555555443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=376.52 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=215.5
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
.+|...+.||+|||+.||+++. .+|+.||+|++.+. ..........+|+++.++++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688999999999999999996 78999999999642 45667788999999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
|+|.+++|..++.. .+++++.+++.++.||+.||.|||++ +|+|||||-.|+++++++++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999998884 56799999999999999999999999 999999999999999999999999999998875
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
+. ....+.+|||.|+|||++....++..+||||+|||+|-|+.|++||+.....+. ...+...+
T Consensus 171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket--------y~~Ik~~~------- 234 (592)
T KOG0575|consen 171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET--------YNKIKLNE------- 234 (592)
T ss_pred cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH--------HHHHHhcC-------
Confidence 42 334568899999999999999999999999999999999999999986544322 22111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
- ..|.....+..+++.++|+.+|.+|||+++|+..
T Consensus 235 Y---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 Y---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred c---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 1234555677889999999999999999999763
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=362.57 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=209.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEeccCCCch------hHHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPG------GEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++....... .....++|+++|++++|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45568889999999999999999 4589999999997543222 2334679999999999999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC---CcEEEee
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCD 418 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~D 418 (595)
..|+||||++||+|.+.+-. ++.+.+...+.++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999876 45678888899999999999999999 99999999999999766 7899999
Q ss_pred ccccccccCcCcceeecccccccccCccccCCCCC---CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
||+|+...+ ...+.+.+||+.|.|||++.+..+ ..++|+||+|||||-+++|.+||..... ...+.+.+..
T Consensus 323 FGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~----~~sl~eQI~~ 396 (475)
T KOG0615|consen 323 FGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT----DPSLKEQILK 396 (475)
T ss_pred cchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC----CccHHHHHhc
Confidence 999998763 445677899999999999976553 3478999999999999999999975332 2223333322
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+++.. .+..+.+..++..+++.+|+..||++|||+.|++++
T Consensus 397 ----G~y~f-----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 ----GRYAF-----GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ----Ccccc-----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11110 011345667788999999999999999999999764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=355.91 Aligned_cols=203 Identities=26% Similarity=0.390 Sum_probs=183.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
.++|...+.||+|+||+||+|+.+ ++..||||.+.... .....+....|+.+|+.++|||||.+++++..++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888899999999999999964 68999999987542 5667778899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC------CcEEEeeccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN------FEAVLCDFGL 421 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfG~ 421 (595)
|||.+|+|.++++. ...+++.+.+.++.|+|.||++||++ +||||||||.|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999997 34799999999999999999999999 99999999999999764 5689999999
Q ss_pred cccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCch
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~ 481 (595)
|+.+.. .....+.+|++-|||||+++..+|+.|+|+||+|+|+|||++|+.||+....
T Consensus 162 AR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 162 ARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 998874 3344568899999999999999999999999999999999999999986544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=390.59 Aligned_cols=263 Identities=25% Similarity=0.400 Sum_probs=222.8
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 340 (595)
++...+....+.||+|+||.||+|+.. +...||||.+++..+....++|++|+++++.++|||||+++|.|..+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344555666889999999999999842 34569999999888877899999999999999999999999999999
Q ss_pred CceEEEEEecccCcHhhhhcccCCC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPG----------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 410 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 410 (595)
+..++|+|||..|+|.++|+...+. ..+++..+.+.||.|||.||+||.++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 9999999999999999999854321 12388999999999999999999999 8999999999999999
Q ss_pred CCcEEEeeccccccccCcCcce-eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhh
Q 007625 411 NFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 488 (595)
Q Consensus 411 ~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~ 488 (595)
+..|||+|||+++..-..+.+. .....-+.+|||||.++.+++|++||||||||+|||+++ |+.|+.+...++
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----- 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----- 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence 9999999999999654433332 224445789999999999999999999999999999998 889988655422
Q ss_pred HHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 489 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
+.+.++. ..+...+++++.++.++|..||+..|.+||+++||-..|+..
T Consensus 714 ----VIe~i~~--------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 714 ----VIECIRA--------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ----HHHHHHc--------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 2222222 334456788899999999999999999999999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=350.54 Aligned_cols=245 Identities=26% Similarity=0.309 Sum_probs=206.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
..++|++.++||+|+||.||.++. ++++.||+|++++. ......+...+|..+|.+++||+||+++-.|++.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 456899999999999999999995 57899999999753 233457788999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
|+||+.||.|...|.+ +..+++..+.-++..|+.||.|||+. +||||||||+|||+|++|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999986 45789999999999999999999999 9999999999999999999999999999854
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
-.. ...+.+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+. .+++.......
T Consensus 176 ~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~I~~~k----- 241 (357)
T KOG0598|consen 176 LKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDKILKGK----- 241 (357)
T ss_pred ccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHHHhcCc-----
Confidence 332 2334457899999999999999999999999999999999999999986543 22333332222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 538 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs 538 (595)
+...+.-...+..+++...++.||++|..
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 11122224456777888999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=326.92 Aligned_cols=262 Identities=25% Similarity=0.358 Sum_probs=207.9
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCC-chhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
+.|+...++|+|+||.|||++.+ +|+.||||++.+... +...+-..+|+++|++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999965 699999999986544 4445667899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
||+. ++.+.|..+ ...++....++++.|++.|+.|+|++ ++|||||||+|||++.++.+||||||+|+.+...
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9987 444444432 45689999999999999999999999 9999999999999999999999999999988753
Q ss_pred CcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc--cccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE--DRLNDI 505 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~ 505 (595)
....+.++.|..|+|||.+.+ .+|...+||||+||++.||++|.+-|.+.+..+ ..-.++..+.+ .+...+
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD-----QLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID-----QLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH-----HHHHHHHHHcccCHHHHHH
Confidence 334556778999999999987 789999999999999999999999998765422 22222222111 011111
Q ss_pred ccc----------------cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDR----------------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~----------------~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.. .+..--+....-+++++..|+..||.+|++-+|++.+
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111 0111122334567899999999999999999999753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=353.70 Aligned_cols=263 Identities=26% Similarity=0.432 Sum_probs=207.7
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEe------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeec
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 339 (595)
.+..++|++.++||+|+||.||+|.. .++..||+|+++..........+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567899999999999999999974 235689999997554445567889999999999 89999999998876
Q ss_pred CC-ceEEEEEecccCcHhhhhcccCCC-----------------------------------------------------
Q 007625 340 SS-ERILVYPFMQNLSVAYRLRDLKPG----------------------------------------------------- 365 (595)
Q Consensus 340 ~~-~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 365 (595)
.+ ..++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 578999999999999998743210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc-eeeccccc
Q 007625 366 -----EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGT 439 (595)
Q Consensus 366 -----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt 439 (595)
...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 13588889999999999999999999 9999999999999999999999999999865432221 12233467
Q ss_pred ccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHH
Q 007625 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV 518 (595)
Q Consensus 440 ~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 518 (595)
..|+|||++.+..++.++|||||||++|||++ |..||......+. ..... ..+. ....+....
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~----~~~~~----~~~~--------~~~~~~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE----FCQRL----KDGT--------RMRAPENAT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH----HHHHH----hcCC--------CCCCCCCCC
Confidence 88999999998899999999999999999997 9999975432111 11111 1111 011123345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 519 ETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 519 ~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+.+++.+||+.||++|||+.||++.|+.
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=369.12 Aligned_cols=257 Identities=28% Similarity=0.401 Sum_probs=218.3
Q ss_pred CCCcCCeeeeccceEEEEEEeC----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
...+.++||.|.||.|++|+++ ....||||.++...+++++.+|+.|..+|.++.||||+++.|+.......++|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4456889999999999999975 345699999999999999999999999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
|||++|+|+.+|+... ..+++.+...+.++||.||.||.+. ++|||||.++|||++.+...|++|||+++.+.+
T Consensus 710 EyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999743 4589999999999999999999999 999999999999999999999999999998866
Q ss_pred cCcceeecc--cccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 428 KLTHVTTQI--RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 428 ~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
+.....+.. .-+.+|.|||.+..+++|.+||||||||||||.++ |.+||...... +.+......-++.
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--------dVIkaIe~gyRLP- 854 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVIKAIEQGYRLP- 854 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--------HHHHHHHhccCCC-
Confidence 543333222 23579999999999999999999999999999876 89998743321 1222222222222
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL 551 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 551 (595)
.+.+++..+.+||+.||++|-.+||.+.||+..|++...
T Consensus 855 --------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 855 --------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred --------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 245677899999999999999999999999999987443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=341.81 Aligned_cols=262 Identities=25% Similarity=0.339 Sum_probs=207.6
Q ss_pred cCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEec-cCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC--CceEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV 346 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 346 (595)
+.|+..++||+|.||.||+|+ ..+|+.||+|+++ +...++...-..+|+.+|++++||||+++.+...+. ...|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456678899999999999999 5689999999997 334556667778999999999999999999988776 689999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
+|||+. +|..++.. ..-.++..+++.++.|++.||+|+|.+ +|+|||||.+|||||.+|.+||+|||+|+.+.
T Consensus 197 FeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999987 77777764 234699999999999999999999999 99999999999999999999999999999887
Q ss_pred CcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc---cccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---EDRL 502 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~ 502 (595)
.......+..+-|..|.|||.+.+. .|+.++|+||.|||+.||++|++.|.+....+.. ..+-+... +..+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl-----~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL-----HKIFKLCGSPTEDYW 344 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH-----HHHHHHhCCCChhcc
Confidence 7666656666789999999999875 5999999999999999999999999876543221 11111111 1111
Q ss_pred c--cccc----ccCCCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 503 N--DIVD----RNLNTYDS-------KEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 503 ~--~~~d----~~l~~~~~-------~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. .+.. .....+.. ......++|+..+|..||.+|.|+.++++
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1 0000 00001111 12345678888999999999999999976
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=343.81 Aligned_cols=263 Identities=23% Similarity=0.305 Sum_probs=212.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCC-ceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS-ERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 345 (595)
..++|...++||.|.||.||+|+. .+|..||||+++.....-....-.+|+..|++++ ||||+++.+.+.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346888899999999999999994 5799999999986554444555678999999998 999999999998888 8999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
|||||+. +|++++.+. ++.+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.+
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999975 999999874 57899999999999999999999999 9999999999999998889999999999977
Q ss_pred cCcCcceeecccccccccCccccC-CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc----
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---- 500 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~---- 500 (595)
.... ..+.++.|..|+|||++. .+-|+.+.||||+|||++|+.+-++-|.+.+.-+. .--+...+...
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-----i~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-----IYKICEVLGTPDKDS 233 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-----HHHHHHHhCCCcccc
Confidence 5433 345567899999999975 56789999999999999999999999987553211 11111111111
Q ss_pred -------------cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 -------------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 -------------~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
++.......+....+....+..+++.+|++.||.+|||+.|.+++
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111112222334478889999999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=313.78 Aligned_cols=262 Identities=25% Similarity=0.317 Sum_probs=210.7
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
++|...++||+|.||.||+|+. .+|+.||||+++-. ..++......+|++.|+.++|+||+.+++.|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688899999999999999994 58999999999843 344555677899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
||+. +|...+++ ....++....+.++.++++|++|+|++ .|+||||||.|+|++.+|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9985 88888876 346799999999999999999999999 8999999999999999999999999999988765
Q ss_pred CcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc---cccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---EDRLND 504 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~ 504 (595)
......+ +-|..|+|||.+.+. .|+..+||||.|||+.||+-|.+-|.+.+.-+. ...+-..+. ++.+.+
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ-----L~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ-----LSKIFRALGTPTPDQWPE 228 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH-----HHHHHHHcCCCCcccCcc
Confidence 5444433 569999999998875 589999999999999999999877776543221 122211111 111211
Q ss_pred c------------ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 505 I------------VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 505 ~------------~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+ ..+.+...-+.+..+.++++..++..+|.+|+++.|++++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1 1111122334456677999999999999999999999764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.82 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=205.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC--ceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 347 (595)
.++...+.||+|+||+||++... +|...|||.+....... .+.+.+|+.+|.+++|||||+++|...... ..++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 45677899999999999999965 48999999986433222 677899999999999999999999865555 588999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-CCcEEEeecccccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVD 426 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~~~~~~ 426 (595)
||+++|+|.+++.... . .+++..+..++.||++||+|||++ +|+|+||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999998743 2 699999999999999999999999 9999999999999999 7999999999998776
Q ss_pred C--cCcceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 427 A--KLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 427 ~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
. ..........||+.|||||++..+. ...++|||||||++.||+||++||.... ....++-......
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-------~~~~~~~~ig~~~--- 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-------EEAEALLLIGRED--- 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-------chHHHHHHHhccC---
Confidence 3 2222344577999999999998643 3459999999999999999999997420 0111111111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
..+..+...+.+..+++..|++.+|++||||++++++.-
T Consensus 240 -----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 -----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 122344456677888899999999999999999987653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=350.93 Aligned_cols=267 Identities=27% Similarity=0.429 Sum_probs=216.2
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeec
Q 007625 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (595)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 339 (595)
.+.+++++..+.+.++..||+|.||+||+|+|.+ .||||++... -++...+.|++|+.++++-+|.||+=+.|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3447788888888999999999999999999854 5999999843 355677899999999999999999999999998
Q ss_pred CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
++. .+|+.+|+|-+|+.++|..+ ..++..+...|+.|||+||.|||.+ +|||||||..||++.+++.|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 887 99999999999999999743 5689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccC-cCcceeecccccccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 420 GLAKLVDA-KLTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 420 G~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
|++..-.. ..........|...|||||+++. .+|+..+||||||+|+|||+||..||.....+ . .+..
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-q---Iifm---- 604 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-Q---IIFM---- 604 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-h---eEEE----
Confidence 99864321 11122233458889999999864 46899999999999999999999999832211 0 0100
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
+..+ .+.+.+.....++..++.+|+..||..++++||.+.+|+..|+..
T Consensus 605 -VGrG----~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 605 -VGRG----YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred -eccc----ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 0011 011122223455667888999999999999999999999988763
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=343.65 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=210.3
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCce
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (595)
....+|..++.||+|+|++|++|+. .+++.||||++.+.. .+...+.+..|-.+|.+| .||.|++|+..|.+....
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3556788999999999999999995 478999999986432 233456677888999999 899999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
|+|+||+++|+|.++++.+ ..+++...+.++.+|+.||+|||++ |||||||||+|||+|+||+++|+|||.|+
T Consensus 150 YFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 9999999999999999975 4589999999999999999999999 99999999999999999999999999999
Q ss_pred cccCcCcc----------ee--ecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH
Q 007625 424 LVDAKLTH----------VT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 491 (595)
Q Consensus 424 ~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~ 491 (595)
.+...... .. ...+||..|.+||++.....+..+|+|+|||++|+|+.|.+||.+.+.. ...+
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-----liFq 297 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-----LIFQ 297 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-----HHHH
Confidence 88643211 11 3478999999999999999999999999999999999999999865432 1122
Q ss_pred HHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 492 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
.+.. ++-. +++..++.+.+|+.+.+..||.+|++..||-++.
T Consensus 298 kI~~----------l~y~---fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 298 KIQA----------LDYE---FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHH----------hccc---CCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 2221 1111 2233336777888899999999999998886653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.00 Aligned_cols=264 Identities=26% Similarity=0.358 Sum_probs=209.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
..+.|++..+||.|..++||+|+ ...++.||||++.-.......+.+++|++.++.++||||++++..|..+...++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 45678999999999999999999 56789999999973333344788999999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
.||.+|++.+.+..... ..+++..+..|.+++++||.|||++ |.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 104 pfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999997653 4599999999999999999999999 999999999999999999999999999887654
Q ss_pred cCcce---eecccccccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 428 KLTHV---TTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 428 ~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..... .....||++|||||+++. ..|+.|+||||||+...||.+|..||....+.. .+..-.....+. ..
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk----vLl~tLqn~pp~-~~ 253 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK----VLLLTLQNDPPT-LL 253 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH----HHHHHhcCCCCC-cc
Confidence 33221 144679999999999543 458999999999999999999999998543211 111111110000 00
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...++.. ........+.+++..|++.||.+|||++++++.
T Consensus 254 t~~~~~d---~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKD---EDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChH---HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0001100 112233478889999999999999999999863
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=317.11 Aligned_cols=238 Identities=24% Similarity=0.294 Sum_probs=202.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|+..+.||.|+||.|..++.+ +|..+|+|++... ....+.+...+|..+|+.+.||+++++++.+.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 346778999999999999999965 6889999999642 2345567788999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||.+||.|.++++. ..+++++.++-++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+...
T Consensus 123 meyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999997 35689999999999999999999999 99999999999999999999999999999875
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.. +.+.+|||.|+|||++....+..++|+|||||++|||+.|.+||....... ...++..
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~--------iY~KI~~-------- 255 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ--------IYEKILE-------- 255 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH--------HHHHHHh--------
Confidence 43 566889999999999999999999999999999999999999998655421 1111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDR 536 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~R 536 (595)
.. ..+|+-...++.+++...++.|-.+|
T Consensus 256 -~~-v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 -GK-VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -Cc-ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 11 12344455677788889999999888
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=345.90 Aligned_cols=240 Identities=28% Similarity=0.426 Sum_probs=204.0
Q ss_pred CcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccC
Q 007625 274 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
..++-||.|+.|.||.|++ .++.||||+++... +.+++.|++++||||+.+.|+|....-+++|||||..|
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 3478899999999999998 67899999886422 46788999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCccee
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 433 (595)
.|...|+. ...+.......+..+||.||.|||.+ .|||||||+-||||+.+..+||+|||-++...+. ...
T Consensus 198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk 268 (904)
T KOG4721|consen 198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK 268 (904)
T ss_pred cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence 99999986 56788889999999999999999999 9999999999999999999999999999877654 233
Q ss_pred ecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCC-C
Q 007625 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-T 512 (595)
Q Consensus 434 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~ 512 (595)
....||..|||||++.+.+.++|+||||||||||||+||..||..-+... .+. -+-...+. .
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--------IIw---------GVGsNsL~Lp 331 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--------IIW---------GVGSNSLHLP 331 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--------eEE---------eccCCccccc
Confidence 45779999999999999999999999999999999999999986322110 000 00011111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.+..+++-+.-++++||+..|..||++.+|+.+|+-
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 466778888899999999999999999999999974
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=371.68 Aligned_cols=261 Identities=30% Similarity=0.441 Sum_probs=218.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC--CCc----EEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS--DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 342 (595)
..++.+..+.||+|.||.||.|... +|. .||+|.+++..+.+...+|.+|..+|+.++|||||+++|.|.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3556667899999999999999964 343 4999999988888889999999999999999999999999999999
Q ss_pred eEEEEEecccCcHhhhhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPG---EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
.++++|||++|+|..+|++.+.. ...++....+.++.|||+|+.||+++ ++|||||.++|+||+....+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999975432 35689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcceeecc-cccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHh
Q 007625 420 GLAKLVDAKLTHVTTQI-RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 497 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~ 497 (595)
|+|+.+........... .-+.+|||||.+..+.++.|+|||||||++||++| |..||...+..+ ......
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------v~~~~~ 918 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------VLLDVL 918 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------HHHHHH
Confidence 99995544333332222 34579999999999999999999999999999999 888987544321 112222
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 498 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
+.+++ ..++.++..+.++|.+||+.+|++||++..|++.+..+
T Consensus 919 ~ggRL---------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 919 EGGRL---------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred hCCcc---------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 33322 23566778899999999999999999999999977653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=339.09 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=214.2
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
++|-+.+.||+|.||.||||+.+ +.+.||+|.+.+. ..+.....+.+|+++++.++||||+.+++.|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778899999999999999965 6788999998643 445567789999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+.| +|..+|.+ +..++++.+..++.++..||.|||+. +|.|||+||.|||++..+.+|++|||+++.+...
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9987 99999986 56799999999999999999999999 9999999999999999999999999999988653
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
+...+.+.|||-|||||+..+++|+..+|+||+|||+|||++|++||.... +...++.+..+.
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~-------- 216 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDP-------- 216 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCC--------
Confidence 445566889999999999999999999999999999999999999997432 222333322211
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..++.+....+..++...+.+||.+|.+-.+++.+
T Consensus 217 --v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 --VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 12355777888999999999999999999998753
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=335.20 Aligned_cols=266 Identities=21% Similarity=0.323 Sum_probs=206.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCC-----------------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCcc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSD-----------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 332 (595)
.++|++.+.||+|+||.||+|.+++ +..||+|.++..........|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578889999999999999998532 33699999876555556678999999999999999999
Q ss_pred ccceeecCCceEEEEEecccCcHhhhhcccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcE
Q 007625 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397 (595)
Q Consensus 333 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 397 (595)
+++++...+..++||||+++++|.+++..... ....+++.+..+++.|++.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999998864221 113478899999999999999999999 999
Q ss_pred EcCCCCCCEEEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhC--CC
Q 007625 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG--QR 474 (595)
Q Consensus 398 H~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg--~~ 474 (595)
||||||+||++++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 22234467899999999888899999999999999999974 45
Q ss_pred CCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 475 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 475 p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
||...... .....+....+....... ...++..+..+.+++.+||+.||++|||+.||.+.|++
T Consensus 241 p~~~~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDE-----QVIENAGEFFRDQGRQVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHH-----HHHHHHHHHhhhcccccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 66543221 122222222111110000 01122344678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=339.46 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=209.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
...|..-.+||+|+.|.||.|.. .+++.||||++.-. ......-+.+|+.+|+..+|+|||.+++.|...++.+.|||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~-~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR-KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEec-cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 34577788999999999999994 57889999998632 23345667899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
||++|+|.+.+.. ..+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 351 ym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999998875 3489999999999999999999999 9999999999999999999999999999987655
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.. ......||+.|||||++....|++|.||||||++++||+-|++||-.... +.... .++.....+
T Consensus 423 ~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAly--LIa~ng~P~---- 488 (550)
T KOG0578|consen 423 QS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALY--LIATNGTPK---- 488 (550)
T ss_pred cC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHH--HHhhcCCCC----
Confidence 43 33456799999999999999999999999999999999999999964222 11111 111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...++.....+.++..+|++.|+++||++.|++++
T Consensus 489 --lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 --LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11355667788999999999999999999999764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=328.65 Aligned_cols=256 Identities=22% Similarity=0.307 Sum_probs=207.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
.++|++.+.||+|+||.||+|.++ .+..||+|+++...+......|.+|+..+.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457888999999999999999853 3568999999865555556789999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998753 24689999999999999999999999 9999999999999999999999999987654
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
............++..|+|||++.+..++.++|||||||++||+++ |+.||......+ ..+.+. ...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-----~~~~~~----~~~--- 225 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-----VIKAVE----DGF--- 225 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHHH----CCC---
Confidence 3222111222335678999999999999999999999999999875 999997543211 111111 110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
....+...+..+.+++.+||+.+|++||+++||.+.|..
T Consensus 226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 001123345678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=334.59 Aligned_cols=255 Identities=20% Similarity=0.215 Sum_probs=208.5
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
.+..++|+.+.+||+|+||.||.|+- ++|..+|+|++++. ...++...++.|-.+|....+|+||+++-.|++.+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45778899999999999999999994 57999999999853 3456678899999999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
||||||++||+...+|.. ...+++..+..++.+++.|++.+|+. |+|||||||+|+|||..|++||+|||++.
T Consensus 217 YLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999986 45799999999999999999999999 99999999999999999999999999985
Q ss_pred cccC----------------------cCcc-----e-------------------eecccccccccCccccCCCCCCccc
Q 007625 424 LVDA----------------------KLTH-----V-------------------TTQIRGTMGHIAPEYLSTGKSSEKT 457 (595)
Q Consensus 424 ~~~~----------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~s 457 (595)
-+.. .... . ....+|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3211 0000 0 0124599999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 007625 458 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 537 (595)
Q Consensus 458 Dv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP 537 (595)
|+||+|||+|||+.|.+||....+.+.- ..+..|-.....+.. .....+..++|.+|+. ||++|.
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~-rkI~nwr~~l~fP~~-------------~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETY-RKIVNWRETLKFPEE-------------VDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhhhccCCCc-------------CcccHHHHHHHHHHhc-CHHHhc
Confidence 9999999999999999999977654332 233444332221111 1122677788889998 999997
Q ss_pred C---HHHHH
Q 007625 538 P---MAQVV 543 (595)
Q Consensus 538 s---~~evl 543 (595)
. ++||-
T Consensus 435 G~~G~~EIK 443 (550)
T KOG0605|consen 435 GSKGAEEIK 443 (550)
T ss_pred CcccHHHHh
Confidence 6 55553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=337.20 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=207.2
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC---C-chhHHHHHHHHHHHHhcC-CCCCccccceeecCC
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY---S-PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS 341 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 341 (595)
...++|...+.||+|.||+|+.|.. .++..||+|++.... . ......+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3566899999999999999999985 478999999765421 1 133556678999999999 999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-CcEEEeecc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFG 420 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG 420 (595)
..++||||+.+|+|.+++.+ ..++.+..+..++.|++.|++|+|++ +|+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999987 35688899999999999999999999 99999999999999999 999999999
Q ss_pred ccccccCcCcceeecccccccccCccccCCCC-CC-ccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SS-EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..... ...+....
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--------~l~~ki~~ 237 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--------NLYRKIRK 237 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--------HHHHHHhc
Confidence 999774 2233455678999999999999877 75 7899999999999999999999863321 11111111
Q ss_pred cccccccccccCCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 499 EDRLNDIVDRNLNTYDSKE-VETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+. ..++... ..++..++.+|+..+|.+|+++.+|+.
T Consensus 238 -~~---------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 -GE---------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -CC---------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 10 0112222 678889999999999999999999973
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=343.85 Aligned_cols=262 Identities=25% Similarity=0.380 Sum_probs=207.6
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEe------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecC
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 340 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 340 (595)
...++|++.+.||+|+||.||+|++ .++..||||+++..........+.+|+.++..+ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3456788899999999999999973 246689999997544445567789999999999 899999999999999
Q ss_pred CceEEEEEecccCcHhhhhcccCC--------------------------------------------------------
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKP-------------------------------------------------------- 364 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 364 (595)
+..++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999864221
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 365 ---------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 365 ---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 112578899999999999999999999 99999999999999999999999999998664432
Q ss_pred cce-eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 430 THV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 430 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ...+.+.. +...
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----~~~~~~~~----~~~~---- 336 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----KFYKMIKE----GYRM---- 336 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----HHHHHHHh----CccC----
Confidence 211 122335678999999999999999999999999999998 888886533211 11122111 1000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+...+.++.+++.+||+.||++||++.||++.|+.
T Consensus 337 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 ----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0111224578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.30 Aligned_cols=265 Identities=27% Similarity=0.381 Sum_probs=214.3
Q ss_pred CHHHHHHHhcCCCcCCeeeeccceEEEEEEeCC--C--cE-EEEEEecc--CCCchhHHHHHHHHHHHHhcCCCCCcccc
Q 007625 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSD--N--TK-VAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLI 334 (595)
Q Consensus 262 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~l~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 334 (595)
....+++..++....++||+|+||.||+|+++. + .. ||||..+. ........+|.+|.+++++++|||||+++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 344566666777778999999999999999642 2 23 89999884 35667789999999999999999999999
Q ss_pred ceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcE
Q 007625 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 414 (595)
Q Consensus 335 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 414 (595)
|++......++|||+|.||+|.++|.... ..++..++..++.+.|.||+|||++ +++||||.++|+|++.++.+
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeE
Confidence 99999999999999999999999999743 2599999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHH
Q 007625 415 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 415 kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~ 493 (595)
||+|||+++.-.. .........-+.+|+|||.+...-++.++|||||||++||+++ |..||.+.... ....++
T Consensus 302 KISDFGLs~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~v~~kI 375 (474)
T KOG0194|consen 302 KISDFGLSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----EVKAKI 375 (474)
T ss_pred EeCccccccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----HHHHHH
Confidence 9999999875431 1111111235689999999999999999999999999999999 78898764432 122222
Q ss_pred HHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 494 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
. ..+. ....+...+.++..++.+||..+|++||+|.+|.+.|+..
T Consensus 376 ~---~~~~--------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 376 V---KNGY--------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred H---hcCc--------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 1 1111 1112334566777888899999999999999999999764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=326.63 Aligned_cols=260 Identities=17% Similarity=0.271 Sum_probs=205.0
Q ss_pred cccccCHHHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCC--chhHHHHHHHHHHHHhcCCCCCcccc
Q 007625 257 QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLI 334 (595)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~ 334 (595)
+++.++.++++ ......||+|++|.||+|.+ +|+.||||+++.... ....+.|.+|+.++.+++||||++++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 34455556652 22247899999999999998 789999999874322 12246788999999999999999999
Q ss_pred ceeec----CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC
Q 007625 335 GYCTT----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 410 (595)
Q Consensus 335 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 410 (595)
+++.+ ....++||||+++|+|.+++.. ...+++.....++.|++.||.|||+.. +++||||||+||++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~ 158 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTE 158 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECC
Confidence 99876 3467899999999999999975 346899999999999999999999742 7889999999999999
Q ss_pred CCcEEEeeccccccccCcCcceeecccccccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhh
Q 007625 411 NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488 (595)
Q Consensus 411 ~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~ 488 (595)
++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+
T Consensus 159 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~----- 229 (283)
T PHA02988 159 NYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE----- 229 (283)
T ss_pred CCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-----
Confidence 9999999999998654321 22357899999999976 678999999999999999999999997543211
Q ss_pred HHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 489 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
....+ ..... . . ..+...+..+.+++.+||+.||++|||+.||++.|+.
T Consensus 230 ~~~~i---~~~~~-~----~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 230 IYDLI---INKNN-S----L---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHH---HhcCC-C----C---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11111 11110 0 0 1122345678899999999999999999999999875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=325.31 Aligned_cols=266 Identities=19% Similarity=0.274 Sum_probs=204.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47889999999999999999975 68889999987432 23345678899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|++++.+..+... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998776654432 34689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH--------HHHHHhccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD--------HIRKLLRED 500 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~--------~~~~~~~~~ 500 (595)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||.......... .... .........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF-TIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhhCCCCHHHHHhhhccc
Confidence 3333334568999999999998889999999999999999999999997643221100 0000 000000000
Q ss_pred cccccccccCC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 501 RLNDIVDRNLN-------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 501 ~~~~~~d~~l~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.......+... .+....+.++.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 011224567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=328.68 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=211.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
...|+..+.||+|.||.||+|.. .+++.||+|++.-........++++|+.++.+++++||.++++.+..+...+++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 34577789999999999999995 47899999999755666777889999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
||.+|++.+.|.. ...+.+....-+++++..|+.|||.+ +.+|||||+.||++..+|.+|++|||.+..+...
T Consensus 92 y~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999985 33447777788999999999999999 9999999999999999999999999999887655
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.... .+.+||+.|||||++....|+.|+||||||++.+||.+|.+|+..-.+ .+...++..
T Consensus 165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------------mrvlflIpk 225 (467)
T KOG0201|consen 165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------------MRVLFLIPK 225 (467)
T ss_pred hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------------ceEEEeccC
Confidence 4443 667899999999999988999999999999999999999999874332 111111211
Q ss_pred -cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 509 -NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 509 -~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..+.........+.+++..|++++|+.||++.+++++
T Consensus 226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1222333556678899999999999999999999864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=331.09 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=207.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||.||+++.. ++..||+|.+...........+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999965 6888999998754444556789999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999875 345889999999999999999999852 6999999999999999999999999998765432
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc---cc----
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DR---- 501 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~---- 501 (595)
. .....|++.|+|||++.+..++.++|||||||++|||+||+.||......+. ...+...... +.
T Consensus 158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-----EAIFGRPVVDGEEGEPHSI 229 (331)
T ss_pred c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHhcccccccccCCcccc
Confidence 1 2334689999999999998999999999999999999999999975433211 1111000000 00
Q ss_pred ---------------------------ccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 502 ---------------------------LNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 502 ---------------------------~~~~~d~~l~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
...+....... .......++.+++.+||+.||++|||++|++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000001 0112456789999999999999999999997654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=324.57 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=209.9
Q ss_pred cCCCcCCeeeeccceEEEEEEeCC------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
++|++.+.||+|+||.||+|.... ...||+|.++..........|.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467889999999999999998532 25799999876555556678999999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC
Q 007625 345 LVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 412 (595)
++|||+++++|.+++...... ...+++.+...++.|++.||+|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998753211 14588999999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHH
Q 007625 413 EAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL 490 (595)
Q Consensus 413 ~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~ 490 (595)
.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+ ..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-----~~ 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-----VI 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HH
Confidence 999999999986543221 12233456789999999988899999999999999999998 999987543211 11
Q ss_pred HHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 491 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 491 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+. .. .....+...+.++.+++.+||+.||.+||++.||++.|+.
T Consensus 237 ~~i~----~~--------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 EMIR----SR--------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH----cC--------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111 11 1111234456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=320.31 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=204.6
Q ss_pred cCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
++|++.+.||+|+||.||+|.++++..+|+|.+... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 457888999999999999999888889999987642 233567889999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++|+|.++++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.++.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999999887532 3588999999999999999999999 999999999999999999999999999886543322
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....+. .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-----~~~~i~---~~~~~------- 220 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-----VVEMIS---RGFRL------- 220 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHH---CCCCC-------
Confidence 22223345678999999988889999999999999999999 899987543211 111111 11110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
..+......+.+++.+||+.+|.+||++.++++.|.
T Consensus 221 --~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 --YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011223357889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=325.83 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=202.0
Q ss_pred CCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.|+..+.||+|+||+||+|.. .+++.||+|.+.... .......+.+|+.++.+++|+|++++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999995 578999999986422 22334567899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++|+|.+.+.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999988876432 34689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||........ .+.+.......
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~-------- 220 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-----REEVDRRVKED-------- 220 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHHhhcc--------
Confidence 2 22345689999999999999999999999999999999999999985432111 01111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 544 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 544 (595)
...++.....++.+++.+||+.||++||+ ++++++
T Consensus 221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01122334567889999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.41 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=207.2
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeec
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 339 (595)
....++|++.+.||+|+||.||+|+.. ++..||+|+++..........+.+|+.+++.+ +|+||+++++++..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345568899999999999999998842 34579999997654445567788999999999 89999999999999
Q ss_pred CCceEEEEEecccCcHhhhhcccCC-------------------------------------------------------
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKP------------------------------------------------------- 364 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 364 (595)
....++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999998864210
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc-e
Q 007625 365 -----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-V 432 (595)
Q Consensus 365 -----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~ 432 (595)
...++++.++.+++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++........ .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 113478899999999999999999999 9999999999999999999999999999865433221 1
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 511 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 511 (595)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ....... ... ...
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~~~~~----~~~-----~~~-- 335 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFYKMVK----RGY-----QMS-- 335 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHHHHHH----ccc-----Ccc--
Confidence 122335678999999998899999999999999999997 999987532211 1111111 110 000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 512 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 512 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.+...+.++.+++.+||+.||++||++.+|++.|++
T Consensus 336 -~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 336 -RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011124578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.84 Aligned_cols=247 Identities=26% Similarity=0.342 Sum_probs=206.6
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhc-CCCCCccccceeecCC
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS 341 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 341 (595)
.....++|...++||+|.||.|+++..+ +++.+|||++++. ...+.......|.+++... +||.+++++..+++++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3456678999999999999999999975 6889999999854 2455667778888888777 4999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
+.++||||..||++..+.+ ...+++..+.-++..|+.||.|||++ +||+||||-+|||+|.+|++||+|||+
T Consensus 443 ~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred eEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence 9999999999999433332 35699999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
++.--. ....+.+.+||+.|||||++.+..|+.++|+|||||+||||+.|..||.+.+.++.-+ -+. .+
T Consensus 515 cKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd-----sI~---~d-- 583 (694)
T KOG0694|consen 515 CKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD-----SIV---ND-- 583 (694)
T ss_pred ccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-----HHh---cC--
Confidence 985432 2235667899999999999999999999999999999999999999999766433211 111 11
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 539 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 539 (595)
. ..||...+.+.+.++.+++.++|++|.-+
T Consensus 584 ------~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 ------E--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------C--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 0 12566677888899999999999999877
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=331.87 Aligned_cols=268 Identities=22% Similarity=0.360 Sum_probs=219.9
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
+.+.+...+.++||+|-||.|..+....+..||||+++.......+.+|.+|+++|.+++||||++++|+|..++..++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 44566677799999999999999999788999999999888778889999999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
+|||++|+|.+++..... ..+.-....+|+.|||.||+||.+. ++||||+.++|+|+|.++++||+|||+++.+-
T Consensus 614 ~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999986432 1234556678999999999999999 99999999999999999999999999999554
Q ss_pred CcC-cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh--CCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 427 AKL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 427 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt--g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
... .+......-+.+|||||.+..+++|+++|||+||+.+||+++ ...||.... +....+......+.....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-----~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-----DEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-----HHHHHHhhhhhcCCCCcc
Confidence 333 333334455789999999999999999999999999999887 456765322 222333333333333222
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..+ ..++-++..+++++.+||..|-++||+++++...|++.
T Consensus 764 ~~l-----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVL-----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eec-----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 222 23566778899999999999999999999999998764
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=299.32 Aligned_cols=263 Identities=25% Similarity=0.324 Sum_probs=212.7
Q ss_pred HHhcCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC-----C
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----S 341 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 341 (595)
+..++|++.+.||+|||+-||.++ ..+++.||+|++.-. +.++....++|++..++++|||+++++++...+ .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~-~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH-SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc-chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 456789999999999999999999 668999999998642 346677889999999999999999999987543 3
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
+.+++++|+..|+|.+.+......+..+++.+.+.|+.++++||.+||+. .|+++||||||.||++.+++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 58999999999999999998777677899999999999999999999998 34599999999999999999999999999
Q ss_pred cccccCcCccee--------ecccccccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHH
Q 007625 422 AKLVDAKLTHVT--------TQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 490 (595)
Q Consensus 422 ~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~ 490 (595)
+....-...... .....|..|+|||.+. +...++++|||||||++|+|+.|..||+....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------- 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------- 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence 876543221111 1234799999999985 45579999999999999999999999974211
Q ss_pred HHHHHHhccccccc-cccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 491 DHIRKLLREDRLND-IVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 491 ~~~~~~~~~~~~~~-~~d~~l~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+.+.- +....+.. .....++.+.+++.+|++.||.+||++.+++..++.
T Consensus 247 -------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 -------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 1111211 11211111 122367889999999999999999999999998865
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.02 Aligned_cols=246 Identities=21% Similarity=0.215 Sum_probs=202.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47888999999999999999965 68999999986321 2234567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.. ...+++.....++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999875 34689999999999999999999999 999999999999999999999999999986543
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
. .....|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....... ..
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--------~~~~i~~-~~------ 214 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--------IYEKILA-GK------ 214 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHh-CC------
Confidence 2 123458999999999998889999999999999999999999997543211 1111111 10
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM 545 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 545 (595)
..++......+.+++.+|++.||.+||+ +.|++++
T Consensus 215 ---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 ---LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0112223457788999999999999995 7777644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.10 Aligned_cols=277 Identities=22% Similarity=0.369 Sum_probs=231.5
Q ss_pred HHHHHhcCCCcCCeeeeccceEEEEEEeC---CC--cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec
Q 007625 265 ELQLATDNFSESNIIGQGGFGKVYKGVLS---DN--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (595)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~---~~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 339 (595)
..++..+.....+.||.|-||.||+|.+. .| -.||||+.+....++..+.|..|..++++++||||++++|.|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 34455556666889999999999999953 23 34899999987778889999999999999999999999999975
Q ss_pred CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
...++|||.++-|.|..+|...+ ..++..+...++.||+.||+|||+. .+|||||..+|||+.....+||+||
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred -cceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence 45789999999999999998643 4689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
|+++.++++.........-+..|||||.+.-.+++.++|||.|||.+||++. |..||.+-...+.
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-------------- 601 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-------------- 601 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------------
Confidence 9999998776665555556789999999999999999999999999999886 8999976332111
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccchhhHHHHHHHHHH
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVR 565 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~ 565 (595)
+..+-.......+++++..+..++.+||+.+|.+||+++|+...|.++...|.....|+....+
T Consensus 602 ---I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq~r~~R 665 (974)
T KOG4257|consen 602 ---IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQLRRQR 665 (974)
T ss_pred ---EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHHHHhhh
Confidence 1111222223357788899999999999999999999999999999887777776666655544
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=322.76 Aligned_cols=261 Identities=23% Similarity=0.386 Sum_probs=207.4
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
+..++|+..+.||+|+||.||+|... ++..||+|++...........+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999753 356799999865444445667899999999999999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEE
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPG------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 415 (595)
..++||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998753321 23467889999999999999999998 999999999999999999999
Q ss_pred EeeccccccccCcCcce-eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHH
Q 007625 416 LCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 416 l~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~ 493 (595)
|+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ..+.+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-----~~~~~ 234 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-----VLRFV 234 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHH
Confidence 99999987654322211 112345778999999998889999999999999999999 688886543211 11111
Q ss_pred HHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 494 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
. ... ....+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 235 ~----~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 M----EGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred H----cCC--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1 111 111122334578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=322.91 Aligned_cols=250 Identities=30% Similarity=0.473 Sum_probs=196.8
Q ss_pred cCCeeeeccceEEEEEEeC-----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 275 ESNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
..+.||.|.||.||+|.+. .+..|+||.++..........|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999975 35679999997655555678999999999999999999999999988889999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++|+|.+++.... ...+++.++..++.|++.||+|||+. +++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999999742 35689999999999999999999999 99999999999999999999999999998763322
Q ss_pred c-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 430 T-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 430 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
. .......+...|+|||.+.+..++.++||||||+++|||+| |+.||...... +..........
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--------~~~~~~~~~~~------ 223 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--------EIIEKLKQGQR------ 223 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--------HHHHHHHTTEE------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccc------
Confidence 2 22233446789999999998889999999999999999999 67887643221 11111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
...+...+..+.+++.+||+.+|++||++.+|++.|
T Consensus 224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111223456788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=324.96 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=201.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|+..+.||+|+||+||+|+.+ ++..||+|+++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56889999999999999999964 68999999987544344456778999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 985 888887642 23578999999999999999999999 99999999999999999999999999997654322
Q ss_pred cceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc---ccccc--
Q 007625 430 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---EDRLN-- 503 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~~-- 503 (595)
. ......+++.|+|||++.+ ..++.++||||+||++|||+||+.||......+... .+..... ...+.
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH-----LIFRLLGTPTEETWPGI 231 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHHHhCCCChHHhhcc
Confidence 1 1233457899999999865 568999999999999999999999997654322211 1111000 00000
Q ss_pred -------ccccccCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 504 -------DIVDRNLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 504 -------~~~d~~l~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
....+.... ..+....+..+++.+|++.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000 01123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=319.27 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=208.8
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
..++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.+++.++|+|++++++++...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 45678899999999999999999888889999987642 2345688999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.... ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999987532 34688999999999999999999998 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.........++..|+|||++.+..++.++||||||+++|||+| |+.||....... ....+.. ....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~~---~~~~----- 223 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-----VMSALQR---GYRM----- 223 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-----HHHHHHc---CCCC-----
Confidence 3222223346778999999988889999999999999999998 999986533211 1111111 1000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
+ .....+.++.+++.+|+..+|++||+++++.+.|++
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 P----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 111234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=317.72 Aligned_cols=257 Identities=27% Similarity=0.394 Sum_probs=209.0
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
+..++|++.+.||+|+||.||+|...+++.||+|.++... .....+.+|+.++++++|||++++++++...+..++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 3456788999999999999999998778899999986432 23567899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.... ...+++.....++.|++.|+.|||+. +++|+||||+||++++++.++|+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999987633 34689999999999999999999999 999999999999999999999999999987653
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
...........+..|+|||++.+..++.++||||||+++|||+| |+.||...... .....+. .....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~---~~~~~---- 223 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----EVLQQVD---QGYRM---- 223 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHH---cCCCC----
Confidence 32222222223468999999998899999999999999999999 99998643321 1111111 11000
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+......+.+++.+|++.+|++||++.++++.|++
T Consensus 224 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1122344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=330.60 Aligned_cols=243 Identities=21% Similarity=0.256 Sum_probs=198.1
Q ss_pred CeeeeccceEEEEEEe-CCCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccC
Q 007625 277 NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
+.||+|+||.||+|+. .+|+.||+|+++... .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999996 478999999987421 2334567788999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCccee
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 433 (595)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 99988875 34689999999999999999999999 9999999999999999999999999998753221 1122
Q ss_pred ecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCC
Q 007625 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 513 (595)
Q Consensus 434 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 513 (595)
....||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+. . +. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-----~~~~~~---~-~~---------~~~ 214 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELIL---M-EE---------IRF 214 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-----HHHHHH---c-CC---------CCC
Confidence 34568999999999999999999999999999999999999997543211 111111 1 10 112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 514 DSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 514 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
+.....++.+++.+|++.||++|| ++.+++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 233456788899999999999999 78888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=330.96 Aligned_cols=254 Identities=19% Similarity=0.218 Sum_probs=205.6
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||.||+|+.. +++.||+|+++... .......+..|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999975 58899999987432 2234567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999975 34688999999999999999999999 999999999999999999999999999986543
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+.... ..+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-----~~i~~~~------~~~~ 218 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW-----ENLKYWK------ETLQ 218 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH-----HHHHhcc------cccc
Confidence 223456899999999999989999999999999999999999999765432211 1111100 0000
Q ss_pred c-cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 508 R-NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 508 ~-~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
. ...........++.+++.+|+..+|.+||++.|++++-
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 0 00000123456788899999999999999999998763
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=316.43 Aligned_cols=256 Identities=27% Similarity=0.392 Sum_probs=208.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
.++|++.+.||+|+||+||+|.+. +...||+|.++..........|.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 457889999999999999999964 2457999998765555566789999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +|+|+||||+||++++++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999987532 3689999999999999999999998 9999999999999999999999999999877
Q ss_pred cCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 426 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 426 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...+.+.. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~---~~~~- 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----DVIKAVED---GYRL- 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----HHHHHHHc---CCCC-
Confidence 522221 2222335678999999998889999999999999999998 99998643221 11121111 1000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+...+..+.+++.+|++.+|++||++.||+++|+.
T Consensus 228 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 --------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0122334678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.31 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=208.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
.++|.+.+.||+|+||.||+|... ++..||+|.++..........+.+|+++++.++|+|++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 346778899999999999999863 34789999987654444567899999999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc
Q 007625 344 ILVYPFMQNLSVAYRLRDLK----------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 413 (595)
++||||+++++|.++++... .....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999997532 1234588999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHH
Q 007625 414 AVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 491 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~ 491 (595)
++|+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ..+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-----~~~ 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-----VIE 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHH
Confidence 99999999876533221 11223345788999999999999999999999999999998 999986543221 112
Q ss_pred HHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 492 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
.+. .+. ....+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 236 ~~~----~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CIT----QGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHH----cCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 211 111 11112234567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.50 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=217.2
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEec-cCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc-eEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE-RILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 347 (595)
++|..++++|+|+||.++.++.+ +++.|++|.+. ...+...+.....|+.++++++|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999864 67889999987 33455556678899999999999999999999999988 89999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
+|++||++.+.+...+ ...+++..+..++.|++.|+.|||++ .|+|||||+.||+++.+..|+|+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998755 45689999999999999999999988 999999999999999999999999999999876
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.. ....++.||+.|+.||.+.+.+|..|+|||||||++|||++-+++|...+... .+.+..+
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~--------Li~ki~~--------- 220 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE--------LILKINR--------- 220 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH--------HHHHHhh---------
Confidence 54 23455779999999999999999999999999999999999999998765422 2222111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
......+..+..++..++..|+..+|+.||++.+++.+
T Consensus 221 ~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11223456677889999999999999999999999887
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=331.51 Aligned_cols=246 Identities=22% Similarity=0.263 Sum_probs=201.3
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||.||+|+.. +++.||+|+++.. ........+.+|+.++.+++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999965 6889999998642 12234567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999875 34688899999999999999999999 999999999999999999999999999986643
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... .+..
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------~~~~i~-~~~~----- 232 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR--------IYEKIL-AGRL----- 232 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH--------HHHHHh-cCCc-----
Confidence 22 23468999999999999999999999999999999999999997533211 111111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM 545 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 545 (595)
..+......+.+++.+||+.||.+||+ +++++++
T Consensus 233 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011123356788999999999999997 5666544
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=331.14 Aligned_cols=262 Identities=26% Similarity=0.422 Sum_probs=206.0
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecC
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 340 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 340 (595)
...++|++.+.||+|+||.||+|... +++.||+|+++..........+..|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34568999999999999999999742 35789999987544444556788899999999 899999999988654
Q ss_pred -CceEEEEEecccCcHhhhhcccCCC------------------------------------------------------
Q 007625 341 -SERILVYPFMQNLSVAYRLRDLKPG------------------------------------------------------ 365 (595)
Q Consensus 341 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 365 (595)
...++++||+++++|.+++......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5678999999999999988642210
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc-eeeccccccc
Q 007625 366 ---EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMG 441 (595)
Q Consensus 366 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~ 441 (595)
...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++.+...... ......++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 13689999999999999999999999 9999999999999999999999999999876432221 1223446778
Q ss_pred ccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHH
Q 007625 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVET 520 (595)
Q Consensus 442 y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 520 (595)
|+|||++.+..++.++|||||||++|||++ |..||......+. +..... .... ...+.....+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----~~~~~~----~~~~--------~~~~~~~~~~ 304 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----FCRRLK----EGTR--------MRAPEYATPE 304 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----HHHHHh----ccCC--------CCCCccCCHH
Confidence 999999999999999999999999999998 9999875332111 111111 1100 0112233467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 521 MVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 521 l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
+.+++.+||+.+|++||++.||+++|+.
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 8899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=306.81 Aligned_cols=262 Identities=25% Similarity=0.285 Sum_probs=203.8
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC--CceEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV 346 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 346 (595)
++|+.++.|++|.||.||+|+.+ +++.||+|+++-. ...+-...-.+|+.+|.+.+|||||.+..+.... +..++|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45778999999999999999964 7899999999833 3334445668999999999999999998876543 578999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
||||+. +|...++... +++...+.+.+..|+++|++|||.+ .|+|||||++|+|+++.|.+||+|||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 8888888744 5789999999999999999999999 89999999999999999999999999999987
Q ss_pred CcCcceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc---cccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---EDRL 502 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~ 502 (595)
..... .+..+-|..|+|||.+.+.+ |++..|+||+|||+.||+++++-|.+...... .+.+-..+. +..+
T Consensus 229 sp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-----l~~If~llGtPte~iw 302 (419)
T KOG0663|consen 229 SPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-----LDKIFKLLGTPSEAIW 302 (419)
T ss_pred CCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-----HHHHHHHhCCCccccC
Confidence 76433 33455799999999998765 89999999999999999999999887553221 111111111 1111
Q ss_pred ccccc------ccCCCCCHH----------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 503 NDIVD------RNLNTYDSK----------EVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 503 ~~~~d------~~l~~~~~~----------~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..+.. -.+...+.+ ..+.-++++...+..||.+|.|++|.+++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11111 011111111 23566788889999999999999998653
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=346.99 Aligned_cols=259 Identities=23% Similarity=0.288 Sum_probs=209.0
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCC---
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--- 341 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 341 (595)
....++|++.+.||+|+||+||+|+. .+++.||+|++... .+......+.+|+..+..++|+|++++...+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34557999999999999999999985 47899999998643 34455677889999999999999999887764432
Q ss_pred -----ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEE
Q 007625 342 -----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 416 (595)
Q Consensus 342 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 416 (595)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 25799999999999999986554456799999999999999999999999 9999999999999999999999
Q ss_pred eeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 417 CDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 417 ~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--------~~~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--------EVMHK 256 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHH
Confidence 99999986643321 2233456999999999999999999999999999999999999999754321 11111
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..... ....+.....++.+++.+||+.||.+||++.+++++
T Consensus 257 ~~~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11110 111223345678899999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=333.66 Aligned_cols=249 Identities=22% Similarity=0.282 Sum_probs=210.9
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
+-|..++.||.|+.|.|..|+. .+|+.+|||++... .+......+++|+-+|+-+.|||++++++.+.+..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3577799999999999999994 58999999999743 34445678899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|.|++++.. ..++++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|....+
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999986 46799999999999999999999999 999999999999999999999999999986533
Q ss_pred cCcceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
...-.+.+|++.|.|||++++.+| ..++||||.|||||.|+||+.||+.++.. .+..-++ .+..
T Consensus 165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir-----~LLlKV~----~G~f---- 229 (786)
T KOG0588|consen 165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR-----VLLLKVQ----RGVF---- 229 (786)
T ss_pred --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH-----HHHHHHH----cCcc----
Confidence 233456789999999999999998 67899999999999999999999854321 1222222 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
..+.+.+.+..+++.+|+..||++|.|++||+++-
T Consensus 230 -----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 230 -----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 12345566788888999999999999999998864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=326.71 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=205.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
..++|++.+.||+|+||.||+|... ++..+|+|.+...........+.+|++++++++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4578999999999999999999975 688899998875444455677899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.. ...+++.....++.|++.||.|||+.. +++|+||||+||++++++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999875 345889999999999999999999742 699999999999999999999999999876533
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc-----
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL----- 502 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~----- 502 (595)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ...... .....
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~-~~~~~~~~~~ 227 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-----LMFGCP-VEGDPAESET 227 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-----HHhcCc-ccCCcccccc
Confidence 21 22346899999999999888999999999999999999999999754331110 000000 00000
Q ss_pred ----------------------------cccccccCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 503 ----------------------------NDIVDRNLNTY-DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 503 ----------------------------~~~~d~~l~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..+.....+.. ......++.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000000 01134568899999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.95 Aligned_cols=265 Identities=25% Similarity=0.342 Sum_probs=196.2
Q ss_pred cCCCcCCeeeeccceEEEEEEeC--CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhc---CCCCCccccceeec-----
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA---IHKNLLQLIGYCTT----- 339 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 339 (595)
++|++.+.||+|+||+||+|+.. ++..||+|+++... .......+.+|+.+++.+ .||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 46789999986432 223344566777776665 69999999998852
Q ss_pred CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
....++||||+. ++|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 345789999997 58888887533 34589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ...+........
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~-~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG-KILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH-HHHHHhCCCChh
Confidence 999866433 22234568999999999988889999999999999999999999998654322111 111110000000
Q ss_pred cccc------cccccc----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 500 DRLN------DIVDRN----LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 500 ~~~~------~~~d~~----l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.... ..+... +....+.....+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 000000 00011223456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=317.65 Aligned_cols=264 Identities=29% Similarity=0.408 Sum_probs=198.2
Q ss_pred CCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHh--cCCCCCccccceeecCC----ceEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTTSS----ERIL 345 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l 345 (595)
..+..++||+|+||.||||.+ +++.||||++.. ...+.|++|-++++. ++|+||++++++-.... +..+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 344467899999999999999 569999999853 567888888888775 57999999999876555 7899
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc------CCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ------CNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
|++|.+.|+|.++|.. ..++|....+++..+++||+|||+. .+|+|+|||||++|||+..|+...|+||
T Consensus 286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999985 4599999999999999999999965 4678999999999999999999999999
Q ss_pred cccccccCcCcc-eeecccccccccCccccCCCC-CC-----ccchhHHHHHHHHHHHhCCCCCCC--------Cchhhh
Q 007625 420 GLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGK-SS-----EKTDVFGYGITLLELVTGQRAIDF--------SRLEEE 484 (595)
Q Consensus 420 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDv~SlGvvl~elltg~~p~~~--------~~~~~~ 484 (595)
|+|..+...... .....+||.+|||||++.+.- +. .+.||||+|.|+|||++...-++. ....+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999988654332 223367999999999997643 22 368999999999999986543321 111010
Q ss_pred hhhhHHHHHHHH-hccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 485 EDVLLLDHIRKL-LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 485 ~~~~l~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..--..+.++.. ++.+.-..+.|.... ...+.-+.+.+..||+.||+.|.|+.=|.+.+.+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~ 502 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAE 502 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence 000011122222 222222222221111 1456778889999999999999999988777755
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=314.02 Aligned_cols=262 Identities=21% Similarity=0.336 Sum_probs=211.9
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||.||+|+.. +++.||+|.+... ........+.+|+++++.++|||++++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999954 7899999987632 23344567899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.........+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999876554456689999999999999999999999 999999999999999999999999999887643
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ............ .
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~------~ 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKIEQCD------Y 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHHhcCC------C
Confidence 321 122345888999999998888999999999999999999999998643221 111111111100 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
+.. ........+.+++.+||+.+|++||++.+|++.++...
T Consensus 226 ~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PPL--PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCC--ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 100 12334567889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.85 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=208.3
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecC
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTS 340 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 340 (595)
...++|.+.++||+|+||.||+|+.. .+..||+|+++..........+.+|+++++++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 35678899999999999999999852 234699999976555555678999999999996 99999999999999
Q ss_pred CceEEEEEecccCcHhhhhcccCC--------------------------------------------------------
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKP-------------------------------------------------------- 364 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 364 (595)
+..++||||+++|+|.++++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999988864210
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE
Q 007625 365 ------------------------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 408 (595)
Q Consensus 365 ------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 408 (595)
....+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 013478889999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhh
Q 007625 409 DDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEED 486 (595)
Q Consensus 409 ~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~ 486 (595)
++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--- 347 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--- 347 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---
Confidence 99999999999999865432221 1223446788999999998889999999999999999997 889986432211
Q ss_pred hhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 487 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 487 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.....+. .+. ....+.....++.+++.+||+.+|++||++.+|.++|+.
T Consensus 348 -~~~~~~~----~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 348 -TFYNKIK----SGY--------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred -HHHHHHh----cCC--------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 1111111 110 001123345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=316.90 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=206.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
..+|+..+.||+|+||.||+|..+ +++.||+|++... ......+.+|++++++++|||++++++++...+..+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 345778899999999999999964 5889999998642 2345678999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999987532 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.........++..|+|||++.+..++.++||||||+++|||++ |..||......+ ..........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~------ 223 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKGYR------ 223 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCC------
Confidence 3222222334678999999998899999999999999999998 899987543211 1111111000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
. ..+...+.++.+++.+|++.+|++||++.|++++|+.
T Consensus 224 ~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 224 M---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred C---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 0 1122334678889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=329.97 Aligned_cols=248 Identities=23% Similarity=0.246 Sum_probs=201.9
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCC--CcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSD--NTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
..++|++.+.||+|+||.||+|..+. +..||+|++... ........+.+|+.++..++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34578889999999999999998543 368999998632 22334567889999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999875 34689999999999999999999999 999999999999999999999999999986
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .... ..
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~---~i~~-~~--- 244 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-----IYQ---KILE-GI--- 244 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-----HHH---HHhc-CC---
Confidence 6432 234568999999999998889999999999999999999999997543211 111 1111 10
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
..++......+.+++.+|++.||++|+ +++|++++
T Consensus 245 ------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 ------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011222335677899999999999995 88888654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=332.05 Aligned_cols=261 Identities=20% Similarity=0.233 Sum_probs=197.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
..++|++.+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 446799999999999999999996 468899999653 234678999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
|++. ++|..++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 163 e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9985 678777764 34589999999999999999999999 999999999999999999999999999975433
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhh--hhhhHHHHHHHHhcc---c--
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE--EDVLLLDHIRKLLRE---D-- 500 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~--~~~~l~~~~~~~~~~---~-- 500 (595)
..........||+.|+|||++.+..++.++|||||||++|||+||+.|+........ ........+...... .
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 222233345799999999999998999999999999999999999988653221000 000000111000000 0
Q ss_pred -----cccccc---------ccc-CCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 501 -----RLNDIV---------DRN-LNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 501 -----~~~~~~---------d~~-l~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
...... .+. ... .......++.+++.+|++.||++|||++|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 000 000 01123557889999999999999999999974
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.36 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=204.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCc----EEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
..+|+..+.||+|+||.||+|++. ++. .||+|+++..........+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 346889999999999999999853 333 38999987544455667899999999999999999999998764 567
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
++++|+++|+|.+++... ...+++...+.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999998853 23588999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCccee-ecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 425 VDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 425 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
......... ....++..|+|||++.+..++.++||||||+++|||++ |+.||....... ...... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----~~~~~~---~~~~~ 230 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILE---KGERL 230 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHh---CCCCC
Confidence 654332221 22334678999999999999999999999999999998 999987533211 111111 01000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..+.....++.+++.+||+.+|.+||++.+++..+...
T Consensus 231 ---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01122345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.35 Aligned_cols=248 Identities=21% Similarity=0.314 Sum_probs=195.2
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
+|+..+.||+|+||+||+|+.. +++.||+|++...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556789999999999999964 689999999975544455678999999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++|... ...++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 99987542 2345677889999999999999999 999999999999999999999999999987643321
Q ss_pred ceeecccccccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 431 HVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
......||..|+|||++.. ...+.++|||||||++|||++|+.||....... ............
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~----- 292 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMCAICMSQ----- 292 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHhccC-----
Confidence 1233568999999998743 234568999999999999999999997432211 111111110000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+.....++.+++.+||+.||++||++.|++++
T Consensus 293 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011123345678899999999999999999999764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.36 Aligned_cols=265 Identities=20% Similarity=0.341 Sum_probs=196.5
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCC-----ceE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI 344 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 344 (595)
+|++.+.||+|+||.||+|+.. ++..||+|++... ........+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5788999999999999999964 7899999998743 22334457889999999999999999999875432 479
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 688888764 34689999999999999999999999 999999999999999999999999999986
Q ss_pred ccCcCc--ceeecccccccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH-------
Q 007625 425 VDAKLT--HVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI------- 493 (595)
Q Consensus 425 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~------- 493 (595)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.......... ...+..
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~ 231 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD-LITDLLGTPSPET 231 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH-HHHHHhCCCCHHH
Confidence 533211 11234568999999999865 678999999999999999999999997543211100 000000
Q ss_pred HHHhcccccccccc---ccCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 494 RKLLREDRLNDIVD---RNLN----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 494 ~~~~~~~~~~~~~d---~~l~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+.......+. .... ...+.....+.+++.+|++.||++||+++|++++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000000 0000 0011223567899999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=326.58 Aligned_cols=245 Identities=24% Similarity=0.269 Sum_probs=197.5
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcH
Q 007625 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (595)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (595)
||+|+||.||+|+.. +++.||+|+++.. ........+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 6889999998642 2334456788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeec
Q 007625 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435 (595)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 435 (595)
.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 999875 34589999999999999999999999 99999999999999999999999999987543222 22334
Q ss_pred ccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCH
Q 007625 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 515 (595)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 515 (595)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...... +......... ..++.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--------~~~~~~~~~~----------~~~~~ 214 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--------EMYRKILQEP----------LRFPD 214 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCC----------CCCCC
Confidence 56899999999999999999999999999999999999999754321 1111111110 11223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 516 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 516 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
....++.+++.+|++.||++||++..+.+.|...
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 3446778899999999999998755554445443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=313.29 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=204.2
Q ss_pred cCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
++|++.+.||+|+||+||+|...++..+|+|.+.... .....|.+|+.++.+++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 4577889999999999999998777789999886432 23467899999999999999999999999888999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999987532 3589999999999999999999999 999999999999999999999999999886644322
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....+. ...+.
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~~~---~~~~~------- 220 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-----TVEKVS---QGLRL------- 220 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHHh---cCCCC-------
Confidence 22222345678999999988889999999999999999999 999986433211 111111 11110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
..+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011123467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=321.63 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=199.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||+||+|+.. +++.||+|+++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999965 7889999998754333444567889999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+. +++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 5777777642 34588899999999999999999999 9999999999999999999999999998754332
Q ss_pred CcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc---cccc-
Q 007625 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLN- 503 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~~- 503 (595)
. .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ..+.+...... ..+.
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD----QLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhCCCChhhccc
Confidence 2 12233457899999999865 4578999999999999999999999975432111 11111110000 0000
Q ss_pred -----ccccccCCCC-C---H------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 504 -----DIVDRNLNTY-D---S------KEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 504 -----~~~d~~l~~~-~---~------~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.......... + . .....+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 0 0 11246778999999999999999999965
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.07 Aligned_cols=253 Identities=22% Similarity=0.268 Sum_probs=199.7
Q ss_pred CCCcCCeeeeccceEEEEEEe----CCCcEEEEEEeccCC---CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCce
Q 007625 272 NFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (595)
+|++.+.||+|+||+||+++. .+++.||+|++.... .......+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999985 368899999986421 223345678899999999 599999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999875 34589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..............||+.|+|||++.+. .++.++|||||||++|||+||+.||......... .........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~---- 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILK---- 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhc----
Confidence 6544333333445699999999998765 4788999999999999999999999753321111 111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
.++. .+......+.+++.+|++.||++|| +++|++++
T Consensus 226 ---~~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ---CDPP---FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCC---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0111 1223345678889999999999999 66677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=314.25 Aligned_cols=249 Identities=20% Similarity=0.323 Sum_probs=210.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++. .++...-.+++|+++|..++||||++++.+|.+.+..++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788899999999999999995 68999999999754 3445556789999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||..+|.|++++.. ...+++.++.+++.||..|+.|+|.+ +++|||||.+|||+|+++++||+|||++-++.
T Consensus 132 MEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999987 45699999999999999999999999 99999999999999999999999999998775
Q ss_pred CcCcceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.. ...++.+|++-|.+||++.+.+| .+.+|.||+||+||-|+.|.-||++.+.. ..++++.+ +...+
T Consensus 205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk--------~lvrQIs~-GaYrE- 272 (668)
T KOG0611|consen 205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK--------RLVRQISR-GAYRE- 272 (668)
T ss_pred cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH--------HHHHHhhc-ccccC-
Confidence 43 23456889999999999999987 67899999999999999999999975432 22222222 11111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
++.+.+..-++++|+..+|++|.|..+|..+.
T Consensus 273 ---------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 ---------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 22233556788899999999999999998764
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.59 Aligned_cols=252 Identities=19% Similarity=0.264 Sum_probs=205.1
Q ss_pred CCCcCCeeeeccceEEEEEEeC-C-CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-D-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
.|.+.+.||+|+||.||+|... + +..||+|.+.. ........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4888999999999999999854 3 67788887643 2334456788899999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++|+|.+++........++++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998875444455789999999999999999999999 99999999999999999999999999998765432
Q ss_pred c-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 430 T-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 430 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.........
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~~-------- 287 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYGK-------- 287 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC--------
Confidence 2 1233456999999999999999999999999999999999999999754321 1111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
....+.....++.+++.+|++.||++||++.+++.
T Consensus 288 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 -YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01112234467889999999999999999999975
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=294.40 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=210.4
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
+.++|++++.||+|.||.||.|+.+ ++..||+|++.+.+ ..+...++.+|+++-+.++||||+++++|+.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4467889999999999999999954 67889999986432 33446788999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
++||..+|++...|.... ...+++.....++.|+|.||.|+|.. +++||||||+|+|++.++..||+|||-+-.-
T Consensus 100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999998543 45688889999999999999999999 9999999999999999999999999987644
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
. .......+||..|.+||...+..++..+|+|++|++.||++.|.+||...... ...+.++.. ++
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-----etYkrI~k~-------~~ 239 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-----ETYKRIRKV-------DL 239 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-----HHHHHHHHc-------cc
Confidence 3 22345577999999999999999999999999999999999999999743311 122222211 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
. ++........+++.+|+..+|.+|.+..||+.+-
T Consensus 240 ~------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 240 K------FPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred c------CCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1 2344556788899999999999999999997653
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=319.71 Aligned_cols=257 Identities=23% Similarity=0.316 Sum_probs=204.4
Q ss_pred CCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
+|++.+.||+|+||.||+|... ++..||+|+++..........+.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4666889999999999999853 2578999999754444445678999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc
Q 007625 346 VYPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 413 (595)
++||+.+++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 1123588899999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHH
Q 007625 414 AVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 491 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~ 491 (595)
+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||...... +
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~ 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--------D 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--------H
Confidence 99999999886543221 11223346789999999988889999999999999999998 77887643221 1
Q ss_pred HHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 492 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
........ .....+...+..+.+++.+|++.+|++||++++|++.|+.
T Consensus 235 ~~~~i~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNR---------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcC---------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111 1111233445678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=316.55 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=205.6
Q ss_pred cCCCcCCeeeeccceEEEEEEe-----CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
++|++.+.||+|+||+||+|.. .++..||+|.+...........+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677889999999999999984 25678999999754444556788999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC
Q 007625 346 VYPFMQNLSVAYRLRDLKP-------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 412 (595)
||||+++++|.+++..... ....+++.+...++.|++.||+|||+. +++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853211 123578899999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccCcC-cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHH
Q 007625 413 EAVLCDFGLAKLVDAKL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL 490 (595)
Q Consensus 413 ~~kl~DfG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~ 490 (595)
.+||+|||+++...... ........++..|+|||++.+..++.++||||||+++|||++ |..||...... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-----~~~ 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----EVI 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HHH
Confidence 99999999998654322 112223345778999999988889999999999999999998 88898643321 111
Q ss_pred HHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 491 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 491 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
+.+. .... ...+......+.+++.+|++.||++||++.+|.++|..
T Consensus 237 ~~~~----~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVR----KRQL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH----cCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 1110 01122334578889999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.33 Aligned_cols=264 Identities=27% Similarity=0.409 Sum_probs=211.1
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceee
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 338 (595)
+.+..++|+..+.||+|+||.||++... ....+|+|++...........+.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3455677889999999999999999863 23679999987554455567789999999999 7999999999999
Q ss_pred cCCceEEEEEecccCcHhhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCE
Q 007625 339 TSSERILVYPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (595)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 406 (595)
.++..+++|||+++++|..+++... .....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999987432 2245689999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhh
Q 007625 407 LLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 484 (595)
Q Consensus 407 ll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~ 484 (595)
++++++.++|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 9999999999999999876543221 1122335678999999988889999999999999999998 888886543211
Q ss_pred hhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 485 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 485 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..+... .... ...+......+.+++.+|+..+|++|||+.|+++.|+..
T Consensus 243 ----~~~~~~---~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 ----LFKLLK---EGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHHH---cCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111111 1110 111223456788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=324.53 Aligned_cols=243 Identities=21% Similarity=0.265 Sum_probs=196.7
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccC
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
+.||+|+||.||+++.. +|..||+|+++.. ........+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 7899999998742 12334567788999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCccee
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 433 (595)
+|..++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 99888865 34689999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred ecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCC
Q 007625 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 513 (595)
Q Consensus 434 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 513 (595)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ........ ...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~---~~~~~~~~----------~~~ 214 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----L---FELILMEE----------IRF 214 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-----H---HHHHhcCC----------CCC
Confidence 33568999999999999999999999999999999999999997543211 1 11111100 011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 514 DSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 514 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
+.....++.+++.+|++.||++|| ++.+++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 223346778899999999999998 78888654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=328.83 Aligned_cols=266 Identities=23% Similarity=0.295 Sum_probs=200.1
Q ss_pred CCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCC-----ceE
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI 344 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 344 (595)
+|+..+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999996 478999999986432 2334567889999999999999999999998776 789
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+|+||+. ++|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 477776653 35689999999999999999999999 999999999999999999999999999986
Q ss_pred ccCcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhH--------------
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL-------------- 489 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l-------------- 489 (595)
.............+++.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 544333333344578999999998774 47899999999999999999999997654321110000
Q ss_pred HHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 490 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 490 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..............................++.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000000000000001112235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=312.04 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=201.4
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC-----ceEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERIL 345 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 345 (595)
.|+..+++|+|+||.||+|... +++.||||++..... .-.+|+++|+.+.|||||++..+|.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4556899999999999999964 579999998753221 2247999999999999999998885432 2358
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-CcEEEeecccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKL 424 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~~~ 424 (595)
|||||+. +|.+.++.+...+..++...++-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999986 99999998766678899999999999999999999998 99999999999999977 9999999999998
Q ss_pred ccCcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc-
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL- 502 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~- 502 (595)
+....... ....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+... ....+.+.+.-...
T Consensus 176 L~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d-----QL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 176 LVKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD-----QLVEIIKVLGTPTRE 248 (364)
T ss_pred eccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH-----HHHHHHHHhCCCCHH
Confidence 87655443 34578999999999875 58999999999999999999999998754322 11222222111111
Q ss_pred --------------cccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 503 --------------NDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 503 --------------~~~~d~~l~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..+....... +......+.++++.++++.+|.+|.++.|++.+
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111111111 334556788999999999999999999999653
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.79 Aligned_cols=243 Identities=22% Similarity=0.268 Sum_probs=197.8
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccC
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
+.||+|+||.||+++.. +++.||+|++.... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999964 68999999987432 2344567889999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCccee
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 433 (595)
+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 99888865 34689999999999999999999999 99999999999999999999999999987543221 122
Q ss_pred ecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCC
Q 007625 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 513 (595)
Q Consensus 434 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 513 (595)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--------~~~~~~~~~----------~~~ 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMED----------IKF 214 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--------HHHHhccCC----------ccC
Confidence 34568999999999998899999999999999999999999997543211 111111000 011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 514 DSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 514 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
+.....++.+++.+|++.||++|| ++.|++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 223345778899999999999997 88998765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=324.29 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=220.5
Q ss_pred HHHHHHhcCCCcCCeeeeccceEEEEEEeCC-CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc
Q 007625 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 342 (595)
++++....+....++||-|-||.||.|.|+. .-.||||.+++.. ....+|+.|..+|+.++|||+|+++|+|..+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 5566666677778999999999999999864 5679999998643 567899999999999999999999999999999
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
+|+|+|||.+|+|.++|++.. ...++.-..+.++.||+.||+||..+ .+|||||.++|+|+.++..+||+|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999999764 34577778899999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
+++..+.........-++.|.|||.+....++.|+|||+|||+|||+.| |..||.+-+... ..+...+..
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-----VY~LLEkgy---- 483 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYGLLEKGY---- 483 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-----HHHHHhccc----
Confidence 9987654443333445789999999999999999999999999999998 778887543321 111111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
....++.++..++++|+.||+..|.+||++.|+-+.++...
T Consensus 484 --------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 --------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 11236677889999999999999999999999999887643
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.16 Aligned_cols=256 Identities=30% Similarity=0.449 Sum_probs=209.9
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
+..+|+..+.||+|+||.||+|...++..+|+|.+.... ......+.+|+.+++.++|+|++++++++......++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 455788899999999999999998889999999986432 2345678899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999999998643 34689999999999999999999999 9999999999999999999999999999876443
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||......+ ....+.. ...
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-----~~~~~~~---~~~------ 222 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-----VYDQITA---GYR------ 222 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-----HHHHHHh---CCc------
Confidence 221 223346778999999988889999999999999999998 899986543211 1111111 100
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+...+..+.+++.+|++.||.+|||+.++++.|+.
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 ---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01123344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.18 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=201.6
Q ss_pred CeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcHh
Q 007625 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVA 356 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 356 (595)
++||+|+||.||+|...++..||+|.++..........+.+|+++++.++|||++++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988899999999876554455567899999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeecc
Q 007625 357 YRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436 (595)
Q Consensus 357 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~ 436 (595)
+++... ...+++.++..++.|++.||.|+|+. +++|+||||+||++++++.++|+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 988642 23578999999999999999999998 999999999999999999999999999876543322222223
Q ss_pred cccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCH
Q 007625 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 515 (595)
Q Consensus 437 ~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 515 (595)
.++..|+|||++.+..++.++||||||+++||+++ |..||....... ....+. ..... ..+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----~~~~~~---~~~~~---------~~~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----AREQVE---KGYRM---------SCPQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHH---cCCCC---------CCCC
Confidence 34678999999998889999999999999999998 999987543211 111111 11000 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 516 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 516 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
..+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 34567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=315.95 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=211.5
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCC-----CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec-CC
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SS 341 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 341 (595)
+..++|++.+.||+|+||.||+|...+ +..|++|++...........+.+|+.++++++|+|++++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 356789999999999999999999755 688999998765556667888999999999999999999998766 46
Q ss_pred ceEEEEEecccCcHhhhhcccCCCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEe
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGE----KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC 417 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 417 (595)
..+++++|+++++|.+++....... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 7889999999999999987643221 5689999999999999999999998 99999999999999999999999
Q ss_pred eccccccccCcCcce-eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHH
Q 007625 418 DFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 418 DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
|||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...... ....+...
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~ 234 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-----EMAAYLKD 234 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-----HHHHHHHc
Confidence 999998664332221 222346778999999988889999999999999999999 99998753321 11122111
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
.... ......+.++.+++.+||..||++|||+.|+++.|++.
T Consensus 235 ---~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 ---GYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred ---CCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1110 01122345788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=309.81 Aligned_cols=260 Identities=22% Similarity=0.329 Sum_probs=212.6
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEecc--CCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||.||+|... +|+.||+|.++. .........+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 789999998863 223344678899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.........+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876554456689999999999999999999999 999999999999999999999999999876543
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.... .....++..|+|||++.+..++.++|||||||++|+|++|+.||..... ...+....... +.
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~------ 224 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEK-CD------ 224 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhc-CC------
Confidence 3221 2234578899999999888899999999999999999999999864321 11111111111 10
Q ss_pred ccCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 508 RNLNTYD-SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 508 ~~l~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
....+ ......+.+++.+|+..+|.+||++.+|+++|++.
T Consensus 225 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 --YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11111 24456788999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.74 Aligned_cols=254 Identities=28% Similarity=0.402 Sum_probs=205.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
.++|++.+.||+|+||+||+|...++..||+|+++... .....+.+|+++++.++||||+++++++. ....++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 46789999999999999999998777789999987422 23467899999999999999999998774 4567999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999997532 34578999999999999999999999 99999999999999999999999999998765443
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
........++..|+|||+..+..++.++||||||+++|||+| |..||....... .. ........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-----~~---~~~~~~~~------- 221 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VL---DQVERGYR------- 221 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-----HH---HHHhcCCC-------
Confidence 322233446778999999988899999999999999999999 788886433211 11 11111000
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.......+..+.+++.+|++.+|++||++.++++.|++
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 01123455678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=317.78 Aligned_cols=260 Identities=23% Similarity=0.372 Sum_probs=209.2
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 342 (595)
..++|++.+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.++|||++++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4567888999999999999999864 2468999998755444556788999999999999999999999999999
Q ss_pred eEEEEEecccCcHhhhhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEE
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPG------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 416 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 416 (595)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 99999999999999999754322 23478999999999999999999998 9999999999999999999999
Q ss_pred eeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHH
Q 007625 417 CDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR 494 (595)
Q Consensus 417 ~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~ 494 (595)
+|||+++....... .......++..|+|||.+.+..++.++||||||+++||++| |..||....... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----~~~~~~ 235 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-----VLKFVI 235 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-----HHHHHh
Confidence 99999886543321 11223346789999999988889999999999999999998 888986533211 111111
Q ss_pred HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
... ....+.....++.+++.+|++.+|++|||+.|+++.|+.
T Consensus 236 ----~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 ----DGG--------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ----cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111 111122235688899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=308.87 Aligned_cols=248 Identities=28% Similarity=0.404 Sum_probs=199.5
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcH
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (595)
+.||+|+||.||+|... +++.||+|.+...........+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999964 78999999887555555667899999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCccee-e
Q 007625 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT-T 434 (595)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~-~ 434 (595)
.+++... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998742 24589999999999999999999999 999999999999999999999999999876543211111 1
Q ss_pred cccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCC
Q 007625 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 513 (595)
Q Consensus 435 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 513 (595)
...++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....... ... ...
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----~~~~~~~---~~~---------~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----TREAIEQ---GVR---------LPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----HHHHHHc---CCC---------CCC
Confidence 1123467999999998889999999999999999998 888886432211 1111110 000 011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 514 DSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 514 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
+...+..+.+++.+|++.+|++||++.||+++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=311.73 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=202.9
Q ss_pred cCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
.+|++.+.||+|+||.||+|..+++..+|+|.+.... .....+.+|+++++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 3577899999999999999998777889999986422 23457889999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++|.+++.... ..+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 9999999987532 3689999999999999999999999 999999999999999999999999999886543322
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+.. .. ..
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~---~~------~~- 220 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-----VVESVSA---GY------RL- 220 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-----HHHHHHc---CC------cC-
Confidence 22222234568999999998899999999999999999999 789987543211 1111111 00 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
..+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 --YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11122456788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=311.56 Aligned_cols=255 Identities=28% Similarity=0.427 Sum_probs=205.3
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
..++|++.+.||+|+||.||+|...++..+|+|.+.... .....+.+|+.++++++|+|++++++++. ....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 346788899999999999999998888899999986432 23467899999999999999999999875 456899999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.++++... ...+++.+++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999987532 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.........++..|+|||++.+..++.++||||||+++|||++ |..||...... ...+... ....
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~---~~~~------ 221 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-----EVLEQVE---RGYR------ 221 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHH---cCCC------
Confidence 3222222345678999999988889999999999999999999 88888643321 1111111 1100
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+......+.+++.+|+..+|.+|||+.++.+.|+.
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 ---MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01122344678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=330.72 Aligned_cols=254 Identities=22% Similarity=0.262 Sum_probs=205.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+|+.. +++.||+|+++... .......+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999965 68999999987421 2245567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999863 4689999999999999999999998 999999999999999999999999999986654
Q ss_pred cC----------------------------cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 007625 428 KL----------------------------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (595)
Q Consensus 428 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~ 479 (595)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223356899999999999999999999999999999999999999764
Q ss_pred chhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHh
Q 007625 480 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-MAQVVKML 546 (595)
Q Consensus 480 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L 546 (595)
..... ........ ... .++. ......++.+++.+|+. ||.+||+ ++|++++-
T Consensus 234 ~~~~~--------~~~i~~~~--~~~---~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 234 TLQET--------YNKIINWK--ESL---RFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CHHHH--------HHHHhccC--Ccc---cCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 42111 11111100 000 0000 01134677888889997 9999999 99998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=317.11 Aligned_cols=262 Identities=23% Similarity=0.388 Sum_probs=207.5
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
+..++|++.+.||+|+||.||+|..+ .+..||+|.+...........+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 46778999999999999999999743 245799999875444445567889999999999999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEE
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKP------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 415 (595)
..++||||+++|+|.+++..... .....++..+..++.|++.||.|||+. +|+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975332 123457788899999999999999999 999999999999999999999
Q ss_pred EeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHH
Q 007625 416 LCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 416 l~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~ 493 (595)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-----~~~~- 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-----VLKF- 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHH-
Confidence 9999998865432221 1122335678999999998889999999999999999998 788886433211 1111
Q ss_pred HHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 494 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..... ....+......+.+++.+|++.||++|||+.|+++.|++.
T Consensus 234 --~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 --VMDGG---------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --HHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11111 1111223346889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=316.23 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=197.3
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcH
Q 007625 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (595)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (595)
||+|+||+||++... +++.||+|.+.... .......+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999964 78899999986422 122345678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeec
Q 007625 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435 (595)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 435 (595)
.+.+.........+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865444456799999999999999999999999 999999999999999999999999999976543322 2233
Q ss_pred ccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCH
Q 007625 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 515 (595)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 515 (595)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......... ........ .. ....+.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~---------~~-~~~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRIL---------ND-SVTYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhhc---------cc-CCCCcc
Confidence 56899999999999999999999999999999999999999754321110 01111110 00 011233
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007625 516 KEVETMVQVALLCTQSTPEDRP-----PMAQVVK 544 (595)
Q Consensus 516 ~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 544 (595)
.....+.+++.+|++.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 4556788999999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=314.88 Aligned_cols=259 Identities=28% Similarity=0.392 Sum_probs=206.3
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 342 (595)
.+++|.+.+.||+|+||.||+|... .+..||+|.+...........|..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4567889999999999999999964 3567999988755545556789999999999999999999999999999
Q ss_pred eEEEEEecccCcHhhhhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC---cEEE
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPG---EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVL 416 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 416 (595)
.++||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 99999999999999998764321 23589999999999999999999999 999999999999998654 5999
Q ss_pred eeccccccccCcCcce-eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHH
Q 007625 417 CDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR 494 (595)
Q Consensus 417 ~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~ 494 (595)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||....... ..+.+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~- 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-----VMEFV- 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHH-
Confidence 9999998764322111 112233568999999998899999999999999999997 999987543321 11111
Q ss_pred HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
...... ..+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 235 --~~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 --TGGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111110 112233467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=323.53 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=197.1
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
++||+|+||.||+|+.. +++.||+|+++... .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999964 68899999997432 223446688899999888 699999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 999888864 34689999999999999999999999 9999999999999999999999999998743211 112
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+.............++.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------R 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------C
Confidence 2345689999999999999999999999999999999999999975332211111112222222221111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPP------MAQVVK 544 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~ 544 (595)
.+.....++.+++.+|++.||.+||+ +.|+++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12233456788999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=323.03 Aligned_cols=246 Identities=23% Similarity=0.294 Sum_probs=193.2
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
+.||+|+||.||+|+.. +++.||+|+++... .......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 68899999987432 233445677888888776 799999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
++|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 999888765 34689999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...............+.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~ 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------R 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------C
Confidence 2345689999999999999999999999999999999999999964222111111112222221111111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPM 539 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~ 539 (595)
.+.....++.+++.+|++.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 223345677889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=311.00 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=206.9
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
+..++|++.++||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++|+|++++++++. .+..+++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 3456789999999999999999998889999999986432 33567899999999999999999998864 56789999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.... ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999999987532 34689999999999999999999998 999999999999999999999999999987653
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
..........++..|+|||++....++.++||||||+++|||++ |+.||....... ....... ....
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~---~~~~---- 222 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-----VIQNLER---GYRM---- 222 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----HHHHHHc---CCCC----
Confidence 32222223346778999999988889999999999999999999 999997543211 1111111 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 -----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0112234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=315.32 Aligned_cols=265 Identities=25% Similarity=0.354 Sum_probs=202.2
Q ss_pred CcCCeeeeccceEEEEEEe-----CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC--CceEEE
Q 007625 274 SESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV 346 (595)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 346 (595)
...+.||+|+||+||++.. .++..||+|.++..........|.+|+++++.++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7889999999999988653 367889999987544444567889999999999999999999988654 357899
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999874 3489999999999999999999999 99999999999999999999999999998665
Q ss_pred CcCcc--eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 427 AKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 427 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
..... ......++..|+|||.+.+..++.++||||||+++|||+||..|+......... ...............+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE---MIGPKQGQMTVVRLIE 235 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh---hhcccccccchhhhhh
Confidence 43221 112233566799999998888999999999999999999999998643221000 0000000000000111
Q ss_pred cccccC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 505 IVDRNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 505 ~~d~~l-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..+... ...+...+.++.+++.+||+.+|++|||+++|++.|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111111 112233456889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=315.16 Aligned_cols=265 Identities=24% Similarity=0.375 Sum_probs=208.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCC-----------------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCcc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSD-----------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 332 (595)
..+|++.+.||+|+||.||+|...+ +..||+|.+...........+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999988532 24589999876555566778999999999999999999
Q ss_pred ccceeecCCceEEEEEecccCcHhhhhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCC
Q 007625 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (595)
Q Consensus 333 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 405 (595)
+++++..++..++++||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999876431 123689999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh--CCCCCCCCchh
Q 007625 406 ILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLE 482 (595)
Q Consensus 406 Ill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt--g~~p~~~~~~~ 482 (595)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999886543322 12233446788999999988889999999999999999998 66676543211
Q ss_pred hhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 483 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
..........+......... .+...+.++.+++.+|++.||.+|||+.||++.|+
T Consensus 241 -----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 -----QVIENAGHFFRDDGRQIYLP-----RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -----HHHHHHHhccccccccccCC-----CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11222221111111111111 12233468899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=321.71 Aligned_cols=243 Identities=25% Similarity=0.303 Sum_probs=196.1
Q ss_pred CeeeeccceEEEEEEe----CCCcEEEEEEeccCC---CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 277 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+.||+|+||.||+++. .+++.||+|+++... .......+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357899999986421 223345678899999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999998875 34578889999999999999999999 99999999999999999999999999987543222
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........ .
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~--------~~~~~~~~-~-------- 216 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--------TIDKILKG-K-------- 216 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcC-C--------
Confidence 1 2233568999999999998889999999999999999999999997543211 11111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
...+.....++.+++.+|++.||++|| ++.+++++
T Consensus 217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 011222345778999999999999999 78887664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=329.64 Aligned_cols=257 Identities=19% Similarity=0.240 Sum_probs=203.9
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
....++|++.+.||+|+||.||+|+.. +++.||+|++... ........+.+|+.+++.++||||+++++++.++...
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345678999999999999999999964 6889999998632 1223345678899999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 999999999999998864 2478888999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCCC----CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
..............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ........
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~ 262 (370)
T cd05596 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMDH 262 (370)
T ss_pred eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--------HHHHHHcC
Confidence 7654332223345699999999998653 47899999999999999999999997644311 11111111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 007625 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM 545 (595)
Q Consensus 500 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 545 (595)
..... .+. ....+.++.+++.+|++.+|.+ ||++.|++++
T Consensus 263 ~~~~~-----~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 263 KNSLT-----FPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCcCC-----CCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 10000 000 1123467788899999999987 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=306.68 Aligned_cols=265 Identities=24% Similarity=0.295 Sum_probs=206.5
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCC-chhHHHHHHHHHHHHhcCCCC-CccccceeecCC------
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKN-LLQLIGYCTTSS------ 341 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 341 (595)
..|+..++||+|+||+||+|+. .+|+.||+|+++-... ++......+|+.+++.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4566678899999999999995 4789999999974332 445556689999999999999 999999998877
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++|+||++. +|..++.........++...++.++.|++.||+|||++ +|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 77899999975 89999987654335677789999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc--
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR-- 498 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~-- 498 (595)
|+........ .....+|..|.|||++.+. .|+...||||+|||+.||++++.-|.+.... .....+-..+.
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-----~ql~~If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-----DQLFRIFRLLGTP 240 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-----HHHHHHHHHcCCC
Confidence 9976644333 3344579999999999887 6899999999999999999999888875542 12222222221
Q ss_pred -cccccccc---ccc--CCC------CC---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 499 -EDRLNDIV---DRN--LNT------YD---SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 499 -~~~~~~~~---d~~--l~~------~~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+..+.... +-. ... .. +....+..+++.+|++.+|.+|.|++.++++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 12222211 111 111 11 1112477889999999999999999999776
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=315.62 Aligned_cols=260 Identities=26% Similarity=0.390 Sum_probs=206.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEe------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
.++|.+.+.||+|+||+||++.. .++..+|+|.+... .......+.+|++++++++|||++++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 45788899999999999999984 23456899988643 334566789999999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcE
Q 007625 344 ILVYPFMQNLSVAYRLRDLKP---------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 414 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 414 (595)
++||||+++++|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999875321 123589999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHH
Q 007625 415 VLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH 492 (595)
Q Consensus 415 kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~ 492 (595)
+|+|||+++........ ......++..|+|||++.+..++.++||||||+++|||+| |..||....... ....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-----~~~~ 234 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----VIEC 234 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHH
Confidence 99999999865432211 1222345778999999998889999999999999999998 899986543211 1111
Q ss_pred HHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
+ ..+... ..+...+.++.+++.+||+.+|.+|||+.||++.|+...
T Consensus 235 i----~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 I----TQGRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred H----HcCCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1 111110 011123356899999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.11 Aligned_cols=265 Identities=20% Similarity=0.339 Sum_probs=204.5
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCC---------------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCcccc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSD---------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 334 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 334 (595)
.++|++.+.||+|+||.||+++..+ ...||+|.++..........|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578999999999999999987532 2348999987654555567899999999999999999999
Q ss_pred ceeecCCceEEEEEecccCcHhhhhcccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCE
Q 007625 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKP--------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (595)
Q Consensus 335 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 406 (595)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999864211 112478899999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh--CCCCCCCCchhh
Q 007625 407 LLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEE 483 (595)
Q Consensus 407 ll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt--g~~p~~~~~~~~ 483 (595)
++++++.+||+|||++......... ......++..|+|||+..+..++.++||||||+++|||++ +..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999765432211 1222345778999999988889999999999999999998 556665433211
Q ss_pred hhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 484 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
.................. ..++..+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 241 -----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 -----VIENTGEFFRNQGRQIYL-----SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -----HHHHHHHhhhhccccccC-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111111000000 011223468999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=316.69 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=207.5
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 342 (595)
..++|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.++++++|||++++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567899999999999999999853 4678999998755444556789999999999999999999999999999
Q ss_pred eEEEEEecccCcHhhhhcccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCC
Q 007625 343 RILVYPFMQNLSVAYRLRDLKP------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA 404 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 404 (595)
.++|+||+++++|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999974321 123578899999999999999999999 9999999999
Q ss_pred CEEEcCCCcEEEeeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchh
Q 007625 405 NILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE 482 (595)
Q Consensus 405 NIll~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~ 482 (595)
||++++++.++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876533221 11122334678999999988899999999999999999998 88888643321
Q ss_pred hhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 483 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
+..... ..+. ....+...+.++.+++.+|++.+|++||++.|+++.|+.
T Consensus 240 --------~~~~~~-~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --------EVIYYV-RDGN--------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --------HHHHHH-hcCC--------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111 1111 111122345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=308.85 Aligned_cols=254 Identities=30% Similarity=0.425 Sum_probs=204.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
.++|++.+.||+|+||.||+|...++..+|+|++.... .....+.+|+.++++++|+|++++++++. ....++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 45688899999999999999998777789999876422 33467889999999999999999998875 4567899999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.++++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999997532 34589999999999999999999999 99999999999999999999999999998664432
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
........++..|+|||+..+..++.++||||||+++|||+| |+.||......+ ....+. ....
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~---~~~~------- 221 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-----VLEQVE---RGYR------- 221 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH---cCCC-------
Confidence 222223346778999999988889999999999999999999 899987533211 111111 1100
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01123345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=315.49 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=202.8
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.|+..++||+|+||+||++... +++.||+|.+.... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999964 68999999986422 22234567889999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886432 34689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.. .....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ..+.+......
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~--------- 219 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRVKE--------- 219 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHhhh---------
Confidence 21 123458999999999998889999999999999999999999997543211 11111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
....++......+.+++.+|++.||++|| ++++++++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11112334556788999999999999999 78887554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=309.49 Aligned_cols=260 Identities=22% Similarity=0.341 Sum_probs=210.0
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||.||+|.. .++..+|+|.+... ........+.+|+.+++.++|+|++++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999995 58899999987642 22334568889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.........+++.+.+.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875444456789999999999999999999999 999999999999999999999999999876643
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
... ......|+..|+|||++.+..++.++||||||+++|||++|..||...... .......... ...
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~------~~~ 225 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQ------CDY 225 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhhc------CCC
Confidence 322 122345889999999998888999999999999999999999998643221 1111111110 001
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
+.. ........+.+++.+|++.+|.+|||+.+|++.+.+
T Consensus 226 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 226 PPL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 111 112345678899999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.26 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=203.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCc--EEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (595)
++|++.++||+|+||.||+|... ++. .+++|.++..........+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999864 333 47888887544445567889999999999 799999999999999999999
Q ss_pred EEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcE
Q 007625 347 YPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 414 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 414 (595)
+||+++++|.++++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999975321 113588999999999999999999998 99999999999999999999
Q ss_pred EEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHH
Q 007625 415 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 415 kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~ 493 (595)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------LY 228 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HH
Confidence 9999999864322111 111223567999999988889999999999999999997 999997543211 11
Q ss_pred HHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 494 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
........ ...+......+.+++.+|++.+|.+||++.++++.|+..
T Consensus 229 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 229 EKLPQGYR---------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111100 011223446788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=336.95 Aligned_cols=262 Identities=22% Similarity=0.278 Sum_probs=212.6
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCCC-cEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccc-eeecC----
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIG-YCTTS---- 340 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~---- 340 (595)
+...++++.++|.+|||+.||.|....+ ..||+|++... .+.....+.+|+++|+.|. |+|||.+++ .....
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 4556677899999999999999997655 99999998754 6677888999999999997 999999999 33221
Q ss_pred --CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEee
Q 007625 341 --SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (595)
Q Consensus 341 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 418 (595)
-+.++.||||.+|.|-+++..+.. ..+++.++++|+.|+++|+++||.. +|+|||||||-+||||+.+++.||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 256899999999999999997653 3499999999999999999999987 66799999999999999999999999
Q ss_pred ccccccccCcCccee--------ecccccccccCcccc---CCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhh
Q 007625 419 FGLAKLVDAKLTHVT--------TQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 487 (595)
Q Consensus 419 fG~~~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~ 487 (595)
||.+.-......... -...-|+.|+|||++ .+...++|+|||+|||+||-|+....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 999874432221100 012368999999987 477899999999999999999999999985421
Q ss_pred hHHHHHHHHhccccccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccchh
Q 007625 488 LLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 554 (595)
Q Consensus 488 ~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 554 (595)
..|++..... -.+.+...+.+||..||+.+|.+||++.||+..+-.+.-.+.
T Consensus 264 ---------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 264 ---------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ---------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 1233333222 136789999999999999999999999999998876544333
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.79 Aligned_cols=203 Identities=21% Similarity=0.264 Sum_probs=176.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|+..+.||+|+||+||+|... +++.||+|+++... .......+.+|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999864 68899999986421 2234467888999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999875 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred cCc----------------------------------ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCC
Q 007625 428 KLT----------------------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473 (595)
Q Consensus 428 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~ 473 (595)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346999999999999999999999999999999999999
Q ss_pred CCCCCCc
Q 007625 474 RAIDFSR 480 (595)
Q Consensus 474 ~p~~~~~ 480 (595)
.||....
T Consensus 234 ~Pf~~~~ 240 (363)
T cd05628 234 PPFCSET 240 (363)
T ss_pred CCCCCCC
Confidence 9997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=309.41 Aligned_cols=256 Identities=26% Similarity=0.391 Sum_probs=199.1
Q ss_pred CCcCCeeeeccceEEEEEEeCC-Cc--EEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC------Cc
Q 007625 273 FSESNIIGQGGFGKVYKGVLSD-NT--KVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SE 342 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 342 (595)
|.+.+.||+|+||.||+|...+ +. .||+|.++.. ........+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999754 32 5899988643 2344567889999999999999999999987432 24
Q ss_pred eEEEEEecccCcHhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 343 RILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
.++++||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998875322 2234589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCcCcce-eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 421 LAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 421 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
+++......... .....+++.|+|||+..+..++.++||||||+++|||++ |+.||...... ...+.+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~---~ 229 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-----EIYDYLR---Q 229 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHH---c
Confidence 998764432211 122335678999999998899999999999999999999 78888653221 1111111 1
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.... ..+......+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 230 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 230 GNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1110 1122334568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=309.35 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=202.5
Q ss_pred CCcCCeeeeccceEEEEEEeC-C---CcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc-----
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-D---NTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----- 342 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 342 (595)
|.+.+.||+|+||.||+|... + +..||+|+++.. ........+.+|++.++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999864 2 367999998743 233445678999999999999999999998866554
Q ss_pred -eEEEEEecccCcHhhhhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 343 -RILVYPFMQNLSVAYRLRDLKP--GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 343 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
.++++||+++++|..++..... ....+++.....++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7899999999999998864321 234689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcce-eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHh
Q 007625 420 GLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 497 (595)
Q Consensus 420 G~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~ 497 (595)
|+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...... ...+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-----~~~~~~~~-- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-----EIYDYLRH-- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHc--
Confidence 9998664432221 112235678999999988889999999999999999999 88888653321 11122211
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 498 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.. ....+.....++.+++.+|++.||.+||++.||++.|+.
T Consensus 231 -~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 -GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred -CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11 111223445688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=314.61 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=205.5
Q ss_pred CCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
+|++.+.||+|+||.||+|... ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999852 2357899988755444556788999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCC
Q 007625 346 VYPFMQNLSVAYRLRDLKP--------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 405 (595)
++||+.+++|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999998864321 123588999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhh
Q 007625 406 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE 483 (595)
Q Consensus 406 Ill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~ 483 (595)
|++++++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|||+| |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999865432221 1122345678999999988889999999999999999998 99998654321
Q ss_pred hhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 484 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
.+...... .. .. ..+.....++.+++.+|++.+|++||++.|+++.|++.
T Consensus 237 ----~~~~~~~~----~~-----~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 ----RLFNLLKT----GY-----RM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred ----HHHHHHhC----CC-----CC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11121111 00 00 01223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=311.59 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=200.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCc----EEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
++|++.+.||+|+||+||+|.+. ++. .+++|.+..........++..|+..++++.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46778899999999999999963 444 477887754333344567888888999999999999999875 455788
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
++||+++|+|.+++... ...+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999753 24689999999999999999999999 9999999999999999999999999999866
Q ss_pred cCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 426 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 426 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ..+.+. .+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~~~~----~~~~~ 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-----VPDLLE----KGERL 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHH----CCCcC
Confidence 433221 2233457789999999998899999999999999999998 999987543211 111111 11100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.. +......+.+++.+||..+|++|||+.|+++.|..
T Consensus 231 --~~------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 231 --AQ------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred --CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 00 11123467888999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.93 Aligned_cols=239 Identities=24% Similarity=0.329 Sum_probs=190.1
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHh-cCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
++||+|+||.||+|+.. +++.||+|+++... .......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 67899999987421 22334455666666665 4899999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999988875 34589999999999999999999999 99999999999999999999999999997543322 22
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...... . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-----~---~~~i~~-~---------~~~ 214 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-----L---FDSILN-D---------RPH 214 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-----H---HHHHHc-C---------CCC
Confidence 334568999999999999899999999999999999999999997543211 1 111111 0 011
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPMAQ 541 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 541 (595)
++.....++.+++.+|++.||.+||++.+
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 22233456778899999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=328.95 Aligned_cols=265 Identities=24% Similarity=0.385 Sum_probs=208.6
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceee
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCT 338 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 338 (595)
+++..++|.+.+.||+|+||.||+|++. .+..||+|+++..........+.+|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4455667888999999999999999853 346799999975544444567899999999997 999999999999
Q ss_pred cCCceEEEEEecccCcHhhhhcccCC------------------------------------------------------
Q 007625 339 TSSERILVYPFMQNLSVAYRLRDLKP------------------------------------------------------ 364 (595)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 364 (595)
..+..++|+||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999874321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCC
Q 007625 365 ----------------------------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA 404 (595)
Q Consensus 365 ----------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 404 (595)
....+++.....++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 113467888899999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEeeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchh
Q 007625 405 NILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE 482 (595)
Q Consensus 405 NIll~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~ 482 (595)
||++++++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986533211 11223346789999999988889999999999999999998 88898643321
Q ss_pred hhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 483 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
+. ....+. ...+. ..+.....++.+++.+||..+|.+||++.||++.|+..
T Consensus 349 ~~----~~~~~~---~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 EQ----FYNAIK---RGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HH----HHHHHH---cCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 111111 11000 11222346788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.70 Aligned_cols=253 Identities=20% Similarity=0.236 Sum_probs=196.7
Q ss_pred CCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.|+..+.||+|+||+||+|+. .+++.||+|++... ........+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999995 46889999998642 223445678999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999875 34588999999999999999999999 9999999999999999999999999997643110
Q ss_pred Cc----------------------------------------------ceeecccccccccCccccCCCCCCccchhHHH
Q 007625 429 LT----------------------------------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGY 462 (595)
Q Consensus 429 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~Sl 462 (595)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123469999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHH--cccCCCCCCCCHH
Q 007625 463 GITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALL--CTQSTPEDRPPMA 540 (595)
Q Consensus 463 Gvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~~ 540 (595)
||++|||+||+.||......+.. ..+.. ..... ..+. ......++.+++.+ |+..+|..||++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~-----~~i~~--~~~~~------~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ-----LKVIN--WENTL------HIPP-QVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH-----HHHHc--ccccc------CCCC-CCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999999764432111 00100 00000 0000 01123455566665 6666777799999
Q ss_pred HHHHH
Q 007625 541 QVVKM 545 (595)
Q Consensus 541 evl~~ 545 (595)
|++++
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=326.66 Aligned_cols=253 Identities=19% Similarity=0.242 Sum_probs=199.4
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+|+.. +++.||+|++... ........+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999964 6899999999642 12334567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999875 34589999999999999999999999 999999999999999999999999999875432
Q ss_pred cCcc-------------------------------------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHH
Q 007625 428 KLTH-------------------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 470 (595)
Q Consensus 428 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ell 470 (595)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011245899999999999999999999999999999999
Q ss_pred hCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 007625 471 TGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP---MAQVVKM 545 (595)
Q Consensus 471 tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~ 545 (595)
+|..||........ ......... . + ..+. ......++.+++.+|+. +|.+|++ +.|++++
T Consensus 234 ~G~~Pf~~~~~~~~--------~~~i~~~~~--~-~--~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQET--------YRKIINWKE--T-L--QFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHHH--------HHHHHcCCC--c-c--CCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999975443211 111111000 0 0 0000 01123466778888886 9999998 8887654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=323.61 Aligned_cols=243 Identities=21% Similarity=0.257 Sum_probs=196.2
Q ss_pred CeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccC
Q 007625 277 NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
+.||+|+||.||++.. .++..||+|++... ........+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 47899999998742 22334567788999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
+|..++.. ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 99988865 3468999999999999999999997 6 89999999999999999999999999987543221 12
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+. ... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-----~~~~i~----~~~---------~~ 214 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELIL----MEE---------IR 214 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-----HHHHHh----cCC---------CC
Confidence 233568999999999999999999999999999999999999997543211 111111 000 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
++.....++.+++.+|++.||++|+ ++.+++++
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1222345778899999999999996 89998765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=313.15 Aligned_cols=266 Identities=21% Similarity=0.337 Sum_probs=205.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-----------------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCcc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-----------------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 332 (595)
.++|++.+.||+|+||.||++... ++..||+|+++..........+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457899999999999999998632 234689999875545556678999999999999999999
Q ss_pred ccceeecCCceEEEEEecccCcHhhhhcccCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCC
Q 007625 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG-------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (595)
Q Consensus 333 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 405 (595)
+++++...+..++||||+++++|.+++...... ...+++.++..++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998764321 13478889999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccCcCcce-eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh--CCCCCCCCchh
Q 007625 406 ILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLE 482 (595)
Q Consensus 406 Ill~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt--g~~p~~~~~~~ 482 (595)
|++++++.++|+|||+++.+....... .....++..|+|||+..++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999998654322111 122334678999999888889999999999999999998 66777543321
Q ss_pred hhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 483 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.. ................. + .+..++..+.+++.+||+.||++||++.||++.|++
T Consensus 241 ~~-----~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QV-----IENTGEFFRDQGRQVYL-P----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH-----HHHHHHHHhhccccccC-C----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 11111111111000000 0 112234678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.29 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=206.5
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|+..+.||+|++|.||+|... +++.|++|.+... ........+.+|+++++.++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999964 6899999998632 3345667889999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.++++... ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998642 35689999999999999999999998 99999999999999999999999999988665432
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.. .....|++.|+|||+..+..++.++|+||||+++|||++|+.||....... ... .... ..
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~---~~~~---------~~ 217 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-----LIL---KIIR---------GV 217 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-----HHH---HHHc---------CC
Confidence 21 233457899999999999889999999999999999999999997544211 111 1111 11
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+......+.+++.+|++.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111222445678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=314.99 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=208.3
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEe--------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceee
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 338 (595)
...++|.+.+.||+|+||.||+|+. .++..||+|.+...........+.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4566788899999999999999974 134579999987544445567889999999999 8999999999999
Q ss_pred cCCceEEEEEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCE
Q 007625 339 TSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (595)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 406 (595)
.....++||||+++++|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999975422 123588899999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCcCcce-eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhh
Q 007625 407 LLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 484 (595)
Q Consensus 407 ll~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~ 484 (595)
++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-- 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 99999999999999998765432221 222345678999999988889999999999999999998 78887643321
Q ss_pred hhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 485 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 485 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
+........... ..+...+..+.+++.+||+.+|.+||++.||++.|+.
T Consensus 247 ------~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 247 ------ELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred ------HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 111111111110 1122345678889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=309.19 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=208.6
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
+..++|++.+.||+|+||.||+|..+++..||+|.+.... ....++.+|+.++++++|+|++++++++......++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 4567899999999999999999998888899999987432 34567899999999999999999999999889999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.... ...+++.++..++.|++.|+.|||+. +++|+||||+||++++++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999997632 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
..........++..|+|||.+.+..++.++||||||+++|||+| |+.||....... ....+. .....
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-----~~~~~~---~~~~~---- 223 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-----VLEQVE---RGYRM---- 223 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH---cCCCC----
Confidence 32222222335678999999998889999999999999999999 999986433211 111111 11000
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 -----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0111224578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=323.90 Aligned_cols=254 Identities=19% Similarity=0.229 Sum_probs=203.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+|+.. +++.||+|+++... .......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999964 78999999987432 2334567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999763 24689999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCccccC------CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLS------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||....... ..........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~ 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--------TYNNIMNFQR 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--------HHHHHHcCCC
Confidence 4333333456899999999986 4567899999999999999999999997543211 1111111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.... + .......++.+++..|++ +|.+||++.+++++
T Consensus 227 ~~~~-----~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FLKF-----P-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ccCC-----C-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0000 0 011234567788889997 99999999998653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.91 Aligned_cols=246 Identities=24% Similarity=0.324 Sum_probs=194.7
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHH---HhcCCCCCccccceeecCCceEEE
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLI---SVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
|++.+.||+|+||.||+|... +++.||+|+++... .......+.+|..++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999964 68999999987421 223345566666554 566899999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|...++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999887753 3589999999999999999999999 99999999999999999999999999987533
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.. ........|++.|+|||++.+..++.++|||||||++|||++|+.||....... . ........
T Consensus 153 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-----~---~~~i~~~~------ 217 (324)
T cd05589 153 GF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-----V---FDSIVNDE------ 217 (324)
T ss_pred CC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-----H---HHHHHhCC------
Confidence 22 122234568999999999999899999999999999999999999997543221 1 11111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
..++......+.+++.+|++.||.+|| ++.++++.
T Consensus 218 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 ----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 011223346778899999999999999 46666543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.65 Aligned_cols=237 Identities=26% Similarity=0.340 Sum_probs=191.7
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
+.||+|+||+||+|+.+ +++.||+|+++.. ........+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 6889999998642 1233456677888888776 699999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999988875 34689999999999999999999999 99999999999999999999999999987542221 12
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...... .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~---~~~i~~-~~---------~~ 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-----L---FEAILN-DE---------VV 214 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----H---HHHHhc-CC---------CC
Confidence 234568999999999998899999999999999999999999997544211 1 111111 10 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPM 539 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~ 539 (595)
.+.....++.+++.+|++.||++||++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 122234577889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.23 Aligned_cols=242 Identities=24% Similarity=0.302 Sum_probs=194.5
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCC-CCccccceeecCCceEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHK-NLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 347 (595)
+|++.+.||+|+||.||+|+.. +++.||+|+++... .......+..|..++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999965 57899999987421 234456778899999998765 5888888999899999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999988875 34588999999999999999999999 999999999999999999999999999875322
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+. . ..
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-----~~~~i~---~-~~------ 217 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-----LFQSIM---E-HN------ 217 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHH---c-CC------
Confidence 21 12234568999999999999999999999999999999999999997543211 111111 1 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 539 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 539 (595)
..++.....++.+++.+|+..||.+|++.
T Consensus 218 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ---VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122334577889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=308.15 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=206.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
.++|++.+.||+|+||.||+|... ++..+|+|.++..........+.+|+.++.+++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888999999999999999853 2347999998754444556789999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++++|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999999753 24589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCcCcceee--cccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 426 DAKLTHVTT--QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 426 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
......... ...++..|+|||++.+..++.++|+||||+++||+++ |..||......+ ....+.. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-----~~~~~~~---~~~~ 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-----VIKAIEE---GYRL 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-----HHHHHhC---CCcC
Confidence 543322221 1223568999999998889999999999999999886 999986533211 1111111 1000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 229 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 ---------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0112234577899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=310.20 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=204.8
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCc----EEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
..++|+..+.||+|+||+||+|++. ++. .||+|+++..........+.+|+.++..+.|||++++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 3457888999999999999999853 444 4899998765555667788999999999999999999999875 457
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
+++++|+++|+|.++++.. ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 84 ~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 8999999999999998753 24589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcce-eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 424 LVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 424 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
......... .....++..|+|||...+..++.++||||||+++|||++ |..||...... .....+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~----~~ 228 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-----EIPDLLEK----GE 228 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHC----CC
Confidence 765332221 112235678999999998899999999999999999998 88998643321 11122211 10
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
. ...+.....++.+++.+||+.||++||++.++++.|+..
T Consensus 229 ~--------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 229 R--------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred c--------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0 001223445788999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=313.72 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=206.2
Q ss_pred cCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
.+|.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|++.+++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45777899999999999999842 3456899987642 2334567899999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC
Q 007625 345 LVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 412 (595)
+||||+++++|.+++..... ....+++..++.++.|++.|++|||++ +++||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999875321 123589999999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHH
Q 007625 413 EAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL 490 (595)
Q Consensus 413 ~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~ 490 (595)
.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||+| |+.||......+ ..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----~~ 235 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-----VI 235 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH
Confidence 999999999976543221 11223446788999999998899999999999999999999 999986543211 11
Q ss_pred HHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 491 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 491 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
+.. ..+... ..+...+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus 236 ~~~----~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 236 ECI----TQGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHH----hCCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111 111111 11223346788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.82 Aligned_cols=260 Identities=28% Similarity=0.401 Sum_probs=206.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC--------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeec
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 339 (595)
..++|.+.+.||+|+||.||+|... ++..+|+|.++..........+..|++++..+ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3467999999999999999999852 23569999987544445566788999999999 79999999999999
Q ss_pred CCceEEEEEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEE
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 407 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 407 (595)
.+..++||||+++++|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 9999999999999999999976432 123589999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhh
Q 007625 408 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE 485 (595)
Q Consensus 408 l~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~ 485 (595)
++.++.++|+|||.++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-- 250 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 250 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--
Confidence 999999999999998765432111 1112234568999999998889999999999999999998 888886533211
Q ss_pred hhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 486 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 486 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...... .... ...+.....++.+++.+|+..+|.+||++.+|++.|+.
T Consensus 251 ---~~~~~~----~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 251 ---LFKLLK----EGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred ---HHHHHH----cCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 111111 1110 11123345688889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=306.57 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=196.8
Q ss_pred eeeeccceEEEEEEe---CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccC
Q 007625 278 IIGQGGFGKVYKGVL---SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 278 ~lG~G~~g~Vy~~~~---~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
.||+|+||.||+|.+ +++..+|+|+++... .......+..|+.+++.+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 357889999986432 2345678899999999999999999999875 45678999999999
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCccee
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 433 (595)
+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999864 34589999999999999999999999 999999999999999999999999999987654332211
Q ss_pred --ecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 434 --TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 434 --~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... .....+. .+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~i~----~~~~-------- 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----EVTQMIE----SGER-------- 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH----CCCC--------
Confidence 12234678999999988889999999999999999998 99998753321 1111111 1110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+...+.++.+++.+||+.||++||++.+|.+.|+.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 01122344678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=309.82 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=206.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CC---cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.++........+.+..|++++.+++|||++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999964 33 37999998755445556789999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++++|.+++... ...+++.++..++.|++.|++|||+. +++|+||||+||++++++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999998752 24689999999999999999999999 9999999999999999999999999999866
Q ss_pred cCcCcceee--cccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 426 DAKLTHVTT--QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 426 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
......... ....+..|+|||++.+..++.++||||||+++|||++ |+.||...... +...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~~~~ 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDGFRL 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcCCCC
Confidence 443222111 1223467999999988889999999999999999998 99998643321 111111111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
.........+.+++.+|++.+|++||++.+|++.|++.
T Consensus 230 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ---------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01122346788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.67 Aligned_cols=259 Identities=20% Similarity=0.257 Sum_probs=202.4
Q ss_pred HHHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 265 ELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
.+....++|++.+.||+|+||.||+|+.. +++.||+|++... ........+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34455678999999999999999999965 6889999998632 22234556889999999999999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999998864 2478899999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCCC----CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHh
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 497 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 497 (595)
+...............||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~--------~~~~i~ 260 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG--------TYSKIM 260 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH--------HHHHHH
Confidence 987654333233456699999999998654 37889999999999999999999997544211 111111
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 007625 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM 545 (595)
Q Consensus 498 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 545 (595)
....... ++. .......+.+++..|++.++.+ |+++.|++++
T Consensus 261 ~~~~~~~-----~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKNSLN-----FPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCcccC-----CCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1110000 000 1123456677788888755543 8899999775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=310.07 Aligned_cols=255 Identities=25% Similarity=0.298 Sum_probs=200.3
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCC-------------chhHHHHHHHHHHHHhcCCCCCccc
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-------------PGGEAAFQREVHLISVAIHKNLLQL 333 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-------------~~~~~~~~~E~~~l~~l~h~niv~l 333 (595)
...+.|++.+.||+|.||.|-+|+. .+++.||+|++.+... -...+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3456899999999999999999995 4799999999853210 1123578899999999999999999
Q ss_pred cceeecC--CceEEEEEecccCcHhhhhcccCCCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC
Q 007625 334 IGYCTTS--SERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 410 (595)
Q Consensus 334 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 410 (595)
+++..++ +..|+|+|||..|.+...-. ..+ ++..++++++.++..||+|||.+ +||||||||+|+|+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 9998775 56899999999887643222 334 99999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccccccccCcCc----ceeecccccccccCccccCCCC----CCccchhHHHHHHHHHHHhCCCCCCCCchh
Q 007625 411 NFEAVLCDFGLAKLVDAKLT----HVTTQIRGTMGHIAPEYLSTGK----SSEKTDVFGYGITLLELVTGQRAIDFSRLE 482 (595)
Q Consensus 411 ~~~~kl~DfG~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~SlGvvl~elltg~~p~~~~~~~ 482 (595)
+|++||+|||.+........ .......|||.|+|||...++. .+.+.||||+||.||-|+.|+.||-....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~- 324 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE- 324 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-
Confidence 99999999999986632211 1122367999999999987633 35678999999999999999999975432
Q ss_pred hhhhhhHHHHHHHHhccccccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 483 EEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
.+...+ ++...+.. -.++....+.+++.++|.+||++|.+..+|..+..
T Consensus 325 -------~~l~~K---------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 325 -------LELFDK---------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred -------HHHHHH---------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 122222 22222221 12345677889999999999999999999987653
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=314.78 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=202.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCc--EEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 345 (595)
.++|++.+.||+|+||.||+|..+ ++. .+|+|.++..........+.+|++++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457888999999999999999964 454 46888776544555667889999999999 89999999999999999999
Q ss_pred EEEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc
Q 007625 346 VYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 413 (595)
||||+++++|.++++.... ....+++.+++.++.|++.|++|||+. +++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975321 123588999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHH
Q 007625 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH 492 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~ 492 (595)
+||+|||++........ .....++..|+|||++.+..++.++|||||||++|||+| |..||......+ ..+.
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~ 235 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEK 235 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----HHHH
Confidence 99999999864321111 111224668999999988889999999999999999998 999986543211 1111
Q ss_pred HHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.. ..... ..+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 236 ~~---~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 236 LP---QGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred Hh---cCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 00000 0111234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.36 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=195.2
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC-------
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------- 340 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 340 (595)
...+|++.+.||+|+||.||+|... +++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 4567999999999999999999964 68899999885321 2345799999999999999998876432
Q ss_pred -CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC-cEEEee
Q 007625 341 -SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCD 418 (595)
Q Consensus 341 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D 418 (595)
...++||||+++ ++.+++.........+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 135689999985 77777765444456799999999999999999999999 999999999999998664 799999
Q ss_pred ccccccccCcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHh
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 497 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 497 (595)
||+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||+||+.||........ +...+. ..
T Consensus 215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~----~~~i~~-~~ 287 (440)
T PTZ00036 215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ----LVRIIQ-VL 287 (440)
T ss_pred cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHH-Hh
Confidence 999986643222 2234689999999998654 689999999999999999999999976543221 111111 00
Q ss_pred ccc----------ccccc-----ccccCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 498 RED----------RLNDI-----VDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 498 ~~~----------~~~~~-----~d~~l~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... ....+ ....+. .++...+.++.+++.+||+.||.+|||+.|++++
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000 00000 000000 0122344678899999999999999999999754
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.75 Aligned_cols=264 Identities=22% Similarity=0.330 Sum_probs=200.2
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|...+.||+|+||+||+|+.+ +++.||+|.++..........+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 67889999987544344455678899999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++ ++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 985 777777642 34578999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc-----
Q 007625 430 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN----- 503 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~----- 503 (595)
. ......+++.|+|||++.+ ..++.++||||||+++|||+||+.||......+..... ..... ......+.
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~ 235 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI-FRLLG-TPTEETWPGISSN 235 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhC-CCCHHHHhhhcch
Confidence 1 1223457899999999865 45899999999999999999999999765432211110 00000 00000000
Q ss_pred -ccccccCCC--------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 504 -DIVDRNLNT--------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 504 -~~~d~~l~~--------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
...+...+. ..+....++.+++.+|++.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 11223456789999999999999999999965
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=321.93 Aligned_cols=239 Identities=23% Similarity=0.273 Sum_probs=194.2
Q ss_pred CeeeeccceEEEEEEe----CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecc
Q 007625 277 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 351 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 351 (595)
+.||+|+||.||+++. .+|+.||+|++.... .......+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 368899999987422 22334567789999999999999999999999999999999999
Q ss_pred cCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc
Q 007625 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (595)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 431 (595)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999998865 34689999999999999999999999 999999999999999999999999999886543322
Q ss_pred eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCC
Q 007625 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 511 (595)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 511 (595)
......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ........ . .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--------~~~~i~~~-~---------~ 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--------TMTMILKA-K---------L 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--------HHHHHHcC-C---------C
Confidence 2234568999999999998889999999999999999999999997543211 11111111 0 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 007625 512 TYDSKEVETMVQVALLCTQSTPEDRPPMAQ 541 (595)
Q Consensus 512 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 541 (595)
..+......+.+++.+|++.||++||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112233457788999999999999999666
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=305.52 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=203.5
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCC----chhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
++|+..+.||+|++|.||+|.. .++..||+|.+..... ......+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999995 4689999999864321 1234578899999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
|+||+++++|.+.+.. ...+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998875 34588899999999999999999999 9999999999999999999999999998765
Q ss_pred cCcCccee--ecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 426 DAKLTHVT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 426 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
........ ....|+..|+|||++.+..++.++||||||+++|||++|+.||....... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~--- 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--------AIFKIATQP--- 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--------HHHHHhccC---
Confidence 43222111 23457889999999999889999999999999999999999986432211 011111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.....+......+.+++.+|+..+|.+||++.|++++
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011233445678899999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=313.81 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=207.9
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEe------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecC
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 340 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 340 (595)
...++|...+.||+|+||.||+|.. .++..||+|+++..........+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 4556799999999999999999974 135579999987544445567889999999999 799999999999999
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
+..++||||+++++|.++++... ...+++.+...++.|++.||+|||+. +++|+||||+||+++.++.++++|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999987532 23489999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 421 LAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 421 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+. ......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~----~~~~~~---- 258 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK----FYKLIK---- 258 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----HHHHHH----
Confidence 99865433221 1222346778999999998889999999999999999998 9999865432111 111111
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.+.. ...+.....++.+++.+|++.+|++||++.||++.|++
T Consensus 259 ~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 259 EGYR--------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred cCCc--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1100 00111234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=315.57 Aligned_cols=261 Identities=28% Similarity=0.419 Sum_probs=206.9
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC--------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceee
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 338 (595)
...++|.+.+.||+|+||.||+|+.. ....+|+|.++..........+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34567888999999999999999742 24569999987655555567889999999999 6999999999999
Q ss_pred cCCceEEEEEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCE
Q 007625 339 TSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (595)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 406 (595)
.....++||||+++|+|.+++..... ....+++.+..+++.|++.||.|||+. +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 98899999999999999999975321 124589999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCcCcce-eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhh
Q 007625 407 LLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 484 (595)
Q Consensus 407 ll~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~ 484 (595)
++++++.+||+|||.++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~- 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE- 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 99999999999999998664322111 112234567999999988889999999999999999999 888886543211
Q ss_pred hhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 485 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 485 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...... .... ...+.....++.+++.+|++.+|++||++.|+++.|+.
T Consensus 245 ----~~~~~~----~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 245 ----LFKLLR----EGHR--------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred ----HHHHHH----cCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111111 1110 01122334578889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=305.24 Aligned_cols=251 Identities=20% Similarity=0.281 Sum_probs=204.9
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
+|++.+.||+|+||.||++... ++..||+|.++........+.+..|+.+++.++|+|++++++++...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999964 688999999864444455678889999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
+++++.+++.... ...+++.....++.|++.||.|||+. +++|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999887532 34578999999999999999999999 999999999999999999999999999986643222
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....... ..... ......
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~-~~~~~~------- 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--------LILKV-CQGSYK------- 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--------HHHHH-hcCCCC-------
Confidence 2233458899999999988889999999999999999999999997533211 11111 111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..+......+.+++.+||+.||++||++.+|++.
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122334567889999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=323.35 Aligned_cols=262 Identities=19% Similarity=0.256 Sum_probs=205.1
Q ss_pred HHHHHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeec
Q 007625 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (595)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 339 (595)
..++....++|++.+.||+|+||.||+|+.+ +++.||+|++... ........+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4556667789999999999999999999965 6889999998632 222344567889999999999999999999999
Q ss_pred CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
....++||||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999998864 3478888999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCC----CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
|+++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~ 258 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSK 258 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH--------HHHH
Confidence 99987654333233456699999999998653 37899999999999999999999998644311 1111
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKML 546 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 546 (595)
.........+.+ .......+.+++..|+..++.+ ||++.|++++.
T Consensus 259 i~~~~~~~~~~~------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 259 IMNHKNSLTFPD------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHcCCCcccCCC------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111001100 1223456778888999844433 78899888765
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.58 Aligned_cols=243 Identities=24% Similarity=0.348 Sum_probs=194.8
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
++||+|+||.||+|+.. +++.||+|+++.. ........+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999965 5789999998742 1233455677888888865 799999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
++|...+.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 999988875 34588999999999999999999999 99999999999999999999999999987543222 12
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....... ... ....... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-----~~~---~i~~~~~----------~ 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-----LFE---SILHDDV----------L 214 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-----HHH---HHHcCCC----------C
Confidence 234568999999999998899999999999999999999999997644221 111 1111110 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRP-------PMAQVVKM 545 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~evl~~ 545 (595)
.+.....++.+++.+|++.||++|| ++.+++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1122345778899999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.15 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=203.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecC-
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS- 340 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 340 (595)
..++|++.+.||+|+||.||+|.. .+++.||||+++..........+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 456899999999999999999973 357789999997544444566788999999999 689999999988654
Q ss_pred CceEEEEEecccCcHhhhhcccCCC-------------------------------------------------------
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPG------------------------------------------------------- 365 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 365 (595)
...++||||+++|+|.++++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4578999999999999998642110
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc-eeecc
Q 007625 366 --------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQI 436 (595)
Q Consensus 366 --------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~ 436 (595)
...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 12478888999999999999999999 9999999999999999999999999999865332211 11223
Q ss_pred cccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCH
Q 007625 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 515 (595)
Q Consensus 437 ~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 515 (595)
.++..|+|||++.+..++.++||||||+++|||++ |..||........ ....+ ..+... . .+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~----~~~~~~-----~---~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRL----KEGTRM-----R---APD 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----HHHHH----hccCCC-----C---CCC
Confidence 45678999999988889999999999999999997 8999865322111 11111 111100 0 011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 516 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 516 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
....++.+++..||+.+|++||++.||++.|+..
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1234688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=315.99 Aligned_cols=241 Identities=26% Similarity=0.351 Sum_probs=192.1
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHh-cCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
+.||+|+||+||+|+.. +++.||+|+++... .......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999987431 12334556677777776 4899999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 999999875 34588999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.. .. . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~~~i~~---~~-------~---~ 214 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-----LFQSIRM---DN-------P---C 214 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh---CC-------C---C
Confidence 234568999999999999899999999999999999999999997543211 1111111 00 0 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPMA-QVV 543 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 543 (595)
++.....++.+++.+|++.||++||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1222345678889999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=308.59 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=196.2
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcH
Q 007625 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (595)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (595)
||+|+||+||+++.+ +|+.||+|++.... .......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999964 68999999986321 122344566799999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeec
Q 007625 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435 (595)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 435 (595)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 98886432 34588999999999999999999999 99999999999999999999999999988664322 2233
Q ss_pred ccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCH
Q 007625 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 515 (595)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 515 (595)
..|+..|+|||++.+..++.++|||||||++|||++|+.||........ ........... .......
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~---------~~~~~~~ 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRTLED---------EVKFEHQ 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHhhcc---------ccccccc
Confidence 4589999999999988899999999999999999999999874322111 11111111111 0110112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 516 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 516 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
....++.+++.+|++.||++||++.|+++.+.
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 23456889999999999999999988875554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.59 Aligned_cols=253 Identities=19% Similarity=0.221 Sum_probs=197.2
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+|.. .+++.||+|++... ........+.+|++++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4788999999999999999985 47899999998632 12334567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999875 34688999999999999999999999 999999999999999999999999999863321
Q ss_pred cCcc----------------------------------------------eeecccccccccCccccCCCCCCccchhHH
Q 007625 428 KLTH----------------------------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFG 461 (595)
Q Consensus 428 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S 461 (595)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001245899999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCC---CC
Q 007625 462 YGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR---PP 538 (595)
Q Consensus 462 lGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps 538 (595)
|||++|||+||+.||......+. ......... .+ .++. ......++.+++.+|+. +|.+| ++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~--------~~~i~~~~~--~~---~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHET--------YRKIINWRE--TL---YFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHH--------HHHHHccCC--cc---CCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999999975432111 111111000 00 0000 01223567788889997 66665 59
Q ss_pred HHHHHHH
Q 007625 539 MAQVVKM 545 (595)
Q Consensus 539 ~~evl~~ 545 (595)
+.|++++
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.11 Aligned_cols=242 Identities=24% Similarity=0.302 Sum_probs=194.5
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 347 (595)
+|++.+.||+|+||.||+|+.. +++.||+|++.... .......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999965 57899999987432 223345567777887776 5889999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+.+.. ...+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999988875 34588999999999999999999999 999999999999999999999999999875432
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||....... +...+. . ..
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-----~~~~i~---~-~~------ 217 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----LFQSIM---E-HN------ 217 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-----HHHHHH---h-CC------
Confidence 21 12234568999999999999999999999999999999999999997543211 111111 1 10
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 539 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 539 (595)
..++.....++.+++.+|++.||.+|++.
T Consensus 218 ---~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01223345677889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=303.93 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=197.1
Q ss_pred eeeeccceEEEEEEeC---CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCc
Q 007625 278 IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 354 (595)
Q Consensus 278 ~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (595)
.||+|+||.||+|.+. ++..||+|++.........+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999853 455799999875544455677999999999999999999999875 457899999999999
Q ss_pred HhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCccee-
Q 007625 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT- 433 (595)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~- 433 (595)
|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99988742 34689999999999999999999999 999999999999999999999999999986543322211
Q ss_pred -ecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCC
Q 007625 434 -TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 511 (595)
Q Consensus 434 -~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 511 (595)
....++..|+|||++.+..++.++||||||+++||+++ |..||......+ ....+. .+.. .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~----~~~~--------~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----VMSFIE----QGKR--------L 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHHH----CCCC--------C
Confidence 11223578999999988889999999999999999996 999987543211 111111 1110 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 512 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 512 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..+.....++.+++.+||..+|++||++.+|.+.|+..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12233456888899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=304.64 Aligned_cols=256 Identities=24% Similarity=0.391 Sum_probs=206.8
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
+..++|++.+.||+|+||.||+|...++..+|+|.+... ......+.+|++++++++|+|++++.+++.. ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 445788999999999999999999878888999988642 2345678999999999999999999998877 7789999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.... ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999997532 34578899999999999999999998 999999999999999999999999999986644
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
..........++..|+|||++....++.++|+||||+++|+++| |+.||....... ...... ....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~----~~~~---- 221 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALE----RGYR---- 221 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHh----CCCC----
Confidence 32222223345678999999988889999999999999999999 899987533211 111111 1100
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.........++.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01122344678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=305.98 Aligned_cols=255 Identities=24% Similarity=0.296 Sum_probs=201.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++.+++|||++++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 35789999999999999999996 478899999986432 2344568899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.++++. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999998874 34689999999999999999999999 9999999999999999999999999999866432
Q ss_pred CcceeecccccccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.. ......|+..|+|||.+. ...++.++|||||||++|||++|+.||......... .. ..... .
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~----~~-----~~~~~---~ 226 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL----FL-----MSKSN---F 226 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh----ee-----eecCC---C
Confidence 21 122345788999999874 345788999999999999999999998533211100 00 00000 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
..+.. .........+.+++.+||+.+|++||+++++++.|
T Consensus 227 ~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00111 11123446788999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=305.24 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=200.7
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|+..++||+|+||.||+|.. .++..||+|++...........+.+|++++.+++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999995 478899999986544445567789999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|..+. .+++.....++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999886432 367888999999999999999999 99999999999999999999999999997654321
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... ............. ...
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~------~~~ 219 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDED------PPV 219 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccC------CCC
Confidence 223468999999999998889999999999999999999999996532211110 0111111111000 000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
+ .......++.+++.+|++.+|++||+++|++++-
T Consensus 220 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 220 L--PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred C--CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0 0122345688999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.04 Aligned_cols=250 Identities=29% Similarity=0.403 Sum_probs=205.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
.++|+..+.||+|+||.||+|.. .|+.||+|.+..... ....+.+|+.+++.++|+|++++++++.+....++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 45788899999999999999997 478999999875432 567889999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.... ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999987532 23689999999999999999999999 99999999999999999999999999998764322
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
. ...++..|+|||++.+..++.++||||||+++|||++ |+.||....... +...... ...
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~----~~~------ 217 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPHVEK----GYR------ 217 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHhc----CCC------
Confidence 1 2234678999999988889999999999999999997 999986543211 1111111 100
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+...+..+.+++.+|+..+|++||++.|++++|+.
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 --MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 01122335678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=315.28 Aligned_cols=243 Identities=26% Similarity=0.350 Sum_probs=195.6
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
+.||+|+||+||+|+.. ++..||+|+++.. ........+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5789999998743 1233455677888888877 699999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
++|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 999988875 34689999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..... .. ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-----~~---~~i~~-~~---------~~ 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-----LF---QSILE-DE---------VR 214 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-----HH---HHHHc-CC---------CC
Confidence 233468999999999999999999999999999999999999997543211 11 11111 10 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPM-----AQVVKM 545 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 545 (595)
++......+.+++.+||+.||.+||++ .++++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 122344678899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=325.22 Aligned_cols=202 Identities=22% Similarity=0.239 Sum_probs=173.5
Q ss_pred CCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
+|+..++||+|+||+||+|+. .+++.||+|++.... .......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999996 468899999986421 23345678899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999875 24588899999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------cceeecccccccccCccccCCCCCCccchhHHH
Q 007625 429 L----------------------------------------------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGY 462 (595)
Q Consensus 429 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~Sl 462 (595)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000122468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCc
Q 007625 463 GITLLELVTGQRAIDFSR 480 (595)
Q Consensus 463 Gvvl~elltg~~p~~~~~ 480 (595)
||++|||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=315.89 Aligned_cols=241 Identities=25% Similarity=0.334 Sum_probs=191.9
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
++||+|+||.||+|+.+ +|+.||+|+++... .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999987432 123345566777777654 899999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++..... ...
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence 999988875 34688999999999999999999999 9999999999999999999999999998743221 122
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.+.+.. .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-----~~~~~~~----~~---------~~ 214 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-----LFESIRV----DT---------PH 214 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh----CC---------CC
Confidence 334568999999999999999999999999999999999999997543211 1111111 00 11
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPMA-QVV 543 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 543 (595)
.+.....++.+++.+|++.||++||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1222345678899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=309.31 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=203.3
Q ss_pred cCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
.+|...++||+|+||.||++... ++..+|+|.+... .......+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46777899999999999999732 3567999987643 3455678999999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPG-----------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 413 (595)
++|||+++++|.++++..... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 999999999999998754321 13588999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHH
Q 007625 414 AVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 491 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~ 491 (595)
++|+|||++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||....... ...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~ 235 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-----AIE 235 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-----HHH
Confidence 999999998765432211 1122335788999999998899999999999999999998 899886432211 111
Q ss_pred HHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 492 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
... ..... ..+...+..+.+++.+||+.||.+||++.||++.|+
T Consensus 236 ~~~---~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CIT---QGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHH---cCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111 11000 111223456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=318.22 Aligned_cols=265 Identities=27% Similarity=0.383 Sum_probs=209.2
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeC--------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCcccccee
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYC 337 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 337 (595)
++...+|.+.+.||+|+||.||+|... ++..||+|.++..........+.+|++++.++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 334457889999999999999999742 12368999887544455567899999999999 799999999999
Q ss_pred ecCCceEEEEEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCC
Q 007625 338 TTSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (595)
Q Consensus 338 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 405 (595)
...+..++++||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 999999999999999999999875321 124588999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhh
Q 007625 406 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE 483 (595)
Q Consensus 406 Ill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~ 483 (595)
|++++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 243 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE- 243 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999866432211 1122234568999999999899999999999999999998 88888654321
Q ss_pred hhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 007625 484 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL 551 (595)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 551 (595)
+.......... ...+.....++.+++.+|++.+|++||++.|+++.|+....
T Consensus 244 -------~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 244 -------ELFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred -------HHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11111111110 01122334578899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.77 Aligned_cols=251 Identities=31% Similarity=0.463 Sum_probs=205.6
Q ss_pred CeeeeccceEEEEEEeCC----CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
+.||+|+||.||+|.... +..|++|.++..........+.+|++.+..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999653 8889999997654444578899999999999999999999999999999999999999
Q ss_pred CcHhhhhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 353 LSVAYRLRDLKPG-----EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 353 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875322 36789999999999999999999999 999999999999999999999999999987654
Q ss_pred cCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 428 KLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 428 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
... .......++..|+|||.+....++.++||||+|+++|||++ |..||...... ...+... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~---~~------ 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-----EVLEYLR---KG------ 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHH---cC------
Confidence 321 12233457889999999988889999999999999999999 69998754321 1111111 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
.....+...+.++.+++.+|++.+|.+|||+.|+++.|+
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122334578889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=311.18 Aligned_cols=263 Identities=23% Similarity=0.341 Sum_probs=203.8
Q ss_pred CCCcCCeeeeccceEEEEEEe-----CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC--CceE
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERI 344 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 344 (595)
.|++.+.||+|+||.||.+.. .++..||+|.++..........+.+|+++++.++|||++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999984 357889999987544445567899999999999999999999998775 5678
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999998642 23589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCcc--eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhh-------hhhhhHHHHHHH
Q 007625 425 VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE-------EEDVLLLDHIRK 495 (595)
Q Consensus 425 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~-------~~~~~l~~~~~~ 495 (595)
....... ......++..|+|||++.+..++.++||||||+++|||+|++.|........ ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR- 237 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-
Confidence 6543221 1223446778999999988889999999999999999999876643211100 00000111111
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...... ....+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 238 ~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGK--------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCc--------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111110 0011223456899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=306.46 Aligned_cols=257 Identities=22% Similarity=0.370 Sum_probs=205.2
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCC----CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
..++|.+.+.||+|+||.||+|...+ ...||+|...........+.+.+|+.++++++|||++++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34568889999999999999998643 346899988755445566789999999999999999999998875 5578
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++++|.+++... ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 999999999999999753 23589999999999999999999998 999999999999999999999999999986
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
.............++..|+|||.+....++.++||||||+++||+++ |..||......+ ....+. .....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~~~---~~~~~- 227 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-----VIGRIE---NGERL- 227 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHH---cCCcC-
Confidence 65432222223335568999999988889999999999999999996 999997543221 111111 11111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..+...+..+.+++.+|+..+|.+|||+.++++.|+..
T Consensus 228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11223346788899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=305.02 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=197.0
Q ss_pred CeeeeccceEEEEEEeC-CCc--EEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
++||+|+||.||+|... ++. .+++|.++..........+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999975 343 46888887544455667889999999999 799999999999999999999999999
Q ss_pred CcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 353 LSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 353 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
++|.+++..... ....+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999875321 123588999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
++........ ......+..|+|||++....++.++||||||+++|||++ |..||....... ........
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQG 227 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--------HHHHHhCC
Confidence 9863321111 111223567999999988889999999999999999997 999986433211 11111111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 500 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
... ..+.....++.+++.+|++.+|.+|||+.|+++.|+.
T Consensus 228 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 228 YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 110 0112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=304.03 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=203.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
.+|+..+.||+|+||.||+|.+.++..+|+|.+.... .....|.+|+++++++.|||++++++++......++|+||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 4677889999999999999998778899999886422 23467899999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++|.+++... ...+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.++.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999988752 23578999999999999999999999 999999999999999999999999999886543322
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.......++.+|+|||++.+..++.++||||||+++|||++ |+.||....... ..+... ... ....
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~---~~~---~~~~-- 222 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----VVETIN---AGF---RLYK-- 222 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-----HHHHHh---CCC---CCCC--
Confidence 22222335678999999998889999999999999999998 899986433211 111111 100 0011
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 223 ----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 ----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1113467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.02 Aligned_cols=262 Identities=22% Similarity=0.339 Sum_probs=204.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|++.+.||+|+||.||++... ++..+|+|.++..........+.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999964 67889999887544444556788999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.. ...+++.....++.|++.||+|||+.+ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999975 245889999999999999999999732 89999999999999999999999999987553321
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc--------
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR-------- 501 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~-------- 501 (595)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||....... .............
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-----LEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-----HHHhhcCccccccccCCcccc
Confidence 233468899999999988889999999999999999999999986543211 1111100000000
Q ss_pred ----------------ccccccccCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 502 ----------------LNDIVDRNLNTY-DSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 502 ----------------~~~~~d~~l~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
...+.....+.. ......++.+++.+|++.+|++||+++||++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000000 112345688999999999999999999997654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.05 Aligned_cols=255 Identities=28% Similarity=0.363 Sum_probs=193.9
Q ss_pred CeeeeccceEEEEEEeCC---CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccC
Q 007625 277 NIIGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
+.||+|+||.||+|...+ +..+|+|.++..........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 45799998875544445567899999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 354 SVAYRLRDLKPG-EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 354 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
+|.++++..... ....++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999754321 23467788889999999999999999 99999999999999999999999999987543322211
Q ss_pred -eecccccccccCccccCCC-------CCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 433 -TTQIRGTMGHIAPEYLSTG-------KSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 433 -~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||........ . .. ..... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~----~-~~---~~~~~-~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV----L-TY---TVREQ-QL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH----H-HH---Hhhcc-cC
Confidence 1234577889999998642 35789999999999999996 9999975432211 0 11 01111 11
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
...++.+. ......+.+++..|+ .+|++|||++||++.|+
T Consensus 229 ~~~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLK---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccC---CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111 112345677888998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=309.38 Aligned_cols=263 Identities=25% Similarity=0.322 Sum_probs=194.3
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhc---CCCCCccccceeecC-----C
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA---IHKNLLQLIGYCTTS-----S 341 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 341 (595)
+|++.+.||+|+||+||+|+.. +++.||+|.++... .......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999965 68899999986432 222234556677776655 799999999987642 3
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 47899999985 8888876532 24589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.......... ........ .....
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~-~~~~~~~~-~~~~~ 230 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG-KIFDLIGL-PPEDD 230 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH-HHHHHhCC-CChhh
Confidence 98664322 1223457899999999998899999999999999999999999987543321111 01111000 00000
Q ss_pred cc-------cccccc----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 502 LN-------DIVDRN----LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 502 ~~-------~~~d~~----l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+. ..+.+. .....+.....+.+++.+|++.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000 00111234556789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=302.00 Aligned_cols=264 Identities=22% Similarity=0.352 Sum_probs=203.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEecc-CCCchhHHHHHHHHHHHHhcCCCCCccccceeec-----CC
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-----SS 341 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 341 (595)
....|...+.||+|+||.|..|.. .+|+.||+|++.+ .......+...+|+.+++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 344566678999999999999995 4789999999874 3444556778899999999999999999998865 34
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..|+|+|+|+ .+|...++. ++.++......+..|+++||.|+|+. +|+||||||+|++++.+..+||+|||+
T Consensus 100 DvYiV~elMe-tDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHHh-hHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 6899999994 478777775 45599999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcC-cceeecccccccccCccccC-CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 422 AKLVDAKL-THVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 422 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
|+...... ....+..+.|..|.|||++. ...|+.+.||||.|||+.||++|++-|.+.+.... ...+...+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q-----l~lI~~~lGt 246 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ-----LQLILELLGT 246 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH-----HHHHHHhcCC
Confidence 99875431 22235667899999999975 46799999999999999999999999987654221 1111111100
Q ss_pred -----------ccccccc-------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 -----------DRLNDIV-------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 -----------~~~~~~~-------d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.....+ ...+...-+......+++..+|+..||.+|+|++|.+++
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000 001111112445667888889999999999999999764
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=309.34 Aligned_cols=259 Identities=23% Similarity=0.358 Sum_probs=207.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||+||++... +++.||+|++...........+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 456788899999999999999964 6889999998754445556789999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.. ...+++.....++.+++.||.|||+.. +++|+||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999988875 345899999999999999999999732 7999999999999999999999999998754322
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhh---hhhhHHHHHHHHhcccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE---EDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~---~~~~l~~~~~~~~~~~~~~~~ 505 (595)
. .....|+..|+|||++.+..++.++|||||||++|+|+||+.||........ ......+.......+.
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 1 1234689999999999888899999999999999999999999985443211 1111222222222111
Q ss_pred ccccCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 506 VDRNLNTYD-SKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 506 ~d~~l~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
....+ .....++.+++.+|++.||++||++.||+++.
T Consensus 230 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 ----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111 12446788999999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.35 Aligned_cols=253 Identities=21% Similarity=0.214 Sum_probs=196.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
.+|++.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++.+++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999954 68999999986321 2234567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999875 34588899999999999999999999 999999999999999999999999999753210
Q ss_pred c------------------------------------------CcceeecccccccccCccccCCCCCCccchhHHHHHH
Q 007625 428 K------------------------------------------LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGIT 465 (595)
Q Consensus 428 ~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvv 465 (595)
. .........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 0000123469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC---CHHHH
Q 007625 466 LLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP---PMAQV 542 (595)
Q Consensus 466 l~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~ev 542 (595)
+|||++|+.||......+.. ..+... .. ....+. ......++.+++.+|+ .+|.+|+ ++.|+
T Consensus 234 lyell~G~~Pf~~~~~~~~~-----~~i~~~--~~---~~~~~~----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQ-----LKVINW--ET---TLHIPS----QAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eeehhhCCCCCCCCCHHHHH-----HHHhcc--Cc---cccCCC----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999999865432111 011000 00 000000 1112345556666665 4999999 88888
Q ss_pred HHH
Q 007625 543 VKM 545 (595)
Q Consensus 543 l~~ 545 (595)
+++
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=305.04 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=203.7
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CC---cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
.|++.+.||+|+||.||+|... ++ ..||+|.+...........|..|+.+++.++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4778899999999999999964 33 3699999876545556778999999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++... ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998753 24589999999999999999999999 999999999999999999999999999876543
Q ss_pred cCcce--eeccc--ccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 428 KLTHV--TTQIR--GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 428 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..... ..... .+..|+|||++.+..++.++||||||+++|||++ |..||...... ....++.. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~~~~~i~~---~~~~ 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVINAIEQ---DYRL 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----HHHHHHHc---CCcC
Confidence 22211 11111 2457999999998899999999999999999887 99998653321 12222211 1000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+...+..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 ---------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0112334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=316.37 Aligned_cols=239 Identities=26% Similarity=0.284 Sum_probs=189.5
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHH-HHHhcCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
+.||+|+||+||+|+.. +|+.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 78999999986421 1222344455544 56788999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999988875 34688999999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........ . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~-~---------~~ 214 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--------MYDNILNK-P---------LR 214 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH--------HHHHHHcC-C---------CC
Confidence 334568999999999999999999999999999999999999997543211 11111111 0 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPMAQ 541 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 541 (595)
..+.....+.+++.+|++.||.+||++.+
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 11223567888999999999999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=301.46 Aligned_cols=248 Identities=28% Similarity=0.463 Sum_probs=198.4
Q ss_pred CeeeeccceEEEEEEeC-C---CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-D---NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~---~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
++||+|+||.||+|.+. . +..+|+|.+...........+.+|+++++++.|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999853 2 26899999875544445678999999999999999999999876 4567999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
++|.+++... ..+++..+..++.|++.||+|||.. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999752 3689999999999999999999999 99999999999999999999999999998764433221
Q ss_pred e--ecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 433 T--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 433 ~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
. ....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+.. ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-----~~~~~~~~---~~~~------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-----EVIAMLES---GERL------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHHHc---CCcC-------
Confidence 1 11224568999999998899999999999999999998 99998653321 12222211 1100
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..+...+..+.+++.+|+..+|++||++.+|++.|+..
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11223346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.27 Aligned_cols=256 Identities=21% Similarity=0.251 Sum_probs=197.2
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+++.. +++.||+|++... ........+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999964 6899999998632 22334566889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998752 34588999999999999999999999 999999999999999999999999999876544
Q ss_pred cCcceeecccccccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+ ...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~ 226 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKEH 226 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCc
Confidence 33322233468999999999863 457889999999999999999999997543211 11111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQS--TPEDRPPMAQVVKM 545 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~evl~~ 545 (595)
.. +..........+.+++.+|+.. ++..||++.+++++
T Consensus 227 ~~-----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 FQ-----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cc-----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 1111112344566677776654 33447899888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=306.11 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=201.2
Q ss_pred cCCCcCCeeeeccceEEEEEEe-----CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC--Cce
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 343 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 343 (595)
.+|++.+.||+|+||+||+|.. .++..||+|++... .......+.+|++++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 4688899999999999999974 25789999998643 334567889999999999999999999987543 467
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++|+||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 8999999999999998753 23589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCccee--ecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhh-------hhhHHHHHH
Q 007625 424 LVDAKLTHVT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE-------DVLLLDHIR 494 (595)
Q Consensus 424 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~-------~~~l~~~~~ 494 (595)
.......... ....++..|+|||++.+..++.++||||||+++|||++|..++......... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 7644322111 1122345699999998888999999999999999999988765432211000 000000000
Q ss_pred HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...... .........+.++.+++.+||+.+|++|||+.||++.|+.+
T Consensus 237 ~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNN--------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcC--------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111000 00011223446788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=303.64 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=199.4
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchh-HHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGG-EAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
|+..+.||+|+||+||+++.. +++.||+|++........ .....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999975 567899999975432222 223456999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred ccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 99999999983 35689999999999999999999999 999999999999999999999999999976422 12
Q ss_pred ceeecccccccccCccccC-CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 431 HVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.......++..|+|||++. +...+.++||||+|+++|+|++|..||.......... ..............
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~-------- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE-IIEKILKRPLPSSS-------- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH-HHHHHHHTHHHHHT--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh-hhhhcccccccccc--------
Confidence 2334456899999999998 7889999999999999999999999998652111111 11111110000000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. ........+.+++.+|++.||++||++.++++
T Consensus 224 -~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 -Q-QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -T-SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -c-ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00011268899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.38 Aligned_cols=252 Identities=20% Similarity=0.295 Sum_probs=206.7
Q ss_pred CCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|+..++||+|+||.||.++. .++..+++|.+... .+......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999985 46889999998633 3445567889999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.... ...+++.++..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999987533 34689999999999999999999998 99999999999999999999999999998664433
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
. ......|++.|+|||+..+..++.++||||||+++|||++|+.||...... +........ .
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~-~-------- 217 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--------NLVVKIVQG-N-------- 217 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcC-C--------
Confidence 2 223455899999999998888999999999999999999999998753321 111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
..........++.+++.+|+..+|.+||+++|+++.+
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1111233456788899999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=319.21 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=197.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCC-----
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----- 341 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 341 (595)
..++|++.+.||+|+||.||+|... +|..||+|++... ........+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999964 6899999998643 23344567889999999999999999999886543
Q ss_pred -ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 342 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 342 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
..++||||+++ ++...+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999975 55555532 378889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhh------------
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL------------ 488 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~------------ 488 (595)
+++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+........
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99754332 1223356899999999999999999999999999999999999999765321110000
Q ss_pred --HHHHHHHHhccc-c-----cccccc----ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 489 --LLDHIRKLLRED-R-----LNDIVD----RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 489 --l~~~~~~~~~~~-~-----~~~~~d----~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+....... . ..+.+. +...........++.+++.+|++.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000011100000 0 000000 00000111234567899999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.76 Aligned_cols=244 Identities=23% Similarity=0.271 Sum_probs=192.0
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
+.||+|+||+||+|+.. +++.||+|+++... .......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 67899999997432 223456688899998888 699999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
++|...+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 999888764 34689999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+.......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~---------~~ 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM--NTEDYLFQVILEKP---------IR 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc--ccHHHHHHHHHhCC---------CC
Confidence 23456899999999999999999999999999999999999999643221110 11111111111110 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPM 539 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~ 539 (595)
.+......+.+++.+|++.||++|+++
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 122234567889999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=300.59 Aligned_cols=253 Identities=23% Similarity=0.242 Sum_probs=204.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCC-CcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.+.|+..+.||.|.-|+||++++++ +..+|+|++.+.. ........+.|-++|+.++||.++.+|+.+..+...++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3456668999999999999999764 5889999996432 233445677899999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
||||+||+|....+... .+.+++..++-++..++.||+|||-. |||+|||||+||||-++|++.|+||.++....
T Consensus 156 meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999888644 56799999999999999999999999 99999999999999999999999999864331
Q ss_pred C---------------------------------cCc----------------------ceeecccccccccCccccCCC
Q 007625 427 A---------------------------------KLT----------------------HVTTQIRGTMGHIAPEYLSTG 451 (595)
Q Consensus 427 ~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~ 451 (595)
. ... ..+...+||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 000 011224699999999999999
Q ss_pred CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC-CCHHHHHHHHHHHHHccc
Q 007625 452 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQ 530 (595)
Q Consensus 452 ~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~cl~ 530 (595)
..+.++|+|+|||++|||+.|..||.+....+.- ..++...+.- ..+..+....++|++.+.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl-----------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL-----------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH-----------------HHHhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 9999999999999999999999999987654321 1122221111 112556778899999999
Q ss_pred CCCCCCCC----HHHHHH
Q 007625 531 STPEDRPP----MAQVVK 544 (595)
Q Consensus 531 ~dP~~RPs----~~evl~ 544 (595)
+||.+|.. +.||-+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999998 666644
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.05 Aligned_cols=267 Identities=21% Similarity=0.274 Sum_probs=199.7
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|+..+.||+|+||.||+|+.. ++..||+|+++... .......+.+|+.++.+++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999964 68999999986432 233456788999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
++ ++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 588888765432 35689999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHH---HHhc-------
Q 007625 430 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR---KLLR------- 498 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~---~~~~------- 498 (595)
. ......+++.|+|||++.+. .++.++||||||+++|||+||+.||...............+.. ....
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1 12223468899999988654 4789999999999999999999999764432111100000000 0000
Q ss_pred -cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 499 -EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 499 -~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.....................++.+++.+|++.||.+|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000011123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=338.19 Aligned_cols=260 Identities=22% Similarity=0.319 Sum_probs=202.9
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.++||+|+||.||+|... +++.||+|+++... .+.....|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999964 68999999987432 2334567999999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 348 PFMQNLSVAYRLRDLKP-------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
||+++++|.+++..... .....++..+.+++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998874321 123467788899999999999999999 99999999999999999999999999
Q ss_pred ccccccCcCc-----------------ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhh
Q 007625 421 LAKLVDAKLT-----------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 483 (595)
Q Consensus 421 ~~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~ 483 (595)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 01122468999999999999999999999999999999999999997532211
Q ss_pred hhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhc
Q 007625 484 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-PMAQVVKMLQG 548 (595)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~ 548 (595)
. . .... . .++.-.......+..+.+++.+|++.||++|| +++++.+.|+.
T Consensus 239 i-----~--~~~~-----i---~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 I-----S--YRDV-----I---LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred h-----h--hhhh-----c---cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0 0000 0 00000000123345678899999999999995 56667666654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=294.72 Aligned_cols=254 Identities=22% Similarity=0.255 Sum_probs=207.9
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEec-cCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
..+.|++-++||+|.|+.||++.. .+|+.+|+|++. ...+....+.+.+|+.+-+.++||||+++...+......++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999884 579999999986 334455778899999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc---CCCcEEEeeccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAK 423 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~~~ 423 (595)
+|+|.|++|..-+-. ....++..+-..+.||+++|.|+|.+ +|||||+||+|+++. ...-+||+|||++.
T Consensus 89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999998876654 24578888899999999999999999 999999999999994 33469999999999
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
.+. .........|||+|||||++...+|+..+|||+.|||||-|+.|+.||.+.+.. .+.+.+... .
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----rlye~I~~g----~-- 228 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYEQIKAG----A-- 228 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----HHHHHHhcc----c--
Confidence 887 333445677999999999999999999999999999999999999999864332 122332211 0
Q ss_pred ccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 504 DIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 504 ~~~d~~l~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
.| .+. .++...++..+++++|+..||.+|.|+.|.+++-
T Consensus 229 --yd--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 229 --YD--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred --cC--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 11 111 3344556778888999999999999999997653
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=305.24 Aligned_cols=255 Identities=23% Similarity=0.396 Sum_probs=204.2
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|++.+.||+|+||.||+|... ++..||+|.++..........+.+|++++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999975 78999999987544445567889999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|..++.... ....+++..+..++.|++.||.|||+.+ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999988887532 1346899999999999999999999632 89999999999999999999999999987653322
Q ss_pred cceeecccccccccCccccCCCC------CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
.....++..|+|||++.+.. ++.++|||||||++|||++|+.||....... .......
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~-------- 221 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-----IFAQLSA-------- 221 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-----HHHHHHH--------
Confidence 22334788999999985443 4889999999999999999999996432211 1111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.+......+.....++.+++.+|++.+|++||++.+++..
T Consensus 222 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 222 -IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -HhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111122334466788899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.70 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=196.9
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
|+..+.||+|+||+||+|... +++.||+|.+.... .......+.+|+++++.++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667889999999999999964 68899999986422 222345678899999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998886532 34699999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||......... ..+........
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-----~~~~~~~~~~~-------- 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-----EEVDRRVLETE-------- 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHHhhhccc--------
Confidence 123346899999999999888999999999999999999999999754321111 11111111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMA 540 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 540 (595)
..+......++.+++..|++.||++||++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred -cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 011223345678899999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=302.66 Aligned_cols=255 Identities=26% Similarity=0.367 Sum_probs=192.0
Q ss_pred CeeeeccceEEEEEEeCC---CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccC
Q 007625 277 NIIGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
+.||+|+||.||+|...+ ...+|+|.+...........|.+|+..++.++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997533 45688888765444455677889999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc-
Q 007625 354 SVAYRLRDLKPG-EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH- 431 (595)
Q Consensus 354 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~- 431 (595)
+|.+++...... ....++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999764322 23356788899999999999999999 9999999999999999999999999998754332111
Q ss_pred eeecccccccccCccccCC-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 432 VTTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
......++..|+|||++.. ..++.++|||||||++|||++ |..||......+ . ......... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~----~~~~~~~~~-~ 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----V----LKQVVREQD-I 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----H----HHHHhhccC-c
Confidence 1222345678999998742 456889999999999999999 778876432211 1 111111111 1
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
.+.++. ........+.+++..|+ .||++||+++||++.|.
T Consensus 229 ~~~~~~---~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQ---LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCc---ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 12234456667788888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=299.13 Aligned_cols=249 Identities=29% Similarity=0.381 Sum_probs=200.1
Q ss_pred CeeeeccceEEEEEEeCC--C--cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLSD--N--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
++||+|++|.||+|.+.+ + ..||+|.+.........+.+.+|+..+++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 36999998754433566789999999999999999999999988 888999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
++|.+++..... ..+++...+.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999986432 4689999999999999999999999 99999999999999999999999999998765432221
Q ss_pred --eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 433 --TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 433 --~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ....... ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~---~~~-------- 218 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-----ILKKIDK---EGE-------- 218 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHh---cCC--------
Confidence 122456789999999998899999999999999999999 999986433211 1111111 000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
....+...+..+.+++.+|++.+|++||++.||++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00112233467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=298.16 Aligned_cols=248 Identities=29% Similarity=0.451 Sum_probs=200.6
Q ss_pred CeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcHh
Q 007625 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVA 356 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 356 (595)
++||+|+||.||+|...+++.||+|.+...........+.+|+++++++.|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999987799999999875444445678999999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCccee-ec
Q 007625 357 YRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT-TQ 435 (595)
Q Consensus 357 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~-~~ 435 (595)
+++... ...+++.....++.+++.|++|||++ +++||||||+||+++.++.++|+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998753 23578999999999999999999999 999999999999999999999999999986543221111 12
Q ss_pred ccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCC
Q 007625 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD 514 (595)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 514 (595)
..++..|+|||++.+..++.++||||||+++|||+| |..||....... ....+.. ... ...+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----~~~~~~~---~~~---------~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TRERIES---GYR---------MPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----HHHHHhc---CCC---------CCCC
Confidence 234667999999988889999999999999999999 788886433211 1111110 000 0112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 515 SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 515 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
...+.++.+++.+|+..+|.+||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=314.58 Aligned_cols=243 Identities=24% Similarity=0.308 Sum_probs=194.3
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 347 (595)
+|+..+.||+|+||+||+|... +++.||+|++.... .......+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999964 68899999987421 2334456778888888875 567888999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999988875 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+. . ..
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-----~~~~i~---~-~~------ 217 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-----LFQSIM---E-HN------ 217 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHH---h-CC------
Confidence 21 12234568999999999998889999999999999999999999997543211 111111 1 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 540 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 540 (595)
..++.....++.+++.+|++.+|.+|++..
T Consensus 218 ---~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 ---VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ---CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 011223345778899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.46 Aligned_cols=252 Identities=28% Similarity=0.448 Sum_probs=200.0
Q ss_pred CeeeeccceEEEEEEeCC-------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 277 NIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+.||+|+||.||+|+..+ +..+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998642 2579999886544445567889999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC-----cEEEeeccc
Q 007625 350 MQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-----EAVLCDFGL 421 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfG~ 421 (595)
+++++|.+++..... ....+++.++..++.|++.||+|||+. +++|+||||+||+++.+. .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 124578999999999999999999998 999999999999999877 899999999
Q ss_pred cccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 422 AKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 422 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
++........ ......++..|+|||++.+..++.++||||||+++|||+| |+.||....... ....+. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~---~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-----VLQHVT---AG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-----HHHHHh---cC
Confidence 8765432211 1122345688999999999999999999999999999998 999986433211 111111 11
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 500 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.. ...+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 230 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 GR---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred Cc---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 11123345678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.90 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=204.7
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|+..+.||.|+||.||+|... +++.||+|.+...........+.+|+++++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999965 68899999987544445567789999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.. ..+++.....++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999875 2689999999999999999999999 99999999999999999999999999998775432
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
. ......+++.|+|||++.+..++.++||||||+++|||+||+.||....... ....+. ......
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~~~~~----~~~~~~----- 217 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFLIP----KNNPPS----- 217 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HHHHhh----hcCCCC-----
Confidence 2 2223457889999999998889999999999999999999999996433210 111111 111111
Q ss_pred CCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 510 LNTYDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 510 l~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.... ....+.+++.+|+..+|++||++++++++
T Consensus 218 ---~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 ---LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ---CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 44578889999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=316.55 Aligned_cols=246 Identities=26% Similarity=0.284 Sum_probs=192.2
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHH-HHHHhcCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREV-HLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
+.||+|+||+||+|+.. +++.||+|++.... .......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 67889999986421 112233444444 456788999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
++|.+.+.. ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 999998875 34578888999999999999999999 99999999999999999999999999987543221 12
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+. .. .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~---~~-~~---------~ 214 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDNIL---NK-PL---------Q 214 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HHHHHH---hC-Cc---------C
Confidence 334569999999999999999999999999999999999999997543221 111111 10 00 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+.....+.+++.+|++.||.+||++.+.+..+.+
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 122334567888899999999999998865554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.32 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=199.7
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
|+..+.||+|+||+||++... +++.||+|.+.... .......+..|+.++++++|++++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677899999999999999964 68899999986432 222345677899999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.... ...+++.++..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999886432 34589999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
. .....|+..|+|||++.+..++.++||||||+++|||++|+.||.......... ........ ..
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-~~~~~~~~-~~----------- 221 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE-VQ----------- 221 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-HHHhhhhh-hh-----------
Confidence 1 123468999999999999999999999999999999999999997533211000 01010000 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM 545 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 545 (595)
..++.....++.+++.+|++.||++||| ++|++++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 -EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0112223456788999999999999999 7888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=300.36 Aligned_cols=255 Identities=21% Similarity=0.336 Sum_probs=191.3
Q ss_pred CeeeeccceEEEEEEeCCC---cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccC
Q 007625 277 NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
+.||+|+||+||+|...++ ..+++|.+...........|.+|+.+++.++|||++++++++......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3589999999999985433 3466776654444455678999999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC-cce
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL-THV 432 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~-~~~ 432 (595)
+|.++++.........++...+.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999986433334567788889999999999999998 99999999999999999999999999986432211 112
Q ss_pred eecccccccccCccccCC-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 433 TTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+ .+....... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~~~~~~~~-~~~ 228 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--------VLNHVIKDQ-QVK 228 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHhhc-ccc
Confidence 233457889999999743 245789999999999999997 466775432211 111111111 112
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
..++.+.. .....+.+++..|| .+|++||+++||++.|.
T Consensus 229 ~~~~~~~~---~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLEL---PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCC---CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222221 23356677888899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=298.99 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=202.2
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC-CceEEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-SERILVYP 348 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 348 (595)
+|++.+.||+|++|.||++... +++.||+|.+... ......+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999964 5788999998643 2334456788999999999999999999887644 45789999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997532 34589999999999999999999999 9999999999999999999999999999866432
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.. ......+++.|+|||++.+..++.++||||||+++|||++|+.||....... ....... +.
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--------~~~~~~~-~~------- 218 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS--------LVYRIIE-GK------- 218 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHh-cC-------
Confidence 22 2233457899999999999889999999999999999999999987543211 1111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+...+......+.+++.+|++.+|++||++.+++++
T Consensus 219 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 -LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111233455678899999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.10 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=206.1
Q ss_pred CCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeec--CCceEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILVY 347 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 347 (595)
+|++.+.||.|+||.||+|.. .++..||+|++... ........+..|++++++++|||++++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999985 47889999998643 344456778899999999999999999998764 34578999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH-----EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
||+++++|.+++.........+++..++.++.|++.||+||| +. +++|+||||+||++++++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999865544567999999999999999999999 66 9999999999999999999999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
......... .....++..|+|||++.+..++.++|+||||+++|+|++|+.||....... ..+.+. .
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~----~--- 224 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-----LASKIK----E--- 224 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-----HHHHHh----c---
Confidence 876543321 223458999999999998889999999999999999999999997644211 111111 1
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
......+......+.+++.+|++.+|++||++.||+++
T Consensus 225 -----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 -----GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11122334556788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=317.65 Aligned_cols=265 Identities=20% Similarity=0.280 Sum_probs=198.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCC-----
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----- 341 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 341 (595)
..++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999854 68899999987432 3344567788999999999999999999886432
Q ss_pred -ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 342 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 342 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 46899999975 56555542 478889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHH----------
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL---------- 490 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~---------- 490 (595)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998654321 22335689999999999998999999999999999999999999976543211110000
Q ss_pred ----HHHHHHhcc-cccccc-----ccccC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 491 ----DHIRKLLRE-DRLNDI-----VDRNL----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 491 ----~~~~~~~~~-~~~~~~-----~d~~l----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..+...... .....+ ..... .........++.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000111000 000000 00000 00112234577899999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=301.73 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=203.9
Q ss_pred CCCcCCeeeeccceEEEEEEeCC--CcEEEEEEeccC---------CCchhHHHHHHHHHHHHh-cCCCCCccccceeec
Q 007625 272 NFSESNIIGQGGFGKVYKGVLSD--NTKVAVKRLQDY---------YSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTT 339 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l~~~---------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 339 (595)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ........+..|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999754 688999987522 122334567778888765 799999999999999
Q ss_pred CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
.+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+.. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988754444567899999999999999999999631 7999999999999999999999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
|.+....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ...... .
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--------~~~~~~-~ 227 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--------LATKIV-E 227 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--------HHHHHh-h
Confidence 9998765432 2334568899999999998889999999999999999999999986433211 111111 1
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 500 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
....... .......+.+++.+|++.||++||++.||..++++
T Consensus 228 ~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYEPLP-------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCCcCC-------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1111000 11234578889999999999999999999998853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.73 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=205.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
++|+..+.||+|+||.||+|+.+ +.+.|++|.+...........+.+|++++++++|+|++++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999953 346799998865433335678999999999999999999999999989999
Q ss_pred EEEEecccCcHhhhhcccCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGE-----KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
+||||+++++|.+++....... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997543221 2689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
|++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||...... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----~~~~~~~---- 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----EVLNRLQ---- 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----HHHHHHH----
Confidence 9987543332222333456788999999988888999999999999999999 77888532211 1111111
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
....... .+...+..+.+++.+|++.+|.+||++.|+++.|+
T Consensus 233 ~~~~~~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 AGKLELP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCcCCC-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111100 11223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=299.72 Aligned_cols=250 Identities=28% Similarity=0.398 Sum_probs=193.1
Q ss_pred CeeeeccceEEEEEEeC----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec-CCceEEEEEecc
Q 007625 277 NIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILVYPFMQ 351 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 351 (595)
+.||+|+||.||+|... +...||+|++...........+.+|+.+++.++|||++++++++.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998644444556788899999999999999999997754 556789999999
Q ss_pred cCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc
Q 007625 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (595)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 431 (595)
+++|.+++.... ...++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999987532 3467788899999999999999998 9999999999999999999999999999765432111
Q ss_pred ---eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhC-CCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 432 ---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 432 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg-~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
......++..|+|||++.+..++.++||||||+++|||++| ..||...... ...... .....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-----~~~~~~---~~~~~------ 220 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-----DITVYL---LQGRR------ 220 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHH---hcCCC------
Confidence 11223457789999999888899999999999999999995 4555432211 111111 11110
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+...+..+.+++.+||+.+|++||++.||++.|+..
T Consensus 221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001112245788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=303.65 Aligned_cols=263 Identities=24% Similarity=0.298 Sum_probs=206.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC--CceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 347 (595)
++|+..+.||.|++|.||+|... +++.+|+|++...........+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999974 68899999987544445567889999999999999999999988654 3679999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.........+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988775444455689999999999999999999999 999999999999999999999999999875543
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...............+.... ....+.+
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 230 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELKD 230 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhhcc
Confidence 221 234478899999999988999999999999999999999999986532111111222222211 0011110
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
. . .........+.+++.+|++.+|.+|||+.||++.
T Consensus 231 ~-~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 231 E-P-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred C-C-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 0 0011235678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.64 Aligned_cols=265 Identities=19% Similarity=0.267 Sum_probs=198.1
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC------
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------ 340 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 340 (595)
..++|+..+.||+|+||.||+|... .++.||||++... ........+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4568999999999999999999964 6889999998743 2334456788999999999999999999987543
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
...++||||+++ ++...+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 346899999975 66666542 378889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHH----------
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL---------- 490 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~---------- 490 (595)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||............+.
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 998654322 22334689999999999999999999999999999999999999976543221111000
Q ss_pred H----HHHHHhccc-c-----ccccccccC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 491 D----HIRKLLRED-R-----LNDIVDRNL----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 491 ~----~~~~~~~~~-~-----~~~~~d~~l----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
. .+....... . ....+.... .........++.+++.+|++.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000000000 0 000000000 00111123567899999999999999999999664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.12 Aligned_cols=263 Identities=25% Similarity=0.344 Sum_probs=201.5
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|+..+.||+|+||.||+|+.+ +++.||+|.++..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999965 68899999987443344455678899999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5888887653 34588999999999999999999999 99999999999999999999999999997654322
Q ss_pred cceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc---ccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---EDRLNDI 505 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~~ 505 (595)
.. .....+++.|+|||++.+ ..++.++|||||||++|||+||+.||......+. ...+..... ...+..+
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-----LHFIFRILGTPTEETWPGI 232 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHcCCCChhhchhh
Confidence 11 223346889999999865 4578899999999999999999999976543211 111111100 0111111
Q ss_pred ccc------cCCC--------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 506 VDR------NLNT--------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 506 ~d~------~l~~--------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
.+. ..+. ........+.+++.+|++.||.+|||++|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 100 0010 1112345678899999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.70 Aligned_cols=253 Identities=23% Similarity=0.269 Sum_probs=213.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCC--chhHHHHHHHHHHHHhcC-CCCCccccceeecCCceE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 344 (595)
..+.|++.+.||+|.||.||+++.+ +|+.+|+|++..... ......+.+|+.+|+++. ||||+.+.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4457888999999999999999976 599999999975432 234578899999999998 999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC----CcEEEeecc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLCDFG 420 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG 420 (595)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.++++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999874 389999999999999999999998 99999999999999643 579999999
Q ss_pred ccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
++..... .......+||+.|+|||++....|+..+||||+||++|.|+.|..||.......... .... +
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~i~~-~ 253 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------AILR-G 253 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------HHHc-C
Confidence 9998876 445667889999999999999999999999999999999999999998755322111 1111 1
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.+ ++.+ ...+.......+++..|+..||.+|+|+.+++++
T Consensus 254 ~~-~f~~----~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 DF-DFTS----EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC-CCCC----CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11 1111 1345557788899999999999999999999986
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.33 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=202.2
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
.|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566788999999999999864 678899999875444455678899999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988863 3588999999999999999999998 999999999999999999999999999986643321
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
......|+..|+|||++.+..++.++||||||+++|||+||+.|+....... .... .... ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~----~~~~--------~~ 218 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----VLFL----IPKN--------SP 218 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----HHhh----hhcC--------CC
Confidence 1223457889999999998889999999999999999999999986432111 0001 0011 01
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..........+.+++.+|++.+|++||++.+|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11223345678899999999999999999999885
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.70 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=201.5
Q ss_pred CCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCC-----chhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
+|...+.||+|+||+||+|...+++.+|+|.+..... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999998863221 22345688999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999875 24578999999999999999999998 99999999999999999999999999987653
Q ss_pred CcC-----cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 427 AKL-----THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 427 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
... ........|+..|+|||++.+..++.++||||||+++|||++|+.||........ . ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------~-~~~~~~~~ 225 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-------M-FYIGAHRG 225 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-------H-HHhhhccC
Confidence 211 1112234588999999999988899999999999999999999999974332110 0 00000000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.....+.....++.+++.+|++.+|.+||++.|+++
T Consensus 226 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011122234567888999999999999999999965
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=313.66 Aligned_cols=238 Identities=25% Similarity=0.290 Sum_probs=188.7
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHH-HHHhcCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
++||+|+||.||+|+.. +++.||+|++.... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 68899999986421 1223344555554 57889999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
++|...+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999888864 34588899999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...... .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~---~~~i~~-~~---------~~ 214 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-----M---YDNILH-KP---------LQ 214 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-----H---HHHHhc-CC---------CC
Confidence 234568999999999998889999999999999999999999997543211 1 111111 10 11
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPMA 540 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 540 (595)
.+......+.+++.+|++.||.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2233456788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=316.63 Aligned_cols=245 Identities=27% Similarity=0.305 Sum_probs=192.8
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHH-HHHhcCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
+.||+|+||+||+|+.. +|+.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999964 78999999986421 2233345555654 46778999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 999888864 34689999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~~~~~~-~---------~ 214 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--------MYDNILHKP-L---------V 214 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--------HHHHHHcCC-c---------c
Confidence 234568999999999999999999999999999999999999997543211 111111110 0 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
..+.....+.+++.+|++.+|.+||++.+.++.+.
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 11223456778899999999999999875554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=301.41 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=206.5
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|+..+.||+|+||.||+|..+ +++.||+|++...........+.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778899999999999999975 68999999987654455667889999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
+++++|.+++.... ..+++.....++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999988632 568899999999999999999999 7 9999999999999999999999999998765432
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
... ...++..|+|||++.+..++.++||||||+++|+|++|+.||......... ..+.+......
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~--------- 219 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG---IFELLQYIVNE--------- 219 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc---HHHHHHHHhcC---------
Confidence 221 155888999999999889999999999999999999999998754221111 11222221111
Q ss_pred cCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 509 NLNTYDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 509 ~l~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.....+.. ...++.+++.+|+..+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11111222 55678899999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=299.64 Aligned_cols=249 Identities=26% Similarity=0.354 Sum_probs=200.5
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceee-cCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT-TSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e 348 (595)
.++|.+.+.||+|+||.||++.. .|..||+|.++.. ...+.+.+|+.++++++|+|++++++++. ..+..++|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 34788899999999999999987 5788999988642 23567899999999999999999999764 4566899999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999987532 24588999999999999999999999 9999999999999999999999999998755332
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
. ....++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....+. .+...
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-----~~~~~~----~~~~~---- 218 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVE----KGYKM---- 218 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHh----cCCCC----
Confidence 1 12234678999999988889999999999999999998 999986433211 111111 11000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+...+..+.+++.+|++.+|++|||+.++++.|++
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 ----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1122345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=302.66 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=204.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCc----EEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
.++|+..+.||+|+||.||+|..+ +|. .||+|.+...........+.+|+.++++++|||++++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356788999999999999999964 333 5899988755545556788999999999999999999999987 7889
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+|+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999998753 23589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCcCccee-ecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 425 VDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 425 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
......... ....++..|+|||.+....++.++|+||||+++||+++ |+.||......+ +...+. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~---~~~~- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----IPDLLE---KGER- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHh---CCCC-
Confidence 653322211 11224568999999988889999999999999999999 999987543211 111111 1100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+......+.+++.+||..+|.+||++.++++.|+..
T Consensus 230 --------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 --------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011122335688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=298.54 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=204.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCC-CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|+..+.||+|+||.||+|...+ +..|++|.+.... ....+.+|++++++++|||++++++++......++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 3678899999999999999999764 7899999986432 26789999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999998642 35689999999999999999999999 9999999999999999999999999998876543
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.||........ .... .... .
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~~~-~~~~------~ 216 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IFMI-PNKP------P 216 (256)
T ss_pred cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hhhh-ccCC------C
Confidence 21 22234478899999999888999999999999999999999999875332110 0000 0000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.....+.....++.+++.+|++.+|++||+++||++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000112334567889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=300.85 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=200.4
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCc--------hhHHHHHHHHHHHHhcCCCCCccccceeecCCc
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP--------GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 342 (595)
+|.+...||+|+||.||+|... +++.||+|.+...... .....+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999864 6889999988643211 123568899999999999999999999999999
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999975 24588899999999999999999998 9999999999999999999999999999
Q ss_pred ccccCcCcc-----eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHh
Q 007625 423 KLVDAKLTH-----VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 497 (595)
Q Consensus 423 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 497 (595)
+........ ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--------AIFKIG 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--------HHHHHh
Confidence 876532111 1122457889999999998889999999999999999999999997532110 111100
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 498 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. ......+......+.+++.+||+.||.+||++.||++
T Consensus 226 ~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E---------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c---------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 0011122334567888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=299.71 Aligned_cols=240 Identities=23% Similarity=0.355 Sum_probs=187.9
Q ss_pred CeeeeccceEEEEEEeCC-------------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 277 NIIGQGGFGKVYKGVLSD-------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
+.||+|+||.||+|.+.+ ...|++|.+... .......|.+|+.++..++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999998532 225888887542 233456788899999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc-------EEE
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-------AVL 416 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl 416 (595)
++||||+++++|..++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998887642 24589999999999999999999999 9999999999999987654 899
Q ss_pred eeccccccccCcCcceeecccccccccCccccC-CCCCCccchhHHHHHHHHHHH-hCCCCCCCCchhhhhhhhHHHHHH
Q 007625 417 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELV-TGQRAIDFSRLEEEEDVLLLDHIR 494 (595)
Q Consensus 417 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~ell-tg~~p~~~~~~~~~~~~~l~~~~~ 494 (595)
+|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..|+......+. ....
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~ 222 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------ERFY 222 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH------HHHH
Confidence 999998754321 2234788999999986 466899999999999999998 58888764322110 0000
Q ss_pred HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
.... . .......++.+++.+||+.||++||++.+|++.++
T Consensus 223 ----~~~~-~--------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 ----EGQC-M--------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ----hcCc-c--------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000 0 01112356889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=309.15 Aligned_cols=197 Identities=24% Similarity=0.370 Sum_probs=160.6
Q ss_pred CCeeeeccceEEEEEEeC---CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec--CCceEEEEEec
Q 007625 276 SNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILVYPFM 350 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 350 (595)
+++||+|+||+||+|+.. +++.||+|.+... .....+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 578999999999999964 4678999998642 223456789999999999999999998854 34578999998
Q ss_pred ccCcHhhhhcccCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE----cCCCcEEEeeccc
Q 007625 351 QNLSVAYRLRDLKP-----GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGL 421 (595)
Q Consensus 351 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~ 421 (595)
.+ +|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 64 77777653211 123589999999999999999999999 99999999999999 4567899999999
Q ss_pred cccccCcCcc--eeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 007625 422 AKLVDAKLTH--VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (595)
Q Consensus 422 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~ 479 (595)
++........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9876543221 22345689999999998764 5899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=320.22 Aligned_cols=262 Identities=21% Similarity=0.230 Sum_probs=195.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
..+|.+.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++|+||+++++++...+..++||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457999999999999999999965 57889999642 2345689999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
++. ++|..++... ...+++.+++.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++.....
T Consensus 241 ~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 6888877642 23689999999999999999999999 9999999999999999999999999999866432
Q ss_pred Ccc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhh---hhhhhHHHHHHHHhc-ccccc
Q 007625 429 LTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE---EEDVLLLDHIRKLLR-EDRLN 503 (595)
Q Consensus 429 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~---~~~~~l~~~~~~~~~-~~~~~ 503 (595)
... ......||..|+|||++.+..++.++|||||||++|||++|..|+....... .....+...+..... .....
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 221 2234569999999999999999999999999999999999886653221110 001111111111000 00000
Q ss_pred ccc---------c----ccCCC----CC---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 504 DIV---------D----RNLNT----YD---SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 504 ~~~---------d----~~l~~----~~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... . ..... .. .....++.+++.+|++.||.+|||+.|++++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 0 00000 00 0123467889999999999999999999765
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.43 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=198.5
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecC------
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS------ 340 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 340 (595)
+.+.|+..+.||+|+||.||+|... +++.||+|++... ......+..|+.++.++ +|+|++++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 5677888999999999999999964 6889999998642 23456788999999998 699999999998653
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
...++||||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 35789999999999999988532 34689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcCcceeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||....... ....
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~- 227 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFL- 227 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHH-
Confidence 9986543222 223356889999999986 3457889999999999999999999986432211 0110
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
... ... ... .....+.++.+++.+||..+|.+|||+.|+++
T Consensus 228 ~~~-~~~-----~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 IPR-NPA-----PRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred Hhc-CCC-----CCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 000 000 11223457889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.20 Aligned_cols=256 Identities=20% Similarity=0.248 Sum_probs=197.6
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+++.+ +++.||+|++... ........+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999965 5788999998632 12233456888999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999753 24589999999999999999999999 999999999999999999999999999876543
Q ss_pred cCcceeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKER 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCcc
Confidence 3333333456999999999986 3457899999999999999999999997543211 11111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPE--DRPPMAQVVKM 545 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~--~RPs~~evl~~ 545 (595)
. ..+........++.+++.+|+..++. .|+++.|++++
T Consensus 227 ~-----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 F-----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c-----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 01111122345667777787755443 46889888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.52 Aligned_cols=262 Identities=19% Similarity=0.237 Sum_probs=195.0
Q ss_pred cCCeeeec--cceEEEEEEe-CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 275 ESNIIGQG--GFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 275 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
+.++||+| +|++||++.. .+|+.||+|++.... .......+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6899999986 478999999987432 2334567788999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999986532 23589999999999999999999999 999999999999999999999999986543321111
Q ss_pred c------eeecccccccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc----
Q 007625 431 H------VTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---- 498 (595)
Q Consensus 431 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---- 498 (595)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~ 232 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM----LLEKLNGTVPCLLD 232 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH----HHHHhcCCcccccc
Confidence 0 0112346778999999875 4589999999999999999999999975332111 0000000000
Q ss_pred -----cccc-----cccccc------------------cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 499 -----EDRL-----NDIVDR------------------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 499 -----~~~~-----~~~~d~------------------~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.+.. ....+. ............+.+++.+|++.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 000000 0001122345678899999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=315.27 Aligned_cols=256 Identities=21% Similarity=0.250 Sum_probs=198.5
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+++.. +++.||+|++... ........+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57899999999999999999965 6788999998642 22233456888999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999753 24588999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~ 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHEER 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH--------HHHHHHcCCCc
Confidence 33333334569999999999865 467889999999999999999999997543211 11111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM 545 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 545 (595)
..++........++.+++.+|+..++.+ |+++++++++
T Consensus 227 -----~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 -----FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -----ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0011111223456777888888765543 4677777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.92 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=195.8
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecC-----
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS----- 340 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 340 (595)
...++|+..+.||+|+||+||+|.. .+++.||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3567899999999999999999995 478899999986432 223345677899999999999999999887543
Q ss_pred -CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 341 -SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 341 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
...+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468899987 6788877653 4589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.. +.....
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~-~~~~~~ 233 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ----LKR-IMEVVG 233 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH----HHH-HHHHhC
Confidence 999865432 223458999999999876 5689999999999999999999999975432111 111 100000
Q ss_pred c-----------ccccccccccCCCCC--------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 499 E-----------DRLNDIVDRNLNTYD--------SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 499 ~-----------~~~~~~~d~~l~~~~--------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
. ....... ..+...+ ......+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 234 TPSPEVLKKISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCCHHHHHhcchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000 0000001 1122356789999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=286.11 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=203.1
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC----Cch---hHHHHHHHHHHHHhc-CCCCCccccceeec
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY----SPG---GEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~----~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 339 (595)
....|...+.||+|..++|.++.. .+|..+|+|++.... ++. -...-.+|+.+|+++ .||+|+++.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345677788999999999998885 478999999986322 111 123456789999998 59999999999999
Q ss_pred CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
+...++|+|.|+.|.|.++|.. ...+++....+|+.|+..|++|||.. .||||||||+|||++++.+++|+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 9999999999999999999986 45699999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcceeecccccccccCccccC------CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLS------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~ 493 (595)
|++..+.... .-...+|||+|+|||.+. ...|+..+|+|+.||++|-|+.|.+||..... ......
T Consensus 168 GFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----mlMLR~- 239 (411)
T KOG0599|consen 168 GFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----MLMLRM- 239 (411)
T ss_pred ceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----HHHHHH-
Confidence 9999876543 335678999999999984 23578899999999999999999999974221 111111
Q ss_pred HHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 494 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+.++...- -. .-+.+...+..+++.+|++.||.+|.|++|+++
T Consensus 240 ---ImeGkyqF-~s----peWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 ---IMEGKYQF-RS----PEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ---HHhccccc-CC----cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11221110 00 123455667889999999999999999999965
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.19 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=204.2
Q ss_pred HHHHHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceee--
Q 007625 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT-- 338 (595)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 338 (595)
++.+..+.++|++.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.++..+ +|||++++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 4555667889999999999999999999964 6889999987542 22345678899999999 6999999999874
Q ss_pred ---cCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEE
Q 007625 339 ---TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 339 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 415 (595)
.++..++||||+++++|.++++........+++..+..++.|++.||.|||+. +++||||||+||++++++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 34568999999999999998875443345689999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCcCcceeecccccccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHH
Q 007625 416 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 490 (595)
Q Consensus 416 l~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~ 490 (595)
|+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||........
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------ 237 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------ 237 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------
Confidence 999999886643221 1223458999999999753 4478899999999999999999999875332110
Q ss_pred HHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 491 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 491 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
...... .......+ +.....++.+++.+|++.||++||++.||++.+
T Consensus 238 --~~~~~~-~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 --LFKIPR-NPPPTLHQ------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --Hhhccc-cCCCcccC------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000000 00001111 112335688999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=304.85 Aligned_cols=250 Identities=20% Similarity=0.285 Sum_probs=202.7
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
.+|+..+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.+.|+|++++++++......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4788899999999999999995 4688999999864332 3456788999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.. ..+++.+...++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998864 3478999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.. .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ..... ..... ..
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~~----~~~~~-~~----- 235 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLI----ATNGT-PE----- 235 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHHH----hcCCC-CC-----
Confidence 11 223458899999999988889999999999999999999999997543211 01111 11100 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...+......+.+++.+|+..+|++||++.||++.
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 01123345678889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=299.73 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=201.2
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
++.+++++.....||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|+||+++++++..++..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3456677777789999999999999954 67889999886432 344567899999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-CCcEEEeeccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGL--DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGL 421 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~ 421 (595)
+|+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||.
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 9999999999999997532 234 7888899999999999999998 9999999999999976 67999999999
Q ss_pred cccccCcCcceeecccccccccCccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
+........ ......|+..|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..+....
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~~~--- 226 (268)
T cd06624 156 SKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKVGM--- 226 (268)
T ss_pred heecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhhhh---
Confidence 876543221 122335789999999986543 78899999999999999999999864221110 0000000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.......+.....++.+++.+||+.+|.+|||+.|++++
T Consensus 227 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 227 -------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 001111233445678899999999999999999999764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=300.93 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=206.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
..|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.+.|||++++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999965 68899999987544445567899999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.. ..+++.+...++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998864 3578899999999999999999999 99999999999999999999999999997664332
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
. ......++..|+|||++.+..++.++|+||||+++|||+||..||....... .... .... .
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~----~~~~--------~ 217 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VLFL----IPKN--------N 217 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hhhh----hhcC--------C
Confidence 1 1223457889999999988889999999999999999999999987433211 0000 0000 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
........+..+.+++.+||+.+|++||++.++++.-
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 1223445677889999999999999999999997763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.88 Aligned_cols=261 Identities=22% Similarity=0.261 Sum_probs=198.9
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC---CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
...+|++.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3457999999999999999999753 3578999987542 234689999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
|||++. ++|.+++.. ...+++.+++.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999986 578777743 35689999999999999999999999 9999999999999999999999999999866
Q ss_pred cCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc-
Q 007625 426 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN- 503 (595)
Q Consensus 426 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~- 503 (595)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...+.. .......
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~l~~i~~~-~~~~~~~~ 313 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS-SSQLRSIIRC-MQVHPLEF 313 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc-HHHHHHHHHH-hccCcccc
Confidence 543222 22345699999999999999999999999999999999999999976443211 1111111111 0000000
Q ss_pred ----------------cccccc--CCCC--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 504 ----------------DIVDRN--LNTY--DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 504 ----------------~~~d~~--l~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+. .+.. ......++.+++.+|+..||++||++.|++.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 0000 01123567788999999999999999999765
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=296.34 Aligned_cols=252 Identities=30% Similarity=0.484 Sum_probs=203.3
Q ss_pred CCcCCeeeeccceEEEEEEeCC-----CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 273 FSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
|++.+.||+|+||.||++...+ +..||+|+++..........+..|+.++..++|+|++++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999653 38899999976544446778999999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++..... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999875321 2289999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
..........+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ....... ....
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~-----~~~~~~~---~~~~----- 222 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE-----EVLEYLK---KGYR----- 222 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHh---cCCC-----
Confidence 42222222336789999999988889999999999999999998 78887643221 1111111 1110
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
...+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111222456788899999999999999999998865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.72 Aligned_cols=193 Identities=24% Similarity=0.324 Sum_probs=165.2
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
....+|++.+.||+|+||.||+|+.. ++..||+|+.... ....|+.++++++||||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34568999999999999999999965 5778999975432 224689999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
+||+. ++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 136 ~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99995 5888877642 35689999999999999999999999 99999999999999999999999999987543
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~ 476 (595)
... ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 221 223356899999999999999999999999999999999966554
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=298.09 Aligned_cols=251 Identities=20% Similarity=0.324 Sum_probs=204.5
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|+..+.||+|+||.||++... +++.||+|++... .......++.+|+.++++++|||++++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5788999999999999999954 6889999998632 2334556889999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+.+.... ...+++.+...++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999887532 23578999999999999999999998 99999999999999999999999999998664432
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
. ......|++.|+|||+..+...+.++|+||||+++|+|++|+.||...... +.+.......
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~~--------- 217 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--------NLVLKIIRGS--------- 217 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--------HHHHHHhcCC---------
Confidence 1 122345788999999999888999999999999999999999998753321 1111111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+.....++.+++.+|++.+|.+||++.||+++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111223345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.03 Aligned_cols=203 Identities=22% Similarity=0.279 Sum_probs=175.7
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|+..+.||+|+||+||+|+.. +++.||+|+++.. ........+..|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999964 6899999998632 22334567888999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999875 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred cCc----------------------------------ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCC
Q 007625 428 KLT----------------------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473 (595)
Q Consensus 428 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~ 473 (595)
... .......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0011346999999999999999999999999999999999999
Q ss_pred CCCCCCc
Q 007625 474 RAIDFSR 480 (595)
Q Consensus 474 ~p~~~~~ 480 (595)
.||....
T Consensus 234 ~Pf~~~~ 240 (360)
T cd05627 234 PPFCSET 240 (360)
T ss_pred CCCCCCC
Confidence 9997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=302.03 Aligned_cols=265 Identities=25% Similarity=0.373 Sum_probs=205.5
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec--CCce
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSER 343 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 343 (595)
+.|+..+.||+|+||.||+|++. ++..||+|++...........|.+|+++++.+.|+|++++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677899999999999999853 3678999999754333356789999999999999999999999877 5578
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997532 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcce--eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhh------hhhHHHHHHH
Q 007625 424 LVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE------DVLLLDHIRK 495 (595)
Q Consensus 424 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~------~~~l~~~~~~ 495 (595)
......... .....++..|+|||...+..++.++||||||+++|||+||+.|+......... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765322211 11233566799999998888999999999999999999999998643221100 0000011111
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...... . ...+.....++.+++.+|++.+|.+||++.||+++|+.+
T Consensus 238 ~~~~~~-------~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGE-------R-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCC-------c-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111100 0 011223346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=339.58 Aligned_cols=259 Identities=19% Similarity=0.246 Sum_probs=201.5
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC--Cc
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SE 342 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 342 (595)
....++|++.+.||+|+||+||+|+.. ++..||+|.+... ........|..|+.++.+++||||+++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999964 5778999988632 3344567889999999999999999999988543 46
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCcEEcCCCCCCEEEcC--------
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN----PKIIHRDLKAANILLDD-------- 410 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~Dlkp~NIll~~-------- 410 (595)
.++||||+++++|.+++.........+++..++.|+.||+.||+|||+... .+|+||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 789999999999999998654444579999999999999999999998521 25999999999999964
Q ss_pred ---------CCcEEEeeccccccccCcCcceeecccccccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 007625 411 ---------NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (595)
Q Consensus 411 ---------~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~p~~~~ 479 (595)
...+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3358999999998664322 2234568999999999854 45889999999999999999999999743
Q ss_pred chhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 480 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 480 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
... ...+....... +..+ .....++.+++..||+.+|.+||++.|++.
T Consensus 247 ~~~-------~qli~~lk~~p------~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNF-------SQLISELKRGP------DLPI----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcH-------HHHHHHHhcCC------CCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 321 11111111110 0011 122457889999999999999999999984
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=302.80 Aligned_cols=266 Identities=21% Similarity=0.315 Sum_probs=201.7
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47888999999999999999975 68999999986432 22334568899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|++++++..++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888877654 33589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc-------cc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR-------ED 500 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~-------~~ 500 (595)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+... ........... ..
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChHHhhhcccc
Confidence 22 1223447889999999876 457899999999999999999999997544321110 01110000000 00
Q ss_pred cc-cccccccCC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 RL-NDIVDRNLN------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ~~-~~~~d~~l~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. .....+... ...+.....+.+++.+|++.+|++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 000000000 0011234678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=297.12 Aligned_cols=254 Identities=23% Similarity=0.279 Sum_probs=205.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|+..+.||+|+||.||+|... +++.+++|.+..... .....+.+|++++++++|||++++++++......+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 367889999999999999999964 678899999874332 356788999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++... ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999988752 24689999999999999999999998 9999999999999999999999999998865432
Q ss_pred CcceeecccccccccCccccCCC---CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.. ......++..|+|||.+.+. .++.++||||||+++|||+||+.||......... ..... ..
T Consensus 155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~----~~~~~-----~~---- 220 (262)
T cd06613 155 IA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL----FLISK-----SN---- 220 (262)
T ss_pred hh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHh-----cc----
Confidence 21 12234578899999998776 7899999999999999999999999754321110 00000 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+.............++.+++.+|+..+|.+||++.+|+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 221 FPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011111123445677899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=306.37 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=201.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCc----EEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+...........+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456778899999999999999853 444 47889887544444556789999999999999999999998754 467
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
++++|+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 999999999999998752 23588999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 425 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 425 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ..+.+.. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~---~~~~ 230 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-----IPDLLEK---GERL 230 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHC---CCCC
Confidence 6433221 1222345778999999998899999999999999999997 889986533211 1122111 1100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..+......+.+++..||..+|++||++.++++.|+..
T Consensus 231 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 ---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01122345788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=316.06 Aligned_cols=250 Identities=27% Similarity=0.365 Sum_probs=207.5
Q ss_pred CcCCeeeeccceEEEEEEeC--CCc--EEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 274 SESNIIGQGGFGKVYKGVLS--DNT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
...++||+|.||.|++|.|+ .|+ .||||.++.........+|.+|+.+|.+++|||++++||...+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34688999999999999975 344 4899999865544477899999999999999999999999887 778899999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
++.|+|.+.|+.. ....+-......++.|||.||.||..+ ++|||||..+|+++-....+||+|||+.+.+....
T Consensus 192 aplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999972 345688889999999999999999999 99999999999999999999999999999887654
Q ss_pred ccee--ecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 430 THVT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 430 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.... ....-.+.|.|||.+....++.++|||+|||.+|||+| |+.||.+-... .+.+.+.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----qIL~~iD------------ 329 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----QILKNID------------ 329 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----HHHHhcc------------
Confidence 4432 22345678999999999999999999999999999998 67888754321 1111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
+......+..+++++++++..||...|.+|||+..|.+.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1222234677889999999999999999999999997443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=303.28 Aligned_cols=266 Identities=21% Similarity=0.331 Sum_probs=203.7
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
++|+..+.||+|+||.||+|... +++.||+|+++... .......+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999965 68899999986432 33445788999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|++++.+..+... ...+++.++..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998777655543 34589999999999999999999999 9999999999999999999999999999877654
Q ss_pred CcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH-------Hh-cc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK-------LL-RE 499 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~-------~~-~~ 499 (595)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.. ......... .. ..
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL-YLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHhhhcccC
Confidence 43233345678899999999887 7899999999999999999999999754322110 000000000 00 00
Q ss_pred c-----ccccccccc-C-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 500 D-----RLNDIVDRN-L-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 500 ~-----~~~~~~d~~-l-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. ......+.. . ..++.....++.+++.+||..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 000000000 0 0012223678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=320.29 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=211.8
Q ss_pred cCCeeeeccceEEEEEEe-CCC----cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 275 ESNIIGQGGFGKVYKGVL-SDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
..++||+|+||+||+|.+ .+| .+||+|++.+........++.+|+-.|.+++|||+++++|+|..+. ..+|++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 378999999999999995 344 3589999988777788899999999999999999999999998776 8899999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
|+.|+|.++++..+ ..+.....+.|..|||+||.|||++ +++||||..+|||+..-..+||.|||+++......
T Consensus 779 mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999743 4688899999999999999999999 99999999999999999999999999999887654
Q ss_pred ccee-ecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 430 THVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 430 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.... ....-.+.|||-|.+....|+.++|||||||.+||++| |..|+++...++.. ..++.+
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~---------dlle~g------- 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP---------DLLEKG------- 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh---------HHHhcc-------
Confidence 4432 22334678999999999999999999999999999998 88998876543321 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.....++.+..++..++.+||..|++.||+++++...+.+
T Consensus 917 -eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 917 -ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 1123467788899999999999999999999999987754
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=300.84 Aligned_cols=263 Identities=24% Similarity=0.323 Sum_probs=199.0
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|+..+.||.|++|.||+|+.. ++..||+|++.... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999964 68999999986432 233446788999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+. ++|..++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 58888876532 34689999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc--------
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED-------- 500 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~-------- 500 (595)
.. .....++..|+|||++.+.. ++.++||||||+++|||+||+.||........ ..+.........
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ----LFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHHhCCCChhhhhhhh
Confidence 21 22234688999999887644 58899999999999999999999975432211 111111100000
Q ss_pred -------cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 -------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 -------~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.........+....+....++.+++.+|++.||.+||+++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000111233567789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=302.13 Aligned_cols=262 Identities=23% Similarity=0.271 Sum_probs=203.5
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|++.+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++++++|||++++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999964 68999999987433 234457889999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+ +++|.+++.... ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987532 5689999999999999999999999 99999999999999999999999999998765443
Q ss_pred cceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc--------
Q 007625 430 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED-------- 500 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~-------- 500 (595)
........|+..|+|||++.+. .++.++||||+|+++|||+||..||....... ....+.......
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-----QLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-----HHHHHHHHcCCCChHHHhhc
Confidence 2223344588999999998654 46899999999999999999988776543211 111111110000
Q ss_pred ----ccccccccc-----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 ----RLNDIVDRN-----LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ----~~~~~~d~~-----l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.+..+..+. +....++....+.+++.+|++.+|++||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 000112334788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=303.21 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=205.6
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceee
Q 007625 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (595)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 338 (595)
+..+++..+.++|++.+.||+|+||.||+|.. .+++.+|+|++... ......+.+|+.++.++ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 34455566788999999999999999999996 46889999998642 22346678899999998 7999999999986
Q ss_pred cC-----CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc
Q 007625 339 TS-----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (595)
Q Consensus 339 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 413 (595)
.. ...++|+||+++++|.++++........+++..++.++.|++.||+|||+. +++|+||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 54 357999999999999998875443455789999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccccCcCcceeecccccccccCccccCCC-----CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhh
Q 007625 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~ 488 (595)
++|+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||....... .
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~----~ 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK----T 241 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH----H
Confidence 99999999886543221 12234578999999997543 36889999999999999999999986432211 0
Q ss_pred HHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 489 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+. ...+. ....+. .+......+.+++.+|++.+|++||++.|++++
T Consensus 242 ~~----~~~~~-~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 LF----KIPRN-PPPTLL------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HH----HHhcC-CCCCCC------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 11111 000111 122344578899999999999999999999764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=302.01 Aligned_cols=266 Identities=24% Similarity=0.368 Sum_probs=201.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
++|+..+.||+|+||.||+|..+ +++.||+|++.... .......+.+|+++++.++|||++++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 58999999986432 22345678899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|++++++.++... ...+++.+++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999888876654 23589999999999999999999999 9999999999999999999999999998866443
Q ss_pred CcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH-------Hhccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK-------LLRED 500 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~-------~~~~~ 500 (595)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ......... .....
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL-YHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH-HHHHHHhCCCchhhHHHhccc
Confidence 22 2223457889999999875 44788999999999999999999998754321110 000000000 00000
Q ss_pred cc-cccccccCC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 RL-NDIVDRNLN------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ~~-~~~~d~~l~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. .....+... ...+.....+.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 000000000 0112335678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=302.45 Aligned_cols=262 Identities=25% Similarity=0.364 Sum_probs=197.9
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|+..+.||+|+||+||+|..+ +++.||+|.+...........+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999965 68999999987443333345677899999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+.+ +|.+++.... ..+++...+.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 8988887532 3688999999999999999999999 99999999999999999999999999987543221
Q ss_pred cceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc---ccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---EDRLNDI 505 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~~ 505 (595)
.. .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||......... ...+..... +..+...
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ----LHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH----HHHHHHhcCCCChhhhhhh
Confidence 11 122346889999999865 45789999999999999999999999754321111 111110000 0000000
Q ss_pred ------c--------cccCCCCCHHH--HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 506 ------V--------DRNLNTYDSKE--VETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 506 ------~--------d~~l~~~~~~~--~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. ...+....... ..++.+++.+|++.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000000011 256788999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=299.17 Aligned_cols=266 Identities=25% Similarity=0.347 Sum_probs=203.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHh--cCCCCCccccceeecCC----c
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTTSS----E 342 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~ 342 (595)
........+.||+|+||.||+|.+ .|+.||||++.. ..++.+.+|.++++. ++|+||+.+++.-..+. +
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 445677789999999999999999 688999999854 345677777777765 59999999998876554 5
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCcEEcCCCCCCEEEcCCCcEEEe
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLC 417 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl~ 417 (595)
.++|++|.+.|||+|+|.. ..++....++++..+|.||+|||. +.+|.|.|||||+.|||+..++...|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 7899999999999999985 468999999999999999999995 357899999999999999999999999
Q ss_pred eccccccccCcCcc---eeecccccccccCccccCCCC----C--CccchhHHHHHHHHHHHhC----------CCCCCC
Q 007625 418 DFGLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTGK----S--SEKTDVFGYGITLLELVTG----------QRAIDF 478 (595)
Q Consensus 418 DfG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--~~~sDv~SlGvvl~elltg----------~~p~~~ 478 (595)
|+|+|-........ .....+||.+|||||++...- + -..+||||||.|+||+.-. +.||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999876554322 234567999999999986432 1 2358999999999999742 456653
Q ss_pred CchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 479 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 479 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
--..+.. .+.+++.+=..++...++... ...+....+.++|+.||..+|..|.|+-.|-+.|.+..
T Consensus 439 ~Vp~DPs----~eeMrkVVCv~~~RP~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 439 VVPSDPS----FEEMRKVVCVQKLRPNIPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCCCC----HHHHhcceeecccCCCCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 2211111 111222221122222222211 34677889999999999999999999999988887643
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=295.37 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=202.7
Q ss_pred CCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|+..+.||+|+||.||+|.. .++..+|+|++... ........+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578899999999999999996 47889999998643 2344567889999999999999999999999989999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-CcEEEeeccccccccCc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~~~~~~~ 428 (595)
+++++|.+++.... ...+++..+..++.|++.||+|||++ +++|+||||+||+++++ +.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997532 34589999999999999999999999 99999999999999855 46899999999876543
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .+.......
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--------~~~~~~~~~-------- 217 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--------LVLKIMSGT-------- 217 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--------HHHHHHhcC--------
Confidence 21 223457889999999998889999999999999999999999987543211 111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+.....++.+++.+||+.+|++|||+.|++++
T Consensus 218 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 -FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111122345678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=300.31 Aligned_cols=239 Identities=24% Similarity=0.326 Sum_probs=186.3
Q ss_pred eeeeccceEEEEEEeCC-------------------------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCcc
Q 007625 278 IIGQGGFGKVYKGVLSD-------------------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332 (595)
Q Consensus 278 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 332 (595)
.||+|+||.||+|.+.. ...|++|++.... ......|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 58999999999997421 1358889886422 233457888999999999999999
Q ss_pred ccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC
Q 007625 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (595)
Q Consensus 333 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 412 (595)
+++++......++||||+++++|..++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 999999999999999999999999888642 34688999999999999999999998 999999999999997643
Q ss_pred -------cEEEeeccccccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHH-hCCCCCCCCchhh
Q 007625 413 -------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELV-TGQRAIDFSRLEE 483 (595)
Q Consensus 413 -------~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~ell-tg~~p~~~~~~~~ 483 (595)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3899999987643221 12346788999998865 56899999999999999995 6899887543211
Q ss_pred hhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 484 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
. ...... .. . .+.....++.+++.+||+.+|++||++.+|++.|.
T Consensus 230 ~-----~~~~~~---~~--------~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 K-----ERFYEK---KH--------R---LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H-----HHHHHh---cc--------C---CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 111110 00 0 01112246888999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=299.66 Aligned_cols=254 Identities=24% Similarity=0.298 Sum_probs=199.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|+..+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.++|||++++++++...+..++|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 346777899999999999999964 68899999986432 2334567889999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.. ...+++.+.+.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 87 FCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred ccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999998875 34689999999999999999999999 9999999999999999999999999998765432
Q ss_pred CcceeecccccccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.. ......|+..|+|||++. ...++.++|||||||++|||++|+.||........ .... ......
T Consensus 160 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~----~~~~----~~~~~~--- 227 (267)
T cd06645 160 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----LFLM----TKSNFQ--- 227 (267)
T ss_pred cc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh----HHhh----hccCCC---
Confidence 21 123345899999999974 45588999999999999999999999854321110 0000 000000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.+.... .......+.+++.+|++.+|++||++.+|+++
T Consensus 228 -~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 -PPKLKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -CCcccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000000 11123467889999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.75 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=195.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC----CchhHHHHHHHHHHHHhcCCCCCccccceeecC--Cce
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 343 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 343 (595)
.+|+..+.||+|+||.||+|... ++..||+|++.... .......+.+|+.++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999964 68999999886321 123345788999999999999999999988653 567
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999875 23588999999999999999999998 99999999999999999999999999987
Q ss_pred cccCcCc--ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 424 LVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 424 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
....... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~~~~- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIATQP- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcCC-
Confidence 6543211 1112345789999999999888999999999999999999999999743221 1111111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.. ...+......+..++ +|+..+|++||+++||++
T Consensus 226 ----~~---~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 ----TN---PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CC---CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01 112233344555555 688899999999999965
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=302.23 Aligned_cols=249 Identities=20% Similarity=0.306 Sum_probs=202.3
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
.+|+..+.||.|+||.||+|.. .+++.|++|.+.... ......+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4688899999999999999985 578999999986432 33456788999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|..++.. ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999998864 3589999999999999999999999 99999999999999999999999999988654332
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ .. ... ... ...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~----~~-~~~---~~~-~~~----- 234 (296)
T cd06655 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LY-LIA---TNG-TPE----- 234 (296)
T ss_pred cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HH-HHH---hcC-Ccc-----
Confidence 21 2234588899999999988899999999999999999999999976443111 00 010 000 000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
...+......+.+++.+||..||.+||++.+|+.
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0112234457888999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=300.22 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=196.3
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHH-HHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHL-ISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
++|++.+.||+|+||.||+|+.. +|+.||+|+++..........+..|+.. ++..+|||++++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999965 6899999998754333344555666665 566789999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|++ ++|.+++.........+++.+++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 6888887754444467999999999999999999999853 7999999999999999999999999998865432
Q ss_pred CcceeecccccccccCccccCC----CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
. ......|+..|+|||++.+ ..++.++|+||||+++|||++|+.||....... +..........
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~--- 225 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-------QQLKQVVEEPS--- 225 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-------HHHHHHHhcCC---
Confidence 1 1122457889999998864 446889999999999999999999986322110 01111111000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
..+. ....+.++.+++.+|+..+|.+||++.||++
T Consensus 226 ---~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 ---PQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---CCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 1123467889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=296.75 Aligned_cols=259 Identities=27% Similarity=0.397 Sum_probs=206.8
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|++.+.||.|+||+||+|... ++..+|+|++...........+.+|++.++.++|+|++++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999954 68899999987544344677899999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.++++.... ...+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976432 24689999999999999999999999 99999999999999999999999999988665432
Q ss_pred cc---eeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 430 TH---VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 430 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.. ......|+..|+|||++... .++.++|+|||||++|||++|+.||....... ...+.. .... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~----~~~~--~~ 226 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTL----QNDP--PS 226 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHh----cCCC--CC
Confidence 22 22334588999999998776 78999999999999999999999997543211 111111 1100 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..... ........+.+++.+|++.||++||++.|++++
T Consensus 227 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGA--DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCcc--ccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 012345678899999999999999999999763
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=302.91 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=197.1
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|+..+.||+|+||.||+|+.. +|+.||+|+++.. ........+.+|++++++++|||++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999964 6899999998642 2223345678899999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++ +|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 974 777776542 34589999999999999999999999 99999999999999999999999999998654332
Q ss_pred cceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc---cc---
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RL--- 502 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~---~~--- 502 (595)
.. .....++..|+|||++.+.. ++.++|||||||++|||+||+.|+......... .+.+....... .+
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ----LKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH----HHHHHHHhCCCChHHhHHh
Confidence 21 22345788999999987644 689999999999999999999886433221111 11111100000 00
Q ss_pred cccccc-cCC---------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 503 NDIVDR-NLN---------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 503 ~~~~d~-~l~---------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+. ... ...+....++.+++.+|++.||.+|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000 000 0112235677889999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=305.87 Aligned_cols=197 Identities=24% Similarity=0.371 Sum_probs=160.1
Q ss_pred CCeeeeccceEEEEEEeC---CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec--CCceEEEEEec
Q 007625 276 SNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILVYPFM 350 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 350 (595)
+.+||+|+||+||+|+.. ++..||+|.+... .....+.+|+.+++.++||||+++++++.. +...++|+||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC---CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 468999999999999964 4578999988642 223467889999999999999999998854 45678999998
Q ss_pred ccCcHhhhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE----cCCCcEEEeeccc
Q 007625 351 QNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGL 421 (595)
Q Consensus 351 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~ 421 (595)
.+ +|.+.+.... .....+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 6766664221 1123588999999999999999999999 99999999999999 5667999999999
Q ss_pred cccccCcCcc--eeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 007625 422 AKLVDAKLTH--VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (595)
Q Consensus 422 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~ 479 (595)
++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9876543221 22335689999999998764 5799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.41 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=201.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.+.|++.+.||+|+||.||+|+.. ++..|++|.+... .......+.+|+.+++.++|||++++++++..+...++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 467889999999999999999965 5889999998643 34456778899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|...+.+. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999998887642 24589999999999999999999998 9999999999999999999999999998754332
Q ss_pred CcceeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
. .......++..|+|||++. ...++.++|||||||++|||++|+.||....... .......... .
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~-~ 233 (292)
T cd06644 164 L-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSEP-P 233 (292)
T ss_pred c-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--------HHHHHhcCCC-c
Confidence 1 1122345788999999984 3446889999999999999999999986533211 1111111110 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. ..+.....++.+++.+||+.+|++||++.|+++.
T Consensus 234 ~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 TL------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cC------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 1122344578889999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.96 Aligned_cols=250 Identities=19% Similarity=0.281 Sum_probs=202.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
..+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+|++++++++......++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 35788999999999999999995 479999999986433 2345678899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999998864 3578899999999999999999999 9999999999999999999999999998765433
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||......... . .....+ .
T Consensus 169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~----~----~~~~~~-------~ 232 (297)
T cd06656 169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----Y----LIATNG-------T 232 (297)
T ss_pred ccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe----e----eeccCC-------C
Confidence 221 22345788999999999888999999999999999999999999653321100 0 000000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.....+......+.+++.+|++.+|++||++++|++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001112334466788999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=293.87 Aligned_cols=247 Identities=24% Similarity=0.326 Sum_probs=209.7
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecc
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 351 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 351 (595)
|.++.+||+|+||.||+|..+ .|..+|+|.+.. +...+++..|+.++++...|++|++||.|......++|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 666889999999999999964 799999998853 2457788999999999999999999999999999999999999
Q ss_pred cCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc
Q 007625 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (595)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 431 (595)
-|+..+.++-. ++++++.++..++...+.||+|||.. .-+|||||+.|||++.+|.+||+|||.+..+.+....
T Consensus 112 AGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 112 AGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999999853 46899999999999999999999998 8899999999999999999999999999876543322
Q ss_pred eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCC
Q 007625 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 511 (595)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 511 (595)
..++.||+.|||||++..-.|..++||||+|+...||..|++||..-.+. +. +-.+.....+
T Consensus 186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-----------RA------IFMIPT~PPP 247 (502)
T KOG0574|consen 186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-----------RA------IFMIPTKPPP 247 (502)
T ss_pred -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-----------ce------eEeccCCCCC
Confidence 34567999999999999999999999999999999999999998642221 00 0011111112
Q ss_pred C--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 512 T--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 512 ~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
. -++..+.++.+++++|+-+.|++|-|+.+++++-
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 2 3677788999999999999999999999998753
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=321.59 Aligned_cols=267 Identities=19% Similarity=0.244 Sum_probs=191.9
Q ss_pred HHHHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCC------CCCccccce
Q 007625 264 RELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH------KNLLQLIGY 336 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~ 336 (595)
+++....++|++.++||+|+||+||+|... +++.||||+++... .....+..|++++..++| .++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 344556789999999999999999999964 67889999986421 223445667777766654 458888888
Q ss_pred eecC-CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCEEEcCCC--
Q 007625 337 CTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNF-- 412 (595)
Q Consensus 337 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~-- 412 (595)
+... ...++||+++ +++|.+++.. ...+++..+..|+.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcc
Confidence 8765 4678888887 6788888765 3468999999999999999999997 5 899999999999998765
Q ss_pred --------------cEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 007625 413 --------------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (595)
Q Consensus 413 --------------~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~ 478 (595)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998764322 22345689999999999999999999999999999999999999986
Q ss_pred CchhhhhhhhH-------HHHHHH--------Hhc-ccccccccccc----C----CCCCHHHHHHHHHHHHHcccCCCC
Q 007625 479 SRLEEEEDVLL-------LDHIRK--------LLR-EDRLNDIVDRN----L----NTYDSKEVETMVQVALLCTQSTPE 534 (595)
Q Consensus 479 ~~~~~~~~~~l-------~~~~~~--------~~~-~~~~~~~~d~~----l----~~~~~~~~~~l~~l~~~cl~~dP~ 534 (595)
....+...... ..|... ... ........++. + ..........+.+++.+||+.||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 54321110000 000000 000 00000000000 0 000001234577999999999999
Q ss_pred CCCCHHHHHH
Q 007625 535 DRPPMAQVVK 544 (595)
Q Consensus 535 ~RPs~~evl~ 544 (595)
+|||++|+++
T Consensus 428 ~R~ta~e~L~ 437 (467)
T PTZ00284 428 KRLNARQMTT 437 (467)
T ss_pred hCCCHHHHhc
Confidence 9999999975
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.71 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=199.8
Q ss_pred CCcCCeeeeccceEEEEEEeC----CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCC------
Q 007625 273 FSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 341 (595)
|.+.+.||+|+||.||+|.+. ++..||+|++... ......+.+.+|++++++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566889999999999999853 3678999998743 23445677899999999999999999999886542
Q ss_pred ceEEEEEecccCcHhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 342 ERILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
..+++++|+.+|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999988875322 1123578999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHh
Q 007625 420 GLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 497 (595)
Q Consensus 420 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~ 497 (595)
|.++........ ......++..|++||.+.+..++.++||||||+++|||++ |+.||...... .......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~--- 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYNYLI--- 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----HHHHHHH---
Confidence 999866432211 1122345678999999988889999999999999999999 88888644321 1111111
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 498 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..... ..+......+.+++.+|++.+|++||++.|+++.|+..
T Consensus 230 ~~~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11110 01123346889999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=295.79 Aligned_cols=238 Identities=26% Similarity=0.385 Sum_probs=188.7
Q ss_pred CeeeeccceEEEEEEeCCCc-----------EEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 277 NIIGQGGFGKVYKGVLSDNT-----------KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
+.||+|+||.||+|...+.. .+++|.+..... ....|.+|+.+++.++|||++++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999975433 478887654322 26788999999999999999999999988 77899
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC-------cEEEee
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-------EAVLCD 418 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~D 418 (595)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .++|+|
T Consensus 78 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999988632 2689999999999999999999998 999999999999999887 799999
Q ss_pred ccccccccCcCcceeecccccccccCccccCCC--CCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHH
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+......+ ......
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-----~~~~~~- 220 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-----KERFYQ- 220 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-----HHHHHh-
Confidence 999886543 1223467789999999876 78999999999999999999 566765432111 011111
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
.... . +......+.+++.+|+..+|.+||++.||++.|+
T Consensus 221 --~~~~--------~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --DQHR--------L---PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --cCCC--------C---CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 0 0011168889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=294.05 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=201.4
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC----CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
+|+..+.||+|+||.||+|... ++..|++|.+.... .......+.+|+.+++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999976 78999999986422 123456789999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
+||+++++|.+++.. ...+++.....++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999875 24588999999999999999999999 99999999999999999999999999988654
Q ss_pred CcCcceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||...... ..........
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~----- 218 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--------AAVFKIGRSK----- 218 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--------HHHHHHHhcc-----
Confidence 332 223455889999999987766 899999999999999999999998643311 1111110000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.....+......+.+++.+|++.+|.+||++.++++
T Consensus 219 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 ---ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 011122334567788999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.34 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=198.5
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecc
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 351 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 351 (595)
|++.+.||+|+||.||+|... ++..+++|.+... .......+.+|+++++.++|||++++++++...+..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 567889999999999999965 5778899988532 33456678899999999999999999999999999999999999
Q ss_pred cCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc
Q 007625 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (595)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 431 (595)
+++|...+... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... .
T Consensus 86 ~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 99998887642 34689999999999999999999999 99999999999999999999999999987653321 1
Q ss_pred eeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 432 VTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
......++..|+|||++. +..++.++|||||||++|||++|+.||....... .+......... ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~-~~- 228 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSEPP-TL- 228 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--------HHHHHhhcCCC-CC-
Confidence 223345889999999974 3457789999999999999999999987433211 11111111000 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
..+.....++.+++.+||+.+|.+||++.+++++-
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 229 -----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 01222346788999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=294.06 Aligned_cols=247 Identities=27% Similarity=0.402 Sum_probs=199.2
Q ss_pred cCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
++|++.+.||+|+||.||++.. +++.||+|.++.. .....+.+|+.++..++|||++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4688899999999999999985 7788999998642 2346788999999999999999999988654 579999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++|.+++.... ...+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 9999999997532 34588999999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+. .... .
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~----~~~~---~--- 216 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----VKECVE----KGYR---M--- 216 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHHh----CCCC---C---
Confidence 12234578999999988899999999999999999998 999987543221 111111 1100 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 217 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 --EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0122334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.76 Aligned_cols=237 Identities=24% Similarity=0.271 Sum_probs=183.7
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc---CCCCCccccceeecCCceEEEEEeccc
Q 007625 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA---IHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
||+|+||+||+|+.. +++.||+|++.... .......+..|..++... .||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999964 68999999985321 122234455566666655 699999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 999988875 34689999999999999999999999 99999999999999999999999999987543221 12
Q ss_pred eecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCC
Q 007625 433 TTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 511 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 511 (595)
.....||+.|+|||++.+. .++.++|||||||++|||+||+.||....... ....... +.. .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--------~~~~i~~-~~~------~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--------MYRNIAF-GKV------RFP 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--------HHHHHHc-CCC------CCC
Confidence 2345689999999998754 47999999999999999999999997543211 1111111 100 011
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007625 512 TYDSKEVETMVQVALLCTQSTPEDRPPMA 540 (595)
Q Consensus 512 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 540 (595)
......++.+++.+|++.||.+||++.
T Consensus 218 --~~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 218 --KNVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 112345677889999999999998543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=294.95 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=207.9
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|++.+.||+|++|.||+|... +++.|++|++...........+.+|+..+.+++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999975 58999999987544335567899999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
+++++|.+++... ..+++.....++.|++.|++|||+ . +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999753 568999999999999999999999 8 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.... ....++..|+|||.+.+..++.++|+||||+++|||+||+.||...... ........+. . .
T Consensus 154 ~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~---~---------~ 218 (264)
T cd06623 154 LDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAIC---D---------G 218 (264)
T ss_pred CCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHh---c---------C
Confidence 3221 2345788999999999888999999999999999999999998754320 1111111111 1 1
Q ss_pred cCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 509 NLNTYDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 509 ~l~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.....+.. .+..+.+++.+|+..+|++||++.|+++.
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11112222 55688899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.90 Aligned_cols=245 Identities=23% Similarity=0.354 Sum_probs=200.8
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcH
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (595)
-+||+|.||+||.|+.. +...+|||-+....+ ...+-+..|+.+-++++|.|||+++|.+..++..-+.||..+||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 37999999999999964 566799999875433 3456678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc-CCCcEEEeeccccccccCcCcce
Q 007625 356 AYRLRDLKPGEKGL--DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 356 ~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
.++|+... .++ ++.++-.+.+||++||.|||++ .|||||||-+|||++ -.|.+||+|||-++.+..- ...
T Consensus 660 SsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~ 732 (1226)
T KOG4279|consen 660 SSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPC 732 (1226)
T ss_pred HHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccc
Confidence 99999643 344 7888889999999999999999 999999999999996 5689999999999877532 334
Q ss_pred eecccccccccCccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 433 TTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
+.+.-||..|||||++..+ .|..++|||||||.+.||.||++||..-.... ...++- + +-..-
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------AAMFkV----G-----myKvH 797 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------AAMFKV----G-----MYKVH 797 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------Hhhhhh----c-----ceecC
Confidence 5556699999999999765 48899999999999999999999996322110 000100 0 11122
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+..+++...+...++.+|+.+||.+||+++++++
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 3457888899999999999999999999999964
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.30 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=201.2
Q ss_pred CCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC---CCCCccccceeecCCceEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 347 (595)
.|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.+++++. |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477789999999999999996 5789999999875444555678889999999986 999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.. ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999988864 2689999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.... .....|+..|+|||++.++ .++.++||||||+++|+|++|+.||....... .... .... .
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--------~~~~-~~~~-----~ 218 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--------AMML-IPKS-----K 218 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--------hhhc-cccC-----C
Confidence 3322 2334588999999998654 46899999999999999999999997533211 1110 0000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.+.+. ......++.+++.+|++.||++||++.|++++
T Consensus 219 ~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 01111 11145678899999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.00 Aligned_cols=265 Identities=23% Similarity=0.246 Sum_probs=197.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++++|...+.||+|+||.||+|.. .++..||+|++...........+.+|+++++.++|+||+++++++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 356899999999999999999985 4689999999875443444456788999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+. +++.+.+... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 6776666432 24578888999999999999999999 999999999999999999999999999875433
Q ss_pred cCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH-----------
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK----------- 495 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~----------- 495 (595)
.... .....++..|+|||++.+. .++.++||||||+++|||++|+.||........ .+.+....
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE---QLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH---HHHHHHHHcCCCChhhhhh
Confidence 2211 2233468899999998754 578899999999999999999999975432111 11110000
Q ss_pred Hhc-cccccccccccCCC----CC--HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 496 LLR-EDRLNDIVDRNLNT----YD--SKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 496 ~~~-~~~~~~~~d~~l~~----~~--~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
... .....+........ .. ......+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 00000000000000 00 012456778999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.64 Aligned_cols=262 Identities=24% Similarity=0.268 Sum_probs=199.9
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCC----chhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
+|+..+.||+|+||.||+|... +++.||+|.++.... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999964 689999999974322 22345677899999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+ +++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999987522 3689999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc--c----
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--E---- 499 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~--~---- 499 (595)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||........ +......... .
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ----LGKIFEALGTPTEENWP 228 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH----HHHHHHHcCCCchhhhh
Confidence 43221 122346788999998865 4578999999999999999999887765432111 1111110000 0
Q ss_pred --ccccccc------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 --DRLNDIV------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 --~~~~~~~------d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....... .............++.+++.+|++.+|++|||++||+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000 000011122345678899999999999999999999774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.17 Aligned_cols=255 Identities=23% Similarity=0.350 Sum_probs=199.3
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCC---------chhHHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS---------PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
+|...+.||+|+||.||+|... +++.||+|.++.... ....+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999854 688999998753111 112346788999999999999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+++++|.++++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999998763 4688999999999999999999998 999999999999999999999999999
Q ss_pred cccccCcCcc-eeecccccccccCccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 422 AKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 422 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
++........ ......|+..|+|||++.... ++.++|+||||+++||+++|..||....... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~ 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--------AMFKLGN 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--------HHHHhhc
Confidence 9765432211 123345889999999987654 7899999999999999999999986332211 0111111
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. ....+.. .........+.+++.+|+..+|.+||++.||+++
T Consensus 227 ~~-~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 KR-SAPPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cc-cCCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11 0111111 1122345678889999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=296.44 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=202.4
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
-|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.++.+++|||++++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677899999999999999864 688999998864444455678899999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++|.+++.. ..+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999988863 3588999999999999999999998 999999999999999999999999999876543221
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
......++..|+|||++.+...+.++|+|||||++|+|++|..||...... .....+ .... .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~----~~~~--------~ 218 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFLI----PKNN--------P 218 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHHH----hcCC--------C
Confidence 122345788999999998888899999999999999999999998643211 011111 1110 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.........++.+++.+|++.+|.+||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223345678889999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.64 Aligned_cols=253 Identities=28% Similarity=0.358 Sum_probs=202.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||.||+|... ++..||+|++... .......|.+|++++++++|||++++++++......++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 467888999999999999999964 6889999998642 33455678999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999988753 24689999999999999999999999 9999999999999999999999999998765432
Q ss_pred CcceeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
.. ......+++.|+|||++. ...++.++||||||+++|||++|+.||....... ......... ..
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~-~~ 226 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------VLLKILKSE-PP 226 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--------HHHHHhcCC-CC
Confidence 22 122345889999999974 3446789999999999999999999987533211 111111110 00
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+.....++.+++.+||+.+|.+||++.+|++.
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 ------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001122344578889999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=292.06 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=202.0
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCC-chhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|...+.||+|+||.||+|... +++.|++|.++.... ......+.+|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999964 789999999874332 24677899999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999875 34578899999999999999999999 99999999999999999999999999998765433
Q ss_pred cceee---cccccccccCccccCCCC---CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 430 THVTT---QIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 430 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
..... ...++..|+|||++.+.. .+.++||||||+++||+++|+.||....... ....... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~~~----~~~-- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFHVG----AGH-- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHHHh----cCC--
Confidence 32211 345788999999998766 8899999999999999999999996432111 0111111 000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.+.++. .......+.+++.+|++.+|++||++.|++.
T Consensus 224 ---~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ---KPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011111 1122556778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=292.24 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=202.5
Q ss_pred CCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCC-----chhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
+|+..+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999995 5789999999864321 1234678999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC-cEEEeecccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKL 424 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~ 424 (595)
|+||+++++|.+++.. ...+++.....++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999875 34688999999999999999999999 999999999999998775 599999999886
Q ss_pred ccCcCcc---eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 425 VDAKLTH---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 425 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
....... ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||........ ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~-- 226 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-----LALIFKIASA-- 226 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-----HHHHHHHhcc--
Confidence 6543211 12234578899999999888899999999999999999999999864332111 1111111000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
......+.....++.+++.+|+..+|.+||++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011233455678889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=297.32 Aligned_cols=240 Identities=23% Similarity=0.377 Sum_probs=187.8
Q ss_pred CeeeeccceEEEEEEeCC--------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 277 NIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
+.||+|+||.||+|.... ...||+|.+... .......+.+|+.+++.+.|||++++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 468999999999998632 234888877432 23345678889999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc--------EEEeecc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--------AVLCDFG 420 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfG 420 (595)
|+++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999987532 3589999999999999999999999 9999999999999987765 6999999
Q ss_pred ccccccCcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCC-CCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQ-RAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~-~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
++...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+....... ......
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-----~~~~~~---- 219 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-----KLQFYE---- 219 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-----HHHHHH----
Confidence 88654321 224578899999999764 5799999999999999999995 5554322111 000000
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
.. ...+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 220 -~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 -DR---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -cc---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0112223357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.59 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=202.1
Q ss_pred CHHHHHHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeec
Q 007625 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (595)
Q Consensus 262 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 339 (595)
++.++..+.+.|++.+.||+|+||.||+|.. .+++.||+|++... ......+..|+.++.++ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 4555556778999999999999999999996 46889999987532 23456788899999998 69999999998853
Q ss_pred ------CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc
Q 007625 340 ------SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (595)
Q Consensus 340 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 413 (595)
....+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 356789999999999999987543 24578888999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCcCcceeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhh
Q 007625 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~ 488 (595)
++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||.........
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--- 235 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--- 235 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh---
Confidence 99999999876543221 123345889999999975 345788999999999999999999999643221100
Q ss_pred HHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 489 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
....+.. .... .......++.+++.+||+.||.+||++.|+++
T Consensus 236 -----~~~~~~~------~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 -----FLIPRNP------PPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----hhHhhCC------CCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000000 0000 11234567899999999999999999999965
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.69 Aligned_cols=255 Identities=27% Similarity=0.363 Sum_probs=202.2
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCC-----
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS----- 341 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 341 (595)
++++|++.+.||+|+||.||+|..+ +++.+++|++.... .....+.+|+.+++++ .|+|++++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 5689999999999999999999974 67899999986432 3456789999999998 6999999999997654
Q ss_pred -ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 342 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 342 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 47999999999999999876543456789999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcCcceeecccccccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
++........ ......|+..|+|||++.. ..++.++||||||+++|+|++|+.||....... ....
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~---- 229 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR----ALFK---- 229 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH----HHHH----
Confidence 9876543222 1223458899999998753 346789999999999999999999996432111 1111
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.... .. .. ...+......+.+++.+|+..||++|||+.|+++
T Consensus 230 ~~~~-~~-----~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRN-PP-----PT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhcc-CC-----CC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1110 00 00 0112335567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=293.77 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=202.1
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|+..+.||+|+||.||+|... +|..||+|.+... ........+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999965 6889999998642 2233456788999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC-cEEEeeccccccccCc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK 428 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~~~~~ 428 (595)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999987532 23579999999999999999999999 999999999999999885 5699999999876543
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.. ......|++.|+|||+..+..++.++|+||||+++|||++|..||..... .+.+...... .
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~------- 218 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLKICQG-Y------- 218 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhcc-c-------
Confidence 22 22234588999999999888899999999999999999999999874332 1122211111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.....+....++.+++.+|++.+|++|||+.||++.
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 219 -FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111122334578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=292.14 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=197.7
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC----CchhHHHHHHHHHHHHhcCCCCCccccceeecC--Cce
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 343 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 343 (595)
.+|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999964 68999999875221 123346788899999999999999999988664 456
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
+++|||+++++|.+++... ..+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 7999999999999988752 3478889999999999999999999 99999999999999999999999999988
Q ss_pred cccCcCc--ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 424 LVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 424 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
....... .......|+..|+|||++.+..++.++||||||+++|||++|+.||....... . +......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~-~~~~~~~-- 224 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------A-IFKIATQ-- 224 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------H-HHHHhcC--
Confidence 6543211 11223458899999999988889999999999999999999999986432111 0 1111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.....+......+.+++.+|+. +|++||+++||++.
T Consensus 225 ------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 225 ------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 01112344555677888888984 99999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=301.24 Aligned_cols=255 Identities=23% Similarity=0.256 Sum_probs=201.3
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCc--hhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP--GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|+..+.||+|+||+||+|... +++.||+|.+...... .....+..|++++..++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999965 5899999998743322 24567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+.+++|.+++.... ...+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987432 35689999999999999999999999 999999999999999999999999999875532
Q ss_pred cCcc----------------------------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 007625 428 KLTH----------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (595)
Q Consensus 428 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~ 479 (595)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 111235788999999999888999999999999999999999999754
Q ss_pred chhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 480 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 480 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
..... ....... .. ... ........+.+++.+|++.+|++||++...++.+
T Consensus 236 ~~~~~--------~~~~~~~-~~------~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l 286 (316)
T cd05574 236 NRDET--------FSNILKK-EV------TFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286 (316)
T ss_pred chHHH--------HHHHhcC-Cc------cCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence 32111 1111100 00 000 0112457889999999999999999944433333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=309.35 Aligned_cols=198 Identities=25% Similarity=0.330 Sum_probs=171.7
Q ss_pred CCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-C-----CCCccccceeecCCceE
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-H-----KNLLQLIGYCTTSSERI 344 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 344 (595)
+|++.++||+|+||.|-+|.. ++++.||||+++... .-..+-..|+.+|..++ | -|+|++++|+...++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 899999999999999999995 579999999998532 33455677899998886 3 58999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC--CcEEEeecccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN--FEAVLCDFGLA 422 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG~~ 422 (595)
+|+|.+. .+|++++.... ..+++....+.++.||+.||.+||+. +|||+||||+||||.+. ..+||+|||.+
T Consensus 265 iVfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999986 49999998754 45699999999999999999999999 99999999999999754 37999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCch
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~ 481 (595)
........ ...-+..|+|||++.+.+|+.+.||||||||+.||+||.+-|.+.+.
T Consensus 339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 87654322 34457899999999999999999999999999999999888876553
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.50 Aligned_cols=265 Identities=20% Similarity=0.247 Sum_probs=197.3
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcC-CCCCccccceeecCCc-----
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSE----- 342 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 342 (595)
++|+..+.||+|+||.||+|... +++.||+|.++... .......+.+|+.+++.+. |||++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47889999999999999999964 68999999886432 2233467888999999995 6999999999877665
Q ss_pred eEEEEEecccCcHhhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-CCcEEEeecc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPG-EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFG 420 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 420 (595)
.++||||+++ ++.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 788887653322 35689999999999999999999999 9999999999999998 8899999999
Q ss_pred ccccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||........ +..........
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ----LLHIFKLLGTP 231 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHHHhCCC
Confidence 98865432211 122346789999998865 4578999999999999999999999975432211 11111110000
Q ss_pred c--cccccc------------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 500 D--RLNDIV------------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 500 ~--~~~~~~------------d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. .+.... ...+....+....++.+++.+|++.+|.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000000 00000011234567889999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=296.72 Aligned_cols=245 Identities=24% Similarity=0.291 Sum_probs=201.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||.||++... +++.||+|++.... .......+.+|++++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999965 68999999986422 2334567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999875 34689999999999999999999998 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
. .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||....... ....+ . .+.
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~---~-~~~------ 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-----IYEKI---L-EGK------ 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH---h-cCC------
Confidence 3 233458899999999988888999999999999999999999987543211 11111 1 110
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVK 544 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 544 (595)
...+......+.+++.+||+.+|.+|| +++|+++
T Consensus 215 ---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 ---VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 011222346778899999999999998 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=296.41 Aligned_cols=266 Identities=22% Similarity=0.313 Sum_probs=201.6
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
+|+..+.||+|++|.||+|+.. +|..||+|+++..........+.+|+.++++++|+|++++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999975 688999999875444445567788999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++ +|.+++..... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 88887765332 34689999999999999999999999 999999999999999999999999999976543322
Q ss_pred ceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH--------HHHhcccc
Q 007625 431 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI--------RKLLREDR 501 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~--------~~~~~~~~ 501 (595)
......++..|++||++.+. .++.++||||||+++|||++|+.||......+..... .... ........
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI-FRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH-HHHhCCCChhhHHHHhcCch
Confidence 12233468899999988654 4688999999999999999999999765432211110 0000 00000000
Q ss_pred ccc----cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 502 LND----IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 502 ~~~----~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
... ..+.......+.....+.+++.+|++.||.+||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0000000111233567789999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=295.49 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=199.0
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
|+..+.||.|++|.||+|... +|..||+|++.... .......+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567899999999999999964 79999999986432 2334467889999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
+ ++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68888887533 24689999999999999999999998 999999999999999999999999999976543322
Q ss_pred ceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc---------
Q 007625 431 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED--------- 500 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~--------- 500 (595)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||........ +...........
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ----LFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHHhhhhhh
Confidence 1 1223468899999988654 578999999999999999999999975433211 111111100000
Q ss_pred ------cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 ------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ------~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..............+.....+.+++.+|++.||.+||+++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000001111122334678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=299.19 Aligned_cols=257 Identities=23% Similarity=0.271 Sum_probs=203.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|+..+.||+|+||.||++... +++.|++|.+.... .......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999965 57899999986432 1234567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999975 34589999999999999999999999 999999999999999999999999999864211
Q ss_pred cCc--------------ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH
Q 007625 428 KLT--------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 428 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~ 493 (595)
... .......++..|+|||++.+..++.++|+||||+++|||++|..||......+ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--------~~ 225 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--------LF 225 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HH
Confidence 100 01112357889999999988889999999999999999999999997533211 11
Q ss_pred HHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 494 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
....... ... +......+.++.+++.+|++.+|++||++.++.+.|+..
T Consensus 226 ~~~~~~~----~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 226 GQVISDD----IEW---PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHHhcc----cCC---CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 1111110 000 001113445788999999999999999988777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=289.46 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=207.5
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|++.+.||+|+||.||++... +++.+++|++... ........+.+|+++++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999854 6889999998643 2334566788999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.........+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876444446789999999999999999999999 9999999999999999999999999999876544
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
......++..|+|||...+..++.++|+||||+++|||++|+.||......+ +...+ .. ..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~----~~--------~~ 217 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----LRYKV----QR--------GK 217 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH----hc--------CC
Confidence 1222457889999999999889999999999999999999999997544321 11111 11 11
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+.....++.+++.+|++.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 122234556788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=304.54 Aligned_cols=245 Identities=28% Similarity=0.375 Sum_probs=201.9
Q ss_pred CCcCCeeeeccceEEEEEEe-CCCcEEEEEEec--cCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 273 FSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~--~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
|+.++.||.|+||.||-|+. .+...||||++. ...+.....++..|+..|.+++|||++.+.|+|..+...++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55578899999999999995 478899999985 234455678999999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
|- |+-.+.+.-. .+++.+.++..|..+.+.||+|||+. +.||||||+.|||+++.|.|||+|||.+....+.
T Consensus 108 Cl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred Hh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 96 4777777653 36789999999999999999999999 9999999999999999999999999999876543
Q ss_pred cceeecccccccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
...+|||.|||||++. .+.|+-|+||||+|+...||...++|.-..+.. .-...+. ..+
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-----SALYHIA---QNe------ 241 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIA---QNE------ 241 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-----HHHHHHH---hcC------
Confidence 4467999999999984 678999999999999999999999886532211 1111111 010
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.+.+ -..+....+..++..|+++-|.+|||.++++++
T Consensus 242 sPtL--qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTL--QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC--CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1111 245677888899999999999999999999874
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=293.74 Aligned_cols=258 Identities=22% Similarity=0.278 Sum_probs=195.3
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecC--CceEEEEE
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTS--SERILVYP 348 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 348 (595)
|++.+.||+|+||.||+|... +++.||+|+++............+|+..+.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999954 689999999875433333344567888888885 99999999999887 88999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|++ +++.+.+... ...+++.++..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5777777642 24689999999999999999999999 9999999999999999 99999999999866433
Q ss_pred CcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHh----------
Q 007625 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL---------- 497 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~---------- 497 (595)
... ....++..|+|||++.. ..++.++|||||||++|||++|..||......+. ........
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ-----IAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH-----HHHHHHHcCCCCHHHHHh
Confidence 221 22457889999997654 5578899999999999999999999976443211 11111110
Q ss_pred -cccccccc-----ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 498 -REDRLNDI-----VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 498 -~~~~~~~~-----~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
........ ....+.......+.++.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000 0000001122346789999999999999999999999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.34 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=200.2
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEec-cCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEE
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~-~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 345 (595)
+....|++.+.||+||.+.||++...+.+.||+|++. ...+......|..|+..|.+++ |.+|+++++|-..++..|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3455689999999999999999998888889888876 3345666788999999999995 9999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||-+ -+|..+|..... ....| .++.+..|++.++.++|.+ ||||.||||.|+|+-+ |.+||+|||+|..+
T Consensus 438 vmE~Gd-~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred Eeeccc-ccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 999864 489999986442 22234 7889999999999999999 9999999999999965 58999999999988
Q ss_pred cCcCccee-ecccccccccCccccCCC-----------CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH
Q 007625 426 DAKLTHVT-TQIRGTMGHIAPEYLSTG-----------KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 426 ~~~~~~~~-~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~ 493 (595)
..+..... ...+||+.||+||.+... +.+.++||||+|||||+|+.|+.||... ...+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~----------~n~~ 579 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI----------INQI 579 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----------HHHH
Confidence 76655433 346799999999998422 2578999999999999999999999621 1111
Q ss_pred HHHhcccccccccccc----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 494 RKLLREDRLNDIVDRN----LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 494 ~~~~~~~~~~~~~d~~----l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.+ +..+.|+. ++..++. .+++++|..||+.||.+||+..+++++
T Consensus 580 aK------l~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 AK------LHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HH------HHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11 12233331 1111111 228999999999999999999999764
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=292.04 Aligned_cols=248 Identities=25% Similarity=0.285 Sum_probs=203.2
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
+|++.+.||+|+||.||+|... ++..||+|.+.... .....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999975 68999999986422 22456789999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+.+++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998752 4688999999999999999999999 9999999999999999999999999998866443
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||....... ...+......
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~--------- 216 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI------RDQIRAKQET--------- 216 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH------HHHHHHHhcc---------
Confidence 2 2233458889999999988889999999999999999999999998544311 1111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPM--AQVV 543 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl 543 (595)
.....+...+..+.+++.+|++.||.+||++ +|++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111223345788899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=297.33 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=198.6
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
.|.....||+|+||.||++... ++..||+|.+... .......+.+|+..++.++|+|++++++.+...+..++||||+
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 3444577999999999999964 6889999988642 2344567889999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++|.+++.. ..+++.+...++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 102 ~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 102 EGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 99999988753 3488999999999999999999999 999999999999999999999999999876543222
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ....+... .....
T Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~---------~~~~~ 238 (292)
T cd06658 174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRRIRDN---------LPPRV 238 (292)
T ss_pred -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhc---------CCCcc
Confidence 1223458899999999988889999999999999999999999987533211 11111110 01111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
. ........+.+++.+|+..||.+|||++|+++.
T Consensus 239 ~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 K-DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c-cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 112234567788999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.87 Aligned_cols=262 Identities=21% Similarity=0.343 Sum_probs=197.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC-----ce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 343 (595)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+...........+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 4789999999864333344567888999999999999999999875443 47
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++|+||+.+ ++...+.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 899999975 77766653 4589999999999999999999999 99999999999999999999999999988
Q ss_pred cccCcCcc--eeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 424 LVDAKLTH--VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 424 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
........ ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-----~~~~~~~~~~~~ 229 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-----QLNLILGVLGTP 229 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCCC
Confidence 65432221 1123468899999998754 568999999999999999999999997543211 111111111000
Q ss_pred ---cccccccc-------------cC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 ---RLNDIVDR-------------NL--NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ---~~~~~~d~-------------~l--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+.+. .. ....+....++.+++.+|++.+|++||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 00 00011235678899999999999999999999776
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=296.88 Aligned_cols=266 Identities=22% Similarity=0.282 Sum_probs=199.2
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecC--CceEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV 346 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 346 (595)
++|+..+.||+|+||.||+|... +++.+|+|.++... .......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888999999999999999975 68899999987432 223344677899999999999999999998877 889999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+.+ +|.+.+.... ..+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 8888887532 3689999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH--------HHH--H
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD--------HIR--K 495 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~--------~~~--~ 495 (595)
..... .....+++.|+|||++.+.. ++.++|+||||+++|||++|+.||............... |.. .
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 43221 22334788999999987544 689999999999999999999999764432211110000 000 0
Q ss_pred H--hccccccccccccCCC-CCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 496 L--LREDRLNDIVDRNLNT-YDSK-EVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 496 ~--~~~~~~~~~~d~~l~~-~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. .............+.. ++.. ....+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0000000000001111 1111 3567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=288.08 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=207.9
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|+..+.||+|+||.||++... ++..|++|++.... .......+.+|+++++.++|+|++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5778899999999999999964 68999999987432 235567789999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.........+++.++..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543346799999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||...... +........ .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~---------~ 219 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKG---------Q 219 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcC---------C
Confidence 2223346889999999998888999999999999999999999998754321 111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+......+.+++.+|+..+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111222344678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=298.46 Aligned_cols=270 Identities=21% Similarity=0.284 Sum_probs=198.4
Q ss_pred CCCcCCeeeeccceEEEEEEeC---CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecC--CceE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERI 344 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 344 (595)
+|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++..++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999964 47899999987522 123346678899999999999999999999888 7889
Q ss_pred EEEEecccCcHhhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC----CCcEEEeec
Q 007625 345 LVYPFMQNLSVAYRLRDLKPG-EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD----NFEAVLCDF 419 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 419 (595)
+||||+++ ++.+.+...... ...+++...+.++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 666666543322 23689999999999999999999999 9999999999999999 999999999
Q ss_pred cccccccCcCc--ceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhh-----hhhhHHH
Q 007625 420 GLAKLVDAKLT--HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE-----EDVLLLD 491 (595)
Q Consensus 420 G~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~-----~~~~l~~ 491 (595)
|++........ .......++..|+|||++.+. .++.++||||||+++|||++|+.||........ ....+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987644322 112334578899999988664 578999999999999999999999975443220 0001111
Q ss_pred HHHHHhcc-----------ccccccc-cccCCCCC---------H--HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 492 HIRKLLRE-----------DRLNDIV-DRNLNTYD---------S--KEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 492 ~~~~~~~~-----------~~~~~~~-d~~l~~~~---------~--~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.+...-.. ....... ......++ . ....++.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11100000 0000000 00000011 0 234568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=295.49 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=196.0
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|+..+.||+|+||.||++... +++.||+|.+...........+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999999964 689999999875444455678899999999996 99999999999999999999999
Q ss_pred cccCcHhhhhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 350 MQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 350 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
+.. ++.++.... ......+++.....++.|++.||+|||+.. +++||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 554433211 112356899999999999999999999742 8999999999999999999999999998765432
Q ss_pred CcceeecccccccccCccccCCC---CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
... ....|+..|+|||++.+. .++.++|||||||++|||++|+.||..... ....+........ ..
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~- 230 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVKGDP-PI- 230 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcCCCC-Cc-
Confidence 211 223578899999998766 689999999999999999999999864321 1111111111110 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+. .........++.+++.+|++.+|++|||++||++.
T Consensus 231 ~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LS---NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CC---CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 01122355678999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.36 Aligned_cols=261 Identities=24% Similarity=0.316 Sum_probs=199.6
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecC--CceEEEEE
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILVYP 348 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 348 (595)
|++.+.||+|+||.||+|... +++.+|+|++.... .......+.+|+++++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999965 58899999997543 334456788999999999999999999999888 78999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++ +|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 888777642 24689999999999999999999999 9999999999999999999999999999876554
Q ss_pred CcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc---cccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---EDRLND 504 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~ 504 (595)
.........++..|+|||.+.+ ..++.++||||||+++|||+||+.||........ ...+..... ...+..
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-----LEKIFELCGSPTDENWPG 228 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHhCCCchhhccc
Confidence 3222333456889999998764 4578999999999999999999999975443211 111111100 000000
Q ss_pred ccc--------------ccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 505 IVD--------------RNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 505 ~~d--------------~~l~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..+ ..+.. +...+...+.+++.+|++.+|.+||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 00000 011125678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=307.06 Aligned_cols=244 Identities=25% Similarity=0.383 Sum_probs=195.6
Q ss_pred CCeeeeccceEEEEEEeC-CCcEEE---EEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc--eEEEEEe
Q 007625 276 SNIIGQGGFGKVYKGVLS-DNTKVA---VKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE--RILVYPF 349 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-~~~~va---vK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 349 (595)
..+||+|+|-+||+|.+. +|..|| ||.-.-..++.....|..|+.+|+.|+||||++++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 568999999999999964 566665 3322223455667899999999999999999999999987665 6789999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-CcEEEeeccccccccCc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~~~~~~~ 428 (595)
|..|+|..++.++ +.++....++|++||++||.|||++ .|+|||||||.+||+|+.+ |.|||+|.|+|......
T Consensus 125 ~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999874 4578889999999999999999998 5689999999999999865 89999999999987643
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
. ...+.|||.|||||++. ..|.+.+||||||+.++||+|+.-||.--.. ...+.+.+.....+..+..+-|
T Consensus 200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n----~AQIYKKV~SGiKP~sl~kV~d- 270 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN----PAQIYKKVTSGIKPAALSKVKD- 270 (632)
T ss_pred c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC----HHHHHHHHHcCCCHHHhhccCC-
Confidence 2 23367999999999986 7899999999999999999999999863221 1123333333333333333333
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.++.+++.+|+.. .++|||+.|++.
T Consensus 271 ----------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 ----------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 4778899999999 999999999965
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=296.69 Aligned_cols=246 Identities=21% Similarity=0.261 Sum_probs=197.4
Q ss_pred cCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccC
Q 007625 275 ESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
....||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..++|||++++++++..++..++|+||++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 3557999999999999964 68999999986432 234567889999999999999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCccee
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 433 (595)
+|...+.. ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........ ..
T Consensus 104 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 174 (297)
T cd06659 104 ALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 174 (297)
T ss_pred CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence 99887753 3588999999999999999999999 999999999999999999999999999875543321 12
Q ss_pred ecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCC
Q 007625 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 513 (595)
Q Consensus 434 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 513 (595)
....|+..|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.. .... ....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~----~~~~------~~~~ 239 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----AMKRLRD----SPPP------KLKN 239 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhc----cCCC------Cccc
Confidence 23458899999999998889999999999999999999999997533211 1111110 0000 0001
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 514 DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 514 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.......+.+++.+|++.+|++||+++++++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 12234567889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=293.00 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=201.6
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|...+.||+|+||.||++.. .++..||+|.+... .......+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 5788899999999999999985 46889999998532 233456788999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999998864 3478899999999999999999999 99999999999999999999999999987654332
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.. .....|++.|+|||.+.+..++.++||||||+++|++++|+.||........ .......+. +.
T Consensus 170 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--------~~~~~~~~~------~~ 234 (293)
T cd06647 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIATNGT------PE 234 (293)
T ss_pred cc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--------eeehhcCCC------CC
Confidence 21 2234588899999999888899999999999999999999999975332110 000000000 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...+......+.+++.+||+.+|++||++.+++.+
T Consensus 235 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 -LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00122344568889999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=315.66 Aligned_cols=271 Identities=19% Similarity=0.237 Sum_probs=189.5
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCC--CcEEEEEEe--------------cc--CCCchhHHHHHHHHHHHHhcCCCCC
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSD--NTKVAVKRL--------------QD--YYSPGGEAAFQREVHLISVAIHKNL 330 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l--------------~~--~~~~~~~~~~~~E~~~l~~l~h~ni 330 (595)
..++|++.+.||+|+||+||++..+. +..++.|.+ .. .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987532 222222211 00 0122334568899999999999999
Q ss_pred ccccceeecCCceEEEEEecccCcHhhhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc
Q 007625 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 409 (595)
Q Consensus 331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 409 (595)
+++++++...+..++|++++.+ ++..++.... .............++.|++.||+|||+. +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9999999999999999999864 6666654321 1122344667788999999999999999 999999999999999
Q ss_pred CCCcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCC-CCCCchhhhhhhh
Q 007625 410 DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA-IDFSRLEEEEDVL 488 (595)
Q Consensus 410 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p-~~~~~~~~~~~~~ 488 (595)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +....... ...
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~--~~~ 379 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP--GKQ 379 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH--HHH
Confidence 999999999999987754433333446799999999999999999999999999999999998754 43221111 111
Q ss_pred HHHHHHHHhc-cccc-------cccccc-cC----CCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 489 LLDHIRKLLR-EDRL-------NDIVDR-NL----NTYD-----SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 489 l~~~~~~~~~-~~~~-------~~~~d~-~l----~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.+.+..... .... ...++. .. ...+ .....++.+++.+|++.||.+|||+.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111111000 0000 000000 00 0000 0112356777889999999999999999764
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.11 Aligned_cols=260 Identities=18% Similarity=0.196 Sum_probs=183.3
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCC----CcEEEEEEeccCCCch-hH---------HHHHHHHHHHHhcCCCCCcccc
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPG-GE---------AAFQREVHLISVAIHKNLLQLI 334 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~-~~---------~~~~~E~~~l~~l~h~niv~l~ 334 (595)
..++|.+.++||+|+||+||+|...+ +..+|+|+........ .. .....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 44689999999999999999999654 3456666533111110 00 1122233445567899999999
Q ss_pred ceeecCC----ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC
Q 007625 335 GYCTTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 410 (595)
Q Consensus 335 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 410 (595)
+++.... ..+++++++.. ++.+.+... ...++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 8765543 23566776543 555555432 2357788899999999999999999 9999999999999999
Q ss_pred CCcEEEeeccccccccCcCcc------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhh
Q 007625 411 NFEAVLCDFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484 (595)
Q Consensus 411 ~~~~kl~DfG~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~ 484 (595)
++.++|+|||+++........ ......||+.|+|||+..+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999866432211 11224699999999999999999999999999999999999999976532111
Q ss_pred h-hhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 485 E-DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 485 ~-~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
. .....++..... .+.. ........+.+++..|++.+|++||++.++.+.++
T Consensus 242 ~~~~~~~~~~~~~~-~~~~----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLH-EGKI----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhh-hhhh----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 111111111111 1100 01123467889999999999999999999998763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=288.25 Aligned_cols=266 Identities=24% Similarity=0.295 Sum_probs=222.0
Q ss_pred HHHHHHHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccce
Q 007625 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336 (595)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 336 (595)
.+++.+..++++...++.+|.||.||.|.|. +.+.|-+|.++...++-+...+..|.-++..+.|||+.++.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 5677888889999999999999999999653 3556889999988888888999999999999999999999999
Q ss_pred eecC-CceEEEEEecccCcHhhhhcccCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC
Q 007625 337 CTTS-SERILVYPFMQNLSVAYRLRDLKP----GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (595)
Q Consensus 337 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 411 (595)
+..+ ...+.+|.++.-|+|..+|...+. ..+.++-.+...++.|++.|++|||.+ ++||.||..+|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8665 456888999999999999984332 234577888899999999999999999 99999999999999999
Q ss_pred CcEEEeeccccccccCcCccee-ecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhH
Q 007625 412 FEAVLCDFGLAKLVDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 489 (595)
Q Consensus 412 ~~~kl~DfG~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l 489 (595)
.++||+|-.+++.+.+.+.+.- .....+..||+||.+....|+.++|||||||++|||+| |+.|+..-++.+...
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~--- 509 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH--- 509 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH---
Confidence 9999999999998876655543 33446789999999999999999999999999999998 888886544332211
Q ss_pred HHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 490 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 490 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.. .|......+-+++++++.+|..||+.+|++||+++|++..|.+
T Consensus 510 --yl------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 510 --YL------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred --HH------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11 1221122356778999999999999999999999999998864
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=291.42 Aligned_cols=248 Identities=28% Similarity=0.357 Sum_probs=197.7
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
..|+..+.||+|+||+||+|... +++.||+|.+... ........+.+|+++++.++|||++++.+++...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888999999999999999964 6899999998632 22334567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+. |++.+.+... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 5666666532 24589999999999999999999998 999999999999999999999999999876543
Q ss_pred cCcceeecccccccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
. ....++..|+|||++. ...++.++||||||+++|||+||+.||........ ........ .
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--------~~~~~~~~-~-- 231 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQND-S-- 231 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--------HHHHhcCC-C--
Confidence 2 2245788999999874 45688999999999999999999999864332110 11110000 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
+ ..........+.+++.+||+.+|++||++.+|+.+.
T Consensus 232 ---~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 ---P--TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ---C--CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 011233456789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=320.15 Aligned_cols=266 Identities=26% Similarity=0.395 Sum_probs=217.5
Q ss_pred HHHHHhcCCCcCCeeeeccceEEEEEEeC----C----CcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccc
Q 007625 265 ELQLATDNFSESNIIGQGGFGKVYKGVLS----D----NTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIG 335 (595)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 335 (595)
.+++..++..+.+.||+|.||.|++|... . ...||||.+++.......+.+..|+++++.+ .|+|++.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56666677777889999999999999842 1 4569999999877777889999999999998 5999999999
Q ss_pred eeecCCceEEEEEecccCcHhhhhcccC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCC
Q 007625 336 YCTTSSERILVYPFMQNLSVAYRLRDLK---P-------GE--KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 403 (595)
Q Consensus 336 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp 403 (595)
+|...+..++|+||+..|+|..+|+..+ . .. ..++....+.++.|||.|++||++. ++|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999999755 0 01 2388999999999999999999999 999999999
Q ss_pred CCEEEcCCCcEEEeeccccccccCcCcceeecccc--cccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCc
Q 007625 404 ANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (595)
Q Consensus 404 ~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~ 480 (595)
+|||++++..+||+|||+++..............| +..|||||.+....++.|+|||||||+|||++| |..|+..-.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765544443232222 457999999999999999999999999999998 778886421
Q ss_pred hhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 481 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 481 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
. ...+.++++. + .....+..+..++.++|+.||+.+|++||++.|+++.++..
T Consensus 527 ~----~~~l~~~l~~----G--------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 P----TEELLEFLKE----G--------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred c----HHHHHHHHhc----C--------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1 1112222222 1 11223455678899999999999999999999999999873
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=291.04 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=205.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
.++.|+..+.||+|+||.||+|..+ ++..|++|++..... ....+.+|++.++.++|+|++++++++......++|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4567888899999999999999976 688999999864332 5677889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998632 3689999999999999999999998 999999999999999999999999999875543
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
... ......++..|+|||++.+..++.++||||||+++|+|++|+.||........ . .... . ......
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~----~-~~~~---~-~~~~~~-- 236 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA----L-FLIT---T-KGIPPL-- 236 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH----H-HHHH---h-cCCCCC--
Confidence 221 12234478899999999888899999999999999999999999874332110 0 1110 0 000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.........+.+++.+|++.+|.+||++.+|++.
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 ----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0112245678899999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=284.38 Aligned_cols=250 Identities=29% Similarity=0.381 Sum_probs=203.9
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
+|+..+.||+|++|.||++... ++..+++|++..... .....+.+|++.++.++|+|++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4777899999999999999975 688999999875332 45678899999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999987632 4689999999999999999999998 999999999999999999999999999987654332
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
.....++..|+|||++.+...+.++||||||+++|+|++|+.||........ . .... . .......
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~-~~~~---~-~~~~~~~---- 218 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA----L-FKIA---T-NGPPGLR---- 218 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH----H-HHHH---h-cCCCCcC----
Confidence 2344588999999999888899999999999999999999999875422110 0 0010 0 1011111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
........+.+++.+|++.||++|||+.|++++
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111124678899999999999999999999753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.24 Aligned_cols=266 Identities=24% Similarity=0.278 Sum_probs=199.9
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCC----
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS---- 341 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 341 (595)
...++|++.+.||+|+||.||+|..+ +++.||+|+++... .......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 68899999987432 2334467788999999999999999999887654
Q ss_pred ------ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEE
Q 007625 342 ------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 342 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 415 (595)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 666666542 34689999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHH
Q 007625 416 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494 (595)
Q Consensus 416 l~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~ 494 (595)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-----~~~~~~ 231 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-----QLELIS 231 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHH
Confidence 99999998765433222222346788999998865 457899999999999999999999997543211 111111
Q ss_pred HHhcc---cccccccc--------c------cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 495 KLLRE---DRLNDIVD--------R------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 495 ~~~~~---~~~~~~~d--------~------~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..... ..+..+.. . .........+..+.+++.+|++.+|.+||++++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11100 00000000 0 0000011234678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=291.65 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=210.6
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.-|...+.||+|.|..|-.|+. -+|..||||++.+. ...-....+.+|+..|+.++|||||++|++.......|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577788999999999999983 48999999999643 334456778899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE-cCCCcEEEeeccccccccC
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfG~~~~~~~ 427 (595)
.-.+|+|++++... ...+.+..+.+++.||..|+.|+|+. .+|||||||+||.+ ..-|-+||+|||++-.+..
T Consensus 98 LGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999864 45699999999999999999999999 89999999999987 4568999999999987654
Q ss_pred cCcceeecccccccccCccccCCCCCC-ccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSS-EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.. .-...+|+..|-|||++.+..|+ +++||||+|||||.|+.|+.||...+..+. +..++
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-----------------LTmIm 232 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-----------------LTMIM 232 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-----------------hhhhh
Confidence 32 23456799999999999998885 578999999999999999999986554322 22233
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
|... ..+.....++.+++..|+..||.+|.+.+||+..
T Consensus 233 DCKY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 233 DCKY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cccc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 3321 2467788899999999999999999999999864
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.94 Aligned_cols=263 Identities=25% Similarity=0.296 Sum_probs=197.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecC--CceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 345 (595)
.++|++.+.||+|+||.||+|... +|+.||+|+++... .......+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999964 68999999986332 222234567899999999999999999998755 45799
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+.+ +|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 788777653 24689999999999999999999999 9999999999999999999999999999876
Q ss_pred cCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc---cc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DR 501 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~ 501 (595)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+...... ..
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-----~~~~~~~~~~~~~~~ 232 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-----LDLIIQLLGTPNESI 232 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhcCCCChhh
Confidence 543211 122335788999999865 4578999999999999999999999975433211 1111111100 00
Q ss_pred cc-----------ccccccCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 502 LN-----------DIVDRNLNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 502 ~~-----------~~~d~~l~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+. ..-...... .......++.+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000000000 011135567889999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=303.41 Aligned_cols=251 Identities=25% Similarity=0.328 Sum_probs=202.7
Q ss_pred CCCcCCeeeeccceEEEEEEeCCCcE-EEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~-vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
.|++...||.|+||.||+|..++... .|.|++ +..+.....+|.-|+++|..+.||+||++++.|...+..++..|||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI-etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI-ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhh-cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34556789999999999999765444 456665 3455667788999999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
.||.+...+-.. ...+++.++..++.|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+..... ..
T Consensus 112 ~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TR 184 (1187)
T ss_pred CCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HH
Confidence 999998888764 46799999999999999999999999 999999999999999999999999999864322 12
Q ss_pred ceeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 431 HVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.......|||.|||||+.+ ..+|+.++||||||+.|.||..+.+|-..-+. -..+.+...
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----MRVllKiaK----------- 249 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAK----------- 249 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----HHHHHHHhh-----------
Confidence 2334567999999999975 46799999999999999999999998653221 111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
-+++-.-.+......+.++..+|+..+|..||++.|++++
T Consensus 250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 0111112366777888999999999999999999999875
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=289.34 Aligned_cols=248 Identities=21% Similarity=0.268 Sum_probs=199.2
Q ss_pred CCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
.|...+.||+|++|.||++.. .+++.+++|++... .......+.+|+.+++.++|||++++++++...+..++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 344568999999999999995 47889999988632 2234566889999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 99 EGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999998875 3588999999999999999999999 999999999999999999999999998875543222
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
......|++.|+|||...+..++.++||||||+++|||++|+.||...... ......... ....
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------~~~~~~~~~-~~~~------ 234 (285)
T cd06648 171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------QAMKRIRDN-LPPK------ 234 (285)
T ss_pred -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHhc-CCCC------
Confidence 122345889999999998888999999999999999999999998653321 111111111 0000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
..........+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 235 LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0011224467899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=281.43 Aligned_cols=243 Identities=23% Similarity=0.271 Sum_probs=201.9
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
.-++|..+++||+|.||.|-.++-+ +++.||+|++++.. .....+.-..|-++|+..+||.+..+.-.++..++.|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4467888999999999999999955 78999999997532 33445666789999999999999999989999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||..||.|..+|.. ...+++....-+...|..||.|||++ +||.||+|.+|.|+|.+|++||+|||+++.-
T Consensus 246 VMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999988876 45688899999999999999999999 9999999999999999999999999999742
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
- .....+...+|||.|+|||++....|..++|+|.+|||+|||+.|+.||...+.+ .+.+.+..
T Consensus 319 I-~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----kLFeLIl~---------- 382 (516)
T KOG0690|consen 319 I-KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----KLFELILM---------- 382 (516)
T ss_pred c-cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----HHHHHHHh----------
Confidence 2 2344566789999999999999999999999999999999999999999854432 12222211
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 537 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP 537 (595)
.. ..++.....+...+....+.+||.+|.
T Consensus 383 --ed-~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 383 --ED-LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --hh-ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 00 123445556677778889999999994
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.67 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=196.4
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
++|+..+.||+|++|+||+|... +++.||+|.+.... .......+.+|++++++++|||++++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999965 68899999986432 22344678899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-CCcEEEeeccccccccC
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~~~~~~~ 427 (595)
|++ +++.+.+.... ...+++.....++.|++.||+|||+. +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 47777765422 23467888899999999999999999 9999999999999985 56799999999976543
Q ss_pred cCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc--cccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--EDRLND 504 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~--~~~~~~ 504 (595)
... ......+++.|+|||++.+. .++.++||||||+++|+|+||+.||......+. .......... ...+..
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE----LFKIFRILGTPNEETWPG 230 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChhhccc
Confidence 221 12233478899999998664 578999999999999999999999975433211 1111100000 000000
Q ss_pred -------------cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 505 -------------IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 505 -------------~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
..........+....++.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000011223456788999999999999999999976
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=285.89 Aligned_cols=252 Identities=20% Similarity=0.316 Sum_probs=200.2
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC----CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
+|.+.+.||+|+||.||++... .+..+++|.++.. ........+..|+.+++.++|||++++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788899999999999999864 3455666666532 1233445677899999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999886554456799999999999999999999999 9999999999999976 469999999987664
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.... ......|+..|+|||...+..++.++|+||||+++|+|++|..||...... ........
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------~~~~~~~~-------- 219 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--------SVVLRIVE-------- 219 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHc--------
Confidence 3221 223345788999999998888899999999999999999999998643221 11111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
......+.....++.+++.+|+..+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 -GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11122334556788899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=321.78 Aligned_cols=254 Identities=26% Similarity=0.333 Sum_probs=189.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC-------
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------- 340 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 340 (595)
-..+|++.++||+||||.||+++.+ ||+.||||++.-..+......+.+|+..+++++|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4457888999999999999999966 89999999997544556667889999999999999999975321000
Q ss_pred --------------------------------------------------------------------------------
Q 007625 341 -------------------------------------------------------------------------------- 340 (595)
Q Consensus 341 -------------------------------------------------------------------------------- 340 (595)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 007625 341 --------------------------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388 (595)
Q Consensus 341 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L 388 (595)
...|+-||||+..++.+++++.... -.....++++.+|+.||+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHH
Confidence 0135667888877777777652211 14678899999999999999
Q ss_pred hhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc------C-----------cCcceeecccccccccCccccCCC
Q 007625 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD------A-----------KLTHVTTQIRGTMGHIAPEYLSTG 451 (595)
Q Consensus 389 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~ 451 (595)
|++ |||||||||.||+++++..|||+|||++.... . ......+...||.-|+|||++.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 999 99999999999999999999999999998721 0 001122345699999999999754
Q ss_pred ---CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHc
Q 007625 452 ---KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLC 528 (595)
Q Consensus 452 ---~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c 528 (595)
+|+.|+|+||+|||++||+. ||... .+..... ..++.+.+... ..+..+....=.+++.++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL----~~LR~g~iP~~-----~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS----MERASIL----TNLRKGSIPEP-----ADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCch----HHHHHHH----HhcccCCCCCC-----cccccccchHHHHHHHHH
Confidence 49999999999999999986 55421 1111111 22222222221 223444555667888999
Q ss_pred ccCCCCCCCCHHHHHH
Q 007625 529 TQSTPEDRPPMAQVVK 544 (595)
Q Consensus 529 l~~dP~~RPs~~evl~ 544 (595)
++.||.+|||+.|+++
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999965
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=293.12 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=202.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
..+.|+.-++||+|+||.||.++. .+|+-||.|.+.+. ...........|-.++.+++.+.||.+--.|.+.+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 445688889999999999999985 47999999987532 123445667889999999999999999989999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
|+..|.||+|..++.+.. +..+++..+.-++.+|+.||++||+. +||.||+||+|||+|+.|+++|+|.|+|..+
T Consensus 263 VLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999998754 46899999999999999999999999 9999999999999999999999999999987
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
...... ...+||.+|||||++.+..|+...|+||+||++|||+.|+.||....... -.+.+.....
T Consensus 338 ~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-----k~eEvdrr~~------- 403 (591)
T KOG0986|consen 338 PEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-----KREEVDRRTL------- 403 (591)
T ss_pred CCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-----hHHHHHHHHh-------
Confidence 654433 33479999999999999999999999999999999999999997432110 0001111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 540 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 540 (595)
..-..++...+++..++....++.||++|..-.
T Consensus 404 --~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 --EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 001124455566777778888999999986543
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=290.13 Aligned_cols=244 Identities=24% Similarity=0.287 Sum_probs=187.8
Q ss_pred eeeeccceEEEEEEeC-CCcEEEEEEeccCCC--chhHHHHHHHHHHHH---hcCCCCCccccceeecCCceEEEEEecc
Q 007625 278 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLIS---VAIHKNLLQLIGYCTTSSERILVYPFMQ 351 (595)
Q Consensus 278 ~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 351 (595)
+||+|+||.||++... +++.||+|.+..... ......+.+|..++. ..+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 689999998864321 122233444544333 3479999999999999999999999999
Q ss_pred cCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc
Q 007625 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (595)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 431 (595)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 9999988875 34689999999999999999999999 999999999999999999999999999875543221
Q ss_pred eeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 432 VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
....|+..|+|||.+.+ ..++.++|||||||++|||++|..||......... ........ .+
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~------~~--- 215 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------EIDRMTLT------VN--- 215 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH------HHHHHhhc------CC---
Confidence 23458999999999864 55899999999999999999999999754321111 11110000 00
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKML 546 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 546 (595)
...+.....++.+++.+|+..||.+|| +++|++++-
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 112333456788999999999999999 598886653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.24 Aligned_cols=265 Identities=20% Similarity=0.294 Sum_probs=198.8
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC------
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------ 340 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 340 (595)
..++|+..+.||+|+||.||+|... +++.||+|++... ........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 7899999998642 2334456677899999999999999999987543
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
...++||||+.+ +|.+.+.. .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 346899999964 77777653 278889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhH----------H
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL----------L 490 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l----------~ 490 (595)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+......... .
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9987644321 223457889999999999999999999999999999999999997544321100000 0
Q ss_pred HH----HHHHhccc------cccccccccC-C----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 491 DH----IRKLLRED------RLNDIVDRNL-N----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 491 ~~----~~~~~~~~------~~~~~~d~~l-~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. ........ .....+.... . .........+.+++.+|++.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00000000 0001111000 0 0112345677899999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=292.29 Aligned_cols=267 Identities=23% Similarity=0.302 Sum_probs=195.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCC------
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 341 (595)
.++|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999964 68999999986432 2233445678999999999999999999886654
Q ss_pred --ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 342 --ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 342 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
..++||||+.+ ++.+.+... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 34999999975 777777542 23689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcc---eeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 420 GLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 420 G~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
|++......... ......++..|+|||++.+. .++.++||||||+++|||+||+.||........ ......+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~--~~~~~~~~~ 241 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ--LTLISQLCG 241 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhC
Confidence 999866433221 11234578899999988664 468899999999999999999999875443211 111111110
Q ss_pred Hhcccccccc-----ccc-cCCCC----------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 496 LLREDRLNDI-----VDR-NLNTY----------DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 496 ~~~~~~~~~~-----~d~-~l~~~----------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.......... .+. ..... .......+.+++.+|+..||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000000 000 00000 00123456789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=291.38 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=196.3
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCC-CcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 346 (595)
..++|++.+.||+|+||.||+|..++ ++.||+|.++..........+..|+.++.+.. ||||+++++++.+....++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34668889999999999999999764 89999999975444445566777887776665 99999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+.+ ++.+..... ...+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.++|+|||++....
T Consensus 93 ~e~~~~-~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMST-CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccCc-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999854 666665542 236899999999999999999999732 89999999999999999999999999987654
Q ss_pred CcCcceeecccccccccCccccCCCC----CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGK----SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .+..........
T Consensus 167 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~- 236 (296)
T cd06618 167 DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEEP- 236 (296)
T ss_pred CCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCCC-
Confidence 32221 2234788999999987553 788999999999999999999998642211 011111111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
.. .. .......++.+++.+|++.||.+||++.+++++-
T Consensus 237 ~~-----~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 PS-----LP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CC-----CC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00 00 0112345788999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=288.14 Aligned_cols=265 Identities=22% Similarity=0.273 Sum_probs=198.7
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEEEEEec
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
|.+.+.||+|+||+||+|... +++.|++|++.............+|+..+.+++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 578899999875433333445567999999999 999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++++.+.+.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789988887532 24689999999999999999999999 999999999999999999999999999986643222
Q ss_pred ceeecccccccccCccccC-CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhH--------HHHHHHHhcccc
Q 007625 431 HVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL--------LDHIRKLLREDR 501 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l--------~~~~~~~~~~~~ 501 (595)
.....++..|+|||++. ...++.++|+||||+++|||++|+.||............. ..|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 12345788999999875 4457899999999999999999999987543321110000 000000000000
Q ss_pred ccccccc----cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 502 LNDIVDR----NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 502 ~~~~~d~----~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+.. .+....+....++.+++.+|++.+|++||+++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 0001111224678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=297.39 Aligned_cols=267 Identities=20% Similarity=0.326 Sum_probs=199.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeec----CCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 343 (595)
.++|++.+.||+|+||.||+|... ++..||+|++.... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999964 69999999987432 22345677889999999999999999998753 3457
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 89999996 588888764 34589999999999999999999998 99999999999999999999999999997
Q ss_pred cccCcCcc---eeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHH-------
Q 007625 424 LVDAKLTH---VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH------- 492 (595)
Q Consensus 424 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~------- 492 (595)
........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~-~~~~~g~~~~~ 234 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL-ILSVLGSPSEE 234 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHH-HHHHhCCChhH
Confidence 65432211 1223468899999999765 4589999999999999999999999975433211000 0000
Q ss_pred HHHHhcccccccccc---ccC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 493 IRKLLREDRLNDIVD---RNL----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d---~~l----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..............+ ... ....+....++.+++.+|++.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000000000 000 00112346788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=289.58 Aligned_cols=259 Identities=20% Similarity=0.255 Sum_probs=203.5
Q ss_pred CCCcCCeeeeccceEEEEEEe----CCCcEEEEEEeccCC---CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCce
Q 007625 272 NFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (595)
+|++.+.||+|+||.||+++. .+++.||+|+++... .......+..|++++.++ +|||++++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477789999999999999984 357889999986421 123345788999999999 599999999999988999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999988874 34588999999999999999999998 99999999999999999999999999988
Q ss_pred cccCcCcceeecccccccccCccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
..............|+..|+|||...+.. .+.++||||||+++|||++|..||........ ..+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~- 228 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----QSEISRRILKSK- 228 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----HHHHHHHHHccC-
Confidence 65443332233355889999999987655 78899999999999999999999864321110 111111111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL 551 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 551 (595)
...+......+.+++.+|++.+|++|||+.++.+.|+...+
T Consensus 229 ---------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 229 ---------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred ---------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 11122334567889999999999999999999888877544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=285.21 Aligned_cols=243 Identities=24% Similarity=0.296 Sum_probs=196.8
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcH
Q 007625 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (595)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (595)
||.|+||.||+|+.. +++.||+|++.... .......+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 58999999986432 234457789999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeec
Q 007625 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435 (595)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 435 (595)
.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999975 24588999999999999999999998 99999999999999999999999999998765432 2223
Q ss_pred ccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCH
Q 007625 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 515 (595)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 515 (595)
..++..|+|||.+.+..++.++|+||||+++|||++|..||...... ..+......... ....++.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~--------~~~~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED------PMEIYNDILKGN--------GKLEFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC------HHHHHHHHhccC--------CCCCCCc
Confidence 45788999999998888999999999999999999999999754321 111111111100 0111223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007625 516 KEVETMVQVALLCTQSTPEDRPP-----MAQVVK 544 (595)
Q Consensus 516 ~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 544 (595)
....++.+++.+||+.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 33578899999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=288.42 Aligned_cols=260 Identities=23% Similarity=0.306 Sum_probs=201.9
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
|+..+.||+|++|.||+|... +++.+++|++.... .......+.+|++++++++|+|++++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999964 78899999987433 2244567889999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++ ++.+.+... ...+++.++..++.|++.||.|||+. +++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 887777652 24689999999999999999999999 99999999999999999999999999998765443
Q ss_pred ceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc---ccccccc
Q 007625 431 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLNDIV 506 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~ 506 (595)
.......++..|+|||.+.+. ..+.++||||||+++|+|+||+.||......+... ........ ..+....
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF-----KIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHHHcCCCchHhcccch
Confidence 112234578899999998776 68999999999999999999999997654322111 01110000 0000000
Q ss_pred --------------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 --------------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 --------------d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.......+....++.+++.+|++.||.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000011223456788999999999999999999999753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=292.34 Aligned_cols=260 Identities=24% Similarity=0.271 Sum_probs=193.5
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCc
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 354 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (595)
++.+|.|+++.||++.. +++.||+|++... ........+.+|+++++.++|+||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 44445555555555554 7899999998753 344566789999999999999999999999999999999999999999
Q ss_pred HhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc----
Q 007625 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT---- 430 (595)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~---- 430 (595)
+.+++.... ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+........
T Consensus 86 l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999998543 24588999999999999999999999 999999999999999999999999998875532211
Q ss_pred --ceeecccccccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc----cc--
Q 007625 431 --HVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR----ED-- 500 (595)
Q Consensus 431 --~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~----~~-- 500 (595)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+....... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM----LLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccCccccccCch
Confidence 11123446788999999865 3578999999999999999999999975432111 1111110000 00
Q ss_pred -----cccc----ccccc-----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 -----RLND----IVDRN-----LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 -----~~~~----~~d~~-----l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.... ..+.. ..........++.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 011233445678899999999999999999999664
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=280.40 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=205.9
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecC--CceEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILVY 347 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 347 (595)
+|...+.||+|++|.||+|... +++.|++|++.... .....+.+.+|+..+++++|+|++++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 78999999986432 234567889999999999999999999999888 7899999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998763 3789999999999999999999998 999999999999999999999999999987755
Q ss_pred cCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.... ......++..|+|||...+...+.++||||||+++|+|++|..||...... ..........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~------- 219 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-------MAALYKIGSS------- 219 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHhcccc-------
Confidence 4321 123345788999999998888999999999999999999999999754411 1111111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
......+......+.+++.+|++.+|.+||++.|+++.
T Consensus 220 -~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 220 -GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11112233346788999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=296.39 Aligned_cols=267 Identities=21% Similarity=0.331 Sum_probs=198.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhc-CCCCCccccceeecC--Cce
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS--SER 343 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 343 (595)
..++|++.+.||+|+||.||+|... +++.+|+|++... ........+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999965 6889999988532 2233445677899999999 999999999988654 357
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||++ ++|..++.. ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 488887764 2678999999999999999999998 99999999999999999999999999998
Q ss_pred cccCcCc----ceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH-----
Q 007625 424 LVDAKLT----HVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI----- 493 (595)
Q Consensus 424 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~----- 493 (595)
....... .......|+..|+|||++.+ ..++.++||||||+++|||+||+.||........... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~ 234 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK-IIEVIGPPSA 234 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCCH
Confidence 6643322 12233458899999998765 4578899999999999999999999975443221100 00000
Q ss_pred ------HHHhccccccccccc---cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 494 ------RKLLREDRLNDIVDR---NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 494 ------~~~~~~~~~~~~~d~---~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
............... ...........++.+++.+|++.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000 0011112245678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=294.30 Aligned_cols=261 Identities=24% Similarity=0.294 Sum_probs=193.6
Q ss_pred Ceeeec--cceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQG--GFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
..||+| +||+||+|... +|+.||+|++.... .....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999964 79999999986432 334457889999999999999999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
+++.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999988643 23589999999999999999999998 99999999999999999999999998654332111100
Q ss_pred ------eecccccccccCccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHH--------
Q 007625 433 ------TTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL-------- 496 (595)
Q Consensus 433 ------~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~-------- 496 (595)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||........ ........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM----LLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH----HHHHhcCCCCCCcccc
Confidence 0112245679999998763 478999999999999999999999975432111 00000000
Q ss_pred ------------------------hccccccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 497 ------------------------LREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 497 ------------------------~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
..........+..+.. ........+.+++.+|++.||++|||+.|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0000000000011111 1234567889999999999999999999996543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=283.61 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=198.7
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC----CCchhHHHHHHHHHHHHhcCCCCCccccceeecC--Cce
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 343 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 343 (595)
.+|++.+.||+|+||.||+|.. .++..||+|.+... ........+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5788999999999999999996 46899999987521 1233456888999999999999999999998764 357
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999998875 23578999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCc--ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 424 LVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 424 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
....... .......++..|+|||++.+...+.++|||||||++|||++|+.||....... .+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--------AIFKIATQP- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--------HHHHHHcCC-
Confidence 6533211 11223458899999999988889999999999999999999999997432111 111111100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.....+......+.+++.+|++ +|.+||++.+++++
T Consensus 226 -------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 -------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0112344455778899999999 57999999988653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=287.01 Aligned_cols=260 Identities=23% Similarity=0.330 Sum_probs=196.3
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCC-chhHHHHHHHHHHHHhc---CCCCCccccceeecCCc-----
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVA---IHKNLLQLIGYCTTSSE----- 342 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 342 (595)
|++.+.||+|+||.||+|+.+ +++.||+|+++.... ......+.+|+.++.++ .|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 589999999974322 23345566787776655 59999999999988776
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.+++|||+.+ +|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 7888876533 23589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc-
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR- 501 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~- 501 (595)
........ .....++..|+|||++.+..++.++||||||+++|||++|+.||......+. .............
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ----LDKIFDVIGLPSEE 228 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH----HHHHHHHcCCCChH
Confidence 87643321 1223478899999999988899999999999999999999999875433211 1111111100000
Q ss_pred ------------ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 502 ------------LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 502 ------------~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.............+.....+.+++.+||+.||.+||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000111112334567789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=288.29 Aligned_cols=242 Identities=26% Similarity=0.336 Sum_probs=191.4
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcH
Q 007625 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (595)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (595)
||+|+||+||+|... +|+.||+|.+.... .......+..|++++++++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68999999986321 223345677899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeec
Q 007625 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435 (595)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 435 (595)
.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+...... .....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 99987533 24689999999999999999999999 9999999999999999999999999998765432 12223
Q ss_pred ccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCH
Q 007625 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 515 (595)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 515 (595)
..++..|+|||++.+..++.++||||||+++|+|++|+.||......... ..+...... .....+.
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~---------~~~~~~~ 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-----EELKRRTLE---------MAVEYPD 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-----HHHHhcccc---------ccccCCc
Confidence 45788999999998888999999999999999999999999754321110 011110000 0011223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHH
Q 007625 516 KEVETMVQVALLCTQSTPEDRPPMAQ 541 (595)
Q Consensus 516 ~~~~~l~~l~~~cl~~dP~~RPs~~e 541 (595)
.....+.+++.+||+.+|.+||+..+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCc
Confidence 34567889999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.91 Aligned_cols=266 Identities=21% Similarity=0.316 Sum_probs=198.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC-----Cc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE 342 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 342 (595)
.++|.+.+.||+|+||+||+|+. .+++.||+|.+... ........+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45789999999999999999995 47899999998643 2233455677899999999999999999988654 34
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++|+||+. ++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 678777764 34689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHH-------
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR------- 494 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~------- 494 (595)
....... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.......... .......
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK-LITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH-HHHHHhCCCChHHh
Confidence 8664432 12233457889999998765 468999999999999999999999997543211100 0000000
Q ss_pred HHhcccccccc-------ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 495 KLLREDRLNDI-------VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 495 ~~~~~~~~~~~-------~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
........... .+.......+....++.+++.+|++.+|++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000 0000011112345678899999999999999999999776
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=288.10 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=197.5
Q ss_pred CCCcCCeeeeccceEEEEEEe----CCCcEEEEEEeccCC---CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCce
Q 007625 272 NFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (595)
+|++.+.||+|+||.||+|+. .+|..||+|+++... .......+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 368899999986421 123346778899999999 599999999999988899
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999875 34588999999999999999999998 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
..............|+..|+|||++.+. .++.++||||||+++|+|++|+.||....... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~~- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN----SQAEISRRILKSE- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc----cHHHHHHHhhccC-
Confidence 7644332223345588999999998753 46789999999999999999999986432211 1111111111100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
..++......+.+++.+|++.+|++|| ++++++.+
T Consensus 229 ---------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ---------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 112223446778899999999999997 66666443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=326.66 Aligned_cols=253 Identities=25% Similarity=0.297 Sum_probs=205.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.+-++..+..||.|.||.||.|. .++|...|+|-++-.. .....+.+.+|+.++..++|||+|+++|+-...+..++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 44467778899999999999999 5679999999886322 234456788999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
||||++|+|.+.+.. ....++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+.
T Consensus 1313 MEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999986 33467777788999999999999999 99999999999999999999999999999876
Q ss_pred CcCcce---eecccccccccCccccCCCC---CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHH-hcc
Q 007625 427 AKLTHV---TTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL-LRE 499 (595)
Q Consensus 427 ~~~~~~---~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~-~~~ 499 (595)
...... -....||+.|||||++.+.. ...+.||||+|||+.||+||++||...+. +|...+ +..
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWAIMYHVAA 1456 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhHHHhHHhc
Confidence 553222 23467999999999997644 56789999999999999999999974332 222221 111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+ ..+..|.....+-.+++..|++.||++|.++.|+++.
T Consensus 1457 g--------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 G--------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred c--------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1 2233455566777889999999999999888877654
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.88 Aligned_cols=261 Identities=23% Similarity=0.344 Sum_probs=201.9
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCC-chhHHHHHHHHHHHHhcCCCCCccccceeecCC-----ceE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI 344 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 344 (595)
+|++.+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999965 589999999875432 345577899999999999999999999988775 789
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||+|+++ +|.+.+.. ...+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999984 78877764 33789999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCc--ceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc--
Q 007625 425 VDAKLT--HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE-- 499 (595)
Q Consensus 425 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~-- 499 (595)
...... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.. ..+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~-----~~i~~~~~~~~ 227 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL-----NLIVEVLGTPS 227 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH-----HHHHHhcCCCC
Confidence 654321 112334578899999999887 7899999999999999999999999765432211 111110000
Q ss_pred ---------cccccccc-------ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 ---------DRLNDIVD-------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 ---------~~~~~~~d-------~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
......+. ..+....+.....+.+++.+||+.+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 00000112245678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=289.44 Aligned_cols=247 Identities=27% Similarity=0.370 Sum_probs=196.2
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
|...+.||+|+||.||+|+.. ++..||+|.+... ........+..|+++++.++|||++++++++..+...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666889999999999999964 6889999998632 2233456788999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+.+ ++.+.+... ...+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 974 777766532 34589999999999999999999999 9999999999999999999999999998754332
Q ss_pred cceeecccccccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
....|+..|+|||++. ...++.++|||||||++|||++|+.||........ ..... ....
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----~~~~~----~~~~----- 241 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIA----QNES----- 241 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHH----hccC-----
Confidence 2345788999999974 45688999999999999999999999864321110 11111 1110
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
...........+.+++.+|++.+|.+||++.+|++.+.
T Consensus 242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00112234456889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=295.75 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=192.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCC------
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 341 (595)
.++|...+.||+|+||.||+|+. .+|+.||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999996 478999999986432 2333456889999999999999999999886543
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++|+||+.. ++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999864 5554432 3588999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH-------
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI------- 493 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~------- 493 (595)
++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||........... .....
T Consensus 164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ-ILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCCHHH
Confidence 87653321 23357889999999876 4688999999999999999999999986443211100 00000
Q ss_pred HHHhccccccccc-------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 494 RKLLREDRLNDIV-------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 494 ~~~~~~~~~~~~~-------d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
............. ...+....+....++.+++.+|++.||++||++.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000000 000000011234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=316.43 Aligned_cols=261 Identities=22% Similarity=0.283 Sum_probs=212.3
Q ss_pred HHHHHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeec
Q 007625 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (595)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 339 (595)
..+++...++|++.++||+|+||.|..++.+ +++.||+|++.+. ......+.|..|-.+|..-+.+.|+++.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4677788899999999999999999999964 6889999999753 223456789999999999999999999999999
Q ss_pred CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
+...|+|||||+||+|..++..+. .+++..++-++..|..||.-+|+. |+|||||||+|||+|..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999998743 699999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcceeecccccccccCccccC----C-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHH
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLS----T-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~ 494 (595)
|.+-.+..+..-.+...+|||.|++||++. + +.|+..+|+||+||++|||+.|..||..... ++.+.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--------veTY~ 291 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--------VETYG 291 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--------HHHHH
Confidence 999988866665666678999999999985 3 6789999999999999999999999986543 34444
Q ss_pred HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 007625 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP---MAQVVKM 545 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~ 545 (595)
++......-.+.+. ...+.+..++|.+.+. +|+.|.. ++++-.+
T Consensus 292 KIm~hk~~l~FP~~------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 292 KIMNHKESLSFPDE------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHhchhhhcCCCcc------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 44333211111110 1233455555555443 7888888 7777443
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=280.19 Aligned_cols=248 Identities=27% Similarity=0.404 Sum_probs=202.7
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|+..+.||+|++|.||+|... +++.|++|.+.... .......+.+|++++.+++|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 67899999987532 224567899999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999988753 4689999999999999999999999 99999999999999999999999999998775443
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.. .....++..|+|||...+...+.++||||+|+++|+|++|+.||....... .. ...... .
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~----~~~~~~---------~ 215 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----AL----FRIVQD---------D 215 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HH----HHHhcc---------C
Confidence 22 233457889999999988778999999999999999999999986432110 00 011000 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
....+......+.+++.+|+..+|++||++.|++.
T Consensus 216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 01112233567889999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=282.85 Aligned_cols=246 Identities=24% Similarity=0.309 Sum_probs=197.9
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcH
Q 007625 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (595)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (595)
||+|+||.||+++.. +|+.|++|++.... .......+.+|++++++++|||++++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 58999999986432 224456788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc-----
Q 007625 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT----- 430 (595)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~----- 430 (595)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998753 3689999999999999999999999 999999999999999999999999999875533211
Q ss_pred --ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 431 --HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 431 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.......++..|+|||...+...+.++||||||+++||+++|..||....... ....... +..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~-~~~------ 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--------IFQNILN-GKI------ 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhc-CCc------
Confidence 12233457889999999988889999999999999999999999997543211 1111111 100
Q ss_pred cCCCCCHH--HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 509 NLNTYDSK--EVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 509 ~l~~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..+.. ....+.+++.+|++.+|.+||++.++.+.|+..
T Consensus 219 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 219 ---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred ---CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 01111 256788999999999999999997777666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=285.52 Aligned_cols=249 Identities=23% Similarity=0.323 Sum_probs=202.7
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 346 (595)
++|...+.||+|+||.||+|... ++..||+|++... ........+.+|.+++.++. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47888999999999999999965 7899999998642 23344567889999999998 99999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999762 3699999999999999999999999 99999999999999999999999999988664
Q ss_pred CcCc-------------------ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhh
Q 007625 427 AKLT-------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 487 (595)
Q Consensus 427 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~ 487 (595)
.... .......++..|+|||+......+.++||||||++++++++|+.||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---- 229 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---- 229 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence 4321 11223457889999999988889999999999999999999999997543110
Q ss_pred hHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 007625 488 LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM----AQVVK 544 (595)
Q Consensus 488 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~ 544 (595)
....+. ... ...+......+.+++.+|++.+|.+||++ +|+++
T Consensus 230 -~~~~~~---~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 -TFQKIL---KLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -HHHHHH---hcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111 000 01222335678899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=280.08 Aligned_cols=249 Identities=20% Similarity=0.240 Sum_probs=191.9
Q ss_pred HHHHHHhcCCCcCCee--eeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeec
Q 007625 264 RELQLATDNFSESNII--GQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 339 (595)
.+.....++|++.+.+ |+|+||.||++.. .++..+|+|.+....... .|+.....+ +|||++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEec
Confidence 3334445677777776 9999999999996 468889999986422111 122222222 69999999999999
Q ss_pred CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC-cEEEee
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCD 418 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D 418 (595)
.+..++||||+++++|.+++.. ...+++.++..++.|++.||.|||+. +++||||||+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999875 23789999999999999999999999 999999999999999998 999999
Q ss_pred ccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
||+++...... ...++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+....
T Consensus 154 fg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~-- 223 (267)
T PHA03390 154 YGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLKRQ-- 223 (267)
T ss_pred CccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHHHhh--
Confidence 99987654321 2357899999999998889999999999999999999999997433211 1111121111
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-MAQVVK 544 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 544 (595)
.. ...........+.+++.+|++.+|.+||+ ++|+++
T Consensus 224 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 QK---------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cc---------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 00112345567889999999999999996 588864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=291.35 Aligned_cols=266 Identities=23% Similarity=0.281 Sum_probs=194.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCC------
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 341 (595)
.++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999965 68999999986432 2223346678999999999999999999875443
Q ss_pred --ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 342 --ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 342 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
..++|++|+.+ ++...+... ...+++.++..++.|+++||+|||+. +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 35899999875 666666542 34689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcc----------eeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhh
Q 007625 420 GLAKLVDAKLTH----------VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488 (595)
Q Consensus 420 G~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~ 488 (595)
|+++........ ......+++.|+|||++.+. .++.++||||||+++|||++|+.||...........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~- 238 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL- 238 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence 999865432211 11223568889999987654 578999999999999999999999975443211110
Q ss_pred HHHHHHHHhcccc------ccccc----cccCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 489 LLDHIRKLLREDR------LNDIV----DRNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 489 l~~~~~~~~~~~~------~~~~~----d~~l~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
...... ...+.. ..... ...... ........+.+++.+|++.+|++|||+.|++.
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCG-TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhC-CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 000000 00000 000000 00112356889999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=281.60 Aligned_cols=246 Identities=21% Similarity=0.240 Sum_probs=190.6
Q ss_pred CeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHH-HhcCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLI-SVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
+.||+|+||.||+|... +++.||+|++.... .......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999964 68899999986422 112223344554443 455899999999999999999999999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999875 24588999999999999999999999 999999999999999999999999999875432
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....++..|+|||.+.+..++.++||||||+++|||+||..||....... ...... ..... ... .
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~----~~~~~--~~~---~ 215 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-----VFDNIL----SRRIN--WPE---E 215 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHH----hcccC--CCC---c
Confidence 223457889999999988888999999999999999999999997543211 111111 00000 000 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
........+.+++.+|++.+|++||++.++.+.|..
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 112345678899999999999999988777666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=296.07 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=208.3
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
....|.+...||+|.|+.|..|+. .++..||+|.+.+.. .......+.+|++++..++|||||+++.+.......++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 456788999999999999999995 479999999997543 333446689999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||..+|.+++++... ..+....+..++.|+..|++|+|++ .|+|||||++||||+.++++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999863 3456688999999999999999999 99999999999999999999999999998876
Q ss_pred CcCcceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
. .......+|++.|.|||++.+.+| .+.+|+||+|+++|-|+.|..||++....+.....+..
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g-------------- 270 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG-------------- 270 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee--------------
Confidence 3 344566789999999999998876 67999999999999999999999975543221110000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.-..+.-...++.+++++++..+|.+|++.+++.+.
T Consensus 271 ----k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 ----KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ----eecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 001122334567788889999999999999999764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.63 Aligned_cols=202 Identities=27% Similarity=0.367 Sum_probs=177.0
Q ss_pred CCcCCeeeeccceEEEEEE-eCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC------CceEE
Q 007625 273 FSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SERIL 345 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 345 (595)
+...+.||+|+||.||+|+ ..+|+.||||.++........+..-+|++++++++|+|||++++.-.+. ...++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3446789999999999999 5589999999998766777788889999999999999999999876544 36789
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc--CCC--cEEEeeccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNF--EAVLCDFGL 421 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DfG~ 421 (595)
|||||.+|+|...|++-. +..++++.+.+.+..+++.||.|||++ +|+||||||.||++- .+| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999999744 457899999999999999999999999 999999999999993 333 469999999
Q ss_pred cccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~ 480 (595)
|+.++++. ......||..|++||++.. +.|+..+|.|||||++||+.||..||....
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99887654 4566789999999999984 889999999999999999999999997543
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=291.66 Aligned_cols=267 Identities=22% Similarity=0.290 Sum_probs=199.4
Q ss_pred CHHHHHHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeec
Q 007625 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (595)
Q Consensus 262 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 339 (595)
...++...+++|++.+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999985 478999999986432 23335667889999999999999999998754
Q ss_pred C------CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc
Q 007625 340 S------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (595)
Q Consensus 340 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 413 (595)
. ...+++++++ +++|.+.+.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 2356777776 7788877753 3589999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHH
Q 007625 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~ 492 (595)
++|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........ +...
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~~~~ 230 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ----LKLI 230 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHH
Confidence 999999998765332 223457889999999866 5678999999999999999999999965432211 1111
Q ss_pred HHHH----------hccccc-------cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 493 IRKL----------LREDRL-------NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 493 ~~~~----------~~~~~~-------~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.... ...... .................++.+++.+|++.||.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 000000 0000000000011134567899999999999999999999654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=283.18 Aligned_cols=243 Identities=24% Similarity=0.293 Sum_probs=186.9
Q ss_pred eeeeccceEEEEEEe-CCCcEEEEEEeccCCC--chhHHHHHHHHH---HHHhcCCCCCccccceeecCCceEEEEEecc
Q 007625 278 IIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS--PGGEAAFQREVH---LISVAIHKNLLQLIGYCTTSSERILVYPFMQ 351 (595)
Q Consensus 278 ~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 351 (595)
+||+|+||.||+|.. .+++.||+|.+..... ......+..|.. .+....||+++++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4688999999864321 122223344433 3444579999999999999999999999999
Q ss_pred cCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc
Q 007625 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (595)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 431 (595)
+++|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999988864 34699999999999999999999998 99999999999999999999999999987554322
Q ss_pred eeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 432 VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
.....|+..|+|||++.++ .++.++||||+|+++|||++|+.||.......... ....... .+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~~------~~~-- 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE------IDRMTLT------MAV-- 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH------HHHHhhc------cCC--
Confidence 1234589999999998754 68999999999999999999999997542211110 0000000 011
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
..+.....++.+++.+|+..+|.+|| ++.+++++
T Consensus 217 -~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 -ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11222356788899999999999999 99999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=285.52 Aligned_cols=244 Identities=23% Similarity=0.292 Sum_probs=195.8
Q ss_pred CCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCc
Q 007625 276 SNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 354 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (595)
..+||+|+||.||++.. .++..||+|.+... .......+.+|+.+++.++|+|++++++++...+..++||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 46799999999999986 47899999988532 33456678999999999999999999999999999999999999999
Q ss_pred HhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceee
Q 007625 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 434 (595)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~ 434 (595)
|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ...
T Consensus 104 L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~ 174 (292)
T cd06657 104 LTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 174 (292)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccc
Confidence 9987753 3578999999999999999999999 999999999999999999999999999876543221 123
Q ss_pred cccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCC
Q 007625 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD 514 (595)
Q Consensus 435 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 514 (595)
...|++.|+|||++.+..++.++|+||||+++|||++|..||....... .......... ..+.. .
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-----~~~~~~~~~~---------~~~~~-~ 239 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRDNLP---------PKLKN-L 239 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhhCC---------cccCC-c
Confidence 3457899999999988888999999999999999999999987533211 1111111110 11101 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 515 SKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 515 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
......+.+++.+|++.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 223456778899999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=288.27 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=198.5
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeec-CCce
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSER 343 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 343 (595)
...+++|+..+.||+|+||.||+|... +++.||+|++... ........+..|++++..++|||++++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999954 7899999988642 233445678899999999999999999998865 4578
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++++||+ +++|...+.. ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 8999998 4588877753 3578888899999999999999999 99999999999999999999999999987
Q ss_pred cccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH--------HHH
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD--------HIR 494 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~--------~~~ 494 (595)
..... .....++..|+|||++.+ ..++.++||||||+++|||+||+.||......... ..+.+ +..
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF-SIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHH
Confidence 55332 123356889999999766 56899999999999999999999999754431110 00111 111
Q ss_pred HHhccccccccccccCC-CC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 495 KLLREDRLNDIVDRNLN-TY-----DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~-~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..........+...... .. .+.....+.+++.+|++.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000000 00 11234678899999999999999999998554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.07 Aligned_cols=261 Identities=22% Similarity=0.265 Sum_probs=195.7
Q ss_pred cCCCc-CCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCch-------------hHHHHHHHHHHHHhcCCCCCccccc
Q 007625 271 DNFSE-SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPG-------------GEAAFQREVHLISVAIHKNLLQLIG 335 (595)
Q Consensus 271 ~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~~ 335 (595)
++|.. .+.||+|+||+||+|... +++.||+|.++...... ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45653 577999999999999964 68999999986432111 1125778999999999999999999
Q ss_pred eeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEE
Q 007625 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 336 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 415 (595)
++...+..++||||+. ++|.+++.. ...+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 588888864 34589999999999999999999998 999999999999999999999
Q ss_pred EeeccccccccCcC-------------cceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCch
Q 007625 416 LCDFGLAKLVDAKL-------------THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (595)
Q Consensus 416 l~DfG~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~ 481 (595)
|+|||.+....... ........++..|+|||++.+. .++.++||||||+++|||+||+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998664111 1111223467889999998764 468999999999999999999999976543
Q ss_pred hhhhhhhHHHHHHHHhcc---ccccccc------------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 482 EEEEDVLLLDHIRKLLRE---DRLNDIV------------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 482 ~~~~~~~l~~~~~~~~~~---~~~~~~~------------d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.+. ...+...... ..+.... .............++.+++.+|++.+|++||+++|++.
T Consensus 240 ~~~-----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQ-----LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHH-----HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 211 1111111110 0000000 00000111223567889999999999999999999975
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.32 Aligned_cols=265 Identities=24% Similarity=0.339 Sum_probs=197.0
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCC---
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--- 341 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 341 (595)
....++|++.+.||+|+||.||+|.. .++..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 33567899999999999999999985 478999999986432 2334456889999999999999999999886553
Q ss_pred ---ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEee
Q 007625 342 ---ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (595)
Q Consensus 342 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 418 (595)
..++||+|+ +++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 358999998 6788877753 3589999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhH-------H
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL-------L 490 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l-------~ 490 (595)
||++...... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||............. .
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999865432 123357889999999876 458899999999999999999999997543211100000 0
Q ss_pred HHHHHHhccc------cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 491 DHIRKLLRED------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 491 ~~~~~~~~~~------~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.+........ .........+..........+.+++.+|++.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 00000000000111223456889999999999999999999974
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.11 Aligned_cols=259 Identities=24% Similarity=0.320 Sum_probs=199.4
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
|+..+.||+|+||.||+|+.. +++.||+|++.... .......+..|+.++++++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999965 58999999987543 2334567788999999999999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 58999988632 4689999999999999999999999 999999999999999999999999999986654322
Q ss_pred ceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc---cccccc--
Q 007625 431 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---EDRLND-- 504 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~-- 504 (595)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ...+..... +..+..
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-----LFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHHHHhCCCcHHHHHhhc
Confidence 1 1223457789999998766 789999999999999999999999876442211 111111000 000000
Q ss_pred -c--ccccCCC--------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 505 -I--VDRNLNT--------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 505 -~--~d~~l~~--------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. .+..... ..+.....+.+++.+|++.+|++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000110 11122567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=284.26 Aligned_cols=249 Identities=28% Similarity=0.333 Sum_probs=196.0
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.|+..+.||+|+||.||+|+.. ++..+|+|.+... ........+.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999964 6788999988632 223345678889999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+. +++.+.+... ...+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 997 5777776532 24588999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcceeecccccccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
....++..|+|||++. ...++.++|||||||++|||++|+.||....... ......... ..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~-~~-- 232 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNE-SP-- 232 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--------HHHHHhhcC-CC--
Confidence 2235788999999974 3567889999999999999999999986432111 011111110 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..........+.+++.+||+.+|++||++.++++....
T Consensus 233 -----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 233 -----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred -----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 00122345678889999999999999999999987554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=266.30 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=195.6
Q ss_pred CCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEEEEEecccC
Q 007625 276 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
+..||.|..|+|++++.+ +|...|||.+.........+.++..+.++..-+ .|.||+-+|||..+....+.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 567999999999999964 689999999987766667778888888877664 89999999999999999999998853
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCccee
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 433 (595)
-...++... ..++++..+-++...+..||.||-+++ +|+|||+||+|||+|+.|++|++|||++..+-+...+
T Consensus 176 C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 176 CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 344444432 346888888899999999999999876 9999999999999999999999999999877654333
Q ss_pred ecccccccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 434 TQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 434 ~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
+...|-+.|||||.+. ..+|+.++||||||+.++||.||+.||.....+-+ .......++ ...++
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-------~ltkvln~e--PP~L~--- 316 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-------VLTKVLNEE--PPLLP--- 316 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-------HHHHHHhcC--CCCCC---
Confidence 3345889999999985 34689999999999999999999999986443211 111111111 01111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.....+..+.+++..|+++|+.+||...+++++
T Consensus 317 --~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 --GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 122256788899999999999999999999764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=287.75 Aligned_cols=264 Identities=20% Similarity=0.292 Sum_probs=191.4
Q ss_pred CCCcCCeeeeccceEEEEEEeC-C--CcEEEEEEeccCC-CchhHHHHHHHHHHHHhc-CCCCCccccceeecC----Cc
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-D--NTKVAVKRLQDYY-SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS----SE 342 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 342 (595)
+|++.+.||+|+||.||+++.. + +..||+|++.... .......+.+|+.++.++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999964 4 7789999986432 223356678899999999 599999999875432 34
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.+++++|+. ++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 678888886 588888764 35689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcc---eeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhH-------HH
Q 007625 423 KLVDAKLTH---VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL-------LD 491 (595)
Q Consensus 423 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l-------~~ 491 (595)
+........ ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||............. .+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 1223468999999998765 468999999999999999999999997644221100000 00
Q ss_pred HHHHHhcccc------ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007625 492 HIRKLLREDR------LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 543 (595)
Q Consensus 492 ~~~~~~~~~~------~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 543 (595)
.......... ........+....+.....+.+++.+|++.+|++|||+.|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000000 000000000011112246788999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=290.98 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=197.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCc----
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE---- 342 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 342 (595)
..++|+..+.||+|+||.||+|+.. ++..||+|++.... .......+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999975 68899999986432 23344667789999999999999999998866554
Q ss_pred --eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 343 --RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 343 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5688888764 4589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||........ ...+......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-----~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-----LKRIMNLVGT 234 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHhcCC
Confidence 99866432 223457889999999865 3678999999999999999999999975433211 1111110000
Q ss_pred -----------cccccccc-------ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 -----------DRLNDIVD-------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 -----------~~~~~~~d-------~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
......+. ..+.........++.+++.+|++.+|++|||+.||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000 00000011235678899999999999999999999654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=279.79 Aligned_cols=245 Identities=27% Similarity=0.377 Sum_probs=192.8
Q ss_pred CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
|...+.||+|+||+||+|+.. ++..|++|++... ........+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566788999999999999964 6889999998632 2223446788999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+. +++.+.+... ...+++.++..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 5777766542 34689999999999999999999999 999999999999999999999999999864322
Q ss_pred cceeecccccccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.....|+..|+|||++. ...++.++||||||+++|||++|..||....... ......... ....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~-~~~~- 240 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQND-SPTL- 240 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHhcC-CCCC-
Confidence 12345888999999984 4568889999999999999999999986432211 111111111 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
........+.+++.+|++.+|.+||++.++++.
T Consensus 241 ------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112233467889999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.53 Aligned_cols=264 Identities=22% Similarity=0.284 Sum_probs=192.6
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC---------
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--------- 340 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 340 (595)
.+|+..+.||.|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57899999999999999999964 68899999986432 24456788999999999999999999876544
Q ss_pred -----CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc-CCCcE
Q 007625 341 -----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEA 414 (595)
Q Consensus 341 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 414 (595)
...++|+||++ ++|.+.+.. ..+++...+.++.|++.||.|||+. +++||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 34689999997 488777753 3588999999999999999999999 999999999999997 45678
Q ss_pred EEeeccccccccCcCcce--eecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH
Q 007625 415 VLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 491 (595)
Q Consensus 415 kl~DfG~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~ 491 (595)
+++|||.++......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............+..
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998654322111 122357889999998654 55788999999999999999999999754432111110000
Q ss_pred H-------HHHHhccccccccc-cccCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 492 H-------IRKLLREDRLNDIV-DRNLN-----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 492 ~-------~~~~~~~~~~~~~~-d~~l~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
. ...... ....... +.... ...+....++.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 000000 0000000 00000 0111234578899999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=265.07 Aligned_cols=264 Identities=21% Similarity=0.302 Sum_probs=199.3
Q ss_pred HHHHHHHhcCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecC
Q 007625 263 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTS 340 (595)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 340 (595)
+++.-..+ .+.||+|+|+.|..+. ..+|..||||++.+. ....+..+.+|++++.+.+ |+||++++++|.++
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 44544444 5789999999999998 678999999999653 5567788899999999885 99999999999999
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC---cEEEe
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLC 417 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 417 (595)
...|+|||-|.||+|...+.. ...+++.++.+++.+|+.||.|||.+ ||.|||+||+|||..+.. -+||+
T Consensus 149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence 999999999999999999987 45689999999999999999999999 999999999999997654 38999
Q ss_pred eccccccccC--cCc----ceeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhh--
Q 007625 418 DFGLAKLVDA--KLT----HVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE-- 484 (595)
Q Consensus 418 DfG~~~~~~~--~~~----~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~-- 484 (595)
||.+..-+.. +.+ ..-.+.+|+..|||||+.. ...|+.++|.||||||+|-|+.|++||.+.-....
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 9988754321 111 1123456889999999863 34578999999999999999999999976432111
Q ss_pred -hh---hhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 485 -ED---VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 485 -~~---~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.+ .......-.-+.++.. ++.|.. +...+.+..+++...+..|+.+|.++.++++
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkY-eFPdkd----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKY-EFPDKD----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCC-cCChhh----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 00 0111111111122211 111111 2223445567777888899999999999976
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=265.06 Aligned_cols=272 Identities=23% Similarity=0.315 Sum_probs=202.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC---C--CcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeec-CCc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS---D--NTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSE 342 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 342 (595)
...|+....||+|.||.||+|..+ + ...+|+|.++.. ...+.....-+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346888999999999999999743 2 336899999743 233445667899999999999999999999877 677
Q ss_pred eEEEEEecccCcHhhhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC----CcEEEe
Q 007625 343 RILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLC 417 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~ 417 (595)
.++++||.+. +|...++..+. ....++....++|+.||+.|+.|||++ =|+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999986 78777774332 235689999999999999999999999 79999999999999877 999999
Q ss_pred eccccccccCcCcce--eecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhh----hhhHH
Q 007625 418 DFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE----DVLLL 490 (595)
Q Consensus 418 DfG~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~----~~~l~ 490 (595)
|+|+++.+....... ...++-|..|.|||.+.+.+ ||.+.|||+.|||..||+|-++-|.+....... .....
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999987654432 34466799999999998865 899999999999999999998888754322111 11222
Q ss_pred HHHHHHhcc---ccccccccc----------cCCCCCH-----------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 491 DHIRKLLRE---DRLNDIVDR----------NLNTYDS-----------KEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 491 ~~~~~~~~~---~~~~~~~d~----------~l~~~~~-----------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.+-..+.- +.+..+..- +...+.. .....-+++...+++.||.+|.|++|.++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 222222211 111111100 0000000 012236788889999999999999999765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=271.42 Aligned_cols=237 Identities=26% Similarity=0.261 Sum_probs=193.3
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEeccCCC--chhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcH
Q 007625 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (595)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (595)
||+|+||.||++... +++.+|+|++..... ......+..|++++++++|||++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 589999999864322 23456889999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeec
Q 007625 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435 (595)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 435 (595)
.+++.. ...+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 999875 23589999999999999999999998 99999999999999999999999999998664432 12233
Q ss_pred ccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCH
Q 007625 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 515 (595)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 515 (595)
..++..|+|||...+...+.++|+||||+++||+++|+.||...... ........ .. ...+.
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~-~~---------~~~~~ 214 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--------EIYEKILK-DP---------LRFPE 214 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHhc-CC---------CCCCC
Confidence 45788999999998888899999999999999999999999654321 11111111 00 11122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHH
Q 007625 516 KEVETMVQVALLCTQSTPEDRPPMAQ 541 (595)
Q Consensus 516 ~~~~~l~~l~~~cl~~dP~~RPs~~e 541 (595)
.....+.+++.+|+..||++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 23567888999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=305.51 Aligned_cols=146 Identities=27% Similarity=0.351 Sum_probs=131.4
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|.+.+.||+|+||+||+|... +++.||+|+++.. ........+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999975 6899999998742 22334577889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
||+.+++|.+++... ..+++..++.++.||+.||+|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998752 3578899999999999999999998 99999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=274.95 Aligned_cols=246 Identities=24% Similarity=0.310 Sum_probs=197.8
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCc
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE 342 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 342 (595)
.+...+|..+.+||+|+||.|..|..+ +.+.||||++++.. ..+..+--..|-++|+.. +-|.++++..+++.-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 344457888999999999999999965 46779999998543 222233334566666665 47889999999999999
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++||||+.||+|-..+.+.. .+.++.+.-++..||.||-+||++ +|+.||||..|||+|.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 999999999999999998743 467778889999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
+.--. ....+.+.+||+.|+|||++...+|+.++|+|||||+||||+.|++||++.+.++ +...+.
T Consensus 498 KEni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-----lF~aI~-------- 563 (683)
T KOG0696|consen 498 KENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-----LFQAIM-------- 563 (683)
T ss_pred ccccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHH--------
Confidence 84321 2334566889999999999999999999999999999999999999999765422 111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 538 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs 538 (595)
+. -..++...+.+...+....+.+.|.+|..
T Consensus 564 ----eh-nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 564 ----EH-NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ----Hc-cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11 12355666677888888999999999943
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=264.00 Aligned_cols=254 Identities=23% Similarity=0.292 Sum_probs=198.4
Q ss_pred HhcCCCc-CCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecC----C
Q 007625 269 ATDNFSE-SNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS----S 341 (595)
Q Consensus 269 ~~~~~~~-~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~ 341 (595)
.+++|++ .++||-|-.|.|-.+.. .+++.+|+|++.+. ...++|+++--.. .|||||+++++|.+. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4556665 45899999999999985 47999999999752 2335677765444 699999999988543 4
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC---CCcEEEee
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCD 418 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D 418 (595)
...+|||.|+||.|...+.+.. ...+++.++-.|+.||+.|+.|||+. +|.||||||+|+|.+. |..+||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 5678999999999999998744 56799999999999999999999999 9999999999999964 45799999
Q ss_pred ccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
||+|+.-.. .....+.+.|+.|.|||++...+|+...|+||+||++|-|+.|.+||.... +..+...++..++
T Consensus 208 fGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h-----g~aispgMk~rI~ 280 (400)
T KOG0604|consen 208 FGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKRRIR 280 (400)
T ss_pred cccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC-----CccCChhHHhHhh
Confidence 999986543 223345667999999999999999999999999999999999999997432 1222233333333
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.+... +.++ -+...++...++++.++..+|.+|.|++|++..
T Consensus 281 ~gqy~-FP~p----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 281 TGQYE-FPEP----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCcc-CCCh----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 22211 1111 134556677889999999999999999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=239.98 Aligned_cols=262 Identities=24% Similarity=0.329 Sum_probs=195.7
Q ss_pred CCCcCCeeeeccceEEEEEE-eCCCcEEEEEEec-cCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|...++||+|.||+||+|+ +.+++.||+|+++ +...++......+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667889999999999999 4578999999998 334455567789999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
|.. +|..+.... +..++.....+++.|+++||.|.|++ .+.|||+||.|.+++.+|+.|++|||+++.++-..
T Consensus 83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 964 666666543 45689999999999999999999999 99999999999999999999999999999887654
Q ss_pred cceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhC-CCCCCCCchhhhhhhhHHHHHHH--Hhccccccc-
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTG-QRAIDFSRLEEEEDVLLLDHIRK--LLREDRLND- 504 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg-~~p~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~- 504 (595)
... ....-|..|.+|.++.+.+ |++..|+||-||++.|+... ++.|.+.+... .+...++. ...++.+..
T Consensus 156 rcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd----qlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 156 RCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD----QLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred Eee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH----HHHHHHHHhCCCccccCCcc
Confidence 433 3344689999999998876 78999999999999999974 44455443321 12222221 111222211
Q ss_pred --ccccc-CCCCC---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 505 --IVDRN-LNTYD---------SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 505 --~~d~~-l~~~~---------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.|-. .+.++ +.....=.++....+.-+|.+|.++++.++.
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111 11111 1111122355556777789999999887653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=265.74 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=195.0
Q ss_pred CCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHh-cCCCCCccccceeecCCceEEEEEecccC
Q 007625 276 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
+..||.|+||+|+|-..+ .|+..|||+++.........+++.|.+...+ -+.||||+++|.+..++..++.||.|.-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 567999999999999864 7999999999866666677888888887555 4799999999999999999999999963
Q ss_pred cHhhhhcc-cCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 354 SVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 354 sL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
++..+... +.-.+..+++...-+|+.-...||.||-+.. .|||||+||+|||++..|.+||+|||++..+.+....
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk- 224 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK- 224 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHHh-
Confidence 55443321 1222456888888899999999999998864 8999999999999999999999999999876543222
Q ss_pred eecccccccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 433 TTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
+.-.|-..|||||.+.. ..|+.+|||||||+.|||+.||+.|+..-.. ..+.+....... ++.
T Consensus 225 -T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv~gd-------pp~ 289 (361)
T KOG1006|consen 225 -TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVVIGD-------PPI 289 (361)
T ss_pred -hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHHcCC-------CCe
Confidence 22347789999999853 3489999999999999999999999874221 333333333222 211
Q ss_pred CCCC---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 511 NTYD---SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 511 ~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...+ -+....+.+++.-|+.+|-.+||+..++.++
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1112 2356788899999999999999999998653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=265.11 Aligned_cols=220 Identities=21% Similarity=0.183 Sum_probs=176.2
Q ss_pred ccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcHhhhhc
Q 007625 282 GGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 360 (595)
Q Consensus 282 G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 360 (595)
|.||.||+++.. +++.||+|+++... .+..|...+....|||++++++++...+..++||||+++++|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999964 78999999986421 23345555556679999999999999999999999999999999987
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeecccccc
Q 007625 361 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440 (595)
Q Consensus 361 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~ 440 (595)
.. ..+++.....++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KF----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 52 3589999999999999999999998 9999999999999999999999999987655432 12234577
Q ss_pred cccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHH
Q 007625 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVET 520 (595)
Q Consensus 441 ~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 520 (595)
.|+|||...+..++.++||||+|+++|||++|+.|+........ . .... ..+......
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------~-----~~~~---~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------T-----HTTL---NIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------c-----cccc---CCcccCCHH
Confidence 89999999888899999999999999999999988653211000 0 0000 112223457
Q ss_pred HHHHHHHcccCCCCCCCCHH
Q 007625 521 MVQVALLCTQSTPEDRPPMA 540 (595)
Q Consensus 521 l~~l~~~cl~~dP~~RPs~~ 540 (595)
+.+++.+|++.||++||++.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHccCCHHHhcCCC
Confidence 78899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-33 Score=272.73 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=197.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEeccCCCch------hHHHHHHHHHHHHhcCCCCCccccceeec-C
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPG------GEAAFQREVHLISVAIHKNLLQLIGYCTT-S 340 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 340 (595)
..++|-.+++||+|||+.||+|. +...+.||||+-.-..+.. -.+...+|..+-+.+.||.||++|+|+.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 44567788999999999999999 4567889999865322211 12445678999999999999999999965 4
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc---CCCcEEEe
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLC 417 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~ 417 (595)
+.+|-|+|||+|-+|.-+|.. .+.+++.++..|+.||+.||.||.+. +++|||-||||.|||+- .-|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 567899999999999999986 56799999999999999999999987 66899999999999994 45889999
Q ss_pred eccccccccCcCcc------eeecccccccccCccccC----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhh
Q 007625 418 DFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLS----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 487 (595)
Q Consensus 418 DfG~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~ 487 (595)
|||+++.++.+... .+....||..|++||.+. ..+.+.|+||||.|||+|+++.|+.||......
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ----- 690 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ----- 690 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-----
Confidence 99999999765433 234567999999999874 235789999999999999999999999753221
Q ss_pred hHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 488 LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 488 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.+ ++.+..+-....-.++. .+....+...++++|++.--++|....|+..
T Consensus 691 --Qd----ILqeNTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 691 --QD----ILQENTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --HH----HHhhhchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11 11111111101111111 1223346678888999999999998777743
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-33 Score=257.26 Aligned_cols=265 Identities=24% Similarity=0.347 Sum_probs=197.1
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEec-cCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC--------C
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--------S 341 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 341 (595)
.|+...+||+|.||.||+|+.+ +|+.||+|++. +...++-.....+|+.+|..+.|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4566788999999999999954 68889998764 334445455668999999999999999999988542 2
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||++|+. +|...|.+. ...++..++.++..++..||.|+|+. .|+|||+|+.|+|++.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 47999999986 788888753 35689999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcC---cceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHh
Q 007625 422 AKLVDAKL---THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 497 (595)
Q Consensus 422 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 497 (595)
++.+.... ....+..+-|..|++||.+.+ ..|+++.|||.-|||+.||+|+.+-+.+... .....+......-.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--qqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQLHLISQLCGSI 248 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--HHHHHHHHHHhccC
Confidence 98765332 122334456999999999876 4589999999999999999999988775432 11111222111111
Q ss_pred cccccccccc---------ccCCC----CCHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 498 REDRLNDIVD---------RNLNT----YDSKE------VETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 498 ~~~~~~~~~d---------~~l~~----~~~~~------~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..+.+.+... ++++. ...+. .++.++++..++..||.+|+++.+++.+
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1122211111 11111 01111 2367788889999999999999999765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=279.76 Aligned_cols=240 Identities=21% Similarity=0.263 Sum_probs=191.8
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (595)
.++.|.....+|.|+|+.|-.+.. .+++..++|++.+.. .+-.+|+.++... +|||++++.+.+.+..+.++|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 356788888899999999999985 478899999986531 2223566555444 799999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE-cCCCcEEEeeccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfG~~~~~ 425 (595)
||.+.++-+.+.+.... ... ..+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++..
T Consensus 395 ~e~l~g~ell~ri~~~~----~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP----EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred ehhccccHHHHHHHhcc----hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 99999998888877522 222 67778999999999999999 99999999999999 68899999999999877
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
... ....+-|..|.|||+.....+++++||||||++||+|++|+.||...... .. +...+..+.
T Consensus 467 ~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~e----i~~~i~~~~---- 530 (612)
T KOG0603|consen 467 ERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IE----IHTRIQMPK---- 530 (612)
T ss_pred chh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HH----HHHhhcCCc----
Confidence 654 22234588999999999999999999999999999999999999754432 11 111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+....+....+++.+|++.||.+||+|.|+..
T Consensus 531 -------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 -------FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -------cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 12344567788888999999999999999954
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=283.82 Aligned_cols=259 Identities=25% Similarity=0.341 Sum_probs=210.4
Q ss_pred HHHHHHHhcCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeec-
Q 007625 263 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT- 339 (595)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 339 (595)
++.+...++-|++.++||.|.+|.||+++ .++++.+|+|++.... ....+++.|.++++.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 44444567789999999999999999999 5678999999986433 3456677888888887 69999999999843
Q ss_pred ----CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEE
Q 007625 340 ----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 340 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 415 (595)
+++.++|||||.+|+..+++.... ...+.|..+..|+..++.|+.+||.+ .++|||||-.|||++.++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 568899999999999999999877 56799999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCcCcceeecccccccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHH
Q 007625 416 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 490 (595)
Q Consensus 416 l~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~ 490 (595)
+.|||.+..+..... ...+..||+.|||||++.. ..|+..+|+||||++..||--|.+|+.....
T Consensus 164 LvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------- 233 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------- 233 (953)
T ss_pred Eeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---------
Confidence 999999987764433 3344569999999999853 3467889999999999999999999864332
Q ss_pred HHHHHHhccccccccccccCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 491 DHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 491 ~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
++....-. -+++.. ..+.....++.+++..|+.+|.++||++.+++++
T Consensus 234 --mraLF~Ip-----RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 234 --MRALFLIP-----RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --hhhhccCC-----CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111000 011111 2477889999999999999999999999988653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=264.79 Aligned_cols=263 Identities=21% Similarity=0.266 Sum_probs=200.8
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCC--C----CCccccceeecCC
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--K----NLLQLIGYCTTSS 341 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~ 341 (595)
.+++|.+...+|+|.||.|-++... .+..||+|+++... .-.....-|++++.++.+ | -++++.+++...+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 3779999999999999999999954 57899999997421 233455678999999842 2 2778889999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc------------
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD------------ 409 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~------------ 409 (595)
+.++|+|.+ |.|+.++|.... -.+++...+..++.|++++++|||+. +++|.||||+|||+.
T Consensus 165 hiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence 999999988 558999998633 45788999999999999999999999 999999999999993
Q ss_pred --------CCCcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCch
Q 007625 410 --------DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (595)
Q Consensus 410 --------~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~ 481 (595)
.+..++|+|||.|+...... ..++.|..|.|||++.+-.++..+||||+||||+|+.||..-|...+.
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 24468999999998654432 445679999999999999999999999999999999999999986553
Q ss_pred hhhhhhhHHHHHH--------------HHhcccccc-----------ccccccC-----CCCCHHHHHHHHHHHHHcccC
Q 007625 482 EEEEDVLLLDHIR--------------KLLREDRLN-----------DIVDRNL-----NTYDSKEVETMVQVALLCTQS 531 (595)
Q Consensus 482 ~~~~~~~l~~~~~--------------~~~~~~~~~-----------~~~d~~l-----~~~~~~~~~~l~~l~~~cl~~ 531 (595)
.+.. .+.+.+. +....+++. ...+... ......+..++++++.+|+..
T Consensus 315 ~EHL--aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 315 LEHL--AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred HHHH--HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 3211 1111111 111111110 0011100 012345677899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 007625 532 TPEDRPPMAQVVKM 545 (595)
Q Consensus 532 dP~~RPs~~evl~~ 545 (595)
||.+|+|+.|++.+
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=278.79 Aligned_cols=264 Identities=20% Similarity=0.224 Sum_probs=181.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-----------------CCCcEEEEEEeccCCCchhHHH--------------HHH
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-----------------SDNTKVAVKRLQDYYSPGGEAA--------------FQR 317 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~~--------------~~~ 317 (595)
..++|++.++||+|+||+||+|.+ .+++.||||++.... .....+ +..
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~-~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR-QGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc-hhhHHHHHhhhhhhhcccchhHH
Confidence 567899999999999999999964 235679999986322 122222 334
Q ss_pred HHHHHHhcCCCCC-----ccccceeec--------CCceEEEEEecccCcHhhhhcccCC--------------------
Q 007625 318 EVHLISVAIHKNL-----LQLIGYCTT--------SSERILVYPFMQNLSVAYRLRDLKP-------------------- 364 (595)
Q Consensus 318 E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------- 364 (595)
|+.++.+++|.++ +++++||.. .+..++||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6667777766554 677777753 3567999999999999999874211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeecccccccccC
Q 007625 365 GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444 (595)
Q Consensus 365 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~a 444 (595)
....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...............+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 012357788999999999999999999 99999999999999999999999999997654332222222235789999
Q ss_pred ccccCCCCC----------------------CccchhHHHHHHHHHHHhCCC-CCCCCchhhh----hhhhHHHHHHHHh
Q 007625 445 PEYLSTGKS----------------------SEKTDVFGYGITLLELVTGQR-AIDFSRLEEE----EDVLLLDHIRKLL 497 (595)
Q Consensus 445 PE~~~~~~~----------------------~~~sDv~SlGvvl~elltg~~-p~~~~~~~~~----~~~~l~~~~~~~~ 497 (595)
||.+..... ..+.||||+||++|||++|.. |+........ ....+..|.. ..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~ 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YK 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hc
Confidence 998754321 234799999999999999875 6643111000 0111111211 00
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 007625 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTP---EDRPPMAQVVKM 545 (595)
Q Consensus 498 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~~ 545 (595)
... .+-. ..........+++.+++..+| .+|+|++|++++
T Consensus 458 -~~~----~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 -GQK----YDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -ccC----CCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000 0100 112234567778888888765 689999999654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=273.42 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=198.9
Q ss_pred CCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccC
Q 007625 276 SNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
.++||+|-||+||-|.. ++|+.||||++.+. ........+++|+.+|++++||.||.+.-.|++.+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 57899999999999994 58999999999643 45566788999999999999999999999999999999999999765
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC---CcEEEeeccccccccCcCc
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~~~~~~~~~~ 430 (595)
-|...|... ...+++...+-++.||+.||.|||.+ +|+|.||||+|||+.+. -++||+|||+|+.+.+..
T Consensus 649 MLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 649 MLEMILSSE---KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred HHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 555555542 35689999999999999999999999 99999999999999643 579999999999987643
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
....+.||+.|+|||++....|...-|+||.|||+|--++|..||..+. .+.+.+... .++.+
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-------dIndQIQNA-------aFMyP-- 784 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-------DINDQIQNA-------AFMYP-- 784 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-------chhHHhhcc-------ccccC--
Confidence 3456789999999999999999999999999999999999999986322 122222211 01111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.-+.+.....++++...++..=++|-|..+-+.+
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 11234555667788888888888888888776543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=287.35 Aligned_cols=263 Identities=16% Similarity=0.201 Sum_probs=170.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-C----CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccce------e
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-D----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY------C 337 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~ 337 (595)
..++|+..+.||+|+||.||+|++. + +..||+|++..... ...+..| .+....+.++..++.. .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 5678999999999999999999964 4 68999998764221 1111111 1112222222222221 2
Q ss_pred ecCCceEEEEEecccCcHhhhhcccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCC
Q 007625 338 TTSSERILVYPFMQNLSVAYRLRDLKPG----------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 401 (595)
Q Consensus 338 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 401 (595)
......++||||+.+++|.+++...... ........+..++.|++.||+|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4556789999999999999988742100 01112344668999999999999999 9999999
Q ss_pred CCCCEEEcC-CCcEEEeeccccccccCcCcceeecccccccccCccccCCC----------------------CCCccch
Q 007625 402 KAANILLDD-NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG----------------------KSSEKTD 458 (595)
Q Consensus 402 kp~NIll~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 458 (595)
||+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999987654433344456789999999965322 2345679
Q ss_pred hHHHHHHHHHHHhCCCCCCCCchhh-----hhhhhHHHHHHHHhccccccccccccCCC---CCHHHHHHHHHHHHHccc
Q 007625 459 VFGYGITLLELVTGQRAIDFSRLEE-----EEDVLLLDHIRKLLREDRLNDIVDRNLNT---YDSKEVETMVQVALLCTQ 530 (595)
Q Consensus 459 v~SlGvvl~elltg~~p~~~~~~~~-----~~~~~l~~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~l~~l~~~cl~ 530 (595)
||||||++|||+++..+++...... ..+.....|...... . ....+.. ..........+++.+|++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-R-----ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-c-----cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 9999999999999776644211000 000011111111000 0 0000000 000112234579999999
Q ss_pred CCCCCCCCHHHHHHH
Q 007625 531 STPEDRPPMAQVVKM 545 (595)
Q Consensus 531 ~dP~~RPs~~evl~~ 545 (595)
.||++|||++|++++
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=270.15 Aligned_cols=244 Identities=23% Similarity=0.277 Sum_probs=202.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCc-EEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNT-KVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
..+++....||-|+||.|-.+..+... .+|+|++++. ....+...+..|-++|...+.|.||++|-.|.++...|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 334555788999999999999975443 4899988743 4556677888999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
||-|-||.+-..|++ ...++..+.+-++..+.+|++|||++ +||.|||||+|.+++.+|.+||.|||+|+.+.
T Consensus 499 mEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999997 45688889999999999999999999 99999999999999999999999999999886
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
... .+-+.+||+.|.|||++.+...+.++|.||+|+++|||+||.+||.+.++.......+ +.+..+
T Consensus 572 ~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL-kGid~i---------- 638 (732)
T KOG0614|consen 572 SGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL-KGIDKI---------- 638 (732)
T ss_pred cCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-hhhhhh----------
Confidence 543 3445789999999999999999999999999999999999999999866533322211 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 538 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs 538 (595)
.+|........+++++.....|.+|..
T Consensus 639 -----~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 -----EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -----hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 123444456677888888899999976
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=255.25 Aligned_cols=239 Identities=27% Similarity=0.310 Sum_probs=192.6
Q ss_pred cceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcHhhhhcc
Q 007625 283 GFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 361 (595)
Q Consensus 283 ~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 361 (595)
+||.||+|... +++.+|+|++...........+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999987543333267899999999999999999999999999999999999999999998875
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeeccccccc
Q 007625 362 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441 (595)
Q Consensus 362 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~ 441 (595)
. ..+++.....++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 2 2388999999999999999999999 99999999999999999999999999998765432 2233457889
Q ss_pred ccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHH
Q 007625 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETM 521 (595)
Q Consensus 442 y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 521 (595)
|++||...+..++.++||||||+++|++++|..||...... ....+.... ..... .........++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~~~~~~~----~~~~~------~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LELFKKIGK----PKPPF------PPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhc----cCCCC------ccccccCCHHH
Confidence 99999998888999999999999999999999998752211 111111111 10000 00000144678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 007625 522 VQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 522 ~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=252.10 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=196.9
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-C-CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCce
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-Y-SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (595)
....+|...++||+|+|..|..++++ +.+.||+|++++. . .....+=.+.|-.+..+. +||.+|.+..++.++...
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 35567899999999999999999964 6788999998743 1 223334456677777765 699999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++|.||.+||+|--.+.+ +..+++..+.-+...|+.||.|||++ |||.||||..|||+|..|++|++|+|+++
T Consensus 327 ffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 999999999999877765 45699999999999999999999999 99999999999999999999999999997
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
.-- .....+.+.+||+.|+|||++.+..|...+|+|++||+++||+.|+.||+.-.... .+.+..+..-+.+-+..+
T Consensus 400 e~l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n-~d~ntedylfqvilekqi- 476 (593)
T KOG0695|consen 400 EGL-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN-PDMNTEDYLFQVILEKQI- 476 (593)
T ss_pred cCC-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC-cccchhHHHHHHHhhhcc-
Confidence 432 22344567889999999999999999999999999999999999999998532111 111111222221111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 537 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP 537 (595)
..+...+.....+...-+.+||.+|.
T Consensus 477 --------riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 --------RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --------cccceeehhhHHHHHHhhcCCcHHhc
Confidence 12333445556777788899999884
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=239.12 Aligned_cols=208 Identities=22% Similarity=0.337 Sum_probs=176.0
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCce
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (595)
+++..+.......||+|+||.|-+-++ .+|...|+|+++........+....|+.+..+. .+|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 455556666688999999999998885 589999999998766667777888898876654 799999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++.||.|.. +|..+-++.......+++...-+|+..+..||.|||++. .++|||+||+|||++.+|++|+||||++.
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999964 777777765556778999999999999999999999985 89999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCC----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~SlGvvl~elltg~~p~~~ 478 (595)
.+.+..... .-.|-..|||||.+.. ..|+.|+||||||+.+.||.+++.||+.
T Consensus 198 ~L~dSiAkt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDSIAKT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhhhHHH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 775543221 1236678999999853 4689999999999999999999999874
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=265.80 Aligned_cols=206 Identities=22% Similarity=0.262 Sum_probs=175.0
Q ss_pred hcCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
..-|..++.||-|+||.|.+++ .++...||+|.+++. ....+......|..+|.....+.||+|+-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3457778899999999999998 455677999998743 2345567788999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|+|++||++-.+|-+ ..-+.+..+.-++..+..|+++.|.. |+|||||||+|||||.+|++||+|||++.-+.
T Consensus 708 MdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 999999999988876 34578888999999999999999999 99999999999999999999999999975331
Q ss_pred ---------CcCcc--------------------------------eeecccccccccCccccCCCCCCccchhHHHHHH
Q 007625 427 ---------AKLTH--------------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGIT 465 (595)
Q Consensus 427 ---------~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvv 465 (595)
..... .....+||+.|+|||++....++..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 00000 0012459999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchh
Q 007625 466 LLELVTGQRAIDFSRLE 482 (595)
Q Consensus 466 l~elltg~~p~~~~~~~ 482 (595)
||||+.|+.||......
T Consensus 861 l~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPG 877 (1034)
T ss_pred HHHHhhCCCCccCCCCC
Confidence 99999999999876543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-31 Score=276.30 Aligned_cols=247 Identities=26% Similarity=0.311 Sum_probs=186.4
Q ss_pred CCcCCeeeeccce-EEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEEEec
Q 007625 273 FSESNIIGQGGFG-KVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 273 ~~~~~~lG~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
|...+++|.|+.| .||+|.. +|+.||||++-. +-..-..+|+..++.- .|||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4446688999988 4899998 788999999853 2344567899999887 5999999988888889999999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC---C--CcEEEeeccccccc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---N--FEAVLCDFGLAKLV 425 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfG~~~~~ 425 (595)
. .+|.+++...........-...+.+..|++.||++||+. +||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 6 499999986311111111144567889999999999998 9999999999999975 2 57999999999988
Q ss_pred cCcCcce--eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhC-CCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 426 DAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 426 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg-~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
....... .....||.+|+|||++.....+.++||||+|||+|+.++| .+||...-..+ ..++.....
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----------~NIl~~~~~ 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----------ANILTGNYT 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh----------hhhhcCccc
Confidence 6543332 3456799999999999998889999999999999999996 89997432110 111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... +.. ..++ +..+++.+|+.++|..||++.+|+.+
T Consensus 732 L~~----L~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LVH----LEP-LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eee----ecc-CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 000 000 1111 67788899999999999999999753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=251.08 Aligned_cols=267 Identities=23% Similarity=0.289 Sum_probs=197.9
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-----C---CCCccccceeec
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----H---KNLLQLIGYCTT 339 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~ 339 (595)
...+|-+.++||.|.|++||++.+ .+.+.||+|+.+... .-.+....|+.+|++++ | .+||+++++|..
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 346888999999999999999995 467889999997532 33455678999999874 3 469999999854
Q ss_pred ----CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-----
Q 007625 340 ----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD----- 410 (595)
Q Consensus 340 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----- 410 (595)
+.+.++|+|++ |-+|..++.... -+.++....+.|+.||+.||.|||+.| +|||.||||+|||+..
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~ 228 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDP 228 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccch
Confidence 45789999998 558888887533 467999999999999999999999999 9999999999999940
Q ss_pred --------------------------------------------------------------------------------
Q 007625 411 -------------------------------------------------------------------------------- 410 (595)
Q Consensus 411 -------------------------------------------------------------------------------- 410 (595)
T Consensus 229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~ 308 (590)
T KOG1290|consen 229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR 308 (590)
T ss_pred hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 007625 411 -------------------------------------------------------------------------------- 410 (595)
Q Consensus 411 -------------------------------------------------------------------------------- 410 (595)
T Consensus 309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~ 388 (590)
T KOG1290|consen 309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE 388 (590)
T ss_pred CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence
Q ss_pred -CCcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhh-hhhhh
Q 007625 411 -NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE-EEDVL 488 (595)
Q Consensus 411 -~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~-~~~~~ 488 (595)
+..+||+|||.|.......+.. ..|..|+|||++.+..|++.+||||++|++|||+||.-.|+...-+. ..+..
T Consensus 389 ~di~vKIaDlGNACW~~khFT~D----IQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 389 CDIRVKIADLGNACWVHKHFTED----IQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred cceeEEEeeccchhhhhhhhchh----hhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 0124666666666544332221 24789999999999999999999999999999999998887543221 11111
Q ss_pred HHHHHH--------HHhcc-cccccccccc--------------------CCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007625 489 LLDHIR--------KLLRE-DRLNDIVDRN--------------------LNTYDSKEVETMVQVALLCTQSTPEDRPPM 539 (595)
Q Consensus 489 l~~~~~--------~~~~~-~~~~~~~d~~--------------------l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 539 (595)
....+. ..... ....+++++. .-.++.+...++.++..-|++.+|++||||
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA 544 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTA 544 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccH
Confidence 122211 11111 2223333331 112467788899999999999999999999
Q ss_pred HHHHHHh
Q 007625 540 AQVVKML 546 (595)
Q Consensus 540 ~evl~~L 546 (595)
.+.+++-
T Consensus 545 ~~cl~hP 551 (590)
T KOG1290|consen 545 AQCLKHP 551 (590)
T ss_pred HHHhcCc
Confidence 9997653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=241.17 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=192.8
Q ss_pred cCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCC-----ceEEEE
Q 007625 275 ESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERILVY 347 (595)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~ 347 (595)
..+.||.|+||.||.+++ ++|+.||+|++.... +-...+.+.+|++++..++|.|++..++...... +.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 367899999999999996 489999999986432 2334577889999999999999999988775543 456777
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
|.|.. +|...+- ..+.++....+-+..||++||.|||+. +|.||||||.|.|++.+...||+|||+++..+.
T Consensus 137 ELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 137 ELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 77753 4444443 366788899999999999999999999 999999999999999999999999999998776
Q ss_pred cCcceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhh-------HHHHHHHHhcc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL-------LLDHIRKLLRE 499 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~-------l~~~~~~~~~~ 499 (595)
+.....+...-|..|.|||++++.+ |+.+.||||.|||+.|++..+-.|......+..... ..+.++..-+
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE- 287 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE- 287 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh-
Confidence 6555556666789999999998765 899999999999999999888777754432211100 0011111100
Q ss_pred ccccccccc-----c---CCCC--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 500 DRLNDIVDR-----N---LNTY--DSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 500 ~~~~~~~d~-----~---l~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
+....++.. . +-.. +.....+-+.+...++..||.+|.+.++.+..+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 000111111 0 0011 112334455666788999999999999988754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-28 Score=229.09 Aligned_cols=212 Identities=33% Similarity=0.486 Sum_probs=183.2
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcHhh
Q 007625 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 357 (595)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 357 (595)
||+|.+|.||++... +++.+++|++...........+.+|++.++.+.|++++++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999975 4899999998754332245789999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-CCcEEEeeccccccccCcCcceeecc
Q 007625 358 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAKLTHVTTQI 436 (595)
Q Consensus 358 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~~~~~~~~~~~~~~~~ 436 (595)
++.... ..+++..+..++.+++.++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987532 4589999999999999999999999 9999999999999999 89999999999986654321 12234
Q ss_pred cccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCH
Q 007625 437 RGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 515 (595)
Q Consensus 437 ~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 515 (595)
.+...|++||..... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 478899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 516 KEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 516 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3567888899999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=221.81 Aligned_cols=260 Identities=17% Similarity=0.282 Sum_probs=192.1
Q ss_pred HhcCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCC--ceE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS--ERI 344 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~ 344 (595)
..++|++.+++|+|.|+.||.|. ..+.++++||+++. -..+.+.+|+.+|..+. ||||+++++...++. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 34678899999999999999999 45788999999975 34567899999999997 999999999987764 457
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-CcEEEeeccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAK 423 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~~ 423 (595)
+|+||+.+.+...... .++-..+..++.+++.||.|+|+. ||+|||+||.|+++|.. ..++|+|+|+|.
T Consensus 112 LiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 9999999877655443 366677889999999999999999 99999999999999965 569999999999
Q ss_pred cccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH---------HH
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD---------HI 493 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~---------~~ 493 (595)
........ .....+..|.-||.+.. ..|+..-|+|||||++..|+..+.||-........-+.+.+ .+
T Consensus 182 FYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 182 FYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 87654332 22345677889999865 45788999999999999999999998654332222111111 11
Q ss_pred HHH--hccccccccccccCCC----C----C-HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 494 RKL--LREDRLNDIVDRNLNT----Y----D-SKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 494 ~~~--~~~~~~~~~~d~~l~~----~----~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.+. .-+.....++...-.. + . .-...+.++++...+..|-.+|||++|...
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111 0011111111111000 0 0 012367778888999999999999999843
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=249.13 Aligned_cols=197 Identities=23% Similarity=0.357 Sum_probs=167.3
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-------CchhHHHHHHHHHHHHhcC---CCCCccccceeec
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAI---HKNLLQLIGYCTT 339 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 339 (595)
.+|...+.+|.|+||.|+.|.++ +...|++|.+.+.. .....-.+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888999999999999999976 45678999875321 1111223557999999997 9999999999999
Q ss_pred CCceEEEEEec-ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEee
Q 007625 340 SSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (595)
Q Consensus 340 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 418 (595)
++..+++||-. ++.+|.+++.. ...+++.+++.|++|++.|+++||++ +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999976 56688888875 46799999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCcCcceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAID 477 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~ 477 (595)
||.+....... ....+||..|.|||++.+.+| ...-|||++|++||-++....||.
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987664432 234679999999999998887 566899999999999999888875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=226.16 Aligned_cols=200 Identities=30% Similarity=0.402 Sum_probs=172.2
Q ss_pred CCcCCeeeeccceEEEEEEeCC-CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecc
Q 007625 273 FSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 351 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 351 (595)
|...+.||+|++|+||++...+ ++.+++|.+...........+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999764 889999998753322256788999999999999999999999999999999999999
Q ss_pred cCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc
Q 007625 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (595)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 431 (595)
+++|.+++..... .+++.....++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999876321 178999999999999999999999 9999999999999999999999999999877544211
Q ss_pred eeecccccccccCcccc-CCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 007625 432 VTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (595)
Q Consensus 432 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvvl~elltg~~p~~~ 478 (595)
......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334577899999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=228.04 Aligned_cols=262 Identities=22% Similarity=0.264 Sum_probs=193.2
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCC------c
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------E 342 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 342 (595)
.+|.-+..+|.|.- .|-.|.. -.++.||+|++... ......+...+|..++..+.|+|+++++.++.... +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666788888888 5555553 36889999987532 33344566689999999999999999999986543 6
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.|+|||+|. .+|...+.. .++-.+...|..|++.|+.|||+. +|+||||||+||++..+..+||.|||++
T Consensus 96 ~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 799999996 477777762 366678899999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhh--------------hhhh
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE--------------EDVL 488 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~--------------~~~~ 488 (595)
+.-... ...+.+..|..|.|||++.+..+.+.+||||.||++.||++|+--|.+...-.. --..
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 865443 345667789999999999998899999999999999999999988875322110 0111
Q ss_pred HHHHHHHHhcccc------cccc-ccccCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 489 LLDHIRKLLREDR------LNDI-VDRNLNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 489 l~~~~~~~~~~~~------~~~~-~d~~l~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+...++..++... ..+. .|..+.. .+........+++.+|+..+|++|-++.+++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 2222222222100 0011 1111111 122334456678889999999999999999765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-28 Score=251.50 Aligned_cols=254 Identities=24% Similarity=0.273 Sum_probs=203.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
..++|+....+|.|.||.||||+. .+++..|+|+++- ........++.|+-+++..+||||+.++|.+...+..++.|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL-ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL-EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeec-cCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 456788899999999999999995 4789999999973 23345667788999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
|||.+|+|++.-+- ..++++.++..+.+...+||+|||+. +=+|||||-.||++++.|.+|++|||.+..+..
T Consensus 92 EycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999988775 46799999999999999999999999 889999999999999999999999999876654
Q ss_pred cCcceeecccccccccCcccc---CCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
... ......||+.|||||+. ..+.|.+++|||+.|+...|+-.-+.|.-.... ..+....- ..
T Consensus 165 ti~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---------mr~l~LmT----kS 230 (829)
T KOG0576|consen 165 TIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---------MRALFLMT----KS 230 (829)
T ss_pred hhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---------HHHHHHhh----cc
Confidence 322 22346699999999986 356789999999999999999887776432111 11111110 01
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.+++.-..-.......+.++++.|+.++|++||+++.+++
T Consensus 231 ~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1222222223455677888999999999999999998866
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=219.21 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=184.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccce-eecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGY-CTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv 346 (595)
.+.|.+.+.+|+|.||.+-.++.+ +.+.+++|-+.... ...++|.+|..---.+ .|.||+.-++. |...+..+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 357888999999999999999965 67889999886543 4568899998765455 58999987764 5666778899
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc--CCCcEEEeecccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKL 424 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~~~~ 424 (595)
+||++.|+|.+-+.. .++-+...++++.|++.|+.|+|+. .+||||||.+|||+- +...+||+|||.++.
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999999877764 4688888999999999999999999 999999999999993 345899999999886
Q ss_pred ccCcCcceeecccccccccCccccCCC-----CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
.+.... ...-+..|.+||..... ...+.+|||.||++++.++||+.||.........-.....|..
T Consensus 173 ~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~----- 243 (378)
T KOG1345|consen 173 VGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK----- 243 (378)
T ss_pred cCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc-----
Confidence 543221 12235679999986432 3477899999999999999999999854432222222222221
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+....+...+. .......++.++-+..+|++|=...++.++
T Consensus 244 -rk~~~~P~~F~----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 244 -RKNPALPKKFN----PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred -ccCccCchhhc----ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 11111222222 233455666777889999999555555443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=237.07 Aligned_cols=211 Identities=21% Similarity=0.236 Sum_probs=176.9
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC------CCCCccc
Q 007625 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI------HKNLLQL 333 (595)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l 333 (595)
|.+.--+....+|.+....|+|-|++|..|... .|..||||+++... ...+.=+.|+++|++|+ -.|++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 444444566789999999999999999999954 58899999998643 22334468999999985 3578999
Q ss_pred cceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-C
Q 007625 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-F 412 (595)
Q Consensus 334 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~ 412 (595)
+..|...+++|+|+|-+. .+|.+.|..+.. +..+.......++.|+..||..|-.. +|+|.||||.|||+++. .
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 999999999999999874 689999987654 56799999999999999999999987 99999999999999876 4
Q ss_pred cEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCch
Q 007625 413 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (595)
Q Consensus 413 ~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~ 481 (595)
.+||||||.|....... .+.+.-+..|.|||++.+.+|+...|+||.||.||||.||+..|.+...
T Consensus 575 iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred eeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 68999999998765432 2334456789999999999999999999999999999999999987654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=226.67 Aligned_cols=266 Identities=22% Similarity=0.313 Sum_probs=195.0
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeC----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCC
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS 341 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 341 (595)
....+.|...++||.|.|++||++.+. ..+.||+|.+..... ...+..|+++|..+. +.||+++.+++...+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 335567888999999999999999843 467899999865433 345789999999985 999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-CcEEEeecc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFG 420 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG 420 (595)
...+|+||++.....++... ++...+..++..+..||+++|.+ |||||||||+|++.+.. +.-.|.|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 99999999999888888775 66889999999999999999999 99999999999999754 667899999
Q ss_pred ccccccCcC-------------c------------------------------ceeecccccccccCccccCCC-CCCcc
Q 007625 421 LAKLVDAKL-------------T------------------------------HVTTQIRGTMGHIAPEYLSTG-KSSEK 456 (595)
Q Consensus 421 ~~~~~~~~~-------------~------------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~ 456 (595)
++....... . ...-...||++|.|||++... ..+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 987321000 0 000124599999999998754 57899
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH-----HHHH-Hhcccc--ccc---------------ccc-ccCC-
Q 007625 457 TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD-----HIRK-LLREDR--LND---------------IVD-RNLN- 511 (595)
Q Consensus 457 sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~-----~~~~-~~~~~~--~~~---------------~~d-~~l~- 511 (595)
+||||.|||++-+++++.||-.....-..-..+.. .+++ ..-.++ +.+ -++ ..+.
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 99999999999999999998654332111111111 0111 011111 000 000 0000
Q ss_pred ---------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 512 ---------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 512 ---------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
......+..++++..+|+..+|.+|.|+++.+++
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0111223467899999999999999999999654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=259.77 Aligned_cols=195 Identities=13% Similarity=0.114 Sum_probs=137.2
Q ss_pred cCC-CCCcccccee-------ecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 007625 325 AIH-KNLLQLIGYC-------TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396 (595)
Q Consensus 325 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 396 (595)
+.| +||.++++++ ......+.++||+ +++|.+++... ...+++.+++.++.||+.||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 345 5777777776 2223567778887 56999999742 34589999999999999999999999 99
Q ss_pred EEcCCCCCCEEEcC-------------------CCcEEEeeccccccccCcCc---------------ceeecccccccc
Q 007625 397 IHRDLKAANILLDD-------------------NFEAVLCDFGLAKLVDAKLT---------------HVTTQIRGTMGH 442 (595)
Q Consensus 397 vH~Dlkp~NIll~~-------------------~~~~kl~DfG~~~~~~~~~~---------------~~~~~~~gt~~y 442 (595)
+||||||+|||++. ++.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999964 34556666666653211000 000113578899
Q ss_pred cCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHH
Q 007625 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMV 522 (595)
Q Consensus 443 ~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 522 (595)
+|||++.+..++.++|||||||++|||++|..|+..... ......... +.+. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~------~~~~~~~~~---------~~~~----~~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR------TMSSLRHRV---------LPPQ----ILLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH------HHHHHHHhh---------cChh----hhhcCHHHH
Confidence 999999999999999999999999999998887642110 011111000 1110 011223456
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 007625 523 QVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 523 ~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.++.+||+++|.+||+|.||+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 78889999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-25 Score=204.70 Aligned_cols=166 Identities=20% Similarity=0.184 Sum_probs=125.4
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
|+|.++++.. ...+++.+++.++.|++.||+|||++ + ||+||+++.++.+++ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6888888752 34699999999999999999999998 5 999999999999999 99988664322
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
..||+.|+|||++.+..++.++|||||||++|||+||+.||....... ..+....... .... .....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~-~~~~------~~~~~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS---AILEILLNGM-PADD------PRDRS 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc---HHHHHHHHHh-ccCC------ccccc
Confidence 258999999999999999999999999999999999999986432211 1111111111 1100 00000
Q ss_pred CCHHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 513 YDSKEVE--TMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 513 ~~~~~~~--~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
....... ++.+++.+|++.+|++||++.|+++++..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 1122222 68999999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-25 Score=208.42 Aligned_cols=248 Identities=19% Similarity=0.288 Sum_probs=190.0
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEecc-CCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCc
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 354 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (595)
..+|.+...|..|+|+++ |..+++|++.. ..+....++|..|.-.++.+.||||+++++.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 457888999999999995 45566777762 3445566889999999999999999999999999999999999999999
Q ss_pred HhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceee
Q 007625 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 434 (595)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~ 434 (595)
|+..|+... ...++-.++.+++.++|+|++|||+. .|-|.---+.+..|++|++.+++|+ .+-++.... ..
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsfq-----e~ 344 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ-----EV 344 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeeee-----cc
Confidence 999999743 34577789999999999999999997 3345555689999999999988774 111111100 11
Q ss_pred cccccccccCccccCCCCC---CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCC
Q 007625 435 QIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 511 (595)
Q Consensus 435 ~~~gt~~y~aPE~~~~~~~---~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 511 (595)
...-.+.||+||.++..+. -.++|+|||++++||+.|...||..-...+..-..-.+..+ .
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr----------------v 408 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR----------------V 408 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc----------------c
Confidence 1223688999999987664 35789999999999999999999754443322111111111 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 512 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 512 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..++.....+.+++.-|+..||.+||.+.+|+-.|+..
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 23556667889999999999999999999999988764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=213.52 Aligned_cols=168 Identities=20% Similarity=0.232 Sum_probs=130.8
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeC--CCcEEEEEEeccCC----CchhHHHHHHHHHHHHhcCCCCCccccceeecC
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 340 (595)
....++|...+.||+|+||+||+|..+ +++.||||++.... .......|.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999864 57778999875321 22345679999999999999999863322 2
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCC-CCCCEEEcCCCcEEEeec
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL-KAANILLDDNFEAVLCDF 419 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Df 419 (595)
+..++||||+++++|... .. .. ...++.|++.+|.|||+. +|+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~----~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP----HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc----cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 457999999999998622 10 01 146788999999999999 9999999 999999999999999999
Q ss_pred cccccccCcCcce-------eecccccccccCccccCCC
Q 007625 420 GLAKLVDAKLTHV-------TTQIRGTMGHIAPEYLSTG 451 (595)
Q Consensus 420 G~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 451 (595)
|+++.+....... .....+++.|+|||++...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999765432111 1345688899999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=207.94 Aligned_cols=258 Identities=20% Similarity=0.250 Sum_probs=189.6
Q ss_pred CCCcCCeeeeccceEEEEEEeCCC--cEEEEEEeccCCCchhHHHHHHHHHHHHhcCC----CCCcccccee-ecCCceE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLSDN--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH----KNLLQLIGYC-TTSSERI 344 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~ 344 (595)
+|.+.+.||+|+||.||.|..... ..+|+|........... .+..|..++..+.. +++..+++.. ..+...+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 799999999999999999996543 47888887643222222 67788888888863 5788888888 4677889
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-----CcEEEeec
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-----FEAVLCDF 419 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Df 419 (595)
+||+.+ |.+|.++..... ...++..+..+|+.|++.+|.++|+. |++||||||.|+++... ..++|.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999976 679988776544 46799999999999999999999999 99999999999999865 46999999
Q ss_pred cccc--cccCcCc-------ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHH
Q 007625 420 GLAK--LVDAKLT-------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 490 (595)
Q Consensus 420 G~~~--~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~ 490 (595)
|+++ ....... .......||.+|.++....+...+.+.|+||++.++.|++.|..||........ .
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~ 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----K 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----H
Confidence 9998 3321111 112235599999999999999999999999999999999999999965432111 1
Q ss_pred HHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 491 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 491 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..+......... .. .....+.+ +.++...+-..+...+|....+...+++.
T Consensus 247 ~~~~~~~~~~~~----~~-~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 247 SKFEKDPRKLLT----DR-FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHHHhhhhcc----cc-ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 111111111100 00 11223333 44444445568899999999998887553
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=230.06 Aligned_cols=159 Identities=36% Similarity=0.607 Sum_probs=140.1
Q ss_pred CCCCChhHHHHHHHHHHHccCCCCCCCCCCCCCCCCCC----CcceeEecC------CCEEEEEcCCCCCCCCCCccccc
Q 007625 29 SSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCF----SWSHVTCRN------GNVISLTLGSNGFSGKISPSITK 98 (595)
Q Consensus 29 ~~~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~----~w~gv~c~~------~~l~~l~l~~n~l~g~~~~~~~~ 98 (595)
.....+.|..||+.+|+++.++.. .+|+++ +|+ .|.||.|.. ..|+.|+|++|+++|.+|..+++
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~~--~~W~g~---~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~ 440 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPLR--FGWNGD---PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISK 440 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCccc--CCCCCC---CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhC
Confidence 345567799999999999976542 489764 553 799999952 14899999999999999999999
Q ss_pred cCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcCCccCchhhhc----cccc
Q 007625 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS----VATF 174 (595)
Q Consensus 99 l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l~~----l~~l 174 (595)
|++|+.|+|++|+|+|.+|..++.|++|+.|||++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+.. +..+
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 999999999999999999999999999999999999999999999999999999999999999999988754 3578
Q ss_pred cccccccccCCCCCCCCC
Q 007625 175 NFTGTHLICGSSLEQPCM 192 (595)
Q Consensus 175 ~~~~n~~~~~~~~~~~c~ 192 (595)
++.+|+.+|+.+....|.
T Consensus 521 ~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 521 NFTDNAGLCGIPGLRACG 538 (623)
T ss_pred EecCCccccCCCCCCCCc
Confidence 899999999987666674
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-21 Score=193.76 Aligned_cols=262 Identities=26% Similarity=0.337 Sum_probs=198.1
Q ss_pred CCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCch--hHHHHHHHHHHHHhcCCC-CCccccceeecCCceEEEEEe
Q 007625 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHK-NLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 349 (595)
|...+.||.|+||.||++... ..+++|.+....... ....+.+|..+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999976 889999987544333 477899999999999988 799999999777778999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC-cEEEeeccccccccCc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK 428 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~~~~~ 428 (595)
+.++++.+.+...... ..+.......+..|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999666642211 3688899999999999999999999 899999999999999988 7999999999865543
Q ss_pred Ccc-----eeecccccccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 429 LTH-----VTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 429 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..|+...... .......+.+......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc-
Confidence 322 2355679999999999987 57889999999999999999999997654321 0001111111111100
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
......... ........+.+++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPS---NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCcc---ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000 002223567788889999999999999987764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=183.86 Aligned_cols=259 Identities=19% Similarity=0.246 Sum_probs=194.9
Q ss_pred HHhcCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCC-CCCccccceeecCCceEE
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 345 (595)
+....|..+++||.|+||.+|.|. ..+|..||+|+-... ....++..|..+...+++ ..|..+..|..+.....+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 345689999999999999999999 568999999986432 234567789999999874 678888888889999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC---CcEEEeecccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLA 422 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~~ 422 (595)
||+.. |.+|.++.... ...++..+.+-++.|++.-++|+|.+ +++||||||+|+|..-+ ..+.++|||++
T Consensus 89 VMdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence 99987 67999888764 35689999999999999999999999 89999999999999643 46899999999
Q ss_pred ccccCcCcc------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHH
Q 007625 423 KLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 496 (595)
Q Consensus 423 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 496 (595)
+.+.+..+. ......||.+|.+-....+...+.+.|+-|+|.++.++.-|..||.+-...... +-...
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-----QKyEk- 235 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-----QKYEK- 235 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-----HHHHH-
Confidence 977543221 223456999999988888888899999999999999999999999864432111 11111
Q ss_pred hccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 497 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 497 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
+.+.... ..+...+...+.++.-.+..|-..--++-|...-+-+.+
T Consensus 236 I~EkK~s----~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 236 ISEKKMS----TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred HHHhhcC----CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 1111111 111112233345666677778888888888876655544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-22 Score=218.40 Aligned_cols=253 Identities=19% Similarity=0.235 Sum_probs=187.1
Q ss_pred cCCeeeeccceEEEEEEe-CCCcEEEEEEec----cCCCchh-HHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 275 ESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQ----DYYSPGG-EAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~----~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
..+++|.|++|.|+.... ...+.++.|..+ ....... ...+..|+.+-..+.|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 477899999998887774 234444444332 1111111 1226667777888999999988887777766666699
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++ +|...+.. ...+...++..++.|+..|++|+|+. ||.|||+|++|++++.++.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99998886 23578888999999999999999999 9999999999999999999999999999876543
Q ss_pred Cc---ceeecccccccccCccccCCCCCCc-cchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 429 LT---HVTTQIRGTMGHIAPEYLSTGKSSE-KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 429 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
.. .......|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||.........- .......+ ..
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~-~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQ-RN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccccc-cc
Confidence 33 3455678999999999999999876 5799999999999999999998654432210 00000000 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+.. .........+.+...++.++++.||.+|.|+++|++
T Consensus 546 ~~~-~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFE-GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccc-ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 001123344566778888999999999999999965
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=180.75 Aligned_cols=202 Identities=20% Similarity=0.255 Sum_probs=169.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEE-eCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 346 (595)
..-.|.++++||+|.||..+.|+ +-+++.||||.-... ....++..|...++.+. .++|..++-|...+-+..+|
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 34479999999999999999999 558999999974321 23456778888888875 78999988887888888999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-----CcEEEeeccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-----FEAVLCDFGL 421 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfG~ 421 (595)
+|.+ |.+|.++..-. ...++..+...+|.|+..-++|+|++ .+|.|||||+|+||... ..+.++|||+
T Consensus 103 idLL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 9987 67888887753 45799999999999999999999999 89999999999999643 4589999999
Q ss_pred cccccCcCcc------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 007625 422 AKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (595)
Q Consensus 422 ~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~ 480 (595)
|+.+.+..+. ......||.+||+-....+.+.+.+.|+-|+|-|+.+.+-|..||.+-.
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 9987654332 2234569999999999999999999999999999999999999998744
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=177.71 Aligned_cols=141 Identities=16% Similarity=0.163 Sum_probs=108.9
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCc-hh-------H-----------------HHHHHHHHHHHhcCCCCC
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-GG-------E-----------------AAFQREVHLISVAIHKNL 330 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~-------~-----------------~~~~~E~~~l~~l~h~ni 330 (595)
...||+|+||.||+|...+|+.||+|+++..... .. . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999999743211 11 1 122349999999988877
Q ss_pred ccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCcEEcCCCCCCEEEc
Q 007625 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL-HEQCNPKIIHRDLKAANILLD 409 (595)
Q Consensus 331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlkp~NIll~ 409 (595)
.....+.. ...++||||++++++...... ...++..+...++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54433322 234899999998766544321 24688999999999999999999 687 999999999999998
Q ss_pred CCCcEEEeecccccccc
Q 007625 410 DNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 410 ~~~~~kl~DfG~~~~~~ 426 (595)
+ +.++|+|||++....
T Consensus 153 ~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 D-GKLYIIDVSQSVEHD 168 (190)
T ss_pred C-CcEEEEEccccccCC
Confidence 4 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-21 Score=208.95 Aligned_cols=258 Identities=21% Similarity=0.214 Sum_probs=188.1
Q ss_pred CCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHH--HHhcCCCCCccccceeecCCceEEEEEe
Q 007625 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL--ISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+|...+.||+++|=.|.+|+.++|. |+||++-+....-....|.++++- ...++|||.+++.-.-......|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4666889999999999999987776 999998655444445555554433 4556899999998877777777888888
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc--ccC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL--VDA 427 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~--~~~ 427 (595)
..+ +|+|++.. +.-+...+.+-|+.|++.|+.-+|.. ||.|||||.+|||++.-.-+.|+||..-+. +.+
T Consensus 103 vkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 765 78888774 45688889999999999999999999 999999999999999999999999986542 222
Q ss_pred cCcc----eeecccccccccCccccCCC----------C-CCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHH
Q 007625 428 KLTH----VTTQIRGTMGHIAPEYLSTG----------K-SSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 491 (595)
Q Consensus 428 ~~~~----~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~ 491 (595)
+... ...+...-.+|+|||.+... . .+++.||||+||++.||++ |++||..+.. ..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL--------~a 246 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL--------LA 246 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH--------Hh
Confidence 2111 11222334589999987531 1 5778999999999999998 5777753221 00
Q ss_pred HHH--HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccchhhHH
Q 007625 492 HIR--KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAE 557 (595)
Q Consensus 492 ~~~--~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 557 (595)
.-. ...++..++.+-| ..+..++..|++.||++|.++++.++.-.+..+.+.+-.
T Consensus 247 Yr~~~~~~~e~~Le~Ied-----------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~ 303 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIED-----------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYS 303 (1431)
T ss_pred HhccCccCHHHHHHhCcC-----------ccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHH
Confidence 000 0000111111222 256788899999999999999999999888887776643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=178.77 Aligned_cols=173 Identities=12% Similarity=0.080 Sum_probs=134.2
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCch--hHHH------HHHHHHHHHhcCCCCCccccceeec
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAA------FQREVHLISVAIHKNLLQLIGYCTT 339 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~------~~~E~~~l~~l~h~niv~l~~~~~~ 339 (595)
...++|+..+++|.|+||.||.+.. ++..+|+|.+++..... .... +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3578999999999999999999766 67789999997543222 1122 6899999999999999999888653
Q ss_pred C--------CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC
Q 007625 340 S--------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (595)
Q Consensus 340 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 411 (595)
. ...++||||++|.+|.+... ++. ....+++.++..+|+. +++|||+||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 3 35789999999999877632 222 3456999999999999 99999999999999998
Q ss_pred CcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHH
Q 007625 412 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 470 (595)
Q Consensus 412 ~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ell 470 (595)
+ ++|+|||........... ..+.....+..++|+||||+.+..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988654321111 01334555678999999999877654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=171.13 Aligned_cols=141 Identities=18% Similarity=0.159 Sum_probs=111.5
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCc-hh------------------------HHHHHHHHHHHHhcCCCCC
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-GG------------------------EAAFQREVHLISVAIHKNL 330 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~------------------------~~~~~~E~~~l~~l~h~ni 330 (595)
...||+|+||.||+|...+|+.||||+++..... .. ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999778999999998753211 00 1224578899999999987
Q ss_pred ccccceeecCCceEEEEEecccCcHhhh-hcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCEEE
Q 007625 331 LQLIGYCTTSSERILVYPFMQNLSVAYR-LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILL 408 (595)
Q Consensus 331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll 408 (595)
.....+... ..++||||++++++... +. ...++......++.|++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 554444332 34899999998855433 32 2357788899999999999999999 8 99999999999999
Q ss_pred cCCCcEEEeeccccccccC
Q 007625 409 DDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 409 ~~~~~~kl~DfG~~~~~~~ 427 (595)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-20 Score=178.60 Aligned_cols=233 Identities=22% Similarity=0.247 Sum_probs=150.8
Q ss_pred CcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCC-----------CCCccccc----
Q 007625 274 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIH-----------KNLLQLIG---- 335 (595)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h-----------~niv~l~~---- 335 (595)
..++.||.|+++.||.+++. +++.+|+|+..-. ......+.+.+|.-....+.+ ..++++--
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34788999999999999975 6899999997632 233455677777655554332 22222211
Q ss_pred ----eeecCC--------ceEEEEEecccCcHhhhhcc---cCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcC
Q 007625 336 ----YCTTSS--------ERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 400 (595)
Q Consensus 336 ----~~~~~~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 400 (595)
+..... ..+++|+-+. ++|.+.+.. .......+....+..+..|+.+.+++||+. |++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 111111 2356677664 577776542 222223355666778889999999999999 999999
Q ss_pred CCCCCEEEcCCCcEEEeeccccccccCcCcceeecccccccccCccccCC--------CCCCccchhHHHHHHHHHHHhC
Q 007625 401 LKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--------GKSSEKTDVFGYGITLLELVTG 472 (595)
Q Consensus 401 lkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~SlGvvl~elltg 472 (595)
|+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|..|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999987765442221 234578999997643 2478899999999999999999
Q ss_pred CCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 007625 473 QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR 536 (595)
Q Consensus 473 ~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~R 536 (595)
+.||+.......... .+..+. +.++.+..++..+++.+|++|
T Consensus 247 ~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999986543222111 233344 778889999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=189.36 Aligned_cols=215 Identities=24% Similarity=0.374 Sum_probs=162.8
Q ss_pred HHhcCCCCCccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCc-EEcC
Q 007625 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI-IHRD 400 (595)
Q Consensus 322 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-vH~D 400 (595)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.-...+.++++.||+|+|.. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3567899999999999999999999999999999999986 245689999999999999999999987 44 9999
Q ss_pred CCCCCEEEcCCCcEEEeeccccccccCcC-cceeecccccccccCccccCCCC-------CCccchhHHHHHHHHHHHhC
Q 007625 401 LKAANILLDDNFEAVLCDFGLAKLVDAKL-THVTTQIRGTMGHIAPEYLSTGK-------SSEKTDVFGYGITLLELVTG 472 (595)
Q Consensus 401 lkp~NIll~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDv~SlGvvl~elltg 472 (595)
++++|+++|....+|++|||+........ ........-..-|.|||.+.... .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987764310 01111112345799999987531 46789999999999999999
Q ss_pred CCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 473 QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 473 ~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
+.||+.....+.. ..+...+.. .....+-+.+.... +...++..++..||..+|++||++++|-..++..
T Consensus 155 ~~~~~~~~~~~~~-~eii~~~~~-----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP-DEIILRVKK-----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cCccccccccCCh-HHHHHHHHh-----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9999865443332 122222222 01111112111111 3344788999999999999999999999887653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=165.38 Aligned_cols=186 Identities=16% Similarity=0.080 Sum_probs=138.6
Q ss_pred CcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCC---chhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEEEEEe
Q 007625 274 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
.+...|++|+||+||.+.. .+.+++.+.+..... .-....|.+|+++++++. |+++.+++++ +..+++|+|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4578899999999997776 778888887753221 111236889999999995 5778888876 456999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCC-CCCCEEEcCCCcEEEeeccccccccCc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL-KAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
+.|.+|...+.. ....++.|++.+|.++|+. ||+|||| ||+||+++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999888643321 1135778999999999999 9999999 799999999999999999999865433
Q ss_pred Ccc----e--------eecccccccccCccccCCC-CCC-ccchhHHHHHHHHHHHhCCCCCCC
Q 007625 429 LTH----V--------TTQIRGTMGHIAPEYLSTG-KSS-EKTDVFGYGITLLELVTGQRAIDF 478 (595)
Q Consensus 429 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDv~SlGvvl~elltg~~p~~~ 478 (595)
... . ..-...++.|++|+...-. ..+ ...++++-|.-+|.++|++.+...
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 210 0 0112256777777754321 223 567999999999999999987653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-20 Score=195.28 Aligned_cols=235 Identities=23% Similarity=0.239 Sum_probs=183.7
Q ss_pred eeeeccceEEEEEE----eCCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEEEEEecc
Q 007625 278 IIGQGGFGKVYKGV----LSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQ 351 (595)
Q Consensus 278 ~lG~G~~g~Vy~~~----~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 351 (595)
++|+|.||.|+.++ .+.|..+|+|+++... ..........|..++...+ ||.++++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999876 3457789999886432 1112224456778888887 9999999999999999999999999
Q ss_pred cCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc
Q 007625 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (595)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 431 (595)
+|.+...+.. ...........+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999888775 34566777778888999999999999 9999999999999999999999999999865433222
Q ss_pred eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCC
Q 007625 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 511 (595)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 511 (595)
+||..|||||++. .....+|+||||++++||+||..||.. +..+.+.. .-.
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~----------~~~ 204 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILK----------AEL 204 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhh----------hcc
Confidence 7899999999997 678899999999999999999999974 11111111 112
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHHHHhhc
Q 007625 512 TYDSKEVETMVQVALLCTQSTPEDRPPM--AQVVKMLQG 548 (595)
Q Consensus 512 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl~~L~~ 548 (595)
..+........+++.+++..+|..|.-. ..+.+..+.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h 243 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQH 243 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence 2466677777888889999999999766 344444443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-19 Score=173.68 Aligned_cols=198 Identities=20% Similarity=0.217 Sum_probs=139.5
Q ss_pred CCCCCccccceeecC---------------------------CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHH
Q 007625 326 IHKNLLQLIGYCTTS---------------------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 378 (595)
Q Consensus 326 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 378 (595)
+|||||++.++|.++ ...|+||..++. +|..++.. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 599999998876442 135677776643 77777764 335667778889
Q ss_pred HHHHHHHHHHhhcCCCCcEEcCCCCCCEEE--cCCC--cEEEeeccccccccCc-----CcceeecccccccccCccccC
Q 007625 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILL--DDNF--EAVLCDFGLAKLVDAK-----LTHVTTQIRGTMGHIAPEYLS 449 (595)
Q Consensus 379 ~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DfG~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~ 449 (595)
.|+++|+.|||.+ ||.|||+|++|||+ |+|. ...|+|||++-.-+.. ........-|....||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 3443 4689999987543221 111112234777899999985
Q ss_pred CCC--C----CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHH
Q 007625 450 TGK--S----SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQ 523 (595)
Q Consensus 450 ~~~--~----~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~ 523 (595)
..+ . -.|+|.|+.|-+.||+++...||........+ ... .-...++..++..+..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~---~r~-------------Yqe~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD---TRT-------------YQESQLPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec---hhh-------------hhhhhCCCCcccCChHHHH
Confidence 332 1 46899999999999999999999852211100 000 0112233345555667788
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 524 VALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 524 l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
++...++.||.+|++..-....|+-
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHHH
Confidence 8889999999999998877777653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=205.47 Aligned_cols=147 Identities=35% Similarity=0.621 Sum_probs=113.5
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCCCCCCCCCCCcceeEecC-CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCc
Q 007625 33 PDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRN-GNVISLTLGSNGFSGKISPSITKLKFLASLELQDND 111 (595)
Q Consensus 33 ~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~~w~gv~c~~-~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~ 111 (595)
.+.|+.||++||+++.++.+.+.+|+.. ++||.|.||+|+. ++|+.|+|++|+++|.+++.|..+++|+.|+|++|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS--ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC--CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 5679999999999999888888999754 5788999999984 689999999999999999999999999999999999
Q ss_pred cCCCCCcccc-CCCcccEEEeccccccC----------------------ccccccccCCCCceecCCCCcCCccCchhh
Q 007625 112 LSGTLPDFLG-SMTHLQSLNLANNKFSG----------------------SIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168 (595)
Q Consensus 112 l~g~~p~~~~-~l~~L~~L~l~~N~l~g----------------------~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l 168 (595)
++|.+|..+. ++++|++|+|++|+++| .+|..++++++|++|+|++|.+++.+|..+
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~ 184 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhh
Confidence 9988888765 66666666666666654 445555666666666666666666666543
Q ss_pred ---hcccccccccccc
Q 007625 169 ---FSVATFNFTGTHL 181 (595)
Q Consensus 169 ---~~l~~l~~~~n~~ 181 (595)
.+|+.|++++|..
T Consensus 185 ~~l~~L~~L~L~~n~l 200 (968)
T PLN00113 185 TNLTSLEFLTLASNQL 200 (968)
T ss_pred hhCcCCCeeeccCCCC
Confidence 3345556666654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.3e-18 Score=188.35 Aligned_cols=199 Identities=21% Similarity=0.187 Sum_probs=161.3
Q ss_pred HHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC---CCCCccccceeecC
Q 007625 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTS 340 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 340 (595)
.+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+=+...... |.-=.+++.+|+ -+-|..+...+...
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 45566777899999999999999999998889999999876433221 111223333443 34566666667778
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc-------CCCc
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-------DNFE 413 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~ 413 (595)
+..++|++|.+.|+|.+++.. .+.++|.....++.|+++-+++||.. +|||+||||+|+||. +..-
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 888999999999999999983 67799999999999999999999999 999999999999994 2345
Q ss_pred EEEeeccccccccCc-CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCC
Q 007625 414 AVLCDFGLAKLVDAK-LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~ 473 (595)
++|+|||.+..+.-- ........++|-.+-.+|...+..++...|.|.++-+++-|+.|+
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 899999998765322 223445567899999999999999999999999999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=155.95 Aligned_cols=136 Identities=19% Similarity=0.240 Sum_probs=104.5
Q ss_pred CcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-----CCCCCccccceeecCC---c-eE
Q 007625 274 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-----IHKNLLQLIGYCTTSS---E-RI 344 (595)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~ 344 (595)
...+.||+|+||.||. .++....+||++.... ......+.+|+.+++.+ .||||+++++++.++. . ..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4468899999999996 4333334799886422 23456789999999999 5799999999998874 2 23
Q ss_pred EEEEe--cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCcEEcCCCCCCEEEcC----CCcEEEe
Q 007625 345 LVYPF--MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL-EYLHEQCNPKIIHRDLKAANILLDD----NFEAVLC 417 (595)
Q Consensus 345 lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~ 417 (595)
+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+||+++. +..++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 5579999999651 24444 35677888777 999999 9999999999999974 3479999
Q ss_pred ecccc
Q 007625 418 DFGLA 422 (595)
Q Consensus 418 DfG~~ 422 (595)
||+-+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=159.28 Aligned_cols=143 Identities=15% Similarity=0.122 Sum_probs=110.8
Q ss_pred CCCcCCeeeeccceEEEEEE--eCCCcEEEEEEeccCCCc-h----------------------hHHHHHHHHHHHHhcC
Q 007625 272 NFSESNIIGQGGFGKVYKGV--LSDNTKVAVKRLQDYYSP-G----------------------GEAAFQREVHLISVAI 326 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~-~----------------------~~~~~~~E~~~l~~l~ 326 (595)
.|++.+.||+|+||.||+|. ..+|+.||+|+++..... . ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999998 568999999998743210 0 1124578999999997
Q ss_pred CCC--CccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-cEEcCCCC
Q 007625 327 HKN--LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK-IIHRDLKA 403 (595)
Q Consensus 327 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp 403 (595)
+.+ +.+++++ ...++||||+++.++...... .......+...++.|++.++.+||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 633 3333332 245899999999887665422 23455666789999999999999999 8 99999999
Q ss_pred CCEEEcCCCcEEEeecccccccc
Q 007625 404 ANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 404 ~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 7899999999987544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=153.97 Aligned_cols=135 Identities=21% Similarity=0.246 Sum_probs=113.9
Q ss_pred CeeeeccceEEEEEEeCCCcEEEEEEeccCCCc-------hhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-------GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+.||+|++|.||+|.. +|..+++|+....... .....+.+|+.++..+.|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999997 7778999986532211 1124577899999999999998888787778888999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
++|++|.+.+... .. +...++.+++.+|.++|+. +++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999888642 11 7889999999999999999 999999999999999 78899999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=152.48 Aligned_cols=146 Identities=21% Similarity=0.137 Sum_probs=111.8
Q ss_pred HHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCc---------------------hhHHHHHHHHHHHH
Q 007625 265 ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP---------------------GGEAAFQREVHLIS 323 (595)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------------~~~~~~~~E~~~l~ 323 (595)
++.....-|...+.||+|+||.||++..++|+.||||++...... .....+..|...+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333344348888999999999999999888999999987532100 01123677888898
Q ss_pred hcCCCC--CccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCC
Q 007625 324 VAIHKN--LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 401 (595)
Q Consensus 324 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 401 (595)
.+.|++ +.+.++ ....++||||+++++|...... .....++.+++.++.++|+. +++||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 888874 333332 3456899999999988654321 23467889999999999998 9999999
Q ss_pred CCCCEEEcCCCcEEEeeccccccccC
Q 007625 402 KAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 402 kp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+||++++++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.8e-17 Score=152.74 Aligned_cols=132 Identities=20% Similarity=0.282 Sum_probs=108.4
Q ss_pred eeeeccceEEEEEEeCCCcEEEEEEeccCC--Cc-----hhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEec
Q 007625 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYY--SP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 278 ~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
.||+|+||.||+|.+ ++..|++|+..... .. .....+.+|++++..+.|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 479999999999996 67889999865321 11 11356778999999999988766666667777789999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
++++|.+.+.... . .++.+++.+|.++|+. +++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999988875411 0 7899999999999999 999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-17 Score=181.41 Aligned_cols=216 Identities=24% Similarity=0.279 Sum_probs=147.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
..++|+.++.|..|+||.||.++++ +.+.+|+|+=+.. .+.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-------lilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-------LILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccc-------hhhhc--cccccCCccee----------------
Confidence 3457888999999999999999875 4667888532211 00110 22233344333
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
|+-...+.. ...++. +++.+++|||+. +|+|||+||+|.+++.-|++|++|||+++....
T Consensus 136 -----gDc~tllk~----~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 -----GDCATLLKN----IGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred -----chhhhhccc----CCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 333333433 122332 237899999999 999999999999999999999999999875421
Q ss_pred cCc--------------ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH
Q 007625 428 KLT--------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 428 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~ 493 (595)
... ....+++||+.|+|||++....|...+|+|++|+|+||.+-|..||.++..++.-+..+.+.+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 110 112357899999999999999999999999999999999999999998766543332222211
Q ss_pred HHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 494 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. +.+ -......+..+++.+.++.+|..|--....++
T Consensus 276 ~-------wpE--------~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 276 E-------WPE--------EDEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred c-------ccc--------cCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 1 111 11223346677777888999999955444433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-17 Score=170.95 Aligned_cols=123 Identities=27% Similarity=0.359 Sum_probs=107.8
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++.|++|.-.+|.+++..... ....++...+.++.|++.|+.| + +.+|+|+||.||+...+.++||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 46789999999999999985443 4567889999999999999999 5 899999999999999999999999999
Q ss_pred cccccCcC-----cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh
Q 007625 422 AKLVDAKL-----THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471 (595)
Q Consensus 422 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt 471 (595)
........ ....+...||..||+||.+.+..|+.|+||||||++++|+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 88776544 223445679999999999999999999999999999999997
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=172.37 Aligned_cols=139 Identities=21% Similarity=0.283 Sum_probs=112.5
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEe-ccCCC-c-----hhHHHHHHHHHHHHhcCCCCCccccceeecCCc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYS-P-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l-~~~~~-~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 342 (595)
...|...+.||+|+||+||+|.+.+. .+++|+. ..... . .....+.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44556789999999999999997544 3444432 22111 1 123568899999999999999988888877778
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++||||+++++|.+++. ....++.+++.+|.|||+. +++|||+||+||++ +++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999988875 3467899999999999999 99999999999999 5779999999998
Q ss_pred ccc
Q 007625 423 KLV 425 (595)
Q Consensus 423 ~~~ 425 (595)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.4e-15 Score=132.54 Aligned_cols=135 Identities=19% Similarity=0.159 Sum_probs=113.6
Q ss_pred cCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCC--CCCccccceeecCCceEEEEEeccc
Q 007625 275 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..+.| .++.+++++....+..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35789999999999999844 7899998864332 5678899999999976 5888988888888889999999988
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+.+... +......++.+++.+++++|.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 765433 5567778899999999999986445799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.9e-15 Score=138.97 Aligned_cols=138 Identities=21% Similarity=0.233 Sum_probs=98.3
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCc-hhHHH----------------------HHHHHHHHHhcCCCC--C
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-GGEAA----------------------FQREVHLISVAIHKN--L 330 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~----------------------~~~E~~~l~~l~h~n--i 330 (595)
.+.||+|+||+||+|...+++.||||+++..... ..... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5789999999999999878999999998643211 11111 134555555554433 3
Q ss_pred ccccceeecCCceEEEEEecccCcHhhh-hcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCEEE
Q 007625 331 LQLIGYCTTSSERILVYPFMQNLSVAYR-LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILL 408 (595)
Q Consensus 331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll 408 (595)
.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. . +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333322 245899999998654321 22111 11 5678899999999999999 7 99999999999999
Q ss_pred cCCCcEEEeeccccccccC
Q 007625 409 DDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 409 ~~~~~~kl~DfG~~~~~~~ 427 (595)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.4e-14 Score=138.59 Aligned_cols=137 Identities=17% Similarity=0.148 Sum_probs=105.5
Q ss_pred CCeee-eccceEEEEEEeCCCcEEEEEEeccCC------------CchhHHHHHHHHHHHHhcCCCCC--ccccceeecC
Q 007625 276 SNIIG-QGGFGKVYKGVLSDNTKVAVKRLQDYY------------SPGGEAAFQREVHLISVAIHKNL--LQLIGYCTTS 340 (595)
Q Consensus 276 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~l~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 340 (595)
...|| .|+.|+||.+.. ++..++||++.... +......+.+|++++..+.|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 56788 899999999988 47789999874310 11234567889999999998885 5666664332
Q ss_pred Cc----eEEEEEeccc-CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEE
Q 007625 341 SE----RILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 341 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 415 (595)
.. .++|+|++++ .+|.+++.. ..++.. .+.+++.++.+||+. ||+|+||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 22 2599999997 688888754 234433 367899999999999 999999999999999988999
Q ss_pred Eeeccccccc
Q 007625 416 LCDFGLAKLV 425 (595)
Q Consensus 416 l~DfG~~~~~ 425 (595)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999998743
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2e-15 Score=164.84 Aligned_cols=255 Identities=21% Similarity=0.254 Sum_probs=187.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC--CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 345 (595)
...|...+.||+|.|+.|-..... ....+|+|.+.... ..........|..+-..+. |+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345667788999999999888753 34456666664322 2233344455777777776 9999999999999999999
Q ss_pred EEEecccCcHhhhh-cccCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCcEEcCCCCCCEEEcCCC-cEEEeecccc
Q 007625 346 VYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTAYGLEYLH-EQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLA 422 (595)
Q Consensus 346 v~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~ 422 (595)
+.+|..++++.+.+ +. .....+......++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||++
T Consensus 99 ~~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred ccCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhh
Confidence 99999999988887 32 1124666778889999999999999 77 999999999999999999 9999999999
Q ss_pred ccccC--cCcceeecccc-cccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 423 KLVDA--KLTHVTTQIRG-TMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 423 ~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
..+.. ..........| ++.|+|||...+. ......|+||.|+++.-+++|..|++....... ....|....
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---~~~~~~~~~-- 247 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---RYSSWKSNK-- 247 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---cceeecccc--
Confidence 87765 23333445668 9999999999885 457788999999999999999999986554221 111111110
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 543 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 543 (595)
+..-............++...++..+|..|.+.+++.
T Consensus 248 --------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 --------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred --------cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0000011223334556667788889999999988874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.5e-13 Score=142.02 Aligned_cols=143 Identities=22% Similarity=0.239 Sum_probs=99.8
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchh---------------------------------------HHHHH
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGG---------------------------------------EAAFQ 316 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~---------------------------------------~~~~~ 316 (595)
.+.||.|++|.||+|++++|+.||||+.+....... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 468999999999999999999999999864321100 01244
Q ss_pred HHHHHHHhcC-----CCCCccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHH-HHHHHhh
Q 007625 317 REVHLISVAI-----HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-GLEYLHE 390 (595)
Q Consensus 317 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~ 390 (595)
+|...+.++. ++++.-..-|.......++||||++|+++.+...... ... ....++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 4555444442 2332211112223456799999999999988765311 112 23456666665 4678888
Q ss_pred cCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 391 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
. |++|+|+||.||+++.++.++++|||++..+..
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.9e-13 Score=131.68 Aligned_cols=206 Identities=19% Similarity=0.259 Sum_probs=144.6
Q ss_pred HHHHHHhcCCCCCccccceeecC-----CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 007625 318 EVHLISVAIHKNLLQLIGYCTTS-----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392 (595)
Q Consensus 318 E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ 392 (595)
-+..+-++.|.|||++..|+.+. .+..++.|||..|++..+|++.......+......+++.||..||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 34456667899999999988654 357899999999999999998777778888899999999999999999985
Q ss_pred CCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC----cceeecccccccccCccccCCCCCCccchhHHHHHHHHH
Q 007625 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL----THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLE 468 (595)
Q Consensus 393 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~e 468 (595)
.|.|+|+++..+-|++..++-+|++---- ....... ........+-++|.|||+-...+.+..+|||+||.-..|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 67899999999999999999888743211 1111100 001111235789999999888888899999999999999
Q ss_pred HHhCCCC-CCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 469 LVTGQRA-IDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 469 lltg~~p-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
|.-+.-- -....... ....+.... ..+..-++ ..++..|++..|..||+|.+++.+.
T Consensus 275 mailEiq~tnseS~~~-----~ee~ia~~i--~~len~lq--------------r~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVE-----VEENIANVI--IGLENGLQ--------------RGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHheeccCCCcceee-----hhhhhhhhe--eeccCccc--------------cCcCcccccCCCCCCcchhhhhcCc
Confidence 9887632 11111100 000010000 00001111 2345589999999999999988653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.1e-12 Score=138.47 Aligned_cols=148 Identities=20% Similarity=0.199 Sum_probs=93.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCC-CcEEEEEEeccCCCc---------------------------------hhHH--
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSP---------------------------------GGEA-- 313 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---------------------------------~~~~-- 313 (595)
-..|+. +.||+|++|.||+|++++ |+.||||+.+....+ +-..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345775 789999999999999877 999999999743210 0011
Q ss_pred ----HHHHHHHHHHhcC----CCCCcccccee-ecCCceEEEEEecccCcHhhhh--cccCCCCCCCCHHHHHHHHHHHH
Q 007625 314 ----AFQREVHLISVAI----HKNLLQLIGYC-TTSSERILVYPFMQNLSVAYRL--RDLKPGEKGLDWPTRKRVAFGTA 382 (595)
Q Consensus 314 ----~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia 382 (595)
+|.+|...+.++. +.+.+.+=..+ ......++||||++|+.+.+.. .........+.......++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 2333443333332 33323222222 2245678999999999987642 2110000112222333333333
Q ss_pred HHHHHHhhcCCCCcEEcCCCCCCEEEcCCC----cEEEeeccccccccCc
Q 007625 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDFGLAKLVDAK 428 (595)
Q Consensus 383 ~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~~~~~~~~ 428 (595)
... |++|+|+||.||+++.++ .+++.|||++..++..
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 345 999999999999999888 9999999999877543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.7e-13 Score=118.90 Aligned_cols=105 Identities=29% Similarity=0.516 Sum_probs=95.5
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|.|++|+++ .+|+.+..|.+|+.|++++|+|. .+|.+|++|++|++|+++-|++. .+|..|+.++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 47899999999999 99999999999999999999999 89999999999999999999999 99999999999999999
Q ss_pred CCCcCC-ccCchhhhc---ccccccccccccc
Q 007625 156 SSNNLT-GRIPMQLFS---VATFNFTGTHLIC 183 (595)
Q Consensus 156 ~~N~l~-g~ip~~l~~---l~~l~~~~n~~~~ 183 (595)
+.|+++ ..+|..|+- +..++++.|.+.-
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe~ 141 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEI 141 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCccc
Confidence 999997 467877654 5667888887643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-11 Score=113.65 Aligned_cols=130 Identities=20% Similarity=0.135 Sum_probs=96.0
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCcc-ccceeecCCceEEEEEecccCc
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ-LIGYCTTSSERILVYPFMQNLS 354 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~gs 354 (595)
.+.|+.|.++.||+++. .+..|++|....... ....+..|+..+..+.+.++++ ++.+ .....++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCc
Confidence 46788999999999997 478899998754321 2335678999999887666554 4333 2334689999999987
Q ss_pred HhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--NPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
+... . .....++.+++++|+.||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 78 l~~~--~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE--D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6533 0 011345679999999999982 22369999999999999 5689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.3e-10 Score=119.73 Aligned_cols=166 Identities=17% Similarity=0.204 Sum_probs=124.5
Q ss_pred eCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCH
Q 007625 292 LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW 371 (595)
Q Consensus 292 ~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 371 (595)
..++.+|.|...+.... .......+-++.++.++||||++++..+..++..|+|+|.+. .|...+.+. ..
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GK 103 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HH
Confidence 34788888888864333 344566788899999999999999999999999999999885 455556542 24
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeecccccccccCccccCCC
Q 007625 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451 (595)
Q Consensus 372 ~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 451 (595)
....-.+.||+.||.|||+.| +++|++|.-..|+++..|+.||++|.++........ ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 455667889999999999876 899999999999999999999999998764432211 00001111245666655332
Q ss_pred CCCccchhHHHHHHHHHHHhC
Q 007625 452 KSSEKTDVFGYGITLLELVTG 472 (595)
Q Consensus 452 ~~~~~sDv~SlGvvl~elltg 472 (595)
. -..|.|.||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.2e-11 Score=127.37 Aligned_cols=248 Identities=21% Similarity=0.166 Sum_probs=176.7
Q ss_pred CCCcCCeeee--ccceEEEEEEe---CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceE
Q 007625 272 NFSESNIIGQ--GGFGKVYKGVL---SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 272 ~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 344 (595)
.|.....+|. |.+|.||.+.. .++..+|+|+-+... .+.....-.+|+.....+ .|+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556788899 99999999986 368889999854322 222233334566666666 4999999888888888999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCcEEcCCCCCCEEEcCC-CcEEEeec
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDF 419 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 419 (595)
+-+|++. .++..+.+.. ...++....+.+..+..+ |+.++|.. .++|-|+||.||+...+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999886 5777766642 233667778888888888 99999999 99999999999999999 88999999
Q ss_pred cccccccCcCcce----eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 420 GLAKLVDAKLTHV----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 420 G~~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
|+...+....-.. .....|...|++||...+ -++.++|+|++|.+..+-.++.......-. ..|..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~- 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQ- 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC--------CCccc-
Confidence 9998876543221 122357889999998854 568899999999999999988765443210 01111
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.+... +-+ .+......++.....++++.+|..|++...+..
T Consensus 338 -~r~~~---ip~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -LRQGY---IPL----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccc---Cch----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000 001 122222334445788899999999999887754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.3e-10 Score=105.05 Aligned_cols=139 Identities=18% Similarity=0.201 Sum_probs=99.6
Q ss_pred CCeeeeccceEEEEEEeCC-------CcEEEEEEeccCC---------------------CchhHHHHH----HHHHHHH
Q 007625 276 SNIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYY---------------------SPGGEAAFQ----REVHLIS 323 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~---------------------~~~~~~~~~----~E~~~l~ 323 (595)
...||.|.-+.||.|...+ +..+|||+.+... .......+. +|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998543 4799999874210 011233344 7999998
Q ss_pred hcCC--CCCccccceeecCCceEEEEEecccCcHh-hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCcEEc
Q 007625 324 VAIH--KNLLQLIGYCTTSSERILVYPFMQNLSVA-YRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL-HEQCNPKIIHR 399 (595)
Q Consensus 324 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~ 399 (595)
++.. -++..++++ ...++||||+.+..+. ..+.+ ..++..+...+..+++.+|..+ |.. +++|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8864 345555543 5678999999765332 12322 2344556677889999999999 777 99999
Q ss_pred CCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 400 DLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 400 Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||++.||++++ +.++|+|||.+-...+
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeCCC
Confidence 99999999974 5899999998875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.6e-10 Score=108.48 Aligned_cols=144 Identities=18% Similarity=0.212 Sum_probs=109.7
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCC--CCccccceeecCC---ceEEEEEec
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK--NLLQLIGYCTTSS---ERILVYPFM 350 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~ 350 (595)
.+.|+.|.++.||++...+|..+++|.............+..|.+++..+.+. ++.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 36789999999999998777899999876433222455788999999998764 4566776665532 568999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-------------------------------------- 392 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 392 (595)
++.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99887765531 24677777888888888888888521
Q ss_pred ---------------CCCcEEcCCCCCCEEEcC--CCcEEEeecccccc
Q 007625 393 ---------------NPKIIHRDLKAANILLDD--NFEAVLCDFGLAKL 424 (595)
Q Consensus 393 ---------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~~~~ 424 (595)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.9e-11 Score=124.89 Aligned_cols=248 Identities=18% Similarity=0.192 Sum_probs=173.6
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEe--CCCcEEEEEEeccCCCc-hhHHHHHHHHHHHHhc-CCCCCccccceeecCCce
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVL--SDNTKVAVKRLQDYYSP-GGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (595)
.-..+|..+..||.|.|+.|++... .++..|++|.+.+.... .....-..|+.+...+ .|.+++.....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3455788899999999999999873 46888999988754322 2222234566666665 488888887777777777
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-CcEEEeecccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLA 422 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~ 422 (595)
++--||++++++.....- ...++....+++..|++.++.++|+. .++|+|+||+||++..+ +.-+++|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 888999999987766621 34577788899999999999999998 99999999999999886 78899999998
Q ss_pred ccccCcCcceeeccccccccc--CccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 423 KLVDAKLTHVTTQIRGTMGHI--APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
..+.-. .....+..++. +|+......+-.+.|+||||.-+.|..++..--.. . ..|
T Consensus 415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~---------~~~-------- 472 (524)
T KOG0601|consen 415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-G---------VQS-------- 472 (524)
T ss_pred ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcc-c---------ccc--------
Confidence 643211 11111233344 55555667788999999999999999998643211 0 001
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
..+........+..- .++..+...+..+++..||.+.+...+..
T Consensus 473 --~~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 473 --LTIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --eeeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111111111112222 56666777788999999999888765543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.9e-11 Score=133.13 Aligned_cols=90 Identities=31% Similarity=0.529 Sum_probs=83.0
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccC-CCCceec
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQL-SNLKHLD 154 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~~L~~l~ 154 (595)
.+++.|+|++|+|.|.+|+.+++|++|+.|+|++|+|+|.+|..+++|++|++|+|++|+|+|.+|..++.+ .++..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 478999999999999999999999999999999999999999999999999999999999999999998774 4678999
Q ss_pred CCCCcCCccCc
Q 007625 155 LSSNNLTGRIP 165 (595)
Q Consensus 155 l~~N~l~g~ip 165 (595)
+++|...+.+|
T Consensus 522 ~~~N~~lc~~p 532 (623)
T PLN03150 522 FTDNAGLCGIP 532 (623)
T ss_pred ecCCccccCCC
Confidence 99998765554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.6e-11 Score=132.10 Aligned_cols=250 Identities=16% Similarity=0.170 Sum_probs=173.7
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
....+.+.+.+-+-+|.++.++-+.- ..|...+.|+.... ......+....+-.++-..+||.++....-+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 34567788888889999999998773 24544555544321 1111122233333333334566666655445556778
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
+++++|..++++...|+... ..+..-.......+..+++|||.. .+.|+|++|.|.+...++..+++|||...
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred chhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence 99999999999999998633 345555566777788999999998 79999999999999999999999998433
Q ss_pred cccC---------------------cC---------cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCC
Q 007625 424 LVDA---------------------KL---------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473 (595)
Q Consensus 424 ~~~~---------------------~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~ 473 (595)
.... .. ........||+.|.+||...+......+|+|+.|+.++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 2210 00 01122356899999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhHHHHHHHHhccccccccccc--cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007625 474 RAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR--NLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 540 (595)
Q Consensus 474 ~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 540 (595)
.||....... .+ ..+... .....+.....+..+++...+..+|.+|-.|.
T Consensus 1033 pp~na~tpq~--------~f---------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQ--------IF---------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhh--------hh---------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9997544311 11 112222 22334555666777888888899999998776
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-11 Score=107.78 Aligned_cols=98 Identities=27% Similarity=0.425 Sum_probs=83.9
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccC-ccccccccCCCCceecC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG-SIPATWSQLSNLKHLDL 155 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l 155 (595)
++..|++.+|+|. .+|.+++.|++|+.|+++-|++. .+|..||+++.|+.|||++|+++. .+|..|..+..|+.|+|
T Consensus 57 nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl 134 (264)
T KOG0617|consen 57 NLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL 134 (264)
T ss_pred hhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence 6788999999998 88999999999999999999998 899999999999999999999864 57888888888888888
Q ss_pred CCCcCCccCchhhhcccccccc
Q 007625 156 SSNNLTGRIPMQLFSVATFNFT 177 (595)
Q Consensus 156 ~~N~l~g~ip~~l~~l~~l~~~ 177 (595)
+.|.|. -+|..+++++.+.+-
T Consensus 135 ~dndfe-~lp~dvg~lt~lqil 155 (264)
T KOG0617|consen 135 GDNDFE-ILPPDVGKLTNLQIL 155 (264)
T ss_pred cCCCcc-cCChhhhhhcceeEE
Confidence 888888 788776666555443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.5e-09 Score=93.81 Aligned_cols=132 Identities=22% Similarity=0.325 Sum_probs=100.1
Q ss_pred CeeeeccceEEEEEEeCCCcEEEEEEe-ccCC-Cch-----hHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 277 NIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYY-SPG-----GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~l-~~~~-~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
..+++|+-+.+|.+.+. |..+++|.- .+.. .+. ....-.+|+.++.++.--.|.-.+=|..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999773 444666643 2222 121 123456788999988766666666677888888999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
++|..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888752 245666777778889999 999999999999998774 99999999863
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.1e-10 Score=103.91 Aligned_cols=99 Identities=29% Similarity=0.457 Sum_probs=39.2
Q ss_pred CEEEEEcCCCCCCCCCCcccc-ccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCcccccc-ccCCCCceec
Q 007625 77 NVISLTLGSNGFSGKISPSIT-KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATW-SQLSNLKHLD 154 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~-~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~l~ 154 (595)
+++.|+|.+|+|+ .|. .++ .|.+|+.|||++|.|+ .++ .+..|+.|++|+|++|+|+ .+++.+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 6789999999998 564 466 6899999999999999 665 4888999999999999999 676555 4699999999
Q ss_pred CCCCcCCccCc-----hhhhcccccccccccc
Q 007625 155 LSSNNLTGRIP-----MQLFSVATFNFTGTHL 181 (595)
Q Consensus 155 l~~N~l~g~ip-----~~l~~l~~l~~~~n~~ 181 (595)
|++|+|. .+- ..+.+|..|++.|||.
T Consensus 95 L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 95 LSNNKIS-DLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp -TTS----SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred CcCCcCC-ChHHhHHHHcCCCcceeeccCCcc
Confidence 9999997 332 2466778889999987
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.9e-08 Score=103.40 Aligned_cols=220 Identities=15% Similarity=0.127 Sum_probs=150.9
Q ss_pred cceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec----CCceEEEEEecccC-cHh
Q 007625 283 GFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVYPFMQNL-SVA 356 (595)
Q Consensus 283 ~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~g-sL~ 356 (595)
-..+.|++.. .||..|++|+++....... .....-+++++++.|+|+|++.+.+.. +...++||+|.++. +|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3468899984 4899999999954322111 112345788999999999999988763 45678999999864 555
Q ss_pred hhhcccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 357 YRLRDLK-----------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 357 ~~l~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
+.-.... ..+...++...|.++.|+..||.++|+. |+.-+-|.+.+|+++.+.+++|+..|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 4433211 1234578899999999999999999999 9999999999999999999999999988766
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
..+.. |-+. --.+-|.=.||.+++.|.||..--...+. ......+.
T Consensus 444 ~~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~---~~~s~~~~------------- 489 (655)
T KOG3741|consen 444 QEDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDS---TQSSHLTR------------- 489 (655)
T ss_pred cCCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccc---hHHHHHHH-------------
Confidence 54321 1111 12467999999999999999643111110 00000111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
....+..++.+++.......+++ -+..+++.+.-+
T Consensus 490 -------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~ 524 (655)
T KOG3741|consen 490 -------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGS 524 (655)
T ss_pred -------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence 12344555666666666777766 677777776543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.4e-08 Score=91.25 Aligned_cols=144 Identities=20% Similarity=0.228 Sum_probs=105.6
Q ss_pred cCCeeeeccceEEEEEEeCCCcEEEEEEec-c-CCCc-----hhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 275 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-D-YYSP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~-~-~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
....|-+|+-+.|+++.+ .|+...||.-. + ...+ -......+|.+.+.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467889999999999998 67776776432 1 1111 13456678999999887656655555777778889999
Q ss_pred Eeccc-CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC---cEEEeeccccc
Q 007625 348 PFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAK 423 (595)
Q Consensus 348 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~~~ 423 (595)
||+++ .++.+++..... ..........++.+|-+.+.-||.+ +|+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 367777765332 1222233367888899999999999 999999999999996554 35899999976
Q ss_pred c
Q 007625 424 L 424 (595)
Q Consensus 424 ~ 424 (595)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=7.4e-10 Score=83.36 Aligned_cols=61 Identities=41% Similarity=0.653 Sum_probs=45.8
Q ss_pred CCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcC
Q 007625 100 KFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNL 160 (595)
Q Consensus 100 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l 160 (595)
++|++|+|++|+|+...+..|.++++|++|+|++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4677888888888844445777888888888888888755556778888888888888865
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.4e-08 Score=97.51 Aligned_cols=143 Identities=13% Similarity=0.042 Sum_probs=101.4
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCc----------hhHHHHHHHHHHHHhcCCCC--Cccccceeec----
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP----------GGEAAFQREVHLISVAIHKN--LLQLIGYCTT---- 339 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~---- 339 (595)
++.+-......|++..+ +|+.|.||+....... .....+.+|...+.++...+ ..+++++...
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34444444455667766 6788999977432211 11124778988888875433 3344556543
Q ss_pred -CCceEEEEEecccC-cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-------
Q 007625 340 -SSERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD------- 410 (595)
Q Consensus 340 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~------- 410 (595)
....++|+|++++. +|.+++.+.. ....+......++.+++..+.-||.. ||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence 23468999999986 7888876432 13355667789999999999999999 9999999999999975
Q ss_pred CCcEEEeecccccc
Q 007625 411 NFEAVLCDFGLAKL 424 (595)
Q Consensus 411 ~~~~kl~DfG~~~~ 424 (595)
+..+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998853
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.2e-10 Score=124.22 Aligned_cols=112 Identities=30% Similarity=0.481 Sum_probs=97.4
Q ss_pred CCCCCcceeEecCCCEEEEEcCCCCCCCCCC-ccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccc
Q 007625 63 SPCFSWSHVTCRNGNVISLTLGSNGFSGKIS-PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP 141 (595)
Q Consensus 63 ~~c~~w~gv~c~~~~l~~l~l~~n~l~g~~~-~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 141 (595)
+.| |.-..|- .+++.|+|++|+|. .+| ..+.+|..|+.|+||+|+|+ .+|..+.+++.|++|...+|+|. ..|
T Consensus 373 d~c--~p~l~~~-~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP 446 (1081)
T KOG0618|consen 373 DSC--FPVLVNF-KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP 446 (1081)
T ss_pred ccc--hhhhccc-cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence 456 6655553 38999999999998 666 46899999999999999999 89999999999999999999999 899
Q ss_pred cccccCCCCceecCCCCcCC-ccCchhh--hcccccccccccc
Q 007625 142 ATWSQLSNLKHLDLSSNNLT-GRIPMQL--FSVATFNFTGTHL 181 (595)
Q Consensus 142 ~~~~~l~~L~~l~l~~N~l~-g~ip~~l--~~l~~l~~~~n~~ 181 (595)
++.+++.|+.+|+|.|+|+ +.+|..+ .+|+.|+++||.+
T Consensus 447 -e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 447 -ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred -hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 8999999999999999997 3455444 5899999999996
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.9e-10 Score=113.78 Aligned_cols=99 Identities=25% Similarity=0.397 Sum_probs=65.9
Q ss_pred EEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCcccc-CCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 78 VISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG-SMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 78 l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+..|+|.+|+|. .+| +|.+++.|.+|+++.|+|. .+|++.+ +|++|.+|||..|+++ ++|+++..|++|..||+|
T Consensus 208 L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlS 283 (565)
T KOG0472|consen 208 LELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLS 283 (565)
T ss_pred hHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhccc
Confidence 344455555554 444 4555555555555555555 5555555 6777788888888887 788888778888888888
Q ss_pred CCcCCccCchhhhcc--cccccccccc
Q 007625 157 SNNLTGRIPMQLFSV--ATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~~l~~l--~~l~~~~n~~ 181 (595)
+|.|+ .+|.+++++ +.+.+.|||.
T Consensus 284 NN~is-~Lp~sLgnlhL~~L~leGNPl 309 (565)
T KOG0472|consen 284 NNDIS-SLPYSLGNLHLKFLALEGNPL 309 (565)
T ss_pred CCccc-cCCcccccceeeehhhcCCch
Confidence 88887 677777664 5556677774
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.5e-07 Score=94.44 Aligned_cols=263 Identities=16% Similarity=0.118 Sum_probs=155.0
Q ss_pred cCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccc------eeecCCc-eEEE
Q 007625 275 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIG------YCTTSSE-RILV 346 (595)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~------~~~~~~~-~~lv 346 (595)
.++.||+|+-+.+|..-. -..-+.|+++..-.. ... ..+..|... .||-+-.=+. +..+.+. ..+.
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa-~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPA-AQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCch-HHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 478899999999996542 112345666543211 111 223334333 4554332111 1122222 5677
Q ss_pred EEecccCc-Hhhhhc--ccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 347 YPFMQNLS-VAYRLR--DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 347 ~e~~~~gs-L~~~l~--~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
|+.+.+.. ...+++ ..+..-....|+-.++++..+|.+.+.||.. |.+-+|+.++|+|+++++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 77776542 222221 1122234579999999999999999999999 99999999999999999999999855433
Q ss_pred cccCcCcceeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhC-CCCCCCCchhhhhhhhHHHHHHHHh
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEEEDVLLLDHIRKLL 497 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg-~~p~~~~~~~~~~~~~l~~~~~~~~ 497 (595)
...+ ........|...|.+||.-. +..-+...|-|.+||++++++.| ++||.+-........-+...+....
T Consensus 166 i~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 INAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred eccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 3222 22223345889999999764 34557789999999999999987 9999763322111111111111000
Q ss_pred ---ccccccccccccCCCCCHHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHhhc
Q 007625 498 ---REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQST--PEDRPPMAQVVKMLQG 548 (595)
Q Consensus 498 ---~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~d--P~~RPs~~evl~~L~~ 548 (595)
..+.-..........-..-....+..+..+|+... +.-||+++-.+..|..
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 00000000001111111223445666677888653 5689999999888754
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.3e-10 Score=117.00 Aligned_cols=103 Identities=24% Similarity=0.341 Sum_probs=80.0
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccc---cccCCCCcee
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT---WSQLSNLKHL 153 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~---~~~l~~L~~l 153 (595)
++..|+|++|+|+..-+.+|..|..|+.|+|++|+++..--..|..+++|+.|||++|.|++.|.+. |..|++|+.|
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 7889999999999666777888888888888888888555566778888888888888888777653 6678888888
Q ss_pred cCCCCcCCccCch----hhhccccccccccc
Q 007625 154 DLSSNNLTGRIPM----QLFSVATFNFTGTH 180 (595)
Q Consensus 154 ~l~~N~l~g~ip~----~l~~l~~l~~~~n~ 180 (595)
+|.+|+|. .||. .+.+|..|++.+|+
T Consensus 398 ~l~gNqlk-~I~krAfsgl~~LE~LdL~~Na 427 (873)
T KOG4194|consen 398 RLTGNQLK-SIPKRAFSGLEALEHLDLGDNA 427 (873)
T ss_pred eecCceee-ecchhhhccCcccceecCCCCc
Confidence 88888887 7774 44566677776665
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.9e-10 Score=115.32 Aligned_cols=102 Identities=30% Similarity=0.449 Sum_probs=68.1
Q ss_pred CEEEEEcCCCCCCC-CCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccc-cccCCCCceec
Q 007625 77 NVISLTLGSNGFSG-KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKHLD 154 (595)
Q Consensus 77 ~l~~l~l~~n~l~g-~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~ 154 (595)
++.++++.+|+|.. -||+.+.+|..|+.||||+|+|. ..|..+..-+++-+|+||+|+|. +||.. +.+|.-|-+||
T Consensus 79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLD 156 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLD 156 (1255)
T ss_pred hhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhc
Confidence 35566666666642 35666777777777777777777 67777777777777777777776 66655 45667777777
Q ss_pred CCCCcCCccCchhh---hcccccccccccc
Q 007625 155 LSSNNLTGRIPMQL---FSVATFNFTGTHL 181 (595)
Q Consensus 155 l~~N~l~g~ip~~l---~~l~~l~~~~n~~ 181 (595)
||+|+|. .+|+++ ..|++|.+++||+
T Consensus 157 LS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL 185 (1255)
T KOG0444|consen 157 LSNNRLE-MLPPQIRRLSMLQTLKLSNNPL 185 (1255)
T ss_pred cccchhh-hcCHHHHHHhhhhhhhcCCChh
Confidence 7777776 666543 4456666777764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=3e-08 Score=92.30 Aligned_cols=127 Identities=22% Similarity=0.292 Sum_probs=82.5
Q ss_pred EEEEEEeCCCcEEEEEEeccCCC--------------------c-----hhHHHHHHHHHHHHhcCCCC--Cccccceee
Q 007625 286 KVYKGVLSDNTKVAVKRLQDYYS--------------------P-----GGEAAFQREVHLISVAIHKN--LLQLIGYCT 338 (595)
Q Consensus 286 ~Vy~~~~~~~~~vavK~l~~~~~--------------------~-----~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~ 338 (595)
.||.|...+|..+|+|+.+.... . .......+|.+.|.++..-+ +.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999998999999998742110 0 01245678999999997664 4555543
Q ss_pred cCCceEEEEEecc--cCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCcEEcCCCCCCEEEcCCCcEE
Q 007625 339 TSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL-HEQCNPKIIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 339 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlkp~NIll~~~~~~k 415 (595)
....+||||++ +..+.. +.+.. ++......++.+++..+..+ |.. ||+|+|+.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 25589999998 544433 33211 11334566777888866664 677 99999999999999988 999
Q ss_pred Eeecccccccc
Q 007625 416 LCDFGLAKLVD 426 (595)
Q Consensus 416 l~DfG~~~~~~ 426 (595)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.2e-10 Score=110.78 Aligned_cols=102 Identities=26% Similarity=0.408 Sum_probs=61.4
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccc-cccCCCCceecC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKHLDL 155 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~l 155 (595)
+++.|+|++|-+. .+|.+++.+..||.||+|+|+|. .+|..+..+..|+.+-.++|++. .+|++ +.+|.+|++|||
T Consensus 436 kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL 512 (565)
T KOG0472|consen 436 KLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDL 512 (565)
T ss_pred cceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceecc
Confidence 3444444444444 44444444444444444444444 44444444444444444444444 44444 889999999999
Q ss_pred CCCcCCccCchhhhc---cccccccccccc
Q 007625 156 SSNNLTGRIPMQLFS---VATFNFTGTHLI 182 (595)
Q Consensus 156 ~~N~l~g~ip~~l~~---l~~l~~~~n~~~ 182 (595)
.+|.|. .||+.+++ ++++.+.|||+.
T Consensus 513 ~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 513 QNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred CCCchh-hCChhhccccceeEEEecCCccC
Confidence 999999 89988765 577889999884
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.5e-09 Score=112.85 Aligned_cols=101 Identities=35% Similarity=0.556 Sum_probs=58.2
Q ss_pred CEEEEEcCCCCCCCCCCc-cccccCCCCeEEccCCccCCCCCccccCCCcccEEEecccccc------------------
Q 007625 77 NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS------------------ 137 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~-~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~------------------ 137 (595)
+...|+|++|+|. +||. -|.+|+.|-+||||+|+|. .+|+.+..|..|++|+||+|.|.
T Consensus 127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence 4556666666666 4543 3566677777777777766 56666666666666666655442
Q ss_pred -------CccccccccCCCCceecCCCCcCCccCchhhh---ccccccccccc
Q 007625 138 -------GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTH 180 (595)
Q Consensus 138 -------g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l~---~l~~l~~~~n~ 180 (595)
..+|.++..|.+|..+|||.|.|. .+|..++ +|..|++++|.
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ 256 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNK 256 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCc
Confidence 234555555556666666666665 5555433 23444455543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.3e-09 Score=78.24 Aligned_cols=60 Identities=32% Similarity=0.506 Sum_probs=54.8
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccc
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l 136 (595)
+++.|+|++|+|+...+..|.++++|++|+|++|.|+...|..|.++++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 688999999999955556899999999999999999977778999999999999999986
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.1e-07 Score=90.97 Aligned_cols=138 Identities=20% Similarity=0.175 Sum_probs=97.3
Q ss_pred CCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCC---------------------chhHHHHHHHHHHHHhcCCC--C
Q 007625 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---------------------PGGEAAFQREVHLISVAIHK--N 329 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--n 329 (595)
..+++.||-|.-+.||.|...+|.++|||.-+...+ .-.....++|++.|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 445789999999999999999999999996531110 01234567899999988654 5
Q ss_pred CccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc
Q 007625 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 409 (595)
Q Consensus 330 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 409 (595)
+.+.++ .+...+||||+++-.|...- ++......++..|+.-+.-+-.. ||||+|+.+-||+++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 555544 35678999999985543221 11222334444455544444455 999999999999999
Q ss_pred CCCcEEEeecccccccc
Q 007625 410 DNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 410 ~~~~~kl~DfG~~~~~~ 426 (595)
+||.+.++||-.+....
T Consensus 237 ~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 237 EDGDIVVIDWPQAVPIS 253 (304)
T ss_pred cCCCEEEEeCcccccCC
Confidence 99999999998776443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.2e-09 Score=107.77 Aligned_cols=104 Identities=27% Similarity=0.394 Sum_probs=90.9
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
.+..|+|++|.|+..-+..|.+|++|+.++|.+|.|+ .||...+...+|+.|+|.+|.|+..-.+++.-++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 4567999999999877888999999999999999999 899988888889999999999996666779999999999999
Q ss_pred CCcCCccCchh-h---hccccccccccccc
Q 007625 157 SNNLTGRIPMQ-L---FSVATFNFTGTHLI 182 (595)
Q Consensus 157 ~N~l~g~ip~~-l---~~l~~l~~~~n~~~ 182 (595)
.|.|+ .||.. + -+++.|++++|...
T Consensus 158 rN~is-~i~~~sfp~~~ni~~L~La~N~It 186 (873)
T KOG4194|consen 158 RNLIS-EIPKPSFPAKVNIKKLNLASNRIT 186 (873)
T ss_pred hchhh-cccCCCCCCCCCceEEeecccccc
Confidence 99999 88843 3 35788999998753
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.7e-08 Score=69.67 Aligned_cols=41 Identities=39% Similarity=0.654 Sum_probs=29.7
Q ss_pred hhHHHHHHHHHHHcc-CCCCCCCCCCCCCCCCCCCcceeEec
Q 007625 34 DVEGEALIEVLKALN-DTHGQFTDWNDHFVSPCFSWSHVTCR 74 (595)
Q Consensus 34 ~~~~~al~~~~~~~~-~~~~~l~~w~~~~~~~c~~w~gv~c~ 74 (595)
+.|++||++||+++. ++.+.+.+|+.....+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999999 46788999997642355599999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.6e-09 Score=104.82 Aligned_cols=126 Identities=29% Similarity=0.471 Sum_probs=94.1
Q ss_pred CCCCC-CCc---ceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCc
Q 007625 61 FVSPC-FSW---SHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTH 125 (595)
Q Consensus 61 ~~~~c-~~w---~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~ 125 (595)
.+.+| |+= .-|.|+. ...+.|+|+.|+|+-..|.+|+.+.+|+.||||+|+|+-.-|..|..|++
T Consensus 37 CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~ 116 (498)
T KOG4237|consen 37 CPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLAS 116 (498)
T ss_pred CCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHh
Confidence 34566 443 4577864 26788999999999555568999999999999999999777999999999
Q ss_pred ccEEEe-ccccccCcccc-ccccCCCCceecCCCCcCCccCch----------------------------hhhcccccc
Q 007625 126 LQSLNL-ANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPM----------------------------QLFSVATFN 175 (595)
Q Consensus 126 L~~L~l-~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~ip~----------------------------~l~~l~~l~ 175 (595)
|..|-+ ++|+|+ .+|. .|++|.+|+.|.+.-|++. .++. .+.+++.+.
T Consensus 117 l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlh 194 (498)
T KOG4237|consen 117 LLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLH 194 (498)
T ss_pred hhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHh
Confidence 988744 559999 6664 4778888888887777776 3332 123345666
Q ss_pred ccccccccCCCCC
Q 007625 176 FTGTHLICGSSLE 188 (595)
Q Consensus 176 ~~~n~~~~~~~~~ 188 (595)
++.||++|+|.+.
T Consensus 195 lA~np~icdCnL~ 207 (498)
T KOG4237|consen 195 LAQNPFICDCNLP 207 (498)
T ss_pred hhcCccccccccc
Confidence 6777877877664
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.6e-09 Score=102.01 Aligned_cols=100 Identities=24% Similarity=0.406 Sum_probs=83.6
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
.+++|||++|.|+ .+..++.-++.++.|+||+|.|. .+-+ +..|++|+.||||+|.++ .+-..-.+|-+++.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 6789999999998 88888998999999999999998 5554 888999999999999998 777776778888888999
Q ss_pred CCcCCccCc--hhhhcccccccccccc
Q 007625 157 SNNLTGRIP--MQLFSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip--~~l~~l~~l~~~~n~~ 181 (595)
+|.|. .+. ..+.++.+|++.+|+.
T Consensus 361 ~N~iE-~LSGL~KLYSLvnLDl~~N~I 386 (490)
T KOG1259|consen 361 QNKIE-TLSGLRKLYSLVNLDLSSNQI 386 (490)
T ss_pred hhhHh-hhhhhHhhhhheeccccccch
Confidence 99887 443 2567778888888864
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.7e-09 Score=103.98 Aligned_cols=94 Identities=30% Similarity=0.398 Sum_probs=84.3
Q ss_pred cccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcCCccCch---hhhcc
Q 007625 95 SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM---QLFSV 171 (595)
Q Consensus 95 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~---~l~~l 171 (595)
.|.+|++|+.|+|++|+|++.-+.+|..+.+|+.|+|..|+|...-...|.++..|+.|+|.+|+|+-..|. .+.++
T Consensus 269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l 348 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL 348 (498)
T ss_pred HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence 499999999999999999988899999999999999999999955556789999999999999999966664 45788
Q ss_pred ccccccccccccCCCCC
Q 007625 172 ATFNFTGTHLICGSSLE 188 (595)
Q Consensus 172 ~~l~~~~n~~~~~~~~~ 188 (595)
.++++-+|||.|.|.+.
T Consensus 349 ~~l~l~~Np~~CnC~l~ 365 (498)
T KOG4237|consen 349 STLNLLSNPFNCNCRLA 365 (498)
T ss_pred eeeehccCcccCccchH
Confidence 99999999999998653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.9e-08 Score=90.96 Aligned_cols=85 Identities=29% Similarity=0.441 Sum_probs=43.5
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccc-cCCCcccEEEeccccccCccc--cccccCCCCce
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL-GSMTHLQSLNLANNKFSGSIP--ATWSQLSNLKH 152 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~-~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~ 152 (595)
.+++.|+|++|+|+ .++ .+..|++|+.|+|++|+|+ .+++.+ ..+++|+.|+|++|+|.. +- ..+..+++|+.
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRV 117 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--E
T ss_pred cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcce
Confidence 47999999999999 555 4889999999999999999 676655 479999999999999983 32 35788999999
Q ss_pred ecCCCCcCCccCc
Q 007625 153 LDLSSNNLTGRIP 165 (595)
Q Consensus 153 l~l~~N~l~g~ip 165 (595)
|+|.+|.++ ..+
T Consensus 118 L~L~~NPv~-~~~ 129 (175)
T PF14580_consen 118 LSLEGNPVC-EKK 129 (175)
T ss_dssp EE-TT-GGG-GST
T ss_pred eeccCCccc-chh
Confidence 999999998 444
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.2e-08 Score=108.58 Aligned_cols=150 Identities=17% Similarity=0.286 Sum_probs=103.3
Q ss_pred HHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCccee--------ecccccccccCccccCC
Q 007625 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--------TQIRGTMGHIAPEYLST 450 (595)
Q Consensus 379 ~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~ 450 (595)
.+++.|+.|+|... ++||++|.|++|.++..+..||+.|+++........... .-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999984 899999999999999999999999998765543211100 01123457999999999
Q ss_pred CCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcc
Q 007625 451 GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCT 529 (595)
Q Consensus 451 ~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl 529 (595)
...+.++|+||+|+++|-+.. |+.-+......... ...+ ...+-....+..+.+.++.+-+.+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-----~~~~---------~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-----SFSR---------NLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh-----hhhh---------cccccccccccccCcHHHHHHHHHHh
Confidence 888999999999999999994 44444332211100 0000 11111122234455567777777899
Q ss_pred cCCCCCCCCHHHHHH
Q 007625 530 QSTPEDRPPMAQVVK 544 (595)
Q Consensus 530 ~~dP~~RPs~~evl~ 544 (595)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998887765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.1e-07 Score=86.18 Aligned_cols=125 Identities=20% Similarity=0.198 Sum_probs=90.6
Q ss_pred CCcEEEEEEeccCC------CchhHHHHHHHHHHHHhcCCCC--CccccceeecCC----ceEEEEEecccC-cHhhhhc
Q 007625 294 DNTKVAVKRLQDYY------SPGGEAAFQREVHLISVAIHKN--LLQLIGYCTTSS----ERILVYPFMQNL-SVAYRLR 360 (595)
Q Consensus 294 ~~~~vavK~l~~~~------~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~ 360 (595)
.++.+-+|...... ..-......+|...+..+...+ +.+.+++..... ..++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 35566666543211 1123445678888877775333 445566655432 347999999874 7888887
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC---cEEEeeccccccc
Q 007625 361 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAKLV 425 (595)
Q Consensus 361 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~~~~~ 425 (595)
... ..+......++.+++..++-||+. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 111 ~~~----~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWE----QLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhc----ccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 532 256667889999999999999999 999999999999999887 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.8e-07 Score=96.17 Aligned_cols=147 Identities=22% Similarity=0.259 Sum_probs=92.8
Q ss_pred CCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchh-----------------------------H----------
Q 007625 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGG-----------------------------E---------- 312 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~-----------------------------~---------- 312 (595)
.|+ .+.|+.++-|.||+|++++|+.||||+.+....+.. .
T Consensus 127 eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 343 478999999999999999999999999854321110 0
Q ss_pred HHHHHHHHHHHhcC-----CCCCccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHH-HH
Q 007625 313 AAFQREVHLISVAI-----HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG-LE 386 (595)
Q Consensus 313 ~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-L~ 386 (595)
-++.+|...+.+++ .+++.-..=|.......+++|||++|-.+.+...-.. ...+. ..++..++++ +.
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~---k~ia~~~~~~f~~ 279 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDR---KELAELLVRAFLR 279 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCH---HHHHHHHHHHHHH
Confidence 11223333333321 2222211112334567899999999988877743211 23442 2333333322 12
Q ss_pred HHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 387 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
.+-.. |++|.|.+|.||+++.++.+.+.|||+...+++.
T Consensus 280 q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 280 QLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 22224 8999999999999999999999999999877643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.7e-06 Score=79.81 Aligned_cols=138 Identities=17% Similarity=0.148 Sum_probs=102.5
Q ss_pred eeccceEEEEEEeCCCcEEEEEEeccC-----CCchhHHHHHHHHHHHHhcCCC--CCccccceee-cC----CceEEEE
Q 007625 280 GQGGFGKVYKGVLSDNTKVAVKRLQDY-----YSPGGEAAFQREVHLISVAIHK--NLLQLIGYCT-TS----SERILVY 347 (595)
Q Consensus 280 G~G~~g~Vy~~~~~~~~~vavK~l~~~-----~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-~~----~~~~lv~ 347 (595)
|+||-+-|+.... +|..+-+|+-... .-+-....|.+|+..+.++..- .+.+++ ++. .. -.-++|+
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 6788888998777 4557889976421 1145678999999999988633 244444 332 11 2357899
Q ss_pred Eeccc-CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc--EEEeecccccc
Q 007625 348 PFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--AVLCDFGLAKL 424 (595)
Q Consensus 348 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~~~~ 424 (595)
|-+.+ -+|.+++.+.. -.+.+...+..+..+++..++-||+. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 47888876422 23467777889999999999999999 9999999999999986666 99999987763
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.7e-07 Score=105.10 Aligned_cols=55 Identities=27% Similarity=0.471 Sum_probs=26.6
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEecccccc
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 137 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~ 137 (595)
+.+.|+|++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt 233 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT 233 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc
Confidence 4555666655555 4444332 34555555555555 3444332 24444444444444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.47 E-value=6.1e-08 Score=100.42 Aligned_cols=100 Identities=26% Similarity=0.488 Sum_probs=84.6
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
-+..|-+++|+++ .+|..++.+.+|..||.+.|.+. .+|..++.|.+|+.|.+..|++. .+|+++..|+ |..||+|
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfS 219 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFS 219 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecc
Confidence 5788888999998 88888998899999999999998 78999999999999999999988 8888888554 8889999
Q ss_pred CCcCCccCchhhhcc---cccccccccc
Q 007625 157 SNNLTGRIPMQLFSV---ATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~~l~~l---~~l~~~~n~~ 181 (595)
.|+++ .||-.|..+ ..+.+..||+
T Consensus 220 cNkis-~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 220 CNKIS-YLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred cCcee-ecchhhhhhhhheeeeeccCCC
Confidence 99998 899776554 5566778876
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.4e-07 Score=105.18 Aligned_cols=98 Identities=29% Similarity=0.426 Sum_probs=73.1
Q ss_pred CCEEEEEcCCCCCCCCCCcccccc-----------------CCCCeEEccCCccCCCCCccccCCCcccEEEeccccccC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKL-----------------KFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l-----------------~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g 138 (595)
.+++.|+|++|+|++ +|....+| .+|+.|+|++|.|+ .+|.. .++|+.|+|++|+|+
T Consensus 342 ~~Lq~LdLS~N~Ls~-LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls- 415 (788)
T PRK15387 342 SGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT- 415 (788)
T ss_pred cccceEecCCCccCC-CCCCCcccceehhhccccccCcccccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-
Confidence 478888888888874 44322221 36888899999888 47754 357889999999998
Q ss_pred ccccccccCCCCceecCCCCcCCccCchhhh---cccccccccccccc
Q 007625 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLIC 183 (595)
Q Consensus 139 ~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l~---~l~~l~~~~n~~~~ 183 (595)
.+|.. ..+|+.|+|++|+|+ .+|..+. ++..+++++|++..
T Consensus 416 sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 416 SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCc
Confidence 57854 346888999999999 8998654 56778899998753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.9e-08 Score=104.15 Aligned_cols=100 Identities=27% Similarity=0.524 Sum_probs=70.9
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
.++.|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|..++.+..|..||.+.|++. .+|+.++.+.+|+.|++.
T Consensus 122 ~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred HHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 5566677777776 6666666665 677777777776 67777777777777777777777 677777777777777777
Q ss_pred CCcCCccCchhhhcc--cccccccccc
Q 007625 157 SNNLTGRIPMQLFSV--ATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~~l~~l--~~l~~~~n~~ 181 (595)
.|++. .+|.++..| ..|+|+.|..
T Consensus 198 Rn~l~-~lp~El~~LpLi~lDfScNki 223 (722)
T KOG0532|consen 198 RNHLE-DLPEELCSLPLIRLDFSCNKI 223 (722)
T ss_pred hhhhh-hCCHHHhCCceeeeecccCce
Confidence 77777 677776543 5677777764
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.8e-08 Score=83.78 Aligned_cols=89 Identities=31% Similarity=0.478 Sum_probs=79.4
Q ss_pred CCEEEEEcCCCCCCCCCCcccc-ccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceec
Q 007625 76 GNVISLTLGSNGFSGKISPSIT-KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~-~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (595)
.+++.++|++|.+. .+|+.|. +.+.++.|+|++|.|+ .+|.++..++.|+.|++++|.|. ..|..+..|.+|-.|+
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 37899999999999 6666655 4569999999999999 89999999999999999999999 8888888999999999
Q ss_pred CCCCcCCccCchhh
Q 007625 155 LSSNNLTGRIPMQL 168 (595)
Q Consensus 155 l~~N~l~g~ip~~l 168 (595)
..+|.+. .||-.+
T Consensus 130 s~~na~~-eid~dl 142 (177)
T KOG4579|consen 130 SPENARA-EIDVDL 142 (177)
T ss_pred CCCCccc-cCcHHH
Confidence 9999998 888654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.9e-08 Score=105.31 Aligned_cols=99 Identities=35% Similarity=0.490 Sum_probs=88.7
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
++.+|+|++|.++ ..|..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|+|.+|++. .+|.++..+++|+.|++|
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 4899999999998 88999999999999999999999 89999999999999999999999 999999999999999999
Q ss_pred CCcCCccCchhh---hcccccccccc
Q 007625 157 SNNLTGRIPMQL---FSVATFNFTGT 179 (595)
Q Consensus 157 ~N~l~g~ip~~l---~~l~~l~~~~n 179 (595)
+|+|. .+|.-+ .....+.+++|
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N 147 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNN 147 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcc
Confidence 99998 899644 33445555665
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.5e-07 Score=101.29 Aligned_cols=92 Identities=24% Similarity=0.361 Sum_probs=49.0
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|..+ ++|+.|+|+
T Consensus 223 ~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 223 HITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIF 290 (788)
T ss_pred CCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEECc
Confidence 4555555555555 3443 1355566666666665 44532 245555555555555 444321 345556666
Q ss_pred CCcCCccCchhhhcccccccccccc
Q 007625 157 SNNLTGRIPMQLFSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~~l~~l~~l~~~~n~~ 181 (595)
+|+|+ .+|..+.+|..|++++|.+
T Consensus 291 ~N~Lt-~LP~~p~~L~~LdLS~N~L 314 (788)
T PRK15387 291 GNQLT-SLPVLPPGLQELSVSDNQL 314 (788)
T ss_pred CCccc-cccccccccceeECCCCcc
Confidence 66665 4555555566666666644
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.8e-07 Score=100.85 Aligned_cols=98 Identities=20% Similarity=0.379 Sum_probs=84.0
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
..++.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|+|
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 37899999999999 6777665 59999999999999 7888664 47999999999999 8898764 58999999
Q ss_pred CCCcCCccCchhhh-cccccccccccccc
Q 007625 156 SSNNLTGRIPMQLF-SVATFNFTGTHLIC 183 (595)
Q Consensus 156 ~~N~l~g~ip~~l~-~l~~l~~~~n~~~~ 183 (595)
++|+|+ .+|..+. +|..|++++|.+..
T Consensus 270 s~N~L~-~LP~~l~~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 270 FHNKIS-CLPENLPEELRYLSVYDNSIRT 297 (754)
T ss_pred cCCccC-ccccccCCCCcEEECCCCcccc
Confidence 999999 7887664 78999999997653
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.3e-07 Score=63.40 Aligned_cols=36 Identities=39% Similarity=0.648 Sum_probs=19.5
Q ss_pred CCCeEEccCCccCCCCCccccCCCcccEEEecccccc
Q 007625 101 FLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 137 (595)
Q Consensus 101 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~ 137 (595)
+|++|+|++|+|+ .+|+.|++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 45555555555555555555555
|
... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.35 E-value=7.5e-06 Score=77.92 Aligned_cols=156 Identities=21% Similarity=0.217 Sum_probs=100.8
Q ss_pred ccCHHHHHHHhcCCCcCCeee---eccceEEEEEEeCCCcEEEEEEeccCCCch------------------hHH-----
Q 007625 260 RFSCRELQLATDNFSESNIIG---QGGFGKVYKGVLSDNTKVAVKRLQDYYSPG------------------GEA----- 313 (595)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~lG---~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~------------------~~~----- 313 (595)
..+.+.+....++..+....| .|.-+.||+|...++..+|||+++...... ...
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 345556666666666655554 566678999998889999999986321110 000
Q ss_pred HHHHHHHHHHhcC--CCCCccccceeecCCceEEEEEecccC-cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 007625 314 AFQREVHLISVAI--HKNLLQLIGYCTTSSERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390 (595)
Q Consensus 314 ~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 390 (595)
=..+|+.-|.++. +-.+.+.+.+ ....+||||+... .-.-.|.+ .++...+...+..++++.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHH
Confidence 0234555555553 2223333322 2457999999643 22222332 223333677788888888888887
Q ss_pred cCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 391 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
.+ ++||+||..-|||+. ++.+.|+|||.+....+
T Consensus 185 ~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 185 EA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred hc--CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 43 999999999999999 77999999999875543
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.7e-07 Score=63.10 Aligned_cols=40 Identities=38% Similarity=0.676 Sum_probs=32.5
Q ss_pred CcccEEEeccccccCccccccccCCCCceecCCCCcCCccCc
Q 007625 124 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165 (595)
Q Consensus 124 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 165 (595)
++|++|+|++|+|+ .+|+.+++|++|+.|++++|+|+ .+|
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 57889999999998 78888899999999999999988 554
|
... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.34 E-value=6.9e-06 Score=79.43 Aligned_cols=138 Identities=14% Similarity=0.175 Sum_probs=84.6
Q ss_pred CeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCC--CccccceeecCCceEEEEEecccCc
Q 007625 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGYCTTSSERILVYPFMQNLS 354 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs 354 (595)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+||++++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999983 35567888875422 3345688999998886443 4566777777777889999999863
Q ss_pred -Hhhh---------------------hcccCCCCCCCCHHHHHH-HHHH----------HH-HHHHHHhhc-CCCCcEEc
Q 007625 355 -VAYR---------------------LRDLKPGEKGLDWPTRKR-VAFG----------TA-YGLEYLHEQ-CNPKIIHR 399 (595)
Q Consensus 355 -L~~~---------------------l~~~~~~~~~l~~~~~~~-i~~~----------ia-~~L~~LH~~-~~~~ivH~ 399 (595)
+... +|...... ........ +..+ +. ....+|... ..+.++|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 1111 12111001 11111100 0000 00 112222211 13357899
Q ss_pred CCCCCCEEEcCCCcEEEeeccccc
Q 007625 400 DLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 400 Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
|+.|.||++++++ +.|+||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.2e-07 Score=90.81 Aligned_cols=85 Identities=22% Similarity=0.338 Sum_probs=73.9
Q ss_pred cccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcCCccCc---hhhhcc
Q 007625 95 SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP---MQLFSV 171 (595)
Q Consensus 95 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip---~~l~~l 171 (595)
.+.....|+.||||+|.|+ .|.++..-+|.++.|++|+|.|. .+-. +..|++|+.||||+|.|+ ++- ..++++
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 3455678999999999999 89999999999999999999998 5554 899999999999999998 444 468999
Q ss_pred cccccccccccc
Q 007625 172 ATFNFTGTHLIC 183 (595)
Q Consensus 172 ~~l~~~~n~~~~ 183 (595)
++|.+++|....
T Consensus 355 KtL~La~N~iE~ 366 (490)
T KOG1259|consen 355 KTLKLAQNKIET 366 (490)
T ss_pred eeeehhhhhHhh
Confidence 999999997643
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=5.1e-08 Score=103.50 Aligned_cols=103 Identities=32% Similarity=0.455 Sum_probs=80.9
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCcc-ccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDF-LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+..|+|++|+++. .. .+..|++|++|||+.|.|. .+|.. ...+. |+.|.|++|.++ ++- .+.+|++|..|||
T Consensus 188 ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~-tL~-gie~LksL~~LDl 261 (1096)
T KOG1859|consen 188 ALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALT-TLR-GIENLKSLYGLDL 261 (1096)
T ss_pred Hhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHH-hhh-hHHhhhhhhccch
Confidence 67789999999884 33 6888899999999999998 67642 22333 899999999888 444 3789999999999
Q ss_pred CCCcCCccC---c-hhhhccccccccccccccCC
Q 007625 156 SSNNLTGRI---P-MQLFSVATFNFTGTHLICGS 185 (595)
Q Consensus 156 ~~N~l~g~i---p-~~l~~l~~l~~~~n~~~~~~ 185 (595)
+.|-|++.- | ..+..|..|++.|||.-|..
T Consensus 262 syNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 262 SYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 999998643 2 24567889999999998875
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.28 E-value=4e-07 Score=96.28 Aligned_cols=100 Identities=37% Similarity=0.617 Sum_probs=86.2
Q ss_pred CEEEEEcCCCCCCCCCCccccccC-CCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLK-FLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.++.|++.+|.++ .+|+....++ +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 5888999999998 7888788885 9999999999998 78888899999999999999999 88877778899999999
Q ss_pred CCCcCCccCchh--hhc-cccccccccc
Q 007625 156 SSNNLTGRIPMQ--LFS-VATFNFTGTH 180 (595)
Q Consensus 156 ~~N~l~g~ip~~--l~~-l~~l~~~~n~ 180 (595)
++|+++ .+|.. ..+ +..+.+++|+
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 999999 88874 444 8888888886
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.7e-06 Score=103.29 Aligned_cols=104 Identities=23% Similarity=0.360 Sum_probs=79.7
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|.+|+|. .++..+..+++|+.|+|++|...+.+|. ++.+++|++|+|++|.....+|..++++++|+.|++
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 47888888888887 6777788888888888888765557774 788888888888887655688888888888888888
Q ss_pred CCCcCCccCchh--hhcccccccccccc
Q 007625 156 SSNNLTGRIPMQ--LFSVATFNFTGTHL 181 (595)
Q Consensus 156 ~~N~l~g~ip~~--l~~l~~l~~~~n~~ 181 (595)
++|..-+.+|.. +.+|..|++++|..
T Consensus 689 ~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 689 SRCENLEILPTGINLKSLYRLNLSGCSR 716 (1153)
T ss_pred CCCCCcCccCCcCCCCCCCEEeCCCCCC
Confidence 886544577763 45677777777643
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.5e-06 Score=101.97 Aligned_cols=88 Identities=24% Similarity=0.294 Sum_probs=44.5
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
.++.|++.++.+. .+|..| .+.+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|+
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~ 665 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLS 665 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEec
Confidence 3455555555554 444444 3455555555555555 4555555555555555555443334442 4555555555555
Q ss_pred CCcCCccCchhh
Q 007625 157 SNNLTGRIPMQL 168 (595)
Q Consensus 157 ~N~l~g~ip~~l 168 (595)
+|.....+|..+
T Consensus 666 ~c~~L~~lp~si 677 (1153)
T PLN03210 666 DCSSLVELPSSI 677 (1153)
T ss_pred CCCCccccchhh
Confidence 544444555443
|
syringae 6; Provisional |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.19 E-value=2e-05 Score=74.26 Aligned_cols=138 Identities=14% Similarity=0.135 Sum_probs=90.6
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHH---------HHHHHHHHHhcCCCC---Cccccc
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA---------FQREVHLISVAIHKN---LLQLIG 335 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~~E~~~l~~l~h~n---iv~l~~ 335 (595)
....+|...+++-......|.+-.. +|+.+++|..++... ...+. ..+++..+.++.... ...++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3566788888888877777777776 678999998764321 12222 223344444443222 223222
Q ss_pred eee-----cCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC
Q 007625 336 YCT-----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 410 (595)
Q Consensus 336 ~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 410 (595)
... -....+++|||++|..|.+... ++. .++..+.+++.-+|.. |+.|+|.+|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 222 1234568999999977655432 221 3556777889999999 9999999999999986
Q ss_pred CCcEEEeeccccc
Q 007625 411 NFEAVLCDFGLAK 423 (595)
Q Consensus 411 ~~~~kl~DfG~~~ 423 (595)
+ .+++.||+.-+
T Consensus 171 ~-~i~iID~~~k~ 182 (229)
T PF06176_consen 171 N-GIRIIDTQGKR 182 (229)
T ss_pred C-cEEEEECcccc
Confidence 6 48999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.15 E-value=5e-07 Score=92.45 Aligned_cols=106 Identities=22% Similarity=0.331 Sum_probs=79.9
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCC---CCeEEccCCccCC----CCCccccCC-CcccEEEeccccccCc----cccc
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKF---LASLELQDNDLSG----TLPDFLGSM-THLQSLNLANNKFSGS----IPAT 143 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~---L~~L~l~~n~l~g----~~p~~~~~l-~~L~~L~l~~N~l~g~----~p~~ 143 (595)
.+++.|+|++|.+.+..+..+..+.+ |++|++++|.+++ .+...+..+ ++|+.|+|++|.+++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 48999999999998777777766666 9999999998873 344456677 8899999999998843 3445
Q ss_pred cccCCCCceecCCCCcCCcc----Cchhhh---cccccccccccc
Q 007625 144 WSQLSNLKHLDLSSNNLTGR----IPMQLF---SVATFNFTGTHL 181 (595)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g~----ip~~l~---~l~~l~~~~n~~ 181 (595)
+..+++|+.|+|++|.+++. ++..+. ++..+++++|..
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i 205 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL 205 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCcc
Confidence 66778899999999998842 333344 778888887754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.3e-05 Score=76.11 Aligned_cols=144 Identities=17% Similarity=0.190 Sum_probs=84.4
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCC--Cccccceeec---CCceEEEEEec
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGYCTT---SSERILVYPFM 350 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~---~~~~~lv~e~~ 350 (595)
++.|+.|..+.||+....+ ..+++|..... .....+..|..++..+.... +.+++.+... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 4678999999999999866 69999987542 45667788888888875443 4456654422 23468999999
Q ss_pred ccCcHhh----------------h---hcccCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHh
Q 007625 351 QNLSVAY----------------R---LRDLKPGEKGLDWPTR---------KRV------------AFGTAY-GLEYLH 389 (595)
Q Consensus 351 ~~gsL~~----------------~---l~~~~~~~~~l~~~~~---------~~i------------~~~ia~-~L~~LH 389 (595)
++..+.. . ++.............. ... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9887766 1 1111111111111110 000 111222 233333
Q ss_pred hc----CCCCcEEcCCCCCCEEEc-CCCcEEEeeccccc
Q 007625 390 EQ----CNPKIIHRDLKAANILLD-DNFEAVLCDFGLAK 423 (595)
Q Consensus 390 ~~----~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~~~ 423 (595)
+. ....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 21 234799999999999999 66667899998865
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.9e-05 Score=84.40 Aligned_cols=143 Identities=20% Similarity=0.213 Sum_probs=90.7
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCch------------------------------------hHHHHHHHH
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG------------------------------------GEAAFQREV 319 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~------------------------------------~~~~~~~E~ 319 (595)
.+.||.-+.|.||+|++++|+.||||+-+...... .+-+|..|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46899999999999999999999999865422111 011233444
Q ss_pred HHHHh----cCCCC------CccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 007625 320 HLISV----AIHKN------LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389 (595)
Q Consensus 320 ~~l~~----l~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH 389 (595)
+-..+ +.|-+ |.+++ ..-...+.++||||+|..+.+.-.-. ...++..... ..+.++ |++
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i~---~~l~~~--~~~ 315 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAID---KRGISPHDIL---NKLVEA--YLE 315 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHH---HcCCCHHHHH---HHHHHH--HHH
Confidence 33322 23444 22332 22345779999999998776653311 2335554333 333332 222
Q ss_pred hcCCCCcEEcCCCCCCEEEcC----CCcEEEeeccccccccCc
Q 007625 390 EQCNPKIIHRDLKAANILLDD----NFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 390 ~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DfG~~~~~~~~ 428 (595)
.-...|++|.|=+|.||+++. ++.+.+-|||+...+...
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 222238999999999999983 678999999998876543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.7e-07 Score=78.68 Aligned_cols=95 Identities=25% Similarity=0.362 Sum_probs=75.6
Q ss_pred CEEEEEcCCCCCCCCCCcc---ccccCCCCeEEccCCccCCCCCccccCC-CcccEEEeccccccCccccccccCCCCce
Q 007625 77 NVISLTLGSNGFSGKISPS---ITKLKFLASLELQDNDLSGTLPDFLGSM-THLQSLNLANNKFSGSIPATWSQLSNLKH 152 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~---~~~l~~L~~L~l~~n~l~g~~p~~~~~l-~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 152 (595)
.+..++|++..|- .++.. +.+...|+..+|++|.|. ..|+.|... +.+++|+|++|+|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3456777777775 56554 555667777899999999 788777765 58999999999999 99999999999999
Q ss_pred ecCCCCcCCccCchhhhcccccc
Q 007625 153 LDLSSNNLTGRIPMQLFSVATFN 175 (595)
Q Consensus 153 l~l~~N~l~g~ip~~l~~l~~l~ 175 (595)
|++++|.|. ..|.-++.|..++
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~ 126 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLD 126 (177)
T ss_pred cccccCccc-cchHHHHHHHhHH
Confidence 999999999 7776555454443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.07 E-value=8e-07 Score=90.94 Aligned_cols=105 Identities=30% Similarity=0.413 Sum_probs=79.7
Q ss_pred CEEEEEcCCCCCCC----CCCcccccc-CCCCeEEccCCccCCC----CCccccCCCcccEEEeccccccCc----cccc
Q 007625 77 NVISLTLGSNGFSG----KISPSITKL-KFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IPAT 143 (595)
Q Consensus 77 ~l~~l~l~~n~l~g----~~~~~~~~l-~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~ 143 (595)
+++.|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++. ++..
T Consensus 109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 188 (319)
T cd00116 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188 (319)
T ss_pred cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence 49999999999883 334456677 8999999999999853 445667788999999999999853 4455
Q ss_pred cccCCCCceecCCCCcCCccCch-------hhhcccccccccccc
Q 007625 144 WSQLSNLKHLDLSSNNLTGRIPM-------QLFSVATFNFTGTHL 181 (595)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g~ip~-------~l~~l~~l~~~~n~~ 181 (595)
+..+++|+.|+|++|.+++.-.. .+.++..+++++|+.
T Consensus 189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l 233 (319)
T cd00116 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL 233 (319)
T ss_pred HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcC
Confidence 66778999999999998743322 234578888888754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.00 E-value=7.7e-05 Score=86.13 Aligned_cols=150 Identities=13% Similarity=0.212 Sum_probs=92.1
Q ss_pred CCeeeeccceEEEEEEeCCC---cEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCC--ccccceeecC---CceEEE
Q 007625 276 SNIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNL--LQLIGYCTTS---SERILV 346 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 346 (595)
.+.++.|.++.+|+....++ ..+++|+............+.+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887554 4677887543222223457889999999985 6664 6777777654 457899
Q ss_pred EEecccCcHhh-----------------------hhcccCCCC-------CCCCH--HHHHHHH---------------H
Q 007625 347 YPFMQNLSVAY-----------------------RLRDLKPGE-------KGLDW--PTRKRVA---------------F 379 (595)
Q Consensus 347 ~e~~~~gsL~~-----------------------~l~~~~~~~-------~~l~~--~~~~~i~---------------~ 379 (595)
|||+++..+.+ .||...... .+..+ .+...+. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 112111100 01111 1111111 1
Q ss_pred HHHHHHHHHhhcCC--------CCcEEcCCCCCCEEEcCC-Cc-EEEeeccccccc
Q 007625 380 GTAYGLEYLHEQCN--------PKIIHRDLKAANILLDDN-FE-AVLCDFGLAKLV 425 (595)
Q Consensus 380 ~ia~~L~~LH~~~~--------~~ivH~Dlkp~NIll~~~-~~-~kl~DfG~~~~~ 425 (595)
.+...+.+|..+.+ +.++|+|+++.||+++.+ .. .-|.||+++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23344566754322 359999999999999753 33 579999987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.1e-06 Score=90.77 Aligned_cols=183 Identities=16% Similarity=0.123 Sum_probs=131.2
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCC-CccccceeecCCceEEEEEecccC-
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN-LLQLIGYCTTSSERILVYPFMQNL- 353 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g- 353 (595)
-+-+++|+++.++|.+-...+....+.+... -...-++++|.+++||| .+..++-+..+....++++++.++
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 4557899999999988533444445555321 34456889999999999 666666667777788999999877
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCccee
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 433 (595)
+....... ....+...+...+...-+++++|+|+. .=+|+| ||+..+ ...+..||+....+.... ..
T Consensus 321 s~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 321 SSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred cccccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 22111110 112233344455666777899999987 458888 777665 588999999988776543 23
Q ss_pred ecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 007625 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477 (595)
Q Consensus 434 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~ 477 (595)
....+++.++|||+.....+..+.|+|+.|+--.++.-|-+|-.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 44568999999999999999999999999988778877776643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 595 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-108 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-105 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-38 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-08 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 532 bits (1374), Expect = 0.0
Identities = 204/326 (62%), Positives = 261/326 (80%), Gaps = 1/326 (0%)
Query: 242 FFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK 301
FFDV E+D +V L QL+RFS RELQ+A+DNFS NI+G+GGFGKVYKG L+D T VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 302 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 361
RL++ + GGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 362 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421
+ LDWP R+R+A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEAV+ DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481
AKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQRA D +RL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 482 EEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMA 540
++DV+LLD ++ LL+E +L +VD +L Y +EVE ++QVALLCTQS+P +RP M+
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 541 QVVKMLQGEDLAERWAEWEELEEVRQ 566
+VV+ML+G+ LAERW EW++ E RQ
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 405 bits (1043), Expect = e-139
Identities = 116/312 (37%), Positives = 178/312 (57%), Gaps = 21/312 (6%)
Query: 248 EDDCKVSLTQLRRFSCRELQLATDNFSE------SNIIGQGGFGKVYKGVLSDNTKVAVK 301
+VS T+ FS EL+ T+NF E N +G+GGFG VYKG + +NT VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 302 RL---QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYR 358
+L D + + F +E+ +++ H+NL++L+G+ + + LVY +M N S+ R
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 359 LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418
L G L W R ++A G A G+ +LHE IHRD+K+ANILLD+ F A + D
Sbjct: 121 LSC-LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 419 FGLAKLVDA-KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477
FGLA+ + T +T++I GT ++APE L G+ + K+D++ +G+ LLE++TG A+D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 478 FSRLEEEEDVLLLDHIRKLLREDR-LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR 536
R E LLLD ++ E++ + D +D+ +N DS VE M VA C R
Sbjct: 236 EHR----EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 537 PPMAQVVKMLQG 548
P + +V ++LQ
Sbjct: 292 PDIKKVQQLLQE 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 370 bits (953), Expect = e-125
Identities = 106/295 (35%), Positives = 160/295 (54%), Gaps = 8/295 (2%)
Query: 256 TQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAF 315
+ R +L+ AT+NF +IG G FGKVYKGVL D KVA+KR S G F
Sbjct: 24 FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEF 82
Query: 316 QREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 375
+ E+ +S H +L+ LIG+C +E IL+Y +M+N ++ L + W R
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTT 434
+ G A GL YLH + IIHRD+K+ NILLD+NF + DFG++K + TH++T
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494
++GT+G+I PEY G+ +EK+DV+ +G+ L E++ + AI S E + L +
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN--LAEWAV 257
Query: 495 KLLREDRLNDIVDRNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548
+ +L IVD NL + + + A+ C + EDRP M V+ L+
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 4e-74
Identities = 72/313 (23%), Positives = 121/313 (38%), Gaps = 38/313 (12%)
Query: 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE-- 318
L + + +G FG V+K L N VAVK + ++Q E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF----PIQDKQSWQNEYE 68
Query: 319 VHLISVAIHKNLLQLIGYCTTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR 374
V+ + H+N+LQ IG + + L+ F + S++ L+ + W
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNEL 123
Query: 375 KRVAFGTAYGLEYLHE-------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427
+A A GL YLHE P I HRD+K+ N+LL +N A + DFGLA +A
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 428 KLTHV-TTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRL 481
+ T GT ++APE L + + D++ G+ L EL + A D
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV- 242
Query: 482 EEEEDVLLLDHIRKLLREDRLNDIVDRNL------NTYDSKEV-ETMVQVALLCTQSTPE 534
+E + + I + + + ++V + + + + C E
Sbjct: 243 -DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 535 DRPPMAQVVKMLQ 547
R V + +
Sbjct: 302 ARLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 5e-62
Identities = 69/322 (21%), Positives = 117/322 (36%), Gaps = 45/322 (13%)
Query: 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE-- 318
+ E L DN +IG+G +G VYKG L D VAVK S F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKN 57
Query: 319 VHLISVAIHKNLLQLIGYCTTSS-----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
++ + + H N+ + I + E +LV + N S+ L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVS 112
Query: 374 RKRVAFGTAYGLEYLHE------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD- 426
R+A GL YLH P I HRDL + N+L+ ++ V+ DFGL+ +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 427 ------AKLTHVTTQIRGTMGHIAPEYL-------STGKSSEKTDVFGYGITLLELVTGQ 473
+ + GT+ ++APE L + ++ D++ G+ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 474 RAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR--------NLNTYDSKEVETMVQVA 525
+ E + + + + +V R +S V ++ +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 526 LLCTQSTPEDRPPMAQVVKMLQ 547
C E R + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-56
Identities = 76/272 (27%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
IG G FG V++ + VAVK L + + F REV ++ H N++ +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
T +V ++ S+ L E+ LD R +A+ A G+ YLH NP
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 455
I+HR+LK+ N+L+D + +CDFGL++L A + GT +APE L S+E
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 456 KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 515
K+DV+ +G+ L EL T Q + L + V + K R + ++ +
Sbjct: 219 KSDVYSFGVILWELATLQ--QPWGNLNPAQVVAAV--GFKCKRLEIPRNL--------NP 266
Query: 516 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + C + P RP A ++ +L+
Sbjct: 267 QVAAIIEG----CWTNEPWKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-54
Identities = 68/283 (24%), Positives = 109/283 (38%), Gaps = 37/283 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
++G+G FG V K VA+K+++ S AF E+ +S H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE---SESERKAFIVELRQLSRVNHPNI 63
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
++L G C + LV + + S+ L +P + G+ YLH
Sbjct: 64 VKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHS 120
Query: 391 QCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
+IHRDLK N+LL + +CDFG A + +T+ G+ +APE
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK----GSAAWMAPEVFE 176
Query: 450 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509
SEK DVF +GI L E++T ++ F + ++ V
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIM--------------WAVHNG 220
Query: 510 L-----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
M + C P RP M ++VK++
Sbjct: 221 TRPPLIKNLPKPIESLMTR----CWSKDPSQRPSMEEIVKIMT 259
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 8e-53
Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 28/275 (10%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG G FG VYKG + VAVK L +P AF+ EV ++ H N+L +GY
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 338 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
T + ++ +V + + S+ Y L E + +A TA G++YLH + I
Sbjct: 90 T--APQLAIVTQWCEGSSL-YHH--LHASETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE---YLSTGK 452
IHRDLK+ NI L ++ + DFGLA +H Q+ G++ +APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 453 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512
S ++DV+ +GI L EL+TGQ + +S + + + I + R D+ N
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQI-----IEMVGRGSLSPDLSKVRSNC 254
Query: 513 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
M ++ C + ++RP +++ ++
Sbjct: 255 PKR-----MKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-52
Identities = 62/285 (21%), Positives = 109/285 (38%), Gaps = 36/285 (12%)
Query: 277 NIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
++G+G FG+ K + + + +K L + + F +EV ++ H N+L+ IG
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ +++ ++ ++ + W R A A G+ YLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVD-------------AKLTHVTTQIRGTMGH 442
IIHRDL + N L+ +N V+ DFGLA+L+ + G
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502
+APE ++ EK DVF +GI L E++ A L+ +R L
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--DPDYLPRTMDFGLN-VRGFLDRYCP 245
Query: 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + + + C PE RP ++ L+
Sbjct: 246 PNC------------PPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 5e-51
Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 38/291 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL------QDYYSPGGEAAFQREVHLIS 323
+ IG+GGFG V+KG + D + VA+K L + FQREV ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
H N+++L G +V F+ + +RL D + W + R+ A
Sbjct: 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIAL 133
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-----LCDFGLAKLVDAKLTHVTTQIRG 438
G+EY+ NP I+HRDL++ NI L E + DFGL++ H + + G
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLG 188
Query: 439 TMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 496
+APE + +EK D + + + L ++TG+ F + + +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKIKFINMIREEG 246
Query: 497 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
LR D + V LC P+ RP + +VK L
Sbjct: 247 LRPTIPEDC------------PPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-50
Identities = 73/287 (25%), Positives = 109/287 (37%), Gaps = 46/287 (16%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRL---QDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
IIG GGFGKVY+ +VAVK D ++E L ++ H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
G C LV F + + L K + A A G+ YLH++
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 394 PKIIHRDLKAANILLDDNFEAV--------LCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 445
IIHRDLK++NIL+ E + DFGLA+ T + G +AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWMAP 183
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505
E + S+ +DV+ YG+ L EL+TG+ + F ++ +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE--VPFRGIDGLAVAY---------------GV 226
Query: 506 VDRNL-----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
L +T + M C P RP ++ L
Sbjct: 227 AMNKLALPIPSTCPEPFAKLMED----CWNPDPHSRPSFTNILDQLT 269
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-50
Identities = 72/323 (22%), Positives = 121/323 (37%), Gaps = 63/323 (19%)
Query: 260 RFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 319
R R++ L +G+G +G+V++G VAVK S E ++ RE
Sbjct: 4 RTVARDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRET 51
Query: 320 HLISVAI--HKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
L + + H+N+L I TS L+ + + S+ L+ LD +
Sbjct: 52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVS 106
Query: 374 RKRVAFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
R+ A GL +LH Q P I HRDLK+ NIL+ N + + D GLA +
Sbjct: 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166
Query: 429 LTHV---TTQIRGTMGHIAPE------YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479
+ GT ++APE + S ++ D++ +G+ L E+ +
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
Query: 480 R---------------LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQV 524
E+ V+ +D R + +D +L + M +
Sbjct: 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL-------AKLMKE- 278
Query: 525 ALLCTQSTPEDRPPMAQVVKMLQ 547
C P R ++ K L
Sbjct: 279 ---CWYQNPSARLTALRIKKTLT 298
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 8e-50
Identities = 63/285 (22%), Positives = 116/285 (40%), Gaps = 39/285 (13%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+IG+G FG+VY G + +VA++ + + + AF+REV H+N++ +G
Sbjct: 39 ELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
C + ++ + ++ +RD K LD +++A G+ YLH
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVD----AKLTHVTTQIRGTMGHIAPEYLSTG 451
I+H+DLK+ N+ D+ + V+ DFGL + + G + H+APE +
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 452 KS---------SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502
S+ +DVF G EL + F E I +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE--WPFKTQPAEA-------IIWQMGTGMK 260
Query: 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
++ + + + + L C E+RP +++ ML+
Sbjct: 261 PNLSQIGMG-------KEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-49
Identities = 54/306 (17%), Positives = 104/306 (33%), Gaps = 65/306 (21%)
Query: 272 NFSE---SNIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIH 327
+F + + + G+++KG + VK L +S F E + + H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 328 KNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDL--KPGEKGLDWPTRKRVAFGTAY 383
N+L ++G C + + +M S L ++ + +D + A A
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGS----LYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
G+ +LH P I L + ++++D++ A + + + + +
Sbjct: 123 GMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAWV 175
Query: 444 APEYLSTGKS---SEKTDVFGYGITLLELVTGQRA-IDFSRLEEEEDVLLLD-------- 491
APE L D++ + + L ELVT + D S +E V L
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG 235
Query: 492 ---HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548
H+ KL++ C P RP +V +L
Sbjct: 236 ISPHVSKLMKI----------------------------CMNEDPAKRPKFDMIVPIL-- 265
Query: 549 EDLAER 554
E + ++
Sbjct: 266 EKMQDK 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-49
Identities = 68/319 (21%), Positives = 119/319 (37%), Gaps = 63/319 (19%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 323
+++Q+ IG+G +G+V+ G KVAVK EA++ RE +
Sbjct: 37 KQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVF----FTTEEASWFRETEIYQ 84
Query: 324 VAI--HKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 377
+ H+N+L I + L+ + +N S+ L+ LD + ++
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKL 139
Query: 378 AFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
A+ + GL +LH Q P I HRDLK+ NIL+ N + D GLA + V
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 433 ---TTQIRGTMGHIAPE------YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR--- 480
GT ++ PE + +S D++ +G+ L E+ +
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
Query: 481 ------------LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLC 528
E+ +++ + +R +D R + + M + C
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM-------GKLMTE----C 308
Query: 529 TQSTPEDRPPMAQVVKMLQ 547
P R +V K L
Sbjct: 309 WAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-46
Identities = 69/319 (21%), Positives = 116/319 (36%), Gaps = 63/319 (19%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE--VHL 321
R + L IG+G FG+V++G +VAVK S E ++ RE ++
Sbjct: 42 RTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIF----SSREERSWFREAEIYQ 89
Query: 322 ISVAIHKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 377
+ H+N+L I + LV + ++ S+ L + ++
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKL 144
Query: 378 AFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
A TA GL +LH Q P I HRDLK+ NIL+ N + D GLA D+ +
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 433 T---TQIRGTMGHIAPEYL------STGKSSEKTDVFGYGITLLELVTGQRAIDFSR--- 480
GT ++APE L +S ++ D++ G+ E+
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
Query: 481 ------------LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLC 528
+EE V+ +R + + R + + M + C
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM-------AKIMRE----C 313
Query: 529 TQSTPEDRPPMAQVVKMLQ 547
+ R ++ K L
Sbjct: 314 WYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 36/283 (12%)
Query: 279 IGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG+G FG+V+ G L +DNT VAVK ++ P +A F +E ++ H N+++LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
T +V +Q LR L T ++ A G+EYL + I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ---IRGTMGHIAPEYLSTGK 452
HRDL A N L+ + + DFG+++ + ++ T APE L+ G+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYGR 291
Query: 453 SSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 511
S ++DV+ +GI L E + G + L ++ + + RL
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP--YPNLSNQQ-T-----REFVEKGGRL----PCPEL 339
Query: 512 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 554
D+ + ++ C P RP + + + L + + +R
Sbjct: 340 CPDA-----VFRLMEQCWAYEPGQRPSFSTIYQEL--QSIRKR 375
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 64/293 (21%), Positives = 120/293 (40%), Gaps = 43/293 (14%)
Query: 277 NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
+G+G FGKV + +VAVK L+ A ++E+ ++ H+N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 332 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 388
+ G CT L+ F+ + S L++ L + ++ + + A G++YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGS----LKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 442
+ + +HRDL A N+L++ + + DFGL K ++ + T + +
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY--- 196
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE------DVLLLDHIRK 495
APE L K +DV+ +G+TL EL+T L + + + +
Sbjct: 197 -APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255
Query: 496 LLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
L RL N EV + M + C + P +R +++ +
Sbjct: 256 LKEGKRL----PCPPNC--PDEVYQLMRK----CWEFQPSNRTSFQNLIEGFE 298
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 59/240 (24%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 247 GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVK 301
GE + L L+ E + ++G G FG VYKG+ VA+K
Sbjct: 1 GEAPNQALLRILKE---TEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 50
Query: 302 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 361
L++ SP E ++++ + ++ +L+G C TS+ ++ + M L D
Sbjct: 51 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGC----LLD 105
Query: 362 -LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420
++ + + A G+ YL ++ +++HRDL A N+L+ + DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 421 LAKLVDAKLTHVTTQ-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
LAKL+ A+ + I+ A E + + ++DV+ YG+T+ EL+T G +
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 275 ESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+IG+G FG VY G D + A+K L AF RE L+ H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 331 LQLIGYCTTSSERIL-VYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 388
L LIG + P+M + L ++ ++ A G+EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGD----LLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---AP 445
EQ K +HRDL A N +LD++F + DFGLA+ + + + Q R + A
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT 471
E L T + + K+DV+ +G+ L EL+T
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 42/167 (25%), Positives = 67/167 (40%), Gaps = 34/167 (20%)
Query: 36 EGEALIEVLKALNDTHGQFTDWNDHFVSPCF-SWSHVTC----RNGNVISLTLGS----- 85
+ +AL+++ K L + + W C +W V C + V +L L
Sbjct: 7 DKQALLQIKKDLGN-PTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 86 ----------------------NGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSM 123
N G I P+I KL L L + ++SG +PDFL +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 124 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L +L+ + N SG++P + S L NL + N ++G IP S
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 36/119 (30%), Positives = 51/119 (42%), Gaps = 4/119 (3%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
N N+ + L N G S K + L N L+ L +G +L L+L NN
Sbjct: 196 NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNN 254
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM--QLFSVATFNFTGTHLICGSSLEQPC 191
+ G++P +QL L L++S NNL G IP L + +CGS L C
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL-PAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 1/95 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L + SG I ++++K L +L+ N LSGTLP + S+ +L + N+
Sbjct: 102 QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161
Query: 137 SGSIPATWSQLSNL-KHLDLSSNNLTGRIPMQLFS 170
SG+IP ++ S L + +S N LTG+IP +
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 2/91 (2%)
Query: 78 VISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 137
S+T+ N +GKI P+ L LA ++L N L G GS + Q ++LA N +
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 138 GSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
+ NL LDL +N + G +P L
Sbjct: 235 FDLG-KVGLSKNLNGLDLRNNRIYGTLPQGL 264
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 2/91 (2%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHL-QSLNLANNKFSGS 139
L N SG + PSI+ L L + N +SG +PD GS + L S+ ++ N+ +G
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
IP T++ L NL +DLS N L G + S
Sbjct: 190 IPPTFANL-NLAFVDLSRNMLEGDASVLFGS 219
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 77/284 (27%), Positives = 119/284 (41%), Gaps = 40/284 (14%)
Query: 277 NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+IG+G FG VY G L DN AVK L G + F E ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 333 LIGYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L+G C S L V P+M++ + +R+ A G++YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASK 147
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYL 448
K +HRDL A N +LD+ F + DFGLA+ + K + G + A E L
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQR---AIDFSRLEEEEDVLLLDHIRKLLREDRLND 504
T K + K+DV+ +G+ L EL+T G ++ D+ LL+ RL
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDI-----TVYLLQGRRL-- 251
Query: 505 IVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + E M++ C E RP +++V +
Sbjct: 252 --LQPEYC--PDPLYEVMLK----CWHPKAEMRPSFSELVSRIS 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
IG+G F VYKG+ +VA LQD + F+ E ++ H N+++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 336 YCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
++ + +LV M + ++ L+ K + + GL++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT- 147
Query: 392 CNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 450
P IIHRDLK NI + +V + D GLA L A + GT +APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 451 GKSSEKTDVFGYGITLLELVTGQ 473
E DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 277 NIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
++G G FG V+KGV V +K ++D A + I H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
+L+G C SS ++ V ++ S L D ++ L A G+ YL E
Sbjct: 79 RLLGLCPGSSLQL-VTQYLPLGS----LLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGHIAP 445
++HR+L A N+LL + + DFG+A L+ + I+ A
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----AL 186
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
E + GK + ++DV+ YG+T+ EL+T G
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG G FG V+ G + KVA+K +++ E F E ++ H L+QL G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 337 CTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
C + LV FM++ L D L+ T + G+ YL E
Sbjct: 72 CLEQAPICLVTEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---C 124
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTG 451
+IHRDL A N L+ +N + DFG+ + V D + T+ ++ +PE S
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFS 180
Query: 452 KSSEKTDVFGYGITLLELVT 471
+ S K+DV+ +G+ + E+ +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 78/292 (26%), Positives = 119/292 (40%), Gaps = 42/292 (14%)
Query: 277 NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
+ +G+G FG V + VAVK+LQ P + FQRE+ ++ ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIV 87
Query: 332 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 388
+ G + LV ++ + LRD L+ LD + G+EYL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGC----LRDFLQRHRARLDASRLLLYSSQICKGMEYL 143
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI----- 443
+ + +HRDL A NIL++ + DFGLAKL+ + + G
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR---EPGQSPIFWY 197
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVT-GQR-----AIDFSRLEEEEDVLLLDHIRKLL 497
APE LS S ++DV+ +G+ L EL T + A + E DV L + +LL
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 498 RED-RLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
E RL EV E M C +P+DRP + + L
Sbjct: 258 EEGQRL----PAPPAC--PAEVHELMKL----CWAPSPQDRPSFSALGPQLD 299
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 59/240 (24%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 247 GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVK 301
GE + L L+ E + ++G G FG VYKG+ VA+K
Sbjct: 1 GEAPNQALLRILKE---TEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 50
Query: 302 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 361
L++ SP E ++++ + ++ +L+G C TS+ ++ + M L D
Sbjct: 51 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGC----LLD 105
Query: 362 -LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420
++ + + A G+ YL ++ +++HRDL A N+L+ + DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 421 LAKLVDAKLTHVTTQ-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
LAKL+ A+ + I+ A E + + ++DV+ YG+T+ EL+T G +
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 277 NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+IG+G FG VY G L DN AVK L G + F E ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 333 LIGYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L+G C S L V P+M++ + +R+ A G+++L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK 211
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYL 448
K +HRDL A N +LD+ F + DFGLA+ + K G + A E L
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 449 STGKSSEKTDVFGYGITLLELVT 471
T K + K+DV+ +G+ L EL+T
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 76/312 (24%), Positives = 121/312 (38%), Gaps = 48/312 (15%)
Query: 263 CRELQLATDN--FSESNI-----IGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPG 310
Q D F + + +G+G FGKV VAVK L+ P
Sbjct: 16 EVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ 75
Query: 311 GEAAFQREVHLISVAIHKNLLQLIGYCTTSSER--ILVYPFMQNLSVAYRLRDLKPGEKG 368
+ +++E+ ++ H+++++ G C + LV ++ S LRD P
Sbjct: 76 HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS----LRDYLPRHS- 130
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
+ A G+ YLH Q IHRDL A N+LLD++ + DFGLAK V
Sbjct: 131 IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187
Query: 429 LTHVTTQIRGT-----MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE 482
+ + G APE L K +DV+ +G+TL EL+T +
Sbjct: 188 HEYYRVREDGDSPVFWY---APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244
Query: 483 EEEDV-----LLLDHIRKLLRE-DRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPED 535
E + + + +LL +RL R EV M C ++
Sbjct: 245 LELIGIAQGQMTVLRLTELLERGERL----PRPDKC--PAEVYHLMKN----CWETEASF 294
Query: 536 RPPMAQVVKMLQ 547
RP ++ +L+
Sbjct: 295 RPTFENLIPILK 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 73/322 (22%), Positives = 131/322 (40%), Gaps = 53/322 (16%)
Query: 277 NIIGQGGFGKVYKGVLSDN----TKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLL 331
++G+G FG V + L KVAVK L D + F RE + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 332 QLIGYCTTSSERI------LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AY 383
+L+G S + ++ PFM++ + L + GE + P + V F A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
G+EYL + IHRDL A N +L ++ + DFGL++ + + + +G +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCASKL 201
Query: 444 -----APEYLSTGKSSEKTDVFGYGITLLELVT-GQR---AIDFSRLEEEEDVLLLDHIR 494
A E L+ + +DV+ +G+T+ E++T GQ I+ ++
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE------NAEI-----YN 250
Query: 495 KLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE 553
L+ +RL + +EV + M Q C + P+ RP + L E++
Sbjct: 251 YLIGGNRL----KQPPEC--MEEVYDLMYQ----CWSADPKQRPSFTCLRMEL--ENILG 298
Query: 554 RWAEWEELEEVRQQEVSLLPHQ 575
+ ++ + H
Sbjct: 299 HLSVLSTSQDPLYINIERAHHH 320
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-34
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 26/272 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+GQG FG+V+ G + T+VA+K L+ AF +E ++ H+ L+QL
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
+ I V +M S+ L+ K L P +A A G+ Y+
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 456
+HRDL+AANIL+ +N + DFGLA+L++ + + APE G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 457 TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSK 516
+DV+ +GI L EL T R + + + E +LD + + R + +
Sbjct: 362 SDVWSFGILLTELTTKGR-VPYPGMVNRE---VLDQVERGYRMPCPPEC---------PE 408
Query: 517 EV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + M Q C + PE+RP + L+
Sbjct: 409 SLHDLMCQ----CWRKEPEERPTFEYLQAFLE 436
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 277 NIIGQGGFGKVYKGVLSD----NTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLL 331
I+G+G FG V +G L + KVAVK + D S F E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 332 QLIGYCT-----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYG 384
+L+G C + +++ PFM+ + L + P + + F A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI- 443
+EYL + +HRDL A N +L D+ + DFGL+K + + + +G + +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGRIAKMP 212
Query: 444 ----APEYLSTGKSSEKTDVFGYGITLLELVT 471
A E L+ + K+DV+ +G+T+ E+ T
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G G FG V G VA+K +++ E F E ++ H+ L+QL G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 337 CTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
CT ++ +M N L + L+ + +EYL + +
Sbjct: 88 CTKQRPIFIITEYMANGC----LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 140
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTG 451
+HRDL A N L++D + DFGL++ V D + V ++ +R + PE L
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYS 196
Query: 452 KSSEKTDVFGYGITLLELVT 471
K S K+D++ +G+ + E+ +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 16/198 (8%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G G FG V G VAVK +++ E F +E + H L++ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 338 TTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
+ +V ++ N L + L+ KGL+ + + G+ +L +
Sbjct: 73 SKEYPIYIVTEYISNGC----LLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYLSTGKS 453
IHRDL A N L+D + + DFG+ + V GT + APE K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVL---DDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 454 SEKTDVFGYGITLLELVT 471
S K+DV+ +GI + E+ +
Sbjct: 183 SSKSDVWAFGILMWEVFS 200
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 277 NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
+G+G FG V + VAVK+LQ + F+RE+ ++ H N++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 74
Query: 332 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 388
+ G C ++ R L+ ++ S LRD L+ ++ +D + G+EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGS----LRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 442
+ + IHRDL NIL+++ + DFGL K++ + I
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY--- 184
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVT 471
APE L+ K S +DV+ +G+ L EL T
Sbjct: 185 -APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 279 IGQGGFGKVYKGVL---SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G G FG V +GV VA+K L+ RE ++ + +++LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
C + + V L L + + + + G++YL E+
Sbjct: 78 VCQAEALML-VMEMAGGGP----LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 129
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG------TMGHIAPEYL 448
+HRDL A N+LL + A + DFGL+K + A ++ T + G APE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 185
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQR 474
+ K S ++DV+ YG+T+ E ++ GQ+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-33
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 26/272 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+GQG FG+V+ G + T+VA+K L+ AF +E ++ H+ L+QL
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
+ I V +M S+ L+ K L P +A A G+ Y+
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 456
+HRDL+AANIL+ +N + DFGLA+L++ + + APE G+ + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 457 TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSK 516
+DV+ +GI L EL T R + + + E +LD + + R + +
Sbjct: 445 SDVWSFGILLTELTTKGR-VPYPGMVNRE---VLDQVERGYRMPCPPEC---------PE 491
Query: 517 EV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + M Q C + PE+RP + L+
Sbjct: 492 SLHDLMCQ----CWRKEPEERPTFEYLQAFLE 519
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 74/295 (25%), Positives = 131/295 (44%), Gaps = 53/295 (17%)
Query: 277 NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQ 332
++IG+G FG+V K + + A+KR+++Y S F E+ ++ + H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------------RVAFG 380
L+G C L + + ++ LR + E + A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
A G++YL ++ + IHRDL A NIL+ +N+ A + DFGL++ + ++ TM
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 200
Query: 441 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR 494
G + A E L+ + +DV+ YG+ L E+V+ G + + E +
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAE-------LY 251
Query: 495 KLLRED-RLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ L + RL ++ LN EV + M Q C + P +RP AQ++ L
Sbjct: 252 EKLPQGYRL----EKPLNC--DDEVYDLMRQ----CWREKPYERPSFAQILVSLN 296
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 277 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
IIG G G+V G L + VA+K L+ Y+ F E ++ H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L G T ++V +M+N S L L+ + + G G+ YL +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGS----LDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAP 445
+HRDL A N+L+D N + DFGL+++++ T IR T AP
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----AP 223
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
E ++ S +DV+ +G+ + E++ G+R
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 44/207 (21%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 278 IIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
I+G+G FG+VY+GV + VAVK + + + F E ++ H ++++L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
IG I + L L+ + L T + + YL
Sbjct: 79 IGIIEEEPTWI-IMELYPYGE----LGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI- 132
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYL 448
+HRD+ NIL+ L DFGL++ ++ + + + I+ +PE +
Sbjct: 133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQR 474
+ + + +DV+ + + + E+++ G++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 45/294 (15%)
Query: 277 NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
+G+G FG V + VAVK+LQ + F+RE+ ++ H N++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 105
Query: 332 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 388
+ G C ++ R L+ ++ S LRD L+ ++ +D + G+EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGS----LRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 442
+ + IHRDL NIL+++ + DFGL K++ + + I
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY--- 215
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV-------LLLDHIRK 495
APE L+ K S +DV+ +G+ L EL T E + +++ H+ +
Sbjct: 216 -APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 496 LLRED-RLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
LL+ + RL R E+ M + C + RP + +
Sbjct: 275 LLKNNGRL----PRPDGC--PDEIYMIMTE----CWNNNVNQRPSFRDLALRVD 318
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 7e-33
Identities = 69/288 (23%), Positives = 131/288 (45%), Gaps = 26/288 (9%)
Query: 277 NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+ +G G +G+VY+GV + VAVK L++ F +E ++ H NL+QL+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
CT ++ FM ++ LR + + + +A + +EYL ++
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 455
IHR+L A N L+ +N + DFGL++L+ + + APE L+ K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 456 KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 515
K+DV+ +G+ L E+ T + ++ + + + + K R +R ++
Sbjct: 399 KSDVWAFGVLLWEIATYGM-SPYPGIDLSQ---VYELLEKDYRMERPEGCPEK------- 447
Query: 516 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEE 563
+ ++ C Q P DRP A++ + E + + + +E+E+
Sbjct: 448 -----VYELMRACWQWNPSDRPSFAEIHQAF--ETMFQESSISDEVEK 488
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-32
Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 9/150 (6%)
Query: 26 FGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGS 85
S+ E LI L D DW+ + +PC ++ VTCR+ V S+ L S
Sbjct: 3 QASPSQSLYREIHQLISFKDVLPD-KNLLPDWSSN-KNPC-TFDGVTCRDDKVTSIDLSS 59
Query: 86 NGFS---GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 142
+ +S S+ L L SL L ++ ++G++ F L SL+L+ N SG +
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF-KCSASLTSLDLSRNSLSGPVTT 118
Query: 143 TWS--QLSNLKHLDLSSNNLTGRIPMQLFS 170
S S LK L++SSN L +
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGL 148
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 32/98 (32%), Positives = 52/98 (53%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
+ +L L N +G+I ++ L + L +N L+G +P ++G + +L L L+
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
NN FSG+IPA +L LDL++N G IP +F
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-28
Identities = 46/134 (34%), Positives = 68/134 (50%), Gaps = 7/134 (5%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
G+++ L + N SG I I + +L L L ND+SG++PD +G + L L+L++NK
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIP-MQLFSVATFN---FTGTHLICGSSLEQPC 191
G IP S L+ L +DLS+NNL+G IP M F TF F +CG L C
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE--TFPPAKFLNNPGLCGYPL-PRC 748
Query: 192 MSRPSPPVSTSRTK 205
+ + +
Sbjct: 749 DPSNADGYAHHQRS 762
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-28
Identities = 39/93 (41%), Positives = 52/93 (55%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L +NGF+GKI P+++ L SL L N LSGT+P LGS++ L+ L L N
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML 454
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
G IP + L+ L L N+LTG IP L
Sbjct: 455 EGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-27
Identities = 35/93 (37%), Positives = 48/93 (51%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
++SL L N SG I S+ L L L+L N L G +P L + L++L L
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
N +G IP+ S +NL + LS+N LTG IP
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-26
Identities = 34/98 (34%), Positives = 53/98 (54%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
+ L L N G+I + +K L +L L NDL+G +P L + T+L ++L+
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
NN+ +G IP +L NL L LS+N+ +G IP +L
Sbjct: 499 NNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-26
Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 2/97 (2%)
Query: 76 GNVISLTLGSNGFSGKISPSI--TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLAN 133
++++L L SN FSG I P++ L L LQ+N +G +P L + + L SL+L+
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
N SG+IP++ LS L+ L L N L G IP +L
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 2/93 (2%)
Query: 80 SLTLGSNGFSGKISPSIT-KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L+L N F+G+I ++ L L+L N G +P F GS + L+SL L++N FSG
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332
Query: 139 SIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P ++ LK LDLS N +G +P L +
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L + N SG + +++ L L++ N+ S +P FLG + LQ L+++ NK
Sbjct: 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKL 235
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
SG S + LK L++SSN G IP
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK 269
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 39/96 (40%), Positives = 51/96 (53%), Gaps = 2/96 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP-DFLGSMTHLQSLNLANNK 135
+ L L N F G + P L SL L N+ SG LP D L M L+ L+L+ N+
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354
Query: 136 FSGSIPATWSQLS-NLKHLDLSSNNLTGRIPMQLFS 170
FSG +P + + LS +L LDLSSNN +G I L
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 390
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 18/96 (18%), Positives = 33/96 (34%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
F G S + +L + G + + L+++
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
N SG IP + L L+L N+++G IP ++
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-23
Identities = 37/99 (37%), Positives = 50/99 (50%), Gaps = 6/99 (6%)
Query: 76 GNVISLT---LGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL-GSMTHLQSLNL 131
L + SN F G I P LK L L L +N +G +PDFL G+ L L+L
Sbjct: 244 STCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL 301
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ N F G++P + S L+ L LSSNN +G +PM
Sbjct: 302 SGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-21
Identities = 29/98 (29%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
N+ ++L +N +G+I I +L+ LA L+L +N SG +P LG L L+L
Sbjct: 487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN 546
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
N F+G+IPA + S +++N + G+ + + +
Sbjct: 547 TNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKN 580
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-16
Identities = 26/100 (26%), Positives = 37/100 (37%), Gaps = 6/100 (6%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
R N+ L L +N FSG I + + L L+L N +GT+P + QS +A
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK----QSGKIA 566
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSN--NLTGRIPMQLFS 170
N +G K + N G QL
Sbjct: 567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 74/293 (25%), Positives = 133/293 (45%), Gaps = 36/293 (12%)
Query: 277 NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+ +G G +G+VY+GV + VAVK L++ F +E ++ H NL+QL+G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
CT ++ FM ++ LR+ E + +A + +EYL ++
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---N 131
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYLSTG 451
IHRDL A N L+ +N + DFGL++L+ I+ T APE L+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 452 KSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510
K S K+DV+ +G+ L E+ T G + ++ + + + + K R +R ++
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQ---VYELLEKDYRMERPEGCPEK-- 240
Query: 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEE 563
+ ++ C Q P DRP A++ + E + + + +E+E+
Sbjct: 241 ----------VYELMRACWQWNPSDRPSFAEIHQAF--ETMFQESSISDEVEK 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 75/290 (25%), Positives = 117/290 (40%), Gaps = 44/290 (15%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+G G FG+VY+G +S +VAVK L + S E F E +IS H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR---VAFGTAYGLEY 387
++ IG S R ++ M + LR+ +P VA A G +Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLC---DFGLAKLVDAKLTHVTTQIR-GTMGHI 443
L E IHRD+ A N LL + DFG+A+ + + + R G +
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAML 207
Query: 444 -----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 497
PE G + KTD + +G+ L E+ + G + +E +L+ +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE---VLEFVTSGG 262
Query: 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
R D + Y M Q C Q PEDRP A +++ ++
Sbjct: 263 RMDPPKNCPGP---VY-----RIMTQ----CWQHQPEDRPNFAIILERIE 300
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 64/290 (22%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+GQG FG VY+GV T+VA+K + + S F E ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKR---VAFGTAYG 384
++L+G + +++ M + LR L+P L P+ + +A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI- 443
+ YL+ K +HRDL A N ++ ++F + DFG+ + + + +G G +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLP 203
Query: 444 ----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLR 498
+PE L G + +DV+ +G+ L E+ T ++ + L E+ +L + +
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQ---VLRFVMEGGL 258
Query: 499 EDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
D+ ++ + E M C Q P+ RP +++ ++
Sbjct: 259 LDKPDNC---------PDMLFELMRM----CWQYNPKMRPSFLEIISSIK 295
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 278 IIGQGGFGKVYKGVL---SDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
+G G FG V KG VAVK L + P + E +++ + ++++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
IG C S + V + L L+ + + + G++YL E
Sbjct: 84 IGICEAESWML-VMEMAELGP----LNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEES- 136
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAPE 446
+HRDL A N+LL A + DFGL+K + A + Q ++ APE
Sbjct: 137 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APE 190
Query: 447 YLSTGKSSEKTDVFGYGITLLELVT-GQR 474
++ K S K+DV+ +G+ + E + GQ+
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 278 IIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
IG+G FG V++G+ VA+K ++ S F +E + H ++++L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
IG T + I + LR L+ + LD + A+ + L YL +
Sbjct: 82 IGVITENPVWI-IMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 135
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYL 448
+ +HRD+ A N+L+ N L DFGL++ ++ + ++ I+ APE +
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 189
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQR 474
+ + + +DV+ +G+ + E++ G +
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 278 IIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+IG G FG+VYKG+L VA+K L+ Y+ F E ++ H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L G + +++ +M+N + L L+ + + G A G++YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGA----LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQ-----IRGTMGHIAP 445
+HRDL A NIL++ N + DFGL++++ D TT IR T AP
Sbjct: 167 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----AP 219
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
E +S K + +DV+ +GI + E++T G+R
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-32
Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G FG V G KVAVK +++ + AF E +++ H NL+QL+G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ +V +M S+ LR G L + + +EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLSTGKS 453
+HRDL A N+L+ ++ A + DFGL K +A T T + ++ T APE L K
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT----APEALREKKF 363
Query: 454 SEKTDVFGYGITLLELVT 471
S K+DV+ +GI L E+ +
Sbjct: 364 STKSDVWSFGILLWEIYS 381
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 72/290 (24%), Positives = 116/290 (40%), Gaps = 44/290 (15%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+G G FG+VY+G +S +VAVK L + S E F E +IS H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR---VAFGTAYGLEY 387
++ IG S R ++ M + LR+ +P VA A G +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLC---DFGLAKLVDAKLTHVTTQIR-GTMGHI 443
L E IHRD+ A N LL + DFG+A+ + + R G +
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRAGYYRKGGCAML 248
Query: 444 -----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 497
PE G + KTD + +G+ L E+ + G + +E +L+ +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE---VLEFVTSGG 303
Query: 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
R D + + ++ C Q PEDRP A +++ ++
Sbjct: 304 RMDPPKNCPGP------------VYRIMTQCWQHQPEDRPNFAIILERIE 341
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-32
Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G FG V G KVAVK +++ + AF E +++ H NL+QL+G
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ +V +M S+ LR G L + + +EYL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLSTGKS 453
+HRDL A N+L+ ++ A + DFGL K +A T T + ++ T APE L K
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT----APEALREKKF 191
Query: 454 SEKTDVFGYGITLLELVT 471
S K+DV+ +GI L E+ +
Sbjct: 192 STKSDVWSFGILLWEIYS 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 67/299 (22%), Positives = 120/299 (40%), Gaps = 53/299 (17%)
Query: 277 NIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIH 327
+G+G FG+V VAVK L+D + + E+ ++ + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 328 KNLLQLIGYCTTSSERILVYPFMQN------------LSVAYRLRDLKPGEKGLDWPTRK 375
KN++ L+G CT ++ + + Y + E+ + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
+ A G+EYL Q K IHRDL A N+L+ +N + DFGLA+ ++ + T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 436 -----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 489
++ APE L + ++DV+ +G+ + E+ T G + + EE L
Sbjct: 218 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEE---L 268
Query: 490 LDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+++ R D+ + + E+ M C + P RP Q+V+ L
Sbjct: 269 FKLLKEGHRMDKPANC---------TNELYMMMRD----CWHAVPSQRPTFKQLVEDLD 314
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-32
Identities = 63/211 (29%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 278 IIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLL 331
+G G FG V +G VAVK L+ P F REV+ + H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
+L G T ++ V S L D L+ + T R A A G+ YL
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIA 444
+ + IHRDL A N+LL + DFGL + + H Q A
Sbjct: 140 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----A 192
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
PE L T S +D + +G+TL E+ T GQ
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 26/204 (12%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V+ G + +TKVAVK L+ AF E +L+ H+ L++L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
T I + +M+N S+ L+ P L +A A G+ ++ E+
Sbjct: 77 VTQEPIYI-ITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVD---------AKLTHVTTQIRGTMGHIAPEY 447
IHRDL+AANIL+ D + DFGLA+L++ AK I+ T APE
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-----IKWT----APEA 181
Query: 448 LSTGKSSEKTDVFGYGITLLELVT 471
++ G + K+DV+ +GI L E+VT
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 67/304 (22%), Positives = 120/304 (39%), Gaps = 63/304 (20%)
Query: 277 NIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIH 327
+G+G FG+V VAVK L+D + + E+ ++ + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 328 KNLLQLIGYCTTSSERILVYPFMQN------------LSVAYRLRDLKPGEKGLDWPTRK 375
KN++ L+G CT ++ + + Y + E+ + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---------- 425
+ A G+EYL Q K IHRDL A N+L+ +N + DFGLA+ +
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 484
+ +L ++ APE L + ++DV+ +G+ + E+ T G + + E
Sbjct: 264 NGRLP-----VKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVE 312
Query: 485 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVV 543
E L +++ R D+ + + E+ M C + P RP Q+V
Sbjct: 313 E---LFKLLKEGHRMDKPANC---------TNELYMMMRD----CWHAVPSQRPTFKQLV 356
Query: 544 KMLQ 547
+ L
Sbjct: 357 EDLD 360
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 277 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
++G G FG+V G L VA+K L+ Y+ F E ++ H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L G T S ++V +M+N S L L+ + + G A G++YL +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGS----LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAP 445
+HRDL A NIL++ N + DFGL ++++ T IR T +P
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SP 219
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
E ++ K + +DV+ YGI L E+++ G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 51/298 (17%)
Query: 277 NIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 329
+G+G FG+V + + VAVK L++ + A E+ ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 330 LLQLIGYCTTSSERILV-YPFMQN------------LSVAYRLRDLKPGEKGLDWPTRKR 376
++ L+G CT ++V F + V Y++ + L
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ- 435
+F A G+E+L + K IHRDL A NILL + +CDFGLA+ + +V
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 436 ----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL 490
++ APE + + ++DV+ +G+ L E+ + G + ++ +E+
Sbjct: 210 ARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFC-- 261
Query: 491 DHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
R+L R+ T + E+ +TM+ C P RP +++V+ L
Sbjct: 262 ---RRLKEGTRM----RAPDYT--TPEMYQTMLD----CWHGEPSQRPTFSELVEHLG 306
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V+ + +TKVAVK ++ AF E +++ H L++L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
T I + FM S+ L+ P + A G+ ++ ++
Sbjct: 252 VTKEPIYI-ITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYLSTGKS 453
IHRDL+AANIL+ + + DFGLA++++ + T G I APE ++ G
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 454 SEKTDVFGYGITLLELVT 471
+ K+DV+ +GI L+E+VT
Sbjct: 363 TIKSDVWSFGILLMEIVT 380
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 279 IGQGGFGKVYKGVL---SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G G FG V +GV VA+K L+ RE ++ + +++LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
C + + V L L + + + + G++YL E+
Sbjct: 404 VCQAEALML-VMEMAGGGP----LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 455
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAPEYL 448
+HR+L A N+LL + A + DFGL+K + A ++ T + ++ APE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 511
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQR 474
+ K S ++DV+ YG+T+ E ++ GQ+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 50/296 (16%)
Query: 277 NIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+G+ FGKVYKG L VA+K L+D F+ E L + H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------------RVA 378
+ L+G T +++ + + + L P + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--- 435
A G+EYL ++H+DL N+L+ D + D GL + V A +
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 436 --IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH 492
IR APE + GK S +D++ YG+ L E+ + G + + ++ +++
Sbjct: 192 LPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQD---VVEM 242
Query: 493 IRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
IR +D V M++ C P RP + L+
Sbjct: 243 IRNRQVLPCPDDC---------PAWVYALMIE----CWNEFPSRRPRFKDIHSRLR 285
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 73/337 (21%), Positives = 128/337 (37%), Gaps = 64/337 (18%)
Query: 279 IGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 329
+G+G FG+V + TKVAVK L+ + + E+ ++ + HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 330 LLQLIGYCTTSSERILVYPFMQN------------LSVAYRLRDLKPGEKGLDWPTRKRV 377
++ L+G CT ++ + + Y E+ L
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-- 435
A+ A G+EYL + K IHRDL A N+L+ ++ + DFGLA+ + + T
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 436 ---IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 491
++ APE L + ++DV+ +G+ L E+ T G + + EE L
Sbjct: 254 RLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEE---LFK 304
Query: 492 HIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550
+++ R D+ ++ + E+ M C + P RP Q+V+ L
Sbjct: 305 LLKEGHRMDKPSNC---------TNELYMMMRD----CWHAVPSQRPTFKQLVEDLD--- 348
Query: 551 LAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQE 587
+ QE+ H D +
Sbjct: 349 --------RIVALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 58/300 (19%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 329
+G G FGKV + KVAVK L+ + A E+ ++S + H+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----------RVAF 379
++ L+G CT +++ + + LR + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV----------DAKL 429
A G+ +L + IHRD+ A N+LL + A + DFGLA+ + +A+L
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 488
++ APE + + ++DV+ YGI L E+ + G + +
Sbjct: 229 P-----VKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLG--LNPYPGILVNSKFY 277
Query: 489 LLDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + ++ + K + M C P RP Q+ LQ
Sbjct: 278 -----KLVKDGYQM----AQPAFA--PKNIYSIMQA----CWALEPTHRPTFQQICSFLQ 322
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 73/304 (24%), Positives = 131/304 (43%), Gaps = 58/304 (19%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+G+G FGKV K T VAVK L++ SP E +++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--------- 381
++L G C+ +L+ + + S+ LR+ + G R +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 382 -----------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+ G++YL E K++HRDL A NIL+ + + + DFGL++ V + +
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 431 HVTTQIRGTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 484
+V + + G I A E L + ++DV+ +G+ L E+VT G + + E
Sbjct: 206 YV----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG--NPYPGIPPE 259
Query: 485 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVV 543
L + ++ R +R ++ S+E+ M+Q C + P+ RP A +
Sbjct: 260 R---LFNLLKTGHRMERPDNC---------SEEMYRLMLQ----CWKQEPDKRPVFADIS 303
Query: 544 KMLQ 547
K L+
Sbjct: 304 KDLE 307
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 69/309 (22%), Positives = 114/309 (36%), Gaps = 47/309 (15%)
Query: 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREV 319
F + + ++ +G+GGF V L D A+KR+ + QRE
Sbjct: 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQQDREEAQREA 77
Query: 320 HLISVAIHKNLLQLIGYCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 375
+ + H N+L+L+ YC L+ PF + ++ + LK L
Sbjct: 78 DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--------DA 427
+ G GLE +H HRDLK NILL D + VL D G A
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 428 KLTHVTTQIRGTMGHIAPEYLSTGKS----SEKTDVFGYGITLLELVTGQRAIDFSRLEE 483
R T+ + APE L + +S E+TDV+ G L ++ G+ + + +
Sbjct: 195 LTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--YDMVFQ 251
Query: 484 EEDVLLLDHIRKLLREDRLNDIVDRNL-----NTYDSKEVETMVQVALLCTQSTPEDRPP 538
+ D + L V L + S + ++ + P RP
Sbjct: 252 KGDSVAL--------------AVQNQLSIPQSPRH-SSALWQLLNSMM---TVDPHQRPH 293
Query: 539 MAQVVKMLQ 547
+ ++ L+
Sbjct: 294 IPLLLSQLE 302
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 49/217 (22%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREV 319
R+ ++ + IG+G FG V++G+ + VA+K ++ S F +E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 320 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVA 378
+ H ++++LIG T + I + LR L+ + LD + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGE----LRSFLQVRKFSLDLASLILYA 497
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--- 435
+ + L YL + + +HRD+ A N+L+ N L DFGL++ ++ + ++
Sbjct: 498 YQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 436 -IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
I+ APE ++ + + +DV+ +G+ + E++
Sbjct: 555 PIKWM----APESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 67/305 (21%), Positives = 122/305 (40%), Gaps = 59/305 (19%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 329
++G G FGKV + +VAVK L++ A E+ +++ + H+N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 330 LLQLIGYCTTSSERILVYPFMQN----------------LSVAYRLRDLKPGEKGLDWPT 373
++ L+G CT S L++ + + Y + E+ L+ T
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 374 RKR---VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+ A+ A G+E+L + +HRDL A N+L+ +CDFGLA+ + +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 431 HVTTQ-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 484
+V ++ APE L G + K+DV+ YGI L E+ + G + + +
Sbjct: 228 YVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLG--VNPYPGIPVD 281
Query: 485 EDVLLLDHIRKLLRE-DRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQV 542
+ KL++ ++ D+ ++E+ M C RP +
Sbjct: 282 ANFY------KLIQNGFKM----DQPFYA--TEEIYIIMQS----CWAFDSRKRPSFPNL 325
Query: 543 VKMLQ 547
L
Sbjct: 326 TSFLG 330
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 64/299 (21%), Positives = 113/299 (37%), Gaps = 52/299 (17%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 329
+G G FGKV + VAVK L+ A E+ ++S + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 330 LLQLIGYCTTSSERILVYPFMQN--------------LSVAYRLRDLKPGEKGLDWPTRK 375
++ L+G CT +++ + + ++ E LD
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
++ A G+ +L + IHRDL A NILL +CDFGLA+ + +V
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 436 -----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 489
++ APE + + ++DV+ YGI L EL + G + + +
Sbjct: 206 NARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGS--SPYPGMPVDSKFY- 258
Query: 490 LDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + R+ + E+ + M C + P RP Q+V++++
Sbjct: 259 ----KMIKEGFRM----LSPEHA--PAEMYDIMKT----CWDADPLKRPTFKQIVQLIE 303
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 51/294 (17%)
Query: 279 IGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV+ D VAVK L+D + FQRE L++ H+++++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 81
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR------------VAFG 380
G C I+V+ +M++ + LR P L ++ +A
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQ---- 435
A G+ YL Q +HRDL N L+ N + DFG+++ V V
Sbjct: 142 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR 494
IR PE + K + ++DV+ +G+ L E+ T G++ + +L E +++ I
Sbjct: 199 IRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQLSNTE---VIECIT 249
Query: 495 KLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ +R KEV + M+ C Q P+ R + ++ K+L
Sbjct: 250 QGRVLERPRVC---------PKEVYDVMLG----CWQREPQQRLNIKEIYKILH 290
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 70/304 (23%), Positives = 123/304 (40%), Gaps = 58/304 (19%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
IG+G FG+V++ T VAVK L++ S +A FQRE L++ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 331 LQLIGYCTTSSERILVYPFMQN--------------------LSVAYRLRDLKPGEKGLD 370
++L+G C L++ +M ++ R R PG L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 371 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+ +A A G+ YL E+ K +HRDL N L+ +N + DFGL++ + +
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 431 HVTTQIRGTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 484
+ I PE + + + ++DV+ YG+ L E+ + G + + + E
Sbjct: 230 YK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--YYGMAHE 283
Query: 485 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVV 543
E ++ ++R + E+ M C P DRP +
Sbjct: 284 E---VIYYVRDGNILACPENC---------PLELYNLMRL----CWSKLPADRPSFCSIH 327
Query: 544 KMLQ 547
++LQ
Sbjct: 328 RILQ 331
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 72/295 (24%), Positives = 118/295 (40%), Gaps = 50/295 (16%)
Query: 277 NIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+G+G FGKV+ D VAVK L++ S FQRE L+++ H+++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHI 105
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-----------VAF 379
++ G CT ++V+ +M++ + LR P K L VA
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQ--- 435
A G+ YL +HRDL N L+ + DFG+++ + V +
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 436 -IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI 493
IR PE + K + ++DV+ +G+ L E+ T G++ + +L E +D I
Sbjct: 223 PIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSNTE---AIDCI 273
Query: 494 RKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ +R EV M C Q P+ R + V LQ
Sbjct: 274 TQGRELERPRAC---------PPEVYAIMRG----CWQREPQQRHSIKDVHARLQ 315
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 31/212 (14%)
Query: 278 IIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+GQG F K++KGV T+V +K L +F ++S HK+
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKH 73
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 388
L+ G C E ILV F++ S L LK + ++ + VA A + +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGS----LDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAV--------LCDFGLAKLVDAKLTHVTTQIRGTM 440
E +IH ++ A NILL + L D G++ V K + +I
Sbjct: 130 EEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-DILQERIPWV- 184
Query: 441 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVT 471
PE + K+ + TD + +G TL E+ +
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 61/298 (20%), Positives = 109/298 (36%), Gaps = 47/298 (15%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+F +G+GGFG V++ D+ A+KR++ REV ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 330 LLQLIGY---------CTTSSERILVYPFMQ---NLSVAYRLRDLKPGEKGLDWPTRKRV 377
+++ SS ++ +Y MQ ++ + E+ + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
A +E+LH + ++HRDLK +NI + + DFGL +D T
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 438 -----------GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED 486
GT +++PE + S K D+F G+ L EL+ FS E
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-----FSTQMERVR 235
Query: 487 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
L +R + + + MVQ +P +RP +++
Sbjct: 236 TL------TDVRNLKFPPLFTQK-----YPCEYVMVQ---DMLSPSPMERPEAINIIE 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 59/278 (21%), Positives = 114/278 (41%), Gaps = 21/278 (7%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISVAIH 327
NF IG+G F +VY+ L D VA+K ++ D A +E+ L+ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
N+++ +E +V ++ ++ K ++ + T + LE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
+H + +++HRD+K AN+ + L D GL + +K T + + GT +++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507
+ + K+D++ G L E+ Q ++ L I + +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---LCKKIEQ----CDYPPLPS 260
Query: 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545
+ S+E+ +V +C PE RP + V +
Sbjct: 261 DHY----SEELRQLVN---MCINPDPEKRPDVTYVYDV 291
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 30/215 (13%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL--LQL 333
IG GG KV++ + A+K + + +++ E+ ++ + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 334 IGYCTTSSERILVYPFM--QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
Y T +Y M N+ + L+ +K +D RK + +H+
Sbjct: 94 YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYL- 448
I+H DLK AN L+ D L DFG+A + T V +Q+ GT+ ++ PE +
Sbjct: 147 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 201
Query: 449 ----------STGKSSEKTDVFGYGITLLELVTGQ 473
S K S K+DV+ G L + G+
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 4e-28
Identities = 54/279 (19%), Positives = 96/279 (34%), Gaps = 40/279 (14%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNT------KVAVK-----RLQDYYSPGGE 312
E QL + +++G+G F +VY+ D K +K ++Y
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY----- 112
Query: 313 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-PGEKGLDW 371
+ + + ++ ++ + +LV ++ + K EK +
Sbjct: 113 -IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA-----------VLCDFG 420
A Y +E +H+ +IIH D+K N +L + F L D G
Sbjct: 172 GLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 421 LAKLVDAKL---THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477
+ +D KL + T T G E LS + + D FG T+ ++ G +
Sbjct: 229 QS--IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMK 285
Query: 478 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSK 516
E + R+L D N+ LN D
Sbjct: 286 VK--NEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCH 322
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL--LQL 333
IG GG KV++ + A+K + + +++ E+ ++ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 334 IGYCTTSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
Y T +Y M+ N+ + L+ +K +D RK + +H+
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYL- 448
I+H DLK AN L+ D L DFG+A + T V +Q+ GT+ ++ PE +
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 182
Query: 449 ----------STGKSSEKTDVFGYGITLLELVTGQ 473
S K S K+DV+ G L + G+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 50/235 (21%), Positives = 89/235 (37%), Gaps = 23/235 (9%)
Query: 248 EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQ 304
ED+ V LT+ + E + + +G+G FG+V++ + AVK RL+
Sbjct: 35 EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE 94
Query: 305 DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP 364
E+ + ++ L G + ++ S+ ++ +
Sbjct: 95 V--------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC 146
Query: 365 GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAK 423
L GLEYLH + +I+H D+KA N+LL + LCDFG A
Sbjct: 147 ----LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHAL 199
Query: 424 LVDAKLTHVTTQIRGTM-G---HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
+ + + G H+APE + K D++ +L ++ G
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 25/300 (8%), Positives = 71/300 (23%), Gaps = 49/300 (16%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 334
+ G V+ + A+K + S + + ++ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 335 GYC--------------------------TTSSERILVYPFMQ--NLSVAYRLRDLKPGE 366
+ +L+ P + L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 367 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
+ L + ++H N+ + + +L D V
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 427 AKLTHVTTQIRGTMGHIAPEYLSTGKS--SEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484
+ + + + E+L+ + + + + G+++ + F +
Sbjct: 246 TRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPG 299
Query: 485 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
++ D L L V+T++ L R + ++
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPL----PDFVKTLIG-RFLNFD--RRRRLLPLEAME 352
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 49/292 (16%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+F E +IG GGFG+V+K D +KR+ +REV ++ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLDHVN 65
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRL---------RDL-----KPGEKGLDWPTRK 375
++ G + S L L K + LD
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
+ G++Y+H + K+I+RDLK +NI L D + + DFGL + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS- 181
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR-AIDFSRLEEEEDVLLLDHIR 494
+GT+ +++PE +S+ ++ D++ G+ L EL+ A + S+
Sbjct: 182 -KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF------------- 227
Query: 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546
D+ D ++ K+ +T++Q PEDRP +++++ L
Sbjct: 228 -------FTDLRDGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEILRTL 269
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL--LQL 333
IG GG KV++ + A+K + + +++ E+ ++ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 334 IGYCTTSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
Y T +Y M+ N+ + L+ +K +D RK + +H+
Sbjct: 122 YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLS 449
I+H DLK AN L+ D L DFG+A + T V +Q+ G + ++ PE +
Sbjct: 175 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIK 229
Query: 450 -----------TGKSSEKTDVFGYGITLLELVTGQ 473
K S K+DV+ G L + G+
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 63/313 (20%), Positives = 128/313 (40%), Gaps = 36/313 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+ + IG+G FGK D + +K + S +REV +++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG----EKGLDWPTRKRVAFGTAYG 384
N++Q + +V + + + R+ K ++ LDW
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLA 137
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
L+++H++ KI+HRD+K+ NI L + L DFG+A+++++ + I GT +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504
PE + K+D++ G L EL T + A + ++ L+ I
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----LVLKIIS--------G 240
Query: 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEV 564
Y S ++ ++V + P DRP + + L+ +A+R ++ + +
Sbjct: 241 SFPPVSLHY-SYDLRSLVS---QLFKRNPRDRPSVNSI---LEKGFIAKRIEKFLSPQLI 293
Query: 565 RQQEVSLLPHQFA 577
++ +F
Sbjct: 294 AEEFCLKTFSKFG 306
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 55/222 (24%), Positives = 78/222 (35%), Gaps = 45/222 (20%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVH-LISVAIH 327
+F + +G G +G+V+K D AVKR + P A EV V H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 328 KNLLQLIG-------------YCTTSSERILVYPFMQNLS---VAYRLRDLKPGEKGLDW 371
++L C S ++ + +L V LRD
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHC-EAWGASLPEAQVWGYLRDT--------- 166
Query: 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431
L +LH Q ++H D+K ANI L L DFGL +
Sbjct: 167 ----------LLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGA 212
Query: 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
Q G ++APE L G DVF G+T+LE+
Sbjct: 213 GEVQE-GDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNM 252
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
+ F++ IG+G FG+V+KG+ VA+K + + Q+E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEY 387
+ + G ++ ++ ++ S DL +PG LD + GL+Y
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPG--PLDETQIATILREILKGLDY 134
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM-GH---I 443
LH + K IHRD+KAAN+LL ++ E L DFG V +LT T R T G +
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFG----VAGQLTD-TQIKRNTFVGTPFWM 186
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE + K D++ GIT +EL G+
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 60/220 (27%), Positives = 86/220 (39%), Gaps = 27/220 (12%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
D++ +IG G V KVA+KR+ +E+ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVA----YRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
++ E LV + SV + + + LD T + GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-------- 437
EYLH+ IHRD+KA NILL ++ + DFG V A L R
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG----VSAFLATGGDITRNKVRKTFV 187
Query: 438 GT---MGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
GT M APE + + K D++ +GIT +EL TG
Sbjct: 188 GTPCWM---APEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 40/313 (12%), Positives = 74/313 (23%), Gaps = 62/313 (19%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAA------------FQREVHLISV 324
++GQ + V P A + +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 325 AIHKNLLQLIGYCTTSS-----------------ERILVYPFMQ--NLSVAYRLRDLKPG 365
+H + R +YP MQ + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 366 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425
K L R ++ L LH ++H L+ +I+LD L F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 426 DAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
A + A L + D + G+ + + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTD 319
Query: 481 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 540
+ R + +I + V +++ L + EDR
Sbjct: 320 DAALGG------SEWIFRSCK--NI---------PQPVRALLEGFL---RYPKEDRLLPL 359
Query: 541 QVVKMLQGEDLAE 553
Q ++ + E L
Sbjct: 360 QAMETPEYEQLRT 372
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 67/280 (23%), Positives = 115/280 (41%), Gaps = 20/280 (7%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLI 322
+ +L D+F + + +G G G V+K +A K + P RE+ ++
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 323 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGT 381
++ G + E + M S+ L+ E+ L +V+
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAV 140
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVD--AKLTHVTTQIRG 438
GL YL E+ KI+HRD+K +NIL++ E LCDFG++ +L+D A + V G
Sbjct: 141 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFV-----G 192
Query: 439 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498
T +++PE L S ++D++ G++L+E+ G+ I +E E +
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 538
R LN + M LL + PP
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELL--DYIVNEPPP 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 60/281 (21%), Positives = 110/281 (39%), Gaps = 24/281 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+++ IG G +G+ K SD + K L + + EV+L+ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 329 NLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
N+++ + L V + + +A + + LD RV L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 387 YLHEQCNP--KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
H + + ++HRDLK AN+ LD L DFGLA++++ + T + GT +++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504
PE ++ +EK+D++ G L EL +E L IR+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGKIRE--------G 231
Query: 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545
R Y S E+ ++ RP + ++++
Sbjct: 232 KFRRIPYRY-SDELNEIIT---RMLNLKDYHRPSVEEILEN 268
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 64/252 (25%), Positives = 103/252 (40%), Gaps = 39/252 (15%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
+F E ++GQG FG+V K D+ A+K+++ ++ + EV L++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAY---------RLRDL-KPGEKGLDWPTRKRVA 378
+++ + ++ S + L DL R+
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV------ 432
L Y+H Q IIHRDLK NI +D++ + DFGLAK V L +
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 433 --------TTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 483
T+ I GT ++A E L TG +EK D++ GI E++ FS
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FS--TG 231
Query: 484 EEDVLLLDHIRK 495
E V +L +R
Sbjct: 232 MERVNILKKLRS 243
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 64/259 (24%), Positives = 104/259 (40%), Gaps = 42/259 (16%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNL 330
+F +++G G G + + DN VAVKR+ P + REV L H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI----LPECFSFADREVQLLRESDEHPNV 80
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLH 389
++ +CT + Y ++ A L++ + + + T GL +LH
Sbjct: 81 IRY--FCTEKDRQ-FQYIAIEL--CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 390 EQCNPKIIHRDLKAANILLDDNFE-----AVLCDFGLAKLVDA--KLTHVTTQIRGTMGH 442
I+HRDLK NIL+ A++ DFGL K + + + GT G
Sbjct: 136 SL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 443 IAPEYLS---TGKSSEKTDVFGYGITLLELVT------------------GQRAIDFSRL 481
IAPE LS + D+F G +++ G ++D
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252
Query: 482 EEEEDVLLLDHIRKLLRED 500
E+ EDV+ + I K++ D
Sbjct: 253 EKHEDVIARELIEKMIAMD 271
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 49/218 (22%), Positives = 80/218 (36%), Gaps = 32/218 (14%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVK----------------RLQDYYSPGGEAAFQREVHLI 322
+ QG F K+ DN A+K F+ E+ +I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 323 SVAIHKNLLQLIGYCTTSSERILVYPFMQN------LSVAYRLRDLKPGEKGLDWPTRKR 376
+ ++ L G T E ++Y +M+N + L + K
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF--IPIQVIKC 155
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
+ Y+H + N I HRD+K +NIL+D N L DFG ++ + K +
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS-- 210
Query: 437 RGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 472
RGT + PE+ S + K D++ GI L +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 278 IIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
++G+G +G VY G N ++A+K + + S + E+ L HKN++Q +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGS 87
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
+ + + + S++ LR K G + T GL+YLH+ +I
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 397 IHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGT---MGHIAPEYLSTGK 452
+HRD+K N+L++ + + DFG +K + T GT M APE + G
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYM---APEIIDKGP 199
Query: 453 S--SEKTDVFGYGITLLELVTGQR 474
+ D++ G T++E+ TG+
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 50/238 (21%), Positives = 90/238 (37%), Gaps = 36/238 (15%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-L 321
+ ++L ++ +GGF VY+ + + A+KRL A +EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFM 79
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR----- 376
++ H N++Q + E + L +L G+ +++ +
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEES-----DTGQAEFLLLTELCKGQ-LVEFLKKMESRGPL 133
Query: 377 -------VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
+ + T ++++H Q P IIHRDLK N+LL + LCDFG A +
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 430 THVTT-----------QIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQ 473
+ + T + PE + + EK D++ G L L Q
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
+ + +G G FGKVYK A K + + S + E+ +++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHP 76
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEY 387
+++L+G + ++ F +V + ++GL P + V L +
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---- 443
LH + +IIHRDLKA N+L+ + L DFG V AK T Q R + I
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLK-TLQKRDSF--IGTPY 182
Query: 444 --APEYLSTGKSSE-----KTDVFGYGITLLELVTGQ 473
APE + + K D++ GITL+E+ +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 60/213 (28%), Positives = 85/213 (39%), Gaps = 24/213 (11%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAI 326
FS+ IG G FG VY + ++ VA+K++ E +EV +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H N +Q G LV + S L+ +K L V G GL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLG-SA---SDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT---MGHI 443
YLH +IHRD+KA NILL + L DFG + + + + GT M
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANSFV-GTPYWM--- 217
Query: 444 APEYLSTGKSSE---KTDVFGYGITLLELVTGQ 473
APE + + K DV+ GIT +EL +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 45/230 (19%), Positives = 78/230 (33%), Gaps = 37/230 (16%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI- 326
T F E IG G FG V+K V D A+KR + E REV+ +V
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 327 HKNLLQLIGYCTTSSERILVYPFM---QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
H ++ + Y + +E + S+A + + K +
Sbjct: 70 HSHV---VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-------------------LCDFGLAKL 424
GL Y+H ++H D+K +NI + + D G
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
+++ + G +A E L + K D+F +T++ +
Sbjct: 183 ---RISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 46/217 (21%), Positives = 94/217 (43%), Gaps = 17/217 (7%)
Query: 266 LQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LIS 323
+++ D+ +G+G +G V K + +AVKR++ + + ++ +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
+ G + + M + S+ + + + + ++A
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVD--AKLTHVTTQIRGTM 440
LE+LH +IHRD+K +N+L++ + +CDFG+ LVD AK G
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GCK 173
Query: 441 GHIAPEYLSTGKS----SEKTDVFGYGITLLELVTGQ 473
++APE ++ + S K+D++ GIT++EL +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 42/221 (19%), Positives = 76/221 (34%), Gaps = 27/221 (12%)
Query: 270 TDNFSESNIIGQG--GFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 325
+ +IG+G V V V+R+ + S Q E+H+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
H N++ +E +V FM S + G++ + G L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKAL 141
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-- 443
+Y+H +HR +KA++IL+ + + L + + Q + +
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLR----SNLSMIS-HGQRQRVVHDFPK 193
Query: 444 ---------APEYLSTGKS--SEKTDVFGYGITLLELVTGQ 473
+PE L K+D++ GIT EL G
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 42/232 (18%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-L 321
+ ++ + IG+G +G V K V +AVKR++ + ++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 322 ISVAIHKNLLQLIG-------------YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 368
+ + ++Q G +TS ++ Y + D E+
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFY--------KYVYSVLDDVIPEEI 126
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVD- 426
L ++ T L +L E N KIIHRD+K +NILLD + LCDFG+ +LVD
Sbjct: 127 L-----GKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179
Query: 427 -AKLTHVTTQIRGTMGHIAPEYLSTGKS----SEKTDVFGYGITLLELVTGQ 473
AK G ++APE + S ++DV+ GITL EL TG+
Sbjct: 180 IAKTRDA-----GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIH 327
F ++G G +G+VYKG + A+K + + E ++E++++ + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHH 80
Query: 328 KNLLQLIG-YCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF-- 379
+N+ G + + + LV F SV +++ K +W +A+
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYIC 135
Query: 380 -GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 438
GL +LH+ K+IHRD+K N+LL +N E L DFG++ +D + T I G
Sbjct: 136 REILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 191
Query: 439 T---MGHIAPEYLSTGKSSE-----KTDVFGYGITLLELVTGQ 473
T M APE ++ ++ + K+D++ GIT +E+ G
Sbjct: 192 TPYWM---APEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKR--LQDYYSPGGEAAFQREVHLISVAI 326
+ F +G+G +G VYK + VA+K+ ++ +E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD 82
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGL 385
++++ G +++ +V + SV+ D+ + K L + T GL
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVS----DIIRLRNKTLTEDEIATILQSTLKGL 138
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-- 443
EYLH + IHRD+KA NILL+ A L DFG+A +LT T R T+ I
Sbjct: 139 EYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTD-TMAKRNTV--IGT 188
Query: 444 ----APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE + + D++ GIT +E+ G+
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 48/272 (17%), Positives = 87/272 (31%), Gaps = 51/272 (18%)
Query: 279 IGQGGFGKVYKG---VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
I GG G +Y ++ V +K L +A E ++ +H +++Q+
Sbjct: 88 IAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 336 YCTTSSERILVYPF--MQNLSVAY----RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+ + + M+ Y L+ K + L L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVME-----YVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSYLH 199
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
+++ DLK NI+L + + L D G +++ + GT G APE +
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IV 249
Query: 450 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509
+ TD++ G TL L + +D + + + D R
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPT---------RNGRYVDGLPEDDPVLKTYDSYGR- 299
Query: 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 541
+ P R A+
Sbjct: 300 --------------LLRRAIDPDPRQRFTTAE 317
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 41/310 (13%), Positives = 79/310 (25%), Gaps = 73/310 (23%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAA---------------------- 314
++GQ + V P A
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 315 -----FQREVHLISVAIHKNLLQLIGYCTTSS--ERILVYPFMQ--NLSVAYRLRDLKPG 365
F L+ K ++++ R +YP MQ + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 366 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425
K L R ++ L LH ++H L+ +I+LD L F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 426 DAKLTHVTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQR 474
A++ + G PE + + D + G+ + +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 475 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPE 534
++ + R + +I + V +++ L + E
Sbjct: 312 P--ITKDAALGG------SEWIFRSCK--NI---------PQPVRALLE-GFL--RYPKE 349
Query: 535 DRPPMAQVVK 544
DR Q ++
Sbjct: 350 DRLLPLQAME 359
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 21/220 (9%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-L 321
+ Q ++ +G G G+V+K +AVK+++ + ++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 381
+ ++Q G T+++ + M + + K + + ++
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA----EKLKKRMQGPIPERILGKMTVAI 133
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVD--AKLTHVTTQIRG 438
L YL E+ +IHRD+K +NILLD+ + LCDFG+ +LVD AK G
Sbjct: 134 VKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA-----G 186
Query: 439 TMGHIAPEYLSTGKSSE-----KTDVFGYGITLLELVTGQ 473
++APE + ++ + DV+ GI+L+EL TGQ
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 19/209 (9%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
++ IGQG G VY + ++ +VA++++ + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ + E +V ++ S+ + E +D V LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFL 132
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM-GH---IA 444
H ++IHRD+K+ NILL + L DFG A++T R TM G +A
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITP-EQSKRSTMVGTPYWMA 184
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
PE ++ K D++ GI +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 59/284 (20%), Positives = 104/284 (36%), Gaps = 59/284 (20%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIG 335
+G GG VY N KVA+K + F+REVH S H+N++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS--- 75
Query: 336 YCTTSSERILVYPFMQNLSVAY---------RLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
+ + Y L + L T G++
Sbjct: 76 ----------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAP 445
+ H+ +I+HRD+K NIL+D N + DFG+AK + + LT T + GT+ + +P
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSP 181
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTGQR--------AIDFSRLEEEEDVLLLDHIRKLL 497
E + E TD++ GI L E++ G+ +I +++ +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT-------- 233
Query: 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 541
++ + + ++ L T+ +R Q
Sbjct: 234 ----------TDVRKDIPQSLSNVI---LRATEKDKANRYKTIQ 264
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 17/200 (8%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+GGF K ++ A K L P E+ + H++++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---KPHQREKMSMEISIHRSLAHQHVVG 79
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
G+ + +V + S+ + K L P + G +YLH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN- 134
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 452
++IHRDLK N+ L+++ E + DFGLA V+ + GT +IAPE LS
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 191
Query: 453 SSEKTDVFGYGITLLELVTG 472
S + DV+ G + L+ G
Sbjct: 192 HSFEVDVWSIGCIMYTLLVG 211
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 13/209 (6%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLIS 323
Q A ++F +G+G FG VY +A+K L G E +REV + S
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
H N+L+L GY ++ L+ + +V L+ L D A
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 120
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L Y H + ++IHRD+K N+LL E + DFG + + GT+ ++
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYL 174
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTG 472
PE + EK D++ G+ E + G
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 19/209 (9%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
IG+G G V +VAVK + D EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++++ E ++ F+Q ++ + ++ E+ + V L YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI-----ATVCEAVLQALAYL 157
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM-GH---IA 444
H Q +IHRD+K+ +ILL + L DFG A+++ R ++ G +A
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC----AQISK-DVPKRKSLVGTPYWMA 209
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
PE +S + + D++ GI ++E+V G+
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 17/200 (8%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+GGF K ++ A K L P E+ + H++++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---KPHQREKMSMEISIHRSLAHQHVVG 105
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
G+ + +V + S+ + K L P + G +YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN- 160
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 452
++IHRDLK N+ L+++ E + DFGLA V+ + GT +IAPE LS
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 217
Query: 453 SSEKTDVFGYGITLLELVTG 472
S + DV+ G + L+ G
Sbjct: 218 HSFEVDVWSIGCIMYTLLVG 237
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 13/209 (6%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLIS 323
+ D+F +G+G FG VY + +A+K L G E +RE+ + S
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
H N+L++ Y L+ F + L+ D A
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELAD 125
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L Y HE+ K+IHRD+K N+L+ E + DFG + + GT+ ++
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYL 179
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTG 472
PE + EK D++ G+ E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 3e-22
Identities = 65/304 (21%), Positives = 108/304 (35%), Gaps = 57/304 (18%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVH-LISVAIHK 328
+ I+G G G V VAVKR+ D+ E+ L H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHP 69
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-------KPGEKGLDWPTRKRVAFGT 381
N+++ TT + ++ L+DL K +
Sbjct: 70 NVIRYYCSETTDRFLYIA---LEL--CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLD-------------DNFEAVLCDFGLAKLVDAK 428
A G+ +LH KIIHRDLK NIL+ +N ++ DFGL K +D+
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 429 LTHVTTQIR---GTMGHIAPEYLS-------TGKSSEKTDVFGYGITLLELVTGQRAIDF 478
+ T + GT G APE L + + D+F G +++ +
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 479 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 538
+ E +++ R + D + + DR+L E ++ ++ P RP
Sbjct: 242 DKYSRESNII-----RGIFSLDEMKCLHDRSL----IAEATDLIS-QMIDHD--PLKRPT 289
Query: 539 MAQV 542
+V
Sbjct: 290 AMKV 293
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 50/211 (23%), Positives = 80/211 (37%), Gaps = 34/211 (16%)
Query: 279 IGQGGFGKVYKGVLSDNTK---VAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQL 333
+G+GG G VY+ D + VA+K + + S P QRE +++
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP- 98
Query: 334 IGYCTTSSERILVYPFMQNLSVAY---------RLRDLKPGEKGLDWPTRKRVAFGTAYG 384
++ F + Y L + + L P +
Sbjct: 99 ------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHI 443
L+ H HRD+K NIL+ + A L DFG+A D KLT GT+ ++
Sbjct: 147 LDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYM 202
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
APE S ++ + D++ L E +TG
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 21/218 (9%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+ S+I+GQG V++G A+K + RE ++ HKN
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 330 LLQLIGY--CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
+++L TT+ ++L+ F S+ L + GL V G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNH 127
Query: 388 LHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L E I+HR++K NI+ D L DFG A+ ++ + GT ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLYGTEEYL 182
Query: 444 APEYLSTGKS--------SEKTDVFGYGITLLELVTGQ 473
P+ D++ G+T TG
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 7e-22
Identities = 53/200 (26%), Positives = 81/200 (40%), Gaps = 16/200 (8%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G F VY+ + +VA+K + G Q EV + H ++L+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY---KAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L Y S+ LV N + R LK K + G+ YLH
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEM---NRYLKNRVKPFSENEARHFMHQIITGMLYLHSH- 131
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 452
I+HRDL +N+LL N + DFGLA + T + GT +I+PE +
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSA 188
Query: 453 SSEKTDVFGYGITLLELVTG 472
++DV+ G L+ G
Sbjct: 189 HGLESDVWSLGCMFYTLLIG 208
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 9e-22
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 16/215 (7%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
+ +G GGFG V + + +VA+K+ + SP + E+ ++ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 329 NLLQLI------GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
N++ + +L + + + L GL + + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDIS 131
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGT 439
L YLHE +IIHRDLK NI+L + + + D G AK +D + T+ GT
Sbjct: 132 SALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGT 186
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
+ ++APE L K + D + +G E +TG R
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 63/235 (26%), Positives = 89/235 (37%), Gaps = 43/235 (18%)
Query: 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ--- 316
AT + IG G +G VYK VA+K ++ GG
Sbjct: 3 LGSM----ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST 58
Query: 317 -REVHL---ISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLK---- 363
REV L + H N+++L+ C TS LV+ + +DL+
Sbjct: 59 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLD 110
Query: 364 -PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422
GL T K + GL++LH I+HRDLK NIL+ L DFGLA
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 167
Query: 423 KL--VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
++ LT VT R APE L + D++ G E+ +
Sbjct: 168 RIYSYQMALTPVVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAI--HKNLLQL 333
+G GG +V+ L D+ VAVK L+ + P F+RE + A H ++ +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ--NAAALNHPAIVAV 77
Query: 334 --IGYCTTSSERILVYPFMQNLSVAY----RLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
G + L Y M+ Y LRD+ E + V L +
Sbjct: 78 YDTG-EAETPAGPLPYIVME-----YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT--QIRGTMGHIAP 445
H+ IIHRD+K ANI++ + DFG+A+ + VT + GT +++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTGQR 474
E ++DV+ G L E++TG+
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 8e-21
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 21/218 (9%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+ S+I+GQG V++G A+K + RE ++ HKN
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 330 LLQLIGY--CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
+++L TT+ ++L+ F S+ L + GL V G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 388 LHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L E I+HR++K NI+ D L DFG A+ ++ + GT ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYL 182
Query: 444 APEYLSTGKS--------SEKTDVFGYGITLLELVTGQ 473
P+ D++ G+T TG
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 5e-20
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQ--DYYSPGGEAAFQREVHLIS 323
+ + F + ++G+GGFG+V + K+ A K+L+ GEA E ++
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 324 VAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
+ ++ L Y + + + LV M + + + G+ G R F A
Sbjct: 240 KVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFP---EARAVFYAA 293
Query: 383 ---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 439
GLE LH + +I++RDLK NILLDD+ + D GLA V T GT
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGT 348
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+G++APE + + + D + G L E++ GQ
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 8e-20
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 17/215 (7%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 323
+ D F + ++G+GGFG+V+ + K+ A K+L + G E +++
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 324 VAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
+ ++ L Y + + LV M + Y + ++ G P R F TA
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP---RAIFYTA 296
Query: 383 ---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-G 438
GLE+LH++ II+RDLK N+LLDD+ + D GLA + K T+ G
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAG 351
Query: 439 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
T G +APE L + D F G+TL E++ +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 53/213 (24%), Positives = 82/213 (38%), Gaps = 40/213 (18%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--------RLQDYYSPGGEAAFQREVH 320
+N+ I+G+G V + + + AVK A +EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 321 -LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK---- 375
L V+ H N++QL T++ LV+ M+ GE D+ T K
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK------------GEL-FDYLTEKVTLS 122
Query: 376 -RVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+ + LH+ I+HRDLK NILLDD+ L DFG + +D
Sbjct: 123 EKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--G 177
Query: 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 463
++ GT ++APE + + GYG
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHP---GYG 207
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 70/272 (25%), Positives = 110/272 (40%), Gaps = 59/272 (21%)
Query: 229 CRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVY 288
+ + L+ DVF D + + L ++FS IIG+GGFG+VY
Sbjct: 149 YIEEICQNLRGDVFQKFIESDKFTRFCQW--KNVELNIHLTMNDFSVHRIIGRGGFGEVY 206
Query: 289 KGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER-ILV 346
+D K+ A+K L K + G +ER +L
Sbjct: 207 GCRKADTGKMYAMKCLDK----------------------KRIKMKQGETLALNERIMLS 244
Query: 347 ------YPFMQNLSVAYRLRD--------LKPGEKGLDWPTRK-------RVAFGTA--- 382
PF+ +S A+ D + G+ L + + + F A
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD--LHYHLSQHGVFSEADMRFYAAEII 302
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442
GLE++H + +++RDLK ANILLD++ + D GLA K H + GT G+
Sbjct: 303 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGY 356
Query: 443 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 473
+APE L G + + + D F G L +L+ G
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 41/232 (17%)
Query: 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKRLQ-DYYSPGGEAAFQRE 318
CR A + IG+G +GKV+K N VA+KR++ G + RE
Sbjct: 6 LCR----ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 319 VHL---ISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLK-----PG 365
V + + H N+++L CT S LV+ + +DL
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--------QDLTTYLDKVP 113
Query: 366 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL- 424
E G+ T K + F GL++LH +++HRDLK NIL+ + + L DFGLA++
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 425 -VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
LT VT R APE L + D++ G E+ +
Sbjct: 171 SFQMALTSVVVTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 92.2 bits (228), Expect = 2e-19
Identities = 58/403 (14%), Positives = 125/403 (31%), Gaps = 133/403 (33%)
Query: 226 LFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNII--GQGG 283
R Q KL+ +L +LR N++ G G
Sbjct: 129 YNVSRLQPYLKLRQ--------------ALLELR--------------PAKNVLIDGVLG 160
Query: 284 FGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343
GK T VA+ Y + ++ +++ C +
Sbjct: 161 SGK---------TWVALDVCLSY---KVQCKMDFKIFWLNL----------KNCNSPETV 198
Query: 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 403
+ + +Q L L + P +W +R + + + + + + +
Sbjct: 199 LEM---LQKL-----LYQIDP-----NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 404 ANILLDDNFEAVLCDFGLAKLVDA-----KLTHVTTQIRG--------TMGHIAPEYLST 450
++L + + + AK +A K +TT+ + T HI+ ++ S
Sbjct: 246 CLLVLLN-----VQN---AKAWNAFNLSCK-ILLTTRFKQVTDFLSAATTTHISLDHHSM 296
Query: 451 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE----------- 499
+ ++ +LL R D R + L I + +R+
Sbjct: 297 TLTPDEVK------SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV 350
Query: 500 --DRLNDIVDRNLNTYDSKEVETM-VQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWA 556
D+L I++ +LN + E M ++++ P ++ ++
Sbjct: 351 NCDKLTTIIESSLNVLEPAEYRKMFDRLSVF-----PPSAHIPTILLSLI---------- 395
Query: 557 EWEELEEVRQQEV-------SLLPHQFAWGEDSSIDQEAIQLS 592
W ++ + V SL+ ++S+I +I L
Sbjct: 396 -WFDVIKSDVMVVVNKLHKYSLV---EKQPKESTISIPSIYLE 434
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 7e-09
Identities = 78/529 (14%), Positives = 156/529 (29%), Gaps = 127/529 (24%)
Query: 28 HSSREPDVEGEALIEVLKALNDT-----HGQF----TDW------NDHFVSPCFS----W 68
+ SR L + L L G T W + V W
Sbjct: 130 NVSRLQPYL--KLRQALLELRPAKNVLIDGVLGSGKT-WVALDVCLSYKVQCKMDFKIFW 186
Query: 69 SHV-TCRNGNVISLTLGSNGFSGKISPSITKL-KFLASLELQDNDLSGTLPDFLGSMTHL 126
++ C + + L +I P+ T ++++L+ + + L L S +
Sbjct: 187 LNLKNCNSPETVLEML--QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 127 QSL----NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLI 182
L N+ N K W +LS L + T T +
Sbjct: 245 NCLLVLLNVQNAK-------AW------NAFNLSCKIL----------LTTRFKQVTDFL 281
Query: 183 CGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVL-----------LSL-GAL---F 227
++ + S ++ +++ C L LS+
Sbjct: 282 SAATTTHISLDHHSMTLTPDEV-KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340
Query: 228 ACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCREL--QLATDNFSESNIIGQGGFG 285
+ + + D + + SL L R++ +L+ F S I
Sbjct: 341 LATWDNWKHVNCDKLTTII-----ESSLNVLEPAEYRKMFDRLSV--FPPSAHIPTILLS 393
Query: 286 KVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE--R 343
++ V+ + V V +L Y + +++ +++I L+L R
Sbjct: 394 LIWFDVIKSDVMVVVNKLHKY------SLVEKQPKESTISIPSIYLELKVKLENEYALHR 447
Query: 344 ILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL--H-EQCNPKIIH 398
+V Y N+ + DL P LD Y ++ H +
Sbjct: 448 SIVDHY----NIPKTFDSDDLIP--PYLD-----------QYFYSHIGHHLKNIEH--PE 488
Query: 399 RDLKAANILLDDNF-EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA---PEYLSTGKSS 454
R + LD F E + A + + Q++ +I P+Y +
Sbjct: 489 RMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI 548
Query: 455 EKTDVFGYGITLLE-----LVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498
+ L+ L+ + A L E++ + + +++ R
Sbjct: 549 LDF-LPKIEENLICSKYTDLL--RIA-----LMAEDEAIFEEAHKQVQR 589
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 7e-19
Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 33/217 (15%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 328
+ + + IG+G +G V+K VA+K+ + P + RE+ ++ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 329 NLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
NL+ L+ LV+ + + L +L ++G+ K + + T + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTV-----LHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-----RGTMGH 442
H+ IHRD+K NIL+ + LCDFG A+L+ + ++ R
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR----- 169
Query: 443 IAPEYL------STGKSSEKTDVFGYGITLLELVTGQ 473
+PE L DV+ G EL++G
Sbjct: 170 -SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 27/224 (12%)
Query: 259 RRFSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQ 316
+ + + + ++G+G +G V K VA+K+ + +
Sbjct: 17 ENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM 72
Query: 317 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRK 375
RE+ L+ H+NL+ L+ C LV+ F+ + L DL+ GLD+ +
Sbjct: 73 REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI-----LDDLELFPNGLDYQVVQ 127
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
+ F G+ + H IIHRD+K NIL+ + LCDFG A+ + A +
Sbjct: 128 KYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184
Query: 436 I-----RGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
+ R APE L + DV+ G + E+ G+
Sbjct: 185 VATRWYR------APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 51/251 (20%), Positives = 77/251 (30%), Gaps = 51/251 (20%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK----RLQDYYSPGGEAAFQREVHLISV 324
+ IGQG +G V + A+K +P + EV L+
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 325 AIHKNLLQLIGYCTTSS---------------ERILVYPFMQNLSVAYRLRDLKPGEKGL 369
H N+ +L +++ V+ A + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 370 DWPTRKRVAFGTAY---------------------GLEYLHEQCNPKIIHRDLKAANILL 408
+ L YLH Q I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 409 --DDNFEAVLCDFGLAKLVDAKLT---HVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFG 461
+ +FE L DFGL+K + T GT +APE L+T K D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 462 YGITLLELVTG 472
G+ L L+ G
Sbjct: 262 AGVLLHLLLMG 272
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 21/89 (23%), Positives = 32/89 (35%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L N S S L L+L ++ S++HL +L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+S LS+L+ L NL
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLEN 117
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 29/108 (26%), Positives = 46/108 (42%), Gaps = 5/108 (4%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N F P I T+L+ L L+L L P S++ LQ LN+++N F
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVAT----FNFTGTHLIC 183
+ L++L+ LD S N++ +L + N T C
Sbjct: 510 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-18
Identities = 19/95 (20%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP-DFLGSMTHLQSLNLANNK 135
++ L L NG +S + L+ L L+ Q ++L S+ +L L++++
Sbjct: 374 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ ++ LS+L+ L ++ N+ +F+
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 17/91 (18%), Positives = 29/91 (31%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L + L L++L L N + ++ LQ L +
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L LK L+++ N + + FS
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 19/94 (20%), Positives = 30/94 (31%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L + L L L + N+ + LQ L+ + N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
Query: 137 SGSIPATWSQL-SNLKHLDLSSNNLTGRIPMQLF 169
S S+L L+L+ N+ Q F
Sbjct: 531 MTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 564
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 23/94 (24%), Positives = 40/94 (42%), Gaps = 5/94 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDL-SGTLPDFLGSMTHLQSLNLANNK 135
++ L + + I LK L L + N + S LP++ ++T+L+ L+L++NK
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 136 FSGSIPATWSQLSNLK----HLDLSSNNLTGRIP 165
L + LDLS N + P
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 19/99 (19%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 77 NVISLTLGSNGF-SGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQ----SLNL 131
+ L + N S K+ + L L L+L N + L + + SL+L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ N + P + ++ L L L +N + +
Sbjct: 185 SLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQ 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 24/111 (21%), Positives = 40/111 (36%), Gaps = 9/111 (8%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
N L L + F LK + L G + L+ L+L+ N
Sbjct: 303 NFGWQHLELVNCKFGQ-----FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357
Query: 135 K--FSGSIPATWSQLSNLKHLDLSSNNLTGRIP--MQLFSVATFNFTGTHL 181
F G + ++LK+LDLS N + + L + +F ++L
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 22/117 (18%), Positives = 43/117 (36%), Gaps = 9/117 (7%)
Query: 78 VISLTLGSNGFSGKIS-PSITKLKFLASLELQDNDLS------GTLPDFLGSMTHLQSLN 130
V L LG G + + L+ L +L +++ L+ + D +T++ S +
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSL 187
L + +S +HL+L + ++L S+ FT S
Sbjct: 289 LVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE 343
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 16/104 (15%), Positives = 31/104 (29%), Gaps = 10/104 (9%)
Query: 77 NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGT---LPDFLGSMTHLQSLNLA 132
+ LTL +N S + I L L L + ++ L +L +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 133 NNKFS------GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + I ++ L+N+ L S +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 22/95 (23%), Positives = 31/95 (32%), Gaps = 9/95 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
NV S +L S + LEL + L S+ L +
Sbjct: 283 NVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN----- 335
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT--GRIPMQLF 169
G + L +L+ LDLS N L+ G F
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 11/62 (17%), Positives = 24/62 (38%), Gaps = 3/62 (4%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR 163
+ + + + +PD L ++L+L+ N ++ L+ LDLS +
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 164 IP 165
Sbjct: 68 ED 69
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 16/107 (14%), Positives = 31/107 (28%), Gaps = 28/107 (26%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSM-THLQSLNLANNK 135
++ L + N F + L L L+ N + + L + L LNL N
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 136 F--------------------------SGSIPATWSQLSNLKHLDLS 156
F + P+ + + L+++
Sbjct: 555 FACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 62/212 (29%), Positives = 89/212 (41%), Gaps = 39/212 (18%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-------RLQDYYSPGGEAAFQREVH- 320
+ ++IG+G V + V + + AVK RL A +RE H
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 321 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----- 375
L VA H +++ LI +SS LV+ M+ GE D+ T K
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRK------------GEL-FDYLTEKVALSE 199
Query: 376 ---RVAFGT-AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431
R + + +LH I+HRDLK NILLDDN + L DFG + ++
Sbjct: 200 KETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GE 254
Query: 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 463
++ GT G++APE L K S GYG
Sbjct: 255 KLRELCGTPGYLAPEIL---KCSMDETHPGYG 283
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKR-LQDYYSPGGEAAFQ-REVHLISVAIH 327
++ +IG G FG V++ L ++ +VA+K+ LQD F+ RE+ ++ + H
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-------KRFKNRELQIMRIVKH 91
Query: 328 KNLLQLIGYCTTSSERI------LVYPFM-QNLSVAYR-LRDLKPGEKGLDWPTRKRVAF 379
N++ L + ++ ++ LV ++ + + YR R ++ + K +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV---YRASRHYAKLKQTMPMLLIKLYMY 148
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDA--KLTH--VTT 434
L Y+H I HRD+K N+LLD + L DFG AK++ A +
Sbjct: 149 QLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205
Query: 435 QIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
R APE + + + D++ G + EL+ GQ
Sbjct: 206 YYR------APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 39/215 (18%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVH----LISVAIHK 328
+G+GGFG V+ G L+D +VA+K R+ + EV + + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFG 380
+++L+ + T +LV P + D+ T K R FG
Sbjct: 99 GVIRLLDWFETQEGFMLVLERP------------LPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 381 -TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRG 438
+++ H + ++HRD+K NIL+D L DFG L+ + G
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---G 200
Query: 439 TMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTG 472
T + PE++S + + V+ GI L ++V G
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 45/235 (19%)
Query: 263 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVH 320
C E+ + + IGQG FG+V+K KVA+K++ + G RE+
Sbjct: 13 CDEV----SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 68
Query: 321 LISVAIHKNLLQLIGYCTTSSERI--------LVYPFMQNLSVAYRLRDLK----PGEKG 368
++ + H+N++ LI C T + LV+ F ++ DL
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH--------DLAGLLSNVLVK 120
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA------ 422
KRV GL Y+H KI+HRD+KAAN+L+ + L DFGLA
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 423 -KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
+ T+ VT R PE L + D++G G + E+ T
Sbjct: 178 KNSQPNRYTNRVVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 37/213 (17%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHK--NL 330
+G GGFG VY G+ +SDN VA+K R+ D+ EV L+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFG-T 381
++L+ + +L+ ++DL D+ T + R F
Sbjct: 111 IRLLDWFERPDSFVLILER------PEPVQDL------FDFITERGALQEELARSFFWQV 158
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTM 440
+ + H ++HRD+K NIL+D N + L DFG L+ + GT
Sbjct: 159 LEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTR 212
Query: 441 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTG 472
+ PE++ + V+ GI L ++V G
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 5e-18
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 329
+ + + +G+G +G VYK S VA+KR++ D G + RE+ L+ H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGL 385
++ LI + LV+ FM+ DLK + GL K + G+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK--------DLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGTM 440
+ H+ +I+HRDLK N+L++ + L DFGLA+ TH VT R
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--- 186
Query: 441 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
AP+ L K S D++ G E++TG+
Sbjct: 187 ---APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 38/173 (21%), Positives = 66/173 (38%), Gaps = 33/173 (19%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR------ 437
+E+LH + ++HRDLK +NI + + DFGL +D T
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 438 -----GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492
GT +++PE + S K D+F G+ L EL+ FS E ++
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-----FSTQMERVRII---- 283
Query: 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545
+R + + + + MVQ +P +RP +++
Sbjct: 284 --TDVRNLKFPLLFTQ-----KYPQEHMMVQ---DMLSPSPTERPEATDIIEN 326
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 43/217 (19%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G +GKV + + + AVK +L+ P GEA ++E+ L+ HKN++Q
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR--IPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 333 L--IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTA------- 382
L + Y + +V + G + + D KR A
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVC------------GMQEMLDSVPEKRFPVCQAHGYFCQL 118
Query: 383 -YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK----LTHVTTQIR 437
GLEYLH Q I+H+D+K N+LL + G+A+ + T+Q
Sbjct: 119 IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR-TSQ-- 172
Query: 438 GTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 472
G+ PE + S K D++ G+TL + TG
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKR-LQDYYSPGGEAAFQ-REVHLISVAI 326
+++++ +IG G FG VY+ L D VA+K+ LQD F+ RE+ ++
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLD 105
Query: 327 HKNLLQLIGYCTTSSERI------LVYPFM-QNLSVAYR-LRDLKPGEKGLDWPTRKRVA 378
H N+++L + +S E+ LV ++ + + YR R ++ L K
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYM 162
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDA--KLTH--VT 433
+ L Y+H I HRD+K N+LLD + + LCDFG AK + +
Sbjct: 163 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 434 TQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
R APE + + DV+ G L EL+ GQ
Sbjct: 220 RYYR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+ + IG+G +G V+K + VA+KR++ D G ++ RE+ L+ HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYG 384
N+++L + + LV+ F DLK LD K F G
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ--------DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGT 439
L + H + ++HRDLK N+L++ N E L +FGLA+ + VT R
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR-- 168
Query: 440 MGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAI 476
P+ L K S D++ G EL R +
Sbjct: 169 ----PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 24/89 (26%), Positives = 41/89 (46%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L N + + T+ L SL++ N +S P+ + L+ LNL +N+
Sbjct: 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
S T++ +NL L L SN++
Sbjct: 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 27/94 (28%), Positives = 37/94 (39%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ SL +G N S KL L L LQ N+LS T+L L+L +N
Sbjct: 50 QLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSI 109
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + NL LDLS N L+ +
Sbjct: 110 QKIKNNPFVKQKNLITLDLSHNGLSS-TKLGTQV 142
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 18/113 (15%), Positives = 36/113 (31%), Gaps = 5/113 (4%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
N ++ L + G + L L L L+ N + + L+ ++L N
Sbjct: 512 QHNNLA-RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVAT----FNFTGTHLIC 183
+ + ++ +LK L+L N +T + C
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 22/91 (24%), Positives = 36/91 (39%), Gaps = 1/91 (1%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N S + L L L N + + +L +L+L++N S +
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
T QL NL+ L LS+N + + +
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQA-LKSEELD 166
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-16
Identities = 18/84 (21%), Positives = 35/84 (41%), Gaps = 1/84 (1%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP-DFLGSMTHLQSLNLANNKFSG 138
L L N S S + + L L L+L N++ L + ++ + L+ NK+
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 139 SIPATWSQLSNLKHLDLSSNNLTG 162
+++ + +L+ L L L
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 26/98 (26%), Positives = 39/98 (39%), Gaps = 4/98 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD---FLG-SMTHLQSLNLA 132
+ L + N G S T L L L L ++ S F+ + + L LNL
Sbjct: 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLT 389
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
NK S +S L +L+ LDL N + + Q +
Sbjct: 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 23/104 (22%), Positives = 36/104 (34%), Gaps = 2/104 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG--TLPDFLGSMTHLQSLNLANN 134
N+ + L N + S + L L L+ L + P + +L L+L+NN
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 178
+ L L+ LDL NNL + G
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-15
Identities = 30/91 (32%), Positives = 40/91 (43%), Gaps = 2/91 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L SN + K K L +L+L N LS T + +LQ L L+NNK
Sbjct: 98 NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157
Query: 137 SGSIPA--TWSQLSNLKHLDLSSNNLTGRIP 165
S+LK L+LSSN + P
Sbjct: 158 QALKSEELDIFANSSLKKLELSSNQIKEFSP 188
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-15
Identities = 24/107 (22%), Positives = 44/107 (41%), Gaps = 6/107 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSM--THLQSLNLANN 134
N+I+L L NG S + +L+ L L L +N + + L + L+ L L++N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181
+ P + + L L L++ L + +L T +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC----LELANTSI 224
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 23/111 (20%), Positives = 46/111 (41%), Gaps = 3/111 (2%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKF--LASLELQDNDLSGTLPDFLGSMTHLQSLN 130
N ++ +L+L ++ S + + LK+ L L+L N+L+ D + L+
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFF 278
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM-QLFSVATFNFTGTH 180
L N + L N+++L+L + I + L + F+F
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 22/97 (22%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 77 NVISLTLGSNGFSGKISPSIT----KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
N+ L+L ++ S + + T L L L N +S D + HL+ L+L
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413
Query: 133 NNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQL 168
N+ + W L N+ + LS N
Sbjct: 414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF 450
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 24/117 (20%), Positives = 39/117 (33%), Gaps = 8/117 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ L L SNGF L L ++L N+L+ + L+SLNL N
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 137 SGSIPAT-WSQLSNLKHLDLSSNNLTGRIPMQLF-------SVATFNFTGTHLICGS 185
+ NL LD+ N + + +H +C +
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNT 653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 5/98 (5%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG---SMTHLQSL 129
N ++ L L SN + L L L + L +L + L + T +++L
Sbjct: 168 FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNL 227
Query: 130 NLANNKFSGSIPATWSQL--SNLKHLDLSSNNLTGRIP 165
+L+N++ S + T+ L +NL LDLS NNL
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 18/91 (19%), Positives = 32/91 (35%), Gaps = 4/91 (4%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
+ ++ + + L L N L + L SL++ N S
Sbjct: 8 VADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKL 64
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
P +L LK L+L N L+ + + F+
Sbjct: 65 EPELCQKLPMLKVLNLQHNELSQ-LSDKTFA 94
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 21/104 (20%), Positives = 40/104 (38%), Gaps = 10/104 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL---------PDFLGSMTHLQ 127
+ L N S S+ L + L L+ + ++ + L+
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR-IPMQLFS 170
LN+ +N G ++ L NLK+L LS++ + R + + F
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV 376
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-12
Identities = 21/95 (22%), Positives = 39/95 (41%), Gaps = 4/95 (4%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
+ ++ S LK L L ++DND+ G + + +L+ L+L+N+
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 135 KFSGS--IPATWSQL--SNLKHLDLSSNNLTGRIP 165
S T+ L S L L+L+ N ++
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 28/214 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 329
+ + IG+G +G VYK + A+K+++ + G + RE+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGL 385
+++L T +LV+ + DLK E GL+ T K G+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ--------DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA---KLTH--VTTQIRGTM 440
Y H++ +++HRDLK N+L++ E + DFGLA+ K TH VT R
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--- 167
Query: 441 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
AP+ L K S D++ G E+V G
Sbjct: 168 ---APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+ + + + +G+G + VYKG + VA+K ++ + G REV L+ H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGL 385
++ L T LV+ ++ +DLK ++ K F GL
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD--------KDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGTM 440
Y H Q K++HRDLK N+L+++ E L DFGLA+ + VT R
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--- 167
Query: 441 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
P+ L S + D++G G E+ TG+
Sbjct: 168 ---PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQ----REVHL 321
++ F + +G G + VYKG+ + VA+K +L E RE+ L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS------EEGTPSTAIREISL 56
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
+ H+N+++L T ++ LV+ FM +L R + +GL+ K +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA---KLTH--VTTQ 435
GL + HE KI+HRDLK N+L++ + L DFGLA+ + VT
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW 173
Query: 436 IRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
R AP+ L ++ S D++ G L E++TG+
Sbjct: 174 YR------APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 55/177 (31%), Positives = 78/177 (44%), Gaps = 25/177 (14%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL----QDYYSPGGEAAFQREVHLISVA 325
+ + + +G+G F VYK + N VA+K++ + G RE+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGT 381
H N++ L+ S LV+ FM+ DL+ L K T
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME--------TDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VT 433
GLEYLH+ I+HRDLK N+LLD+N L DFGLAK + TH VT
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT 175
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 24/106 (22%), Positives = 41/106 (38%), Gaps = 9/106 (8%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG-------TLPDFLGSMTH 125
+ NV S+ L +N S + L+S+ L N L+ + +
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489
Query: 126 LQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L S++L NK + + L L +DLS N+ + P Q +
Sbjct: 490 LTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 28/87 (32%), Positives = 40/87 (45%), Gaps = 3/87 (3%)
Query: 80 SLTLGSNGF-SGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
+ +G N + + S+ K+K L LE N L G LP F GS L SLNLA N+ +
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITE 367
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIP 165
+++L + N L IP
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKY-IP 393
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 27/143 (18%), Positives = 45/143 (31%), Gaps = 21/143 (14%)
Query: 36 EGEALIEVLKALNDTHGQF--------TDWNDHFVSPCFSWSH---VTC-RNGNVISLTL 83
+ AL E+ ALN + +WN F W V+ NG V L+L
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWN--FNKELDMWGAQPGVSLNSNGRVTGLSL 88
Query: 84 GSNGFSGKISPSITKLKFLASLELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSGS 139
G SG++ +I +L L L L + P + + + + +
Sbjct: 89 EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKT 148
Query: 140 IPATWSQLSNLKHLDLSSNNLTG 162
DL + +
Sbjct: 149 FV---DYDPREDFSDLIKDCINS 168
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 18/99 (18%), Positives = 33/99 (33%), Gaps = 9/99 (9%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF--- 136
+ LK L +E+ + LP FL ++ +Q +N+A N+
Sbjct: 229 NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288
Query: 137 -----SGSIPATWSQLSNLKHLDLSSNNL-TGRIPMQLF 169
A ++ + + NNL T + L
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 11/98 (11%), Positives = 32/98 (32%), Gaps = 9/98 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDL--------SGTLPDFLGSMTHLQS 128
++ + + + K+ + L + + + N +Q
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 129 LNLANNKF-SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+ + N + + + ++ L L+ N L G++P
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 15/100 (15%)
Query: 80 SLTLGSNGFSG-------KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
++ N + P+ K ++S+ L +N +S + + + L S+NL
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465
Query: 133 NNKFSG-------SIPATWSQLSNLKHLDLSSNNLTGRIP 165
N + + L +DL N LT +
Sbjct: 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LS 504
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 23/111 (20%), Positives = 41/111 (36%), Gaps = 11/111 (9%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASLELQDNDLSG-------TLPDFLGSMTHLQ 127
V +L+ N I + +++++ N++ L ++
Sbjct: 378 QVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 178
S+NL+NN+ S +S S L ++L N LT IP NF
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFKN 486
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 18/102 (17%), Positives = 38/102 (37%), Gaps = 11/102 (10%)
Query: 77 NVISLTLGSNGFSGKISPSI--TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSL----- 129
+ S+ L N + +S T L +L ++L N S P + + L+
Sbjct: 489 LLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 130 -NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ N+ P + +L L + SN++ + ++
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 14/113 (12%), Positives = 37/113 (32%), Gaps = 20/113 (17%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++I + S+ I S + N+++ + + +T L+ + N+ F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218
Query: 137 SG-------------------SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ W L +L +++ + ++P L +
Sbjct: 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 14/100 (14%), Positives = 28/100 (28%), Gaps = 10/100 (10%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQD------NDLSGTLPDFLGSMTHLQSLN 130
++ + L N FS L +++ N P+ + L L
Sbjct: 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ +N + N+ LD+ N +
Sbjct: 573 IGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-15
Identities = 8/83 (9%), Positives = 25/83 (30%), Gaps = 5/83 (6%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
+G++ F + + + T ++ L + + N
Sbjct: 210 QFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 140 IPATWSQLSNLKHLDLSSNNLTG 162
+P L ++ ++++ N
Sbjct: 265 LPTFLKALPEMQLINVACNRGIS 287
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 5/99 (5%), Positives = 24/99 (24%), Gaps = 3/99 (3%)
Query: 80 SLTLGSNGFSGKISPSITKLKF--LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 137
+ + F L + + ++ + +N +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 138 GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNF 176
+ +L+ L+ + ++ + + +
Sbjct: 197 -FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY 234
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 19/84 (22%), Positives = 28/84 (33%), Gaps = 6/84 (7%)
Query: 88 FSGKISPSITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPATWSQ 146
G + F L D+ G P L S + L+L SG +P Q
Sbjct: 49 QQGFGTQPGANWNFNKEL-----DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 147 LSNLKHLDLSSNNLTGRIPMQLFS 170
L+ L+ L L S+ +
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPK 127
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 10/81 (12%), Positives = 23/81 (28%), Gaps = 3/81 (3%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
N + IT L L++ ND+ + + ++ L++ +N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNE--KITPNISVLDIKDNPNISID 603
Query: 141 PATWSQLSNLKHLDLSSNNLT 161
+ L +
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQ 624
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 53/225 (23%), Positives = 87/225 (38%), Gaps = 38/225 (16%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKR-LQDYYSPGGEAAFQ----REVHLIS 323
D F + GQG FG V G VA+K+ +QD F+ + + ++
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-------PRFRNRELQIMQDLA 74
Query: 324 VAIHKNLLQLIGYCTTSSER-------ILVYPFM-QNLSVAYR-LRDLKPGEKGLDWPTR 374
V H N++QL Y T ER +V ++ L +R R+ +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTL---HRCCRNYYRRQVAPPPILI 131
Query: 375 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLV--DAKLTH 431
K F + LH + HRD+K N+L++ + LCDFG AK +
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 432 --VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
+ R APE + + + D++ G E++ G+
Sbjct: 191 YICSRYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 73/330 (22%), Positives = 124/330 (37%), Gaps = 54/330 (16%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL-------QDYYSPGGEAAFQREVHLISVAIHKNL 330
+G G FG V+ V N +V VK + + E+ ++S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
++++ LV M+ L LD P + + YL
Sbjct: 92 IKVLDIFENQGFFQLV---MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLS 449
+ IIHRD+K NI++ ++F L DFG A + KL + GT+ + APE L
Sbjct: 149 K---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLM 202
Query: 450 TGKSSE--KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507
G + +++ G+TL LV + + + V+
Sbjct: 203 -GNPYRGPELEMWSLGVTLYTLVFEE--------------NPFCELEE---------TVE 238
Query: 508 RNLN--TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK---MLQGEDLAERWAEWEELE 562
++ SKE+ ++V L Q PE R + ++V + Q +LA+ WEE+
Sbjct: 239 AAIHPPYLVSKELMSLVSGLL---QPVPERRTTLEKLVTDPWVTQPVNLADY--TWEEVF 293
Query: 563 EVRQQEVSLLPHQFAWGEDSSIDQEAIQLS 592
V + E +L + S+ A
Sbjct: 294 RVNKPESGVLSAASLEMGNRSLSDVAQAQE 323
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 17/211 (8%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
++ + +G G +G+V + + A+K ++ S + EV ++ + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLE 386
N+++L + LV + + + E + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA-----AVIIKQVLSGVT 150
Query: 387 YLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
YLH+ I+HRDLK N+LL + + + DFGL+ + + + GT +I
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYI 205
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
APE L K EK DV+ G+ L L+ G
Sbjct: 206 APEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 46/226 (20%), Positives = 85/226 (37%), Gaps = 42/226 (18%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-------RLQDYYSPGGEAAFQREVHL 321
D + S +G G G+V KVA++ + + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKG-LDWP 372
+ H ++++ + Y + +L G L
Sbjct: 194 LKKLNHPCIIKIKNFFDAED----YYIVL----------ELMEGGELFDKVVGNKRLKEA 239
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKL 429
T K + ++YLHE IIHRDLK N+LL +++ + DFG +K++
Sbjct: 240 TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-- 294
Query: 430 THVTTQIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTG 472
T + + GT ++APE L + + + D + G+ L ++G
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L+YL Q +IIHRD+K NILLD++ + DF +A ++ + T + GT ++
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYM 181
Query: 444 APEYLSTGKSSEKT---DVFGYGITLLELVTGQR 474
APE S+ K + + D + G+T EL+ G+R
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 43/229 (18%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA-AFQ---------REV 319
++ I G +G V GV S+ VA+KR+ + S G RE+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 320 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPT 373
L++ H N+L L E LV M+ +L+ + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA-----QVIHDQRIVI---S 132
Query: 374 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DA 427
+ + + Y GL LH ++HRDL NILL DN + +CDF LA+ DA
Sbjct: 133 PQHIQY-FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 428 KLT-HVTTQ-IRGTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 473
T +VT + R APE + ++ D++ G + E+ +
Sbjct: 189 NKTHYVTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 51/228 (22%), Positives = 91/228 (39%), Gaps = 37/228 (16%)
Query: 262 SCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREV 319
S + D + +G+G +G+VYK + N VA+KR+ ++ G REV
Sbjct: 29 SATSI----DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV 84
Query: 320 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKR 376
L+ H+N+++L + L++ + + DLK + K
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKS 136
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-----LCDFGLAKLV---DAK 428
+ G+ + H + + +HRDLK N+LL + + + DFGLA+ +
Sbjct: 137 FLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193
Query: 429 LTH--VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
TH +T R PE L + S D++ E++
Sbjct: 194 FTHEIITLWYR------PPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 3e-16
Identities = 22/95 (23%), Positives = 32/95 (33%), Gaps = 10/95 (10%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG- 138
S + LK L +EL + LPDFL + LQSLN+A N+
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 139 --------SIPATWSQLSNLKHLDLSSNNLTGRIP 165
+ ++ + NNL P
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FP 564
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 17/99 (17%), Positives = 41/99 (41%), Gaps = 11/99 (11%)
Query: 80 SLTLGSNGFSGKISPSI--TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNL------ 131
++ L N + +S T L +L+++++ N S + P + + L++ +
Sbjct: 732 TIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDA 789
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
N+ P + +L L + SN++ + +L
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTP 827
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 16/96 (16%), Positives = 31/96 (32%), Gaps = 12/96 (12%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG---------TLPDFLGSMTHLQ 127
++ + L + ++ + L L SL + N L D + +Q
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551
Query: 128 SLNLANNKFSGSIPATW--SQLSNLKHLDLSSNNLT 161
+ N PA+ ++ L LD N +
Sbjct: 552 IFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR 586
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 17/97 (17%), Positives = 29/97 (29%), Gaps = 6/97 (6%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLAN 133
N +++ + + N+L P L M L L+ +
Sbjct: 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVH 582
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
NK + A + L L L N + IP +
Sbjct: 583 NKVR-HLEA-FGTNVKLTDLKLDYNQIEE-IPEDFCA 616
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 17/108 (15%), Positives = 36/108 (33%), Gaps = 7/108 (6%)
Query: 77 NVISLTLGSNGFSG-KISPSITKLKFLASLELQDNDLSGTLPDFLGSM-----THLQSLN 130
V L N + + + S++ N + + SM + ++
Sbjct: 620 QVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 178
L+ N+ ++ S + + LS+N +T IP N+
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKN 726
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 14/102 (13%), Positives = 31/102 (30%), Gaps = 20/102 (19%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG-------------------TLPDFL 120
+ +N + IS +I +L L + ++ +
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW 487
Query: 121 GSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 162
++ L + L N +P L L+ L+++ N
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 6e-13
Identities = 21/91 (23%), Positives = 31/91 (34%), Gaps = 4/91 (4%)
Query: 80 SLTLGSNGFSG-KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
+G N S S+ K+ L L+ N + L F G+ L L L N+
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIEE 609
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ ++ L S N L IP
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFN 639
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 8e-13
Identities = 17/120 (14%), Positives = 33/120 (27%), Gaps = 15/120 (12%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQ------DNDLSGTLPDFLGSMTHLQSLNLAN 133
++ + N FS L + ++ N + P + + L L + +
Sbjct: 757 NMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLT-----GRIPMQLFSVATFNFTGTHLICGSSLE 188
N + L LD++ N P + + T I G
Sbjct: 816 NDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDAL 872
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 18/115 (15%), Positives = 42/115 (36%), Gaps = 27/115 (23%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSG------TLPDFLGSMTHLQSLNLANN 134
L + + +P + +K + + L+D + + + +T LQ + AN+
Sbjct: 401 SDLLQDAINR--NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANS 458
Query: 135 KFSG-------------------SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
F+ + +WS L +L ++L + ++P L+
Sbjct: 459 PFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 25/175 (14%), Positives = 57/175 (32%), Gaps = 16/175 (9%)
Query: 36 EGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVT--CRNGNVISLTLGSNGFSGKIS 93
+ +AL + +AL+ + ++ + +W+ G+ + L +NG
Sbjct: 270 DYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGR----- 324
Query: 94 PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 153
+ L L G +PD +G +T L+ L+ + + S +
Sbjct: 325 --------VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMS 376
Query: 154 DLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRI 208
+ + + ++F + L+ + P M S +I
Sbjct: 377 EERKHRIRMHYK-KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQI 430
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 4e-12
Identities = 15/102 (14%), Positives = 33/102 (32%), Gaps = 13/102 (12%)
Query: 80 SLTLGSNGFSGK-----ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
S+ N + S K +++ L N++ + + + + ++ L+NN
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 135 KFS-------GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ + L +DL N LT +
Sbjct: 708 LMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFR 748
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 19/104 (18%), Positives = 42/104 (40%), Gaps = 17/104 (16%)
Query: 77 NVISLTLGSNGFS-------GKISPSITKLKFLASLELQDNDLSGTLPD--FLGSMTHLQ 127
+ ++ L +N + + L +++L+ N L+ +L D ++ +L
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLS 756
Query: 128 SLNLANNKFSGSIPATWSQLSNLKHLDL------SSNNLTGRIP 165
+++++ N FS S P S LK + N + + P
Sbjct: 757 NMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWP 799
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 266 LQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQRE 318
+Q +T FS+ ++G+G FG+V + AVK + + + RE
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 319 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRV 377
V L+ H N+++L + LV + + K E R+
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA-----ARI 131
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTT 434
G+ Y+H+ KI+HRDLK N+LL + + DFGL+ +A +
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMK 186
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
GT +IAPE L G EK DV+ G+ L L++G
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 44/191 (23%), Positives = 78/191 (40%), Gaps = 33/191 (17%)
Query: 279 IGQGGFGKVYKGVLSDNT---KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G+G +G VYK D A+K+++ G + RE+ L+ H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 85
Query: 336 YCTTSSERI--LVYPFMQN----LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+ ++R L++ + ++ + +R L K + + G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAV----LCDFGLAKLVDA---KLTHVTTQI-----R 437
++HRDLK ANIL+ + D G A+L ++ L + + R
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 438 GTMGHIAPEYL 448
APE L
Sbjct: 203 ------APELL 207
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 42/218 (19%), Positives = 75/218 (34%), Gaps = 44/218 (20%)
Query: 264 RELQLATDNFSE-----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQR 317
+ + ++ ++G G GKV + K A+K L D ++
Sbjct: 17 QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD------SPKARQ 70
Query: 318 EV-HLISVAIHKNLLQLIG-YCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EK 367
EV H + +++ ++ Y + + M + G E+
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM----------ECMEGGELFSRIQER 120
Query: 368 GLDWPTRKRVAFGT---AYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGL 421
G T + A +++LH I HRD+K N+L + + L DFG
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
AK + T ++APE L K + D+
Sbjct: 178 AKETT---QNALQTPCYTPYYVAPEVLGPEKYDKSCDM 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 33/203 (16%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
F ++G G F +V+ A+K + +++ + E+ ++ H+
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI-KKSPAFRDSSLENEIAVLKKIKHE 66
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTAY 383
N++ L +++ LV MQ L G + D + + A
Sbjct: 67 NIVTLEDIYESTTHYYLV---MQ----------LVSGGELFDRILERGVYTEKDASLVIQ 113
Query: 384 ----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
++YLHE I+HRDLK N+L ++N + ++ DFGL+K+ + +
Sbjct: 114 QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTA 167
Query: 437 RGTMGHIAPEYLSTGKSSEKTDV 459
GT G++APE L+ S+ D
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDC 190
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 53/228 (23%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ +G G +G V + KVA+K+L FQ RE+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74
Query: 320 HLISVAIHKNLLQLIGYCTTSSERI------LVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 372
L+ H+N++ L+ T +S LV PFMQ +L L+
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK-----------F 123
Query: 373 TRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
+ +++ + Y GL+Y+H + ++HRDLK N+ ++++ E + DFGLA+ DA+
Sbjct: 124 SEEKIQY-LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
Query: 429 LTH-VTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 473
+T V T+ R APE LS ++ D++ G + E++TG+
Sbjct: 180 MTGYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 48/231 (20%), Positives = 84/231 (36%), Gaps = 36/231 (15%)
Query: 259 RRFSCRELQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA 313
+++ + +++ D+ + +G G FG V++ + A K + +
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKE 199
Query: 314 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
++E+ +SV H L+ L +E +++Y FM GE +
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG------------GEL-FEKVA 246
Query: 374 RKRVAF----GTAY------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGL 421
+ Y GL ++HE +H DLK NI+ L DFGL
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
+D K GT APE TD++ G+ L++G
Sbjct: 304 TAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 41/219 (18%), Positives = 81/219 (36%), Gaps = 38/219 (17%)
Query: 259 RRFSCRELQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA 313
+++ + +++ + + +G G FG V++ V + K + + P +
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKY 93
Query: 314 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWP 372
+ E+ +++ H L+ L E +L+ F+ GE L D
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG------------GE--LFDRI 139
Query: 373 TRKRVAFGTAY----------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFG 420
+ A GL+++HE I+H D+K NI+ + + + DFG
Sbjct: 140 AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196
Query: 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
LA ++ + T APE + TD+
Sbjct: 197 LATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYTDM 233
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 24/98 (24%), Positives = 37/98 (37%), Gaps = 1/98 (1%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
+V S+ L + F S + L L+L LS LP L ++ L+ L L+
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
NKF + S +L HL + N +
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 18/94 (19%), Positives = 28/94 (29%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L N + + ++L L L+L + D S L +L L N
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S LKHL ++ I
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISS-IDFIPLH 126
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 1/87 (1%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSG 138
SL L N + + + L L+L L ++ L+ LNL+++
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIP 165
S + L L+HL+L N+
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNI 466
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 23/97 (23%), Positives = 44/97 (45%), Gaps = 3/97 (3%)
Query: 77 NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDL--SGTLPDFLGSMTHLQSLNLAN 133
++ L++ N ++ + L+ L L+L +D+ S L +++HLQSLNL+
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
N+ + + L+ LDL+ L + F
Sbjct: 386 NEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 20/94 (21%), Positives = 34/94 (36%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L +N +++ K L L +S L + L+SL L +N
Sbjct: 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S LK LD +N + + + S
Sbjct: 142 SSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMS 174
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 22/97 (22%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGT---LPDFLGSMTHLQSLNLAN 133
+ L L + L L L LQ N + L ++ L+ L L+
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S ++ L + H+DLS N LT ++ S
Sbjct: 486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALS 521
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 17/91 (18%), Positives = 25/91 (27%), Gaps = 1/91 (1%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L + L +L L N L L L+ L S
Sbjct: 61 FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI 120
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L+ L L SN+++ I +
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISS-IKLPKGF 150
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 7/118 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLE---LQDNDLSGTLPDFLGSMTHLQSLNLAN 133
+ L L N F L+ L LE L DLS S+ + ++L++
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP---MQLFSVATFNFTGTHLICGSSLE 188
N+ + S S L + +L+L+SN+++ +P L T N L C S
Sbjct: 510 NRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI 566
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 24/95 (25%), Positives = 33/95 (34%), Gaps = 5/95 (5%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L K + S L L L L + L + + LQ LNL N F
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 139 SI---PATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L L+ L LS +L+ I F+
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSS-IDQHAFT 497
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 24/100 (24%), Positives = 34/100 (34%), Gaps = 3/100 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L G S + K L SL L N +S L+ L+ NN
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165
Query: 137 SGSIPATWSQLSNLKH--LDLSSNNLTGRIPMQLFSVATF 174
S L + L+L+ N++ G I F A F
Sbjct: 166 HYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVF 204
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 23/93 (24%), Positives = 39/93 (41%), Gaps = 1/93 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L S + T LK + ++L N L+ + + L + + LNLA+N
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHI 535
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
S +P+ LS + ++L N L F
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCTCSNIYF 568
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 16/101 (15%), Positives = 29/101 (28%), Gaps = 6/101 (5%)
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG--SMTHLQSLNL 131
+ +SL L N I P SL + L ++ L
Sbjct: 177 QQATNLSLNLNGN-DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 132 ANNKFSGSIPATWSQLS--NLKHLDLSSNNLTGRIPMQLFS 170
+ PA + L +++ ++L + I F
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFH 275
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 21/105 (20%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ + L N + +++ LK + L L N +S LP L ++ +++NL N
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
Query: 137 SGSIPATW--------------------SQLSNLKHLDLSSNNLT 161
+ + L+ + LS L+
Sbjct: 560 DCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 15/67 (22%), Positives = 27/67 (40%), Gaps = 4/67 (5%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR 163
+ ++ L+ +P L + + L + N T+S+L NL LDL+ +
Sbjct: 16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW- 71
Query: 164 IPMQLFS 170
I F
Sbjct: 72 IHEDTFQ 78
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 13/88 (14%), Positives = 24/88 (27%), Gaps = 3/88 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLS-GTLPDFLGSMTHLQSLNLANNK 135
+ L +N ++ L+ +L L N + QSLN +
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213
Query: 136 FSGSIPA--TWSQLSNLKHLDLSSNNLT 161
I S + +L +
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDE 241
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 46/234 (19%), Positives = 84/234 (35%), Gaps = 56/234 (23%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL------------QDYYSPGGEAAFQ 316
+++ + +G G +G+V + +++ A+K + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 317 REVHLISVAIHKNLLQLIGYCTTSS---------------ERILVYPFMQNLSVAYRLRD 361
E+ L+ H N+++L E+I+ A ++
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 362 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCD 418
+ G+ YLH+ I+HRD+K NILL + + D
Sbjct: 155 I-------------------LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVD 192
Query: 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
FGL+ + GT +IAPE L K +EK DV+ G+ + L+ G
Sbjct: 193 FGLSSFFSK--DYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 52/232 (22%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-------------------------RLQDYYSPGGE 312
IG+G +G V +DNT A+K G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 313 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 372
+E+ ++ H N+++L+ +E L Y + + G ++ P
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFE-----L----VNQGPV-MEVP 129
Query: 373 TRKRVAFGTA--------YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424
T K ++ A G+EYLH Q KIIHRD+K +N+L+ ++ + DFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQ 473
++ + GT +APE LS + S + DV+ G+TL V GQ
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 24/113 (21%), Positives = 40/113 (35%), Gaps = 6/113 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N F ++ L L+L L ++ LQ LN+++N
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVAT----FNFTGTHLICGSSLE 188
+ ++QL +L LD S N + L FN T + C +
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICEHQ 564
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 20/91 (21%), Positives = 32/91 (35%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L + L L++L L N + P +T L++L K +
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
QL LK L+++ N + FS
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 18/94 (19%), Positives = 34/94 (36%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ ++ L N S S + L L+L ++ + HL +L L N
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
P ++S L++L++L L +
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLAS-LESFPIG 125
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ +L L N S + L L +L + L+ +G + L+ LN+A+N
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 137 SG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+PA +S L+NL H+DLS N + I +
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQ 174
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP-DFLGSMTHLQSLNLANNK 135
++ L L NG +S + L+ L L+ Q + L S+ L L+++
Sbjct: 377 SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN 435
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L++L L ++ N+ +F+
Sbjct: 436 TKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 15/85 (17%), Positives = 29/85 (34%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L L L L + N+L + L +L+ + N+
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
S +L +L++N++
Sbjct: 534 ETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 21/99 (21%), Positives = 37/99 (37%), Gaps = 6/99 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG-TLPDFLGSMTHLQSLNLANNK 135
++ +L + S I +L L L + N + LP + ++T+L ++L+ N
Sbjct: 105 SLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164
Query: 136 FSGSIPATWSQLSNLK----HLDLSSNNLTGRIPMQLFS 170
L LD+S N + I Q F
Sbjct: 165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQ 202
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 25/84 (29%), Positives = 37/84 (44%), Gaps = 7/84 (8%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
SL++ L FL SL L N S + ++ L L+L+ N S S
Sbjct: 311 SLSIIRCQLK---QFPTLDLPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFS 365
Query: 140 IPATWSQL--SNLKHLDLSSNNLT 161
++S L ++L+HLDLS N
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAI 389
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 26/94 (27%), Positives = 37/94 (39%), Gaps = 8/94 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
NV +++L + K SL + L P + L+SL L NK
Sbjct: 286 NVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPTL--DLPFLKSLTLTMNK- 339
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
GSI L +L +LDLS N L+ +S
Sbjct: 340 -GSISFKKVALPSLSYLDLSRNALSF-SGCCSYS 371
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 14/91 (15%), Positives = 26/91 (28%), Gaps = 9/91 (9%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTL------PDFLGSMTHLQ--SLN 130
LTL N S I + L L L + P + + +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
L + L+N+ + L+ ++
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 19/81 (23%), Positives = 38/81 (46%), Gaps = 5/81 (6%)
Query: 90 GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSN 149
G ++P I + + + + D LS +PD + S ++++L+ N ++S S
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 150 LKHLDLSSNNLTGRIPMQLFS 170
L+ LDLS + I + +
Sbjct: 58 LQWLDLSRCEIET-IEDKAWH 77
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 11/110 (10%), Positives = 33/110 (30%), Gaps = 10/110 (9%)
Query: 80 SLTLGSNGFSGKIS---PSITKLKFLASLELQDNDLSGT-----LPDFLGSMTHLQSLNL 131
L F + + + ++ L + + + L+ T + ++ +++L
Sbjct: 233 VHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSL 292
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181
A + + + L + L + L + + T
Sbjct: 293 AGVSIK-YLED-VPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKG 340
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 47/211 (22%), Positives = 79/211 (37%), Gaps = 38/211 (18%)
Query: 270 TDNFSE-----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVH-L 321
+NF+ S +G+G F V + + S + A K L+ A E+ L
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTR 374
++ L +SE IL+ + GE + + +
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAG------------GEIFSLCLPELAEMVSE 130
Query: 375 KRVAFGT---AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAK 428
V G+ YLH+ I+H DLK NILL + + DFG+++ +
Sbjct: 131 NDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
+I GT ++APE L+ + TD+
Sbjct: 188 --CELREIMGTPEYLAPEILNYDPITTATDM 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 47/215 (21%), Positives = 79/215 (36%), Gaps = 49/215 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 323
D++ +G G F V K + A K RL +REV+++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQ------------NLS---VAYRLRDLKPGEKG 368
H N++ L ++ +L+ + +L+ L+ +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI------ 117
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 424
LD G+ YLH + +I H DLK NI+L N L DFG+A
Sbjct: 118 LD-------------GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
++A + I GT +APE ++ + D+
Sbjct: 162 IEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADM 194
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 51/226 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
+ ++ ++G+G FG+V K + AVK + + REV L+ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 328 KNLLQLIGYCTTSS---------------ERILVYPFMQNLS---VAYRLRDLKPGEKGL 369
N+++L SS + I+ + S A ++ +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQV------- 130
Query: 370 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVD 426
G+ Y+H+ I+HRDLK NILL + + + + DFGL+
Sbjct: 131 ------------FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
GT +IAPE L G EK DV+ G+ L L++G
Sbjct: 176 Q--NTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 47/215 (21%), Positives = 75/215 (34%), Gaps = 49/215 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 323
D + +G G F V K S + A K + + +REV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTA 382
+H N++ L ++ +L+ + GE L D +A +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSG------------GE--LFD-----FLAQKES 111
Query: 383 Y--------------GLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 424
G+ YLH + KI H DLK NI+L L DFGLA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
++ I GT +APE ++ + D+
Sbjct: 169 IEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 52/228 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ + +G G +G V V KVA+K+L FQ RE+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75
Query: 320 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 372
L+ H+N++ L+ ++ LV PFM +L + L
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL---------- 125
Query: 373 TRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
R+ F Y GL Y+H IIHRDLK N+ ++++ E + DFGLA+ D++
Sbjct: 126 GEDRIQF-LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 429 LT-HVTTQ-IRGTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 473
+T +V T+ R APE L+ + ++ D++ G + E++TG+
Sbjct: 182 MTGYVVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-15
Identities = 43/202 (21%), Positives = 76/202 (37%), Gaps = 26/202 (12%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
D F +G G FG V+ S + +K + S + E+ ++ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLS--------VAYRLRDLKPGEKGLDWPTRKRVAFG 380
N++++ +V M+ V+ + R E + ++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIV---METCEGGELLERIVSAQARGKALSEGYVAELMKQMMN-- 135
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
L Y H Q ++H+DLK NIL + + DFGLA+L + +T
Sbjct: 136 ---ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAA 187
Query: 438 GTMGHIAPEYLSTGKSSEKTDV 459
GT ++APE + K D+
Sbjct: 188 GTALYMAPEVFK-RDVTFKCDI 208
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 52/204 (25%), Positives = 81/204 (39%), Gaps = 33/204 (16%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
+ ++ ++G+G FG+V K + AVK + + REV L+ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 382
N+++L SS +V +L G + D ++ A
Sbjct: 81 PNIMKLFEILEDSSSFYIV---G----------ELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 383 Y----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
G+ Y+H+ I+HRDLK NILL + + + + DFGL+
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKD 182
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDV 459
GT +IAPE L G EK DV
Sbjct: 183 RIGTAYYIAPEVLR-GTYDEKCDV 205
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 51/221 (23%), Positives = 84/221 (38%), Gaps = 38/221 (17%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ IG G G V + VA+K+L FQ RE+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 320 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 372
L+ HKN++ L+ + +V M NL + LD
Sbjct: 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------MELDHE 127
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
+ + G+++LH + IIHRDLK +NI++ + + DFGLA+ + +
Sbjct: 128 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFM 182
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
T T + APE + E D++ G + E++ G
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 44/199 (22%), Positives = 73/199 (36%), Gaps = 38/199 (19%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 335
++G G GKV + K A+K LQD +REV + ++++++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVD 122
Query: 336 -YCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKGLDWPTRKRVAFGT---AY 383
Y + R + M + G ++G T + +
Sbjct: 123 VYENLYAGRKCLLIVM----------ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGTM 440
++YLH I HRD+K N+L L DFG AK + + T T
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTP 227
Query: 441 GHIAPEYLSTGKSSEKTDV 459
++APE L K + D+
Sbjct: 228 YYVAPEVLGPEKYDKSCDM 246
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 53/236 (22%), Positives = 91/236 (38%), Gaps = 50/236 (21%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI 322
++++L ++F +IG+G FG+V L + KV A+K L + E + E
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW-----EMLKRAETA-- 119
Query: 323 SVAIHKNLLQLIGYCTTSSERILVY---PFMQNLSVA-------YRLRDLKPG------- 365
C +LV ++ L A Y + D G
Sbjct: 120 --------------CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL 165
Query: 366 EKGLDWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422
K D + F A ++ +H+ +HRD+K NIL+D N L DFG
Sbjct: 166 SKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-----DVFGYGITLLELVTGQ 473
+ T ++ GT +I+PE L + + D + G+ + E++ G+
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 48/224 (21%), Positives = 85/224 (37%), Gaps = 50/224 (22%)
Query: 261 FSCRELQLATDNFSE------SNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYS 308
F R + + + I+G G FG+V+K + K+A K ++D
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--- 129
Query: 309 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 368
+ + E+ +++ H NL+QL + ++ +LV ++ GE
Sbjct: 130 ---KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG------------GE-- 172
Query: 369 L-DWPTRKRVAFGTAY----------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL- 416
L D + G+ ++H+ I+H DLK NIL + +
Sbjct: 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIK 229
Query: 417 -CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
DFGLA+ + GT +APE ++ S TD+
Sbjct: 230 IIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 38/221 (17%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ IG G G V + VA+K+L FQ RE+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112
Query: 320 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 372
L+ HKN++ L+ + LV M NL + LD
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--------MELDHE 164
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
+ + G+++LH + IIHRDLK +NI++ + + DFGLA+ + +
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFM 219
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
T T + APE + E D++ G + E+V +
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
+F A G+E+L + K IHRDL A NILL + +CDFGLA+ + +V R
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----R 251
Query: 438 GTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 471
+ APE + + ++DV+ +G+ L E+ +
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 23/90 (25%), Positives = 39/90 (43%), Gaps = 8/90 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREV-HLIS 323
D +G+G FG+V + + VAVK L++ + A E+ LI
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 324 VAIHKNLLQLIGYCTTSSERILV-YPFMQN 352
+ H N++ L+G CT ++V F +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKF 111
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 47/215 (21%), Positives = 75/215 (34%), Gaps = 49/215 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 323
D + +G G F V K S + A K + + +REV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTA 382
+H N++ L ++ +L+ + GE L D +A +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSG------------GE--LFD-----FLAQKES 111
Query: 383 Y--------------GLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 424
G+ YLH + KI H DLK NI+L L DFGLA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
++ I GT +APE ++ + D+
Sbjct: 169 IED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGHI 443
LEYLH + IIHRDLK NILL+++ + DFG AK++ + GT ++
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 444 APEYLST---GKSSEKTDVFGYGITLLELVTGQ 473
+PE L+ KSS D++ G + +LV G
Sbjct: 200 SPELLTEKSACKSS---DLWALGCIIYQLVAGL 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 28/281 (9%), Positives = 73/281 (25%), Gaps = 55/281 (19%)
Query: 279 IGQGGFGKVYKGVLSDNT---KVAVK--RLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
G + ++ + D +VA+ Q +S + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
+ T + ++V + L+++ + R A + H
Sbjct: 97 LDVVHTRAGGLVV---AE-WIRGGSLQEV--ADTSPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 453
+ + + + + + VL + +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQ------------------------- 182
Query: 454 SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 513
D+ G G +L L+ + + + + D + + ++ + ++
Sbjct: 183 ---DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA- 238
Query: 514 DSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 554
VA Q R + M Q +A+R
Sbjct: 239 ----------VAARSVQGDGGIRSASTLLNLMQQATAVADR 269
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 34/203 (16%), Positives = 75/203 (36%), Gaps = 33/203 (16%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
+ + + +G+G FG V++ V S K ++ + ++E+ ++++A H+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG----TAY- 383
N+L L + E ++++ F+ + + +Y
Sbjct: 62 NILHLHESFESMEELVMIFEFISG------------LDI-FERINTSAFELNEREIVSYV 108
Query: 384 -----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKLVDAKLTHVTTQI 436
L++LH I H D++ NI+ + + +FG A+ + +
Sbjct: 109 HQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLL 163
Query: 437 RGTMGHIAPEYLSTGKSSEKTDV 459
+ APE S TD+
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDM 186
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 45/214 (21%), Positives = 79/214 (36%), Gaps = 45/214 (21%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-------RLQDYYSPGGEAAFQREVHL 321
D + S +G G G+V KVA+K + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKG-LDWP 372
+ H ++++ + Y + +L G L
Sbjct: 69 LKKLNHPCIIKIKNFFDAED----YYIVL----------ELMEGGELFDKVVGNKRLKEA 114
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKL 429
T K + ++YLHE IIHRDLK N+LL +++ + DFG +K++
Sbjct: 115 TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-- 169
Query: 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 463
T + + GT ++APE L + ++ GY
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTA------GYN 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 40/204 (19%), Positives = 73/204 (35%), Gaps = 31/204 (15%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
T+ + +G+G F V + V + + A + S +RE + + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 382
N+++L + L+ DL G + + + A
Sbjct: 70 PNIVRLHDSISEEGHHYLI---F----------DLVTGGELFEDIVAREYYSEADASHCI 116
Query: 383 Y----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
+ + H+ ++HR+LK N+LL L DFGLA V+ +
Sbjct: 117 QQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFG 172
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDV 459
GT G+++PE L + D+
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDL 196
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 46/215 (21%), Positives = 75/215 (34%), Gaps = 49/215 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 323
D + +G G F V K S + A K R + +REV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQ------------NLS---VAYRLRDLKPGEKG 368
H N++ L ++ IL+ + +L+ L+ +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------ 123
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 424
L+ G+ YLH +I H DLK NI+L + DFGLA
Sbjct: 124 LN-------------GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
+D + I GT +APE ++ + D+
Sbjct: 168 IDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 24/224 (10%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVH 320
+E++L D+F +IG+G F +V + +V A+K + D G + F+ E
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 321 LISVAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 379
++ + + QL + + LV + + L K GE+ + F
Sbjct: 114 VLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS--KFGERI----PAEMARF 166
Query: 380 GTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
A ++ +H +HRD+K NILLD L DFG + A T +
Sbjct: 167 YLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFG-------YGITLLELVTGQ 473
GT +++PE L T +G G+ E+ GQ
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 52/228 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ + + +G G +G V + +VAVK+L FQ RE+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 320 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 372
L+ H+N++ L+ ++ LV M +L+ + + L
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL---------- 129
Query: 373 TRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
T V F Y GL+Y+H + IIHRDLK +N+ ++++ E + DFGLA+ +
Sbjct: 130 TDDHVQF-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 429 LT-HVTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 473
+T +V T+ R APE L+ ++ D++ G + EL+TG+
Sbjct: 186 MTGYVATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 48/227 (21%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
++ + IG+G +G V + +VA+K++ F+ RE+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---------PFEHQTYCQRTLREI 76
Query: 320 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPT 373
++ H+N++ + + +V M+ +L + + L +
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL----------S 126
Query: 374 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
+ + Y GL+Y+H + ++HRDLK +N+LL+ + +CDFGLA++ D
Sbjct: 127 NDHICYFL-YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 430 THVT--TQIRGTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 473
H T+ T + APE L++ ++ D++ G L E+++ +
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 38/210 (18%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G F KV + +VA+K + +P REV ++ + H N+++L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFG-TAYGLEY 387
T L+ + GE D+ R F ++Y
Sbjct: 83 IETEKTLYLIMEYASG------------GE-VFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKL-THVTTQIRGTMGHIA 444
H++ I+HRDLKA N+LLD + + DFG + KL G + A
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPYAA 181
Query: 445 PEYLSTGKSSE--KTDVFGYGITLLELVTG 472
PE GK + + DV+ G+ L LV+G
Sbjct: 182 PELFQ-GKKYDGPEVDVWSLGVILYTLVSG 210
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 8e-14
Identities = 47/204 (23%), Positives = 75/204 (36%), Gaps = 32/204 (15%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
+DN+ +G+G F V + V + + A K + S +RE + H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 382
N+++L S LV DL G + + + A
Sbjct: 65 PNIVRLHDSIQEESFHYLV---F----------DLVTGGELFEDIVAREFYSEADASHCI 111
Query: 383 Y----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQ 435
+ Y H I+HR+LK N+LL + L DFGLA V+ +
Sbjct: 112 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG 166
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDV 459
GT G+++PE L S+ D+
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDI 190
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 41/215 (19%)
Query: 264 RELQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQRE 318
++L + F++ IG G + + + + N + AVK + E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-----TEE 65
Query: 319 VH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-- 375
+ L+ H N++ L +V +L G + LD R+
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVV---T----------ELMKGGELLDKILRQKF 112
Query: 376 -------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAV-LCDFGLAKL 424
V F +EYLH Q ++HRDLK +NIL N E++ +CDFG AK
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
+ A+ + T +APE L D+
Sbjct: 170 LRAE-NGLLMTPCYTANFVAPEVLERQGYDAACDI 203
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 43/249 (17%), Positives = 83/249 (33%), Gaps = 60/249 (24%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIH 327
+ +S +G G FG V + + + A+K++ + + RE+ ++ V H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR------------- 374
N+++L+ Y T+ + P + ++
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 375 -----KRVAFGTA---------------Y----GLEYLHEQCNPKIIHRDLKAANILLD- 409
+V Y + ++H I HRD+K N+L++
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176
Query: 410 DNFEAVLCDFGLAKLV--DAKLTH--VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGI 464
+ LCDFG AK + + R APE + + D++ G
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLWSIGC 230
Query: 465 TLLELVTGQ 473
EL+ G+
Sbjct: 231 VFGELILGK 239
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 48/216 (22%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G+G +G+V V VAVK + + ++E+ + + H+N+++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTA-------- 382
+ + L + GE + A
Sbjct: 75 REGNIQYLFLEYCSG------------GELFDRIEPDI-------GMPEPDAQRFFHQLM 115
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 438
G+ YLH I HRD+K N+LLD+ + DFGLA + +L + G
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---G 169
Query: 439 TMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 472
T+ ++APE L + +E DV+ GI L ++ G
Sbjct: 170 TLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 37/223 (16%)
Query: 271 DNFSESNIIGQGGFGKVY---KGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAI 326
+NF ++G G +GKV+ K D K+ A+K L+ Q+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK------ATIVQKAKTTEHTRT 107
Query: 327 HKNLLQLIG---------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 375
+ +L+ I Y + ++ L+ ++ + L + + E
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-------- 159
Query: 376 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
V LE+LH+ II+RD+K NILLD N VL DFGL+K A T
Sbjct: 160 EVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDV--FGYGITLLELVTGQ 473
GT+ ++AP+ + G S V + G+ + EL+TG
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 47/202 (23%), Positives = 72/202 (35%), Gaps = 47/202 (23%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 335
+G+G F K V N AVK + EA Q+E+ L H N+++L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHE 73
Query: 336 YCTTSS---------------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
ERI +Y +R L
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL------------------ 115
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
+ ++H+ ++HRDLK N+L +DN E + DFG A+L + T
Sbjct: 116 -VSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC- 170
Query: 438 GTMGHIAPEYLSTGKSSEKTDV 459
T+ + APE L+ E D+
Sbjct: 171 FTLHYAAPELLNQNGYDESCDL 192
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 47/204 (23%), Positives = 74/204 (36%), Gaps = 32/204 (15%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
+DN+ +G+G F V + V + + A K + S +RE + H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 382
N+++L S LV DL G + + + A
Sbjct: 88 PNIVRLHDSIQEESFHYLV---F----------DLVTGGELFEDIVAREFYSEADASHCI 134
Query: 383 Y----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
+ Y H I+HR+LK N+LL L DFGLA V+ +
Sbjct: 135 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG 189
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDV 459
GT G+++PE L S+ D+
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDI 213
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 20/93 (21%), Positives = 38/93 (40%), Gaps = 3/93 (3%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
++L L S + +L L + + L LPD + L++L LA
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLA 135
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
N ++PA+ + L+ L+ L + + +P
Sbjct: 136 RNPLR-ALPASIASLNRLRELSIRACPELTELP 167
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 23/92 (25%), Positives = 40/92 (43%), Gaps = 1/92 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ SL + ++ S + P+I L L L+L+ P G L+ L L +
Sbjct: 207 NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSN 265
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
++P +L+ L+ LDL R+P +
Sbjct: 266 LLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 17/91 (18%), Positives = 30/91 (32%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L L P L L L+D TLP + +T L+ L+L +
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 141 PATWSQLSNLKHLDLSSNNLTGRIPMQLFSV 171
P+ +QL + + + + +
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 27/94 (28%), Positives = 42/94 (44%), Gaps = 11/94 (11%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGS---------MTHLQ 127
+ +LTL N + SI L L L ++ LP+ L S + +LQ
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
SL L S+PA+ + L NLK L + ++ L+
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 39/221 (17%)
Query: 271 DNFSESNIIGQGGFGKVY---KGVLSDNTKV-AVKRLQDYYSPGGEAAFQR-EVHLISVA 325
F ++GQG FGKV+ K SD ++ A+K L+ R V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK------ATLKVRDRVRTKM-- 75
Query: 326 IHKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 375
+++L + Y + ++ L+ F++ + RL +++ E+
Sbjct: 76 -ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-------- 126
Query: 376 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
V F A L++LH II+RDLK NILLD+ L DFGL+K
Sbjct: 127 DVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK 182
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT+ ++APE ++ ++ D + +G+ + E++TG
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 42/200 (21%), Positives = 72/200 (36%), Gaps = 43/200 (21%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
IG+G +G+V V + A K ++D F++E+ ++ H N++
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNII 69
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTAY--- 383
+L +++ LV M +L G + + K A
Sbjct: 70 RLYETFEDNTDIYLV---M----------ELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 384 -GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 439
+ Y H+ + HRDLK N L + L DFGLA + GT
Sbjct: 117 SAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGT 171
Query: 440 MGHIAPEYLSTGKSSEKTDV 459
+++P+ L G + D
Sbjct: 172 PYYVSPQVLE-GLYGPECDE 190
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G G FGKV G KVAVK L Q S +RE+ + + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFG-TAYGLEY 387
+T ++ +V ++ GE G R F ++Y
Sbjct: 79 VISTPTDFFMVMEYVSG------------GELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE 446
H ++HRDLK N+LLD + A + DFGL+ + D + + G+ + APE
Sbjct: 127 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 180
Query: 447 YLSTGK--SSEKTDVFGYGITLLELVTG 472
+S G+ + + D++ G+ L L+ G
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCG 207
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 50/221 (22%), Positives = 87/221 (39%), Gaps = 32/221 (14%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 325
++ + F ++G+G FGKV + A+K L+ + + +
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTL 196
Query: 326 IHKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 375
+LQ Y + +R+ V + + + L R+ E
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-------- 248
Query: 376 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
R F A L+YLH + N +++RDLK N++LD + + DFGL K K
Sbjct: 249 RARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGAT 305
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT ++APE L D +G G+ + E++ G+
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 50/225 (22%), Positives = 80/225 (35%), Gaps = 52/225 (23%)
Query: 269 ATDNFSES---------NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQRE 318
+TD+FS +++G+G +V + L + + AVK ++ F RE
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-RE 60
Query: 319 VH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 377
V L H+N+L+LI + LV+ M+ S+ + KR
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH--------------KRR 106
Query: 378 AFG----------TAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL 424
F A L++LH + I HRDLK NIL + +CDF L
Sbjct: 107 HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163
Query: 425 VDAKLTHVTTQIR------GTMGHIAPEYLSTGKSSEKTDVFGYG 463
+ G+ ++APE + Y
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEAS----IYD 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 50/206 (24%), Positives = 81/206 (39%), Gaps = 40/206 (19%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL---QDYYSPGGEAAFQREVHLISVA 325
+D F + +G+G VY+ A+K L D + + E+ ++
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD------KKIVRTEIGVLLRL 105
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFG 380
H N+++L T +E LV + +L G + D K R A
Sbjct: 106 SHPNIIKLKEIFETPTEISLV---L----------ELVTGGELFDRIVEKGYYSERDAAD 152
Query: 381 TAY----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVT 433
+ YLHE I+HRDLK N+L + + DFGL+K+V+ +
Sbjct: 153 AVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLM 207
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDV 459
+ GT G+ APE L + D+
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDM 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 35/220 (15%)
Query: 271 DNFSESNIIGQGGFGKVY---KGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAI 326
+ F ++G+GG+GKV+ K ++ K+ A+K L+ +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK------AMIVRNAKDTAHTKA 70
Query: 327 HKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKR 376
+N+L+ + Y + ++ L+ ++ + +L R+ E
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED--------T 122
Query: 377 VAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433
F A L +LH++ II+RDLK NI+L+ L DFGL K VT
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVT 178
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT+ ++APE L + D + G + +++TG
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 52/228 (22%), Positives = 84/228 (36%), Gaps = 58/228 (25%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
D F +G G FG+V ++ A+K L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----------------KQKVVKLK 83
Query: 330 LLQLIGYCTTSSERILV---YPFMQNLSVA-------YRLRDLKPGEKG-LDWPTRKRVA 378
++ T + +RIL +PF+ L + Y + + G G + R+
Sbjct: 84 QIE----HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG--GEMFSHLRRIGR 137
Query: 379 FGTA----Y------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
F Y EYLH +I+RDLK N+L+D + DFG AK V +
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
Query: 429 LTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQ 473
T + GT +APE + + K+ D + G+ + E+ G
Sbjct: 195 ----TWTLCGTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGY 235
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-13
Identities = 20/84 (23%), Positives = 38/84 (45%), Gaps = 2/84 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ LT+ + + +P I+ L L L + D++ L +T L L+++++
Sbjct: 67 NIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 137 SGSIPATWSQLSNLKHLDLSSNNL 160
SI + L + +DLS N
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-12
Identities = 14/85 (16%), Positives = 36/85 (42%), Gaps = 1/85 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L + + P+++ L L L++ + ++ + ++ + S++L+ N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
I L LK L++ + +
Sbjct: 149 ITDIMPL-KTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-11
Identities = 14/92 (15%), Positives = 38/92 (41%), Gaps = 4/92 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ +TL + + ++ I + L + + + P + +++L+ L +
Sbjct: 45 SLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDV 100
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
+ S L++L LD+S + I ++
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 16/86 (18%), Positives = 30/86 (34%), Gaps = 3/86 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ L + + I I L + S++L N + L ++ L+SLN+ +
Sbjct: 113 SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTG 162
L L S + G
Sbjct: 172 HDYRGI--EDFPKLNQLYAFSQTIGG 195
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 48/216 (22%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G+G +G+V V VAVK + + ++E+ + + H+N+++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTA-------- 382
+ + L + GE + A
Sbjct: 75 REGNIQYLFLEYCSG------------GELFDRIEPDI-------GMPEPDAQRFFHQLM 115
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 438
G+ YLH I HRD+K N+LLD+ + DFGLA + +L + G
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---G 169
Query: 439 TMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 472
T+ ++APE L + +E DV+ GI L ++ G
Sbjct: 170 TLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 51/236 (21%), Positives = 85/236 (36%), Gaps = 53/236 (22%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI 322
R+L++ +++ +IG+G FG+V KV A+K L
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-----------------K 104
Query: 323 SVAIHKNLLQLIGYCTTSSERILVY---PFMQNLSVA-------YRLRDLKPG------- 365
I ++ I+ + P++ L A Y + + PG
Sbjct: 105 FEMIKRSDSA----FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 366 -EKGLDWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421
+ K F TA L+ +H IHRD+K N+LLD + L DFG
Sbjct: 161 SNYDVP---EKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214
Query: 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK----TDVFGYGITLLELVTGQ 473
++ + GT +I+PE L + D + G+ L E++ G
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 22/94 (23%), Positives = 33/94 (35%), Gaps = 4/94 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L N + + L +L+L N L+ + S + ++L NNK
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
I NL+H DL N FS
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 18/94 (19%), Positives = 41/94 (43%), Gaps = 5/94 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ +L +N S ++S S + ++ L +N ++ G + +Q L+L N+
Sbjct: 100 SIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
Query: 137 SG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ + L+HL+L N + + Q+
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 19/81 (23%), Positives = 32/81 (39%), Gaps = 2/81 (2%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
+ + ++ + L+L N LS L T L+ LNL++N
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 141 PATWSQLSNLKHLDLSSNNLT 161
LS L+ LDL++N +
Sbjct: 74 LDL-ESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 16/63 (25%), Positives = 28/63 (44%)
Query: 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158
++ D+ L L S +++ L+L+ N S A + + L+ L+LSSN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 159 NLT 161
L
Sbjct: 69 VLY 71
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 22/94 (23%), Positives = 38/94 (40%), Gaps = 8/94 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
NV L L N S + + L L L N L D S++ L++L+L NN
Sbjct: 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYV 92
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ +++ L ++NN++ R+
Sbjct: 93 Q-ELL----VGPSIETLHAANNNIS-RVSCSRGQ 120
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 16/85 (18%), Positives = 34/85 (40%), Gaps = 8/85 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L +N + + +L +N++S + +++ LANNK
Sbjct: 81 TLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKI 132
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ S +++LDL N +
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 22/119 (18%), Positives = 44/119 (36%), Gaps = 5/119 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L SN + + P + + L++N L + L +L+ +L N F
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 137 S-GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSR 194
G++ +S+ ++ + + + +V T G C L P R
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA--YCCEDLPAPFADR 306
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 9/55 (16%), Positives = 23/55 (41%), Gaps = 1/55 (1%)
Query: 116 LPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + + + + ++ ++ + N+K LDLS N L+ +I +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLA 55
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (167), Expect = 1e-12
Identities = 39/211 (18%), Positives = 59/211 (27%), Gaps = 44/211 (20%)
Query: 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISVA 325
L T+ IG+G FG+V++ + D+T VA+K ++ G E L +
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 326 IHKNLLQLIGYCTTSSERILVY--------PFMQNLSVAYRLRDLKPG------------ 365
I K L L G +E + + L A+ + G
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 366 -------------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406
K T K + L + HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNV 193
Query: 407 LLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
LL L K + I
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 39/93 (41%), Positives = 50/93 (53%), Gaps = 13/93 (13%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
LEYLH + II+RDLK NILLD N + DFG AK V T + GT +I
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYI 170
Query: 444 APEYLST---GKSSEKTDVFGYGITLLELVTGQ 473
APE +ST KS D + +GI + E++ G
Sbjct: 171 APEVVSTKPYNKS---IDWWSFGILIYEMLAGY 200
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 20/104 (19%), Positives = 46/104 (44%), Gaps = 4/104 (3%)
Query: 69 SHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD--FLGSMTHL 126
S ++ L L NG +S + L+ L L+ Q ++L + + S+ +L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNL 423
Query: 127 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L++++ + ++ LS+L+ L ++ N+ +F+
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 21/94 (22%), Positives = 33/94 (35%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L N S S L L+L ++ S++HL +L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+S LS+L+ L NL +
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIG 121
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 2/92 (2%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF-SG 138
+L L N + + L L L + +L+ +G + L+ LN+A+N S
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P +S L+NL+HLDLSSN + I
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLR 170
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 15/81 (18%), Positives = 26/81 (32%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L L + L L++L L N + ++ LQ L +
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 141 PATWSQLSNLKHLDLSSNNLT 161
L LK L+++ N +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 24/96 (25%), Positives = 39/96 (40%), Gaps = 6/96 (6%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDL-SGTLPDFLGSMTHLQSLNLANNKFSG 138
L + + I LK L L + N + S LP++ ++T+L+ L+L++NK
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 139 SIPATWSQLSNLK----HLDLSSNNLTGRIPMQLFS 170
L + LDLS N + I F
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 1/90 (1%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N F P I T+L+ L L+L L P S++ LQ LN+A+N+
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSV 509
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ +L++L+ + L +N P +
Sbjct: 510 PDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 22/94 (23%), Positives = 37/94 (39%), Gaps = 7/94 (7%)
Query: 81 LTLGSNG--FSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L NG F G S S L L+L N + T+ + L+ L+ ++
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK- 409
Query: 139 SIPA--TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + L NL +LD+S + +F+
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFN 442
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 19/66 (28%), Positives = 29/66 (43%), Gaps = 4/66 (6%)
Query: 98 KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK--FSGSIPATWSQLSNLKHLDL 155
KLK L L N + + L+ L+L+ N F G + ++LK+LDL
Sbjct: 323 KLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 156 SSNNLT 161
S N +
Sbjct: 381 SFNGVI 386
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 12/67 (17%), Positives = 26/67 (38%), Gaps = 4/67 (5%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR 163
+ + + + +PD L ++L+L+ N ++ L+ LDLS +
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-T 66
Query: 164 IPMQLFS 170
I +
Sbjct: 67 IEDGAYQ 73
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 46/221 (20%), Positives = 79/221 (35%), Gaps = 44/221 (19%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK----RLQDYYSPGGEAAFQREVHLISV 324
D + +IG+G F V + + + AVK +RE + +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 325 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR--KRVAFGTA 382
H ++++L+ ++ +V+ FM + KR G
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDG------------ADL-CF---EIVKRADAGFV 126
Query: 383 Y--------------GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLV 425
Y L Y H+ IIHRD+K +LL +++ L FG+A +
Sbjct: 127 YSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITL 466
+ V GT +APE + + DV+G G+ L
Sbjct: 184 G-ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 28/106 (26%), Positives = 47/106 (44%), Gaps = 5/106 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L +G+N S I+ + L L L + N +S L +++ L SL L NN+
Sbjct: 244 QLTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQL 299
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPM-QLFSVATFNFTGTHL 181
L+NL L LS N++T P+ L + + +F +
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 8e-12
Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 8/89 (8%)
Query: 75 NGNVISLTLGSNGFSGKIS--PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
+ L +GSN +IS + L L SL L +N L + +G +T+L +L L+
Sbjct: 264 LTKLKMLNVGSN----QISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
N + P + LS + D ++ +
Sbjct: 320 QNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 21/86 (24%), Positives = 34/86 (39%), Gaps = 5/86 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L + S + L + SL L N + L +MT L L + +K
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTG 162
P + L++L L L+ N +
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 5e-11
Identities = 22/89 (24%), Positives = 42/89 (47%), Gaps = 6/89 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L N + ISP ++ L L +L + N ++ L ++T+L+ L L +
Sbjct: 67 NLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNI 122
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
S P + L+ + L+L +N+ +
Sbjct: 123 SDISPL--ANLTKMYSLNLGANHNLSDLS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 6e-11
Identities = 22/89 (24%), Positives = 42/89 (47%), Gaps = 5/89 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ SL LG+N +SP ++ + L L + ++ + P + ++T L SL+L N+
Sbjct: 133 KMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
P + L++L + N +T P
Sbjct: 190 EDISP--LASLTSLHYFTAYVNQITDITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 6/86 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ SL+L N ISP + L L N ++ P + +MT L SL + NNK
Sbjct: 178 DLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTG 162
+ P + LS L L++ +N ++
Sbjct: 234 TDLSP--LANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 6e-10
Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 6/89 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ LT+ + ++P I L L SL L N + L S+T L N+
Sbjct: 156 GLNYLTVTESKVK-DVTP-IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQI 211
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+ P + ++ L L + +N +T P
Sbjct: 212 TDITP--VANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 6/86 (6%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
+L + +I P L LQ ++ + + + L +A K + S
Sbjct: 4 TLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-S 58
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIP 165
I L+NL++L+L+ N +T P
Sbjct: 59 IQG-IEYLTNLEYLNLNGNQITDISP 83
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 54/210 (25%), Positives = 78/210 (37%), Gaps = 39/210 (18%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG G FG VAVK ++ + QRE+ H N+++
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRK-RVAFGTA--------YGLEY 387
T + ++ + GE L + R + A G+ Y
Sbjct: 86 LTPTHLAIIMEYASG------------GE--LYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKL-VDAKLTHVTTQIRGTMGHIA 444
H +I HRDLK N LLD + L CDFG +K V T GT +IA
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIA 185
Query: 445 PEYLSTGK--SSEKTDVFGYGITLLELVTG 472
PE L + + DV+ G+TL ++ G
Sbjct: 186 PEVLL-RQEYDGKIADVWSCGVTLYVMLVG 214
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 22/94 (23%), Positives = 33/94 (35%), Gaps = 4/94 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L N + + L +L+L N L+ + S + ++L NNK
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
I NL+H DL N FS
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 18/94 (19%), Positives = 41/94 (43%), Gaps = 5/94 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ +L +N S ++S S + ++ L +N ++ G + +Q L+L N+
Sbjct: 100 SIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
Query: 137 SG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ + L+HL+L N + + Q+
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 19/81 (23%), Positives = 32/81 (39%), Gaps = 2/81 (2%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
+ + ++ + L+L N LS L T L+ LNL++N
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 141 PATWSQLSNLKHLDLSSNNLT 161
LS L+ LDL++N +
Sbjct: 74 LD-LESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 3/71 (4%)
Query: 92 ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151
I + + K ++ D+ L L S +++ L+L+ N S A + + L+
Sbjct: 5 IKQNGNRYKIE---KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 152 HLDLSSNNLTG 162
L+LSSN L
Sbjct: 62 LLNLSSNVLYE 72
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 22/94 (23%), Positives = 37/94 (39%), Gaps = 8/94 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
NV L L N S + + L L L N L D S++ L++L+L NN
Sbjct: 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYV 92
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+++ L ++NN++ R+
Sbjct: 93 Q-----ELLVGPSIETLHAANNNIS-RVSCSRGQ 120
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 16/85 (18%), Positives = 34/85 (40%), Gaps = 8/85 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L +N + + +L +N++S + +++ LANNK
Sbjct: 81 TLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKI 132
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ S +++LDL N +
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 15/81 (18%), Positives = 34/81 (41%), Gaps = 3/81 (3%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS-G 138
+L L SN + + P + + L++N L + L +L+ +L N F G
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 139 SIPATWSQLSNLKHLDLSSNN 159
++ +S+ ++ + +
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 9/55 (16%), Positives = 23/55 (41%), Gaps = 1/55 (1%)
Query: 116 LPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + + + + ++ ++ + N+K LDLS N L+ +I +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLA 55
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 13/115 (11%), Positives = 30/115 (26%), Gaps = 4/115 (3%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSG----TLPDFLGSMTHLQSLNLANNKF 136
G+ +P +L L E G L + + ++ ++
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPC 191
I + L+ L ++ + A + T + L+
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHAT 403
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 36/168 (21%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 335
++G G GKV + K A+K LQD +REV + ++++++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVD 78
Query: 336 -YCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKGLDWPTRKRVAFGT---AY 383
Y + R + M + G ++G T + +
Sbjct: 79 VYENLYAGRKCLLIVM----------ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 384 GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAK 428
++YLH I HRD+K N+L N L DFG AK +
Sbjct: 129 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G G FGKV G KVAVK L Q S +RE+ + + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFG-TAYGLEY 387
+T S+ +V ++ GE G R F G++Y
Sbjct: 84 VISTPSDIFMVMEYVSG------------GELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE 446
H ++HRDLK N+LLD + A + DFGL+ + D + + G+ + APE
Sbjct: 132 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 185
Query: 447 YLSTGKSSE--KTDVFGYGITLLELVTG 472
+S G+ + D++ G+ L L+ G
Sbjct: 186 VIS-GRLYAGPEVDIWSSGVILYALLCG 212
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 39/205 (19%), Positives = 73/205 (35%), Gaps = 37/205 (18%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
D + ++IG G +G V + + VA+K++ F+ RE+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--------VFEDLIDCKRILREI 103
Query: 320 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLK---PGEKGLDW 371
+++ H ++++++ +V D K L
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--------SDFKKLFRTPVYLTE 155
Query: 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431
K + + G++Y+H I+HRDLK AN L++ + +CDFGLA+ VD
Sbjct: 156 LHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 432 VTTQIRGTMGHIAPEYLSTGKSSEK 456
+ + K
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLK 237
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 34/208 (16%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G+G FGKV KVA+K + Q +RE+ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFG-TAYGLEY 387
TT ++ ++V + GE K R F +EY
Sbjct: 77 VITTPTDIVMVIEYAG-------------GELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE 446
H KI+HRDLK N+LLDDN + DFGL+ + D + G+ + APE
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE 177
Query: 447 YLSTGKSSE--KTDVFGYGITLLELVTG 472
++ GK + DV+ GI L ++ G
Sbjct: 178 VIN-GKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GL++LH + I++RDLK NILLD + + DFG+ K + T GT +I
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYI 185
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE L K + D + +G+ L E++ GQ
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 57/224 (25%), Positives = 85/224 (37%), Gaps = 46/224 (20%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
DNF ++G+G FGKV + + + AVK L+ + Q + + K
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK------DVILQDD-DVECTMTEKR 75
Query: 330 LLQLIG---------YCTTSSERI-LVYPF------MQNLSVAYRLRDLKPGEKGLDWPT 373
+L L C + +R+ V F M ++ + R
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-------------D 122
Query: 374 RKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
R F A L +LH++ II+RDLK N+LLD L DFG+ K
Sbjct: 123 EARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNG 178
Query: 431 HVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 473
T GT +IAPE L D + G+ L E++ G
Sbjct: 179 VTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 33/221 (14%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 325
++ ++F ++G+G FGKV + A+K L+ E ++ +
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK------EVIIAKD-EVAHTV 53
Query: 326 IHKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 375
+LQ Y + +R+ V + + + L R+ E+
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-------- 105
Query: 376 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
R F A LEYLH + +++RD+K N++LD + + DFGL K
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGAT 161
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT ++APE L D +G G+ + E++ G+
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L N + + + L ++L N+L + M L+ L ++NN+
Sbjct: 227 ELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 284
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
++ + LK LDLS N+L +
Sbjct: 285 V-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 19/95 (20%), Positives = 39/95 (41%), Gaps = 5/95 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ + L N KI K++ L L + +N L L + + L+ L+L++N
Sbjct: 249 GLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ Q L++L L N++ + +
Sbjct: 307 LL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH 339
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 17/96 (17%), Positives = 35/96 (36%), Gaps = 5/96 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N +T ++ K+ ++ + + L L D + +Q L + N
Sbjct: 46 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 104
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P + + L L L N+L+ +P +F
Sbjct: 105 IR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 138
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 20/91 (21%), Positives = 34/91 (37%), Gaps = 5/91 (5%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + +N ++ + L L+L N L + L++L L +N +
Sbjct: 276 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 332
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ S LK+L LS N+ LF
Sbjct: 333 LKL--STHHTLKNLTLSHNDWDCNSLRALFR 361
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L +G N + P + + L L L+ NDLS + L +L+++NN
Sbjct: 98 LYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-R 155
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
I T+ ++L++L LSSN LT + + L
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP 186
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 11/91 (12%), Positives = 30/91 (32%), Gaps = 3/91 (3%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
+ + L + +++ + L S ++ LNL + + I
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 84
Query: 141 PA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
++ ++ L + N + +P +F
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ 114
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 22/93 (23%), Positives = 32/93 (34%), Gaps = 5/93 (5%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L +I + L + N + P ++ L L L N S
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 139 SIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S+P + L L +S+NNL RI F
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQ 162
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 16/94 (17%), Positives = 30/94 (31%), Gaps = 11/94 (11%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ + N S ++ + L+ N ++ + L L L +N
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL 238
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L +DLS N L +I F
Sbjct: 239 T-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFV 269
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 7/86 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
V L N + + + L L+LQ N+L+ L L ++L+ N+
Sbjct: 206 AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNEL 260
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLT 161
I + ++ L+ L +S+N L
Sbjct: 261 E-KIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 22/86 (25%), Positives = 40/86 (46%), Gaps = 5/86 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L L N S + I L +L + +N+L D + T LQ+L L++N+
Sbjct: 118 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 176
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
+ + S + +L H ++S N L+
Sbjct: 177 LT-HVDL--SLIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 17/98 (17%), Positives = 38/98 (38%), Gaps = 11/98 (11%)
Query: 74 RNGNVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
+ +L++ +N +I L +L+L N L+ + L + L N++
Sbjct: 139 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVS 194
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
N S ++ ++ LD S N++ + +
Sbjct: 195 YNLLS-TLAI----PIAVEELDASHNSIN-VVRGPVNV 226
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 43/196 (21%), Positives = 74/196 (37%), Gaps = 39/196 (19%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
DN+ ++IG+G +G VY + VA+K++ F+ RE+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------MFEDLIDCKRILREI 76
Query: 320 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTR 374
+++ +++L +V DLK K + T
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD--------SDLKKLFKTPIFLTE 128
Query: 375 KRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+ + Y G ++HE IIHRDLK AN LL+ + +CDFGLA+ ++++
Sbjct: 129 EHIKT-ILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 431 HVTTQIRGTMGHIAPE 446
P
Sbjct: 185 TNIVNDLEENEEPGPH 200
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 33/90 (36%), Positives = 43/90 (47%), Gaps = 4/90 (4%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L YLH I++RDLK NILLD VL DFGL K + + T+ GT ++
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYL 206
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE L D + G L E++ G
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 9e-12
Identities = 52/227 (22%), Positives = 87/227 (38%), Gaps = 44/227 (19%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 325
L +F +IG+G + KV L ++ A+K ++ E E + V
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK------ELVNDDE-DIDWVQ 57
Query: 326 IHKNLLQLIG---------YCTTSSERI-LVYPF------MQNLSVAYRLRDLKPGEKGL 369
K++ + C + R+ V + M ++ +L
Sbjct: 58 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---------- 107
Query: 370 DWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
+ F +A L YLHE+ II+RDLK N+LLD L D+G+ K
Sbjct: 108 ---PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-G 160
Query: 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ T+ GT +IAPE L D + G+ + E++ G+
Sbjct: 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 50/243 (20%), Positives = 98/243 (40%), Gaps = 69/243 (28%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ + +G GG G V+ V +D + +VA+K++ RE+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI----------VLTDPQSVKHALREI 59
Query: 320 HLISVAIHKNLLQLI--------------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKP 364
+I H N++++ G T + +V +M+ +L+ L
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL-- 117
Query: 365 GEKGLDWPTRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDF 419
+ Y GL+Y+H + ++HRDLK AN+ ++ ++ + DF
Sbjct: 118 --------LEEHARL-FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDF 165
Query: 420 GLAKLVDAKLTH-------VTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELV 470
GLA+++D +H + T+ R +P LS ++ D++ G E++
Sbjct: 166 GLARIMDPHYSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEML 219
Query: 471 TGQ 473
TG+
Sbjct: 220 TGK 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 53/227 (23%), Positives = 88/227 (38%), Gaps = 44/227 (19%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 325
++ +F+ ++G+G FGKV ++ AVK L+ + Q + +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK------DVVIQDD-DVECTM 389
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVA-------YRLRDLKPG---------EKGL 369
+ K +L L G PF+ L Y + + G
Sbjct: 390 VEKRVLALPGKP----------PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 439
Query: 370 DWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
P F A GL +L + II+RDLK N++LD + DFG+ K +
Sbjct: 440 KEP---HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-N 492
Query: 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
T GT +IAPE ++ + D + +G+ L E++ GQ
Sbjct: 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GL +L + II+RDLK N++LD + DFG+ K + T GT +I
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYI 188
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE ++ + D + +G+ L E++ GQ
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 50/235 (21%), Positives = 94/235 (40%), Gaps = 55/235 (23%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ +F +++G+G +G V VA+K+++ F RE+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---------PFDKPLFALRTLREI 60
Query: 320 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPT 373
++ H+N++ + S ++ MQ +L + L +
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML----------S 110
Query: 374 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
+ + Y ++ LH +IHRDLK +N+L++ N + +CDFGLA+++D
Sbjct: 111 DDHIQY-FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES- 165
Query: 430 THVTTQIRGTMGHI----------APEY-LSTGKSSEKTDVFGYGITLLELVTGQ 473
++ G + APE L++ K S DV+ G L EL +
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 51/227 (22%), Positives = 87/227 (38%), Gaps = 44/227 (19%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 325
L +F +IG+G + KV L ++ A++ ++ E E + V
Sbjct: 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK------ELVNDDE-DIDWVQ 100
Query: 326 IHKNLLQLIG---------YCTTSSERI-LVYPF------MQNLSVAYRLRDLKPGEKGL 369
K++ + C + R+ V + M ++ +L
Sbjct: 101 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---------- 150
Query: 370 DWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
+ F +A L YLHE+ II+RDLK N+LLD L D+G+ K
Sbjct: 151 ---PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-G 203
Query: 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ T+ GT +IAPE L D + G+ + E++ G+
Sbjct: 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 16/89 (17%), Positives = 36/89 (40%), Gaps = 6/89 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ LG + + S T L + +L+ + D + + +L +N +NN+
Sbjct: 25 EKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQL 80
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+ P L+ L + +++N + P
Sbjct: 81 TDITPL--KNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 30/86 (34%), Positives = 42/86 (48%), Gaps = 6/86 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ SL +N S I+P + L L L L N L L S+T+L L+LANN+
Sbjct: 200 NLESLIATNNQISD-ITP-LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 255
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTG 162
S P S L+ L L L +N ++
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 26/91 (28%), Positives = 39/91 (42%), Gaps = 6/91 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L N I+ LK L L L N++S P + S+T LQ L NNK
Sbjct: 288 ALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 167
S + L+N+ L N ++ P+
Sbjct: 344 SDVSS--LANLTNINWLSAGHNQISDLTPLA 372
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 6/89 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L +N S ++ L L L+L N +S P L +T L +L L N+
Sbjct: 244 NLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL 299
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
P S L NL +L L NN++ P
Sbjct: 300 EDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 24/86 (27%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ + +N + I+P + L L + + +N ++ P L ++T+L L L NN+
Sbjct: 69 NLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 124
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTG 162
+ P L+NL L+LSSN ++
Sbjct: 125 TDIDPL--KNLTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 23/89 (25%), Positives = 38/89 (42%), Gaps = 6/89 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
V +L G I + L L + +N L+ P L ++T L + + NN+
Sbjct: 47 QVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 102
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+ P + L+NL L L +N +T P
Sbjct: 103 ADITPL--ANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 10/93 (10%)
Query: 77 NVISLTLGSNGFSGKIS--PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
+ L + SN K+S + KL L SL +N +S P LG +T+L L+L N
Sbjct: 178 TLERLDISSN----KVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGN 231
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 167
+ T + L+NL LDL++N ++ P+
Sbjct: 232 QLKD--IGTLASLTNLTDLDLANNQISNLAPLS 262
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 21/69 (30%), Positives = 31/69 (44%), Gaps = 4/69 (5%)
Query: 94 PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 153
+ L L L++ N +S L +T+L+SL NN+ S P L+NL L
Sbjct: 171 KPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL 226
Query: 154 DLSSNNLTG 162
L+ N L
Sbjct: 227 SLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 19/90 (21%), Positives = 34/90 (37%), Gaps = 5/90 (5%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
G + S T+ + +I T L L +++ T+ + + +L
Sbjct: 1 GPLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
SI L+NL ++ S+N LT P
Sbjct: 58 IK-SIDG-VEYLNNLTQINFSNNQLTDITP 85
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 24/94 (25%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L SN S +++ L L L N ++ P L ++T L+ L++++NK
Sbjct: 135 NLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKV 189
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S + ++L+NL+ L ++N ++ P+ + +
Sbjct: 190 SD--ISVLAKLTNLESLIATNNQISDITPLGILT 221
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 16/85 (18%), Positives = 34/85 (40%), Gaps = 4/85 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L+ G N S ++P + L + L L D + ++ +++ ++
Sbjct: 354 NINWLSAGHNQISD-LTP-LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
PAT S + D++ N +
Sbjct: 412 I--APATISDGGSYTEPDITWNLPS 434
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 41/200 (20%), Positives = 77/200 (38%), Gaps = 40/200 (20%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ +G+G +G V+K + VAVK++ D AFQ RE+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------AFQNSTDAQRTFREI 59
Query: 320 HLIS-VAIHKNLLQLIGYCTTSSER--ILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRK 375
+++ ++ H+N++ L+ ++R LV+ +M+ +L R L
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL----------EPV 109
Query: 376 RVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431
+ Y ++YLH ++HRD+K +NILL+ + DFGL++
Sbjct: 110 HKQY-VVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 432 VTTQIRGTMGHIAPEYLSTG 451
+
Sbjct: 166 TNNIPLSINENTENFDDDQP 185
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 19/95 (20%), Positives = 39/95 (41%), Gaps = 5/95 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ + L N KI K++ L L + +N L L + + L+ L+L++N
Sbjct: 255 GLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ Q L++L L N++ + +
Sbjct: 313 LL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH 345
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L N + + + L ++L N+L + M L+ L ++NN+
Sbjct: 233 ELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 290
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
++ + LK LDLS N+L +
Sbjct: 291 V-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 322
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 18/81 (22%), Positives = 32/81 (39%), Gaps = 5/81 (6%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L + +N ++ + L L+L N L + L++L L +N ++
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TL 339
Query: 141 PATWSQLSNLKHLDLSSNNLT 161
S LK+L LS N+
Sbjct: 340 KL--STHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 11/91 (12%), Positives = 30/91 (32%), Gaps = 3/91 (3%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
+ + L + +++ + L S ++ LNL + + I
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 90
Query: 141 PA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
++ ++ L + N + +P +F
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ 120
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 26/96 (27%), Positives = 44/96 (45%), Gaps = 5/96 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L +G N + P + + L L L+ NDLS + L +L+++NN
Sbjct: 100 TIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 158
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
I T+ ++L++L LSSN LT + + L
Sbjct: 159 LE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP 192
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 17/96 (17%), Positives = 35/96 (36%), Gaps = 5/96 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N +T ++ K+ ++ + + L L D + +Q L + N
Sbjct: 52 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 110
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P + + L L L N+L+ +P +F
Sbjct: 111 IR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 144
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 7/86 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
V L N + + + L L+LQ N+L+ L L ++L+ N+
Sbjct: 212 AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNEL 266
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLT 161
I + ++ L+ L +S+N L
Sbjct: 267 E-KIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 22/86 (25%), Positives = 40/86 (46%), Gaps = 5/86 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L L N S + I L +L + +N+L D + T LQ+L L++N+
Sbjct: 124 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
+ + S + +L H ++S N L+
Sbjct: 183 LT-HVDL--SLIPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 17/98 (17%), Positives = 38/98 (38%), Gaps = 11/98 (11%)
Query: 74 RNGNVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
+ +L++ +N +I L +L+L N L+ + L + L N++
Sbjct: 145 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVS 200
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
N S ++ ++ LD S N++ + +
Sbjct: 201 YNLLS-TLAI----PIAVEELDASHNSIN-VVRGPVNV 232
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 19/82 (23%), Positives = 32/82 (39%), Gaps = 11/82 (13%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
+L L SN + + S+ + L + N LS L ++ L+ ++N +
Sbjct: 175 NLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-V 225
Query: 140 IPATWSQLSNLKHLDLSSNNLT 161
+ L L L NNLT
Sbjct: 226 VRG--PVNVELTILKLQHNNLT 245
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 43/214 (20%), Positives = 87/214 (40%), Gaps = 24/214 (11%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIH 327
D++ +G+G + +V++ + +++N KV VK L+ P + +RE+ L ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGG 90
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
N++ L R F + D K + L + + L+Y
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNT-----DFKQLYQTLTDYDIRFYMYEILKALDY 145
Query: 388 LHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDA--KLTH-VTTQIRGTMGHI 443
H I+HRD+K N+++D ++ + L D+GLA+ + V ++
Sbjct: 146 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FK 197
Query: 444 APEYLSTGKS-SEKTDVFGYGITLLELVTGQRAI 476
PE L + D++ G L ++ +
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 26/103 (25%), Positives = 41/103 (39%), Gaps = 4/103 (3%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L N I + + L L L N + L + L+ L+L NNK S
Sbjct: 197 ELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS- 254
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181
+PA L L+ + L +NN+T ++ + F F +
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 23/95 (24%), Positives = 41/95 (43%), Gaps = 6/95 (6%)
Query: 77 NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L L +N S ++ L+ L +L L +N +S + LQ L ++ N
Sbjct: 55 DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
IP + S+L L + N + ++P +FS
Sbjct: 114 LV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFS 144
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 22/95 (23%), Positives = 37/95 (38%), Gaps = 6/95 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L + + I + + L L L N + + L + L L L +N+
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI 229
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
I + S L L+ L L +N L+ R+P L
Sbjct: 230 R-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 13/70 (18%), Positives = 23/70 (32%), Gaps = 2/70 (2%)
Query: 102 LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF-SGSIPATWSQLSNLKHLDLSSNNL 160
L L + DN + + ++ + + N + L +L +S L
Sbjct: 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184
Query: 161 TGRIPMQLFS 170
T IP L
Sbjct: 185 T-GIPKDLPE 193
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 22/97 (22%), Positives = 41/97 (42%), Gaps = 8/97 (8%)
Query: 77 NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ +L L +N S KI + + L+ L L + N L +P + L L + +N+
Sbjct: 79 HLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNR 134
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLT-GRIPMQLFS 170
+P +S L N+ +++ N L F
Sbjct: 135 IR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 19/104 (18%), Positives = 33/104 (31%), Gaps = 19/104 (18%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
N I + + S L L L L +N LS +P L + LQ + L N
Sbjct: 225 GHNQIR-MIENGSLSF--------LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274
Query: 135 KFSGSIPAT-------WSQLSNLKHLDLSSNNLT-GRIPMQLFS 170
+ + + + + L +N + + F
Sbjct: 275 NIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 16/88 (18%), Positives = 34/88 (38%), Gaps = 11/88 (12%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD-------FLGSMTHLQSLNLA 132
L L +N S ++ + LK L + L N+++ + F + ++L
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLF 302
Query: 133 NNKFSGSI--PATWSQLSNLKHLDLSSN 158
NN PAT+ +++ + +
Sbjct: 303 NNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 29/117 (24%), Positives = 46/117 (39%), Gaps = 7/117 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITK-----LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNL 131
++ L LG N + L L L L N L+ P +T L+ L+L
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSL 511
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLE 188
+N+ + + +NL+ LD+S N L P S++ + T IC L
Sbjct: 512 NSNRLT-VLSH-NDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELS 566
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 22/95 (23%), Positives = 39/95 (41%), Gaps = 3/95 (3%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+V L L ++ + LK L L L N ++ + + +LQ LNL+ N
Sbjct: 267 SVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + L + ++DL N++ I Q F
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFK 359
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 20/85 (23%), Positives = 31/85 (36%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ L L N + + L L L L N L + + ++L N
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ T+ L L+ LDL N LT
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 19/88 (21%), Positives = 34/88 (38%), Gaps = 5/88 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTL-PDFLGSMTHLQSLNLANN 134
L L N ++ S L+ L LEL T+ + ++ +L+ L+L ++
Sbjct: 25 TTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83
Query: 135 KFSGSIPATW-SQLSNLKHLDLSSNNLT 161
K + L +L L L L+
Sbjct: 84 KIY-FLHPDAFQGLFHLFELRLYFCGLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 27/100 (27%), Positives = 41/100 (41%), Gaps = 7/100 (7%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGT-----LPDFLGSMTHLQSLN 130
++ L L N FS ++ L L L +N L D ++HLQ L
Sbjct: 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY 486
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L +N + P +S L+ L+ L L+SN LT +
Sbjct: 487 LNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLP 525
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 21/104 (20%), Positives = 38/104 (36%), Gaps = 5/104 (4%)
Query: 73 CRNGNVISLTLGSNGFSGKISPS--ITKLKFLASLELQDNDLSG-TLPDFLGSMTHLQSL 129
++ L L G S + LK L L+L N + L G + L+S+
Sbjct: 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSI 153
Query: 130 NLANNKFSGSIPATWSQLS--NLKHLDLSSNNLTGRIPMQLFSV 171
+ ++N+ L L L++N+L R+ +
Sbjct: 154 DFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 17/73 (23%), Positives = 26/73 (35%), Gaps = 2/73 (2%)
Query: 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI-PATWSQLSNLKHLDLSS 157
L L L N + + LQ L L + +I + L NL+ LDL S
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 158 NNLTGRIPMQLFS 170
+ + + F
Sbjct: 83 SKIY-FLHPDAFQ 94
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 17/126 (13%), Positives = 43/126 (34%), Gaps = 3/126 (2%)
Query: 47 LNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLE 106
+ + + F + V+ V SN S + S+ +
Sbjct: 187 YSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAG 246
Query: 107 LQDNDLSGTLPDFLGSM--THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRI 164
+++ + + + ++ L+L++ + L +LK L+L+ N + +I
Sbjct: 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KI 305
Query: 165 PMQLFS 170
+ F
Sbjct: 306 ADEAFY 311
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 20/114 (17%), Positives = 42/114 (36%), Gaps = 14/114 (12%)
Query: 58 NDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP 117
N + ++ + + +L L N + +I + + + L N L TLP
Sbjct: 348 NHIAIIQDQTFKFLE----KLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLP 397
Query: 118 DFLGSMTHLQSLNLANNKFSG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ ++L+ N+ I ++ +L+ L L+ N + Q S
Sbjct: 398 KINLT---ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 13/64 (20%), Positives = 25/64 (39%), Gaps = 4/64 (6%)
Query: 107 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM 166
+ +L+ +P L + L L+ N +++ L L+ L+L S I
Sbjct: 11 YRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 167 QLFS 170
+ F
Sbjct: 67 EAFR 70
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 1e-10
Identities = 29/196 (14%), Positives = 56/196 (28%), Gaps = 25/196 (12%)
Query: 65 CFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDF-LGSM 123
S + C + + + L L +++ L L +
Sbjct: 7 PHGSSGLRCTRDGALD-----------SLHHLPGAENLTELYIENQQHLQHLELRDLRGL 55
Query: 124 THLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL- 181
L++L + + + + L L+LS N L + + + L
Sbjct: 56 GELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ----GLSLQELV 109
Query: 182 ICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDV 241
+ G+ L C R + C L+ +C L+ +
Sbjct: 110 LSGNPLHCSCALRWLQRWEEEGL-GGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNA 168
Query: 242 FFDVAGED---DCKVS 254
DV G+D C+V
Sbjct: 169 SVDV-GDDVLLRCQVE 183
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 25/108 (23%), Positives = 43/108 (39%), Gaps = 13/108 (12%)
Query: 76 GNVISLTLGSNGFSGKIS--PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLAN 133
++ + G+N ++ P + L FL ++ +N L LPD S L+S+ N
Sbjct: 173 PSLEFIAAGNN----QLEELPELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGN 224
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181
N +P L L + +N L +P S+ N +L
Sbjct: 225 NILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 21/94 (22%), Positives = 38/94 (40%), Gaps = 9/94 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L + +N P + FL +++ +N L LPD S L+ + NN+
Sbjct: 132 LLEYLGVSNNQLEK--LPELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQL 185
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P L L + +N+L ++P S
Sbjct: 186 E-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS 216
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 25/113 (22%), Positives = 38/113 (33%), Gaps = 21/113 (18%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
C + L L + G S + L+ SL N L+ LP+ S+ L N
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 133 NNKFSGSIPATWS---------------QLSNLKHLDLSSNNLTGRIPMQLFS 170
S P S LK +D+ +N+L ++P S
Sbjct: 123 LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS 174
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 20/86 (23%), Positives = 30/86 (34%), Gaps = 12/86 (13%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ L SN + L+ L + +N L LP L+ L + N
Sbjct: 297 PNLYYLNASSNEIR-SLCDLPPSLE---ELNVSNNKLI-ELPALPPR---LERLIASFNH 348
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
+ +P NLK L + N L
Sbjct: 349 LA-EVP---ELPQNLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 19/86 (22%), Positives = 36/86 (41%), Gaps = 12/86 (13%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ +L + N + + L FL E + LS P +L LN ++N+
Sbjct: 257 PSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNE 308
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
S+ +L+ L++S+N L
Sbjct: 309 IR-SLC---DLPPSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 18/103 (17%), Positives = 30/103 (29%), Gaps = 19/103 (18%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGS-------------MTHLQ 127
S+ + ++ +K ++ P G
Sbjct: 16 PLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAH 74
Query: 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L L N S S+P +L+ L S N+LT +P S
Sbjct: 75 ELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELPQS 112
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 13/103 (12%), Positives = 33/103 (32%), Gaps = 15/103 (14%)
Query: 92 ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLS--- 148
I+P FL ++L+ +P ++ A +++ + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 149 ----------NLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181
L+L++ L+ +P + + + L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLVASCNSL 103
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 12/79 (15%), Positives = 24/79 (30%), Gaps = 7/79 (8%)
Query: 83 LGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 142
L N ++ LK L ++ N L PD S ++ L + + +
Sbjct: 382 LRMNSHLAEVPELPQNLK---QLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEF 434
Query: 143 TWSQLSNLKHLDLSSNNLT 161
L+ ++
Sbjct: 435 AHETTDKLEDDVFEHHHHH 453
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 22/95 (23%), Positives = 34/95 (35%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L N S + S + L L L N L+ + L+ L+L++N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S+ T+ L L L L L + LF
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 28/94 (29%), Positives = 40/94 (42%), Gaps = 7/94 (7%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFS 137
+L L G ++ P + L L L LQDN L LPD + +L L L N+ S
Sbjct: 109 TLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 138 GSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S+P + L +L L L N + + F
Sbjct: 167 -SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 21/92 (22%), Positives = 33/92 (35%), Gaps = 5/92 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N + L L L L N +S + L L L N+ +
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-H 191
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + L L L L +NNL+ +P + +
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLS-ALPTEALA 222
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 21/103 (20%), Positives = 36/103 (34%), Gaps = 11/103 (10%)
Query: 72 TCRNGNVISLTLGSNGFS---GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128
C N ++ + G I + + L N +S + +L
Sbjct: 7 VCYNEPKVTTSCPQQGLQAVPVGIPAASQ------RIFLHGNRISHVPAASFRACRNLTI 60
Query: 129 LNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L L +N + I A ++ L+ L+ LDLS N + F
Sbjct: 61 LWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 21/82 (25%), Positives = 32/82 (39%), Gaps = 4/82 (4%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N S + L L L L N ++ P + L +L L N S +
Sbjct: 158 LFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-A 215
Query: 140 IPA-TWSQLSNLKHLDLSSNNL 160
+P + L L++L L+ N
Sbjct: 216 LPTEALAPLRALQYLRLNDNPW 237
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ SL +G N IS + L L L L+ +L+ + L + L L L +
Sbjct: 129 NLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLN 187
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ ++ +L LK L++S +
Sbjct: 188 INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 17/92 (18%), Positives = 36/92 (39%), Gaps = 3/92 (3%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
LTL + I +++ L L L L+ +++ + L+ L +++ +
Sbjct: 156 QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
++ NL L ++ NLT +P
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLT-AVPYLAVR 245
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 24/121 (19%), Positives = 48/121 (39%), Gaps = 9/121 (7%)
Query: 69 SHVTCRNGNVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQ 127
+ N+ SL++ + + ++ L +L L L N +S L + LQ
Sbjct: 217 TPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQ 275
Query: 128 SLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF----SVATFNFTGTHLI 182
+ L + + + + L+ L+ L++S N LT + +F ++ T L
Sbjct: 276 EIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
Query: 183 C 183
C
Sbjct: 334 C 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 18/92 (19%), Positives = 37/92 (40%), Gaps = 3/92 (3%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + + ++P+ L SL + +L+ + + +L+ LNL+ N S +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-T 262
Query: 140 IPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
I + +L L+ + L L + F
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLA-VVEPYAFR 293
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 3/95 (3%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ L L N S + P L L +L L+ N L +++L L+++ NK
Sbjct: 57 HLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENK 115
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + L NLK L++ N+L I + FS
Sbjct: 116 IVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 27/108 (25%), Positives = 42/108 (38%), Gaps = 17/108 (15%)
Query: 65 CFSWS-HVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSM 123
C + V C +++ G I L+L N + D S
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEG-------IPTETR------LLDLGKNRIKTLNQDEFASF 55
Query: 124 THLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
HL+ L L N S ++ ++ L NL+ L L SN L IP+ +F+
Sbjct: 56 PHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT 101
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 25/93 (26%), Positives = 33/93 (35%), Gaps = 5/93 (5%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L + N + + L L SLE+ DNDL + L+ L L +
Sbjct: 108 KLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT- 165
Query: 139 SIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
SIP S L L L L N+ I F
Sbjct: 166 SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK 197
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 23/130 (17%), Positives = 38/130 (29%), Gaps = 15/130 (11%)
Query: 44 LKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKF-- 101
LK L + S + LTL + +G P + +
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQ-------ELTLENLEVTGTAPPPLLEATGPD 122
Query: 102 LASLELQDNDLSGTLPDFLGSM-----THLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156
L L L++ + +L + L+ L++A L LDLS
Sbjct: 123 LNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181
Query: 157 SNNLTGRIPM 166
N G +
Sbjct: 182 DNPELGERGL 191
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 22/106 (20%), Positives = 34/106 (32%), Gaps = 6/106 (5%)
Query: 58 NDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTL 116
N +P S + + L L N L SL L L +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV 268
Query: 117 PDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 162
P L + L L+L+ N+ P+ +L + +L L N
Sbjct: 269 PKGLPA--KLSVLDLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 16/93 (17%), Positives = 33/93 (35%), Gaps = 8/93 (8%)
Query: 94 PSITKLKFLASLELQDNDLSGTLPD---FLGSMTHLQSLNLANNKFSGSIPATWSQL--S 148
I K L L ++ + + + ++ LQ L L N + +G+ P +
Sbjct: 62 TDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGP 121
Query: 149 NLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181
+L L+L + + R + + L
Sbjct: 122 DLNILNLRNVSWATRDA---WLAELQQWLKPGL 151
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 26/126 (20%), Positives = 47/126 (37%), Gaps = 7/126 (5%)
Query: 36 EGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPS 95
E LKA++ + D S + +V L L + +
Sbjct: 403 ETLQYFSTLKAVDPMRAAYLDDLRSKF--LLENSVLKMEYADVRVLHLAHKDLT-VL-CH 458
Query: 96 ITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155
+ +L + L+L N L LP L ++ L+ L ++N ++ + L L+ L L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGV-ANLPRLQELLL 515
Query: 156 SSNNLT 161
+N L
Sbjct: 516 CNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 23/87 (26%), Positives = 35/87 (40%), Gaps = 6/87 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
V L L N + P++ L+ L L+ DN L + + ++ LQ L L NN+
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRL 520
Query: 137 SGSIPATW--SQLSNLKHLDLSSNNLT 161
A L L+L N+L
Sbjct: 521 Q-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 26/91 (28%), Positives = 41/91 (45%), Gaps = 2/91 (2%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N F P I T+L+ L L+L L P S++ LQ LN+++N F
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 214
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L++L+ LD S N++ Q
Sbjct: 215 DTFPYKCLNSLQVLDYSLNHIM-TSKKQELQ 244
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 22/98 (22%), Positives = 40/98 (40%), Gaps = 7/98 (7%)
Query: 77 NVISLTLGSNGFSGKISPSIT--KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
+ L+L SNG S K S + L L+L N + T+ + L+ L+ ++
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 111
Query: 135 KFSGSIPA--TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + L NL +LD+S + +F+
Sbjct: 112 NLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 147
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 19/97 (19%), Positives = 43/97 (44%), Gaps = 6/97 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANN 134
++ L L NG +S + L+ L L+ Q ++L + + S+ +L L++++
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136
Query: 135 KFSGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ LS+L+ L ++ N+ +F+
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 172
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 27/102 (26%), Positives = 44/102 (43%), Gaps = 16/102 (15%)
Query: 63 SPCF-SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG 121
S C S + + C + + S+ G I S T+L EL+ N L
Sbjct: 3 SRCSCSGTEIRCNSKGLTSVPTG-------IPSSATRL------ELESNKLQSLPHGVFD 49
Query: 122 SMTHLQSLNLANNKFS-GSIPA-TWSQLSNLKHLDLSSNNLT 161
+T L L+L++N S + + ++LK+LDLS N +
Sbjct: 50 KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 91
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 18/83 (21%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L ++SP+ L L L + N+ + LQ L+ + N +
Sbjct: 180 LDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-T 237
Query: 140 IPATWSQ--LSNLKHLDLSSNNL 160
Q S+L L+L+ N+
Sbjct: 238 SKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 20/148 (13%), Positives = 50/148 (33%), Gaps = 7/148 (4%)
Query: 20 LVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVI 79
L + + + + + +K L TD + + + +
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG-----TLPDFLGSMTHLQSLNLANN 134
G F+ S +++L + ++ ++ + L + ++ + + N+
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 135 KFSGSIPA-TWSQLSNLKHLDLSSNNLT 161
K +P L +L+ LDLS N +
Sbjct: 321 KVF-LVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 25/96 (26%), Positives = 42/96 (43%), Gaps = 3/96 (3%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ L L S+ + I L L L+L DN LS + G ++ L+ LNL N
Sbjct: 51 NLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP 109
Query: 136 FSG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + + + L+NL+ L + + I F+
Sbjct: 110 YQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ SL L N + + L L L+ + ++ D S+ L+ L+L++N
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 137 SGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
S S+ ++W LS+LK+L+L N LF
Sbjct: 87 S-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 22/112 (19%), Positives = 43/112 (38%), Gaps = 11/112 (9%)
Query: 64 PCFSWSHVTCRNGNVISLTLGSNGFSGKISPS---ITKLKFLASLELQDNDLS--GTLPD 118
PC H+ ++ L L N + + L +L L N L +
Sbjct: 326 PCSFSQHLK----SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381
Query: 119 FLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L ++ +L SL+++ N F +P + ++ L+LSS + + +
Sbjct: 382 ILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ 431
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 23/91 (25%), Positives = 35/91 (38%), Gaps = 7/91 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL---PDFLGSMTHLQSLNLAN 133
V +T+ ++ LK L L+L +N + G+ LQ+L L+
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 134 NKFSGSIPATW---SQLSNLKHLDLSSNNLT 161
N S+ T L NL LD+S N
Sbjct: 371 NHLR-SMQKTGEILLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 7/92 (7%)
Query: 81 LTLGSNGFS--GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L N K + LK L SL++ N +PD ++ LNL++
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR- 423
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L+ LD+S+NNL + L
Sbjct: 424 VVK--TCIPQTLEVLDVSNNNLD-SFSLFLPR 452
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 14/84 (16%), Positives = 33/84 (39%), Gaps = 3/84 (3%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L + +S + L+ + + ++++ + F + L+ L+L+ N
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY 350
Query: 141 PATWS---QLSNLKHLDLSSNNLT 161
+ +L+ L LS N+L
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 21/100 (21%), Positives = 40/100 (40%), Gaps = 2/100 (2%)
Query: 77 NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ +L +G+ +I L L LE++ L L S+ + L L ++
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN 175
+ + LS++++L+L NL R V +
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVS 222
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 18/93 (19%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L + +N S + +L+ L + N L TLPD L + ++ N+
Sbjct: 432 TLEVLDVSNNNLD-SFSLFLPRLQ---ELYISRNKLK-TLPDA-SLFPVLLVMKISRNQL 485
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ +L++L+ + L +N P +
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 518
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 14/67 (20%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR 163
+ + + ++P L ++SL+L+ NK + +NL+ L L S+ +
Sbjct: 9 VCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-T 64
Query: 164 IPMQLFS 170
I F
Sbjct: 65 IEGDAFY 71
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 27/97 (27%), Positives = 42/97 (43%), Gaps = 11/97 (11%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
+ N I T+ F+G L L +LEL DN L+ ++ L+ L L NN
Sbjct: 96 SRNHIR-TIEIGAFNG--------LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNN 146
Query: 135 KFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
SIP+ ++++ +L+ LDL I F
Sbjct: 147 PIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 3/94 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L +I P++T L L L+L N LS P + HLQ L + ++
Sbjct: 186 NLRYLNLAMCNLR-EI-PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L +L ++L+ NNLT +P LF+
Sbjct: 244 QVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFT 276
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 25/97 (25%), Positives = 40/97 (41%), Gaps = 12/97 (12%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
+ N I + N F L+ L L+L N + + +L +L L +N
Sbjct: 72 HENQIQ-IIKVNSFKH--------LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122
Query: 135 KFSGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + +IP LS LK L L +N + IP F+
Sbjct: 123 RLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 23/103 (22%), Positives = 37/103 (35%), Gaps = 13/103 (12%)
Query: 73 CR-NGNVISLTLGSNGFS---GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128
C + + IS + L L +N + + + HL+
Sbjct: 39 CSCSNQFSKVICVRKNLREVPDGISTNTR------LLNLHENQIQIIKVNSFKHLRHLEI 92
Query: 129 LNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L L+ N +I ++ L+NL L+L N LT IP F
Sbjct: 93 LQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFV 133
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 20/83 (24%), Positives = 35/83 (42%), Gaps = 4/83 (4%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L N S I P S L L L + + + + ++ L +NLA+N +
Sbjct: 211 ELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT- 268
Query: 139 SIPA-TWSQLSNLKHLDLSSNNL 160
+P ++ L +L+ + L N
Sbjct: 269 LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 27/96 (28%), Positives = 41/96 (42%), Gaps = 4/96 (4%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ L LG N +I L L +LEL DN L+ ++ L+ L L NN
Sbjct: 100 HLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNP 158
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
SIP+ ++++ +L LDL I F
Sbjct: 159 IE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 26/95 (27%), Positives = 45/95 (47%), Gaps = 3/95 (3%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ L LG + P++T L L LE+ N P ++ L+ L + N++
Sbjct: 196 FNLKYLNLGMCNIK-DM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S + L++L L+L+ NNL+ +P LF+
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 24/103 (23%), Positives = 37/103 (35%), Gaps = 13/103 (12%)
Query: 73 CR-NGNVISLTLGSNGFS---GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128
C + + G S I + L L +N++ D + HL+
Sbjct: 50 CSCSNQFSKVVCTRRGLSEVPQGIPSNTRYL------NLMENNIQMIQADTFRHLHHLEV 103
Query: 129 LNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L L N I ++ L++L L+L N LT IP F
Sbjct: 104 LQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFE 144
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 24/82 (29%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 81 LTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N F +I P S L L L + ++ +S + + L LNLA+N S S
Sbjct: 223 LEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-S 280
Query: 140 IPA-TWSQLSNLKHLDLSSNNL 160
+P ++ L L L L N
Sbjct: 281 LPHDLFTPLRYLVELHLHHNPW 302
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 26/91 (28%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L N + K+ S+ L LA L L N +S L + HL+ L+L NNK
Sbjct: 196 ELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 253
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+P + ++ + L +NN++ I F
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNIS-AIGSNDF 283
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 18/94 (19%), Positives = 36/94 (38%), Gaps = 4/94 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ + + + I + L L L N ++ L + +L L L+ N
Sbjct: 172 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S + + +L+ L L++N L ++P L
Sbjct: 229 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 23/100 (23%), Positives = 38/100 (38%), Gaps = 12/100 (12%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L N S + S+ L L L +N L +P L ++Q + L NN S
Sbjct: 220 KLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS- 276
Query: 139 SIPATW-------SQLSNLKHLDLSSNNLT-GRIPMQLFS 170
+I + ++ ++ + L SN + I F
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 21/80 (26%), Positives = 36/80 (45%), Gaps = 9/80 (11%)
Query: 92 ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNL 150
+ P L+LQ+N ++ ++ +L +L L NNK S I ++ L L
Sbjct: 50 LPPDTA------LLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKL 102
Query: 151 KHLDLSSNNLTGRIPMQLFS 170
+ L LS N L +P ++
Sbjct: 103 ERLYLSKNQLK-ELPEKMPK 121
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 13/71 (18%), Positives = 28/71 (39%), Gaps = 3/71 (4%)
Query: 102 LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF-SGSIPA-TWSQLSNLKHLDLSSNN 159
L L + +N+++ + + + L N S I + + L ++ ++ N
Sbjct: 123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182
Query: 160 LTGRIPMQLFS 170
+T IP L
Sbjct: 183 IT-TIPQGLPP 192
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 27/97 (27%), Positives = 42/97 (43%), Gaps = 8/97 (8%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ +L L +N S KISP L L L L N L LP+ LQ L + N+
Sbjct: 77 NLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENE 132
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLT-GRIPMQLFS 170
+ + ++ L+ + ++L +N L I F
Sbjct: 133 IT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 14/87 (16%), Positives = 32/87 (36%), Gaps = 9/87 (10%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG------TLPDFLGSMTHLQSLNLAN 133
L L +N K+ + K++ + L +N++S P + ++L +
Sbjct: 244 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 302
Query: 134 NKFSGSI--PATWSQLSNLKHLDLSSN 158
N P+T+ + + L +
Sbjct: 303 NPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 25/91 (27%), Positives = 39/91 (42%), Gaps = 6/91 (6%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N S + L L L +L+ L G++ L +L+L++N+ S
Sbjct: 36 LHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-S 91
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P L L LD+S N LT +P+
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 28/91 (30%), Positives = 39/91 (42%), Gaps = 5/91 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N + + L L L L+ N+L P L L+ L+LANN +
Sbjct: 105 LDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-E 162
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+PA + L NL L L N+L IP F
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 4/91 (4%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
+L L N + L L L++ N L+ L + LQ L L N+ +
Sbjct: 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-T 138
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+P + L+ L L++NNLT +P L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLT-ELPAGLL 168
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 20/79 (25%), Positives = 30/79 (37%), Gaps = 3/79 (3%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N + P + T L L L +N+L+ L + +L +L L N +
Sbjct: 129 LYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186
Query: 140 IPATWSQLSNLKHLDLSSN 158
IP + L L N
Sbjct: 187 IPKGFFGSHLLPFAFLHGN 205
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 57/247 (23%), Positives = 98/247 (39%), Gaps = 49/247 (19%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLI-----------S 323
+G G F V+ + +NT VA+K R Y EAA + E+ L+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAA-EDEIKLLQRVNDADNTKED 81
Query: 324 VAIHKNLLQLIG---YCTTSSERI-LVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKR 376
++L+L+ + + + +V+ + +NL L K +G+ K+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENL------LALIKKYEHRGIPLIYVKQ 135
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD------NFEAVLCDFGLAKLVDAKLT 430
++ GL+Y+H +C IIH D+K N+L++ + + D G A D T
Sbjct: 136 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 431 H--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
+ T + R +PE L D++ + EL+TG F E
Sbjct: 194 NSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTK 245
Query: 489 LLDHIRK 495
DHI +
Sbjct: 246 DDDHIAQ 252
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 19/93 (20%), Positives = 40/93 (43%), Gaps = 4/93 (4%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
+G +K+ L+ +N L+ T+ + G +T L++L L N+ +
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 141 PAT---WSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+Q+ +L+ LD+S N+++ S
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS 396
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 16/131 (12%), Positives = 43/131 (32%), Gaps = 3/131 (2%)
Query: 34 DVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLT---LGSNGFSG 90
+ + I +L+ + T + ++ + + ++ +L+ + S+ F
Sbjct: 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 91 KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 150
S + + ++ L+ +NN + ++ L+ L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350
Query: 151 KHLDLSSNNLT 161
+ L L N L
Sbjct: 351 ETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 24/127 (18%), Positives = 42/127 (33%), Gaps = 3/127 (2%)
Query: 44 LKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLA 103
L L + + T WN W H T ++ ++ L S T LK L+
Sbjct: 222 LSNLTLNNIETT-WNSFIRILQLVW-HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR 163
++ + +++ N + S++S HLD S+N LT
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-D 338
Query: 164 IPMQLFS 170
+
Sbjct: 339 TVFENCG 345
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 5/91 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N S + K L SL + N L+ T+ L ++ L+L +NK S
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-S 435
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
IP +L L+ L+++SN L +P +F
Sbjct: 436 IPKQVVKLEALQELNVASNQLK-SVPDGIFD 465
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 21/85 (24%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+++SL + SN + I + + L+L N + ++P + + LQ LN+A+N+
Sbjct: 400 SLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
Query: 137 SGSIP-ATWSQLSNLKHLDLSSNNL 160
S+P + +L++L+ + L +N
Sbjct: 457 K-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 16/70 (22%), Positives = 31/70 (44%), Gaps = 6/70 (8%)
Query: 92 ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151
+S T L + N +S + S++ L+ L +++N+ + + L+
Sbjct: 19 LSQKTTIL------NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 152 HLDLSSNNLT 161
+LDLS N L
Sbjct: 73 YLDLSHNKLV 82
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 33/206 (16%), Positives = 60/206 (29%), Gaps = 8/206 (3%)
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNL 131
N + L L N S L L+L N LP G+M+ L+ L L
Sbjct: 67 FNQELEYLDLSHNKLV---KISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGL 122
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRI-PMQLFSVATFNFTGTHLICGSSLEQP 190
+ S + L+ K L + + P L T +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL 182
Query: 191 CMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDD 250
+S + + + ++ V+ C F+ + + L + ++
Sbjct: 183 DVSVKT-VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241
Query: 251 CKVSLTQLRRFSCRELQLATDNFSES 276
V T + FS ++L
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRD 267
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 33/174 (18%), Positives = 57/174 (32%), Gaps = 43/174 (24%)
Query: 279 IGQGGFGKVYKGV---------LSDNTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIHK 328
+ G +Y+ K ++K E F QR + V K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 329 NLL--------QLIGYCTTSSE-RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 379
L +G+ + R LV + +L R L + LD + ++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLG-----RSL---QSALDVSPKHVLSE 158
Query: 380 GTAY--------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAK 423
+ LE+LHE +H ++ A NI +D ++ L +G A
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 21/94 (22%), Positives = 39/94 (41%), Gaps = 10/94 (10%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L N + +++ K L L N+++ L L L L+ ++NK
Sbjct: 171 QLTTLDCSFNKIT---ELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL 224
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ I + L+ L + D S N LT + + S
Sbjct: 225 T-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLS 254
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 16/86 (18%), Positives = 29/86 (33%), Gaps = 6/86 (6%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N + + G +T L L+ Q ++ L L L L L N +
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTE 329
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
+ + S + LK L + ++
Sbjct: 330 LT-ELDV--SHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 22/85 (25%), Positives = 39/85 (45%), Gaps = 8/85 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ SL ++ + I KL L L N+++ TL L T+L L +NK
Sbjct: 43 TLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKL 97
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ ++ + L+ L +L+ +N LT
Sbjct: 98 T-NLDV--TPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 19/82 (23%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
S + + S +L L SL+ ++ ++ + +T L L +N + +
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGI-EKLTGLTKLICTSNNIT-T 78
Query: 140 IPATWSQLSNLKHLDLSSNNLT 161
+ SQ +NL +L SN LT
Sbjct: 79 LD--LSQNTNLTYLACDSNKLT 98
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 16/87 (18%), Positives = 31/87 (35%), Gaps = 9/87 (10%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
N + L +N + + + L L+ N L+ + + +T L + + N
Sbjct: 190 NKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVN 243
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLT 161
+ + S LS L L +L
Sbjct: 244 PLT-ELDV--STLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 21/85 (24%), Positives = 35/85 (41%), Gaps = 9/85 (10%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L SN + + +++ L L N L+ L + +T L LN NK
Sbjct: 65 GLTKLICTSNNIT---TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL 118
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ + SQ L +L+ + N LT
Sbjct: 119 T-KLDV--SQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 13/87 (14%), Positives = 23/87 (26%), Gaps = 8/87 (9%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
+ +L I + Q + T L L+
Sbjct: 253 LSKLTTLHCIQTDLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAA 307
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLT 161
+ + SQ L +L L++ LT
Sbjct: 308 GIT-ELDL--SQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 14/60 (23%), Positives = 25/60 (41%), Gaps = 2/60 (3%)
Query: 102 LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
AS ++ T + L SL+ N+ + + +L+ L L +SNN+T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGI-EKLTGLTKLICTSNNIT 77
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 5/96 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ SL L N + IS + L L+L N L + L+ L L NN
Sbjct: 65 NLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNH 123
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + ++ L+ L LS N ++ R P++L
Sbjct: 124 IV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 10/81 (12%)
Query: 92 ISPSITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSN 149
+ L +L N+LS + +T+L SL L++N + I + + + N
Sbjct: 37 LPSYTALL------DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89
Query: 150 LKHLDLSSNNLTGRIPMQLFS 170
L++LDLSSN+L + LFS
Sbjct: 90 LRYLDLSSNHLH-TLDEFLFS 109
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 24/80 (30%), Positives = 36/80 (45%), Gaps = 10/80 (12%)
Query: 97 TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPA----TWSQLSNL 150
+ L+ L L L +N + + F M LQ L L+ N+ S P ++L L
Sbjct: 109 SDLQALEVLLLYNNHIV-VVDRNAFED-MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKL 165
Query: 151 KHLDLSSNNLTGRIPMQLFS 170
LDLSSN L ++P+
Sbjct: 166 MLLDLSSNKLK-KLPLTDLQ 184
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 18/93 (19%), Positives = 30/93 (32%), Gaps = 3/93 (3%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF-SG 138
L + I + L L L+L N + +L+ L L
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118
Query: 139 SIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + L++L+ L L NN+ P F
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 29/128 (22%), Positives = 55/128 (42%), Gaps = 9/128 (7%)
Query: 47 LNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSI-TKLKFLASL 105
L++++ + + +++ V + L + + S+ + L L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 106 ELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
L N+++ + D F G +THL LNL+ N SI + + L L+ LDLS N++
Sbjct: 305 TLAQNEIN-KIDDNAFWG-LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR- 360
Query: 163 RIPMQLFS 170
+ Q F
Sbjct: 361 ALGDQSFL 368
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 7/94 (7%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFL-GSMTHLQSLNLANNKFS 137
LTL N + KI + L L L L N L ++ + ++ L+ L+L+ N
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360
Query: 138 GSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
++ ++ L NLK L L +N L +P +F
Sbjct: 361 -ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 14/68 (20%), Positives = 25/68 (36%), Gaps = 2/68 (2%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
++L N ++ + LQ L + I T+ LS+L L L N
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 163 RIPMQLFS 170
++ F+
Sbjct: 93 QLETGAFN 100
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 24/105 (22%), Positives = 31/105 (29%), Gaps = 5/105 (4%)
Query: 81 LTLGSNGFSGKISPSIT--KLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFS 137
LTL G + L L L L+DN++ P F +M L+L NK
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167
Query: 138 GSIPATWSQL--SNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTH 180
+ L LSS L L N
Sbjct: 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 19/86 (22%), Positives = 37/86 (43%), Gaps = 4/86 (4%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+++ L L N I + L L L+L N + + +L+ L L N+
Sbjct: 324 HLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQ 382
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNL 160
S+P + +L++L+ + L +N
Sbjct: 383 LK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 15/115 (13%), Positives = 33/115 (28%), Gaps = 17/115 (14%)
Query: 65 CFSWSHVTCRN----------GNVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLS 113
C + +L L I + + L ++ + + +
Sbjct: 10 CHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTL 68
Query: 114 GTLPD--FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIP 165
L F ++ + + + N + I +L LK L + + L P
Sbjct: 69 QQLESHSFYN-LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFP 121
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 5/98 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDN-DLSGTLPDFLGSMTHLQSLNLANN 134
N+ + + + ++ L + +E+++ +L+ PD L + L+ L + N
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
Query: 135 KFSGSIPAT--WSQLSNLKHLDLSSNNLTGRIPMQLFS 170
P L+++ N IP+ F
Sbjct: 116 GLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 19/95 (20%), Positives = 40/95 (42%), Gaps = 6/95 (6%)
Query: 80 SLTLGSNGFSGKISP-SITKL-KFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 137
L + N + I + L +L+L +N + ++ + + T L ++ L NK+
Sbjct: 134 ILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYL 192
Query: 138 GSIPA-TWSQL-SNLKHLDLSSNNLTGRIPMQLFS 170
I + + S LD+S ++T +P +
Sbjct: 193 TVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLE 226
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 12/68 (17%), Positives = 25/68 (36%), Gaps = 6/68 (8%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
+ D+ +P Q+L L +IP+ +S L N+ + +S +
Sbjct: 15 DFRVTCKDIQ-RIPSLP---PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 163 RIPMQLFS 170
++ F
Sbjct: 70 QLESHSFY 77
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 22/104 (21%), Positives = 40/104 (38%), Gaps = 3/104 (2%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L +G+ KI L FL LE+ +DL P L S+ ++ L L +
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 178
+ S+++ L+L +L +L + T +
Sbjct: 210 HI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 24/106 (22%), Positives = 49/106 (46%), Gaps = 14/106 (13%)
Query: 69 SHVTCRNGNVISLTLGSNGFS---GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTH 125
+ ++C + + S + ++ ++ SL+L +N ++ L +
Sbjct: 26 ASLSCDRNGICKGS--SGSLNSIPSGLTEAVK------SLDLSNNRITYISNSDLQRCVN 77
Query: 126 LQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
LQ+L L +N + +I ++S L +L+HLDLS N L+ + F
Sbjct: 78 LQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFK 121
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 18/99 (18%), Positives = 33/99 (33%), Gaps = 12/99 (12%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGT--------LPDFLGSMTHLQSLNL 131
L L + + LEL+D DL + L +++ +
Sbjct: 203 LILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + +Q+S L L+ S N L +P +F
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFD 298
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 16/94 (17%), Positives = 35/94 (37%), Gaps = 11/94 (11%)
Query: 77 NVISLTLGSNGFSGKISPSI--------TKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128
+V L L + K ++++ D L + L ++ L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281
Query: 129 LNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLT 161
L + N+ S+P + +L++L+ + L +N
Sbjct: 282 LEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 25/97 (25%), Positives = 46/97 (47%), Gaps = 5/97 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ +L L SNG + I + L L L+L N LS + ++ L LNL N
Sbjct: 77 NLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNP 135
Query: 136 FSGSIP--ATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ ++ + +S L+ L+ L + + + +I + F+
Sbjct: 136 YK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 8/94 (8%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFL-GSMTHLQSLNLANNKFSG 138
L L N ++ + L L L + +L+ +L +F G + L+ LN+A+N
Sbjct: 81 LILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ- 137
Query: 139 SIPA--TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S +S L+NL+HLDLSSN + I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLR 170
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 21/95 (22%), Positives = 36/95 (37%), Gaps = 9/95 (9%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKF 136
+L L N + L L+L ++ T+ D + ++HL +L L N
Sbjct: 32 NLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQS-LSHLSTLILTGNPI 88
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S+ +S LS+L+ L NL +
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIG 121
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 9/95 (9%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLP----DFLGSMTHLQ-SLNLANN 134
L + N P + L L L+L N + ++ L M L SL+L+ N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ I + LK L L +N L +P +F
Sbjct: 188 PMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIF 220
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 19/93 (20%), Positives = 34/93 (36%), Gaps = 10/93 (10%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS----LNLANNK 135
L++ +N + + L+ +L++ N L +LP H + N+
Sbjct: 164 VLSVRNNQLT-FLPELPESLE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENR 218
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
+ IP L + L N L+ RI L
Sbjct: 219 IT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 24/89 (26%), Positives = 41/89 (46%), Gaps = 11/89 (12%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
C L L S + ++ + LE+ N L +LP+ S L+ L+
Sbjct: 56 CLINQFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPAS---LEYLDAC 108
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
+N+ S ++P ++LKHLD+ +N LT
Sbjct: 109 DNRLS-TLPE---LPASLKHLDVDNNQLT 133
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 13/95 (13%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ L N S + LK L++ +N L+ LP+ L+ +N NN+
Sbjct: 100 ASLEYLDACDNRLS-TLPELPASLK---HLDVDNNQLT-MLPELPAL---LEYINADNNQ 151
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ +P ++L+ L + +N LT +P S
Sbjct: 152 LT-MLPE---LPTSLEVLSVRNNQLT-FLPELPES 181
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 12/91 (13%), Positives = 30/91 (32%), Gaps = 6/91 (6%)
Query: 81 LTLGSNGFSGKISPSITKLKFL----ASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
L + +N + + ++N ++ +P+ + S+ ++ L +N
Sbjct: 185 LDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 167
S I + SQ + + Q
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 21/96 (21%), Positives = 41/96 (42%), Gaps = 9/96 (9%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
C N L +G +G + + + + +L + DN+L+ +LP L++L ++
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVS 89
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
N+ + S+P L L +L +P L
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 22/95 (23%), Positives = 37/95 (38%), Gaps = 12/95 (12%)
Query: 67 SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHL 126
+H+ + L + N + + L+ L + DN L+ +LP L
Sbjct: 112 PLTHLPALPSGLCKLWIFGNQLT-SLPVLPPGLQ---ELSVSDNQLA-SLPALPS---EL 163
Query: 127 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
L NN+ + S+P S L+ L +S N L
Sbjct: 164 CKLWAYNNQLT-SLPM---LPSGLQELSVSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L++ N + + ++L L +N L+ +LP L+ L ++ N+
Sbjct: 181 SGLQELSVSDNQLA-SLPTLPSELY---KLWAYNNRLT-SLPALPSG---LKELIVSGNR 232
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
+ S+P S LK L +S N LT
Sbjct: 233 LT-SLPVL---PSELKELMVSGNRLT 254
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 17/86 (19%), Positives = 31/86 (36%), Gaps = 8/86 (9%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L + N + + + L SL + N L+ LP+ L ++ ++NL N
Sbjct: 241 SELKELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
S T L + S +
Sbjct: 296 LS---ERTLQALREITSAPGYSGPII 318
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 22/85 (25%), Positives = 40/85 (47%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ +L L S + ++P + L L L L N ++ P L +T+LQ L++ N +
Sbjct: 108 SIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV 163
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
S + + LS L L N ++
Sbjct: 164 S-DLTPL-ANLSKLTTLKADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 19/85 (22%), Positives = 41/85 (48%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L N +S I L+ + +L+L ++ L +++LQ L L N+
Sbjct: 86 KITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQI 141
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ +I + L+NL++L + + ++
Sbjct: 142 T-NISPL-AGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 23/85 (27%), Positives = 39/85 (45%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L N + ISP + L L L + + +S L +++ L +L +NK
Sbjct: 130 NLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
S I + L NL + L +N ++
Sbjct: 186 S-DISP-LASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 15/85 (17%), Positives = 35/85 (41%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N I + G + + + + L + +L ++ + + + +L L L +N+
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQI 75
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ + L+ + L+LS N L
Sbjct: 76 T-DLAPL-KNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 23/85 (27%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L++G+ S ++P + L L +L+ DN +S + L S+ +L ++L NN+
Sbjct: 152 NLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQI 207
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
S + + SNL + L++ +T
Sbjct: 208 S-DVSP-LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 13/71 (18%), Positives = 28/71 (39%), Gaps = 5/71 (7%)
Query: 91 KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 150
I P L + ++++ T+ + + +L+ + +I L+NL
Sbjct: 11 VIFP-DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNL 65
Query: 151 KHLDLSSNNLT 161
L+L N +T
Sbjct: 66 IGLELKDNQIT 76
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 27/85 (31%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ SL+L NG S I+ + L L SL L +N ++ L +T L +L+L +N+
Sbjct: 110 KLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 165
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
S I + L+ L++L LS N+++
Sbjct: 166 S-DIVP-LAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 12/88 (13%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDN---DLSGTLPDFLGSMTHLQSLNLAN 133
N+ L L N +S + LK L SL L+ N D++G L + L+SL L N
Sbjct: 88 NLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDING-----LVHLPQLESLYLGN 140
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLT 161
NK + I S+L+ L L L N ++
Sbjct: 141 NKIT-DITVL-SRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 19/85 (22%), Positives = 34/85 (40%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ + ++ + I L + L L N L+ P L ++ +L L L NK
Sbjct: 44 SIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI 99
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ + L LK L L N ++
Sbjct: 100 K-DLSSL-KDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 6/99 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ SL LG+N + I+ +++L L +L L+DN +S L +T LQ+L L+ N
Sbjct: 132 QLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI 187
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN 175
S + A + L NL L+L S + ++ N
Sbjct: 188 S-DLRAL-AGLKNLDVLELFSQECLNKPINHQSNLVVPN 224
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 5e-06
Identities = 12/71 (16%), Positives = 24/71 (33%), Gaps = 5/71 (7%)
Query: 91 KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 150
+I P L+ ++ + + + + N+ S+ L N+
Sbjct: 13 QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGI-QYLPNV 67
Query: 151 KHLDLSSNNLT 161
L L+ N LT
Sbjct: 68 TKLFLNGNKLT 78
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 42/170 (24%), Positives = 67/170 (39%), Gaps = 35/170 (20%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRL----QDYYSPGG---EAAFQREV---HLISVAIHK 328
IGQGGFG +Y ++ + V + G E F + I I
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 329 NLLQLIG-----YCTTSSERILVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK------- 375
L+ +G + Y FM + R DL +K + ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFGSDL---QKIYEANAKRFSRKTVL 155
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAV-LCDFGLAK 423
+++ LEY+HE +H D+KA+N+LL+ N + V L D+GLA
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 9/98 (9%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLAN 133
+ + L N I P + K L ++L +N +S L F G + L SL L
Sbjct: 33 TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG-LRSLNSLVLYG 89
Query: 134 NKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
NK + +P + L +L+ L L++N + + + F
Sbjct: 90 NKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQ 125
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 22/74 (29%), Positives = 29/74 (39%), Gaps = 3/74 (4%)
Query: 98 KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLS 156
L+ L SL L N ++ + LQ L L NK + + + L NL L L
Sbjct: 78 GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136
Query: 157 SNNLTGRIPMQLFS 170
N L I FS
Sbjct: 137 DNKLQ-TIAKGTFS 149
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 16/61 (26%), Positives = 27/61 (44%)
Query: 98 KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSS 157
L L L L N ++ D + +L L+L +NK T+S L ++ + L+
Sbjct: 102 GLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161
Query: 158 N 158
N
Sbjct: 162 N 162
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 44/168 (26%), Positives = 62/168 (36%), Gaps = 34/168 (20%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGG----EAAFQREV---HLISVAIHKNL 330
IG GGFG +Y + K A ++ Y G E F + V I I +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 331 LQLIG-----YCTTSSERILVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK-------RV 377
L +G + + Y FM V RL DL +K ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFM----VMERLGIDL---QKISGQ-NGTFKKSTVLQL 156
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAK 423
LEY+HE +H D+KAAN+LL L D+GL+
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 8/86 (9%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKF 136
L L SN S + +L L L L DN L TLP F + +L++L + +NK
Sbjct: 41 KLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKE-LKNLETLWVTDNKL 97
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLT 161
++P + QL NL L L N L
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK 122
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 9/93 (9%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFS 137
L L N + P + L L L L N+L +LP F +T L+ L L NN+
Sbjct: 114 LRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF-DKLTSLKELRLYNNQLK 170
Query: 138 GSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+P + +L+ LK L L +N L R+P F
Sbjct: 171 -RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAF 201
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 3/68 (4%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
L+LQ N LS +T L+ L L +NK ++PA + +L NL+ L ++ N L
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ- 98
Query: 163 RIPMQLFS 170
+P+ +F
Sbjct: 99 ALPIGVFD 106
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 53/221 (23%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISV------AIHK 328
+IG+G FG+V K + VA+K R + + A E+ ++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH---RQA-AEEIRILEHLRKQDKDNTM 159
Query: 329 NLLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDLKPGE-KGLDWPTRKRVAF 379
N++ ++ C + + + NL Y L +K + +G P ++ A
Sbjct: 160 NVIHMLENFTFRNHIC-------MTFELLSMNL---YEL--IKKNKFQGFSLPLVRKFAH 207
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAKLVDAKLTHVTTQI- 436
L+ LH+ +IIH DLK NILL + + DFG + V T I
Sbjct: 208 SILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH---QRVYTYIQ 261
Query: 437 ----RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
R APE + + D++ G L EL+TG
Sbjct: 262 SRFYR------APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 15/85 (17%), Positives = 37/85 (43%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N + LG + + +L + + ++++ + T+L+ L+L++N+
Sbjct: 20 NAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLSHNQI 75
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
S + L+ L+ L ++ N L
Sbjct: 76 S-DLSPL-KDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 13/88 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL---PDFLGSMTHLQSLNLAN 133
+ L++ N + L + S L L D L + +L+ L++ N
Sbjct: 86 KLEELSVNRN--------RLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRN 137
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLT 161
NK SI LS L+ LDL N +T
Sbjct: 138 NKLK-SIVML-GFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 18/85 (21%), Positives = 38/85 (44%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L +N + LK L L +++N L ++ LG ++ L+ L+L N+
Sbjct: 107 CLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEI 162
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ + ++L + +DL+
Sbjct: 163 T-NTGG-LTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 23/85 (27%), Positives = 32/85 (37%), Gaps = 7/85 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L N S +SP + L L L + N L L L L NN+
Sbjct: 64 NLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNEL 118
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ L NL+ L + +N L
Sbjct: 119 R-DTDS-LIHLKNLEILSIRNNKLK 141
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L N +S + LK L SL L+ N +S + + L + L+SL L NNK
Sbjct: 91 NLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKI 146
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ I S+L+ L L L N ++
Sbjct: 147 T-DITVL-SRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 15/85 (17%), Positives = 31/85 (36%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
I L + +L + + ++D+ ++ + + ++ L L NK
Sbjct: 25 ETIKDNLKKKSVT-DAVT-QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKL 80
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ I + L NL L L N +
Sbjct: 81 T-DIKP-LANLKNLGWLFLDENKVK 103
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 11/71 (15%), Positives = 23/71 (32%), Gaps = 5/71 (7%)
Query: 91 KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 150
+I L+ ++ + + + + N+ S+ L N+
Sbjct: 16 QIFS-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNV 70
Query: 151 KHLDLSSNNLT 161
L L+ N LT
Sbjct: 71 TKLFLNGNKLT 81
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 24/82 (29%), Positives = 35/82 (42%), Gaps = 3/82 (3%)
Query: 81 LTLGSNGFS-GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L + + GKI + L L L + L L + L+ L L+ N+ G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGG 86
Query: 140 IPATWSQLSNLKHLDLSSNNLT 161
+ +L NL HL+LS N L
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-07
Identities = 28/86 (32%), Positives = 41/86 (47%), Gaps = 3/86 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L+L + G +S + KL L LEL +N + G L + +L LNL+ NK
Sbjct: 50 NLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
Query: 137 SG-SIPATWSQLSNLKHLDLSSNNLT 161
S +L LK LDL + +T
Sbjct: 108 KDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 28/169 (16%), Positives = 54/169 (31%), Gaps = 28/169 (16%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQD-NDLSGTLPDFLGSMTHLQSLNLANN 134
++ + + N I + + L L + ++ N+L P+ ++ +LQ L ++N
Sbjct: 55 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 114
Query: 135 KFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMS 193
+P LD+ N I F +F L
Sbjct: 115 GIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL------------ 161
Query: 194 RPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVF 242
++ ++ + AF L L L +L +DVF
Sbjct: 162 --------NKNGIQEI----HNSAFNGTQLDELNLSDNNNLEELPNDVF 198
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 14/71 (19%), Positives = 23/71 (32%), Gaps = 3/71 (4%)
Query: 102 LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLS-SNN 159
L L L+ + ++ N I A +S L L + + +NN
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 160 LTGRIPMQLFS 170
L I + F
Sbjct: 92 LL-YINPEAFQ 101
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 17/98 (17%), Positives = 32/98 (32%), Gaps = 7/98 (7%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLAN 133
N I L I + L +E+ ND+ + F + L + +
Sbjct: 31 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN-LPKLHEIRIEK 88
Query: 134 NKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
I + L NL++L +S+ + +P
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKI 125
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 20/118 (16%), Positives = 33/118 (27%), Gaps = 29/118 (24%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNK- 135
L + + G + L++QDN T+ F+G L L N
Sbjct: 108 YLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166
Query: 136 -------FSG---------------SIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
F+G +P + S LD+S + +P
Sbjct: 167 QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLE 223
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 13/68 (19%), Positives = 28/68 (41%), Gaps = 5/68 (7%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
Q++ ++ +P L + L K I +S +L+ +++S N++
Sbjct: 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 163 RIPMQLFS 170
I +FS
Sbjct: 69 VIEADVFS 76
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 24/115 (20%)
Query: 63 SPCFSWSHVTCRN-----------GNVISLTLGSNGFSGKISPS-ITKLKFLASLELQDN 110
S V N +L+L N S ++ I+ L L L L N
Sbjct: 28 FSNELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHN 86
Query: 111 DLSGTLP----DFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
+ +L F L+ L++++N+ +I +++L+HLDLS N+
Sbjct: 87 RIR-SLDFHVFLFN---QDLEYLDVSHNRLQ-NISCCP--MASLRHLDLSFNDFD 134
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 26/107 (24%), Positives = 46/107 (42%), Gaps = 8/107 (7%)
Query: 67 SWSHVTCRNGNVISLTLGSNGF----SGKISPSITKLKFLASLELQDNDLSGTLPDFLGS 122
++ V N+ SL S + + + L L N L+G++ L
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP 450
Query: 123 MTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
++ L+L NN+ SIP + L L+ L+++SN L +P +F
Sbjct: 451 --KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVF 493
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+++ L L SN +G + + + L+L +N + ++P + + LQ LN+A+N+
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484
Query: 136 FSGSIP-ATWSQLSNLKHLDLSSNN 159
S+P + +L++L+++ L N
Sbjct: 485 LK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 19/93 (20%), Positives = 36/93 (38%), Gaps = 9/93 (9%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N + + + L L++ N L + M L+ L+L+ N F
Sbjct: 81 LRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-V 135
Query: 140 IP--ATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P + L+ L L LS+ ++ + +
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVA 167
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 16/79 (20%), Positives = 25/79 (31%)
Query: 83 LGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 142
+ + F + + L +D S + LN N F+ S+
Sbjct: 312 VKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQ 371
Query: 143 TWSQLSNLKHLDLSSNNLT 161
S L L+ L L N L
Sbjct: 372 GCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 28/213 (13%), Positives = 69/213 (32%), Gaps = 23/213 (10%)
Query: 44 LKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKL---K 100
+ AL ND ++ R ++++TL + K S + + +
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276
Query: 101 FLASLELQDNDLSG-----TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155
+ L + + ++ ++ L ++ N F S A +S + + L
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
Query: 156 SSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRIVV----- 210
S ++ I M + + T L + Q + ++ +L+ ++
Sbjct: 337 SISDTP-FIHMVCPPSPS---SFTFL----NFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388
Query: 211 -ASASCGAFVLLSLGALFACRYQKLRKLKHDVF 242
+ A + ++ +L L L +
Sbjct: 389 LKNFFKVALMTKNMSSLE-TLDVSLNSLNSHAY 420
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 21/99 (21%), Positives = 42/99 (42%), Gaps = 10/99 (10%)
Query: 77 NVISLTLGSNGFSGKISPSIT--KLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLA 132
L L +N F+ + + KL L + +N ++ + + F G + + + L
Sbjct: 33 YTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEG-ASGVNEILLT 89
Query: 133 NNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+N+ ++ + L +LK L L SN +T + F
Sbjct: 90 SNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFI 126
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 16/96 (16%), Positives = 36/96 (37%), Gaps = 5/96 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ + +N + I + + L N L + L++L L +N+
Sbjct: 58 QLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNR 116
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + ++ LS+++ L L N +T + F
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 14/62 (22%), Positives = 33/62 (53%), Gaps = 2/62 (3%)
Query: 98 KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLS 156
L+ L +L L+ N ++ D ++ ++ L+L +N+ + ++ + L +L L+L
Sbjct: 103 GLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLL 161
Query: 157 SN 158
+N
Sbjct: 162 AN 163
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 37/158 (23%), Positives = 59/158 (37%), Gaps = 31/158 (19%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL----- 331
IG G FG +Y G ++ +VA+K E + L I+K +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---------ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 332 -QLIGYCTTSSERILVYPFMQNL--SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
+ ++V M+ L S+ L + + T +A +EY+
Sbjct: 68 PTIRWCGAEGDYNVMV---MELLGPSLED-LFNFCS--RKFSLKTVLLLADQMISRIEYI 121
Query: 389 HEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK 423
H + IHRD+K N L+ + DFGLAK
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 22/86 (25%), Positives = 43/86 (50%), Gaps = 3/86 (3%)
Query: 77 NVISLTLGSNGFS-GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+V L L ++ + GK+ + + L L + L+ ++ + L + L+ L L++N+
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNR 75
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
SG + + NL HL+LS N +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-06
Identities = 29/86 (33%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L+ + G + I+ ++ KL L LEL DN +SG L +L LNL+ NK
Sbjct: 43 ELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
Query: 137 SG-SIPATWSQLSNLKHLDLSSNNLT 161
S +L NLK LDL + +T
Sbjct: 101 KDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 21/85 (24%), Positives = 40/85 (47%), Gaps = 5/85 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
L L +N KIS ++ ++ L L L N + + + L+ L ++ N+
Sbjct: 49 ACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI 105
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ S+ +L NL+ L +S+N +T
Sbjct: 106 A-SLSG-IEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 15/74 (20%), Positives = 30/74 (40%), Gaps = 4/74 (5%)
Query: 88 FSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQL 147
F + S T+ + + L + + L ++ + L L+ N I ++ S +
Sbjct: 14 FEERKSVVATEAEKV-ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGM 69
Query: 148 SNLKHLDLSSNNLT 161
NL+ L L N +
Sbjct: 70 ENLRILSLGRNLIK 83
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 42/201 (20%), Positives = 60/201 (29%), Gaps = 66/201 (32%)
Query: 345 LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 403
+V+ + +L + +GL P K++ GL+YLH +C IIH D+K
Sbjct: 122 MVFEVLGHHL---LKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 404 ANILL-------------------------------------------------DDNFEA 414
NILL + +
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 415 VLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
+ D G A V T T Q R + E L + D++ EL TG
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQYR------SLEVLIGSGYNTPADIWSTACMAFELATG 289
Query: 473 QRAIDFSRLEEEEDVLLLDHI 493
F EE DHI
Sbjct: 290 DYL--FEPHSGEEYTRDEDHI 308
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 21/67 (31%), Positives = 35/67 (52%), Gaps = 4/67 (5%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
L L N + +P L + HL ++L+NN+ S ++ ++S ++ L L LS N L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 163 RIPMQLF 169
IP + F
Sbjct: 92 CIPPRTF 98
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL-GSMTHLQSLNLANNK 135
+V L L N F+ + ++ K L ++L +N +S TL + +MT L +L L+ N+
Sbjct: 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNR 89
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
IP T+ L +L+ L L N+++ +P F
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAF 122
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 18/85 (21%), Positives = 32/85 (37%), Gaps = 3/85 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
L L I L +++ DN++ L D + L++L + NN+
Sbjct: 20 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRI 76
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
L +L L L++N+L
Sbjct: 77 CRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 14/72 (19%), Positives = 25/72 (34%), Gaps = 11/72 (15%)
Query: 96 ITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWS------QLSN 149
L+ L +L + +N + ++ L L L NN L +
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPLASLKS 114
Query: 150 LKHLDLSSNNLT 161
L +L + N +T
Sbjct: 115 LTYLCILRNPVT 126
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 26/91 (28%), Positives = 38/91 (41%), Gaps = 10/91 (10%)
Query: 80 SLTLGSNGFSGKISPSIT--KLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNK 135
L L N +IS +L L LEL+ N L+ + F +H+Q L L NK
Sbjct: 33 ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAF-EGASHIQELQLGENK 89
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIP 165
I + L LK L+L N ++ +
Sbjct: 90 IK-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 19/68 (27%), Positives = 30/68 (44%), Gaps = 4/68 (5%)
Query: 104 SLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLT 161
L L DN+L D G + HL L L N+ + I + S+++ L L N +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 162 GRIPMQLF 169
I ++F
Sbjct: 92 -EISNKMF 98
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 38/165 (23%), Positives = 62/165 (37%), Gaps = 43/165 (26%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL----- 331
IG+G FG +++G L +N +VA+K E L +K L
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF---------EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 332 -QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTAY 383
+ + +LV + L L DL LD RK A
Sbjct: 69 PNVYYFGQEGLHNVLV---IDLLG--PSLEDL------LDLCGRKFSVKTVAMAAKQMLA 117
Query: 384 GLEYLHEQCNPKIIHRDLKAANILL----DDNFEAV-LCDFGLAK 423
++ +HE+ +++RD+K N L+ N + + DFG+ K
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 33/213 (15%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISV------AIH 327
++IG+G FG+V K + VA+K + + + A Q EV L+ + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---NQA-QIEVRLLELMNKHDTEMK 115
Query: 328 KNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKRVAFGTAYG 384
++ L + + LV+ + NL DL +G+ ++ A
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNL------YDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAKLVDAKLTH--VTTQIRGTM 440
L +L IIH DLK NILL + + + DFG + + ++ + R
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--- 225
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+PE L D++ G L+E+ TG+
Sbjct: 226 ---SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 36/161 (22%), Positives = 57/161 (35%), Gaps = 35/161 (21%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK---RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 334
IG G FG++ G L N VA+K E F +++ + Q+
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSG-----DGIPQVY 71
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTAYGLEY 387
+ +V ++ L L DL D R +A +EY
Sbjct: 72 YFGPCGKYNAMV---LELLG--PSLEDL------FDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 388 LHEQCNPKIIHRDLKAANILL-----DDNFEAVLCDFGLAK 423
+H + +I+RD+K N L+ + DF LAK
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 27/91 (29%), Positives = 38/91 (41%), Gaps = 3/91 (3%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L S G + + L L L L N L +T L +L LANN+ + S
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+P + L+ L L L N L +P +F
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVF 127
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 5/91 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N +S + L L +L L +N L+ +T L L L N+ S
Sbjct: 64 LNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-S 121
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+P+ + +L+ LK L L++N L IP F
Sbjct: 122 LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 9/93 (9%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFS 137
L L +N + + + L L L L N L +LP F +T L+ L L N+
Sbjct: 88 LGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVF-DRLTKLKELRLNTNQLQ 144
Query: 138 GSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
SIPA + +L+NL+ L LS+N L +P F
Sbjct: 145 -SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAF 175
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 40/163 (24%), Positives = 64/163 (39%), Gaps = 41/163 (25%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL----- 331
IG G FG++Y G + N +VA+K E + L+ I++ L
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---------ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 332 -QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTAY 383
+ + +LV M L L DL ++ +RK +A
Sbjct: 66 PNVRWFGVEGDYNVLV---MDLLG--PSLEDL------FNFCSRKLSLKTVLMLADQMIN 114
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEA---VLCDFGLAK 423
+E++H + +HRD+K N L+ A + DFGLAK
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 26/91 (28%), Positives = 40/91 (43%), Gaps = 3/91 (3%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L +N + +L L L L N L +T L LNL+ N+ S
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+P + +L+ LK L L++N L +P +F
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQ-SLPDGVF 120
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 23/81 (28%), Positives = 34/81 (41%), Gaps = 4/81 (4%)
Query: 82 TLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP 141
+ +N K I L + L L N L + +T+L L L N+ S+P
Sbjct: 45 QIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-DISAL-KELTNLTYLILTGNQLQ-SLP 101
Query: 142 AT-WSQLSNLKHLDLSSNNLT 161
+ +L+NLK L L N L
Sbjct: 102 NGVFDKLTNLKELVLVENQLQ 122
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L N + + KL L L L +N L +T+L LNLA+N+
Sbjct: 89 YLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ- 146
Query: 139 SIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
S+P + +L+NL LDLS N L +P +F
Sbjct: 147 SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVF 177
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 23/67 (34%), Positives = 37/67 (55%), Gaps = 6/67 (8%)
Query: 98 KLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLD 154
+L L L L N L +LP+ F +T+L+ L L N+ S+P + +L+NL +L+
Sbjct: 83 ELTNLTYLILTGNQLQ-SLPNGVFDK-LTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLN 139
Query: 155 LSSNNLT 161
L+ N L
Sbjct: 140 LAHNQLQ 146
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 5e-05
Identities = 18/114 (15%), Positives = 36/114 (31%), Gaps = 14/114 (12%)
Query: 62 VSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKF--LASLEL---QDNDLSGTL 116
+ + S N+ SL + S G + I L L L ++
Sbjct: 179 IKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGD 238
Query: 117 PDFL------GSMTHLQSLNLANNKFSGSIP---ATWSQLSNLKHLDLSSNNLT 161
+ +L+ L + + + + L L+ +D+S+ LT
Sbjct: 239 MNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 7e-05
Identities = 11/102 (10%), Positives = 38/102 (37%), Gaps = 14/102 (13%)
Query: 81 LTLGSNGFSGKISPSI-------TKLKFLASLELQDNDLSGTLPDFLGS---MTHLQSLN 130
L +G + ++ + L L + D + + + + L++++
Sbjct: 226 LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285
Query: 131 LANNKFSGS----IPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
++ + + ++ +LK +++ N L+ + +L
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 25/74 (33%), Positives = 35/74 (47%), Gaps = 6/74 (8%)
Query: 98 KLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155
L L L+L N L+ LP F + HL+ L + NK + +P +L++L HL L
Sbjct: 86 SLTQLTVLDLGTNQLT-VLPSAVF-DRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142
Query: 156 SSNNLTGRIPMQLF 169
N L IP F
Sbjct: 143 DQNQLK-SIPHGAF 155
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 19/59 (32%), Positives = 31/59 (52%), Gaps = 2/59 (3%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLT 161
L L DN ++ P S+ +L+ L L +N+ ++P + L+ L LDL +N LT
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 20/99 (20%), Positives = 36/99 (36%), Gaps = 13/99 (13%)
Query: 75 NGNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSGT-----LPDFLGSMTH 125
+ + L+L + +G +S ++ L L L L DN L L
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 126 LQSLNLANNKFS----GSIPATWSQLSNLKHLDLSSNNL 160
L+ L L S + + + K L +S+N++
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 18/98 (18%), Positives = 31/98 (31%), Gaps = 19/98 (19%)
Query: 80 SLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMT-HLQSLN 130
L L S ++ + L + +ND++ L L L++L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205
Query: 131 LANNKFSGSIPATWSQLS-------NLKHLDLSSNNLT 161
L + + L +L+ L L SN L
Sbjct: 206 LESCGVT---SDNCRDLCGIVASKASLRELALGSNKLG 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 24/100 (24%), Positives = 38/100 (38%), Gaps = 13/100 (13%)
Query: 75 NGNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSG----TLPDFLGSM-TH 125
+ L G + IS ++ LA L L+ N+L + L +
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86
Query: 126 LQSLNLANNKFS----GSIPATWSQLSNLKHLDLSSNNLT 161
+Q L+L N + G + +T L L+ L LS N L
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 126
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 45/241 (18%), Positives = 83/241 (34%), Gaps = 75/241 (31%)
Query: 278 IIGQGGFGKVYKGV--LSDNTKVAVK---RLQDYYSPGGEAAFQREVHLISV------AI 326
+G+G FGKV + + ++VA+K + Y EAA + E++++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR----EAA-RLEINVLKKIKEKDKEN 80
Query: 327 HKNLLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKR 376
+ + + C + + + +N + + + P +
Sbjct: 81 KFLCVLMSDWFNFHGHMC-------IAFELLGKNT------FEFLKENNFQPYPLPHVRH 127
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-------------------LC 417
+A+ + L +LHE ++ H DLK NIL ++ +
Sbjct: 128 MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 418 DFGLAKLVDAKLTHVTTQI-----RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
DFG A H TT + R PE + ++ DV+ G L E G
Sbjct: 185 DFGSATFDH---EHHTTIVATRHYR------PPEVILELGWAQPCDVWSIGCILFEYYRG 235
Query: 473 Q 473
Sbjct: 236 F 236
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 22/103 (21%), Positives = 41/103 (39%), Gaps = 15/103 (14%)
Query: 74 RNGNVISLTLGSN-----GFSGKISPSITKLKFLASLELQDNDLSGT----LPDFLGSMT 124
+ + ++ + N G + + + L L+LQDN + L L S
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244
Query: 125 HLQSLNLANNKFSG----SIPATWSQLSN--LKHLDLSSNNLT 161
+L+ L L + S ++ +S+L N L+ L L N +
Sbjct: 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 17/101 (16%), Positives = 37/101 (36%), Gaps = 13/101 (12%)
Query: 74 RNGNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDL-----SGTLPDFLGSMT 124
+ S+ G N + + + L ++++ N + L + L
Sbjct: 157 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 216
Query: 125 HLQSLNLANNKFSG----SIPATWSQLSNLKHLDLSSNNLT 161
L+ L+L +N F+ ++ NL+ L L+ L+
Sbjct: 217 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 19/115 (16%), Positives = 31/115 (26%), Gaps = 27/115 (23%)
Query: 74 RNGNVISLTLGSNGFSGK----------ISPSITKLKFLASLELQDNDLSGT----LPDF 119
++ + ++ K L ++ L DN T L DF
Sbjct: 58 SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 117
Query: 120 LGSMTHLQSLNLANNKFS-------------GSIPATWSQLSNLKHLDLSSNNLT 161
L T L+ L L NN ++ L+ + N L
Sbjct: 118 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 50/247 (20%), Positives = 79/247 (31%), Gaps = 83/247 (33%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISV-----AIHKN 329
+G G FG+V + + AVK R Y+ +A + E ++ + N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT---RSA-KIEADILKKIQNDDINNNN 97
Query: 330 LLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKRVAF 379
+++ G C L++ + +L ++ + G K
Sbjct: 98 IVKYHGKFMYYDHMC-------LIFEPLGPSL------YEIITRNNYNGFHIEDIKLYCI 144
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV------------------------ 415
L YL + + H DLK NILLDD +
Sbjct: 145 EILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 416 -LCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPE------YLSTGKSSEKTDVFGYGITL 466
L DFG A + T Q R APE + +D++ +G L
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYR------APEVILNLGW------DVSSDMWSFGCVL 249
Query: 467 LELVTGQ 473
EL TG
Sbjct: 250 AELYTGS 256
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 20/67 (29%), Positives = 31/67 (46%), Gaps = 3/67 (4%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
LEL+ N L +T L L+L+ N+ S+P + +L+ L L L N L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 163 RIPMQLF 169
+P +F
Sbjct: 90 SLPNGVF 96
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 7e-04
Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKF 136
L L SN + + KL L L L N + +LPD F +T L L L NK
Sbjct: 32 RLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVF-DKLTKLTILYLHENKL 88
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
S+P + +L+ LK L L +N L +P +F
Sbjct: 89 Q-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIF 120
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 595 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.88 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.81 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.8 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.66 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.65 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.6 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.58 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.54 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.54 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.53 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.52 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.52 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.48 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.47 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.46 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.45 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.44 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.41 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.39 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.38 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.38 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.38 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.38 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.37 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.37 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.37 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.37 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.37 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.36 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.36 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.36 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.35 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.35 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.34 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.33 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.32 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.32 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.32 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.31 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.3 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.3 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.3 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.3 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.29 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.29 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.28 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.28 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.27 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.27 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.27 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.27 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.27 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.25 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.25 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.25 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.24 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.24 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.24 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.23 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.23 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.23 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.23 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.22 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.22 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.21 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.21 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.21 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.21 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.21 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.2 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.19 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.19 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.19 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.19 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.18 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.18 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.18 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.17 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.16 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.15 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.15 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.15 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.14 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.12 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.06 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.05 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.02 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.01 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.0 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.0 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.0 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.98 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.98 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.97 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.96 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.96 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.95 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.9 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.89 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.89 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.88 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.84 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.83 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.82 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.82 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.81 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.8 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.8 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.79 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.77 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.76 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.67 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.61 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.51 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.46 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.45 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.44 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.38 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.35 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.18 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.11 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.07 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.94 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.94 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.86 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.86 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.76 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.69 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.65 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.62 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.46 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.43 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.24 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.16 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.1 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.04 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.03 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.0 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.93 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.89 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.5 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.47 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.44 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.44 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.37 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.32 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.31 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.08 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.54 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.19 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.81 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.03 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 93.57 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 92.24 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 92.13 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 92.08 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 91.9 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.07 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.69 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 88.22 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.05 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=436.42 Aligned_cols=257 Identities=24% Similarity=0.343 Sum_probs=213.2
Q ss_pred CCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
+++..+.||+|+||+||+|++. +++.||||+++........++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4556789999999999999862 4678999999866555667899999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc
Q 007625 346 VYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 413 (595)
|||||++|+|.++|..... ....++|.++..|+.|||.||+|||++ +||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999975321 124699999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHH
Q 007625 414 AVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 491 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~ 491 (595)
+||+|||+++....... .......||++|||||++.+..++.++|||||||++|||+| |+.||...... .+..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-----~~~~ 258 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVVE 258 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-----HHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-----HHHH
Confidence 99999999987654332 23345679999999999999999999999999999999999 89999764431 1222
Q ss_pred HHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 492 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.+. .+. ....+..++.++.+++.+||+.||++||||.||++.|+.
T Consensus 259 ~i~----~~~--------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 259 MIR----NRQ--------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHH----TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHH----cCC--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 222 111 111234455778999999999999999999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=433.59 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=212.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
.++|.+.+.||+|+||+||+|++. ++..||||+++. .+....++|.+|++++++++|||||+++|+|.+++..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 356778899999999999999863 477899999975 3455678899999999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcE
Q 007625 344 ILVYPFMQNLSVAYRLRDLK---------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 414 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 414 (595)
++|||||++|+|.++|+... .....++|.++..++.|||.||+|||++ +|+||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997532 2235799999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHH
Q 007625 415 VLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH 492 (595)
Q Consensus 415 kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~ 492 (595)
||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...... .+...
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-----~~~~~ 242 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-----EVIEC 242 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHH
Confidence 99999999876544332 2234568999999999999999999999999999999999 89999764432 12222
Q ss_pred HHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
+.. .. ....+..++.++.+++.+||+.||++||||+||++.|+.
T Consensus 243 i~~---~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 243 ITQ---GR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHH---TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHc---CC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 221 11 111233445688999999999999999999999998875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=431.78 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=207.5
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
++..+++++.+.||+|+||+||+|++++ .||||+++.. .+....+.|.+|++++++++|||||++++++.+ +..++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 4456778889999999999999999743 5999999743 345566889999999999999999999998864 56899
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
|||||++|+|.++|+.. ...+++.++..|+.|||.||+|||++ +||||||||+|||+++++.+||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999999999999753 34699999999999999999999999 9999999999999999999999999999876
Q ss_pred cCcC-cceeecccccccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 426 DAKL-THVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 426 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
.... ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||....... .+...+. .+
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~----~~~~~~~----~~- 253 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD----QIIFMVG----RG- 253 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHH----TT-
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH----HHHHHHh----cC-
Confidence 5432 223445679999999999853 468999999999999999999999997543211 1111111 11
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+.+...+..++.++.+++.+||+.||++||||.||++.|+.
T Consensus 254 ---~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 254 ---YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp ---CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred ---CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11222233344556788999999999999999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=433.56 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=206.8
Q ss_pred cCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
++|.+.++||+|+||+||+|++. ++..||||+++. .+....++|.+|++++++++|||||+++++|.+++..+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45677889999999999999864 478899999975 34556788999999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc
Q 007625 345 LVYPFMQNLSVAYRLRDLKP-----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 413 (595)
+|||||++|+|.++++.... ...+++|.++..|+.|||.||+|||+. +|+||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 99999999999999986432 124699999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHH
Q 007625 414 AVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 491 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~ 491 (595)
+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||......+ ...
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-----~~~ 271 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-----AID 271 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-----HHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-----HHH
Confidence 99999999987654332 23345679999999999999999999999999999999999 899997644321 222
Q ss_pred HHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 492 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
.+.. ..+ ...+..++.++.+++.+||+.||++||||.||+++|+..
T Consensus 272 ~i~~---g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 272 CITQ---GRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHH---TCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHc---CCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 2221 111 112334456788999999999999999999999999763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=428.68 Aligned_cols=252 Identities=20% Similarity=0.312 Sum_probs=205.8
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
++|++.+.||+|+||+||+|+.. +|+.||||++... ........|.+|++++++++|||||++++++.+++..++|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999964 7999999999743 344556789999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
||++|+|.+++.... ...+++.+++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997532 34578999999999999999999999 9999999999999999999999999999876532
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
. ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......+ .+.......
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~-------- 241 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--------LVLKIISGS-------- 241 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTC--------
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCC--------
Confidence 2 12334679999999999999999999999999999999999999998654321 111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.+..+...+.++.+++.+||+.||++|||+.|++++
T Consensus 242 -~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 242 -FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223345678899999999999999999999763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=429.44 Aligned_cols=269 Identities=25% Similarity=0.380 Sum_probs=221.7
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccceEEEEEEeCC------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCC-CCCccc
Q 007625 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQL 333 (595)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l 333 (595)
+..+++++..++|++.+.||+|+||+||+|++.. ++.||||+++........+.|.+|++++.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 5667788889999999999999999999998532 367999999876666667889999999999965 899999
Q ss_pred cceeecC-CceEEEEEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcC
Q 007625 334 IGYCTTS-SERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 400 (595)
Q Consensus 334 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 400 (595)
+|+|... +..++|||||++|+|.++|+.... ....+++..+..++.|||.||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 568999999999999999975321 134589999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 007625 401 LKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDF 478 (595)
Q Consensus 401 lkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~ 478 (595)
|||+|||+++++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999976544332 3345679999999999999999999999999999999998 8999976
Q ss_pred CchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 479 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 479 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..... .+...+... .+ ...+...+.++.+++.+||+.||++||||.||+++|+.
T Consensus 291 ~~~~~----~~~~~i~~g---~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VKIDE----EFCRRLKEG---TR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CCCSH----HHHHHHHHT---CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHH----HHHHHHHcC---CC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 43221 122222211 11 11223345678899999999999999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=405.36 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=197.4
Q ss_pred CcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeec----CCceEEEE
Q 007625 274 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVY 347 (595)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 347 (595)
+..++||+|+||+||+|+.. ++..||+|++... ........|.+|++++++++|||||++++++.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999964 6899999999743 344556789999999999999999999999865 34578999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-CCcEEEeecccccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVD 426 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~~~~~~ 426 (595)
|||++|+|.+++.. ...+++..+..++.||+.||+|||++ +++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999986 34689999999999999999999998 123999999999999984 7899999999998654
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.. ......||+.|||||++.+ +|+.++|||||||++|||+||+.||....... .+...+ ..+.....+
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~----~~~~~i----~~~~~~~~~ 251 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIYRRV----TSGVKPASF 251 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHHHHH----TTTCCCGGG
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH----HHHHHH----HcCCCCCCC
Confidence 32 2345679999999999865 69999999999999999999999997533211 111111 111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+ ...+.++.+++.+||+.||++|||+.|+++
T Consensus 252 ~-------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 D-------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G-------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 112346788999999999999999999965
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=416.53 Aligned_cols=250 Identities=20% Similarity=0.210 Sum_probs=204.3
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+.|+..++||+|+||+||+|+.. +|+.||||+++.... +.+|+.++++++|||||++++++.+++..++||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 46778889999999999999964 699999999974321 24799999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC-cEEEeeccccccccCc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK 428 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~~~~~ 428 (595)
|++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++ ++||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999986 34699999999999999999999999 999999999999999987 6999999999977543
Q ss_pred Ccc----eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 429 LTH----VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 429 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||........ . ..+.. ..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~-~~i~~---~~---- 272 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----C-LKIAS---EP---- 272 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----H-HHHHH---SC----
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----H-HHHHc---CC----
Confidence 211 12345799999999999999999999999999999999999999976443211 1 11111 11
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
..+...++..+.++.+++.+||+.||++|||+.|+++.|..
T Consensus 273 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 273 ---PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp ---CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 01111233445678899999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=416.93 Aligned_cols=249 Identities=22% Similarity=0.278 Sum_probs=207.6
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+.|+..+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++++++|||||++++++.+++..++||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 46888999999999999999965 79999999996322 23345688999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
|++|+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999875 3589999999999999999999999 99999999999999999999999999999775432
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ ....+.. .. .+.
T Consensus 225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----~~~~i~~----~~-----~~~ 289 (346)
T 4fih_A 225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRD----NL-----PPR 289 (346)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHH----SS-----CCC
T ss_pred C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHHHHHc----CC-----CCC
Confidence 2 2345679999999999999999999999999999999999999997643211 1122211 10 000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+ ..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 290 ~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 L-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp C-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 112334567889999999999999999999854
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=416.15 Aligned_cols=317 Identities=62% Similarity=1.043 Sum_probs=264.8
Q ss_pred CCcccccccccccCHHHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCC
Q 007625 249 DDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328 (595)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~ 328 (595)
+.......+...++.+++....++|+..+.||+|+||+||+|+..+++.||+|++...........+.+|+++++.++||
T Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ 87 (326)
T 3uim_A 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 87 (326)
T ss_dssp -------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCT
T ss_pred cCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCC
Confidence 33344455677899999999999999999999999999999998889999999997544334444789999999999999
Q ss_pred CCccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE
Q 007625 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 408 (595)
Q Consensus 329 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 408 (595)
||+++++++...+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++|+||||||+||++
T Consensus 88 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~ 167 (326)
T 3uim_A 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167 (326)
T ss_dssp TBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred CccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence 99999999999999999999999999999999766666679999999999999999999999877789999999999999
Q ss_pred cCCCcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhh
Q 007625 409 DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488 (595)
Q Consensus 409 ~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~ 488 (595)
+.++.+||+|||+++..............||+.|+|||++.+..++.++||||||+++|||+||+.||+...........
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 99999999999999987655555555667999999999998888999999999999999999999999755444445556
Q ss_pred HHHHHHHHhccccccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccchhhHHHHHHHHHH
Q 007625 489 LLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVR 565 (595)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~ 565 (595)
..+|+.............+..+.. ........+.+++.+||+.||.+|||+.||+++|+...+.+.|.+|...+..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~ 325 (326)
T 3uim_A 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFR 325 (326)
T ss_dssp HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC---------
T ss_pred HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHHHhhc
Confidence 777777776777777777766554 77888999999999999999999999999999999999999998877666544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=413.10 Aligned_cols=266 Identities=23% Similarity=0.312 Sum_probs=201.5
Q ss_pred cCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC----ceEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERILV 346 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 346 (595)
.+|.+.+.||+|+||+||+|++ +|+.||||++... ......++.|+..+.+++|||||++++++..++ ..++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~--~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc--chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 3567789999999999999998 6899999998642 122233445666677899999999999997654 57899
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ-----CNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
||||++|+|.++++. ..++|..+.+++.|++.||+|||++ ..++|+||||||+|||+++++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999985 3589999999999999999999976 245899999999999999999999999999
Q ss_pred cccccCcCcce---eecccccccccCccccCCC------CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhh------h
Q 007625 422 AKLVDAKLTHV---TTQIRGTMGHIAPEYLSTG------KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE------D 486 (595)
Q Consensus 422 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~------~ 486 (595)
++......... .....||+.|||||++.+. +++.++|||||||++|||+||+.|+......... .
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98775443222 2345799999999998754 4678999999999999999998877543211000 0
Q ss_pred hhHHHHHHHHhccccccccccccCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 487 VLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 487 ~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
......+........ +++.++. ...+....+.+++.+||+.||++||||.||++.|+.
T Consensus 235 ~~~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 001111222211111 2222222 134567789999999999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=415.22 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=209.2
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+|+. .+|+.||+|++... ........+.+|++++++++|||||++++++.+++..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999996 47999999999632 12344678999999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999986 34699999999999999999999999 999999999999999999999999999998754
Q ss_pred cCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+..+ +...+. .. ..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----~~~~i~---~~-~~---- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-----IFAKII---KL-EY---- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---HT-CC----
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHH---cC-CC----
Confidence 332 23456789999999999999999999999999999999999999998654321 111111 11 10
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 543 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 543 (595)
.++...+.++.+++.+|++.||++|||++|++
T Consensus 252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11223345788899999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=400.35 Aligned_cols=246 Identities=21% Similarity=0.330 Sum_probs=192.2
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+|+. .+|+.||+|++.... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999996 479999999996432 2344677999999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+ +|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6799999876 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.. ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||....... +...+.. +..
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-----~~~~i~~----~~~---- 229 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-----LFKNISN----GVY---- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----TCC----
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHc----CCC----
Confidence 32 2344679999999999998876 579999999999999999999998643321 1121211 110
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.++...+.++.+++.+|++.||++|||++|+++
T Consensus 230 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112223457788999999999999999999976
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=416.39 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=208.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.+.|+..+.||+|+||+||+|+.. +|+.||||++... .......+.+|+.+++.++|||||++++++.+++..++|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST-TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 356999999999999999999964 7999999999643 23345668899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
||++|+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 229 y~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 229 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp CCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 9999999999874 3589999999999999999999999 9999999999999999999999999999877543
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....... ....+.. .. .+
T Consensus 301 ~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----~~~~i~~----~~-----~~ 365 (423)
T 4fie_A 301 VP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRD----NL-----PP 365 (423)
T ss_dssp CC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHH----SC-----CC
T ss_pred Cc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHHHHHc----CC-----CC
Confidence 22 2345679999999999999999999999999999999999999997543211 1122211 10 00
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.+ ........++.+++.+||+.||++|||+.|+++
T Consensus 366 ~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 366 RL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CC-SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01 112233467888999999999999999999955
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=407.81 Aligned_cols=243 Identities=23% Similarity=0.278 Sum_probs=195.1
Q ss_pred cCCCcCCeeeeccceEEEEEEe----CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
++|++.+.||+|+||+||+|+. .+++.||+|+++... .......+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999985 247899999986422 22334468899999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999986 34699999999999999999999999 9999999999999999999999999999865
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
..... ......||+.|||||++.+..|+.++||||+||++|||+||+.||...+..+ +...+. .. ..
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-----~~~~i~---~~-~~--- 243 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-----TMTMIL---KA-KL--- 243 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---HC-CC---
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-----HHHHHH---cC-CC---
Confidence 43322 2345679999999999999999999999999999999999999998654321 111111 11 10
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 539 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 539 (595)
.++...+.++.+++.+||+.||++|||+
T Consensus 244 ------~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ------GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1223344678899999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=399.89 Aligned_cols=251 Identities=20% Similarity=0.299 Sum_probs=191.2
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC--------
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-------- 341 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 341 (595)
++|++.+.||+|+||+||+|+.. +|+.||||+++........+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35889999999999999999964 789999999975555556678999999999999999999999986544
Q ss_pred ----ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEe
Q 007625 342 ----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC 417 (595)
Q Consensus 342 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 417 (595)
..++||||+++|+|.+++..... ....++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999985332 23456777899999999999999999 99999999999999999999999
Q ss_pred eccccccccCcCcc-----------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhh
Q 007625 418 DFGLAKLVDAKLTH-----------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED 486 (595)
Q Consensus 418 DfG~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~ 486 (595)
|||+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||.... +.
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~ 233 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ER 233 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HH
Confidence 99999877543221 1233579999999999999999999999999999999997 765311 11
Q ss_pred hhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 487 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 487 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
...+... .... .+...........+++.+||+.||++|||+.|+++
T Consensus 234 ---~~~~~~~-~~~~--------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 ---VRTLTDV-RNLK--------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---HHHHHHH-HTTC--------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHH-hcCC--------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 1111 11112233455678999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=390.91 Aligned_cols=263 Identities=18% Similarity=0.259 Sum_probs=203.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeec------CC
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT------SS 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 341 (595)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... .......+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999964 79999999997432 34455778899999999999999999998754 35
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++|||||+ |+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 679888875 45799999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcC---cceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHh
Q 007625 422 AKLVDAKL---THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 497 (595)
Q Consensus 422 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 497 (595)
++.+.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+. ...+....
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-----l~~I~~~~ 279 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-----LQLIMMVL 279 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-----HHHHHHHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-----HHHHHHhc
Confidence 98764322 2233456899999999998875 469999999999999999999999987543221 11111111
Q ss_pred cccccc---c--------c---ccccCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 498 REDRLN---D--------I---VDRNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 498 ~~~~~~---~--------~---~d~~l~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...... . . +...... ..+....++.+++.+||+.||++|||+.|++++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 100000 0 0 0000000 011224577889999999999999999999653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=382.66 Aligned_cols=199 Identities=23% Similarity=0.366 Sum_probs=171.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCce
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (595)
..++|++.+.||+|+||+||+|+.+ +++.||+|++... .....+.+|++++..+ +||||+++++++.+.+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4678999999999999999999853 4678999998643 2345678999999988 699999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-CcEEEeecccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLA 422 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~ 422 (595)
++||||+++|+|.+++. .+++.+++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999884 388999999999999999999999 99999999999999877 79999999999
Q ss_pred ccccCcCc---------------------------ceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCC
Q 007625 423 KLVDAKLT---------------------------HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQR 474 (595)
Q Consensus 423 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~ 474 (595)
+....... ......+||+.|+|||++.+. .++.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86543211 112335699999999999876 48999999999999999999999
Q ss_pred CCCCCc
Q 007625 475 AIDFSR 480 (595)
Q Consensus 475 p~~~~~ 480 (595)
||....
T Consensus 246 Pf~~~~ 251 (361)
T 4f9c_A 246 PFYKAS 251 (361)
T ss_dssp SSSCCS
T ss_pred CCCCCC
Confidence 996543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=374.75 Aligned_cols=282 Identities=38% Similarity=0.615 Sum_probs=237.3
Q ss_pred CHHHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 262 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
+..++...+++|+..+.||+|+||+||+|+.++++.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 334445578899999999999999999999888999999998643 3345678999999999999999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+++++|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999986544445699999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcC-cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 422 AKLVDAKL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 422 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
++...... ........||+.|+|||++.+..++.++||||||+++|||+||+.||....... ......|.......+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE--MVNLAEWAVESHNNG 263 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS--CCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH--HHHHHHHhhhccccc
Confidence 98654322 222334558999999999988899999999999999999999999997654322 223445555555555
Q ss_pred cccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 501 RLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 501 ~~~~~~d~~l~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
.....+++.+.. ........+.+++.+||+.||++|||+.||++.|+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 566666665543 6788899999999999999999999999999999753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=394.20 Aligned_cols=250 Identities=24% Similarity=0.270 Sum_probs=200.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHH---HHHHHHHhcCCCCCccccceeecCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQ---REVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
.++|++.++||+|+||+||+|+.+ +|+.||+|++.... .......+. .++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999965 79999999996321 112222333 446677788999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||++||+|.+++.. ...+++..+..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999986 34699999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
...... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||........ .......... .
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~i~~~-~- 410 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTM-A- 410 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHHHHHC-C-
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhcCC-C-
Confidence 765432 344679999999999974 5799999999999999999999999975432211 1111111111 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 544 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 544 (595)
..++...+.++.+++.+|++.||.+|++ ++||.+
T Consensus 411 --------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 --------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1122334567889999999999999998 677643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=394.75 Aligned_cols=253 Identities=22% Similarity=0.280 Sum_probs=209.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++... .......+.+|+++|+.++|||||++++++.++...++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 368999999999999999999964 7999999998643 33456778999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC--CcEEEeecccccccc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN--FEAVLCDFGLAKLVD 426 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG~~~~~~ 426 (595)
||++|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 235 ~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999988642 34699999999999999999999999 99999999999999854 899999999999875
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+ ....+. ... . .+.
T Consensus 309 ~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-----~~~~i~---~~~-~-~~~ 376 (573)
T 3uto_A 309 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-----TLRNVK---SCD-W-NMD 376 (573)
T ss_dssp TTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHH---TTC-C-CCC
T ss_pred CCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHHHHH---hCC-C-CCC
Confidence 432 3345679999999999999999999999999999999999999998654321 111111 111 0 000
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.. ......++.+++.+||+.||++|||+.|++++
T Consensus 377 ~~~----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 377 DSA----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SGG----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 11234567889999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=349.99 Aligned_cols=283 Identities=38% Similarity=0.638 Sum_probs=234.6
Q ss_pred cccccCHHHHHHHhcCCCcC------CeeeeccceEEEEEEeCCCcEEEEEEeccCC---CchhHHHHHHHHHHHHhcCC
Q 007625 257 QLRRFSCRELQLATDNFSES------NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIH 327 (595)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~h 327 (595)
....++++++..++++|... +.||+|+||+||+|.. +++.||+|++.... .......+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35678999999999999887 8999999999999997 68899999986432 23456789999999999999
Q ss_pred CCCccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEE
Q 007625 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 407 (595)
Q Consensus 328 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 407 (595)
|||+++++++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999975432 35699999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhh
Q 007625 408 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED 486 (595)
Q Consensus 408 l~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~ 486 (595)
++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-- 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence 999999999999999876543222 2334568999999998864 589999999999999999999999986543221
Q ss_pred hhHHHHHHHHh-ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 487 VLLLDHIRKLL-REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 487 ~~l~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+..... ....+...+++.+...+......+.+++.+||+.||.+|||+.||++.|+..
T Consensus 243 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 243 --LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp --TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111111 1223345556666667888899999999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=366.55 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=214.5
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe--------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeec
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 339 (595)
..++|++.+.||+|+||+||+|+. .++..||+|+++..........+.+|+.+++.+ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 346788999999999999999985 235679999998655556677899999999999 89999999999999
Q ss_pred CCceEEEEEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEE
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 407 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 407 (595)
.+..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999986432 124589999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhh
Q 007625 408 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE 485 (595)
Q Consensus 408 l~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~ 485 (595)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 999999999999999876543221 2233457889999999999999999999999999999999 999997644321
Q ss_pred hhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 486 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 486 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
+...+.. +. ....+.....++.+++.+||+.||++||++.|+++.|+..
T Consensus 314 ---~~~~~~~----~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 ---LFKLLKE----GH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp ---HHHHHHT----TC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhc----CC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111 10 0112233456788999999999999999999999999763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=352.11 Aligned_cols=257 Identities=23% Similarity=0.407 Sum_probs=210.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|+..+.||+|+||+||+|... +++.||+|++.. ........|.+|++++++++||||+++++++.+++..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 457888999999999999999974 689999999854 345667889999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999999863 34689999999999999999999999 9999999999999999999999999999876443
Q ss_pred Ccce-------------eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhh-hhhHHHHHH
Q 007625 429 LTHV-------------TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE-DVLLLDHIR 494 (595)
Q Consensus 429 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~-~~~l~~~~~ 494 (595)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..|+......... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 11456999999999999999999999999999999999999998753322111 111111111
Q ss_pred HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
.. .+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 242 ~~----------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 242 RY----------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp HT----------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 10 1122234678899999999999999999999999763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=356.46 Aligned_cols=266 Identities=26% Similarity=0.404 Sum_probs=206.3
Q ss_pred CHHHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecC
Q 007625 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (595)
Q Consensus 262 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 340 (595)
..+++.+..++|++.+.||+|+||+||+|+. +++.||+|++.... .......+.+|++++++++||||+++++++...
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3444555677899999999999999999987 68899999987433 344567899999999999999999999999999
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--cEEcCCCCCCEEEcCCCcEEEee
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEAVLCD 418 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~D 418 (595)
+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred CceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECC
Confidence 999999999999999999985221 12489999999999999999999999 7 99999999999999999999999
Q ss_pred ccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
||+++...... .......||+.|+|||++.+..++.++||||||+++|||+||+.||....... ....+..
T Consensus 183 fg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-----~~~~~~~--- 253 (309)
T 3p86_A 183 FGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAAVGF--- 253 (309)
T ss_dssp CC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHH---
T ss_pred CCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh---
Confidence 99998654322 12234568999999999999999999999999999999999999997544321 1111110
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
.. .....+.....++.+++.+||+.||++|||+.||++.|+..
T Consensus 254 ~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 254 KC--------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp SC--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC--------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 00112233446788999999999999999999999999763
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=357.11 Aligned_cols=258 Identities=25% Similarity=0.375 Sum_probs=211.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
..++|++.+.||+|+||+||+|+.. .+..||||+++..........|.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3467888999999999999999974 345699999986666667788999999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 127 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999753 34699999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCcc--eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 425 VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 425 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ....+. ....
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~~~~---~~~~ 272 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-----VISSVE---EGYR 272 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----HHHHHH---TTCC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHH---cCCC
Confidence 7543222 2223346788999999998899999999999999999999 999997543321 111111 1110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus 273 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 273 ---------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111233456788999999999999999999999999763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=347.00 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=213.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
..++|+..+.||+|+||+||+|...+++.||+|++.... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 346788899999999999999999889999999997532 345678999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999753 34689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.........+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ....+. ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-----~~~~~~---~~~~------ 225 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDIS---TGFR------ 225 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHH---TTCC------
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHh---cCcc------
Confidence 3333344557889999999998999999999999999999999 999997544321 111111 1100
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+......+.+++.+|++.||++||++.|++++|++.
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 226 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 011222346788999999999999999999999999763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=345.34 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=214.1
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
..++|++.+.||+|+||+||+|..+++..||+|+++... .....+.+|++++.+++||||+++++++......++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 456889999999999999999999888899999997532 345678999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999763 23589999999999999999999999 9999999999999999999999999999877654
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.........+|+.|+|||++.+..++.++||||||+++|||+| |+.||........ .........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------~~~~~~~~~------ 223 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV--------VLKVSQGHR------ 223 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--------HHHHHTTCC------
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH--------HHHHHcCCC------
Confidence 4433444557788999999998889999999999999999999 9999975443211 111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
...+......+.+++.+|++.||++|||+.|+++.|+...
T Consensus 224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 224 ---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0111223457889999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=355.75 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=208.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
..++|++.+.||+|+||.||+|+. .+|+.||+|++... ........+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 456899999999999999999996 58999999999643 3445567789999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999999762 4589999999999999999999999 99999999999999999999999999998665
Q ss_pred CcCcceeecccccccccCccccCCCCCC-ccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSS-EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
... ......||+.|+|||++.+..++ .++|||||||++|||++|+.||....... +...+. . +..
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~---~-~~~--- 231 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-----LRERVL---R-GKY--- 231 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---H-CCC---
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHH---h-CCC---
Confidence 432 23446799999999999888765 79999999999999999999998654321 111111 1 110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..+.....++.+++.+|++.||.+|||++|++++
T Consensus 232 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122234577889999999999999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=359.98 Aligned_cols=267 Identities=26% Similarity=0.407 Sum_probs=218.0
Q ss_pred HHHHHHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCcccccee
Q 007625 264 RELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 337 (595)
..+....++|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344556788999999999999999999964 34789999998655566678899999999999999999999999
Q ss_pred ecCCceEEEEEecccCcHhhhhcccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcE
Q 007625 338 TTSSERILVYPFMQNLSVAYRLRDLKPG--------------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397 (595)
Q Consensus 338 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 397 (595)
...+..++||||+++++|.+++...... ...+++.+++.++.|++.||+|||+. +|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 9999999999999999999999864321 25699999999999999999999999 999
Q ss_pred EcCCCCCCEEEcCCCcEEEeeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCC
Q 007625 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRA 475 (595)
Q Consensus 398 H~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p 475 (595)
||||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||+| |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999986643322 22234568899999999998899999999999999999999 9999
Q ss_pred CCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 476 IDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 476 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
|......+ ....+ ..+. ....+...+..+.+++.+||+.||++||++.||++.|+...
T Consensus 277 ~~~~~~~~-----~~~~~----~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 277 YYGMAHEE-----VIYYV----RDGN--------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTTSCHHH-----HHHHH----HTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCChHH-----HHHHH----hCCC--------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 97543211 11111 1111 11122334467889999999999999999999999998743
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=349.15 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=207.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|+..+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 46899999999999999999995 578999999986432 2345678999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999975 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.. ......||+.|+|||++.+..++.++||||||+++|||+||+.||........ ...... .... .
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~~~~----~~~~-~---- 235 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----LYLIAT----NGTP-E---- 235 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHH----HCSC-C----
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHh----CCCC-C----
Confidence 32 23345699999999999999999999999999999999999999975433211 111111 1100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...+......+.+++.+||+.||++|||+.|++++
T Consensus 236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01123344678899999999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=346.66 Aligned_cols=261 Identities=23% Similarity=0.317 Sum_probs=207.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|++.+.||+|+||.||+|+.. ++..||+|++... ........+.+|+.++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999964 7899999998632 2334557899999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999863 4689999999999999999999999 99999999999999999999999999998775
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
...........||+.|+|||++.+..++.++||||||+++|||+||+.||........ ........ .....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--------~~~~~~~~-~~~~~ 233 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--------AIKHIQDS-VPNVT 233 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--------HHHHHSSC-CCCHH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHhhcc-CCCcc
Confidence 5443344456799999999999999999999999999999999999999986543211 11111111 00000
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcCc
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRP-PMAQVVKMLQGED 550 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~ 550 (595)
. ......+..+.+++.+|++.||++|| ++.++.+.|+...
T Consensus 234 ~----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 234 T----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp H----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred h----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0 01223346788999999999999998 8999999987643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=366.09 Aligned_cols=260 Identities=27% Similarity=0.388 Sum_probs=213.2
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
.+..++|++.+.||+|+||.||+|++. +++.||||+++..........|.+|++++++++||||+++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 345567888999999999999999976 7899999999765555556788999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999753 23589999999999999999999999 9999999999999999999999999999865
Q ss_pred cCcCccee-ecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 426 DAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 426 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
........ ....+++.|+|||++.+..++.++|||||||++|||+| |..||....... ....+. ...+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-----~~~~~~---~~~~-- 333 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----TREFVE---KGGR-- 333 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-----HHHHHH---TTCC--
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH---cCCC--
Confidence 43221111 12235778999999998899999999999999999998 999997543321 111111 1111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 334 -------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 -------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111223446788999999999999999999999999763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=361.71 Aligned_cols=258 Identities=27% Similarity=0.406 Sum_probs=201.3
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
..++|++.+.||+|+||.||+|+.. ++..||||+++..........|.+|+.++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3457999999999999999999864 577899999986555666788999999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++++|.++++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 999999999999999753 34689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCcce--eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 425 VDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 425 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ....+.. ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-----~~~~i~~---~~~ 268 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-----VIKAVDE---GYR 268 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----HHHHHHT---TEE
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHc---CCC
Confidence 65432221 122335778999999999999999999999999999998 999997543211 1111111 100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+...+..+.+++.+||+.||++||++.||++.|+..
T Consensus 269 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 ---------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ---------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 011223456788999999999999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=363.30 Aligned_cols=271 Identities=24% Similarity=0.388 Sum_probs=219.3
Q ss_pred ccCHHHHHHHhcCCCcCCeeeeccceEEEEEEe------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCcc
Q 007625 260 RFSCRELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQ 332 (595)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 332 (595)
.+...+++...++|++.+.||+|+||.||+|++ .+++.||||+++........+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 356677788899999999999999999999983 246789999998665556677899999999999 7999999
Q ss_pred ccceeecCCc-eEEEEEecccCcHhhhhcccCCC----------------------------------------------
Q 007625 333 LIGYCTTSSE-RILVYPFMQNLSVAYRLRDLKPG---------------------------------------------- 365 (595)
Q Consensus 333 l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------- 365 (595)
+++++...+. .++||||+++|+|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999887654 89999999999999999864321
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 366 ----------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 366 ----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12289999999999999999999999 99999999999999999999999999998664432
Q ss_pred c-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 430 T-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 430 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
. .......||+.|+|||++.+..++.++||||||+++|||+| |+.||........ ....+.. ..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----~~~~~~~----~~------ 313 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKE----GT------ 313 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----HHHHHHH----TC------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH----HHHHHHc----CC------
Confidence 2 23344568999999999999999999999999999999998 9999976443211 1111111 10
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
....+.....++.+++.+||+.||.+|||+.||+++|+..
T Consensus 314 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 314 --RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 0111222345788999999999999999999999999763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.98 Aligned_cols=274 Identities=18% Similarity=0.207 Sum_probs=217.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC--ceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 346 (595)
.++|++.+.||+|+||+||+|+.. +++.||+|++...........+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 457889999999999999999975 589999999975444455678889999999999999999999987665 67999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE----cCCCcEEEeecccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLA 422 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~~ 422 (595)
|||+++++|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999986432 23499999999999999999999999 99999999999999 78888999999999
Q ss_pred ccccCcCcceeecccccccccCccccC--------CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHH
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLS--------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~ 494 (595)
+....... .....||+.|+|||++. +..++.++|||||||++|||+||+.||..................
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 87654332 23456899999999986 577899999999999999999999999754332222222222222
Q ss_pred HHhccccccccc---------cccC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 495 KLLREDRLNDIV---------DRNL---NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 495 ~~~~~~~~~~~~---------d~~l---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
......+..+. ...+ ..........+.+++.+||+.||++|||+.|+++...+..
T Consensus 242 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 -GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp -HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred -CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11111111110 0011 1256788889999999999999999999999999988644
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=350.46 Aligned_cols=258 Identities=20% Similarity=0.322 Sum_probs=200.3
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCC----CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
+..++|++.+.||+|+||+||+|.... +..||+|+++..........+.+|+.++++++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 345688999999999999999999642 45799999876555566778999999999999999999999974 5678
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 9999999999999999753 24689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..............+|+.|+|||++.+..++.++||||||+++|||++ |..||....... ....+. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-----~~~~i~---~~~-- 234 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIE---NGE-- 234 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHHHH---TTC--
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----HHHHHH---cCC--
Confidence 775543333334457889999999998899999999999999999997 999997644321 111111 111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
....+...+..+.+++.+|++.||++|||+.|+++.|+..
T Consensus 235 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 235 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0112233456788999999999999999999999999763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.29 Aligned_cols=266 Identities=24% Similarity=0.376 Sum_probs=212.4
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEe------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceee
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 338 (595)
++...++|++.+.||+|+||+||+|+. .++..||+|+++..........+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445678899999999999999999995 245689999997544445567899999999999 8999999999999
Q ss_pred cCCceEEEEEecccCcHhhhhcccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEc
Q 007625 339 TSSERILVYPFMQNLSVAYRLRDLKPG-------------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHR 399 (595)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 399 (595)
..+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999864321 13489999999999999999999999 99999
Q ss_pred CCCCCCEEEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 007625 400 DLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 477 (595)
Q Consensus 400 Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~ 477 (595)
||||+||+++.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|||+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999876543322 2334557889999999998899999999999999999998 999997
Q ss_pred CCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 478 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 478 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
....... ....+. .... ...+.....++.+++.+||+.||.+|||+.||++.|+...
T Consensus 277 ~~~~~~~----~~~~~~----~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 277 GIPVDAN----FYKLIQ----NGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp TCCCSHH----HHHHHH----TTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCcHHH----HHHHHh----cCCC--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 6443211 111111 1100 0112233467889999999999999999999999998643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=360.80 Aligned_cols=259 Identities=28% Similarity=0.376 Sum_probs=212.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
.++|++.+.||+|+||+||+|++. ++..||||+++..........+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 457888999999999999999943 46789999998666666777899999999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC---cEEEe
Q 007625 344 ILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLC 417 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 417 (595)
++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986442 234689999999999999999999999 999999999999999554 59999
Q ss_pred eccccccccCcC-cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHH
Q 007625 418 DFGLAKLVDAKL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 418 DfG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |..||....... ....+.
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-----~~~~i~- 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVT- 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHH-
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH-
Confidence 999998653322 122334557899999999999999999999999999999998 999997644321 111111
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.... ...+......+.+++.+||+.||++|||+.||++.|+.
T Consensus 301 --~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 301 --SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp --TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --cCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111 11122334578899999999999999999999999976
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=346.98 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=202.4
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHh--cCCCCCccccceeecC----Cc
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTTS----SE 342 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~ 342 (595)
..++|++.+.||+|+||+||+|+. +++.||||++.. .....+..|.+++.. ++||||+++++++... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 356899999999999999999998 789999999864 334556667777666 7999999999986543 45
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCcEEcCCCCCCEEEcCCCcE
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--------EQCNPKIIHRDLKAANILLDDNFEA 414 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~ 414 (595)
.++||||+++|+|.++++. ..+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 7899999999999999963 46899999999999999999999 77 99999999999999999999
Q ss_pred EEeeccccccccCcCcce---eecccccccccCccccCCC------CCCccchhHHHHHHHHHHHhC----------CCC
Q 007625 415 VLCDFGLAKLVDAKLTHV---TTQIRGTMGHIAPEYLSTG------KSSEKTDVFGYGITLLELVTG----------QRA 475 (595)
Q Consensus 415 kl~DfG~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlGvvl~elltg----------~~p 475 (595)
||+|||+++......... .....||+.|+|||++.+. .++.++||||||+++|||+|| +.|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999998765443322 2234699999999999876 455799999999999999999 777
Q ss_pred CCCCchhhhhhhhHHHHHHHHhccccccccccccCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 476 IDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 476 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
|.......... ............ .+.++. ........+.+++.+||+.||++|||+.||++.|+.
T Consensus 233 f~~~~~~~~~~----~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 233 FYDVVPNDPSF----EDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTTTSCSSCCH----HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCCCCcch----hhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 75432211111 111111111110 011111 234567889999999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=358.85 Aligned_cols=262 Identities=27% Similarity=0.395 Sum_probs=215.5
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC--------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceee
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 338 (595)
+..++|.+.+.||+|+||+||+|+.. ++..||+|+++..........+.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578899999999999999999852 34579999998766666678899999999999 8999999999999
Q ss_pred cCCceEEEEEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCE
Q 007625 339 TSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (595)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 406 (595)
..+..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 99999999999999999999986432 124599999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhh
Q 007625 407 LLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 484 (595)
Q Consensus 407 ll~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~ 484 (595)
+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |..||.......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~- 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999987654322 22333457889999999999999999999999999999999 999997544321
Q ss_pred hhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 485 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 485 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
....+. .... ...+.....++.+++.+||+.||++|||+.||++.|+..
T Consensus 302 ----~~~~~~---~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 302 ----LFKLLK---EGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp ----HHHHHH---TTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHH---cCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 1111 111223346788999999999999999999999999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=345.03 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=210.8
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.+..++|++.+.||+|+||+||+|...++..||+|+++... .....+.+|++++.+++||||+++++++.+.+..++|
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 34567889999999999999999999888899999997532 3356789999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 98 TEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp ECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999997532 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
...........+|+.|+|||++.+..++.++||||||+++|||+| |+.||....... ....+. ....
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~---~~~~---- 239 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHIA---QGLR---- 239 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHH---TTCC----
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-----HHHHHh---cccC----
Confidence 443333334457889999999998899999999999999999998 999997544321 111111 1100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+......+.+++.+||+.||++|||+.|+++.|++.
T Consensus 240 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 240 -----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 011122245788999999999999999999999999763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=344.91 Aligned_cols=262 Identities=20% Similarity=0.257 Sum_probs=213.7
Q ss_pred cccCHHHHHHHhcC----------CCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCC
Q 007625 259 RRFSCRELQLATDN----------FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 327 (595)
Q Consensus 259 ~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h 327 (595)
..++.+++..+++. |+..+.||+|+||.||+|+.. +|+.||||++... .......+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-TCCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc-chhHHHHHHHHHHHHHhCCC
Confidence 34677777777664 666789999999999999976 7999999998643 23456778999999999999
Q ss_pred CCCccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEE
Q 007625 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 407 (595)
Q Consensus 328 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 407 (595)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999998864 3589999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhh
Q 007625 408 LDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 487 (595)
Q Consensus 408 l~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~ 487 (595)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---- 248 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---- 248 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 99999999999999987654322 2234569999999999999999999999999999999999999997543211
Q ss_pred hHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 488 LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 488 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+... .. +.+ .........+.+++.+||+.||++|||+.|+++.
T Consensus 249 -~~~~~~~~----~~-----~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 -AMKRLRDS----PP-----PKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -HHHHHHHS----SC-----CCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHHHhcC----CC-----CCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111 00 000 0112234578889999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=352.64 Aligned_cols=269 Identities=26% Similarity=0.301 Sum_probs=207.5
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc----eE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----RI 344 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~ 344 (595)
..++|++.++||+|+||+||+|+.. ++.||||++... ......+..|+.++.+++||||+++++++..... .+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 4568899999999999999999974 789999998642 2344566778999999999999999999987543 69
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------CCCcEEcCCCCCCEEEcCCCcEEEe
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-------NPKIIHRDLKAANILLDDNFEAVLC 417 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl~ 417 (595)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999975 34899999999999999999999862 3379999999999999999999999
Q ss_pred eccccccccCcCcc-eeecccccccccCccccCCC-----CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhh-----
Q 007625 418 DFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED----- 486 (595)
Q Consensus 418 DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~----- 486 (595)
|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||..........
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999876543322 22335699999999999763 45678999999999999999999997643211100
Q ss_pred ---hhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 487 ---VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 487 ---~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
........... .......+.... .......++.+++.+||+.||++|||+.||++.|+.
T Consensus 254 ~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 254 GQHPSLEDMQEVVV-HKKKRPVLRDYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp CSSCCHHHHHHHHT-TSCCCCCCCGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCchhhhhhhhh-cccCCCCccccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 01111111111 111111111100 123456779999999999999999999999999976
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=349.63 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=215.4
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEe------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
...++|.+.+.||+|+||.||+|.. .++..||+|+++..........+.+|++++++++||||+++++++...+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3567889999999999999999985 2457899999986556666788999999999999999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCC
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKP--------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 401 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 401 (595)
..++||||+++++|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence 99999999999999999986432 123489999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 007625 402 KAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (595)
Q Consensus 402 kp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~ 479 (595)
||+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543322 2233457889999999998889999999999999999999 99999764
Q ss_pred chhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 480 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 480 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
.... ....+.. .. ....+......+.+++.+||+.||++||++.|+++.|+..
T Consensus 257 ~~~~-----~~~~~~~----~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 257 PPER-----LFNLLKT----GH--------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CGGG-----HHHHHHT----TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHH-----HHHHhhc----CC--------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 4321 1111111 10 0112233456788999999999999999999999999763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=347.07 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=204.4
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
..++|++.+.||+|+||+||+|+..+++.||+|++.... .......+.+|++++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 346899999999999999999999889999999997432 3334577889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++ +|.+.+... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99985 777777652 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc---cc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR---LN 503 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~---~~ 503 (595)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+........ +.
T Consensus 172 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 172 PVRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-----LPKIFSILGTPNPREWP 245 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-----HHHHHHHHCCCCTTTSG
T ss_pred Cccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHHCCCChHHhh
Confidence 3222 233468999999999876 5689999999999999999999999986543221 111211111110 00
Q ss_pred cc------cccc---CCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 504 DI------VDRN---LNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 504 ~~------~d~~---l~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. .+.. ... ..+....++.+++.+|++.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 0000 000 111234578899999999999999999999763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=351.12 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=203.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||+||+|+.. +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999965 7899999998754444445678899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999875 34699999999999999999999999 9999999999999999999999999999866432
Q ss_pred Cc-ceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 429 LT-HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 429 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+.. .... .
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~----~~~~---~ 228 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWKE----KKTY---L 228 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH---HHHHHHT----TCTT---S
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHHhc----cccc---C
Confidence 22 22334679999999999987775 7789999999999999999999976443211 1111111 0000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.........+.+++.+|++.||++|||+.|+++.
T Consensus 229 -----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0112234567889999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=350.79 Aligned_cols=250 Identities=21% Similarity=0.260 Sum_probs=207.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467899999999999999999965 68999999996421 223456788999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999875 34689999999999999999999999 99999999999999999999999999998643
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+. .. .
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~---~~-~----- 221 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELIL---ME-E----- 221 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---HC-C-----
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-----HHHHHH---cC-C-----
Confidence 222 22344679999999999999999999999999999999999999997543221 111111 11 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
..++.....++.+++.+|++.||++|| +++||+++
T Consensus 222 ----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 012223446788899999999999999 89998664
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=369.03 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=215.5
Q ss_pred HHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
+++++..++|++.+.||+|+||+||+|.++++..||||+++... ...+.|.+|+.++++++||||+++++++. .+..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 34456678899999999999999999999888999999997532 35678999999999999999999999986 5678
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++|+|.++++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 99999999999999998532 23578999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..............+|+.|+|||++....++.++|||||||++|||+| |+.||......+ ....+.. ..+.
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i~~---~~~~ 404 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALER---GYRM 404 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHHH---TCCC
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHc---CCCC
Confidence 765432222233456789999999998899999999999999999999 999997543321 1111211 1110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
..+...+.++.+++.+||+.||++|||+++|++.|+...
T Consensus 405 ---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 ---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 112334567889999999999999999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=349.14 Aligned_cols=254 Identities=22% Similarity=0.277 Sum_probs=207.3
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCc-----hhHHHHHHHHHHHHhcCCCCCccccceeecCCc
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 342 (595)
..++|++.+.||+|+||+||+|+.. +|+.||+|+++..... .....+.+|+.++.+++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999999999999975 6899999999753321 235789999999999999999999999999999
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC----cEEEee
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCD 418 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D 418 (595)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999975 34699999999999999999999999 999999999999998877 799999
Q ss_pred ccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+ ....+. .
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-----~~~~i~---~ 232 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANIT---A 232 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHH---T
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHH---h
Confidence 99998765432 2234569999999999999899999999999999999999999997644321 111111 1
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
. ... ++.. ........+.+++.+|+..||++|||+.|++++
T Consensus 233 ~-~~~--~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 233 V-SYD--FDEE---FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp T-CCC--CCHH---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred c-CCC--CCch---hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000 0000 001224567889999999999999999999764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=351.15 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=202.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcE----EEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
.++|+..+.||+|+||+||+|++. +++. ||+|.++..........|.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 457888999999999999999954 4443 68888865555566788999999999999999999999998754 78
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+|++|+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 999999999999999863 34689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 425 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 425 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
....... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||....... ....+.. ...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~~---~~~- 237 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEK---GER- 237 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHHHHT---TCC-
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----HHHHHHc---CCC-
Confidence 6543322 2233457889999999999999999999999999999999 999998654322 1111111 000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+.....++.+++.+||+.||++||++.|++++|+..
T Consensus 238 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 238 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111233456788999999999999999999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=365.27 Aligned_cols=265 Identities=21% Similarity=0.255 Sum_probs=212.8
Q ss_pred CHHHHHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceee
Q 007625 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338 (595)
Q Consensus 262 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 338 (595)
.++++....++|++.++||+|+||+||+|+.+ +++.||+|+++... .......+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 35566677899999999999999999999976 57889999986421 1122334889999999999999999999999
Q ss_pred cCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEee
Q 007625 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (595)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 418 (595)
+.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999853 34699999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCcCcceeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~ 493 (595)
||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. ..+
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-----~~i 293 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-----GKI 293 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----HHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH-----Hhh
Confidence 9999877655444445567999999999986 567899999999999999999999999865432211 111
Q ss_pred HHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 007625 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM 545 (595)
Q Consensus 494 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 545 (595)
..... ...++........++.+++.+|+..+|++ ||+++|++++
T Consensus 294 ---~~~~~-----~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 ---MNHKE-----RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---HTHHH-----HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---hhccc-----cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11000 00011111223457788899999888888 9999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.96 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=201.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 344 (595)
..++|++.++||+|+||+||+|+.+ +++.||+|+++... .......+..|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4567999999999999999999965 67889999997432 223345678899999887 8999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++|+|..++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999999986 34689999999999999999999999 999999999999999999999999999985
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..............+..........
T Consensus 203 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 278 (396)
T 4dc2_A 203 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 278 (396)
T ss_dssp CCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred cccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence 3322 223345679999999999999999999999999999999999999997543221111111111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 539 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 539 (595)
..++.....++.+++.+||+.||++||++
T Consensus 279 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 ------IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11233345678899999999999999996
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=342.25 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=203.4
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
++|++.+.||+|+||+||+|+.. +++.||+|++.... .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999975 68999999997433 33445788999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++ ++.+.+... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 555555432 35699999999999999999999999 9999999999999999999999999999876533
Q ss_pred CcceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc---ccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLND 504 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~ 504 (595)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|..|+........ ....+...... ..+..
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~----~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD----QLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH----HHHHHHHHHCCCCTTTCTT
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH----HHHHHHHHhCCCChhhhhh
Confidence 22 223456899999999998766 79999999999999999999888643322111 11111111111 00000
Q ss_pred cc-------------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 505 IV-------------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 505 ~~-------------d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. ...+....+....++.+++.+|++.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 001111223455678899999999999999999999653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=370.43 Aligned_cols=265 Identities=26% Similarity=0.386 Sum_probs=218.2
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
+++..++|++.+.||+|+||.||+|++. ++..||||+++... .....|.+|+.++++++||||+++++++...+..+
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 3445667888999999999999999976 48899999997532 34678999999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++|+|.++++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 293 lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccccee
Confidence 9999999999999998633 34689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
.............+++.|+|||++.+..++.++|||||||++|||+| |+.||....... ..+.+.. ..+
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~---~~~-- 437 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEK---DYR-- 437 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHHHHHT---TCC--
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHc---CCC--
Confidence 75443333334456789999999998899999999999999999999 999997644321 1122211 100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccchh
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 554 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 554 (595)
...+...+..+.+++.+||+.||++|||+.||++.|+.......
T Consensus 438 -------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~ 481 (495)
T 1opk_A 438 -------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481 (495)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSC
T ss_pred -------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccc
Confidence 11223345678899999999999999999999999988654433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=351.00 Aligned_cols=265 Identities=23% Similarity=0.368 Sum_probs=198.2
Q ss_pred HHHHHhcCCCcCCeeeeccceEEEEEEeCC-Cc---EEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeec
Q 007625 265 ELQLATDNFSESNIIGQGGFGKVYKGVLSD-NT---KVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (595)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 339 (595)
++.+..++|++.+.||+|+||+||+|+... +. .||+|+++... .......+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 334456789999999999999999999653 32 79999987432 44556789999999999999999999999987
Q ss_pred CCce------EEEEEecccCcHhhhhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC
Q 007625 340 SSER------ILVYPFMQNLSVAYRLRDLKP--GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (595)
Q Consensus 340 ~~~~------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 411 (595)
.... ++||||+++++|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 7655 999999999999999975332 223689999999999999999999999 99999999999999999
Q ss_pred CcEEEeeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhH
Q 007625 412 FEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 489 (595)
Q Consensus 412 ~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l 489 (595)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~ 248 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-----I 248 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----H
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-----H
Confidence 9999999999987644322 12233457889999999999999999999999999999999 899997644321 1
Q ss_pred HHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 490 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 490 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+. ... ....+...+.++.+++.+||+.||++|||+.|+++.|++.
T Consensus 249 ~~~~~---~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 249 YNYLI---GGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HHHHH---TTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHh---cCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111 111 1112233446788999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.44 Aligned_cols=266 Identities=23% Similarity=0.336 Sum_probs=206.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-----CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC--C
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--S 341 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 341 (595)
..++|++.+.||+|+||+||+|++ .+++.||+|++... .......+.+|++++++++||||+++++++... .
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 346788999999999999999984 36889999998743 345567899999999999999999999988553 5
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 6899999999999999998632 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcc--eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhh-------hhhhHHHH
Q 007625 422 AKLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE-------EDVLLLDH 492 (595)
Q Consensus 422 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~-------~~~~l~~~ 492 (595)
++........ ......++..|+|||++.+..++.++||||||+++|||+||..|+........ ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 9876543221 22334577889999999999999999999999999999999999875322100 00000111
Q ss_pred HHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
........ .....+...+.++.+++.+||+.||++|||+.|+++.|+..
T Consensus 241 ~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 241 LIELLKNN--------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHTT--------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcc--------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111111 11112334456888999999999999999999999999763
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=345.42 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=215.2
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEe------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeec
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 339 (595)
+...++|++.+.||+|+||+||+|+. .+++.||+|+++..........+.+|+.++.++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34557899999999999999999984 356789999998655555678899999999999 89999999999999
Q ss_pred CCceEEEEEecccCcHhhhhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCC
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKP--------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 405 (595)
.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 9999999999999999999986432 123589999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhh
Q 007625 406 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE 483 (595)
Q Consensus 406 Ill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~ 483 (595)
|+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 99999999999999999877554332 2233457889999999998999999999999999999999 999997644321
Q ss_pred hhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 484 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
. .......... . ..+...+..+.+++.+|++.||.+|||+.|+++.|+.
T Consensus 256 ~----~~~~~~~~~~---------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 256 K----FYKMIKEGFR---------M---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp H----HHHHHHHTCC---------C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H----HHHHhccCCC---------C---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1 1111111100 0 0122334678899999999999999999999999976
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.98 Aligned_cols=261 Identities=23% Similarity=0.343 Sum_probs=201.8
Q ss_pred cCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|++.+.||+|+||+||+|+..+++.||+|++.... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999999889999999986432 223346788999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 888888753 34689999999999999999999999 99999999999999999999999999998765332
Q ss_pred cceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc---cccc-
Q 007625 430 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RLND- 504 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~- 504 (595)
. ......||+.|+|||++.+. .++.++|||||||++|||+||+.||........ +.. +....... .+..
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~-~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ----LMR-IFRILGTPNSKNWPNV 228 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHH-HHHHHCCCCTTTSTTG
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHH-HHHHHCCCChhhchhh
Confidence 2 22334589999999998764 589999999999999999999999986543211 111 11111100 0000
Q ss_pred ----cccccCC--------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 505 ----IVDRNLN--------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 505 ----~~d~~l~--------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
..++... ........++.+++.+|++.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0111110 111234567889999999999999999999965
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=367.84 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=208.8
Q ss_pred HHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
+.+++..++|++.+.||+|+||.||+|.++++..||||+++... .....|.+|++++++++||||+++++++.. +..
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 33445667899999999999999999999888889999997532 335689999999999999999999999876 678
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++|+|.+++.... ...+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred EEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccce
Confidence 99999999999999997532 24589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..............++..|+|||++.+..++.++||||||+++|||+| |+.||......+ ....+. ...+
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i~---~~~~- 399 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVE---RGYR- 399 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHH---TTCC-
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH---cCCC-
Confidence 765433333334457889999999998999999999999999999999 999997543221 111111 1111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
...+...+..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 400 --------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 400 --------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1112334567889999999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=348.46 Aligned_cols=262 Identities=26% Similarity=0.406 Sum_probs=213.7
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC--------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceee
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 338 (595)
...++|++.+.||+|+||+||+|+.. ++..||+|+++..........+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 35678999999999999999999863 56789999998655556678899999999999 8999999999999
Q ss_pred cCCceEEEEEecccCcHhhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCE
Q 007625 339 TSSERILVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (595)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 406 (595)
..+..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 999999999999999999999864321 23489999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhh
Q 007625 407 LLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 484 (595)
Q Consensus 407 ll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~ 484 (595)
+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||......+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-
Confidence 9999999999999999876543322 2233457889999999988889999999999999999999 999997544321
Q ss_pred hhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 485 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 485 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
....+... .. ...+......+.+++.+||+.||.+||++.|+++.|+..
T Consensus 268 ----~~~~~~~~---~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 268 ----LFKLLKEG---HR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ----HHHHHHHT---CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHhcC---CC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111 00 111223346788999999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.40 Aligned_cols=270 Identities=23% Similarity=0.376 Sum_probs=219.3
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCcccc
Q 007625 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 334 (595)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 334 (595)
+..+++++..++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334555667889999999999999999999854 36789999998655556667899999999999999999999
Q ss_pred ceeecCCceEEEEEecccCcHhhhhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE
Q 007625 335 GYCTTSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 408 (595)
Q Consensus 335 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 408 (595)
+++...+..++||||+++++|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999987532 1124579999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhh
Q 007625 409 DDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEED 486 (595)
Q Consensus 409 ~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~ 486 (595)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 248 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 248 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---
Confidence 99999999999999866443222 1223456889999999998899999999999999999999 889987543211
Q ss_pred hhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 487 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 487 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
....+ .. . .....+...+..+.+++.+|++.||++|||+.|+++.|+...
T Consensus 249 --~~~~~---~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 249 --VLRFV---ME-G--------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp --HHHHH---HT-T--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred --HHHHH---Hc-C--------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 11111 11 1 111122334567889999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=353.76 Aligned_cols=266 Identities=23% Similarity=0.343 Sum_probs=215.1
Q ss_pred HHHHHhcCCCcCCeeeeccceEEEEEEeCC------CcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCcccccee
Q 007625 265 ELQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYC 337 (595)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 337 (595)
+++...++|++.+.||+|+||+||+|.... ...||+|++...........+.+|+.++..+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345567889999999999999999999642 2479999998665556678899999999999 899999999999
Q ss_pred ecCCceEEEEEecccCcHhhhhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEE
Q 007625 338 TTSSERILVYPFMQNLSVAYRLRDLKP----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 407 (595)
Q Consensus 338 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 407 (595)
...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999875321 134589999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhh
Q 007625 408 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE 485 (595)
Q Consensus 408 l~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~ 485 (595)
++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+| |..||........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 999999999999999866443322 2233457889999999998899999999999999999999 9999975432211
Q ss_pred hhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 486 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 486 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
.......... . ..+...+..+.+++.+||+.||.+|||+.||++.|+..
T Consensus 276 ---~~~~~~~~~~---------~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 ---FYKLVKDGYQ---------M---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ---HHHHHHHTCC---------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhcCCC---------C---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111111100 0 01122345788899999999999999999999999763
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=350.55 Aligned_cols=257 Identities=20% Similarity=0.265 Sum_probs=206.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC----CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
.++|++.+.||+|+||+||+|+.. +++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457999999999999999999964 7899999998531 11224678999999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc---EEEeeccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGL 421 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~ 421 (595)
+||||+++++|.+.+.........+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988875443345689999999999999999999999 9999999999999986654 99999999
Q ss_pred cccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....+.. . .
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~i~~---~-~ 248 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RLFEGIIK---G-K 248 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------HHHHHHHH---T-C
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------HHHHHHHc---C-C
Confidence 987654322 23345699999999999999999999999999999999999999975321 11111111 1 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... .... ......++.+++.+||+.||++|||+.|++++
T Consensus 249 ~~~-~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 249 YKM-NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CCC-CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCC-Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 0000 01124578899999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.36 Aligned_cols=253 Identities=19% Similarity=0.283 Sum_probs=201.5
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC-------
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------- 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 341 (595)
.++|++.+.||+|+||.||+|+.. +++.||||+++........+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357889999999999999999975 799999999975555566788999999999999999999999885543
Q ss_pred --------------------------------------------------ceEEEEEecccCcHhhhhcccCCCCCCCCH
Q 007625 342 --------------------------------------------------ERILVYPFMQNLSVAYRLRDLKPGEKGLDW 371 (595)
Q Consensus 342 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 371 (595)
..++||||+++++|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 27899999999999999986432 344677
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc-----------ceeecccccc
Q 007625 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-----------HVTTQIRGTM 440 (595)
Q Consensus 372 ~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~-----------~~~~~~~gt~ 440 (595)
..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999999 999999999999999999999999999987754321 1123356999
Q ss_pred cccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHH
Q 007625 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVET 520 (595)
Q Consensus 441 ~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 520 (595)
.|+|||++.+..++.++||||||+++|||++|..|+.. ........ ... ..+........+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~~~~----~~~--------~~~~~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRIITDV----RNL--------KFPLLFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHHHHH----HTT--------CCCHHHHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHHHHh----hcc--------CCCcccccCChh
Confidence 99999999999999999999999999999998766421 10111111 111 111112344567
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 521 MVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 521 l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.+++.+||+.||++|||+.|++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 7899999999999999999999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.27 Aligned_cols=248 Identities=21% Similarity=0.314 Sum_probs=203.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|.+.+.||+|+||+||+|+. .+++.||+|++.... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999996 578999999986321 112345788999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+ +|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 6788888875 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ..
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------------~~ 219 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------------KK 219 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------------------CC
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------------------HH
Confidence 432 2234569999999999988776 78999999999999999999999754321110 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.......+.....++.+++.+|++.||.+|||+.|++++
T Consensus 220 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 220 VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1111111233345678899999999999999999999653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=336.63 Aligned_cols=256 Identities=26% Similarity=0.373 Sum_probs=211.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
..++|+..+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 346788899999999999999999888999999997533 234678999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999763 24689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....+. ....
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~i~---~~~~------ 223 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDIS---TGFR------ 223 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHH---TTCC------
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-----HHHHHh---cCCc------
Confidence 2222334457889999999998889999999999999999999 899987543211 111111 1100
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+......+.+++.+|++.||++||++.|+++.|+..
T Consensus 224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011222346788999999999999999999999999763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=343.42 Aligned_cols=252 Identities=16% Similarity=0.237 Sum_probs=206.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||+||+|... +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 468999999999999999999965 6889999998642 3455678999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC--CCcEEEeecccccccc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVD 426 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~~~~~~ 426 (595)
|+++++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 82 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999998752 34689999999999999999999999 9999999999999987 7899999999998765
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+.. .. .. ..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~---~~-~~-~~ 223 (321)
T 1tki_A 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----IIENIMN---AE-YT-FD 223 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHH---TC-CC-CC
T ss_pred CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-----HHHHHHc---CC-CC-CC
Confidence 432 2334568999999999998889999999999999999999999997644321 1111111 11 00 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... ....+.++.+++.+|++.||++|||+.|++++
T Consensus 224 ~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 224 EEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 01224578899999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=347.61 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=201.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 345 (595)
.++|++.+.||+|+||.||+|+.+ +++.||+|+++... .......+.+|..++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357888999999999999999975 68899999997432 334456788999999987 89999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 99999999999999752 4589999999999999999999999 9999999999999999999999999999864
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........................
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 235 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 235 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence 3221 22345679999999999999999999999999999999999999997532211111001111111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 539 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 539 (595)
..++.....++.+++.+||+.||.+||++
T Consensus 236 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11223345678889999999999999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.77 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=197.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCce---
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER--- 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 343 (595)
.++|++.+.||+|+||.||+|+. .+++.||+|+++... .......+.+|+.++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 578999999997532 234456789999999999999999999998766544
Q ss_pred -EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 344 -ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 344 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 999999999999999985 24689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcc--eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 423 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 423 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
+........ ......||+.|+|||++.+..++.++||||||+++|||+||+.||........ ........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--------~~~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--------AYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------HHHHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHhcCC
Confidence 876543222 22335689999999999999999999999999999999999999976543211 11111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..... . .....+.++.+++.+||+.||++||++.++++.
T Consensus 236 ~~~~~--~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 236 PIPPS--A----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp CCCHH--H----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCcc--c----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 10000 0 011234578899999999999999988877653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.39 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=201.3
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCce
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (595)
...++|++.++||+|+||+||+|+.+ +++.||+|+++... .......+.+|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 45678999999999999999999965 68999999997421 233456778899999988 699999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 9999999999999999863 4589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +...+. ...
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~~~~i~---~~~--- 240 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-----LFEAIL---NDE--- 240 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---HCC---
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-----HHHHHH---cCC---
Confidence 54322 222344679999999999998889999999999999999999999998654321 111111 111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM------AQVVK 544 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~ 544 (595)
..++.....++.+++.+|++.||++||++ .|+++
T Consensus 241 -------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 -------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01222344578889999999999999998 66654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=349.48 Aligned_cols=254 Identities=21% Similarity=0.249 Sum_probs=207.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
..++|++.+.||+|+||.||+|... +++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999965 6899999999743 3444567889999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC---CcEEEeeccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAK 423 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~~~ 423 (595)
|||+++|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999998875 34689999999999999999999999 99999999999999865 459999999998
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+... ...
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----~~~~i~~~----~~~ 248 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-----LYAQIKAG----AYD 248 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHT----CCC
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHhC----CCC
Confidence 765432 2234569999999999999899999999999999999999999997543211 11222111 100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...+ .......++.+++.+||+.||++||++.|++++
T Consensus 249 -~~~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 -YPSP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CCTT----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCcc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 012234578899999999999999999999865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=356.57 Aligned_cols=255 Identities=18% Similarity=0.236 Sum_probs=207.1
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
..++|++.+.||+|+||+||+|.. .+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456799999999999999999996 478999999987433 334556789999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc---CCCcEEEeeccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAK 423 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~~~ 423 (595)
|||+++|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+||+|||+++
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999886 34689999999999999999999999 999999999999998 56789999999998
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....... ....+.. +..
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~~----~~~- 230 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-----LYQQIKA----GAY- 230 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHH----TCC-
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHHh----CCC-
Confidence 7654322 2234579999999999999999999999999999999999999997544221 1111211 110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+. ......++.+++.+|++.||++|||+.|++++
T Consensus 231 ~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 DFPSPE----WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCCTTT----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCccc----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 001111 12234578899999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=359.44 Aligned_cols=262 Identities=19% Similarity=0.260 Sum_probs=210.9
Q ss_pred HHHHHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeec
Q 007625 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (595)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 339 (595)
.+++....++|++.++||+|+||+||+|+.+ +++.||+|+++... .......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4556667889999999999999999999975 68899999986421 11223457889999999999999999999999
Q ss_pred CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
....++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999875 3489999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCC----CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK----SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
|+++..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ...
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--------~~~ 284 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--------YSK 284 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH--------HHH
Confidence 999877654433444667999999999997655 78999999999999999999999986543221 111
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKML 546 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 546 (595)
....... . ..+. ......++.+++.+|++.+|.+ ||+++||+++-
T Consensus 285 i~~~~~~--~---~~p~-~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 285 IMNHKNS--L---TFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp HHTHHHH--C---CCCT-TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred HHhcccc--c---cCCC-cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 1110000 0 0000 0123357788899999999988 99999997754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=337.95 Aligned_cols=263 Identities=29% Similarity=0.461 Sum_probs=200.1
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
++..++|++.+.||+|+||+||+|+.. ..||+|+++... .......|.+|+.++++++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 345678999999999999999999864 359999997433 445567899999999999999999999965 4566899
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 97 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999998642 35689999999999999999999999 9999999999999999999999999999865
Q ss_pred cCcC-cceeecccccccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 426 DAKL-THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 426 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
.... ........||+.|+|||++. +..++.++||||||+++|||++|+.||....... .....+.. ..
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~----~~ 242 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIEMVGR----GS 242 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH----HHHHHHHH----TS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH----HHHHHhcc----cc
Confidence 4322 22233456899999999986 5678899999999999999999999997543221 11122211 11
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
. .+.+.......+..+.+++.+||+.||++|||+.|+++.|++..
T Consensus 243 ~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 243 L----SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp C----CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred c----CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1 11122223344568899999999999999999999999998743
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=343.32 Aligned_cols=258 Identities=17% Similarity=0.172 Sum_probs=206.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 347 (595)
.++|++.+.||+|+||+||+|+. .+++.||||++..... ...+.+|+.+++++ +||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 46799999999999999999996 5789999999864322 23578999999999 9999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc-----EEEeecccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-----AVLCDFGLA 422 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfG~~ 422 (595)
||+ +++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 99999999863 34699999999999999999999999 9999999999999998887 999999999
Q ss_pred ccccCcCcc------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHH
Q 007625 423 KLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 496 (595)
Q Consensus 423 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 496 (595)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~--~~~~~i~~~ 235 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK--ERYQKIGDT 235 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH--HHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH--HHHHHHHhh
Confidence 876443221 123467999999999999999999999999999999999999999864322111 111111111
Q ss_pred hccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 497 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 497 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
....... .+. ...+ ++.+++..|++.||.+||++.+|++.|++
T Consensus 236 ~~~~~~~-----~~~---~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 236 KRATPIE-----VLC---ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHHSCHH-----HHT---TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred hccCCHH-----HHh---ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 1100000 000 1122 78899999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=343.16 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=216.9
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
+++..++|++.+.||+|+||+||+|... ++..||+|++... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 3346678999999999999999999975 5888999998642 345678999999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 86 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999999998633 35689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
.............+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... ....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-----~~~~~~~~~~----- 230 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKDYR----- 230 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHHHHHTTCC-----
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHhccCC-----
Confidence 76554444445567889999999998899999999999999999999 999997644321 1111111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+...+..+.+++.+|++.||++|||+.|+++.|+..
T Consensus 231 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 231 -------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 111223346788999999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=343.63 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=206.5
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCc-----hhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... .....+.+|+.+++.++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456889999999999999999975 6899999998743221 2467899999999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC----cEEEeec
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF 419 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 419 (595)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999975 35689999999999999999999999 999999999999999887 8999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+... .
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~--~ 233 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSAV--N 233 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHHT--C
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HHHHHHhc--C
Confidence 9998765332 2234569999999999998999999999999999999999999997644321 11111110 0
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... .+. ........+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~---~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 YEF---EDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCC---CHH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCc---Ccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 000 001223567889999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=340.80 Aligned_cols=258 Identities=29% Similarity=0.427 Sum_probs=210.9
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
+++..++|++.+.||+|+||+||+|...++..||+|+++... .....+.+|++++++++||||+++++++. .+..++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 334567899999999999999999998888899999986432 34578899999999999999999999886 456899
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 999999999999997522 23589999999999999999999999 9999999999999999999999999999877
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
............++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+. ....
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~~~~---~~~~--- 228 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNLE---RGYR--- 228 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHH---TTCC---
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-----HHHHHh---cccC---
Confidence 6543333334457889999999988889999999999999999999 899987543221 111111 1100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+.....++.+++.+|++.||++|||+.++++.|++
T Consensus 229 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 229 ------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 01122334678899999999999999999999999976
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.96 Aligned_cols=264 Identities=21% Similarity=0.221 Sum_probs=210.8
Q ss_pred CHHHHHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceee
Q 007625 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338 (595)
Q Consensus 262 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 338 (595)
.+++.....++|++.++||+|+||+||+|+.+ +|+.||+|+++... .......+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45666677889999999999999999999975 79999999996421 1223345788999999999999999999999
Q ss_pred cCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEee
Q 007625 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (595)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 418 (595)
+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999998632 3689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCcCcceeecccccccccCccccC-------CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 491 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~ 491 (595)
||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. .
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-----~ 280 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY-----G 280 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----H
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH-----H
Confidence 9999877654443344567999999999987 356899999999999999999999999865432211 1
Q ss_pred HHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 007625 492 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR---PPMAQVVKM 545 (595)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~~ 545 (595)
.+......- .++......+.++.+++.+|+. +|++| |+++||+++
T Consensus 281 ~i~~~~~~~--------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 281 KIVHYKEHL--------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHTHHHHC--------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHhcccCc--------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111000000 0111112334678889999999 99998 689998654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=335.27 Aligned_cols=254 Identities=28% Similarity=0.377 Sum_probs=196.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCC---chhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|+..+.||+|+||+||+|.. .++.||+|+++.... ......+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46788999999999999999997 588999999864322 23356789999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC--------CCcEEEee
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--------NFEAVLCD 418 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~D 418 (595)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+....+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999998863 46899999999999999999999992112999999999999986 77899999
Q ss_pred ccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
||+++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ......
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------~~~~~~ 228 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--------AYGVAM 228 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--------HHHHHT
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHhhhc
Confidence 999986644322 234689999999999988999999999999999999999999975432111 111111
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.. . ....+...+..+.+++.+||+.||.+|||+.|++++|+.
T Consensus 229 ~~-~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 NK-L-------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SC-C-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CC-C-------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 0 011223344678899999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=351.76 Aligned_cols=272 Identities=19% Similarity=0.222 Sum_probs=206.5
Q ss_pred HhcCCCcCCeeeec--cceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 269 ATDNFSESNIIGQG--GFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 269 ~~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
..++|++.+.||+| +||+||+|+.. +++.||||++... ........+.+|+.+++.++||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34679999999999 99999999975 7999999999743 33445678889999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999998642 24589999999999999999999999 999999999999999999999999999865
Q ss_pred ccCcCc------ceeecccccccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHH
Q 007625 425 VDAKLT------HVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 496 (595)
Q Consensus 425 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 496 (595)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....................
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 432111 11122468999999999987 5789999999999999999999999976443222111111000000
Q ss_pred hcc-----cc-------------cccc----------ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 497 LRE-----DR-------------LNDI----------VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 497 ~~~-----~~-------------~~~~----------~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... .. .... .+......+.....++.+++.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 00 0000 0000001223345678999999999999999999999754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=361.15 Aligned_cols=253 Identities=26% Similarity=0.351 Sum_probs=207.6
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC-ceEE
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERIL 345 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~l 345 (595)
++..++|++.+.||+|+||.||+|.+ .++.||||+++... ....|.+|+.++++++||||+++++++.... ..++
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 34567888999999999999999998 47899999997532 4567999999999999999999999987665 7899
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 265 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 999999999999998642 33479999999999999999999999 9999999999999999999999999999854
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
... .....+++.|+|||++.+..++.++||||||+++|||+| |+.||......+ ....+. ...+
T Consensus 340 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i~---~~~~--- 404 (450)
T 1k9a_A 340 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVE---KGYK--- 404 (450)
T ss_dssp C----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----HHHHHH---TTCC---
T ss_pred ccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH---cCCC---
Confidence 322 122357889999999999999999999999999999998 999997644321 111111 1111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus 405 ------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 405 ------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112233456888999999999999999999999999763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.10 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=205.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467899999999999999999965 68899999986321 223457788999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+.+|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999985 35699999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .....+..
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~~~~~~~-------- 234 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK--EIVHTFET-------- 234 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH--HHHHHHHH--------
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH--HHHHHHhh--------
Confidence 432 2345679999999999864 45899999999999999999999999754332111 11111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-MAQVVK 544 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 544 (595)
....++......+.+++.+||+.||.+||+ +.+|.+
T Consensus 235 -----~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 -----TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111123344567889999999999999999 666644
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=338.30 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=206.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCC----CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
..++|++.+.||+|+||+||+|+..+ +..||+|++...........+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45678899999999999999998532 346999999765555667889999999999999999999999765 4578
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 999999999999999753 24589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
.............+|+.|+|||++.+..++.++||||||+++|||+| |+.||....... ....+... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-----~~~~~~~~---~~-- 232 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-----VIGVLEKG---DR-- 232 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-----HHHHHHHT---CC--
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-----HHHHHhcC---CC--
Confidence 65543333344557889999999988899999999999999999998 999997543321 11222111 10
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+......+.+++.+|++.||++||++.|+++.|+..
T Consensus 233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 -------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 011122345788999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=335.67 Aligned_cols=260 Identities=15% Similarity=0.197 Sum_probs=208.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (595)
..++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+|+..+..+ +|+|++++++++......++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 356799999999999999999995 578999999986432 234578899999999 799999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc-----EEEeeccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-----AVLCDFGL 421 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfG~ 421 (595)
|||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 99999999863 24599999999999999999999999 9999999999999987776 99999999
Q ss_pred cccccCcCcc------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 422 AKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 422 ~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~ 235 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKYERIGE 235 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH--HHHHHHHh
Confidence 9876543221 223456999999999999999999999999999999999999999864322111 11111111
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.......... ....+.++.+++.+||+.||++||++.+|++.|+.
T Consensus 236 ~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 236 KKQSTPLREL--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp HHHHSCHHHH--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred hccCccHHHH--------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 1111111000 11234678899999999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=345.81 Aligned_cols=265 Identities=22% Similarity=0.330 Sum_probs=207.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-----CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC--Cc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SE 342 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 342 (595)
.++|++.+.||+|+||.||+|++ .+++.||+|+++..........+.+|+.+++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34588899999999999999983 368899999998555555668899999999999999999999999876 56
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 89999999999999999653 24589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcc--eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhh------hhhhhHHHHHH
Q 007625 423 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE------EEDVLLLDHIR 494 (595)
Q Consensus 423 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~------~~~~~l~~~~~ 494 (595)
......... ......||..|+|||++.+..++.++||||||+++|||+||..|+....... ...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 877554322 2234568889999999999899999999999999999999998864321100 00000111111
Q ss_pred HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...... .....+...+..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 254 ~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 254 NTLKEG--------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHTT--------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcc--------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 111111 1111233445688899999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=340.95 Aligned_cols=265 Identities=24% Similarity=0.342 Sum_probs=192.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||+||+|... +++.||+|+++..........+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999964 6899999999754444455778899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 349 FMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|++ ++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59998887432 2234689999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc---ccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRL 502 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~ 502 (595)
.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+. ...+...... ..+
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-----LKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHHHCSCCTTTC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHhCCCChhHh
Confidence 3322 2233468999999999876 4689999999999999999999999986543221 1111111110 000
Q ss_pred ccc-----ccccCC----C---------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 503 NDI-----VDRNLN----T---------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 503 ~~~-----~d~~l~----~---------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
... ..+.+. . .......++.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 000000 0 01123457889999999999999999999854
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=342.77 Aligned_cols=247 Identities=25% Similarity=0.311 Sum_probs=205.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... .......+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357889999999999999999965 78999999986421 123456788999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999986 34689999999999999999999999 99999999999999999999999999998764
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~------ 219 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAE------ 219 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHCC------
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC------
Confidence 32 234569999999999999999999999999999999999999997644321 111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
..++.....++.+++.+|++.||++|| +++||+++
T Consensus 220 ----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 011223346788899999999999999 88888653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=345.12 Aligned_cols=270 Identities=24% Similarity=0.386 Sum_probs=218.2
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccceEEEEEEe------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccc
Q 007625 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQL 333 (595)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 333 (595)
+...++....++|++.+.||+|+||+||+|+. .+++.||+|+++..........+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45566677788999999999999999999984 356889999998665556667899999999999 79999999
Q ss_pred cceeecCC-ceEEEEEecccCcHhhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcC
Q 007625 334 IGYCTTSS-ERILVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 400 (595)
Q Consensus 334 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 400 (595)
++++...+ ..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987755 489999999999999999864321 12388999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 007625 401 LKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDF 478 (595)
Q Consensus 401 lkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~ 478 (595)
|||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999876543322 2334557899999999999999999999999999999998 9999975
Q ss_pred CchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 479 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 479 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..... .....+... .. ...+......+.+++.+||+.||.+|||+.||+++|+..
T Consensus 254 ~~~~~----~~~~~~~~~---~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDE----EFCRRLKEG---TR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSH----HHHHHHHHT---CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhH----HHHHHhccC---cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 44221 111111111 00 011222345788999999999999999999999999764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=352.29 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=204.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcE----EEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
.++|++.+.||+|+||+||+|+.. +++. ||+|.+...........+.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357888999999999999999964 4443 78888764443344456788999999999999999999886 46688
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999999753 24688999999999999999999999 999999999999999999999999999997
Q ss_pred ccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 425 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 425 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
....... ......||..|+|||++.+..++.++||||||+++|||+| |+.||....... ....+.. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~---~~~- 235 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-----VPDLLEK---GER- 235 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-----HHHHHHT---TCB-
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-----HHHHHHc---CCC-
Confidence 7544322 2334567889999999998999999999999999999999 999998644321 1111111 100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
...+.....++.+++.+||+.||++||++.|+++.|+...
T Consensus 236 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 --------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp --------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred --------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111223346778999999999999999999999998743
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=336.44 Aligned_cols=256 Identities=24% Similarity=0.364 Sum_probs=209.4
Q ss_pred hcCCCcCC-eeeeccceEEEEEEeC---CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 270 TDNFSESN-IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
.++|.+.+ .||+|+||.||+|... ++..||+|+++..........+.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566666 9999999999999853 67889999998665566678899999999999999999999999 4566899
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999998742 35689999999999999999999999 9999999999999999999999999999877
Q ss_pred cCcCcce--eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 426 DAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 426 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
....... .....+|+.|+|||++.+..++.++||||||+++|||+| |+.||....... ....+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~i~~----~~- 230 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIEQ----GK- 230 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----HHHHHHT----TC-
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHhc----CC-
Confidence 5433222 223446889999999988889999999999999999999 999997543311 1111111 11
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
....+...+.++.+++.+||+.||++||++.|+++.|+..
T Consensus 231 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0112334456888999999999999999999999999763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=333.69 Aligned_cols=254 Identities=31% Similarity=0.489 Sum_probs=203.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchh------HHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGG------EAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
..++|++.+.||+|+||+||+|+. .+++.||+|++........ ...+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 346789999999999999999996 4789999999864332211 167899999999999999999999986654
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--cEEcCCCCCCEEEcCCCc-----E
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFE-----A 414 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~ 414 (595)
++||||+++++|.+.+... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++. +
T Consensus 97 --~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred --eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence 7999999999998888752 34699999999999999999999999 7 999999999999988776 9
Q ss_pred EEeeccccccccCcCcceeecccccccccCcccc--CCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHH
Q 007625 415 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL--STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492 (595)
Q Consensus 415 kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~ 492 (595)
||+|||+++.... ......||+.|+|||++ ....++.++||||||+++|||++|+.||........ .....
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~ 241 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI---KFINM 241 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH---HHHHH
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH---HHHHH
Confidence 9999999975433 23445689999999998 455678999999999999999999999975443211 11111
Q ss_pred HHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.. ... .. ...+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 242 ~~---~~~-~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 242 IR---EEG-LR-------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HH---HSC-CC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred Hh---ccC-CC-------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11 111 10 11223345678899999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=333.48 Aligned_cols=252 Identities=19% Similarity=0.262 Sum_probs=205.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecC--CceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 346 (595)
.++|++.+.||+|+||+||+|+. +++.||+|+++... .......+.+|+.++++++||||+++++++... ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 45788999999999999999998 48899999997433 445567899999999999999999999999887 778999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--cEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.++|+|||+...
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999998632 34689999999999999999999998 7 99999999999999999999999998764
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCc---cchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE---KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
... ....||+.|+|||++.+..++. ++||||||+++|||+||+.||........ .........
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~ 228 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI--------GMKVALEGL 228 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH--------HHHHHHSCC
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH--------HHHHHhcCC
Confidence 332 2245899999999998765544 79999999999999999999975443211 111111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
....+.....++.+++.+||+.||++|||+.|+++.|+..
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 229 --------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0112233456788999999999999999999999999763
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=349.70 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=204.6
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCC
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS 341 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 341 (595)
.....++|++.+.||+|+||.||+|+.+ +++.||+|+++... .......+..|..++..+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3456789999999999999999999975 68899999997421 123456678899999876 8999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChh
Confidence 999999999999999999862 4589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+.. ..
T Consensus 165 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~~---~~- 234 (345)
T 1xjd_A 165 CKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----LFHSIRM---DN- 234 (345)
T ss_dssp CBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH---CC-
T ss_pred hhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHh---CC-
Confidence 98543222 22345679999999999999999999999999999999999999998644321 1111111 10
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA-QVV 543 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 543 (595)
..++.....++.+++.+|++.||++||++. ||+
T Consensus 235 ---------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ---------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011223346788899999999999999997 554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=338.16 Aligned_cols=254 Identities=22% Similarity=0.277 Sum_probs=202.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|.+.+.||+|+||+||+|... ++..||+|++...........+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357899999999999999999964 6899999999765555567889999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE---cCCCcEEEeeccccccc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~~~ 425 (595)
|+++++|.+.+.........+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999875433346799999999999999999999999 99999999999999 45678999999999866
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.... ......||+.|+|||++. ..++.++||||||+++|||++|+.||........ ...... ...
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-----~~~~~~---~~~---- 242 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-----QQKATY---KEP---- 242 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHH---CCC----
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-----Hhhhcc---CCc----
Confidence 5432 223456899999999985 5689999999999999999999999986543211 111110 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
...........++.+++.+|++.||++|||+.|+++
T Consensus 243 ---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 ---NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000112357788999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=344.99 Aligned_cols=260 Identities=25% Similarity=0.337 Sum_probs=207.8
Q ss_pred CCcCCeeeeccceEEEEEEeC-----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC--CceEE
Q 007625 273 FSESNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERIL 345 (595)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 345 (595)
|++.+.||+|+||+||++.+. +++.||+|+++..........+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998742 68889999998665566678899999999999999999999999874 56789
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999975 2489999999999999999999999 9999999999999999999999999999877
Q ss_pred cCcCcc--eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhh------hhhHHHHHHHHh
Q 007625 426 DAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE------DVLLLDHIRKLL 497 (595)
Q Consensus 426 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~------~~~l~~~~~~~~ 497 (595)
...... ......+|..|+|||++.+..++.++||||||+++|||+||+.||......... ............
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 554322 223345788999999999889999999999999999999999998753221100 000000011111
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 498 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
... .....+...+.++.+++.+||+.||++|||+.|+++.|+.
T Consensus 265 ~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 265 ERG--------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp HTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcc--------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111 1111233445688999999999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=335.24 Aligned_cols=250 Identities=25% Similarity=0.328 Sum_probs=196.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCC-------------------------chhHHHHHHHHHHHH
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-------------------------PGGEAAFQREVHLIS 323 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------------------------~~~~~~~~~E~~~l~ 323 (595)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999964 688999999864321 112356889999999
Q ss_pred hcCCCCCccccceeec--CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCC
Q 007625 324 VAIHKNLLQLIGYCTT--SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 401 (595)
Q Consensus 324 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 401 (595)
+++||||+++++++.. ....++||||+++++|.+++. ...+++..++.++.|++.||+|||+. +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 567899999999999887654 34699999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCcEEEeeccccccccCcCcceeecccccccccCccccCCCC---CCccchhHHHHHHHHHHHhCCCCCCC
Q 007625 402 KAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDF 478 (595)
Q Consensus 402 kp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlGvvl~elltg~~p~~~ 478 (595)
||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654322 233456999999999997665 37889999999999999999999975
Q ss_pred CchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 479 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 479 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
..... ....+. ...... +. ......++.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~-----~~~~~~----~~~~~~---~~----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIMC-----LHSKIK----SQALEF---PD----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHHH-----HHHHHH----HCCCCC---CS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHHH-----HHHHHh----cccCCC---CC----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 43211 111111 111100 00 1123357889999999999999999999954
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=346.83 Aligned_cols=247 Identities=21% Similarity=0.264 Sum_probs=205.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357889999999999999999975 68999999986421 223456788999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 9999999999999863 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...... +..
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~---~~~i~~-~~~---- 255 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----I---YEKIVS-GKV---- 255 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H---HHHHHH-CCC----
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-----H---HHHHHc-CCC----
Confidence 42 234568999999999999999999999999999999999999997643211 1 111111 110
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 545 (595)
.++.....++.+++.+|++.||.+||+ ++||+++
T Consensus 256 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 112234467889999999999999998 7887543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.92 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=203.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCC-----CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
.++|+..+.||+|+||+||+|.... +..||+|+++..........+.+|+.++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4567778999999999999998642 23599999986555566778999999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999753 34689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCcc--eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 425 VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 425 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+. ....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~~~~~---~~~~ 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----VMKAIN---DGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHH---TTCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHH---CCCc
Confidence 6543221 1222346789999999998899999999999999999999 999997543211 111111 1111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
. ..+......+.+++.+||+.||++||++.||++.|+..
T Consensus 269 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 L---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp C---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 11223446788999999999999999999999999763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=342.62 Aligned_cols=251 Identities=22% Similarity=0.259 Sum_probs=196.4
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe----CCCcEEEEEEeccCC---CchhHHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
..++|++.+.||+|+||.||+|+. .+++.||+|+++... .......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 356799999999999999999996 478999999997532 2234566789999999999999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999999975 24588999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+. .. .
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~---~~-~ 237 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-----TIDKIL---KC-K 237 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHH---HT-C
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHH---hC-C
Confidence 97543322 22334569999999999999899999999999999999999999998644321 111111 11 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
...+.....++.+++.+||+.||++|| ++.|++++
T Consensus 238 ---------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 ---------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011223346788999999999999999 67777654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=337.59 Aligned_cols=258 Identities=21% Similarity=0.284 Sum_probs=208.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceee--cCCceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCT--TSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 345 (595)
.++|++.+.||+|+||+||+|+.. +++.||+|++... ......+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457889999999999999999975 7899999999743 34455678999999999999999999999874 4567899
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----cEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK-----IIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
||||+++++|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999986544455699999999999999999999998 7 9999999999999999999999999
Q ss_pred ccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
+++....... ......||+.|+|||++.+..++.++||||||+++|||+||+.||....... ....+.. +
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~i~~----~ 231 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGKIRE----G 231 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----T
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-----HHHHHhh----c
Confidence 9987654321 1223458999999999998899999999999999999999999997643211 1111111 1
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.. ...+.....++.+++.+||+.||++||++.||++.+..
T Consensus 232 ~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KF--------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cc--------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 11222344678899999999999999999999887754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.94 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=191.4
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
..++|++.+.||+|+||+||+|+.. +++.||+|+++... ....+.+|+.++++++||||+++++++...+..++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 4567999999999999999999975 58899999997532 3456889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC---CCcEEEeecccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFGLAKL 424 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~~~~ 424 (595)
||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999875 34689999999999999999999999 9999999999999975 88999999999986
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+ .... . .
T Consensus 201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~i---~~~~-~-~ 269 (349)
T 2w4o_A 201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ----FMFRRI---LNCE-Y-Y 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH----HHHHHH---HTTC-C-C
T ss_pred cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH----HHHHHH---HhCC-C-c
Confidence 64322 2234568999999999999999999999999999999999999997543211 111111 1111 0 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. .........++.+++.+|++.||++|||+.|++++
T Consensus 270 ~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 FI----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CC----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cC----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 11122345678899999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=342.42 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=202.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcE----EEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
.++|++.+.||+|+||+||+|+.. +++. ||+|.+...........+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999964 4443 58887765555667788999999999999999999999998754 78
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+|++|+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999999863 34689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 425 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 425 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ....+.. ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~~~~~---~~-- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEK---GE-- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHHHHT---TC--
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHc---CC--
Confidence 6543222 2233456889999999999999999999999999999999 999998654322 1111111 00
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
....+.....++.+++.+||+.||.+||++.|+++.|+...
T Consensus 237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01112334457889999999999999999999999998743
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=335.15 Aligned_cols=257 Identities=28% Similarity=0.401 Sum_probs=203.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCC----CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceee-cCCceE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT-TSSERI 344 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 344 (595)
..+|++.+.||+|+||+||+|+..+ ...||+|.+...........+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468888999999999999999642 23589999986666666788999999999999999999999864 456789
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999752 34689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCc---ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 425 VDAKLT---HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 425 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
...... .......||+.|+|||.+.+..++.++||||||+++|||++ |..||....... ...... ...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-----~~~~~~---~~~ 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYLL---QGR 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-----HHHHHH---TTC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHHh---cCC
Confidence 654322 12233457889999999999999999999999999999999 555555433211 111111 110
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
. ...+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 250 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 250 R---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 011222345788999999999999999999999999763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=370.52 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=214.6
Q ss_pred HHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
+.+++..++|++.+.||+|+||.||+|.+.++..||||+++... .....|.+|++++++++||||+++++++.. +..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 44555677899999999999999999999888889999997533 335689999999999999999999999876 678
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred eEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 99999999999999997532 24589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..............++..|+|||++.+..++.++|||||||++|||+| |+.||......+ ....+. ...+
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-----~~~~i~---~~~~- 482 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVE---RGYR- 482 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-----HHHHHH---TTCC-
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH---cCCC-
Confidence 765432222233457889999999998899999999999999999999 899997543221 111111 1111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
...+......+.+++.+||+.||++|||+.+|++.|+...
T Consensus 483 --------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 483 --------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0112334567889999999999999999999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=338.93 Aligned_cols=270 Identities=24% Similarity=0.341 Sum_probs=204.1
Q ss_pred CHHHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHh--cCCCCCccccceeec
Q 007625 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTT 339 (595)
Q Consensus 262 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 339 (595)
+........++|++.+.||+|+||.||+|+.. ++.||||++.. .....+..|.+++.. ++||||+++++++..
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec----cccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 33444456678999999999999999999984 89999999864 233444555555554 489999999999987
Q ss_pred C----CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCcEEcCCCCCCEEEcC
Q 007625 340 S----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-----NPKIIHRDLKAANILLDD 410 (595)
Q Consensus 340 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~ 410 (595)
. ...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 7 678999999999999999975 35899999999999999999999762 348999999999999999
Q ss_pred CCcEEEeeccccccccCcCcce---eecccccccccCccccCCCCCCcc------chhHHHHHHHHHHHhC---------
Q 007625 411 NFEAVLCDFGLAKLVDAKLTHV---TTQIRGTMGHIAPEYLSTGKSSEK------TDVFGYGITLLELVTG--------- 472 (595)
Q Consensus 411 ~~~~kl~DfG~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDv~SlGvvl~elltg--------- 472 (595)
++.+||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||+||
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999998664432221 124569999999999987766655 9999999999999999
Q ss_pred -CCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 473 -QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 473 -~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
+.||......... ............. .+..+. .......++.+++.+||+.||++|||+.||+++|+..
T Consensus 258 ~~~p~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 258 YQLPYHDLVPSDPS----YEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCCTTTTTSCSSCC----HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccHhhhcCCCCc----hhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 5565432221111 1111111111111 111111 1236778899999999999999999999999999763
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=340.10 Aligned_cols=247 Identities=22% Similarity=0.226 Sum_probs=194.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|+..++||+|+||+||+|+.. +++.||||++... ........+..|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 467999999999999999999976 7999999998643 2334445556666666555 899999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 66888888754 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ... .........+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~-~~~~~~~~~~ 273 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQ-LRQGYLPPEF 273 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHH-HTTTCCCHHH
T ss_pred cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHH-HhccCCCccc
Confidence 432 2234568999999999876 789999999999999999999777653211 001 1111111000
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.....++.+++.+|++.||++|||+.|++++
T Consensus 274 -------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 274 -------TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11234678899999999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=348.13 Aligned_cols=266 Identities=17% Similarity=0.210 Sum_probs=202.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCC------CcEEEEEEeccCCCch----------hHHHHHHHHHHHHhcCCCCCcc
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPG----------GEAAFQREVHLISVAIHKNLLQ 332 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~ 332 (595)
..++|++.+.||+|+||+||+|.+.. ++.||+|++....... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999754 4789999986432110 0112334555667788999999
Q ss_pred ccceeecC----CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE
Q 007625 333 LIGYCTTS----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 408 (595)
Q Consensus 333 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 408 (595)
+++++... ...++||||+ +++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998765 3479999999 99999999862 35699999999999999999999999 99999999999999
Q ss_pred c--CCCcEEEeeccccccccCcCcce------eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 007625 409 D--DNFEAVLCDFGLAKLVDAKLTHV------TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (595)
Q Consensus 409 ~--~~~~~kl~DfG~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~ 480 (595)
+ .++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999998765432211 123459999999999999999999999999999999999999998532
Q ss_pred hhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 481 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 481 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.... .......... .....+++..+.. ...+.++.+++..||+.||++||++.+|++.|+.
T Consensus 266 ~~~~----~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 266 KDPK----YVRDSKIRYR-ENIASLMDKCFPA--ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp TCHH----HHHHHHHHHH-HCHHHHHHHHSCT--TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cCHH----HHHHHHHHhh-hhHHHHHHHhccc--ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 2111 1111111111 1122223222211 1224578889999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=349.64 Aligned_cols=254 Identities=27% Similarity=0.399 Sum_probs=195.4
Q ss_pred CCCcCCeeeeccceEEEEEEeC--CC--cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec-CCceEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS--DN--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILV 346 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv 346 (595)
.|...+.||+|+||+||+|+.. ++ ..||+|.++..........|.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4666789999999999999853 22 36899998765556677889999999999999999999998754 4578999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999752 34588999999999999999999999 99999999999999999999999999998664
Q ss_pred CcCcc---eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 427 AKLTH---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 427 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..... ......+|+.|+|||++.+..++.++||||||+++|||+| |..||....... ....+. ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----~~~~~~---~~~~- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYLL---QGRR- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----HHHHHH---TTCC-
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----HHHHHH---cCCC-
Confidence 33211 1233457889999999999999999999999999999999 677776543211 111111 1110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+...+..+.+++.+||+.||++||++.|+++.|+.
T Consensus 315 --------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 315 --------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01122334578899999999999999999999999976
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=341.65 Aligned_cols=265 Identities=25% Similarity=0.387 Sum_probs=202.2
Q ss_pred HHHHHHhcCCCcCCeeeeccceEEEEEEeC----CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceee
Q 007625 264 RELQLATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 338 (595)
+++.+..++|.+.+.||+|+||.||+|... ++..||+|+++.. ........+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 444556778999999999999999999853 3458999998743 34445678999999999999999999999997
Q ss_pred cCCc-----eEEEEEecccCcHhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC
Q 007625 339 TSSE-----RILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (595)
Q Consensus 339 ~~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 411 (595)
.... .++||||+++++|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 7653 499999999999999985322 2346799999999999999999999999 99999999999999999
Q ss_pred CcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhH
Q 007625 412 FEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 489 (595)
Q Consensus 412 ~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l 489 (595)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~ 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-----M 258 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----H
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----H
Confidence 99999999999876443221 2233457889999999999999999999999999999999 888987644321 1
Q ss_pred HHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 490 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 490 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+. ... ....+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 259 ~~~~~---~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 259 YDYLL---HGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp HHHHH---TTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHH---cCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111 111 011123344678899999999999999999999999976
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=345.85 Aligned_cols=254 Identities=20% Similarity=0.294 Sum_probs=199.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCC--CCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 345 (595)
..++|++.+.||+|+||.||+|...+++.||+|++... ........+.+|+.++..++| |||+++++++......++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 35678999999999999999999888999999998743 334455789999999999986 999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||| +.+++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++..
T Consensus 87 v~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 567899999986 35689999999999999999999999 999999999999997 578999999999876
Q ss_pred cCcCcc-eeecccccccccCccccCC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH
Q 007625 426 DAKLTH-VTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 426 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~ 493 (595)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~ 230 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKL 230 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------HHHH
Confidence 543322 2334569999999999864 67899999999999999999999999743221 1111
Q ss_pred HHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 494 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
......... ..++.....++.+++.+||+.||.+|||+.|++++-
T Consensus 231 ~~~~~~~~~--------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 231 HAIIDPNHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HHHHCTTSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHhcCCcc--------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111111110 011222235678899999999999999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=337.15 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=207.3
Q ss_pred HHHHhcCCCcCC-eeeeccceEEEEEEe---CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecC
Q 007625 266 LQLATDNFSESN-IIGQGGFGKVYKGVL---SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (595)
Q Consensus 266 ~~~~~~~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 340 (595)
+....++|.+.+ .||+|+||+||+|.+ .+++.||+|+++... .......+.+|+++++.++||||+++++++ ..
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 334556788887 999999999999964 346889999997432 334467899999999999999999999999 56
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCC
Confidence 678999999999999999986 34589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcCcce--eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHh
Q 007625 421 LAKLVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 497 (595)
Q Consensus 421 ~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~ 497 (595)
++.......... .....+++.|+|||++.+..++.++||||||+++|||+| |+.||....... ....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~--- 234 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLE--- 234 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHH---
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHH---
Confidence 998765443322 122346789999999988889999999999999999999 999997644321 111111
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 498 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
... ....+...+..+.+++.+||+.||++||++.||++.|+..
T Consensus 235 -~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 235 -KGE--------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -TTC--------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 0112233456788999999999999999999999999763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=345.14 Aligned_cols=253 Identities=19% Similarity=0.242 Sum_probs=207.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||+||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 467999999999999999999965 6899999998643 23445678999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC--CCcEEEeecccccccc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVD 426 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~~~~~~ 426 (595)
|+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999988752 34689999999999999999999999 9999999999999974 4789999999998775
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.. .. .. +
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-----~~~~i~~---~~-~~--~ 269 (387)
T 1kob_A 203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-----TLQNVKR---CD-WE--F 269 (387)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHH---CC-CC--C
T ss_pred CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-----HHHHHHh---CC-CC--C
Confidence 4322 233468999999999999999999999999999999999999998643211 1111111 11 00 1
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.. .......++.+++.+||+.||++|||+.|++++
T Consensus 270 ~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DED---AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSS---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Ccc---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111 112334678899999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=333.66 Aligned_cols=266 Identities=20% Similarity=0.288 Sum_probs=201.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
++|++.+.||+|+||+||+|+.. +|+.||+|++.... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999975 58999999986443 33345678899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999888775 34689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH--------HHHhcc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI--------RKLLRE 499 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~--------~~~~~~ 499 (595)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........... ..... ......
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL-IRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCSCCHHHHHHHHTC
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhcccccccccccccc
Confidence 22 2234468999999999876 5689999999999999999999999986543321110 00000 000000
Q ss_pred ccccc--cccccC-CC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 DRLND--IVDRNL-NT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 ~~~~~--~~d~~l-~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..... +.++.- .. ..+.....+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 000000 00 012234568899999999999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.56 Aligned_cols=251 Identities=23% Similarity=0.291 Sum_probs=204.5
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCce
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (595)
...++|++.+.||+|+||.||+|+.+ +++.||+|+++... .......+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 45678999999999999999999975 57889999987421 223456788899999887 799999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 9999999999999999863 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +...+. .. .
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~~~~i~---~~-~-- 237 (353)
T 2i0e_A 170 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----LFQSIM---EH-N-- 237 (353)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---HC-C--
T ss_pred ccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-----HHHHHH---hC-C--
Confidence 643221 22345679999999999999999999999999999999999999998644321 111111 11 1
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 544 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 544 (595)
..++.....++.+++.+|++.||.+||+ ++||++
T Consensus 238 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1122334567889999999999999996 466654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=333.04 Aligned_cols=262 Identities=20% Similarity=0.256 Sum_probs=201.4
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+.++.+++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3468999999999999999999965 78899999987432 23345788999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 99999999999999862 4689999999999999999999999 9999999999999999999999999999876
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
............|++.|+|||++.+..++.++||||||+++|||++|+.||...... .....+. ... ..
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~----~~~-~~- 253 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-----VMGAHIN----QAI-PR- 253 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-----HHHHHHH----SCC-CC-
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-----HHHHHhc----cCC-CC-
Confidence 544333334456899999999999999999999999999999999999999754321 1111111 110 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcCccc
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-PMAQVVKMLQGEDLA 552 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~ 552 (595)
........+.++.+++.+||+.||++|| +++++++.|+.....
T Consensus 254 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 254 ----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 0011223345788899999999999999 999999999875443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=329.65 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=206.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
.++|++.+.||+|+||.||+|... +++.||+|++... ........+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999965 6899999998743 34455678899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc---EEEeecccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKL 424 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~~~~ 424 (595)
||+++++|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999988875 24589999999999999999999999 9999999999999986655 99999999987
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+.. ....
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~----~~~~- 225 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-----LYAQIKA----GAYD- 225 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----TCCC-
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-----HHHHHHh----cccc-
Confidence 654322 234568999999999999999999999999999999999999997543321 1111111 1100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
...+ .......++.+++.+|++.||++|||+.|+++
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 YPSP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCch----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0001 11223457889999999999999999999965
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=337.82 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=197.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
.++|++.+.||+|+||+||+|+. .++.||+|++.. ......|.+|++++++++||||+++++++. +..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 35688899999999999999998 478999999863 245678999999999999999999999887 347999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc-EEEeeccccccccCc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-AVLCDFGLAKLVDAK 428 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfG~~~~~~~~ 428 (595)
+++++|.+++..... ...+++..++.++.|++.||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999985321 235788999999999999999999932228999999999999998876 799999999765432
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||........ .......... .
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~-~------ 222 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------RIMWAVHNGT-R------ 222 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH------HHHHHHHTTC-C------
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH------HHHHHHhcCC-C------
Confidence 2234589999999999999999999999999999999999999975332111 1111111111 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
.......+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 223 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 223 --PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp --CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111122345788899999999999999999999999763
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.53 Aligned_cols=272 Identities=18% Similarity=0.196 Sum_probs=214.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC--ceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 346 (595)
.++|++.++||+|+||+||+|+.. +++.||+|++...........+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457899999999999999999975 589999999975444455678889999999999999999999988765 67999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE----cCCCcEEEeecccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLA 422 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~~ 422 (595)
|||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999986432 23499999999999999999999999 99999999999999 77888999999999
Q ss_pred ccccCcCcceeecccccccccCccccCC--------CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHH
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLST--------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~ 494 (595)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||................ .
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-~ 240 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI-I 240 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH-H
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH-h
Confidence 8765432 2234568999999999864 567889999999999999999999997543322221111111 1
Q ss_pred HHhccccccccc---------c---ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 495 KLLREDRLNDIV---------D---RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 495 ~~~~~~~~~~~~---------d---~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.......+.... . +............+.+++.+||+.||++||++.|+++.+++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 111111111000 0 11112457788899999999999999999999999998865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=367.97 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=203.6
Q ss_pred cCCCcCC-eeeeccceEEEEEEeC---CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 271 DNFSESN-IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 271 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
+++.+.+ .||+|+||.||+|.+. ++..||||+++..........|.+|++++++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3344444 7999999999999863 4667999999865555667889999999999999999999999976 568999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999752 35699999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcce--eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 427 AKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 427 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
...... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+ ....+. ...+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----~~~~i~---~~~~-- 557 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIE---QGKR-- 557 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-----HHHHHH---TTCC--
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHH---cCCC--
Confidence 432221 122335689999999998999999999999999999998 999997644321 112221 1111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+...+.++.+++.+||+.||++||++.+|++.|+.
T Consensus 558 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 558 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11233455788999999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.71 Aligned_cols=262 Identities=21% Similarity=0.212 Sum_probs=202.7
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC----CCchhHHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
....++|++.+.||+|+||+||+|... ++..||+|++... ........+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 446678999999999999999999964 6889999998632 23455678999999999999999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPG------------------------------------EKGLDWPTRKRVAFGTAYGL 385 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~~L 385 (595)
..++||||+++|+|.+++...... ...+++..++.++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998632111 11235777889999999999
Q ss_pred HHHhhcCCCCcEEcCCCCCCEEEcCCC--cEEEeeccccccccCcCc---ceeecccccccccCccccCC--CCCCccch
Q 007625 386 EYLHEQCNPKIIHRDLKAANILLDDNF--EAVLCDFGLAKLVDAKLT---HVTTQIRGTMGHIAPEYLST--GKSSEKTD 458 (595)
Q Consensus 386 ~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~sD 458 (595)
+|||+. +|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 899999999986643221 12344569999999999865 67899999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 007625 459 VFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 538 (595)
Q Consensus 459 v~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs 538 (595)
|||||+++|||++|+.||........ .......... ...+. .......+.+++.+|++.||.+||+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~--------~~~~~~~~~~--~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADT--------ISQVLNKKLC--FENPN----YNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHHCCCC--TTSGG----GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHH--------HHHHHhcccc--cCCcc----cccCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999976543211 1111111100 00000 1123457889999999999999999
Q ss_pred HHHHHHH
Q 007625 539 MAQVVKM 545 (595)
Q Consensus 539 ~~evl~~ 545 (595)
+.|+++.
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999763
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=343.00 Aligned_cols=267 Identities=18% Similarity=0.202 Sum_probs=200.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC----CCcEEEEEEeccCCCch----------hHHHHHHHHHHHHhcCCCCCccccc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPG----------GEAAFQREVHLISVAIHKNLLQLIG 335 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~ 335 (595)
.++|++.+.||+|+||+||+|+.. ++..||+|++....... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467899999999999999999975 57889999987533211 1134667888899999999999999
Q ss_pred eeec----CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC
Q 007625 336 YCTT----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (595)
Q Consensus 336 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 411 (595)
++.. ....++||||+ +++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9887 67889999999 99999999863 2689999999999999999999999 99999999999999988
Q ss_pred C--cEEEeeccccccccCcCcc------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhh
Q 007625 412 F--EAVLCDFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 483 (595)
Q Consensus 412 ~--~~kl~DfG~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~ 483 (595)
+ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876433211 1134569999999999999999999999999999999999999996422211
Q ss_pred hhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 007625 484 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL 551 (595)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 551 (595)
... .......... ....+..... ....+.++.+++.+||+.||++||++.+|++.|+...+
T Consensus 268 ~~~----~~~~~~~~~~-~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VAV----QTAKTNLLDE-LPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHH----HHHHHHHHHT-TTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHH----HHHHHhhccc-ccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111 1111111110 0000000000 01234578899999999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=332.43 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=202.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
+.++|++.+.||+|+||+||+|... ++..||+|++.... .......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4567999999999999999999965 57799999986321 12235678999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++++|.+.+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999999763 4589999999999999999999999 9999999999999999999999999998654
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...+.. ..
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~---~~----- 223 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----YKRISR---VE----- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHH---TC-----
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-----HHHHHh---CC-----
Confidence 332 22345689999999999999999999999999999999999999985443211 111111 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...+......+.+++.+|++.||++|||+.|++++
T Consensus 224 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 -----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01122234577889999999999999999999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.09 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=204.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcE--EEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTK--VAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 345 (595)
.++|++.+.||+|+||.||+|+.. ++.. +|+|+++..........+.+|++++.++ +||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367889999999999999999964 5654 4999987655555667899999999999 89999999999999999999
Q ss_pred EEEecccCcHhhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc
Q 007625 346 VYPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 413 (595)
||||+++++|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999998643 2235699999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHH
Q 007625 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH 492 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~ 492 (595)
+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||+| |+.||....... .
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------~ 250 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------L 250 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------H
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--------H
Confidence 9999999987443221 1122346889999999988889999999999999999998 999997544321 1
Q ss_pred HHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.... ..+. ....+......+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 251 ~~~~-~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 251 YEKL-PQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HHHG-GGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHh-hcCC--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1111 1110 011122334678899999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=331.35 Aligned_cols=255 Identities=27% Similarity=0.338 Sum_probs=204.2
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CC---cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce-EEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER-ILV 346 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 346 (595)
.|...++||+|+||+||+|+.. ++ ..||+|++...........+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3555789999999999999853 22 379999998655556678899999999999999999999999876665 999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+.+++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999752 35689999999999999999999999 99999999999999999999999999998664
Q ss_pred CcCc---ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 427 AKLT---HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 427 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+....... .....+... ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~----~~~~~~~~~---~~-- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF----DLTHFLAQG---RR-- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG----GHHHHHHTT---CC--
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH----HHHHHhhcC---CC--
Confidence 4321 12233567899999999999999999999999999999999665543322111 112222111 00
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+......+.+++.+|++.||.+|||+.|+++.|+.
T Consensus 247 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 247 -------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 01122234578899999999999999999999999976
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=329.33 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=206.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999975 7899999999754444566789999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999998874 34689999999999999999999999 9999999999999999999999999999865432
Q ss_pred Cc-ceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 429 LT-HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 429 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.. .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....+.. .... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~----~~~~---~ 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWKE----KKTY---L 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH---HHHHHHT----TCTT---S
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHhhh----cccc---c
Confidence 21 12334568999999999987765 7799999999999999999999976443211 1111111 1000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.........+.+++.+|++.||++|||+.|+++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011223457788999999999999999999965
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=338.69 Aligned_cols=268 Identities=24% Similarity=0.313 Sum_probs=211.4
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHh--cCCCCCccccceee
Q 007625 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCT 338 (595)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~ 338 (595)
.+...-....++|++.+.||+|+||+||+|+. +++.||+|++.. .....+.+|.+++.. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 34444556678999999999999999999998 689999999864 345677888888887 78999999999998
Q ss_pred cCC----ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCcEEcCCCCCCE
Q 007625 339 TSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--------EQCNPKIIHRDLKAANI 406 (595)
Q Consensus 339 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlkp~NI 406 (595)
... ..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI 178 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI 178 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence 776 78999999999999999975 35899999999999999999999 66 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCcCcc---eeecccccccccCccccCCC------CCCccchhHHHHHHHHHHHhC-----
Q 007625 407 LLDDNFEAVLCDFGLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTG------KSSEKTDVFGYGITLLELVTG----- 472 (595)
Q Consensus 407 ll~~~~~~kl~DfG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlGvvl~elltg----- 472 (595)
+++.++.+||+|||++......... ......||+.|+|||++.+. .++.++||||||+++|||+||
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999999876544322 12345699999999999765 234789999999999999999
Q ss_pred -----CCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 473 -----QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 473 -----~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..||......... ...+.... ..... .+.+.. ........+.+++.+||+.||++|||+.||+++
T Consensus 259 ~~~~~~~p~~~~~~~~~~---~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPS---VEEMRKVV-CEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp BCCCCCCTTTTTSCSSCC---HHHHHHHH-TTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccccccCccccCcCccc---HHHHHHHH-HHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 6777643321111 11111111 11111 111111 134677889999999999999999999999999
Q ss_pred hhcC
Q 007625 546 LQGE 549 (595)
Q Consensus 546 L~~~ 549 (595)
|+..
T Consensus 331 L~~i 334 (342)
T 1b6c_B 331 LSQL 334 (342)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=335.15 Aligned_cols=262 Identities=22% Similarity=0.340 Sum_probs=201.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++.. ........+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35789999999999999999996 47899999998742 3345567889999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999986544456799999999999999999999999 99999999999999999999999999998665
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ........ ........
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~- 258 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKI-EQCDYPPL- 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHHH-HTTCSCCC-
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHHh-hcccCCCC-
Confidence 4322 223346899999999999999999999999999999999999999753321 11111111 11111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
.......++.+++.+||+.||++|||+.||++.|+..
T Consensus 259 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 259 ------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp ------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0122345788999999999999999999999999763
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=343.98 Aligned_cols=254 Identities=21% Similarity=0.263 Sum_probs=195.1
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
..++|++.+.||+|+||+||+|+.. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 3568999999999999999999975 78999999997532 23356889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc--EEEeeccccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--AVLCDFGLAKLV 425 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~~~~~ 425 (595)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++..
T Consensus 96 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 96 EYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999875 24589999999999999999999999 9999999999999987765 999999999744
Q ss_pred cCcCcceeecccccccccCccccCCCCCCcc-chhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK-TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
.... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ....+....... .
T Consensus 169 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~~-~-- 239 (361)
T 3uc3_A 169 VLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQRILSVK-Y-- 239 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHHHHTTC-C--
T ss_pred cccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhcCC-C--
Confidence 3221 2234569999999999988887665 8999999999999999999975433211 112222211111 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.++. ......++.+++.+||+.||++|||+.|++++
T Consensus 240 ----~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 ----SIPD-DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----CCCT-TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----CCCC-cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0000 01123577899999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=343.52 Aligned_cols=270 Identities=22% Similarity=0.255 Sum_probs=211.8
Q ss_pred ccccCHHHHHHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-----CCCCc
Q 007625 258 LRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----HKNLL 331 (595)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----h~niv 331 (595)
...+++++.....++|++.+.||+|+||+||+|+. .+++.||||+++. .......+..|+.+++.+. ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 44566666677789999999999999999999997 4789999999863 2345567788999999886 99999
Q ss_pred cccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-
Q 007625 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD- 410 (595)
Q Consensus 332 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 410 (595)
++++++...+..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP 173 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence 9999999999999999999 899999998633 34589999999999999999999999 9999999999999975
Q ss_pred ------------------------CCcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHH
Q 007625 411 ------------------------NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITL 466 (595)
Q Consensus 411 ------------------------~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl 466 (595)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999865432 2345689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc-----------cccccccc-----cCCC--C---------------
Q 007625 467 LELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED-----------RLNDIVDR-----NLNT--Y--------------- 513 (595)
Q Consensus 467 ~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~-----------~~~~~~d~-----~l~~--~--------------- 513 (595)
|||+||+.||........ ...+....... .....++. ..+. .
T Consensus 250 ~ell~g~~pf~~~~~~~~-----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 324 (360)
T 3llt_A 250 AELYTGSLLFRTHEHMEH-----LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324 (360)
T ss_dssp HHHHHSSCSCCCSSHHHH-----HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred HHHHHCCCCCCCCcHHHH-----HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence 999999999986543211 11111111000 00000000 0000 0
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 514 DSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 514 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.......+.+++.+||+.||++|||+.|+++
T Consensus 325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0011256779999999999999999999964
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=358.60 Aligned_cols=251 Identities=21% Similarity=0.257 Sum_probs=197.3
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
..++|++.+.||+|+||.||+|+.. +|+.||+|+++.. ........+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999964 7899999999742 233445677889999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++.
T Consensus 226 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999876 3468999999999999999999998 7 899999999999999999999999999986
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+. ...
T Consensus 299 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~---~~~---- 365 (446)
T 4ejn_A 299 GIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELIL---MEE---- 365 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---HCC----
T ss_pred ccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----HHHHHH---hCC----
Confidence 43322 22344679999999999999999999999999999999999999997644321 111111 110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
..++.....++.+++.+||+.||.+|| +++|++++
T Consensus 366 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 ------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 012223346788999999999999999 99999654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.96 Aligned_cols=263 Identities=24% Similarity=0.323 Sum_probs=207.2
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceee----cCCce
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT----TSSER 343 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~ 343 (595)
..++|++.+.||+|+||.||+|+. .+++.||+|++.. ........+.+|+++++.++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE-SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec-CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 456899999999999999999996 5789999999864 23455678899999999999999999999986 33467
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++++|.+++.........+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 899999999999999987655567799999999999999999999999 99999999999999999999999999987
Q ss_pred cccCcCcc--------eeecccccccccCccccCCCC---CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHH
Q 007625 424 LVDAKLTH--------VTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492 (595)
Q Consensus 424 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~ 492 (595)
........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ .....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~ 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALA 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---CHHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---hhhHH
Confidence 65321110 012234799999999987554 68999999999999999999999863211100 11111
Q ss_pred HHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
.. .. .. ..........+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 260 ~~----~~-~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 VQ----NQ-LS-------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HH----CC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hh----cc-CC-------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 11 00 00 0011233467889999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=347.40 Aligned_cols=257 Identities=22% Similarity=0.270 Sum_probs=205.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEe----CCCcEEEEEEeccCC---CchhHHHHHHHHHHHHhc-CCCCCccccceeecCC
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 341 (595)
.++|++.+.||+|+||+||+|+. .+++.||||+++... .......+.+|++++..+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46789999999999999999997 478999999986421 122345677899999999 6999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999999863 4589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
++..............||+.|+|||++.+ ..++.++|||||||++|||+||+.||......... ..........
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~~~~ 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKS 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH----HHHHHHHhcc
Confidence 98765444434445679999999999985 34789999999999999999999999754322111 1111111110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHhh
Q 007625 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKMLQ 547 (595)
Q Consensus 500 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 547 (595)
...++......+.+++.+||+.||++|| ++.|++++.-
T Consensus 282 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 0112333446788899999999999999 9999977654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.72 Aligned_cols=252 Identities=20% Similarity=0.297 Sum_probs=198.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcC--CCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 346 (595)
.++|++.+.||+|+||+||+|...+++.||||++... ........+.+|+.++.++. ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999888999999998643 34455678999999999996 59999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|| +.+++|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 567899999986 34688999999999999999999999 999999999999996 5799999999998765
Q ss_pred CcCcc-eeecccccccccCccccCC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHH
Q 007625 427 AKLTH-VTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494 (595)
Q Consensus 427 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~ 494 (595)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~ 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLH 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------HHHHH
Confidence 43222 2334569999999999865 46899999999999999999999999743211 11111
Q ss_pred HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
........ .. ++.....++.+++.+||+.||++|||+.|++++
T Consensus 279 ~~~~~~~~-----~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 AIIDPNHE-----IE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHCTTSC-----CC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCcccc-----CC---CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111110 01 111124578889999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.52 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=181.5
Q ss_pred CCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEEEEEecccC
Q 007625 276 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
.+.||+|+||+||+|... +++.||+|++.. .....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999975 689999999864 34567789999999997 999999999999999999999999999
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC---cEEEeeccccccccCcCc
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~~~~~~~~~~ 430 (595)
+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 92 ~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 92 ELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp BHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999986 35699999999999999999999999 999999999999997765 899999999986654322
Q ss_pred ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccC
Q 007625 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510 (595)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 510 (595)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ....+...... .+.... ..
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~-~~~~~~--~~-- 237 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIK-KGDFSF--EG-- 237 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHT-TTCCCC--CS--
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHH-cCCCCC--Cc--
Confidence 223456899999999999999999999999999999999999999754321110 11111222111 111100 00
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 511 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
........++.+++.+|++.||++|||+.|++++
T Consensus 238 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 238 -EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp -HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred -ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0012235678899999999999999999999754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.67 Aligned_cols=249 Identities=21% Similarity=0.281 Sum_probs=202.5
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 345 (595)
..++|++.+.||+|+||+||+|+.. +++.||+|+++.. ........+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467899999999999999999975 7999999998743 3344567888999999999 89999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC---------------
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--------------- 410 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------------- 410 (595)
||||+++++|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999986433335689999999999999999999999 9999999999999984
Q ss_pred ----CCcEEEeeccccccccCcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhh
Q 007625 411 ----NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485 (595)
Q Consensus 411 ----~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~ 485 (595)
...+||+|||.+....... ...||+.|+|||++.+. .++.++||||||+++|||++|..++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 4479999999998765432 23489999999999766 567899999999999999999877643211
Q ss_pred hhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 486 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 486 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...+ .... ....+.....++.+++.+||+.||++|||+.|++++
T Consensus 237 ----~~~~----~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ----WHEI----RQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ----HHHH----HTTC--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----HHHH----HcCC--------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0111 1111 111222334678899999999999999999999654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=357.73 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=206.9
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
..++|+..++||+|+||.||+|+.. +|+.||+|++.... .......+.+|+.++++++||||+++++++.+....++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3467889999999999999999975 69999999996421 12345678899999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++|+|.+++.........+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999987554456799999999999999999999999 9999999999999999999999999999876
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ........... .
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i~~~-~---- 409 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRVLEQ-A---- 409 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHHHHC-C----
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHHhhc-c----
Confidence 54322 22345799999999999999999999999999999999999999976432111 11111111111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 539 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 539 (595)
..++......+.+++.+|++.||++||++
T Consensus 410 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 -----VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -----cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11233345678889999999999999976
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=353.82 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=206.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357889999999999999999975 79999999986421 123456789999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999875 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... +...+. . +..
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-----~~~~i~---~-~~~--- 233 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-----LFKKIC---D-GIF--- 233 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-----HHHHHH---T-TCC---
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-----HHHHHh---c-CCc---
Confidence 432 2334569999999999988765 789999999999999999999998644321 111111 1 110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..+.....++.+++.+|++.||++|||+.|++++
T Consensus 234 ------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 ------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1122234578889999999999999999999873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.06 Aligned_cols=268 Identities=22% Similarity=0.291 Sum_probs=207.8
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
..++|++.+.||+|+||+||+|... ++..||+|++...........+.+|+.+++.++||||+++++++..++..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3467999999999999999999975 789999999986555666788999999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++... ..+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++.....
T Consensus 111 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999999863 35899999999999999999999832 799999999999999999999999999976533
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH------------
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK------------ 495 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~------------ 495 (595)
. ......||+.|+|||++.+..++.++||||||+++|||+||+.||...................
T Consensus 185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 2 2233568999999999999999999999999999999999999998654322111000000000
Q ss_pred ---------Hhcccc----ccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 496 ---------LLREDR----LNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 496 ---------~~~~~~----~~~~~d~~l~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...... ...+....... .......++.+++.+||+.||++|||+.|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000 00000001111 111234578899999999999999999999753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=345.50 Aligned_cols=253 Identities=25% Similarity=0.282 Sum_probs=196.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHH-HHhcCCCCCccccceeecCCceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHL-ISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
.++|++.+.||+|+||.||+|+.+ +++.||+|+++... .......+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 457889999999999999999975 68899999997432 22334556677776 567899999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999986 24588999999999999999999999 9999999999999999999999999999864
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ . ....... ..
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~---~~~i~~~-~~--- 256 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----M---YDNILNK-PL--- 256 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-----H---HHHHHHS-CC---
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----H---HHHHHhc-cc---
Confidence 3221 22345679999999999999999999999999999999999999997654321 1 1111111 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.++.....++.+++.+|++.||.+||++.+.++.+..
T Consensus 257 ------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 257 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp ------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence 1122234578889999999999999999755555544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=338.72 Aligned_cols=260 Identities=27% Similarity=0.379 Sum_probs=207.8
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 342 (595)
..++|++.+.||+|+||.||+|+. .++..||+|++...........+.+|+.++++++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 456899999999999999999984 25778999999765566667789999999999999999999999999999
Q ss_pred eEEEEEecccCcHhhhhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC---CCcEEE
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPG---EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVL 416 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 416 (595)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999864321 24589999999999999999999999 9999999999999984 456999
Q ss_pred eeccccccccCcCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHH
Q 007625 417 CDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR 494 (595)
Q Consensus 417 ~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~ 494 (595)
+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+| |+.||....... ....+.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~ 259 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVT 259 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-----HHHHHh
Confidence 99999986543322 22234557899999999988899999999999999999998 999987543211 111111
Q ss_pred HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.... ...+......+.+++.+||+.||.+||++.||++.|+.
T Consensus 260 ---~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 260 ---SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp ---TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---cCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1111 11122334578899999999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=336.99 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=206.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCc-----hhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...... .....+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457899999999999999999975 6899999998743321 2467899999999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC----cEEEeec
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF 419 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 419 (595)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999975 34689999999999999999999999 999999999999999887 7999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
|++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+. ..
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~i~---~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANIT---SV 233 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHH---TT
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHH---hc
Confidence 9998765432 2234568999999999999999999999999999999999999997643321 111111 10
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. . .+.. ........+.+++.+|++.||++|||+.|++++
T Consensus 234 -~~-~-~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 -SY-D-FDEE---FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -CC-C-CCHH---HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -cc-c-cChh---hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0 0000 001223568899999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=332.05 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=209.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.+.|+..+.||+|+||.||+|+.. +++.||+|++...........+.+|+.+++.++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456889999999999999999964 6899999999765555667889999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999864 4689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+.. ...
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~----~~~------ 236 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLFLIPK----NNP------ 236 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHH----SCC------
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-----HHHHhhc----CCC------
Confidence 22 2234568999999999999999999999999999999999999997543211 1111111 110
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
..........+.+++.+||+.||++|||+.|+++..
T Consensus 237 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 237 --PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp --CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred --CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 111222345688999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=345.01 Aligned_cols=264 Identities=22% Similarity=0.296 Sum_probs=194.5
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcC-CCCCccccceeecCC--c
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS--E 342 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 342 (595)
...++|++.+.||+|+||.||+|.. .+++.||+|++... ........+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3567899999999999999999996 47899999998643 33455677889999999997 999999999997554 6
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++||||++ ++|...+.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 799999998 588888875 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCcC--------------------cceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCch
Q 007625 423 KLVDAKL--------------------THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (595)
Q Consensus 423 ~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~ 481 (595)
+...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8653211 112234579999999999976 6789999999999999999999999986543
Q ss_pred hhhhhhhHHHHHHHHhcccccccc---------------------ccccCCCCC-------------HHHHHHHHHHHHH
Q 007625 482 EEEEDVLLLDHIRKLLREDRLNDI---------------------VDRNLNTYD-------------SKEVETMVQVALL 527 (595)
Q Consensus 482 ~~~~~~~l~~~~~~~~~~~~~~~~---------------------~d~~l~~~~-------------~~~~~~l~~l~~~ 527 (595)
.... ..+...........+ ......... .....++.+++.+
T Consensus 237 ~~~~-----~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 311 (388)
T 3oz6_A 237 MNQL-----ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311 (388)
T ss_dssp HHHH-----HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred HHHH-----HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence 2211 111111100000000 000000000 0224578899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 007625 528 CTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 528 cl~~dP~~RPs~~evl~~ 545 (595)
||+.||++|||++|++++
T Consensus 312 ~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 312 LLQFNPNKRISANDALKH 329 (388)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred hhccCcccCCCHHHHhCC
Confidence 999999999999999765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=334.57 Aligned_cols=265 Identities=26% Similarity=0.313 Sum_probs=200.3
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC----CchhHHHHHHHHHHHHhcC---CCCCccccceeec
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAI---HKNLLQLIGYCTT 339 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 339 (595)
...++|++.+.||+|+||+||+|+. .+++.||+|++.... .......+.+|+.+++.+. ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3567999999999999999999995 578999999986322 1122345667777777664 9999999999977
Q ss_pred CC-----ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcE
Q 007625 340 SS-----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 414 (595)
Q Consensus 340 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 414 (595)
.. ..++||||+. ++|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 65 4789999997 59999988633 23499999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHH
Q 007625 415 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494 (595)
Q Consensus 415 kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~ 494 (595)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-----~~~i~ 232 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-----LGKIF 232 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-----HHHHH
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHH
Confidence 999999998664332 22445689999999999999999999999999999999999999986543221 11111
Q ss_pred HHhcc---ccccccc---cccCCC--------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 495 KLLRE---DRLNDIV---DRNLNT--------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 495 ~~~~~---~~~~~~~---d~~l~~--------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..... ..+.... ...+.. ..+.....+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11110 1110000 000000 112234678899999999999999999999653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=329.17 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=184.5
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788999999999999999996 478999999986321 122346789999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999998753 35689999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .... .
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~---------~ 225 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LNKV---------V 225 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------C---------C
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HHHH---------h
Confidence 3322 12335689999999999988899999999999999999999999975432211 0000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
... ...+.....++.+++.+|++.||++|||+.|+++
T Consensus 226 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LAD-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcc-cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000 0112233467889999999999999999999965
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.95 Aligned_cols=266 Identities=25% Similarity=0.311 Sum_probs=210.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-----CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceee--cCCc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT--TSSE 342 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 342 (595)
.++|++.+.||+|+||.||+|++ .+++.||+|++... .......+.+|++++++++||||+++++++. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 45788899999999999999984 36889999998753 3455677999999999999999999999886 4456
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 889999999999999997532 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcc--eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhh------hHHHHHH
Q 007625 423 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV------LLLDHIR 494 (595)
Q Consensus 423 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~------~l~~~~~ 494 (595)
+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||........... .......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 877543322 22334578889999999988899999999999999999999999865332110000 0001111
Q ss_pred HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
...... .....+......+.+++.+||+.||++|||+.|++++|+...
T Consensus 255 ~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 255 ELLEEG--------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HHhhcc--------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111 111123445567889999999999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.23 Aligned_cols=245 Identities=21% Similarity=0.265 Sum_probs=203.2
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCC-------chhHHHHHHHHHHHHhcCCCCCccccceeecC
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-------PGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 340 (595)
..++|++.+.||+|+||+||+|+. .+++.||+|+++.... ......+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356899999999999999999995 4788999999874321 11334677899999999999999999999999
Q ss_pred CceEEEEEecccC-cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 341 SERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 341 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
+..++||||+.+| +|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 99998875 34699999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
|+++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 99987654322 233568999999999988776 88999999999999999999999642110
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
...... .+.....++.+++.+||+.||++|||+.|+++.-
T Consensus 237 ---~~~~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 237 ---VEAAIH-----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp ---TTTCCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred ---HhhccC-----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000000 1112345788999999999999999999998863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=353.49 Aligned_cols=264 Identities=20% Similarity=0.258 Sum_probs=197.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCC------
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 341 (595)
.++|++.+.||+|+||+||+|... +++.||||++... ........+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999964 6899999999743 23445678889999999999999999999986553
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||++++ +.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 569999999864 5555532 388999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHH-----------
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL----------- 490 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~----------- 490 (595)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9876542 223446799999999999999999999999999999999999999987553221110000
Q ss_pred ---HHHHHHhccc------cccccccccCC-C---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 491 ---DHIRKLLRED------RLNDIVDRNLN-T---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 491 ---~~~~~~~~~~------~~~~~~d~~l~-~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.......... .....+...+. . .......++.+++.+||+.||++|||++|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 00000000000 0 011235678999999999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=343.23 Aligned_cols=262 Identities=25% Similarity=0.335 Sum_probs=197.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|++.+.||+|+||+||+|+.. +++.||+|++...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999975 78999999986433322233456799999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 98 4888888753 34689999999999999999999999 99999999999999999999999999998654332
Q ss_pred cceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc---cccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLNDI 505 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~~ 505 (595)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+...... ..+...
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-----QLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCChHhchhh
Confidence 2 2233468999999999876 568999999999999999999999998654322 11222221111 111111
Q ss_pred ccc------cCCC--------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDR------NLNT--------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~------~l~~--------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... .... ..+....++.+++.+|++.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 100 0000 011234577899999999999999999999653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=331.04 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=201.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CC-------cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DN-------TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
.++|++.+.||+|+||+||+|+.. ++ ..||+|++... .......+.+|+.++++++||||+++++++..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 467888999999999999999854 33 47999998642 3345678999999999999999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc--------
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-------- 413 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------- 413 (595)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999863 23489999999999999999999999 9999999999999998887
Q ss_pred EEEeeccccccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHH
Q 007625 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~ 492 (595)
+||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+........ ....
T Consensus 160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~----~~~~ 230 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR----KLQF 230 (289)
T ss_dssp EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHHH
T ss_pred eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH----HHHH
Confidence 999999998755432 22447899999999987 6789999999999999999996554432211110 1111
Q ss_pred HHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 007625 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLA 552 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 552 (595)
.. ..... +.....++.+++.+||+.||++|||+.|+++.|+...-+
T Consensus 231 ~~---~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 231 YE---DRHQL-----------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HH---TTCCC-----------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred hh---ccCCC-----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11 11110 111134578899999999999999999999999876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=340.18 Aligned_cols=253 Identities=17% Similarity=0.175 Sum_probs=204.3
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEE------eCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC---CCCCcccccee
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGV------LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYC 337 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~ 337 (595)
+...++|.+.+.||+|+||+||+|. ..+++.||+|+++.. ...++..|++++..++ |+|++++++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 3456789999999999999999994 446889999998642 3556788888888876 99999999999
Q ss_pred ecCCceEEEEEecccCcHhhhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC------
Q 007625 338 TTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD------ 410 (595)
Q Consensus 338 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~------ 410 (595)
...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999985432 245699999999999999999999999 9999999999999998
Q ss_pred -----CCcEEEeeccccccccCc-CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhh
Q 007625 411 -----NFEAVLCDFGLAKLVDAK-LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484 (595)
Q Consensus 411 -----~~~~kl~DfG~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~ 484 (595)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 899999999999765422 2233455679999999999999999999999999999999999999986432110
Q ss_pred hhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhhc
Q 007625 485 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR-PPMAQVVKMLQG 548 (595)
Q Consensus 485 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~evl~~L~~ 548 (595)
......+...+ ....+.+++..|++.+|.+| |++.++.+.|+.
T Consensus 293 -------------------~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 -------------------CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -------------------EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -------------------eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 00111111111 23456677779999999998 678888877765
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=357.45 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=208.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
..++|+..++||+|+||.||+|+.. +|+.||+|++... ........+.+|+++++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4567899999999999999999975 7999999998642 122345678899999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999987532 34589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+...+.. ..
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-~~i~~~i~~----~~---- 405 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKE----VP---- 405 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-HHHHHHHHH----CC----
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-HHHHHHhhc----cc----
Confidence 5432 223457999999999999989999999999999999999999999864321111 111111111 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
..++.....++.+++.+|++.||.+|| ++.||+++
T Consensus 406 -----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 -----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 112233446788999999999999999 67888653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=338.93 Aligned_cols=248 Identities=28% Similarity=0.349 Sum_probs=201.3
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
+.|+..+.||+|+||+||+|+. .+++.||||++.... .......+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999996 578999999986432 2334467899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+. |++.+.+... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 5787777642 34689999999999999999999999 999999999999999999999999999986643
Q ss_pred cCcceeecccccccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
. ....||+.|+|||++. +..++.++|||||||++|||++|+.||....... .......... ..
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------~~~~~~~~~~-~~ 272 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNES-PA 272 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCC-CC
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHhcCC-CC
Confidence 2 2346899999999984 5678999999999999999999999997543211 1111111111 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
. ........+.+++.+||+.||++|||+.|+++..
T Consensus 273 ~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 273 L-------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp C-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred C-------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0 1122345678899999999999999999998753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=325.16 Aligned_cols=260 Identities=18% Similarity=0.228 Sum_probs=201.4
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCcccccee-ecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC-TTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv 346 (595)
..++|++.+.||+|+||+||+|+. .+++.||+|++.... ....+.+|+.++..++|++++..+.++ ...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 457899999999999999999996 578999999875432 223578899999999998887777666 556677999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE---cCCCcEEEeeccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK 423 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~ 423 (595)
|||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 89999998753 34599999999999999999999999 99999999999999 788999999999998
Q ss_pred cccCcCcc------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHh
Q 007625 424 LVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 497 (595)
Q Consensus 424 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 497 (595)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~ 235 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-HHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh-hhhhhhcccc
Confidence 76543321 2234568999999999999999999999999999999999999998643321111 1111111111
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 498 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.. .... .....+.++.+++.+||+.||++|||+.||++.|+.
T Consensus 236 ~~-~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 236 ST-PIEV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HS-CHHH--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred cc-hhhh--------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 00 0000 001123578899999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=353.15 Aligned_cols=268 Identities=21% Similarity=0.254 Sum_probs=188.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC-----Cc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE 342 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 342 (595)
.++|++.+.||+|+||+||+|+.. +++.||||++... ........+.+|+.+++.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999964 7899999998643 3344567889999999999999999999998443 56
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++||||+. ++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 688888875 35699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCc--------------------------ceeecccccccccCcccc-CCCCCCccchhHHHHHHHHHHHh----
Q 007625 423 KLVDAKLT--------------------------HVTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVT---- 471 (595)
Q Consensus 423 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvvl~ellt---- 471 (595)
+....... .......||+.|+|||++ .+..++.++|||||||++|||+|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 87643211 122345689999999986 45679999999999999999999
Q ss_pred -------CCCCCCCCchhh---------------hhhhhHHHHHHHHhccccc------------------cccccccCC
Q 007625 472 -------GQRAIDFSRLEE---------------EEDVLLLDHIRKLLREDRL------------------NDIVDRNLN 511 (595)
Q Consensus 472 -------g~~p~~~~~~~~---------------~~~~~l~~~~~~~~~~~~~------------------~~~~d~~l~ 511 (595)
|+.+|.+..... .........+......... .......+.
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 556665432100 0000111111111100000 000000001
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 512 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 512 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...+....++.+++.+||+.||++|||++|++++
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1112335678899999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=337.01 Aligned_cols=269 Identities=24% Similarity=0.365 Sum_probs=197.5
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHH--HHhcCCCCCccccceee-----cCC
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL--ISVAIHKNLLQLIGYCT-----TSS 341 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~-----~~~ 341 (595)
..++|++.+.||+|+||+||+|+. +++.||||++... ....+..|.++ +..++||||+++++++. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 456899999999999999999987 7899999998642 23344444444 45689999999997543 223
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCcEEcCCCCCCEEEcCCCcEE
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------NPKIIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~k 415 (595)
..++||||+++|+|.+++.. ...++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 56899999999999999975 23589999999999999999999873 33899999999999999999999
Q ss_pred EeeccccccccCcCc-------ceeecccccccccCccccCC-------CCCCccchhHHHHHHHHHHHhCCCCCCCCch
Q 007625 416 LCDFGLAKLVDAKLT-------HVTTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (595)
Q Consensus 416 l~DfG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlGvvl~elltg~~p~~~~~~ 481 (595)
|+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987653221 11224569999999999976 4567799999999999999999777643222
Q ss_pred hhhhhhhH---------HHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 482 EEEEDVLL---------LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 482 ~~~~~~~l---------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
........ ................+.... ........++.+++.+||+.||++|||+.|+++.|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW-KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc-ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 11100000 011111111111111111111 1234567789999999999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.97 Aligned_cols=247 Identities=20% Similarity=0.302 Sum_probs=203.3
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
..++|++.+.||+|+||+||+|... ++..||+|++..... .....+.+|++++++++||||+++++++.+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 3467999999999999999999965 577899999875332 34678899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE---cCCCcEEEeecccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL 424 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~~ 424 (595)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.++|+|||++..
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 86 ELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999998876 34589999999999999999999999 99999999999999 7889999999999987
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
..... ......||+.|+|||++.+. ++.++||||||+++|||++|+.||....... ....+.. ...
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~----~~~-- 224 (277)
T 3f3z_A 159 FKPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-----VMLKIRE----GTF-- 224 (277)
T ss_dssp CCTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----CCC--
T ss_pred ccCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHh----CCC--
Confidence 65432 22345689999999998654 8999999999999999999999997644321 1111111 100
Q ss_pred cccccCCCCCH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 505 IVDRNLNTYDS----KEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 505 ~~d~~l~~~~~----~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
..+. .....+.+++.+|++.||++|||+.|+++
T Consensus 225 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 -------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 23467889999999999999999999954
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=336.32 Aligned_cols=264 Identities=19% Similarity=0.278 Sum_probs=194.8
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
...++|++.+.||+|+||+||+|+.. +++.||+|+++... .......+.+|+.++++++||||+++++++...+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 45678999999999999999999954 78999999997432 23335677899999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE-----cCCCcEEEeecc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-----DDNFEAVLCDFG 420 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DfG 420 (595)
||||+++ +|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||
T Consensus 111 v~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999985 99998876 34589999999999999999999999 99999999999999 455669999999
Q ss_pred ccccccCcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +..........
T Consensus 183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~ 257 (329)
T 3gbz_A 183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ----LFKIFEVLGLP 257 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCC
T ss_pred CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH----HHHHHHHhCCC
Confidence 9987654322 22334589999999999875 489999999999999999999999976543211 11111111000
Q ss_pred --ccccccc-----cccCCC---C------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 500 --DRLNDIV-----DRNLNT---Y------DSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 500 --~~~~~~~-----d~~l~~---~------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
..+.... ...... . ......++.+++.+|++.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 000000 0 0113467889999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=364.06 Aligned_cols=247 Identities=25% Similarity=0.354 Sum_probs=199.3
Q ss_pred CeeeeccceEEEEEEe---CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVL---SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~---~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
+.||+|+||+||+|.+ .+++.||||+++.. ........+.+|++++.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 24678999999753 234456889999999999999999999999964 568899999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc-
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH- 431 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~- 431 (595)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999975 35689999999999999999999999 9999999999999999999999999999876543321
Q ss_pred -eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 432 -VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 432 -~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+. .+.
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----~~~~i~----~~~-------- 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLE----KGE-------- 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHH----TTC--------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH----cCC--------
Confidence 2233446789999999999999999999999999999998 999997644321 111111 111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
....+...+.++.+++..||+.||++||++.+|++.|++
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111233445788999999999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.76 Aligned_cols=267 Identities=23% Similarity=0.355 Sum_probs=201.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357888999999999999999975 58999999986433 3334567889999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999998887664 34689999999999999999999999 999999999999999999999999999986654
Q ss_pred cCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH-------HHHHHhcc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD-------HIRKLLRE 499 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~-------~~~~~~~~ 499 (595)
... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||............... ........
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 322 22345689999999999775 6899999999999999999999999865432211100000 00000000
Q ss_pred ccccccccccCCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 500 DRLNDIVDRNLNT------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 500 ~~~~~~~d~~l~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
........+.+.. ..+.....+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000111110 11234567899999999999999999999965
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.48 Aligned_cols=255 Identities=21% Similarity=0.313 Sum_probs=192.9
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-------CchhHHHHHHHHHHHHhcCCCCCccccceeec
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 339 (595)
...++|.+.+.||+|+||+||+|... +++.||+|++.... .......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35678999999999999999999964 68999999986421 11122357899999999999999999999754
Q ss_pred CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC---CcEEE
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVL 416 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl 416 (595)
+..++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 557999999999999988875 45699999999999999999999999 99999999999999754 45999
Q ss_pred eeccccccccCcCcceeecccccccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH
Q 007625 417 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 417 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~ 493 (595)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+...+
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~~i 357 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQI 357 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC----CHHHHH
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH----HHHHHH
Confidence 999999876542 22344669999999999863 567889999999999999999999997543211 111111
Q ss_pred HHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 494 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. ..... ... ........+.+++.+|++.||++|||+.|++++
T Consensus 358 ~~----~~~~~-~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TS----GKYNF-IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HT----TCCCC-CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hc----CCCCC-Cch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11 11000 000 001234578899999999999999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.19 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=191.8
Q ss_pred cCCCcC-CeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHH-hcCCCCCccccceeec----CCce
Q 007625 271 DNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTT----SSER 343 (595)
Q Consensus 271 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~ 343 (595)
++|.+. ++||+|+||+||+|... +++.||||+++. ...+.+|+.++. ..+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 456655 78999999999999965 689999999863 235678888874 4589999999998865 5568
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC---CCcEEEeecc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFG 420 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 420 (595)
++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 99999999999999998632 34699999999999999999999999 9999999999999997 7899999999
Q ss_pred ccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....+.. +
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~i~~----~ 282 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKTRIRM----G 282 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-SHHHHHHH----T
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-HHHHHHHc----C
Confidence 998654322 2234568999999999999999999999999999999999999997644321111 11111111 1
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... ...+ .......++.+++.+||+.||++|||+.|++++
T Consensus 283 ~~~-~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYE-FPNP----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCC-CCTT----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc-CCCc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 100 0000 112334678899999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.07 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=206.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|.+.+.||+|+||.||+|... +++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457888999999999999999975 5889999998643 2344567889999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998875 24689999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ........ .
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~-~----- 231 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKN-E----- 231 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTT-C-----
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhhc-c-----
Confidence 3322 2234568999999999998889999999999999999999999997644321 11111111 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
...+......+.+++.+|++.||++|||+.|+++
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0112223457888999999999999999999965
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.39 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=198.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCC------
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 341 (595)
.++|+..+.||+|+||.||+|.. .+|+.||+|++... ........+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46789999999999999999996 47999999998643 33444677899999999999999999999987653
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899998875 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... ..+.......
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l-----~~i~~~~g~~ 245 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-----KEIMKVTGTP 245 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHHHHCCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHHhcCCC
Confidence 9876432 234568999999999877 67999999999999999999999999865432211 1111100000
Q ss_pred ------------------cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 ------------------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ------------------~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.........+....+.....+.+++.+|++.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000111111223345678899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=340.27 Aligned_cols=270 Identities=23% Similarity=0.288 Sum_probs=201.9
Q ss_pred CHHHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCc----------hhHHHHHHHHHHHHhcCCCCCc
Q 007625 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP----------GGEAAFQREVHLISVAIHKNLL 331 (595)
Q Consensus 262 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------~~~~~~~~E~~~l~~l~h~niv 331 (595)
..+++....++|++.+.||+|+||.||+|...+|..||||++...... .....+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 357788899999999999999999999999888999999998643221 1237889999999999999999
Q ss_pred cccceeec-----CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCE
Q 007625 332 QLIGYCTT-----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (595)
Q Consensus 332 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 406 (595)
++++++.. ....++||||++ |+|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 99999844 335799999998 5888877742 34699999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhh
Q 007625 407 LLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485 (595)
Q Consensus 407 ll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~ 485 (595)
+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999997544322 2234568999999999876 67899999999999999999999999865432211
Q ss_pred hhhHHHHHHHHhccccc-----------cccccccCC--------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 486 DVLLLDHIRKLLREDRL-----------NDIVDRNLN--------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 486 ~~~l~~~~~~~~~~~~~-----------~~~~d~~l~--------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..+......... ...+..... ...+.....+.+++.+|++.||++|||+.|++++
T Consensus 244 -----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 244 -----NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -----HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111100000 000000000 0112234678899999999999999999999764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=323.98 Aligned_cols=259 Identities=18% Similarity=0.230 Sum_probs=204.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCcccccee-ecCCceEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC-TTSSERILVY 347 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 347 (595)
.++|++.+.||+|+||.||+|+. .+++.||+|++..... ...+.+|+.++..++|++++..+.++ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46899999999999999999996 5789999999864322 24588999999999998877777666 5566779999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE---cCCCcEEEeecccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL 424 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~~ 424 (595)
||+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||++ ++++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 89999999753 34699999999999999999999999 99999999999999 4888999999999987
Q ss_pred ccCcCcc------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 425 VDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 425 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-HHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh-hhhhhcccccC
Confidence 6544321 1234569999999999999999999999999999999999999998643221111 11111111110
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
. .... .....+.++.+++.+||+.||++|||+.||++.|+.
T Consensus 237 ~-~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 237 T-PIEV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp S-CHHH--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred C-chHH--------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 0 0000 011223578899999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=340.74 Aligned_cols=247 Identities=22% Similarity=0.254 Sum_probs=196.3
Q ss_pred CCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEecccCc
Q 007625 276 SNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 354 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (595)
.+.||+|+||.||+|+. .+|+.||+|+++.. .......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 57899999999999996 46899999999753 33456789999999999999999999999999999999999999999
Q ss_pred HhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE--cCCCcEEEeeccccccccCcCcce
Q 007625 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL--DDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99988752 24589999999999999999999999 99999999999999 5678999999999987654322
Q ss_pred eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCC
Q 007625 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 512 (595)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 512 (595)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ......... .......
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~---~~~i~~~~~--~~~~~~~-- 312 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-----T---LNNILACRW--DLEDEEF-- 312 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H---HHHHHHTCC--CSCSGGG--
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----H---HHHHHhccC--CCChhhh--
Confidence 233469999999999998899999999999999999999999997654321 1 111111110 0001111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 513 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 513 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.....++.+++.+|++.||.+|||+.|++++
T Consensus 313 --~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 313 --QDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp --TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1234578899999999999999999999763
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=340.44 Aligned_cols=260 Identities=18% Similarity=0.224 Sum_probs=202.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCC---------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCcc--------
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSD---------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ-------- 332 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 332 (595)
.++|++.+.||+|+||+||+|+... ++.||+|++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 4679999999999999999999753 788999998642 35789999999999999887
Q ss_pred -------ccceeec-CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCC
Q 007625 333 -------LIGYCTT-SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA 404 (595)
Q Consensus 333 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 404 (595)
+++++.. ....++||||+ +++|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 5566655 67789999999 999999998632 25699999999999999999999999 9999999999
Q ss_pred CEEEcCCC--cEEEeeccccccccCcCcc------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 007625 405 NILLDDNF--EAVLCDFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476 (595)
Q Consensus 405 NIll~~~~--~~kl~DfG~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~ 476 (595)
||+++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 8999999999876543221 113346999999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 477 DFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 477 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
........ ........... ....+.+.... ......++.+++.+||+.||++||++.||++.|+.
T Consensus 269 ~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 269 TNCLPNTE---DIMKQKQKFVD--KPGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GGGTTCHH---HHHHHHHHHHH--SCCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ccCCcCHH---HHHHHHHhccC--Chhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 75432111 11111111111 11111111100 01223678899999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=327.41 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=202.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCC-----chhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
.++|++.+.||+|+||+||+|+.. +++.||+|+++.... ......+.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357899999999999999999975 689999999874321 12467899999999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC----cEEEeec
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF 419 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 419 (595)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999975 34689999999999999999999999 999999999999998877 8999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
|++........ .....|++.|+|||++.+..++.++||||||+++|||++|+.||....... ....+. .
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~---~- 225 (283)
T 3bhy_A 157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-----TLTNIS---A- 225 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHH---T-
T ss_pred ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-----HHHHhH---h-
Confidence 99987654322 233468999999999999999999999999999999999999997644311 111111 0
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 500 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.... .+.. ........+.+++.+|++.||++||++.|+++
T Consensus 226 ~~~~--~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 226 VNYD--FDEE---YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp TCCC--CCHH---HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccC--Ccch---hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000 0000 00122456888999999999999999999976
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=329.65 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=198.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC-CceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-SERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 347 (595)
..++|++.+.||+|+||+||+|.. +|+.||+|+++.. ...+.+.+|+.++++++||||+++++++... +..++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 456789999999999999999997 5889999998643 3456789999999999999999999987554 4789999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999997532 22378999999999999999999999 999999999999999999999999999886543
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.. ....+++.|+|||++.+..++.++||||||+++|||+| |+.||....... ....+. ...
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-----~~~~~~----~~~----- 231 (278)
T 1byg_A 170 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVE----KGY----- 231 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----HHHHHT----TTC-----
T ss_pred cc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHh----cCC-----
Confidence 21 22347889999999998899999999999999999998 999997544321 111111 110
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
....+...+..+.+++.+||+.||++||++.|+++.|+..
T Consensus 232 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 ---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0112233456788999999999999999999999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=327.38 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=204.5
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|++.+.||+|+||.||+|+.. ++..||+|++.... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467889999999999999999975 67889999986321 122356789999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999999863 3589999999999999999999999 99999999999999999999999999987654
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
... .....|++.|+|||++.+..++.++||||||+++|||++|+.||........ ....... .
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~-~----- 228 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET--------HRRIVNV-D----- 228 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHHHHTT-C-----
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH--------HHHHhcc-c-----
Confidence 322 2345689999999999999999999999999999999999999976443211 1111110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. .++......+.+++.+|++.||.+||++.|+++
T Consensus 229 -~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 -L---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -C---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -c---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0 112233467889999999999999999999965
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.96 Aligned_cols=263 Identities=17% Similarity=0.261 Sum_probs=198.6
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC----
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS---- 340 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 340 (595)
++...++|++.+.||+|+||+||+|+. .+|+.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345678899999999999999999996 5799999999864321 124799999999999999999998443
Q ss_pred ----------------------------------CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHH
Q 007625 341 ----------------------------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386 (595)
Q Consensus 341 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~ 386 (595)
...++||||++ ++|.+.+.........+++..++.++.|++.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 23789999998 4888888765444567999999999999999999
Q ss_pred HHhhcCCCCcEEcCCCCCCEEEc-CCCcEEEeeccccccccCcCcceeecccccccccCccccCCC-CCCccchhHHHHH
Q 007625 387 YLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGI 464 (595)
Q Consensus 387 ~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGv 464 (595)
|||+. +|+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999 999999999999997 688999999999987644322 2345689999999998765 4899999999999
Q ss_pred HHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc----------cccccccccCCC------CCHHHHHHHHHHHHHc
Q 007625 465 TLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED----------RLNDIVDRNLNT------YDSKEVETMVQVALLC 528 (595)
Q Consensus 465 vl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~----------~~~~~~d~~l~~------~~~~~~~~l~~l~~~c 528 (595)
++|||++|+.||......+. +...+. ..... ...+..-+.... .+...+.++.+++.+|
T Consensus 231 il~ell~g~~pf~~~~~~~~----~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQ----LVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHH----HHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCChHHH----HHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 99999999999986543221 111111 10000 000000000000 1223456788999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 007625 529 TQSTPEDRPPMAQVVK 544 (595)
Q Consensus 529 l~~dP~~RPs~~evl~ 544 (595)
|+.||++|||+.|+++
T Consensus 306 L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCSSGGGSCCHHHHHT
T ss_pred ccCChhhCCCHHHHhc
Confidence 9999999999999965
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=330.77 Aligned_cols=256 Identities=19% Similarity=0.275 Sum_probs=190.0
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHH-HHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~-~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
..++|++.+.||+|+||+||+|+. .+++.||+|+++......... .+.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999996 478999999997544333333 344455557888999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++ +|.+++.........+++..++.++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999985 888887754444567999999999999999999999853 89999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCcccc----CCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYL----STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
.... .....||+.|+|||++ .+..++.++||||||+++|||+||+.||........ ...........
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~ 232 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-------QLKQVVEEPSP 232 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-------HHHHHHHSCCC
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-------HHHHHhccCCC
Confidence 4322 2234589999999996 566789999999999999999999999975322111 11111111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. ........++.+++.+|++.||++|||+.|+++
T Consensus 233 -~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 -Q-------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -C-------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -C-------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 011223457889999999999999999999965
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.65 Aligned_cols=261 Identities=20% Similarity=0.226 Sum_probs=206.2
Q ss_pred HHHHHHhcCCCcC-CeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcC-CCCCccccceeec
Q 007625 264 RELQLATDNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTT 339 (595)
Q Consensus 264 ~~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 339 (595)
+..+...++|.+. +.||+|+||+||+|+.. +++.||+|++... ........+.+|+.++..+. ||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3444556678777 89999999999999965 6899999998743 33445678899999999995 6999999999999
Q ss_pred CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC---CCcEEE
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVL 416 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 416 (595)
.+..++||||+++++|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred CCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999986422 35699999999999999999999999 9999999999999988 789999
Q ss_pred eeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHH
Q 007625 417 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 496 (595)
Q Consensus 417 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 496 (595)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...+...
T Consensus 176 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~i~~~ 248 (327)
T 3lm5_A 176 VDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-----YLNISQV 248 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHT
T ss_pred eeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HHHHHhc
Confidence 9999998765432 22345689999999999999999999999999999999999999976443211 1111110
Q ss_pred hccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 497 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 497 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
. . ... ..........+.+++.+|++.||++|||++|+++.
T Consensus 249 ~--~---~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 N--V---DYS----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C--C---CCC----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c--c---ccC----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 0 000 01122334678889999999999999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.50 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=206.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
.++|.+.+.||+|+||.||+++.. +++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888999999999999999975 5889999998643 2345567889999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998875 24689999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ........ .
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~-~---- 258 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--------YLRIKKNE-Y---- 258 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHHHHHTC-C----
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH--------HHHHhcCC-C----
Confidence 3322 22345689999999999988899999999999999999999999976443211 11111110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
..+......+.+++.+||+.||++||++.|+++
T Consensus 259 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011223356788999999999999999999965
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=324.88 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=197.9
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
..++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999975 78999999986421 22345678999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 99999999999999763 4589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCcCcceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
.... ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ....+.. ..
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~----~~--- 227 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-----LFKKIRG----GV--- 227 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----CC---
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-----HHHHhhc----Cc---
Confidence 5432 1233458999999999987765 689999999999999999999997543211 1111111 10
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...+......+.+++.+|++.||++|||+.|++++
T Consensus 228 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 ------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01122234578889999999999999999999873
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=326.34 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=202.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec--------
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-------- 339 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 339 (595)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 3457899999999999999999975 79999999986432 346789999999999999999998754
Q ss_pred --------CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC
Q 007625 340 --------SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (595)
Q Consensus 340 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 411 (595)
....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 345789999999999999997533 34689999999999999999999999 99999999999999999
Q ss_pred CcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH
Q 007625 412 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 491 (595)
Q Consensus 412 ~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~ 491 (595)
+.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|..|+... ..
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~ 226 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SK 226 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HH
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HH
Confidence 9999999999987654322 23345899999999999889999999999999999999999886311 01
Q ss_pred HHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 492 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
.... ...... +......+.+++.+|++.||++|||+.|+++.|+...
T Consensus 227 ~~~~-~~~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 227 FFTD-LRDGII-----------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHH-HHTTCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHH-hhcccc-----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1111 111111 1112346788999999999999999999999997643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=337.52 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=200.9
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (595)
..++|++.+.||+|+||.||+|..+ +++.||+|++..... .+.+|++++.++ +||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999975 688999999975322 235688888887 799999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC----CcEEEeecccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLCDFGLA 422 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~~ 422 (595)
|||+++|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||++.++ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999875 34689999999999999999999999 99999999999998543 35999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+...+. .+..
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~i~----~~~~ 240 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP--EEILARIG----SGKF 240 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH--HHHHHHHH----HCCC
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH--HHHHHHHc----cCCc
Confidence 87654322 23345689999999999888899999999999999999999999975322111 11111111 1111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
. +. ...+.....++.+++.+|++.||++||++.|++++
T Consensus 241 ~--~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 S--LS---GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp C--CC---STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred c--cC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00 01223345678899999999999999999999763
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=333.40 Aligned_cols=266 Identities=27% Similarity=0.313 Sum_probs=199.7
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCc----hhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
..++|++.+.||+|+||.||+|+.. +|+.||+|++...... .....+.+|+++++.++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999964 6899999998642211 1124678999999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 888877642 34688999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc--cc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--ED 500 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~--~~ 500 (595)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||........ +......... ..
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~----~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ----LTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCTT
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHHcCCCChh
Confidence 7654322 22345689999999998764 489999999999999999999999876543211 1111111110 01
Q ss_pred cccccc---c----ccCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 501 RLNDIV---D----RNLNTYD-----SKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 501 ~~~~~~---d----~~l~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
.+.... + ......+ .....++.+++.+|++.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 111000 0 0001111 23346789999999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=323.76 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=198.7
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeec----CCceEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERIL 345 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 345 (595)
.|.+.+.||+|+||+||+|... ++..||+|++... ........+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677889999999999999964 6889999998743 345566789999999999999999999998764 345789
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--cEEcCCCCCCEEEc-CCCcEEEeecccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLD-DNFEAVLCDFGLA 422 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~~ 422 (595)
||||+++++|.+++... ..+++..++.++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999999863 4589999999999999999999998 7 99999999999997 7899999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
....... .....||+.|+|||++. ..++.++||||||+++|+|++|+.||....... ....... ....
T Consensus 180 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~-~~~~ 247 (290)
T 1t4h_A 180 TLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVT-SGVK 247 (290)
T ss_dssp GGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHT-TTCC
T ss_pred ccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-------HHHHHHh-ccCC
Confidence 7554332 23456899999999886 458999999999999999999999997533211 1111111 1111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....+ .....++.+++.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 248 PASFD-------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CGGGG-------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccC-------CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11111 1122468899999999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.04 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=197.4
Q ss_pred hcCCCcC-CeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEE
Q 007625 270 TDNFSES-NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (595)
.+.|++. +.||+|+||+||+|+. .+++.||||++... .......+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC-SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC-cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 3567774 7899999999999995 47899999999753 334567889999999885 799999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc---EEEeeccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAK 423 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~~~ 423 (595)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 9999999999999863 4689999999999999999999999 9999999999999998776 9999999988
Q ss_pred cccCcCc------ceeecccccccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhh------h
Q 007625 424 LVDAKLT------HVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE------D 486 (595)
Q Consensus 424 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~------~ 486 (595)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6542211 11223458999999999865 45789999999999999999999999764321100 0
Q ss_pred hhHHHHHHHHhccccccccccccCCCCCH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 487 VLLLDHIRKLLREDRLNDIVDRNLNTYDS----KEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 487 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
................ ..+. ....++.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 243 PACQNMLFESIQEGKY---------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHHCCC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHHhccCc---------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000001111111110 1111 124578899999999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.58 Aligned_cols=260 Identities=19% Similarity=0.264 Sum_probs=200.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeec--CCceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTT--SSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l 345 (595)
.++|++.+.||+|+||+||+|+. .+++.||+|+++. .....+.+|+.++++++ ||||+++++++.. ....++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 36789999999999999999985 5789999999864 33567899999999997 9999999999987 567899
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC-cEEEeecccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKL 424 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~ 424 (595)
||||+++++|.+++.. +++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.
T Consensus 111 v~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 9999999999988853 78899999999999999999999 999999999999999776 899999999987
Q ss_pred ccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH---------HHH
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD---------HIR 494 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~---------~~~ 494 (595)
...... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||............... +..
T Consensus 181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 654322 233468999999999877 66899999999999999999999999643322111111111 000
Q ss_pred HHhcc--cccccccc--------ccC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 495 KLLRE--DRLNDIVD--------RNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 495 ~~~~~--~~~~~~~d--------~~l-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..... ........ ... .........++.+++.+|++.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 00000000 000 00112245678999999999999999999999764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=332.99 Aligned_cols=266 Identities=22% Similarity=0.324 Sum_probs=208.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe-----CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC--
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-- 341 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 341 (595)
..++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|++++++++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 345688899999999999999984 36889999999753 3455678999999999999999999999886654
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 679999999999999999863 24589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcce--eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhh-------hhhhHHHH
Q 007625 422 AKLVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE-------EDVLLLDH 492 (595)
Q Consensus 422 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~-------~~~~l~~~ 492 (595)
++......... .....++..|+|||++.+..++.++||||||+++|||+||..|+........ ........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 98775443221 2234577889999999888899999999999999999999998764321100 00001111
Q ss_pred HHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
......... ....+...+.++.+++.+||+.||++|||+.||++.|+..
T Consensus 272 ~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 272 LIELLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhcCC--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111110 0112233456788999999999999999999999999763
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=334.44 Aligned_cols=269 Identities=25% Similarity=0.331 Sum_probs=188.4
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
..+..++|++.+.||+|+||+||+|.. .+++.||+|++...........+.+|+.++.+++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 345678899999999999999999995 4789999999865433445677889999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 345 LVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
+||||+++++|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 9999999999999987421 1234689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcCc----ceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 421 LAKLVDAKLT----HVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 421 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
++........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~-~~~ 241 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV----LML-TLQ 241 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----HHH-HHT
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH----HHH-Hhc
Confidence 9986643211 11233568999999999865 5689999999999999999999999976443211 111 100
Q ss_pred HhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 496 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...........+.. .......++.+++.+||+.||.+||++.|++++
T Consensus 242 ~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 NDPPSLETGVQDKE---MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SSCCCTTC-----C---CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCCCccccccccch---hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000000011111 112234578889999999999999999999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.60 Aligned_cols=244 Identities=15% Similarity=0.100 Sum_probs=190.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHH---HHHHhcCCCCCcccc-------ce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREV---HLISVAIHKNLLQLI-------GY 336 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 336 (595)
.++|++.+.||+|+||+||+|+. .+|+.||||++... ......+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999995 57999999999742 2344567899999 555566899999998 45
Q ss_pred eecCC-----------------ceEEEEEecccCcHhhhhcccC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 007625 337 CTTSS-----------------ERILVYPFMQNLSVAYRLRDLK---PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396 (595)
Q Consensus 337 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 396 (595)
+...+ ..++||||+ +|+|.+++.... .....+++..++.++.|++.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 44443 278999999 579999998532 1122345688899999999999999999 99
Q ss_pred EEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeecccccccccCccccCCC-----------CCCccchhHHHHHH
Q 007625 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-----------KSSEKTDVFGYGIT 465 (595)
Q Consensus 397 vH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~SlGvv 465 (595)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2344567 999999999877 89999999999999
Q ss_pred HHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 466 LLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 466 l~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+|||+||+.||........ ...+.. .. ...+.++.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~-----------------~~~~~~-~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG-----------------SEWIFR-SC----KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CC-----------------SGGGGS-SC----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccc-----------------hhhhhh-hc----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999964332111 111111 11 122357888999999999999999999965
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.38 Aligned_cols=262 Identities=20% Similarity=0.325 Sum_probs=204.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC-----Cce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 343 (595)
.++|++.+.||+|+||.||+|+.. ++..||+|++...........+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 458999999999999999999964 68899999997655555667899999999999999999999998655 367
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+.+ +|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 106 ~iv~e~~~~-~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCSE-EHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccCc-CHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 999999984 89888874 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcce--eecccccccccCccccC-CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 424 LVDAKLTHV--TTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 424 ~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
......... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......... ..+.......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~i~~~~~~~ 251 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-----NHILGILGSP 251 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH-----HHHHHHHCSC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH-----HHHHHHhCCC
Confidence 765432221 23457999999999865 455899999999999999999999999865432211 1111111000
Q ss_pred cc---c------------ccccccCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 RL---N------------DIVDRNLN---TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ~~---~------------~~~d~~l~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. . ........ ...+....++.+++.+|++.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0 00000000 0112234578899999999999999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=349.11 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=204.1
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
..++|++.+.||+|+||+||+|+.. +++.||+|++... ........+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999975 7899999998632 2233467889999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc---CCCcEEEeeccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAK 423 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~~~ 423 (595)
|||+++++|.+.+... ..+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999988753 4689999999999999999999999 999999999999995 55679999999998
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ ....+.. ....
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~----~~~~ 240 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-----ILKRVET----GKYA 240 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----TCCC
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh----CCCC
Confidence 665432 2334569999999999875 58999999999999999999999997644321 1111111 1110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... + .....+.++.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~-~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 FDL-P----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SCS-G----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCC-c----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0 012234578899999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=327.45 Aligned_cols=251 Identities=20% Similarity=0.313 Sum_probs=203.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|.+.+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 457899999999999999999975 78999999997432 2334678899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE---cCCCcEEEeeccccccc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~~~ 425 (595)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.++|+|||+++..
T Consensus 87 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999998752 4589999999999999999999999 99999999999999 78899999999998765
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+.. ... .
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~i~~----~~~-~- 225 (304)
T 2jam_A 160 QNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-----LFEKIKE----GYY-E- 225 (304)
T ss_dssp CCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHH----CCC-C-
T ss_pred CCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHc----CCC-C-
Confidence 4321 223458999999999999999999999999999999999999997543211 1111111 110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... ........++.+++.+|++.||++|||+.|+++.
T Consensus 226 ~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 226 FES---PFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCT---TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCc---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 1122334678899999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=362.83 Aligned_cols=260 Identities=20% Similarity=0.329 Sum_probs=209.0
Q ss_pred HHHHhcCCCcCCeeeeccceEEEEEEeC----CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 266 LQLATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
..+..++|++.+.||+|+||+||+|.+. .+..||+|+++..........|.+|+.++++++||||+++++++. ++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 3445678999999999999999999964 246799999876555566688999999999999999999999985 46
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence 689999999999999999752 34589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
++..............+|+.|+|||++.+..++.++||||||+++|||++ |..||....... ....+.. ..
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-----~~~~i~~---~~ 609 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIEN---GE 609 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHH---TC
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHc---CC
Confidence 98775543333334457889999999998899999999999999999997 999997544321 1112211 11
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
. ...+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus 610 ~---------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 R---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 112233456788999999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=322.08 Aligned_cols=253 Identities=22% Similarity=0.327 Sum_probs=198.9
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|....+||+|+||.||+|.. .++..||+|++... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 3455567999999999999996 46889999998753 334567789999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-CCcEEEeeccccccccCc
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~~~~~~~~ 428 (595)
+++++|.+++.... ....+++..+..++.|++.||+|||+. +|+|+||||+||+++. ++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99999999998632 234577899999999999999999999 9999999999999987 899999999999876432
Q ss_pred CcceeecccccccccCccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.. ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ .. ...... .
T Consensus 177 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~---~~~~~~-~------ 242 (295)
T 2clq_A 177 NP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AM---FKVGMF-K------ 242 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HH---HHHHHH-C------
T ss_pred CC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HH---Hhhccc-c------
Confidence 21 223456899999999987643 78999999999999999999999964322111 00 010000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.....+.....++.+++.+||+.||++||++.|+++
T Consensus 243 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 --VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp --CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred --ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001122334467889999999999999999999965
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=338.06 Aligned_cols=257 Identities=24% Similarity=0.291 Sum_probs=187.9
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceee-------
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCT------- 338 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~------- 338 (595)
....+|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.++.++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 34568999999999999999999964 7899999998643 3455677899999999996 999999999984
Q ss_pred -cCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--cEEcCCCCCCEEEcCCCcEE
Q 007625 339 -TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 339 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~k 415 (595)
.....++||||+. |+|.+++..... ...+++.+++.++.|++.||+|||+. + |+||||||+||+++.++.+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 3344789999996 689888875332 34699999999999999999999998 7 99999999999999999999
Q ss_pred EeeccccccccCcCcce-----------eecccccccccCcccc---CCCCCCccchhHHHHHHHHHHHhCCCCCCCCch
Q 007625 416 LCDFGLAKLVDAKLTHV-----------TTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (595)
Q Consensus 416 l~DfG~~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~ 481 (595)
|+|||+++......... .....||+.|+|||++ .+..++.++||||||+++|||+||+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998765432211 1134589999999998 566789999999999999999999999964321
Q ss_pred hhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 482 EEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 482 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
.. ..... .. .. ........+.+++.+||+.||++|||+.|+++.|+...
T Consensus 259 ~~--------~~~~~-----~~----~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 259 LR--------IVNGK-----YS----IP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp --------------------CC----CC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH--------hhcCc-----cc----CC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 00000 00 00 01111235778999999999999999999999997643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.85 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=206.1
Q ss_pred HHHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCc-------hhHHHHHHHHHHHHhc-CCCCCccccc
Q 007625 265 ELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-------GGEAAFQREVHLISVA-IHKNLLQLIG 335 (595)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l~~ 335 (595)
......++|++.+.||+|+||.||+|+.. +|+.||||++...... .....+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33445678999999999999999999975 7999999998643211 1245678999999999 7999999999
Q ss_pred eeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEE
Q 007625 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 336 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 415 (595)
++......++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999975 34689999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCcCcceeecccccccccCccccCC------CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhH
Q 007625 416 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489 (595)
Q Consensus 416 l~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l 489 (595)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 241 l~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-----~ 313 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-----M 313 (365)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H
T ss_pred EEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-----H
Confidence 99999998765432 2234569999999999853 358899999999999999999999997543211 1
Q ss_pred HHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 490 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 490 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...+.. .... ...+.. ......+.+++.+|++.||++|||+.|++++
T Consensus 314 ~~~i~~----~~~~-~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 314 LRMIME----GQYQ-FSSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHH----TCCC-CCHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHh----CCCC-CCCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111 1000 000000 1123568899999999999999999999763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=334.17 Aligned_cols=263 Identities=25% Similarity=0.310 Sum_probs=201.2
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC--------
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-------- 340 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 340 (595)
++|++.+.||+|+||+||+|+. .+|+.||+|++... ........+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5789999999999999999997 57899999998643 2333456788999999999999999999998763
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
+..++||||+++ ++.+.+... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 467899999985 777777643 24599999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcC---cceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHH
Q 007625 421 LAKLVDAKL---THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 496 (595)
Q Consensus 421 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 496 (595)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ....+...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~~ 244 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-----QLALISQL 244 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHH
Confidence 998765322 122234568999999999876 458999999999999999999999998654322 11112111
Q ss_pred hc---cccccccccc----cC------CCCCHH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 497 LR---EDRLNDIVDR----NL------NTYDSK------EVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 497 ~~---~~~~~~~~d~----~l------~~~~~~------~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. ...+...-+. .+ ...... ....+.+++.+|++.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11 1111110000 00 000011 13457899999999999999999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=333.76 Aligned_cols=270 Identities=20% Similarity=0.235 Sum_probs=193.7
Q ss_pred HHHHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc
Q 007625 264 RELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 342 (595)
.+.....++|++.+.||+|+||+||+|+.. +++.||||++.... .....+.++++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 455667889999999999999999999974 68999999986432 223455678888899999999999999865433
Q ss_pred -------eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCcEEcCCCCCCEEEcC-CC
Q 007625 343 -------RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--EQCNPKIIHRDLKAANILLDD-NF 412 (595)
Q Consensus 343 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~~ 412 (595)
.++||||+++ ++...+.........+++..+..++.|++.||.||| +. +|+||||||+||+++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 7899999986 555555443334567899999999999999999999 77 9999999999999996 89
Q ss_pred cEEEeeccccccccCcCcceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH
Q 007625 413 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 491 (595)
Q Consensus 413 ~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~ 491 (595)
.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||+||+.||........ +..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~----~~~ 243 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ----LHE 243 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHH
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH----HHH
Confidence 999999999987654322 23456899999999986654 89999999999999999999999986543221 111
Q ss_pred HHHHH-----------hccccccccccc-------cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 492 HIRKL-----------LREDRLNDIVDR-------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 492 ~~~~~-----------~~~~~~~~~~d~-------~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..... ..........+. .+.........++.+++.+||+.||.+|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11110 000000000000 0111222346789999999999999999999999653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=343.73 Aligned_cols=200 Identities=24% Similarity=0.345 Sum_probs=168.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC-----Cc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE 342 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 342 (595)
.++|++.+.||+|+||.||+|+.. +++.||||++... ........+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 568999999999999999999964 6889999999743 3344567889999999999999999999998766 56
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++||||+. ++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999987 599998875 35699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcc---------------------eeecccccccccCcccc-CCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 007625 423 KLVDAKLTH---------------------VTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQRAID 477 (595)
Q Consensus 423 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvvl~elltg~~p~~ 477 (595)
+........ ......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543211 12456799999999986 55669999999999999999998655543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=350.23 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=206.6
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
..++|++.+.||+|+||+||+|+.. +++.||||++.... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999975 78999999986432 23456789999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE---cCCCcEEEeecccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLA 422 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~ 422 (595)
||||+.+++|.+.+.. ...+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999998875 34689999999999999999999999 99999999999999 56789999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
+....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||....... ....+.. +..
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~----~~~ 244 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-----ILKKVEK----GKY 244 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----CCC
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHc----CCC
Confidence 87654322 234569999999999865 68999999999999999999999998654321 1122211 111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... .+ .....+.++.+++.+|++.||++|||+.|++++
T Consensus 245 ~~~-~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 TFE-LP----QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCC-SG----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCC-Cc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 000 00 012234678899999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=333.54 Aligned_cols=259 Identities=22% Similarity=0.284 Sum_probs=204.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCC--ch--------------hHHHHHHHHHHHHhcCCCCCccc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--PG--------------GEAAFQREVHLISVAIHKNLLQL 333 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~--------------~~~~~~~E~~~l~~l~h~niv~l 333 (595)
.++|++.+.||+|+||.||+|.. +++.||+|++..... .. ....+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 999999999863211 11 12789999999999999999999
Q ss_pred cceeecCCceEEEEEecccCcHhhh------hcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCE
Q 007625 334 IGYCTTSSERILVYPFMQNLSVAYR------LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANI 406 (595)
Q Consensus 334 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NI 406 (595)
++++...+..++||||+++++|.++ +... ....+++..++.++.|++.||+|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 4431 14679999999999999999999999 8 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCcCcceeecccccccccCccccCCC-CCCc-cchhHHHHHHHHHHHhCCCCCCCCchhhh
Q 007625 407 LLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSE-KTDVFGYGITLLELVTGQRAIDFSRLEEE 484 (595)
Q Consensus 407 ll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~SlGvvl~elltg~~p~~~~~~~~~ 484 (595)
+++.++.+||+|||.+...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||.......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV- 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 9999999999999999876443 33445689999999999877 5666 9999999999999999999998644311
Q ss_pred hhhhHHHHHHHHhcccccccccc------c----cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 485 EDVLLLDHIRKLLREDRLNDIVD------R----NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 485 ~~~~l~~~~~~~~~~~~~~~~~d------~----~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.....+ . ........+ + ...........++.+++.+||+.||.+|||+.|++++
T Consensus 260 ---~~~~~i---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 ---ELFNNI---R-TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ---HHHHHH---T-SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHH---h-ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111 1 111100000 0 0000113345678899999999999999999999774
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.26 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=197.4
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-------CchhHHHHHHHHHHHHhcCCCCCccccceeecC
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 340 (595)
..++|++.+.||+|+||.||+|+.. +++.||||++.... .......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999964 68899999986421 112234688999999999999999999998765
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc---EEEe
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLC 417 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 417 (595)
. .++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 8999999999999998875 45689999999999999999999999 9999999999999987654 9999
Q ss_pred eccccccccCcCcceeecccccccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHH
Q 007625 418 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494 (595)
Q Consensus 418 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~ 494 (595)
|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+...+.
T Consensus 160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~ 233 (322)
T 2ycf_A 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQIT 233 (322)
T ss_dssp CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CHHHHHH
T ss_pred cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HHHHHHH
Confidence 999998765321 223356899999999973 5678999999999999999999999997543211 1122221
Q ss_pred HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
. ..... ... ........+.+++.+|++.||++||++.|++++
T Consensus 234 ~----~~~~~-~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 S----GKYNF-IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp H----TCCCC-CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred h----Ccccc-Cch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1 11000 000 001224578899999999999999999999764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=337.56 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=203.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC--------CCCCccccceee--
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--------HKNLLQLIGYCT-- 338 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~-- 338 (595)
.++|++.+.||+|+||+||+|+. .+++.||+|+++. .......+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS--AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec--CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 47899999999999999999995 4688999999964 2345677889999999885 788999999987
Q ss_pred --cCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC----
Q 007625 339 --TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---- 412 (595)
Q Consensus 339 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 412 (595)
.....++||||+ ++++.+.+.... ...+++..++.++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 556789999999 556666665422 356999999999999999999999864 799999999999999775
Q ss_pred ---------------------------------------------cEEEeeccccccccCcCcceeecccccccccCccc
Q 007625 413 ---------------------------------------------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447 (595)
Q Consensus 413 ---------------------------------------------~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~ 447 (595)
.+||+|||+++..... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999876533 233468999999999
Q ss_pred cCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhh-hhhHHHHHHHHhcc---------ccccccccc---------
Q 007625 448 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE-DVLLLDHIRKLLRE---------DRLNDIVDR--------- 508 (595)
Q Consensus 448 ~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~-~~~l~~~~~~~~~~---------~~~~~~~d~--------- 508 (595)
+.+..++.++|||||||++|||+||+.||......... .......+...... ......+..
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999764432111 11111111111110 000000000
Q ss_pred -----------cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 509 -----------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 509 -----------~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.....+......+.+++.+||+.||++|||+.|++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0012356778889999999999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=347.58 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=199.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
.++|++.+.||+|+||+||+|+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999975 78899999987432 2344577899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC---CCcEEEeecccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFGLAKL 424 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~~~~ 424 (595)
||+++|+|.+.+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999988753 4589999999999999999999999 9999999999999976 45599999999987
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
..... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||......+ ....+.. ....
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~----~~~~- 255 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-----ILRKVEK----GKYT- 255 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----TCCC-
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh----CCCC-
Confidence 65432 233456999999999986 569999999999999999999999998654321 1111111 1100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...+.. ...+..+.+++.+||+.||.+|||+.|++++
T Consensus 256 ~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 FDSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 001111 1234568889999999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.16 Aligned_cols=264 Identities=19% Similarity=0.263 Sum_probs=193.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCC------
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 341 (595)
.++|++.+.||+|+||.||+|... +++.||||++... ........+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367999999999999999999964 6889999999743 33445577889999999999999999999987655
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999985 77777752 488999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhH------------
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL------------ 489 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l------------ 489 (595)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98664321 2234568999999999999999999999999999999999999998654321100000
Q ss_pred --HHHHHHHhccc-c-----cccccccc-CCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 490 --LDHIRKLLRED-R-----LNDIVDRN-LNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 490 --~~~~~~~~~~~-~-----~~~~~d~~-l~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
........... . ....+... .+. .......++.+++.+|++.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000000 0 00000000 000 112346788999999999999999999999764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=348.02 Aligned_cols=253 Identities=20% Similarity=0.275 Sum_probs=202.3
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCc------------hhHHHHHHHHHHHHhcCCCCCccccc
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP------------GGEAAFQREVHLISVAIHKNLLQLIG 335 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~~ 335 (595)
..++|++.+.||+|+||+||+|+.. +++.||+|++...... .....+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999965 6889999998743211 33567899999999999999999999
Q ss_pred eeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC---
Q 007625 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF--- 412 (595)
Q Consensus 336 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 412 (595)
++.+....++||||+++|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999875 24589999999999999999999999 999999999999998775
Q ss_pred cEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHH
Q 007625 413 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492 (595)
Q Consensus 413 ~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~ 492 (595)
.+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||......+ ....
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~ 258 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-----IIKK 258 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH
Confidence 69999999998765432 233456999999999986 468999999999999999999999998654321 1111
Q ss_pred HHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+.. +...... +. ....+.++.+++.+|++.||.+|||+.|++++
T Consensus 259 i~~----~~~~~~~-~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VEK----GKYYFDF-ND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHH----CCCCCCH-HH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHc----CCCCCCc-cc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111 1100000 00 01124578899999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=361.77 Aligned_cols=252 Identities=22% Similarity=0.292 Sum_probs=205.8
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCc
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE 342 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 342 (595)
....++|++.++||+|+||.||+|+.. +++.||||+++... .......+..|..++..+ +||+|+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345678999999999999999999965 68899999987421 223456678899999887 79999999999999999
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence 99999999999999999863 4589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .........
T Consensus 490 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~-- 558 (674)
T 3pfq_A 490 KENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQSIMEHN-- 558 (674)
T ss_dssp EECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHSSC--
T ss_pred eccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH--------HHHHHHhCC--
Confidence 8643222 22345679999999999999999999999999999999999999998644321 111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM-----AQVVK 544 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~ 544 (595)
..++.....++.+++.+||+.||++||++ +||++
T Consensus 559 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 --------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11233445678899999999999999998 56643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.19 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=199.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC---CchhHHHHHHHHHHHHhcCCCCCccccceee--cCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNLLQLIGYCT--TSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 343 (595)
.++|++.+.||+|+||.||+|... +++.||+|+++... .......+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 68899999986421 1245678999999999999999999999984 45578
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||++++ +.+.+.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999976 666666533 35689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcC-cceeecccccccccCccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 424 LVDAKL-THVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 424 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
...... ........||+.|+|||++.+.. .+.++||||||+++|||++|+.||....... ....+. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~i~----~~ 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-----LFENIG----KG 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHH----HC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-----HHHHHh----cC
Confidence 765322 22233456899999999987654 3789999999999999999999998643211 111111 11
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. ..+......+.+++.+|++.||.+|||+.|++++
T Consensus 229 ~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 SY---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10 1122334578889999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.15 Aligned_cols=261 Identities=21% Similarity=0.300 Sum_probs=195.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc------e
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE------R 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~ 343 (595)
..+|+..++||+|+||+||+|+...+..||+|++..... ...+|+++++.++||||+++++++..... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 346888999999999999999987777799998864321 12369999999999999999999855433 7
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc-CCCcEEEeecccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLA 422 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~~ 422 (595)
++||||++++.+ ..+.........+++..++.++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 899999987544 33332222345799999999999999999999999 999999999999999 7999999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +...+...-....
T Consensus 190 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 190 KILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ----LVEIIKVLGTPSR 263 (394)
T ss_dssp EECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCH
T ss_pred ccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCCH
Confidence 87644322 2345689999999998765 589999999999999999999999987543221 1111111000000
Q ss_pred ------ccccccccCCC---------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 502 ------LNDIVDRNLNT---------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 502 ------~~~~~d~~l~~---------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
........++. +......++.+++.+||+.||.+|||+.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000000 122245688999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=327.19 Aligned_cols=258 Identities=28% Similarity=0.363 Sum_probs=198.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC--CCc--EEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS--DNT--KVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
.++|++.+.||+|+||+||+|++. +++ .||+|+++... .......+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457889999999999999999853 333 68999987432 3345678999999999999999999999988754 8
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++|+||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999999853 24589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcce--eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 424 LVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 424 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
......... .....+|..|+|||++.+..++.++||||||+++|||++ |+.||....... .........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~ 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEG 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--------HHHHHHccC
Confidence 775443221 223457889999999988889999999999999999999 999997543211 111111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
.. ...+...+.++.+++.+|++.||++|||+.++++.|++..
T Consensus 242 ~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ER--------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC--------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 00 0112234567889999999999999999999999998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.31 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=200.8
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 4568999999999999999999975 5899999998643 3345678899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999988753 24589999999999999999999999 999999999999999999999999999764322
Q ss_pred cCcceeecccccccccCcccc-----CCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYL-----STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
.. .......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ...........
T Consensus 170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~ 240 (302)
T 2j7t_A 170 TL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSDPP 240 (302)
T ss_dssp HH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCC
T ss_pred cc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HHHHHhccCCc
Confidence 11 112334689999999998 46678999999999999999999999997544211 11111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
. ...+......+.+++.+|++.||++|||+.|++++
T Consensus 241 -~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 -T------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -C------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -c------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 01122334678899999999999999999999764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=339.73 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=196.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC----C--ce
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS----S--ER 343 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~~ 343 (595)
.+|+..+.||+|+||.||+|+.. +++.||||++.... ..+.+|+++++.++||||+++++++... + ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35888999999999999999975 68999999986432 1234799999999999999999988432 1 25
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-CcEEEeecccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLA 422 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~ 422 (595)
++||||+++ ++.+.+.........+++..++.++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999986 66666654433456799999999999999999999999 99999999999999965 67899999999
Q ss_pred ccccCcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc---
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--- 498 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~--- 498 (595)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.+.+...-.
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~----l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ----LVEIIKVLGTPTR 278 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCSCCH
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCCH
Confidence 87644322 2345689999999998765 789999999999999999999999986543221 1111111000
Q ss_pred ------cccccccccccCCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 499 ------EDRLNDIVDRNLNT------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 499 ------~~~~~~~~d~~l~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.....+...+.+.. +......++.+++.+||+.||++||++.|++++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00111111111111 122335678899999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=339.52 Aligned_cols=201 Identities=21% Similarity=0.299 Sum_probs=173.8
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc------CCCCCccccceeecCC
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA------IHKNLLQLIGYCTTSS 341 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~ 341 (595)
...+|++.+.||+|+||+||+|... +++.||||+++. .......+.+|+.++..+ .|+||+++++++....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC--ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 3457999999999999999999865 688999999964 234456778888888776 5779999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc--EEEeec
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--AVLCDF 419 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Df 419 (595)
..++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred eEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999996 68988887633 34589999999999999999999999 9999999999999999887 999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCch
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~ 481 (595)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 999765432 2345689999999999999999999999999999999999999986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=336.20 Aligned_cols=258 Identities=22% Similarity=0.301 Sum_probs=185.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC------C
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------S 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 341 (595)
.++|+..+.||+|+||.||+|.. .+|+.||+|++... ........+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999995 47899999998643 3344567888999999999999999999998654 5
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++|+|++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999998 6788887764 4589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+.......
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----l~~i~~~~g~p 249 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-----LKLILRLVGTP 249 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHHHCSC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHhCCC
Confidence 9865432 234568999999999877 6789999999999999999999999986543211 11111111000
Q ss_pred c---c--------ccccc--ccCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 R---L--------NDIVD--RNLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ~---~--------~~~~d--~~l~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
. + ...+. +.... ........+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0 00000 00000 011224568899999999999999999999764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.46 Aligned_cols=260 Identities=18% Similarity=0.242 Sum_probs=204.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCC-CCccccceeecCCceEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK-NLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 347 (595)
.++|++.++||+|+||.||+|+. .+++.||||++..... ...+..|++++..+.|+ ++..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 46899999999999999999996 5789999998864322 23478899999999875 4555656667778889999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE---cCCCcEEEeecccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL 424 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~~ 424 (595)
||+ +++|.+++... ...+++.+++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 89999999853 34699999999999999999999999 99999999999999 6889999999999987
Q ss_pred ccCcCcc------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 425 VDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 425 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~i~~~~~ 233 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK--QKYEKISEKKV 233 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH--HHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH--HHHHHHhhccc
Confidence 6543321 122467999999999999999999999999999999999999999864332111 11111111111
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
......+. ...+.++.+++..||+.+|++||++.+|++.|+..
T Consensus 234 ~~~~~~l~--------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATSIEALC--------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSCHHHHH--------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccHHHHh--------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111100 11235788999999999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=329.01 Aligned_cols=264 Identities=24% Similarity=0.357 Sum_probs=202.3
Q ss_pred HhcCCCcCCeeeeccceEEEEEEe--CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhc---CCCCCccccceee----
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVL--SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA---IHKNLLQLIGYCT---- 338 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 338 (595)
..++|++.+.||+|+||+||+|+. .+++.||+|+++... .......+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 468899999986322 222233556777777665 8999999999987
Q ss_pred -cCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEe
Q 007625 339 -TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC 417 (595)
Q Consensus 339 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 417 (595)
.....++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 69999988643 34589999999999999999999999 99999999999999999999999
Q ss_pred eccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHh
Q 007625 418 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 497 (595)
Q Consensus 418 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 497 (595)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...+....
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~i~~~~ 235 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-----LGKILDVI 235 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHHH
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHHHc
Confidence 999998665322 22345689999999999999999999999999999999999999986543221 11111111
Q ss_pred cc---ccccc-------cc----cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 498 RE---DRLND-------IV----DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 498 ~~---~~~~~-------~~----d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. ..+.. .+ ...+..........+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 10 00000 00 001111223345678899999999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=331.55 Aligned_cols=262 Identities=21% Similarity=0.319 Sum_probs=201.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC-----Cce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 343 (595)
.++|++.+.||+|+||.||+|+.. +|+.||||++...........+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999975 68999999997555555667888999999999999999999987654 678
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+. ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 589888875 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcc---------eeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHH
Q 007625 424 LVDAKLTH---------VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 424 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~ 493 (595)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~ 235 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-----LLLI 235 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-----HHHH
Confidence 76532211 1123468999999998754 6789999999999999999999999986543211 1111
Q ss_pred HHHhcccc----cc--------ccc-------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 494 RKLLREDR----LN--------DIV-------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 494 ~~~~~~~~----~~--------~~~-------d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
........ .. +.. ...+....+....++.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11110000 00 000 000000112335678899999999999999999999763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=330.89 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=199.8
Q ss_pred HHHHHHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeec-
Q 007625 263 CRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT- 339 (595)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 339 (595)
..++....++|++.+.||+|+||.||+|+. .+++.||+|++... ......+.+|+.++.++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC--cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 334445678899999999999999999996 47899999998643 23456788999999998 79999999999876
Q ss_pred -----CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcE
Q 007625 340 -----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 414 (595)
Q Consensus 340 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 414 (595)
....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence 457899999999999999998643 34689999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCcCcceeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhH
Q 007625 415 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489 (595)
Q Consensus 415 kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l 489 (595)
||+|||++........ ......||+.|+|||++. +..++.++||||||+++|||++|+.||........
T Consensus 169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----- 242 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----- 242 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----
T ss_pred EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----
Confidence 9999999986643221 223346899999999986 56689999999999999999999999975432111
Q ss_pred HHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 490 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 490 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
....... ..... ........+.+++.+||+.||++||++.|++++
T Consensus 243 ---~~~~~~~-~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 243 ---LFLIPRN-PAPRL-------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ---HHHHHHS-CCCCC-------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---HHHhhcC-ccccC-------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111111 11111 111224578889999999999999999999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.69 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=197.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce----
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER---- 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 343 (595)
.++|...+.||+|+||+||+|... +|+.||+|++... ........+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 457889999999999999999964 6899999999743 2334467889999999999999999999999877654
Q ss_pred --EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 344 --ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 344 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
++||||+. ++|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 57777764 2489999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ..... .....
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~~-~~~~~ 261 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL----TQILK-VTGVP 261 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHH-HHCCC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHH-HhCCC
Confidence 9865432 234568999999999887 67899999999999999999999999865432211 11111 00000
Q ss_pred --cc-------------cccccccCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 --RL-------------NDIVDRNLN---TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 --~~-------------~~~~d~~l~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. ..+...... ...+.....+.+++.+|++.||++|||+.|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 000000000 0112235678899999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.39 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=200.6
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
...++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+|+.++..++||||+++++++...+..++|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 35678999999999999999999975 5899999998743 2346788999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 103 MEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred eecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 9999999999998742 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ..... ... ...
T Consensus 177 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~---~~~-~~~-- 244 (314)
T 3com_A 177 DTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-----IFMIP---TNP-PPT-- 244 (314)
T ss_dssp TTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHH---HSC-CCC--
T ss_pred hhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHh---cCC-Ccc--
Confidence 4322 22345689999999999998999999999999999999999999975432110 00111 000 000
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
...+......+.+++.+||+.||.+|||+.|+++
T Consensus 245 ----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 ----FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0012223467889999999999999999999976
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=329.29 Aligned_cols=263 Identities=24% Similarity=0.392 Sum_probs=203.8
Q ss_pred HHHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCC
Q 007625 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (595)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 341 (595)
.+++.+..++|++.+.||+|+||.||+|...+ .||+|+++.. ........+.+|+.++++++||||+++++++...+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34455567889999999999999999999754 4999998643 22334456788999999999999999999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999999999752 34689999999999999999999999 999999999999998 67999999999
Q ss_pred cccccCcC----cceeecccccccccCccccCC---------CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhh
Q 007625 422 AKLVDAKL----THVTTQIRGTMGHIAPEYLST---------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488 (595)
Q Consensus 422 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~ 488 (595)
++...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----- 250 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----- 250 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 87653221 111223458999999999864 457889999999999999999999997544321
Q ss_pred HHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 489 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
....+. ......... .....++.+++.+||+.||++|||+.|+++.|+...
T Consensus 251 ~~~~~~----~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 251 IIWQMG----TGMKPNLSQ-------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHHHHH----TTCCCCCCC-------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred HHHHhc----cCCCCCCCc-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 111111 111111111 112346889999999999999999999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=336.60 Aligned_cols=254 Identities=8% Similarity=-0.002 Sum_probs=181.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhc--CCCCCcccc-------cee
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA--IHKNLLQLI-------GYC 337 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 337 (595)
...|...+.||+|+||+||+|+.. +++.||+|++.... .......+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999965 78999999997543 233456777885544444 699988755 333
Q ss_pred ecC-----------------CceEEEEEecccCcHhhhhcccCCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCC
Q 007625 338 TTS-----------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR------KRVAFGTAYGLEYLHEQCNP 394 (595)
Q Consensus 338 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~ 394 (595)
... ...++||||++ ++|.+++.... ..+.+..+ ..++.|++.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 222 23799999999 89999998642 23455555 78889999999999999
Q ss_pred CcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeecccccccccCccccCC--CCCCccchhHHHHHHHHHHHhC
Q 007625 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTG 472 (595)
Q Consensus 395 ~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg 472 (595)
+|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999866432 224457799999999987 6799999999999999999999
Q ss_pred CCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 473 QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 473 ~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+.||.......... ............... .........+.+++.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS----------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC----------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc----------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998653221100 000000000000000 011234567889999999999999999999953
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=324.70 Aligned_cols=259 Identities=20% Similarity=0.295 Sum_probs=204.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEe--CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCC------CccccceeecCC
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL--SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN------LLQLIGYCTTSS 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 341 (595)
.++|++.+.||+|+||+||+|.. .+++.||+|+++. .......+.+|+++++.++|++ ++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec--CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 46899999999999999999986 3688999999864 2344577889999999887654 899999999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-----------
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD----------- 410 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----------- 410 (595)
..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 889999987632 34689999999999999999999999 9999999999999987
Q ss_pred --------CCcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchh
Q 007625 411 --------NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE 482 (595)
Q Consensus 411 --------~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~ 482 (595)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999865432 23456899999999999999999999999999999999999999865432
Q ss_pred hhhhhhHHHHHHHHhcc--------cccccccc-----------------------ccCCCCCHHHHHHHHHHHHHcccC
Q 007625 483 EEEDVLLLDHIRKLLRE--------DRLNDIVD-----------------------RNLNTYDSKEVETMVQVALLCTQS 531 (595)
Q Consensus 483 ~~~~~~l~~~~~~~~~~--------~~~~~~~d-----------------------~~l~~~~~~~~~~l~~l~~~cl~~ 531 (595)
+.. ..+...... ......+. ............++.+++.+||+.
T Consensus 241 ~~~-----~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 241 EHL-----AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp HHH-----HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred HHH-----HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 211 111111000 00000000 000112345678899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 007625 532 TPEDRPPMAQVVKM 545 (595)
Q Consensus 532 dP~~RPs~~evl~~ 545 (595)
||.+|||+.|++++
T Consensus 316 dP~~Rpt~~ell~h 329 (339)
T 1z57_A 316 DPAKRITLREALKH 329 (339)
T ss_dssp STTTSCCHHHHTTS
T ss_pred CcccccCHHHHhcC
Confidence 99999999999653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=325.67 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=198.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCc-----
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----- 342 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 342 (595)
.++|...+.||+|+||.||+|+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888999999999999999964 68999999997433 33446788999999999999999999999987654
Q ss_pred -eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 343 -RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 343 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
.++||||+. ++|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 57777664 2489999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...+.......
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~~~i~~~~~~~ 243 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-----LTQILKVTGVP 243 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-----HHHHHHHHCBC
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHhCCC
Confidence 9865432 233568999999999876 6789999999999999999999999986543211 11111100000
Q ss_pred ------------------cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 ------------------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ------------------~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.........+....+....++.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000111122233456788999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.76 Aligned_cols=268 Identities=21% Similarity=0.280 Sum_probs=183.5
Q ss_pred cCCCc-CCeeeeccceEEEEEEeC---CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceee--cCCceE
Q 007625 271 DNFSE-SNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT--TSSERI 344 (595)
Q Consensus 271 ~~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 344 (595)
+.|++ +++||+|+||+||+|+.. +++.||+|++.... ....+.+|+.++++++||||+++++++. .....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34555 568999999999999965 57889999986432 2346789999999999999999999995 466789
Q ss_pred EEEEecccCcHhhhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE----cCCCcEE
Q 007625 345 LVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAV 415 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~k 415 (595)
+||||+.+ +|.+.+.... .....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 7777765321 1123589999999999999999999999 99999999999999 6778999
Q ss_pred EeeccccccccCcCc--ceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhh----hhhh
Q 007625 416 LCDFGLAKLVDAKLT--HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE----EDVL 488 (595)
Q Consensus 416 l~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~----~~~~ 488 (595)
|+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987654322 223346789999999999874 589999999999999999999999975432110 0001
Q ss_pred HHHHHHHHhcc---cccccccc-------------ccCCCCC---------HHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007625 489 LLDHIRKLLRE---DRLNDIVD-------------RNLNTYD---------SKEVETMVQVALLCTQSTPEDRPPMAQVV 543 (595)
Q Consensus 489 l~~~~~~~~~~---~~~~~~~d-------------~~l~~~~---------~~~~~~l~~l~~~cl~~dP~~RPs~~evl 543 (595)
....+...... ..+..+.. ....... ......+.+++.+||+.||.+|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 11111111110 00100000 0000000 00134678999999999999999999998
Q ss_pred HH
Q 007625 544 KM 545 (595)
Q Consensus 544 ~~ 545 (595)
++
T Consensus 333 ~h 334 (405)
T 3rgf_A 333 QD 334 (405)
T ss_dssp TS
T ss_pred cC
Confidence 75
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=318.53 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=204.1
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCC--------chhHHHHHHHHHHHHhcC-CCCCccccceee
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--------PGGEAAFQREVHLISVAI-HKNLLQLIGYCT 338 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 338 (595)
..++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4568999999999999999999975 689999999864321 123457889999999995 999999999999
Q ss_pred cCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEee
Q 007625 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (595)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 418 (595)
.....++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999986 34689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCcCcceeecccccccccCccccC------CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHH
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~ 492 (595)
||++....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||....... ....
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~ 240 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-----MLRM 240 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHH
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-----HHHH
Confidence 99998765432 223456899999999984 4568899999999999999999999997543211 1111
Q ss_pred HHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+.. .... ... .........+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~----~~~~-~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMS----GNYQ-FGS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH----TCCC-CCT----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Hhc----CCcc-cCc----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111 1100 000 011234567889999999999999999999965
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=319.77 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=200.0
Q ss_pred HHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcC--CCCCccccceeecC
Q 007625 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTS 340 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 340 (595)
+.+....++|++.+.||+|+||.||+|...+++.||+|++... ........+.+|+.++.+++ ||||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 3344466789999999999999999999888999999998643 34455678999999999997 59999999999999
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
+..++||| +.+++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||++++ +.+||+|||
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence 99999999 667899999986 34689999999999999999999999 9999999999999965 799999999
Q ss_pred ccccccCcCcc-eeecccccccccCccccCC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhh
Q 007625 421 LAKLVDAKLTH-VTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488 (595)
Q Consensus 421 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~ 488 (595)
+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----- 246 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----- 246 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----
Confidence 99876543222 2234568999999999865 468889999999999999999999997532211
Q ss_pred HHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 489 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
............ . ..+.....++.+++.+||+.||++||++.|+++.
T Consensus 247 --~~~~~~~~~~~~-----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 --SKLHAIIDPNHE-----I---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp --HHHHHHHCTTSC-----C---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHhcccc-----c---CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111111110 0 1111224578889999999999999999999754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.51 Aligned_cols=204 Identities=24% Similarity=0.280 Sum_probs=172.7
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CC-----CCccccceeecC
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HK-----NLLQLIGYCTTS 340 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 340 (595)
...++|++.+.||+|+||+||+|+.. +++.||||+++. .......+..|+.++..+. |+ +++++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN--KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec--cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34678999999999999999999965 688999999964 2344567788888888875 44 489999999999
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc--CCCcEEEee
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCD 418 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~D 418 (595)
+..++||||+. ++|.+++.... ...+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999996 59999988643 24589999999999999999999952 12899999999999994 478899999
Q ss_pred ccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCch
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~ 481 (595)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999876432 2345689999999999999999999999999999999999999986543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=316.84 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=203.2
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
..++|++.+.||+|+||+||+|+.. +++.||+|++... ........+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4568999999999999999999975 7899999998643 2334567899999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC---CcEEEeeccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAK 423 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~~~ 423 (595)
+||+++++|.+.+... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999888752 3589999999999999999999999 99999999999999754 479999999998
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
....... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||....... ....+.. +...
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~----~~~~ 240 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-----ILKRVET----GKYA 240 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----CCCC
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHc----CCCC
Confidence 6654321 223458999999999865 48999999999999999999999997644221 1111111 1110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
... +. ....+.++.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~-~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDL-PQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCS-GG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCc-hh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 00 1123457889999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.20 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=192.2
Q ss_pred HHHHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCc-----hhHHHHHHHHHHHHhc----CCCCCcccc
Q 007625 265 ELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVA----IHKNLLQLI 334 (595)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l----~h~niv~l~ 334 (595)
+.+...++|++.+.||+|+||.||+|+. .+++.||+|++...... .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3445677899999999999999999986 47889999998643211 1233456789999888 899999999
Q ss_pred ceeecCCceEEEEEe-cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc-CCC
Q 007625 335 GYCTTSSERILVYPF-MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNF 412 (595)
Q Consensus 335 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~ 412 (595)
+++...+..++|+|| +.+++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 789999999986 24589999999999999999999999 999999999999999 889
Q ss_pred cEEEeeccccccccCcCcceeecccccccccCccccCCCCCC-ccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH
Q 007625 413 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS-EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 491 (595)
Q Consensus 413 ~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~ 491 (595)
.+||+|||+++...... .....||..|+|||++.+..+. .++||||||+++|||++|+.||.....
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------- 244 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------- 244 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------
Confidence 99999999998765432 2345589999999998776664 589999999999999999999964211
Q ss_pred HHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 007625 492 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 546 (595)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 546 (595)
... .. ...+......+.+++.+||+.||++|||+.|++++-
T Consensus 245 ~~~-----~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 245 ILE-----AE---------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp HHH-----TC---------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred Hhh-----hc---------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000 00 011223345788999999999999999999997643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=322.77 Aligned_cols=259 Identities=22% Similarity=0.341 Sum_probs=181.5
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHH-HHHhcCCCCCccccceeecCCceEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
..++|+..+.||+|+||.||+|... +++.||+|+++..........+..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3468889999999999999999974 789999999976554455556666666 67778999999999999999999999
Q ss_pred EEecccCcHhhhhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 347 YPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
|||+++ +|.+++... ......+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999986 777776532 112456899999999999999999999852 7999999999999999999999999999876
Q ss_pred cCcCcceeecccccccccCcccc----CCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYL----STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||....... +...... .+.
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~-~~~ 246 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------DQLTQVV-KGD 246 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCC-CSC
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-------HHHHHHh-cCC
Confidence 44322 2233589999999998 45678999999999999999999999997532110 0000000 000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
...+.. .........+.+++.+||+.||++||++.||++
T Consensus 247 ~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSN----SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCC----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCC----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000 011234467889999999999999999999965
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=318.94 Aligned_cols=252 Identities=24% Similarity=0.358 Sum_probs=193.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec---------
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--------- 339 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 339 (595)
.++|++.+.||+|+||.||+|+.. +++.||+|++.. .......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 457899999999999999999964 789999999864 23456788999999999999999999998754
Q ss_pred ----CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEE
Q 007625 340 ----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (595)
Q Consensus 340 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 415 (595)
....++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 34678999999999999999852 34578899999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCcC-------------cceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCch
Q 007625 416 LCDFGLAKLVDAKL-------------THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (595)
Q Consensus 416 l~DfG~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~ 481 (595)
|+|||++....... ........||+.|+|||++.+. .++.++||||||+++|||++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 99999998664321 1122345689999999999764 68999999999999999998 5432111
Q ss_pred hhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 482 EEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 482 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.......+. .... .+. ..+.......+.+++.+|++.||.+|||+.|++++
T Consensus 234 ----~~~~~~~~~----~~~~--~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 ----RVNILKKLR----SVSI--EFP---PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ----HHHHHHHHH----STTC--CCC---TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHHhcc----cccc--ccC---ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111111 1100 011 11334445678899999999999999999999774
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=326.37 Aligned_cols=265 Identities=21% Similarity=0.303 Sum_probs=201.1
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-----------CCCCcccccee
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----------HKNLLQLIGYC 337 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 337 (595)
.++|++.+.||+|+||+||+|+. .+++.||+|++.. .......+.+|+.++.++. ||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 45799999999999999999996 4789999999863 2344567889999998876 89999999998
Q ss_pred ecCC----ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc----
Q 007625 338 TTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---- 409 (595)
Q Consensus 338 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---- 409 (595)
...+ ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+++ +|+||||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7654 678999999 889999998643 345899999999999999999999953 799999999999994
Q ss_pred --CCCcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhh-h
Q 007625 410 --DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE-D 486 (595)
Q Consensus 410 --~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~-~ 486 (595)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......... .
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999876542 23346899999999999999999999999999999999999999854321110 0
Q ss_pred hhHHHHHHHHhcc--------cc-----------ccccc----------cccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 007625 487 VLLLDHIRKLLRE--------DR-----------LNDIV----------DRNLNTYDSKEVETMVQVALLCTQSTPEDRP 537 (595)
Q Consensus 487 ~~l~~~~~~~~~~--------~~-----------~~~~~----------d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP 537 (595)
......+...... .. ...+. ......++.....++.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 0111111111100 00 00000 0011124577888999999999999999999
Q ss_pred CHHHHHHH
Q 007625 538 PMAQVVKM 545 (595)
Q Consensus 538 s~~evl~~ 545 (595)
|+.|++++
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999663
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.17 Aligned_cols=260 Identities=20% Similarity=0.299 Sum_probs=192.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceee----------
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT---------- 338 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---------- 338 (595)
.++|++.+.||+|+||.||+|... +++.||+|++.. ........+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL-TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec-CChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 467899999999999999999975 589999999864 23455678899999999999999999998873
Q ss_pred ----cCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc-CCCc
Q 007625 339 ----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFE 413 (595)
Q Consensus 339 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 413 (595)
.....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3457789999998 599988863 4589999999999999999999999 999999999999997 5679
Q ss_pred EEEeeccccccccCcCcc--eeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHH
Q 007625 414 AVLCDFGLAKLVDAKLTH--VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 490 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~ 490 (595)
+||+|||+++........ ......+|..|+|||++.+ ..++.++||||||+++|||+||+.||.........
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----- 234 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM----- 234 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH-----
Confidence 999999999876532211 2233457899999998865 67899999999999999999999999865432211
Q ss_pred HHHHHHhcc---c-------cccccccccC--C-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 491 DHIRKLLRE---D-------RLNDIVDRNL--N-----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 491 ~~~~~~~~~---~-------~~~~~~d~~l--~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
..+...... . .......... . ...+....++.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111110000 0 0000000000 0 011223567889999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=333.16 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=188.7
Q ss_pred CCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEEEec
Q 007625 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFM 350 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 350 (595)
.|...++||+|+||+||.+...+|+.||||++.. .....+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 4555788999999999877767899999999864 2345678899999876 8999999999999999999999999
Q ss_pred ccCcHhhhhcccCCCCCC---CCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC-------------CcE
Q 007625 351 QNLSVAYRLRDLKPGEKG---LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-------------FEA 414 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~ 414 (595)
. |+|.+++......... .++..++.++.|++.||+|||+. +|+||||||+||+++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999999864322111 13334578999999999999999 99999999999999754 489
Q ss_pred EEeeccccccccCcCcc---eeecccccccccCccccCC-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCchhh
Q 007625 415 VLCDFGLAKLVDAKLTH---VTTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE 483 (595)
Q Consensus 415 kl~DfG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~ 483 (595)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999877543222 1234569999999999865 568999999999999999999 999997533211
Q ss_pred hhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 484 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
........ .. +............++.+++.+|++.||.+|||+.||+++
T Consensus 248 ------~~i~~~~~---~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 ------SNIIRGIF---SL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ------HHHHHTCC---CC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------HHHhcCCC---Cc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 11111000 00 000011245677889999999999999999999999763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=328.12 Aligned_cols=248 Identities=22% Similarity=0.367 Sum_probs=199.9
Q ss_pred HHHHHHhcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCc-----hhHHHHHHHHHHHHhcC--CCCCccccc
Q 007625 264 RELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAI--HKNLLQLIG 335 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~~ 335 (595)
++.....++|++.+.||+|+||+||+|+. .+++.||+|++...... .....+.+|+.+++++. |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 44455677899999999999999999995 47899999998743211 12345678999999996 599999999
Q ss_pred eeecCCceEEEEEeccc-CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc-CCCc
Q 007625 336 YCTTSSERILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFE 413 (595)
Q Consensus 336 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 413 (595)
++...+..++|+|++.+ ++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++ +++.
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence 99999999999999976 899999876 34689999999999999999999999 999999999999999 7899
Q ss_pred EEEeeccccccccCcCcceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHH
Q 007625 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492 (595)
Q Consensus 414 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~ 492 (595)
+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... .
T Consensus 189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------~ 255 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------I 255 (320)
T ss_dssp EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------H
T ss_pred EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------h
Confidence 9999999998765432 233568999999999877665 6889999999999999999999964211 0
Q ss_pred HHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 493 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 493 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. .. . ........++.+++.+||+.||++|||+.||++.
T Consensus 256 ~~----~~---~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 IR----GQ---V-------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HH----CC---C-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hc----cc---c-------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 0 0111233578899999999999999999999774
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.64 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=200.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CC-cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCC------CccccceeecCC
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN------LLQLIGYCTTSS 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 341 (595)
.++|++.+.||+|+||+||+|... ++ ..||+|+++. .......+.+|+.+++.++|++ ++.+++++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc--cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 468999999999999999999964 44 6899999864 2345677889999999987766 888899999999
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEE-------------
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL------------- 408 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll------------- 408 (595)
..++||||+ ++++.+.+.... ...+++.+++.++.|++.||+|||+. +|+||||||+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 567777766432 34689999999999999999999999 99999999999999
Q ss_pred ------cCCCcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchh
Q 007625 409 ------DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE 482 (595)
Q Consensus 409 ------~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~ 482 (595)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999865432 23456899999999999999999999999999999999999999865432
Q ss_pred hhhhhhHHHHHHHHhcc--------cccccc-cc----------------------ccCCCCCHHHHHHHHHHHHHcccC
Q 007625 483 EEEDVLLLDHIRKLLRE--------DRLNDI-VD----------------------RNLNTYDSKEVETMVQVALLCTQS 531 (595)
Q Consensus 483 ~~~~~~l~~~~~~~~~~--------~~~~~~-~d----------------------~~l~~~~~~~~~~l~~l~~~cl~~ 531 (595)
.. ...+...... ...... .. ............++.+++.+||+.
T Consensus 246 ~~-----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 246 EH-----LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp HH-----HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred HH-----HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 21 1111111100 000000 00 000112334567889999999999
Q ss_pred CCCCCCCHHHHHH
Q 007625 532 TPEDRPPMAQVVK 544 (595)
Q Consensus 532 dP~~RPs~~evl~ 544 (595)
||++|||+.|+++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999954
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=321.38 Aligned_cols=254 Identities=20% Similarity=0.266 Sum_probs=173.5
Q ss_pred HhcCCCcCC-eeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec----CCc
Q 007625 269 ATDNFSESN-IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSE 342 (595)
Q Consensus 269 ~~~~~~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~ 342 (595)
..++|.+.+ +||+|+||+||+|+.. +++.||+|++... . .........+..+.||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 456788854 6999999999999975 6899999998642 1 122223334566799999999999876 345
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC---CCcEEEeec
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDF 419 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 419 (595)
.++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 789999999999999998632 35699999999999999999999999 9999999999999976 455999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
|+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... .........
T Consensus 176 g~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~ 247 (336)
T 3fhr_A 176 GFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-----PGMKRRIRL 247 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred ccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-----hhHHHhhhc
Confidence 9998654322 23356899999999998888999999999999999999999999754321110 000000000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... ....+ .......++.+++.+|++.||++|||+.|++++
T Consensus 248 ~~~-~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 248 GQY-GFPNP----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ----CCCTT----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccc-ccCch----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 00000 112345678899999999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.72 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=187.8
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 347 (595)
...+|+..++||+|+||+||.....+++.||||++..... ..+.+|+++++.+ +||||+++++++.+....++||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 4456888999999999997655566899999999864221 2346899999999 7999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-----CCcEEEeecccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-----NFEAVLCDFGLA 422 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfG~~ 422 (595)
||+. |+|.+++.... ....+..+..++.|++.||+|||+. +|+||||||+||+++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9997 59999987533 2344456678999999999999999 9999999999999953 346889999999
Q ss_pred ccccCcCc--ceeecccccccccCccccC---CCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHH
Q 007625 423 KLVDAKLT--HVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKL 496 (595)
Q Consensus 423 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~ 496 (595)
+....... .......||+.|+|||++. ...++.++|||||||++|||+| |..||....... ....
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---------~~~~ 241 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---------ANIL 241 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---------HHHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---------HHHH
Confidence 87654321 2233466999999999997 4567889999999999999999 899986432211 0111
Q ss_pred hccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 497 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 497 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
...... ............+.+++.+||+.||++|||+.||+++
T Consensus 242 ~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 242 LGACSL------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTCCCC------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccCCc------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 111100 0111123445667899999999999999999999854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=311.75 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=179.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHH-HHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~-~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.......... .+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 457888999999999999999975 78999999997544333333 3444555678889999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
||+ ++.+....... ...+++..+..++.|++.||+|||+ . +|+|+||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 44554444332 3468999999999999999999998 5 89999999999999999999999999997664
Q ss_pred CcCcceeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....... +..........
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~ 247 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-------EVLTKVLQEEP 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------HHHHHHHHSCC
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-------HHHHHHhccCC
Confidence 432 223346899999999984 4568899999999999999999999997532211 11111111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.. +. .......++.+++.+||+.||.+||++.|+++
T Consensus 248 -~~-----~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 -PL-----LP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -CC-----CC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CC-----CC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 00 01123457888999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.14 Aligned_cols=267 Identities=21% Similarity=0.265 Sum_probs=202.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec------CCc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT------SSE 342 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 342 (595)
.++|++.+.||+|+||+||+|.. .+|+.||+|+++..........+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999996 46899999999765566667889999999999999999999998755 667
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCc---EEEeec
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDF 419 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 419 (595)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999986432 34689999999999999999999999 9999999999999997664 999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHH-HHhc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR-KLLR 498 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~-~~~~ 498 (595)
|++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.................. ....
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9998765432 223456899999999999999999999999999999999999999754321110000000000 0000
Q ss_pred cccccc--ccccc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 007625 499 EDRLND--IVDRN---LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQV 542 (595)
Q Consensus 499 ~~~~~~--~~d~~---l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 542 (595)
...... .+... ...........+.+++.+|++.||++|||+.|+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000 00011 112445677889999999999999999999774
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.25 Aligned_cols=238 Identities=19% Similarity=0.288 Sum_probs=193.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC--CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCc-----
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----- 342 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 342 (595)
.++|++.+.||+|+||+||+|... +++.||||++...........+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 6899999998765555666788999999999999999999999987665
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++||||+++++|.+++.. .+++.+++.++.|++.||.|||++ +|+||||||+||+++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999876643 589999999999999999999999 99999999999999986 8999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
+..... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+.........
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------- 285 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------- 285 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-----------------
Confidence 876543 3456999999999987654 89999999999999999998887642211000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-HHHHHHhh
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM-AQVVKMLQ 547 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-~evl~~L~ 547 (595)
. ..........+.+++.+|++.||++||+. +++.+.|.
T Consensus 286 ----~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 ----E---DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ----T---TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ----c---cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 00011234578899999999999999964 55555443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=300.07 Aligned_cols=231 Identities=10% Similarity=0.026 Sum_probs=184.8
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCC--chhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+..+.+++||||+++++++...+..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3467999999999999999999975 589999999975432 3445789999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++++|.+++.. .....++..++.|++.||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999999853 135567889999999999999999 99999999999999999999997443
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
|++ .++.++|||||||++|||+||+.||.......... .....
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------------~~~~~ 217 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------------PAERD 217 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------------ECCBC
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------------HHHHH
Confidence 333 36889999999999999999999998644321000 00000
Q ss_pred ccccCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 007625 506 VDRNLN---TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL 551 (595)
Q Consensus 506 ~d~~l~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 551 (595)
...... ......+.++.+++.+||+.||++| |+.|+++.|+....
T Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 218 TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000000 0112234578899999999999999 99999999987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=316.42 Aligned_cols=243 Identities=16% Similarity=0.077 Sum_probs=181.7
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCC--chhHHHHHHHHHHHHhcCC-CCCccccce----------
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIH-KNLLQLIGY---------- 336 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h-~niv~l~~~---------- 336 (595)
..|...++||+|+||+||+|++ .+|+.||||+++.... ....+.+.+|+.+++.+.| +|...+..+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3466788999999999999995 4799999999873322 2235778999999999987 322211111
Q ss_pred -----------eec-----CCceEEEEEecccCcHhhhhccc---CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcE
Q 007625 337 -----------CTT-----SSERILVYPFMQNLSVAYRLRDL---KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397 (595)
Q Consensus 337 -----------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 397 (595)
+.. ....+++|+++ +++|.+++... ......+++..++.++.|++.||+|||+. +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111 12345666654 57998888522 22345688889999999999999999999 999
Q ss_pred EcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeecccccccccCcccc----------CCCCCCccchhHHHHHHHH
Q 007625 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL----------STGKSSEKTDVFGYGITLL 467 (595)
Q Consensus 398 H~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~SlGvvl~ 467 (595)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998865433 344567 999999999 5566889999999999999
Q ss_pred HHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 468 ELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 468 elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
||+||+.||........ ...++.. .. ..+.++.+++.+||+.||++||++.|+++
T Consensus 309 elltg~~Pf~~~~~~~~-----------------~~~~~~~-~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG-----------------SEWIFRS-CK----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC-----------------SGGGGSS-CC----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh-----------------HHHHHhh-cc----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999975432211 1111111 01 12367889999999999999999999865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=296.31 Aligned_cols=227 Identities=20% Similarity=0.279 Sum_probs=178.3
Q ss_pred cCCCcC-CeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHH-HhcCCCCCccccceeec----CCce
Q 007625 271 DNFSES-NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLI-SVAIHKNLLQLIGYCTT----SSER 343 (595)
Q Consensus 271 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 343 (595)
++|.+. +.||+|+||.||+|.. .+++.||+|+++. ...+.+|+.++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456666 7899999999999996 4789999999864 23567888887 55689999999999876 6678
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC---CCcEEEeecc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFG 420 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 420 (595)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999998632 34699999999999999999999999 9999999999999998 7899999999
Q ss_pred ccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
++.... +..++.++|||||||++|||+||+.||......... ..
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------~~ 209 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------PG 209 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------------HH
Confidence 986432 234678999999999999999999999753321100 00
Q ss_pred cccccccccCCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 501 RLNDIVDRNLNTYD----SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 501 ~~~~~~d~~l~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.... ........+ .....++.+++.+||+.||++|||+.|++++
T Consensus 210 ~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 210 MKTR-IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCCS-SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHH-HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 000001112 1235678899999999999999999999873
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=307.53 Aligned_cols=244 Identities=14% Similarity=0.129 Sum_probs=183.9
Q ss_pred HhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCC-------CchhHHHHHHHHHHHHhcC---------CCCCcc
Q 007625 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAI---------HKNLLQ 332 (595)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~E~~~l~~l~---------h~niv~ 332 (595)
..++|++.+.||+|+||+||+|+. +|+.||||++.... .......+.+|+.+++.++ |||+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346788899999999999999998 78999999997432 2234477889999988886 555555
Q ss_pred cc-----------------ceeec-------------CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHH
Q 007625 333 LI-----------------GYCTT-------------SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382 (595)
Q Consensus 333 l~-----------------~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia 382 (595)
+. +++.+ .+..++||||+++|++.+.+.. ..+++..++.++.|++
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 54 44443 6789999999999977666643 4589999999999999
Q ss_pred HHHHHHh-hcCCCCcEEcCCCCCCEEEcCCC--------------------cEEEeeccccccccCcCcceeeccccccc
Q 007625 383 YGLEYLH-EQCNPKIIHRDLKAANILLDDNF--------------------EAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441 (595)
Q Consensus 383 ~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfG~~~~~~~~~~~~~~~~~gt~~ 441 (595)
.||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 88 999999999999999887 8999999999876532 2368999
Q ss_pred ccCccccCCCCCCccchhHHHHHH-HHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHH
Q 007625 442 HIAPEYLSTGKSSEKTDVFGYGIT-LLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVET 520 (595)
Q Consensus 442 y~aPE~~~~~~~~~~sDv~SlGvv-l~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 520 (595)
|+|||++.+.. +.++||||+|++ .+++++|..||.... ................ .............+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-------WLHYLTDKMLKQMTFK---TKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-------HHHHHHHHHHHTCCCS---SCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-------hhhHHHHhhhhhhccC---cccchhhhhhcCHH
Confidence 99999998766 899999998777 788888998874210 0000111111110000 00011123467788
Q ss_pred HHHHHHHcccCCCCCCCCHHHHH
Q 007625 521 MVQVALLCTQSTPEDRPPMAQVV 543 (595)
Q Consensus 521 l~~l~~~cl~~dP~~RPs~~evl 543 (595)
+.+++.+||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=273.52 Aligned_cols=186 Identities=13% Similarity=0.046 Sum_probs=130.9
Q ss_pred eeeeccceEEEEEE-eCCCcEEEEEEeccCC---------CchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEE
Q 007625 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYY---------SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 278 ~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~---------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (595)
..+.|++|.+..++ .-.|+.||+|++.... .+...++|.+|+++|+++ .|+||+++++++.+++..|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34566677666655 2368889999986431 123346799999999999 699999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||++|++|.+.+.. ..+++.. +|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+++...
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999986 3446553 5899999999999999 99999999999999999999999999998765
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA 475 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p 475 (595)
.... ......||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4322 2344679999999999865 467789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=249.43 Aligned_cols=185 Identities=15% Similarity=0.191 Sum_probs=147.4
Q ss_pred CcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCC--c-----hhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 274 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--P-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
...++||+|+||+||+|.. .+..+++|+...... . ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999954 678899998653221 1 1234589999999999999999877788788888999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++++|.+++.. +..++.|++.||+|||++ +|+||||||+|||+++ .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999875 458999999999999999 9999999999999999 99999999999876
Q ss_pred CcCcce------eecccccccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCC
Q 007625 427 AKLTHV------TTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAI 476 (595)
Q Consensus 427 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~p~ 476 (595)
...... .....||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 532221 234679999999999976 56788899999999888888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-23 Score=207.16 Aligned_cols=154 Identities=13% Similarity=0.045 Sum_probs=124.0
Q ss_pred HHHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCc-----------------hhHHHHHHHHHHHHhc
Q 007625 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-----------------GGEAAFQREVHLISVA 325 (595)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------~~~~~~~~E~~~l~~l 325 (595)
...+......|++.+.||+|+||.||+|...+|+.||+|+++..... .....+.+|+.+++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34455556677788999999999999999977999999998632211 1356789999999999
Q ss_pred CCCCCccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCC
Q 007625 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (595)
Q Consensus 326 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 405 (595)
+ | +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+. +|+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 8 5 777776543 56799999999999988 421 12447999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccCcCcceeecccccccccCccccC
Q 007625 406 ILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449 (595)
Q Consensus 406 Ill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 449 (595)
||++ ++.+||+|||+++. +..|.|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9999 99999999999863 34578888874
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.88 E-value=9.2e-23 Score=207.18 Aligned_cols=149 Identities=27% Similarity=0.497 Sum_probs=135.8
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCCCCCCCCCCC--cceeEecC----CCEEEEEcCCCCCCC--CCCccccccCCC
Q 007625 31 REPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFS--WSHVTCRN----GNVISLTLGSNGFSG--KISPSITKLKFL 102 (595)
Q Consensus 31 ~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~~--w~gv~c~~----~~l~~l~l~~n~l~g--~~~~~~~~l~~L 102 (595)
.|.+.|++||++||+++.++. .+.+|+.+ ++||. |.||.|+. ++|+.|+|++|+++| .+|+.|.++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~--~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC--CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 588999999999999998876 78899764 45667 99999985 689999999999999 899999999999
Q ss_pred CeEEccC-CccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcCCccCchhh---hccccccccc
Q 007625 103 ASLELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTG 178 (595)
Q Consensus 103 ~~L~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l---~~l~~l~~~~ 178 (595)
++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..+.++++|++|+|++|+++|.+|..+ .+++.+++++
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 9999995 99999999999999999999999999999999999999999999999999999999766 4567888999
Q ss_pred cccc
Q 007625 179 THLI 182 (595)
Q Consensus 179 n~~~ 182 (595)
|...
T Consensus 159 N~l~ 162 (313)
T 1ogq_A 159 NRIS 162 (313)
T ss_dssp SCCE
T ss_pred Cccc
Confidence 8763
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-20 Score=215.59 Aligned_cols=152 Identities=27% Similarity=0.368 Sum_probs=117.1
Q ss_pred cCCCCChhHHHHHHHHHHHccCCCCCCCCCCCCCCCCCCCcceeEecCCCEEEEEcCCCCCCCC---CCc----------
Q 007625 28 HSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGK---ISP---------- 94 (595)
Q Consensus 28 ~~~~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~~w~gv~c~~~~l~~l~l~~n~l~g~---~~~---------- 94 (595)
+++.+.+.|++||++||+++.||. .+.+|+.+ ++||.|.||+|+.++|+.|+|+++++.|. +|+
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~~--~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKN-LLPDWSSN--KNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTT-SSTTCCTT--SCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred ccccCCHHHHHHHHHHHhhCCCcc-cccCCCCC--CCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 344457789999999999999988 89999854 57889999999988999999999999987 554
Q ss_pred -------------cccccCCCCeEEccCCccCCCCCc--cccCCCcccEEEeccccccCcccccc-ccCCCCceecCCCC
Q 007625 95 -------------SITKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPATW-SQLSNLKHLDLSSN 158 (595)
Q Consensus 95 -------------~~~~l~~L~~L~l~~n~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~l~l~~N 158 (595)
.|+++++|++|+|++|.++|.+|. .|++|++|++|+|++|.+++.+|..+ .++++|++|+|++|
T Consensus 82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 566677777777777777777777 77777777777777777777777665 67777777777777
Q ss_pred cCCccCchh------hhccccccccccccc
Q 007625 159 NLTGRIPMQ------LFSVATFNFTGTHLI 182 (595)
Q Consensus 159 ~l~g~ip~~------l~~l~~l~~~~n~~~ 182 (595)
++++..|.. +.+++.+++++|...
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~ 191 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKIS 191 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEE
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCccc
Confidence 777666643 345677777777654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.3e-20 Score=210.21 Aligned_cols=147 Identities=22% Similarity=0.339 Sum_probs=127.4
Q ss_pred CCCCChhHHHHHHHHHHHccCCCCCCCCCCCCC----CCCC-CCc------------ceeEecC-CCEEEEEcCCCCCCC
Q 007625 29 SSREPDVEGEALIEVLKALNDTHGQFTDWNDHF----VSPC-FSW------------SHVTCRN-GNVISLTLGSNGFSG 90 (595)
Q Consensus 29 ~~~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~----~~~c-~~w------------~gv~c~~-~~l~~l~l~~n~l~g 90 (595)
.++....|+.||++||+++.+| +|+.+. .+|| |.| .||+|+. ++|+.|+|++|+|.|
T Consensus 263 ~~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G 337 (876)
T 4ecn_A 263 ETAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337 (876)
T ss_dssp CCCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEE
T ss_pred ccccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCC
Confidence 3345567999999999999876 786553 3453 699 9999984 799999999999999
Q ss_pred CCCccccccCCCCeEEc-cCCccCCC------------------------------------------------------
Q 007625 91 KISPSITKLKFLASLEL-QDNDLSGT------------------------------------------------------ 115 (595)
Q Consensus 91 ~~~~~~~~l~~L~~L~l-~~n~l~g~------------------------------------------------------ 115 (595)
.+|++|++|++|++|+| ++|.++|.
T Consensus 338 ~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp EECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred cCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 99999999999999999 77866554
Q ss_pred ----------------------CCccccCCCcccEEEeccccccC-----------------ccccccc--cCCCCceec
Q 007625 116 ----------------------LPDFLGSMTHLQSLNLANNKFSG-----------------SIPATWS--QLSNLKHLD 154 (595)
Q Consensus 116 ----------------------~p~~~~~l~~L~~L~l~~N~l~g-----------------~~p~~~~--~l~~L~~l~ 154 (595)
||..|++|++|++|+|++|+|+| .+|..++ ++++|++|+
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~ 497 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred ccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence 88999999999999999999998 4999988 999999999
Q ss_pred CCCCcCCccCchhhh---ccccccccccc
Q 007625 155 LSSNNLTGRIPMQLF---SVATFNFTGTH 180 (595)
Q Consensus 155 l~~N~l~g~ip~~l~---~l~~l~~~~n~ 180 (595)
|++|++.|.+|..+. +|..|++++|.
T Consensus 498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 498 LYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp EESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 999999999997664 56778889887
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.79 E-value=1e-19 Score=202.59 Aligned_cols=146 Identities=22% Similarity=0.308 Sum_probs=126.4
Q ss_pred CChhHHHHHHHHHHHccCCCCCC--------CCCCCCCCCCCCCc---ceeEecC-CCEEEEEcCCCCCCCCCCcccccc
Q 007625 32 EPDVEGEALIEVLKALNDTHGQF--------TDWNDHFVSPCFSW---SHVTCRN-GNVISLTLGSNGFSGKISPSITKL 99 (595)
Q Consensus 32 ~~~~~~~al~~~~~~~~~~~~~l--------~~w~~~~~~~c~~w---~gv~c~~-~~l~~l~l~~n~l~g~~~~~~~~l 99 (595)
....|+.||.+++++++++.+.. .+|+.+ .+||.| .||+|+. ++|+.|+|++|+++|.+|++|++|
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~--~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L 104 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN--KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQL 104 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS--SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGC
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC--CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcC
Confidence 33469999999999998765442 369865 567799 9999975 699999999999999999999999
Q ss_pred CCCCeEEccCC---------------------------------------------------------------------
Q 007625 100 KFLASLELQDN--------------------------------------------------------------------- 110 (595)
Q Consensus 100 ~~L~~L~l~~n--------------------------------------------------------------------- 110 (595)
++|++|+|++|
T Consensus 105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~ 184 (636)
T 4eco_A 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184 (636)
T ss_dssp TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCC
T ss_pred ccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchh
Confidence 99999999988
Q ss_pred ---------ccCCCCCccccCCCcccEEEeccccccCc-----------------cccccc--cCCCCceecCCCCcCCc
Q 007625 111 ---------DLSGTLPDFLGSMTHLQSLNLANNKFSGS-----------------IPATWS--QLSNLKHLDLSSNNLTG 162 (595)
Q Consensus 111 ---------~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-----------------~p~~~~--~l~~L~~l~l~~N~l~g 162 (595)
+|+| ||.+|+++++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.|
T Consensus 185 ~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~ 263 (636)
T 4eco_A 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263 (636)
T ss_dssp TTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS
T ss_pred hhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc
Confidence 4445 899999999999999999999986 999998 99999999999999999
Q ss_pred cCchhhh---ccccccccccc
Q 007625 163 RIPMQLF---SVATFNFTGTH 180 (595)
Q Consensus 163 ~ip~~l~---~l~~l~~~~n~ 180 (595)
.+|..+. +++.|++++|.
T Consensus 264 ~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 264 KLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp SCCTTTTTCSSCCEEECTTCT
T ss_pred cChHHHhcCCCCCEEECcCCC
Confidence 9997664 56778888887
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.2e-19 Score=174.21 Aligned_cols=140 Identities=19% Similarity=0.142 Sum_probs=106.6
Q ss_pred CCCcCCeeeeccceEEEEEEe-CCCcE--EEEEEeccCCCc-----------------------hhHHHHHHHHHHHHhc
Q 007625 272 NFSESNIIGQGGFGKVYKGVL-SDNTK--VAVKRLQDYYSP-----------------------GGEAAFQREVHLISVA 325 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~~-----------------------~~~~~~~~E~~~l~~l 325 (595)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 366789999999999999997 68888 999987532110 1123678999999999
Q ss_pred CCCCCccccceeecCCceEEEEEeccc-C----cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCcEEc
Q 007625 326 IHKNLLQLIGYCTTSSERILVYPFMQN-L----SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH-EQCNPKIIHR 399 (595)
Q Consensus 326 ~h~niv~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~ 399 (595)
.|+++....-+.. ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| +. +|+||
T Consensus 128 ~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred HhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 9886532221211 467899999943 4 55554332 224457789999999999999 88 99999
Q ss_pred CCCCCCEEEcCCCcEEEeeccccccc
Q 007625 400 DLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 400 Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+|||++. .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999754
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=9.2e-18 Score=157.53 Aligned_cols=125 Identities=26% Similarity=0.417 Sum_probs=111.1
Q ss_pred CCC-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCc-cccccCCCCeEEccCCccCCCCCccccCCCcccEE
Q 007625 63 SPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSL 129 (595)
Q Consensus 63 ~~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~-~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L 129 (595)
..| |.|..+.|.. .+++.|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|++|
T Consensus 4 ~~C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 83 (192)
T 1w8a_A 4 AMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL 83 (192)
T ss_dssp TTSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEE
Confidence 456 6899999974 2788999999999966654 49999999999999999999889999999999999
Q ss_pred EeccccccCccccccccCCCCceecCCCCcCCccCchhh---hccccccccccccccCCCC
Q 007625 130 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLICGSSL 187 (595)
Q Consensus 130 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l---~~l~~l~~~~n~~~~~~~~ 187 (595)
+|++|+|++..|..|.++++|++|+|++|+|++.+|..+ .++..+++++|++.|.+++
T Consensus 84 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 999999998888889999999999999999998888655 4678899999999998754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.5e-18 Score=177.31 Aligned_cols=151 Identities=17% Similarity=0.275 Sum_probs=130.6
Q ss_pred cCCCCChhHHHHHHHHHHHc-cCCCCCCCCCC---CCCCCCCCCcceeEecC----------CCEEEEEcCCCCCCCCCC
Q 007625 28 HSSREPDVEGEALIEVLKAL-NDTHGQFTDWN---DHFVSPCFSWSHVTCRN----------GNVISLTLGSNGFSGKIS 93 (595)
Q Consensus 28 ~~~~~~~~~~~al~~~~~~~-~~~~~~l~~w~---~~~~~~c~~w~gv~c~~----------~~l~~l~l~~n~l~g~~~ 93 (595)
+...+..+|++||++||.++ .++.+.+.+|. .. ...||.|.|+.|.. .+|+.|+|++|+++ .+|
T Consensus 20 ~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~-~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp 97 (328)
T 4fcg_A 20 QGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSN-NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFP 97 (328)
T ss_dssp C--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTT-CTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCC
T ss_pred eccccCchHHHHHHHHHHhccCCchhhhhhhcccccc-cccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcC
Confidence 34456678999999999988 46767778894 22 24556999999952 68999999999999 899
Q ss_pred ccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcCCccCchh------
Q 007625 94 PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ------ 167 (595)
Q Consensus 94 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~------ 167 (595)
+.++++++|++|+|++|.|+ .+|..++++++|++|+|++|+|+ .+|..++++++|++|+|++|++.+.+|..
T Consensus 98 ~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~ 175 (328)
T 4fcg_A 98 DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA 175 (328)
T ss_dssp SCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-
T ss_pred hhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccc
Confidence 99999999999999999999 99999999999999999999999 89999999999999999999999999975
Q ss_pred ------hhccccccccccccc
Q 007625 168 ------LFSVATFNFTGTHLI 182 (595)
Q Consensus 168 ------l~~l~~l~~~~n~~~ 182 (595)
+.+++.|++++|...
T Consensus 176 ~~~~~~l~~L~~L~L~~n~l~ 196 (328)
T 4fcg_A 176 SGEHQGLVNLQSLRLEWTGIR 196 (328)
T ss_dssp CCCEEESTTCCEEEEEEECCC
T ss_pred hhhhccCCCCCEEECcCCCcC
Confidence 456788888888664
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.9e-17 Score=154.24 Aligned_cols=124 Identities=25% Similarity=0.435 Sum_probs=109.9
Q ss_pred CCCC-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEE
Q 007625 62 VSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSL 129 (595)
Q Consensus 62 ~~~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L 129 (595)
+..| |.|..+.|.. .+++.|+|++|+|+ .+|..|.++++|++|+|++|.|++..|..|.+|++|++|
T Consensus 5 P~~C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L 83 (193)
T 2wfh_A 5 PTECTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL 83 (193)
T ss_dssp CTTCEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEE
Confidence 3456 6888899964 27899999999999 888999999999999999999998778889999999999
Q ss_pred EeccccccCccccccccCCCCceecCCCCcCCccCchh----hhccccccccccccccCCCC
Q 007625 130 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHLICGSSL 187 (595)
Q Consensus 130 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~----l~~l~~l~~~~n~~~~~~~~ 187 (595)
+|++|+|++..|..|.++++|+.|+|++|+|+ .+|.. +.++..+++++|++.|+|.+
T Consensus 84 ~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 84 ILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred ECCCCccCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 99999999877888999999999999999999 56653 45788999999999999854
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.7e-17 Score=188.96 Aligned_cols=117 Identities=37% Similarity=0.617 Sum_probs=110.8
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
..++.|+|++|+++|.+|..|++|++|+.|+|++|+|+|.+|..|++|++|++|||++|+|+|.+|..++++++|++|||
T Consensus 632 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~l 711 (768)
T 3rgz_A 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711 (768)
T ss_dssp BCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEEC
T ss_pred ccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEEC
Confidence 36889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCccCch--hhhccccccccccccccCCCCCCCCCC
Q 007625 156 SSNNLTGRIPM--QLFSVATFNFTGTHLICGSSLEQPCMS 193 (595)
Q Consensus 156 ~~N~l~g~ip~--~l~~l~~l~~~~n~~~~~~~~~~~c~~ 193 (595)
++|+|+|.||. .+.++...+|.||+.+||.++. +|..
T Consensus 712 s~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~ 750 (768)
T 3rgz_A 712 SNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDP 750 (768)
T ss_dssp CSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred cCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCC
Confidence 99999999996 4677888899999999999876 7864
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=9.9e-17 Score=148.30 Aligned_cols=123 Identities=25% Similarity=0.369 Sum_probs=106.4
Q ss_pred CCC-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEE
Q 007625 63 SPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLN 130 (595)
Q Consensus 63 ~~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ 130 (595)
+.| |+|.++.|.. .+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|..+++|++|+
T Consensus 3 ~~C~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILY 82 (177)
T ss_dssp TTCEEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEE
Confidence 456 6999999974 3689999999999977677789999999999999999966666789999999999
Q ss_pred eccccccCccccccccCCCCceecCCCCcCCccCchh----hhccccccccccccccCCC
Q 007625 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHLICGSS 186 (595)
Q Consensus 131 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~----l~~l~~l~~~~n~~~~~~~ 186 (595)
|++|+|++..+..+.++++|+.|+|++|+|+ .+|.. +.++..+++++|++.|.++
T Consensus 83 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 83 LHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCCCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9999999766667899999999999999999 56653 3567889999999988764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3.7e-17 Score=167.53 Aligned_cols=147 Identities=14% Similarity=0.113 Sum_probs=103.5
Q ss_pred HHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCC-------------CchhHHH--------HHHHHHHHH
Q 007625 265 ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-------------SPGGEAA--------FQREVHLIS 323 (595)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~--------~~~E~~~l~ 323 (595)
.+....--|++...||+|+||.||+|...+|+.||||+++... ....... ..+|...+.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 3333344589999999999999999999899999999875311 0001111 234555666
Q ss_pred hcCCCCCccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCC
Q 007625 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 403 (595)
Q Consensus 324 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp 403 (595)
++.+.++....-+.. ...++||||+++++|...... .....++.|++.+|.|||+. +||||||||
T Consensus 169 rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp 233 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNE 233 (397)
T ss_dssp HHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred HHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCH
Confidence 665444322211111 234799999999887654321 12357889999999999998 999999999
Q ss_pred CCEEEcCCC----------cEEEeecccccccc
Q 007625 404 ANILLDDNF----------EAVLCDFGLAKLVD 426 (595)
Q Consensus 404 ~NIll~~~~----------~~kl~DfG~~~~~~ 426 (595)
.|||+++++ .+.|+||+-+-...
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999998876 38999999876543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-16 Score=152.30 Aligned_cols=118 Identities=25% Similarity=0.304 Sum_probs=99.0
Q ss_pred CCCCcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEec
Q 007625 64 PCFSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132 (595)
Q Consensus 64 ~c~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~ 132 (595)
..|+|.+|.|.. .+++.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 17 ~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 17 CSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp CEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 335999999974 268899999999998888899999999999999999985445667899999999999
Q ss_pred cccccCccccccccCCCCceecCCCCcCCccCchhh---hccccccccccccc
Q 007625 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (595)
Q Consensus 133 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l---~~l~~l~~~~n~~~ 182 (595)
+|+|++..+..|..+++|+.|+|++|+|+ .+|..+ .++..|++++|...
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 148 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC
Confidence 99999666666888999999999999998 888654 45677788888664
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.9e-16 Score=151.83 Aligned_cols=121 Identities=21% Similarity=0.288 Sum_probs=80.6
Q ss_pred CCCCC-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccE
Q 007625 61 FVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128 (595)
Q Consensus 61 ~~~~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~ 128 (595)
.+..| |.|..|.|.. .+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++
T Consensus 5 CP~~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~ 84 (220)
T 2v9t_B 5 CPAACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS 84 (220)
T ss_dssp SCTTSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCE
T ss_pred CCCCCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCE
Confidence 34566 6888888863 25778888888887655556777777777777777777666777777777777
Q ss_pred EEeccccccCccccccccCCCCceecCCCCcCCccCchhh---hcccccccccccc
Q 007625 129 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHL 181 (595)
Q Consensus 129 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l---~~l~~l~~~~n~~ 181 (595)
|+|++|+|++..+..|.++++|+.|+|++|+|++..|..+ .+|..|++++|..
T Consensus 85 L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 140 (220)
T 2v9t_B 85 LVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140 (220)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcC
Confidence 7777777773333335666777777777777664444333 3445555555544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.4e-15 Score=142.75 Aligned_cols=120 Identities=24% Similarity=0.314 Sum_probs=98.1
Q ss_pred CCC-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEE
Q 007625 63 SPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLN 130 (595)
Q Consensus 63 ~~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ 130 (595)
+.| |.|.+|.|.. .+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 3 ~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN 82 (208)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence 456 6999999974 2688999999999976666789999999999999999965566678999999999
Q ss_pred eccccccCccccccccCCCCceecCCCCcCCccCchh---hhccccccccccccc
Q 007625 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ---LFSVATFNFTGTHLI 182 (595)
Q Consensus 131 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~---l~~l~~l~~~~n~~~ 182 (595)
|++|+|++..+..+.++++|++|+|++|+|++..|.. +.+++.+++++|...
T Consensus 83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 137 (208)
T 2o6s_A 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc
Confidence 9999999665666889999999999999998544432 456788888888654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-15 Score=145.91 Aligned_cols=110 Identities=17% Similarity=0.261 Sum_probs=61.5
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+|++..+..|.++++|++|+|++|.|++..|..|..+++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus 58 ~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 137 (220)
T 2v70_A 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLY 137 (220)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECT
T ss_pred CCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECC
Confidence 44445555555554444455555555555555555554444445556666666666666665555556666666666666
Q ss_pred CCcCCccCchhh---hccccccccccccccCCC
Q 007625 157 SNNLTGRIPMQL---FSVATFNFTGTHLICGSS 186 (595)
Q Consensus 157 ~N~l~g~ip~~l---~~l~~l~~~~n~~~~~~~ 186 (595)
+|+|++..|..+ .++..+++++|++.|.|+
T Consensus 138 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 138 DNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 666664444433 344556666666666654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.58 E-value=4e-15 Score=136.49 Aligned_cols=104 Identities=23% Similarity=0.375 Sum_probs=82.8
Q ss_pred EEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCC
Q 007625 79 ISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158 (595)
Q Consensus 79 ~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N 158 (595)
+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 35677788887 5776664 88899999999999777888889999999999999998655656788999999999999
Q ss_pred cCCccCch----hhhccccccccccccccCCC
Q 007625 159 NLTGRIPM----QLFSVATFNFTGTHLICGSS 186 (595)
Q Consensus 159 ~l~g~ip~----~l~~l~~l~~~~n~~~~~~~ 186 (595)
+|++ +|. .+.+++.+++++|++.|.|+
T Consensus 89 ~l~~-~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKS-IPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCC-CCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCE-eCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9984 543 24567788889999888864
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.54 E-value=3.7e-15 Score=151.00 Aligned_cols=113 Identities=31% Similarity=0.473 Sum_probs=100.0
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
.++.|+|++|.+++.+|..|.++++|+.|+|++|.+++.+|. +..+++|++|+|++|+|+|.+|..+.++++|+.|+|+
T Consensus 198 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 276 (313)
T 1ogq_A 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276 (313)
T ss_dssp CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECC
T ss_pred cccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECc
Confidence 377888888888888888889999999999999999876665 8889999999999999999999999999999999999
Q ss_pred CCcCCccCch--hhhccccccccccccccCCCCCCCC
Q 007625 157 SNNLTGRIPM--QLFSVATFNFTGTHLICGSSLEQPC 191 (595)
Q Consensus 157 ~N~l~g~ip~--~l~~l~~l~~~~n~~~~~~~~~~~c 191 (595)
+|+|+|.+|. .+.++..+++++|+++|+.|+. .|
T Consensus 277 ~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 277 FNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp SSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 9999999996 4677889999999999998765 45
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=1e-14 Score=139.82 Aligned_cols=121 Identities=20% Similarity=0.262 Sum_probs=104.8
Q ss_pred CCCC-CCcceeEecCC-----------CEEEEEcCCCCCCCCCCc-cccccCCCCeEEccCCccCCCCCccccCCCcccE
Q 007625 62 VSPC-FSWSHVTCRNG-----------NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128 (595)
Q Consensus 62 ~~~c-~~w~gv~c~~~-----------~l~~l~l~~n~l~g~~~~-~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~ 128 (595)
+..| |.|..+.|+.. .++.|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|++
T Consensus 6 P~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~ 85 (220)
T 2v70_A 6 PEKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNE 85 (220)
T ss_dssp CTTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCE
Confidence 4566 78999999742 577999999999977554 5899999999999999999877779999999999
Q ss_pred EEeccccccCccccccccCCCCceecCCCCcCCccCchhh---hccccccccccccc
Q 007625 129 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (595)
Q Consensus 129 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l---~~l~~l~~~~n~~~ 182 (595)
|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+ .+|..|++++|...
T Consensus 86 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 142 (220)
T 2v70_A 86 ILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142 (220)
T ss_dssp EECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCC
T ss_pred EECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCC
Confidence 9999999998888889999999999999999997667654 56788899999764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.3e-16 Score=169.75 Aligned_cols=113 Identities=23% Similarity=0.208 Sum_probs=93.5
Q ss_pred CcceeEecC-CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCcccc-CCCcccEEEeccccccCcccccc
Q 007625 67 SWSHVTCRN-GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG-SMTHLQSLNLANNKFSGSIPATW 144 (595)
Q Consensus 67 ~w~gv~c~~-~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~ 144 (595)
.+.++.|.. .+++.|+|++|.|++..|..++++++|++|+|++|.|++.+|..+. ++++|++|+|++|.|++. |. +
T Consensus 110 ~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~ 187 (487)
T 3oja_A 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-Q 187 (487)
T ss_dssp CCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-C
T ss_pred cCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-c
Confidence 566666654 5789999999999988888999999999999999999988888886 799999999999999955 43 4
Q ss_pred ccCCCCceecCCCCcCCccCchhh---hccccccccccccc
Q 007625 145 SQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (595)
Q Consensus 145 ~~l~~L~~l~l~~N~l~g~ip~~l---~~l~~l~~~~n~~~ 182 (595)
..+++|+.|+|++|+|++ +|..+ .++..|++++|...
T Consensus 188 ~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 188 VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC
T ss_pred ccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc
Confidence 468999999999999995 55444 56788888888764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.52 E-value=1.6e-14 Score=148.47 Aligned_cols=108 Identities=18% Similarity=0.298 Sum_probs=92.2
Q ss_pred CCcceeEecCCCEEEEEcCCC-CCCCCCCccccccCCCCeEEccC-CccCCCCCccccCCCcccEEEeccccccCccccc
Q 007625 66 FSWSHVTCRNGNVISLTLGSN-GFSGKISPSITKLKFLASLELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT 143 (595)
Q Consensus 66 ~~w~gv~c~~~~l~~l~l~~n-~l~g~~~~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 143 (595)
|.|..|.|. ++ +|+ .+|. |..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++..|..
T Consensus 8 C~~~~v~~~----------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 75 (347)
T 2ifg_A 8 HGSSGLRCT----------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75 (347)
T ss_dssp SSSSCEECC----------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred ccCCEEEcC----------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHH
Confidence 688776664 44 777 5888 99999999999996 9999777788999999999999999999888888
Q ss_pred cccCCCCceecCCCCcCCccCchhhh---ccccccccccccccCCC
Q 007625 144 WSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLICGSS 186 (595)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g~ip~~l~---~l~~l~~~~n~~~~~~~ 186 (595)
|.+|++|+.|+|++|+|+ .+|..++ +|..|++.+|++.|.|.
T Consensus 76 ~~~l~~L~~L~l~~N~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp GGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred hcCCcCCCEEeCCCCccc-eeCHHHcccCCceEEEeeCCCccCCCc
Confidence 999999999999999999 5665432 37889999999999886
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.7e-14 Score=131.42 Aligned_cols=104 Identities=21% Similarity=0.328 Sum_probs=90.5
Q ss_pred EEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCC
Q 007625 79 ISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158 (595)
Q Consensus 79 ~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N 158 (595)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57899999997 7888775 89999999999999888999999999999999999999655555789999999999999
Q ss_pred cCCccCchh----hhccccccccccccccCCC
Q 007625 159 NLTGRIPMQ----LFSVATFNFTGTHLICGSS 186 (595)
Q Consensus 159 ~l~g~ip~~----l~~l~~l~~~~n~~~~~~~ 186 (595)
+|+ .+|.. +.++..+++++|++.|.+.
T Consensus 92 ~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLK-SIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccc-eeCHHHhccccCCCEEEeCCCCcccccc
Confidence 999 56653 4577889999999998863
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.48 E-value=6.6e-14 Score=136.96 Aligned_cols=105 Identities=25% Similarity=0.349 Sum_probs=87.8
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|++++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 57789999999998878789999999999999999998777788999999999999999996666778889999999999
Q ss_pred CCcCCccCchh----hhccccccccccccc
Q 007625 157 SNNLTGRIPMQ----LFSVATFNFTGTHLI 182 (595)
Q Consensus 157 ~N~l~g~ip~~----l~~l~~l~~~~n~~~ 182 (595)
+|+|+ .+|.. +.+++.|++++|...
T Consensus 116 ~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~ 144 (251)
T 3m19_A 116 GNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144 (251)
T ss_dssp SSCCC-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCcCC-CcChhHhccCCcccEEECcCCcCC
Confidence 99998 45432 456788888888654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=129.47 Aligned_cols=111 Identities=21% Similarity=0.381 Sum_probs=97.5
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++.+|..+..+++|++|+|
T Consensus 54 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 133 (192)
T 1w8a_A 54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133 (192)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEe
Confidence 58999999999999988999999999999999999999888888999999999999999999999999999999999999
Q ss_pred CCCcCCccCchh-hh-ccccccccccccccCCC
Q 007625 156 SSNNLTGRIPMQ-LF-SVATFNFTGTHLICGSS 186 (595)
Q Consensus 156 ~~N~l~g~ip~~-l~-~l~~l~~~~n~~~~~~~ 186 (595)
++|.+++..+.. +. .+....+.++...|..|
T Consensus 134 ~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 134 ASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp TTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 999999987742 22 24444666777777654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1e-13 Score=138.73 Aligned_cols=108 Identities=26% Similarity=0.344 Sum_probs=59.0
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+.++++|+.|+|+
T Consensus 101 ~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~ 180 (290)
T 1p9a_G 101 ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180 (290)
T ss_dssp TCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECC
Confidence 45555555555554444455555555555555555554444445555555666666665553222334555566666666
Q ss_pred CCcCCccCchhhh---ccccccccccccccCC
Q 007625 157 SNNLTGRIPMQLF---SVATFNFTGTHLICGS 185 (595)
Q Consensus 157 ~N~l~g~ip~~l~---~l~~l~~~~n~~~~~~ 185 (595)
+|+|+ .+|..++ ++..+++.+|||.|.|
T Consensus 181 ~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp SSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 66665 5555443 2455566666666665
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.45 E-value=2.1e-13 Score=133.34 Aligned_cols=108 Identities=24% Similarity=0.322 Sum_probs=48.7
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 84 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 163 (251)
T 3m19_A 84 ELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLS 163 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred cCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECC
Confidence 34444444444443333344444444444444444443333334445555555555555543333344455555555555
Q ss_pred CCcCCccCchh---hhccccccccccccccC
Q 007625 157 SNNLTGRIPMQ---LFSVATFNFTGTHLICG 184 (595)
Q Consensus 157 ~N~l~g~ip~~---l~~l~~l~~~~n~~~~~ 184 (595)
+|+|++..|.. +.++..+++++|++.|.
T Consensus 164 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 164 TNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 55554222211 23344445555555444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.45 E-value=2e-13 Score=135.22 Aligned_cols=105 Identities=28% Similarity=0.322 Sum_probs=56.7
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|+.+++|++|+|++|+|++..|..+.++++|+.|+|+
T Consensus 86 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 165 (272)
T 3rfs_A 86 NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLS 165 (272)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECC
Confidence 55666666666665444445556666666666666654444445555566666666665554444445555555555555
Q ss_pred CCcCCccCchh---hhcccccccccccc
Q 007625 157 SNNLTGRIPMQ---LFSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~~---l~~l~~l~~~~n~~ 181 (595)
+|+|++..|.. +.+++.+++++|..
T Consensus 166 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l 193 (272)
T 3rfs_A 166 YNQLQSLPEGVFDKLTQLKDLRLYQNQL 193 (272)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCcCccCHHHhcCCccCCEEECCCCcC
Confidence 55555332221 23445555555543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.7e-13 Score=124.77 Aligned_cols=105 Identities=22% Similarity=0.303 Sum_probs=88.2
Q ss_pred CCC-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEE
Q 007625 63 SPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLN 130 (595)
Q Consensus 63 ~~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ 130 (595)
..| |....+.|.. .+++.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 8 ~~C~C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~ 87 (174)
T 2r9u_A 8 SQCSCDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLD 87 (174)
T ss_dssp TTSEECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEE
Confidence 345 5666777753 3688999999999988899999999999999999999965555679999999999
Q ss_pred eccccccCccccccccCCCCceecCCCCcCCccCchhh
Q 007625 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168 (595)
Q Consensus 131 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l 168 (595)
|++|+|++..+..|.++++|+.|+|++|.+. ..|..+
T Consensus 88 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~-c~~~~~ 124 (174)
T 2r9u_A 88 LNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD-CECRDI 124 (174)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCBC-TTBGGG
T ss_pred CCCCccceeCHHHhccccCCCEEEeCCCCcc-cccccH
Confidence 9999999555556999999999999999999 445433
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=8e-14 Score=154.72 Aligned_cols=112 Identities=26% Similarity=0.360 Sum_probs=100.5
Q ss_pred CCEEEEEcCCCCCC-CCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceec
Q 007625 76 GNVISLTLGSNGFS-GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (595)
Q Consensus 76 ~~l~~l~l~~n~l~-g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (595)
..++.|+|++|.+. +.+|..|..+++|++|+|++|+|++..|..|++|++|++|+|++|+|++..|..|.++++|++|+
T Consensus 469 ~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 548 (635)
T 4g8a_A 469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 548 (635)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEE
T ss_pred hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEE
Confidence 37889999999754 45677899999999999999999998899999999999999999999988888899999999999
Q ss_pred CCCCcCCccCchhh----hccccccccccccccCCCC
Q 007625 155 LSSNNLTGRIPMQL----FSVATFNFTGTHLICGSSL 187 (595)
Q Consensus 155 l~~N~l~g~ip~~l----~~l~~l~~~~n~~~~~~~~ 187 (595)
|++|+|++..|..+ .+++.+++++|||.|+|..
T Consensus 549 Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 549 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp CTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 99999998878765 3578899999999999864
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.41 E-value=4.3e-13 Score=132.64 Aligned_cols=108 Identities=25% Similarity=0.354 Sum_probs=62.1
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|.+++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|++|++++..+..|.++++|+.|+|+
T Consensus 110 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 189 (270)
T 2o6q_A 110 NLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLD 189 (270)
T ss_dssp SCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECC
Confidence 45555555555554444455566666666666666664333445666666666666666664444446666666666666
Q ss_pred CCcCCccCchh----hhccccccccccccccCC
Q 007625 157 SNNLTGRIPMQ----LFSVATFNFTGTHLICGS 185 (595)
Q Consensus 157 ~N~l~g~ip~~----l~~l~~l~~~~n~~~~~~ 185 (595)
+|+|+ .+|.. +.++..+++++|++.|+|
T Consensus 190 ~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 190 NNQLK-RVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp SSCCS-CCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred CCcCC-cCCHHHhccccCCCEEEecCCCeeCCC
Confidence 66666 34432 234556666666666665
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.39 E-value=4e-13 Score=120.07 Aligned_cols=103 Identities=22% Similarity=0.321 Sum_probs=78.9
Q ss_pred CEEEEEcCCCCCC-CCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 77 NVISLTLGSNGFS-GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 77 ~l~~l~l~~n~l~-g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
+++.|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..++++++|++|+|++|++++.+|..+.++++|++|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 6778888888887 77887788888888888888888854 67788888888888888888767777777888888888
Q ss_pred CCCcCCcc-Cchh---hhcccccccccccc
Q 007625 156 SSNNLTGR-IPMQ---LFSVATFNFTGTHL 181 (595)
Q Consensus 156 ~~N~l~g~-ip~~---l~~l~~l~~~~n~~ 181 (595)
++|++++. .|.. +.++..+++++|+.
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l 125 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGG
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcc
Confidence 88888742 2233 34567777887765
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.38 E-value=7.2e-13 Score=131.03 Aligned_cols=105 Identities=27% Similarity=0.317 Sum_probs=64.4
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
.++.|+|++|++++..+..|.++++|++|+|++|.|+...+..|.++++|++|+|++|++++..+..+.++++|+.|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 35666666666665544566667777777777777663333344666777777777777764444456666777777777
Q ss_pred CCcCCccCch---hhhcccccccccccc
Q 007625 157 SNNLTGRIPM---QLFSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~---~l~~l~~l~~~~n~~ 181 (595)
+|++++..|. .+.+++.|++++|..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 145 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNEL 145 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcC
Confidence 7777643332 234556666666644
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=4.6e-13 Score=142.69 Aligned_cols=110 Identities=24% Similarity=0.304 Sum_probs=83.5
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..+.++++|++|+|
T Consensus 299 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 378 (455)
T 3v47_A 299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELAL 378 (455)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEEC
Confidence 36777788888887766777778888888888888887666777788888888888888887777777888888888888
Q ss_pred CCCcCCccCch----hhhccccccccccccccCCC
Q 007625 156 SSNNLTGRIPM----QLFSVATFNFTGTHLICGSS 186 (595)
Q Consensus 156 ~~N~l~g~ip~----~l~~l~~l~~~~n~~~~~~~ 186 (595)
++|+|++ +|. .+.+++.+++++|++.|.|+
T Consensus 379 ~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 379 DTNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCSC-CCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccc-CCHhHhccCCcccEEEccCCCcccCCC
Confidence 8888874 443 23466777888888887765
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.1e-13 Score=138.00 Aligned_cols=123 Identities=19% Similarity=0.197 Sum_probs=103.2
Q ss_pred CCCCC-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCcccc-ccCCCCeEEccCCccCCCCCccccCCCccc
Q 007625 61 FVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSIT-KLKFLASLELQDNDLSGTLPDFLGSMTHLQ 127 (595)
Q Consensus 61 ~~~~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~-~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~ 127 (595)
.+..| |.|..+.|.. ..++.|+|++|+|++..+..+. ++++|++|+|++|+|++..|..|.++++|+
T Consensus 12 Cp~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~ 91 (361)
T 2xot_A 12 CPANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLR 91 (361)
T ss_dssp CCTTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred CCCCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCC
Confidence 34556 7888999964 2578999999999977777777 999999999999999977778899999999
Q ss_pred EEEeccccccCccccccccCCCCceecCCCCcCCccCchh---hhcccccccccccccc
Q 007625 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ---LFSVATFNFTGTHLIC 183 (595)
Q Consensus 128 ~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~---l~~l~~l~~~~n~~~~ 183 (595)
+|+|++|+|++..+..|.++++|+.|+|++|+|++..|.. +.+|..|++++|....
T Consensus 92 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 150 (361)
T 2xot_A 92 YLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR 150 (361)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred EEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe
Confidence 9999999999666667999999999999999999655554 4567888999987643
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=5.2e-13 Score=133.08 Aligned_cols=110 Identities=21% Similarity=0.263 Sum_probs=62.7
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..|..+.++++|+.|+|+
T Consensus 130 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 209 (285)
T 1ozn_A 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209 (285)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCC
Confidence 45555555555554444445556666666666666654333345566666666666666665556666666666666666
Q ss_pred CCcCCccCchh---hhccccccccccccccCCC
Q 007625 157 SNNLTGRIPMQ---LFSVATFNFTGTHLICGSS 186 (595)
Q Consensus 157 ~N~l~g~ip~~---l~~l~~l~~~~n~~~~~~~ 186 (595)
+|++++..|.. +.++..+++++|++.|+|+
T Consensus 210 ~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp SSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 66666322222 2345566666666666654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.37 E-value=3.9e-13 Score=135.46 Aligned_cols=85 Identities=25% Similarity=0.382 Sum_probs=44.2
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCC-CCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG-TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
+++.|+|++|.+.+..+..+.++++|++|+|++|.+++ .+|..+..+++|++|+|++|++++..|..+.++++|+.|+|
T Consensus 127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 206 (306)
T 2z66_A 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206 (306)
T ss_dssp TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEEC
Confidence 45555555555554444445555555555555555543 34555555555555555555555444444555555555555
Q ss_pred CCCcCC
Q 007625 156 SSNNLT 161 (595)
Q Consensus 156 ~~N~l~ 161 (595)
++|+++
T Consensus 207 ~~N~l~ 212 (306)
T 2z66_A 207 SHNNFF 212 (306)
T ss_dssp TTSCCS
T ss_pred CCCccC
Confidence 555554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=7.3e-13 Score=140.65 Aligned_cols=114 Identities=24% Similarity=0.308 Sum_probs=97.1
Q ss_pred CcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEecccc
Q 007625 67 SWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135 (595)
Q Consensus 67 ~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~ 135 (595)
.|..|.|.. .+++.|+|++|+|++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 467899964 368899999999998888899999999999999999997777899999999999999999
Q ss_pred ccCccccccccCCCCceecCCCCcCCccCch----hhhcccccccccccc
Q 007625 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPM----QLFSVATFNFTGTHL 181 (595)
Q Consensus 136 l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~----~l~~l~~l~~~~n~~ 181 (595)
|++..+..|.++++|+.|+|++|+|+ .+|. .+.+|+.|++++|..
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~ 172 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTT
T ss_pred CCeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCCC
Confidence 99655667999999999999999999 5554 345677788877543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=6.2e-13 Score=147.54 Aligned_cols=106 Identities=22% Similarity=0.218 Sum_probs=92.4
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
.++.|+|++|+|++..+.+|.+|++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|.+|++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 68999999999997767789999999999999999997667789999999999999999996666779999999999999
Q ss_pred CCcCCccCch----hhhcccccccccccccc
Q 007625 157 SNNLTGRIPM----QLFSVATFNFTGTHLIC 183 (595)
Q Consensus 157 ~N~l~g~ip~----~l~~l~~l~~~~n~~~~ 183 (595)
+|+|++ +|. .+.+|+.|++++|....
T Consensus 133 ~N~l~~-l~~~~~~~L~~L~~L~Ls~N~l~~ 162 (635)
T 4g8a_A 133 ETNLAS-LENFPIGHLKTLKELNVAHNLIQS 162 (635)
T ss_dssp TSCCCC-STTCCCTTCTTCCEEECCSSCCCC
T ss_pred CCcCCC-CChhhhhcCcccCeeccccCcccc
Confidence 999994 553 34667888899987643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.37 E-value=7.8e-13 Score=140.95 Aligned_cols=113 Identities=22% Similarity=0.304 Sum_probs=97.9
Q ss_pred CcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEecccc
Q 007625 67 SWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135 (595)
Q Consensus 67 ~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~ 135 (595)
.|..|.|.. .+++.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 367899964 268999999999998888999999999999999999998888999999999999999999
Q ss_pred ccCccccccccCCCCceecCCCCcCCccCch----hhhccccccccccc
Q 007625 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPM----QLFSVATFNFTGTH 180 (595)
Q Consensus 136 l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~----~l~~l~~l~~~~n~ 180 (595)
|++..+..|.++++|++|+|++|+|+ .+|. .+.++..|++++|.
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~ 182 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCT
T ss_pred CCccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCC
Confidence 99666667999999999999999999 5664 34566777777754
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=120.25 Aligned_cols=104 Identities=23% Similarity=0.307 Sum_probs=91.2
Q ss_pred CCCC-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEE
Q 007625 62 VSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSL 129 (595)
Q Consensus 62 ~~~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L 129 (595)
+..| |+|+.+.|+. .+++.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|
T Consensus 4 P~~C~C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L 83 (170)
T 3g39_A 4 PSQCSCSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQL 83 (170)
T ss_dssp C-CCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCcCCcCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEE
Confidence 3456 6899999974 368899999999998888899999999999999999997666678999999999
Q ss_pred EeccccccCccccccccCCCCceecCCCCcCCccCc
Q 007625 130 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165 (595)
Q Consensus 130 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 165 (595)
+|++|+|++..|..|.++++|+.|+|++|.+++..+
T Consensus 84 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 84 SLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999999996666679999999999999999996544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.37 E-value=4.5e-13 Score=150.82 Aligned_cols=102 Identities=27% Similarity=0.390 Sum_probs=84.3
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
.++.|+|++|.|. .+|..+.+|++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|++|++|++|+|+
T Consensus 225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~ 301 (727)
T 4b8c_D 225 LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF 301 (727)
T ss_dssp CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence 4567888888887 77878888888888888888888 88888888888889999888888 788888888888888888
Q ss_pred CCcCCccCchhhh---ccccccccccccc
Q 007625 157 SNNLTGRIPMQLF---SVATFNFTGTHLI 182 (595)
Q Consensus 157 ~N~l~g~ip~~l~---~l~~l~~~~n~~~ 182 (595)
+|.|+ .||..+. +|..|++++|++.
T Consensus 302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp SSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 88887 7887654 5677788888764
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=5e-13 Score=142.41 Aligned_cols=116 Identities=22% Similarity=0.269 Sum_probs=100.9
Q ss_pred Ccce--eEecC----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCC-CccccCCCcccEEEecc
Q 007625 67 SWSH--VTCRN----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL-PDFLGSMTHLQSLNLAN 133 (595)
Q Consensus 67 ~w~g--v~c~~----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~L~l~~ 133 (595)
.|.+ |.|.. .+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++
T Consensus 9 ~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 9 SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 5544 88864 36899999999999888999999999999999999998777 56799999999999999
Q ss_pred ccccCccccccccCCCCceecCCCCcCCccCchh-----hhccccccccccccc
Q 007625 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-----LFSVATFNFTGTHLI 182 (595)
Q Consensus 134 N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~-----l~~l~~l~~~~n~~~ 182 (595)
|++++..|..|+++++|++|+|++|++++.+|.. +.+++.|++++|...
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~ 142 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccC
Confidence 9999888999999999999999999999866653 457788899998764
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.36 E-value=6.6e-13 Score=121.25 Aligned_cols=102 Identities=26% Similarity=0.345 Sum_probs=61.7
Q ss_pred CEEEEEcCCCCCC-CCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 77 NVISLTLGSNGFS-GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 77 ~l~~l~l~~n~l~-g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
+++.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+.++++|++|+|
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 4666666666665 56666666666666666666666643 55666666666666666666555655555666666666
Q ss_pred CCCcCCccCc--hh---hhcccccccccccc
Q 007625 156 SSNNLTGRIP--MQ---LFSVATFNFTGTHL 181 (595)
Q Consensus 156 ~~N~l~g~ip--~~---l~~l~~l~~~~n~~ 181 (595)
++|+|++ +| .. +.++..+++++|+.
T Consensus 103 s~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l 132 (168)
T 2ell_A 103 SGNKLKD-ISTLEPLKKLECLKSLDLFNCEV 132 (168)
T ss_dssp BSSSCCS-SGGGGGGSSCSCCCEEECCSSGG
T ss_pred cCCccCc-chhHHHHhcCCCCCEEEeeCCcC
Confidence 6666663 33 22 23455556666654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.36 E-value=6.1e-13 Score=137.42 Aligned_cols=85 Identities=25% Similarity=0.257 Sum_probs=41.9
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus 65 ~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 144 (361)
T 2xot_A 65 NLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLS 144 (361)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred ccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECC
Confidence 45555555555554444445555555555555555553333344455555555555555544444444444444444444
Q ss_pred CCcCC
Q 007625 157 SNNLT 161 (595)
Q Consensus 157 ~N~l~ 161 (595)
+|+|+
T Consensus 145 ~N~l~ 149 (361)
T 2xot_A 145 QNQIS 149 (361)
T ss_dssp SSCCC
T ss_pred CCcCC
Confidence 44444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.4e-12 Score=132.78 Aligned_cols=106 Identities=23% Similarity=0.326 Sum_probs=95.3
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|+|+ .+|..++++++|++|+|++|.++ .+|..++.+++|++|+|++|++.+.+|..++++++|+.|+|
T Consensus 183 ~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp TTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 47999999999999 88999999999999999999999 58888999999999999999999999999999999999999
Q ss_pred CCCcCCccCchhh---hcccccccccccccc
Q 007625 156 SSNNLTGRIPMQL---FSVATFNFTGTHLIC 183 (595)
Q Consensus 156 ~~N~l~g~ip~~l---~~l~~l~~~~n~~~~ 183 (595)
++|++.+.+|..+ .++..+++++|+...
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 9999999999765 456778899987644
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=6.4e-13 Score=147.03 Aligned_cols=111 Identities=24% Similarity=0.288 Sum_probs=89.2
Q ss_pred CCEEEEEcCCCCCCC-CCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceec
Q 007625 76 GNVISLTLGSNGFSG-KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g-~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (595)
.+++.|+|++|.+++ .+|..+..+++|++|+|++|++++..|..|+++++|++|+|++|++++.+|..+.++++|+.|+
T Consensus 448 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 527 (606)
T 3vq2_A 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527 (606)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEE
Confidence 367788888888876 3677788888888888888888877788888888888888888888877788888888888888
Q ss_pred CCCCcCCccCchhhh----ccccccccccccccCCCC
Q 007625 155 LSSNNLTGRIPMQLF----SVATFNFTGTHLICGSSL 187 (595)
Q Consensus 155 l~~N~l~g~ip~~l~----~l~~l~~~~n~~~~~~~~ 187 (595)
|++|+|+ .+|..+. ++..+++++|++.|+|+.
T Consensus 528 l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 528 CSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 8888888 7776543 367788888888888764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.2e-12 Score=138.88 Aligned_cols=108 Identities=25% Similarity=0.387 Sum_probs=89.3
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+|+ .+| .+..+++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 186 ~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 263 (440)
T 3zyj_A 186 NLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263 (440)
T ss_dssp SCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECT
T ss_pred ccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECC
Confidence 5667777777777 454 47788888888888888887778889999999999999999998888889999999999999
Q ss_pred CCcCCccCchh----hhccccccccccccccCCCC
Q 007625 157 SNNLTGRIPMQ----LFSVATFNFTGTHLICGSSL 187 (595)
Q Consensus 157 ~N~l~g~ip~~----l~~l~~l~~~~n~~~~~~~~ 187 (595)
+|+|+ .+|.. +.++..+++++||+.|+|.+
T Consensus 264 ~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 264 HNNLT-LLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp TSCCC-CCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred CCCCC-ccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 99999 55542 45678899999999999864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=8.3e-13 Score=144.24 Aligned_cols=115 Identities=23% Similarity=0.231 Sum_probs=101.2
Q ss_pred CCcceeEecC-------------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEec
Q 007625 66 FSWSHVTCRN-------------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132 (595)
Q Consensus 66 ~~w~gv~c~~-------------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~ 132 (595)
|.|.|+ |+. .+++.|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 489888 863 279999999999998888899999999999999999998888999999999999999
Q ss_pred cccccCccccccccCCCCceecCCCCcCCc-cCchh---hhcccccccccccc
Q 007625 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTG-RIPMQ---LFSVATFNFTGTHL 181 (595)
Q Consensus 133 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~ip~~---l~~l~~l~~~~n~~ 181 (595)
+|++++..|..|+++++|++|+|++|++++ .+|.. +.+++.+++++|..
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~ 135 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSS
T ss_pred CCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCcc
Confidence 999998777779999999999999999985 35543 45678888888863
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-12 Score=138.98 Aligned_cols=108 Identities=23% Similarity=0.355 Sum_probs=91.1
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|++++ +| .+..+++|+.|+|++|.|++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|+
T Consensus 197 ~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 274 (452)
T 3zyi_A 197 NLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA 274 (452)
T ss_dssp TCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECC
Confidence 56777777787774 33 47888888999999999988788899999999999999999998888889999999999999
Q ss_pred CCcCCccCch----hhhccccccccccccccCCCC
Q 007625 157 SNNLTGRIPM----QLFSVATFNFTGTHLICGSSL 187 (595)
Q Consensus 157 ~N~l~g~ip~----~l~~l~~l~~~~n~~~~~~~~ 187 (595)
+|+|+ .+|. .+.++..+++++||+.|+|.+
T Consensus 275 ~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 275 HNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp SSCCS-CCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred CCcCC-ccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 99999 5554 345678899999999999874
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.2e-12 Score=134.61 Aligned_cols=113 Identities=21% Similarity=0.279 Sum_probs=96.2
Q ss_pred CCcceeEecC-------------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEec
Q 007625 66 FSWSHVTCRN-------------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132 (595)
Q Consensus 66 ~~w~gv~c~~-------------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~ 132 (595)
|.|.|+ |+. .+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 30 C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 30 CDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp ECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 588887 652 278999999999997666689999999999999999998778889999999999999
Q ss_pred cccccCccccccccCCCCceecCCCCcCCccCch-----hhhccccccccccc
Q 007625 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM-----QLFSVATFNFTGTH 180 (595)
Q Consensus 133 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~-----~l~~l~~l~~~~n~ 180 (595)
+|++++..+..+.++++|++|+|++|+++ .+|. .+.+++.+++++|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp SSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCc
Confidence 99999544445899999999999999999 6765 34577888888884
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.9e-13 Score=157.13 Aligned_cols=109 Identities=27% Similarity=0.359 Sum_probs=92.8
Q ss_pred CEEEEEcCCCCCC-----CCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCc
Q 007625 77 NVISLTLGSNGFS-----GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151 (595)
Q Consensus 77 ~l~~l~l~~n~l~-----g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 151 (595)
+++.|+|++|.++ +..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+. ++|+
T Consensus 452 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~ 529 (844)
T 3j0a_A 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLE 529 (844)
T ss_dssp TCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCC
T ss_pred ccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cccc
Confidence 5666667777665 33445688899999999999999988888899999999999999999966665555 8999
Q ss_pred eecCCCCcCCccCchhhhccccccccccccccCCCC
Q 007625 152 HLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSL 187 (595)
Q Consensus 152 ~l~l~~N~l~g~ip~~l~~l~~l~~~~n~~~~~~~~ 187 (595)
.|+|++|+|+|.+|..+.++..+++++||+.|+|+.
T Consensus 530 ~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 530 ILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp EEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred EEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 999999999999998899999999999999998874
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.7e-12 Score=140.21 Aligned_cols=103 Identities=23% Similarity=0.354 Sum_probs=91.4
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
.++.|+|++|+|++ +|. |++|++|+.|+|++|+|+ .+|..|++|++|++|+|++|+|++ +| .+++|++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 57889999999995 676 999999999999999999 899999999999999999999995 78 89999999999999
Q ss_pred CCcCCccC-chhh---hccccccccccccccC
Q 007625 157 SNNLTGRI-PMQL---FSVATFNFTGTHLICG 184 (595)
Q Consensus 157 ~N~l~g~i-p~~l---~~l~~l~~~~n~~~~~ 184 (595)
+|+|++.+ |..+ .+|..|++++|++...
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 99999765 8765 4567889999987443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4.7e-12 Score=128.94 Aligned_cols=125 Identities=20% Similarity=0.280 Sum_probs=101.7
Q ss_pred CCCCCCCCCCCC-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCcccc
Q 007625 54 FTDWNDHFVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG 121 (595)
Q Consensus 54 l~~w~~~~~~~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~ 121 (595)
+..|....+..| |.|+.+.|.. ..++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|+
T Consensus 18 i~~~~~~cp~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (330)
T 1xku_A 18 IEPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 97 (330)
T ss_dssp ----CCCCCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTT
T ss_pred cccccCCCCCCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhc
Confidence 345655444556 6899999973 3688999999999977777899999999999999999987799999
Q ss_pred CCCcccEEEeccccccCccccccccCCCCceecCCCCcCCccCchh---hhcccccccccccc
Q 007625 122 SMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ---LFSVATFNFTGTHL 181 (595)
Q Consensus 122 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~---l~~l~~l~~~~n~~ 181 (595)
++++|++|+|++|+++ .+|..+. ++|+.|++++|++++..+.. +.+++.+++++|..
T Consensus 98 ~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 157 (330)
T 1xku_A 98 PLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 157 (330)
T ss_dssp TCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCC
T ss_pred CCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcC
Confidence 9999999999999999 7887765 79999999999999544433 45677888888865
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.1e-12 Score=137.19 Aligned_cols=116 Identities=22% Similarity=0.344 Sum_probs=101.0
Q ss_pred CcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEecccc
Q 007625 67 SWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135 (595)
Q Consensus 67 ~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~ 135 (595)
.|..|.|.. .+++.|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 578999974 268899999999998888899999999999999999998889999999999999999999
Q ss_pred ccCccccccccCCCCceecCCCCcCCccCchhh---hccccccccccccc
Q 007625 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (595)
Q Consensus 136 l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l---~~l~~l~~~~n~~~ 182 (595)
+++..+..|.++++|++|+|++|++++..|..+ .+|+.|++++|...
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~ 141 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCC
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccc
Confidence 995555568999999999999999997666544 56788888888653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.1e-12 Score=130.44 Aligned_cols=123 Identities=22% Similarity=0.346 Sum_probs=100.3
Q ss_pred CCCCCCCCCC-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCC
Q 007625 56 DWNDHFVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSM 123 (595)
Q Consensus 56 ~w~~~~~~~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l 123 (595)
.|....+..| |.|..+.|.. .+++.|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++
T Consensus 22 ~~~~~cp~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 101 (332)
T 2ft3_A 22 TYSAMCPFGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL 101 (332)
T ss_dssp ---CCCCSSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTC
T ss_pred cccCCCCCCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCc
Confidence 3443334455 6899999974 268899999999997777789999999999999999998789999999
Q ss_pred CcccEEEeccccccCccccccccCCCCceecCCCCcCCccCchh----hhccccccccccccc
Q 007625 124 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHLI 182 (595)
Q Consensus 124 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~----l~~l~~l~~~~n~~~ 182 (595)
++|++|+|++|+++ .+|..+. ++|++|++++|+++ .+|.. +.+++.+++++|...
T Consensus 102 ~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~ 160 (332)
T 2ft3_A 102 RKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160 (332)
T ss_dssp TTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCB
T ss_pred CCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccc
Confidence 99999999999999 7887766 89999999999998 55542 456788888888763
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.4e-12 Score=131.34 Aligned_cols=119 Identities=27% Similarity=0.339 Sum_probs=98.5
Q ss_pred CCC-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccC--CCCCccccCCCcccE
Q 007625 63 SPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLS--GTLPDFLGSMTHLQS 128 (595)
Q Consensus 63 ~~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~--g~~p~~~~~l~~L~~ 128 (595)
..| |.|.+|.|.. .+++.|+|++|+++...+..|.++++|++|+|++|.++ |.+|..+..+++|++
T Consensus 3 ~~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 82 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82 (306)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCE
T ss_pred CCCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCE
Confidence 456 7999999974 26899999999999444445899999999999999998 334778888999999
Q ss_pred EEeccccccCccccccccCCCCceecCCCCcCCccCc-h---hhhccccccccccccc
Q 007625 129 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP-M---QLFSVATFNFTGTHLI 182 (595)
Q Consensus 129 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip-~---~l~~l~~l~~~~n~~~ 182 (595)
|+|++|.++ .+|..+.++++|++|+|++|++++..+ . .+.+++.+++++|...
T Consensus 83 L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~ 139 (306)
T 2z66_A 83 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 139 (306)
T ss_dssp EECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCE
T ss_pred EECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCC
Confidence 999999999 788889999999999999999985433 2 3456788888888653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.30 E-value=2.5e-12 Score=117.38 Aligned_cols=103 Identities=26% Similarity=0.272 Sum_probs=89.6
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCc-cccccccCCCCceec
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS-IPATWSQLSNLKHLD 154 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~l~ 154 (595)
.+++.|+|++|.|++. ..+..+++|++|+|++|.+++.+|..+.++++|++|+|++|+|++. .+..+.++++|+.|+
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~ 126 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEE
Confidence 4899999999999966 7899999999999999999988999998999999999999999953 227899999999999
Q ss_pred CCCCcCCccCch----h---hhcccccccccccc
Q 007625 155 LSSNNLTGRIPM----Q---LFSVATFNFTGTHL 181 (595)
Q Consensus 155 l~~N~l~g~ip~----~---l~~l~~l~~~~n~~ 181 (595)
|++|.+++ +|. . +.++..+++++|..
T Consensus 127 l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 127 LFNCEVTN-LNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp CCSSGGGT-STTHHHHHHTTCSSCCEETTEETTS
T ss_pred eeCCcCcc-hHHHHHHHHHhCccCcEecCCCCCh
Confidence 99999994 554 3 45677888888765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.29 E-value=6.8e-12 Score=124.15 Aligned_cols=103 Identities=26% Similarity=0.373 Sum_probs=61.4
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|.+++ + +.+.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..+.++++|++|+|+
T Consensus 64 ~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 141 (272)
T 3rfs_A 64 NVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLA 141 (272)
T ss_dssp TCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECC
Confidence 56666666666664 2 256666666666666666665555556666666666666666665555556666666666666
Q ss_pred CCcCCccCch---hhhcccccccccccc
Q 007625 157 SNNLTGRIPM---QLFSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~---~l~~l~~l~~~~n~~ 181 (595)
+|+|++..|. .+.++..|++++|..
T Consensus 142 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l 169 (272)
T 3rfs_A 142 HNQLQSLPKGVFDKLTNLTELDLSYNQL 169 (272)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCccCccCHHHhccCccCCEEECCCCCc
Confidence 6666633332 234455666666654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.29 E-value=2.4e-12 Score=114.94 Aligned_cols=88 Identities=31% Similarity=0.347 Sum_probs=79.9
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCc-cccccccCCCCceec
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS-IPATWSQLSNLKHLD 154 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~l~ 154 (595)
.+++.|+|++|.+++. ..+.++++|++|+|++|.+++.+|..++.+++|++|+|++|++++. .|..+.++++|+.|+
T Consensus 42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~ 119 (149)
T 2je0_A 42 EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119 (149)
T ss_dssp TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEE
T ss_pred CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEe
Confidence 4899999999999966 7799999999999999999988999999999999999999999963 458899999999999
Q ss_pred CCCCcCCccCc
Q 007625 155 LSSNNLTGRIP 165 (595)
Q Consensus 155 l~~N~l~g~ip 165 (595)
+++|.+++..+
T Consensus 120 l~~N~l~~~~~ 130 (149)
T 2je0_A 120 LFNCEVTNLND 130 (149)
T ss_dssp CTTCGGGGSTT
T ss_pred CcCCcccchHH
Confidence 99999995444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=4.7e-12 Score=125.47 Aligned_cols=106 Identities=22% Similarity=0.205 Sum_probs=91.2
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..+.++++|+.|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 68999999999997767789999999999999999997677789999999999999999997777889999999999999
Q ss_pred CCcCCccCch---hhhccccccccccccc
Q 007625 157 SNNLTGRIPM---QLFSVATFNFTGTHLI 182 (595)
Q Consensus 157 ~N~l~g~ip~---~l~~l~~l~~~~n~~~ 182 (595)
+|++++..+. .+.+++.|++++|...
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 137 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQ 137 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccc
Confidence 9999854443 3456788888888653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.28 E-value=6.7e-12 Score=138.58 Aligned_cols=126 Identities=15% Similarity=0.192 Sum_probs=70.9
Q ss_pred CCCCCCCCCCCCCC----CcceeEecC------------------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCC
Q 007625 53 QFTDWNDHFVSPCF----SWSHVTCRN------------------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDN 110 (595)
Q Consensus 53 ~l~~w~~~~~~~c~----~w~gv~c~~------------------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n 110 (595)
.+.+|... .+|| .|.++.|+. .+++.|++++|.+....+..|.++++|++|+|++|
T Consensus 8 ~l~~~~~~--~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n 85 (597)
T 3oja_B 8 NVKPRQPE--YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 85 (597)
T ss_dssp ---CCCSE--ECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTS
T ss_pred cccCCCCC--CcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCC
Confidence 46788765 4565 376665541 24455666666665333333555666666666666
Q ss_pred ccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcCCccCchh----hhcccccccccccc
Q 007625 111 DLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHL 181 (595)
Q Consensus 111 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~----l~~l~~l~~~~n~~ 181 (595)
.|++..|..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|.|+ .+|.. +.+|..|++++|..
T Consensus 86 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l 159 (597)
T 3oja_B 86 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL 159 (597)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcC
Confidence 666555556666666666666666666555555566666666666666666 44432 23455556666544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.27 E-value=6.5e-12 Score=120.13 Aligned_cols=112 Identities=24% Similarity=0.291 Sum_probs=99.3
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 135 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence 48999999999999888999999999999999999999544555789999999999999999888999999999999999
Q ss_pred CCCcCCccCchh---hhccccccccccccccCCCC
Q 007625 156 SSNNLTGRIPMQ---LFSVATFNFTGTHLICGSSL 187 (595)
Q Consensus 156 ~~N~l~g~ip~~---l~~l~~l~~~~n~~~~~~~~ 187 (595)
++|+|++..|.. +.++..+++++|++.|+|.+
T Consensus 136 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l 170 (220)
T 2v9t_B 136 YDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL 170 (220)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred CCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence 999999544433 45678899999999998754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.27 E-value=3.6e-12 Score=119.69 Aligned_cols=103 Identities=21% Similarity=0.255 Sum_probs=77.1
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|.++ . ++.+..+++|++|+|++|.+++..|..|+.+++|++|+|++|++++..|..+.++++|+.|+|+
T Consensus 67 ~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~ 144 (197)
T 4ezg_A 67 NIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144 (197)
T ss_dssp TCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred CCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence 6788888888665 2 3467788888888888888887777788888888888888888887777778888888888888
Q ss_pred CCcCCccCch--hhhcccccccccccc
Q 007625 157 SNNLTGRIPM--QLFSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~--~l~~l~~l~~~~n~~ 181 (595)
+|++.+.+|. .+.+++.+++++|..
T Consensus 145 ~n~~i~~~~~l~~l~~L~~L~l~~n~i 171 (197)
T 4ezg_A 145 YNGAITDIMPLKTLPELKSLNIQFDGV 171 (197)
T ss_dssp SCTBCCCCGGGGGCSSCCEEECTTBCC
T ss_pred CCCCccccHhhcCCCCCCEEECCCCCC
Confidence 8873336662 334567777777765
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.27 E-value=8.3e-12 Score=124.72 Aligned_cols=104 Identities=25% Similarity=0.291 Sum_probs=66.8
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+|+ .+|..+.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 156 (290)
T 1p9a_G 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (290)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECC
Confidence 5666666666666 566666667777777777777765445566677777777777777765444456666777777777
Q ss_pred CCcCCccCchh----hhccccccccccccc
Q 007625 157 SNNLTGRIPMQ----LFSVATFNFTGTHLI 182 (595)
Q Consensus 157 ~N~l~g~ip~~----l~~l~~l~~~~n~~~ 182 (595)
+|+|+ .+|.. +.++..+++++|...
T Consensus 157 ~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp TSCCS-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCcCC-ccCHHHhcCcCCCCEEECCCCcCC
Confidence 77776 45532 345566666666553
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.9e-12 Score=130.79 Aligned_cols=104 Identities=18% Similarity=0.228 Sum_probs=74.7
Q ss_pred CEEEEEcCCCCCCCCCCccc--cccCCCCeEEccCCccCCCCCccccCC-----CcccEEEeccccccCccccccccCCC
Q 007625 77 NVISLTLGSNGFSGKISPSI--TKLKFLASLELQDNDLSGTLPDFLGSM-----THLQSLNLANNKFSGSIPATWSQLSN 149 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~--~~l~~L~~L~l~~n~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~l~~ 149 (595)
+++.|+|++|++++.+|..+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|+|++..|..++++++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 67777777777777777765 7777777777777777755 7777766 77777777777777666677777777
Q ss_pred CceecCCCCcCCccC--c-----hhhhcccccccccccc
Q 007625 150 LKHLDLSSNNLTGRI--P-----MQLFSVATFNFTGTHL 181 (595)
Q Consensus 150 L~~l~l~~N~l~g~i--p-----~~l~~l~~l~~~~n~~ 181 (595)
|++|+|++|++.|.+ | ..+.+++.|++++|..
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l 213 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCC
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcC
Confidence 777777777776552 2 2345666777777654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=4e-12 Score=139.38 Aligned_cols=110 Identities=21% Similarity=0.303 Sum_probs=72.7
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccC-CCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLS-GTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
+++.|+|++|.+.+.+|..+.++++|++|+|++|.++ +.+|..+..+++|++|+|++|++++..|..+.++++|+.|+|
T Consensus 422 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 501 (570)
T 2z63_A 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501 (570)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeC
Confidence 5566666666666666666666677777777777665 456666777777777777777777666666777777777777
Q ss_pred CCCcCCccCchhh---hccccccccccccccCCC
Q 007625 156 SSNNLTGRIPMQL---FSVATFNFTGTHLICGSS 186 (595)
Q Consensus 156 ~~N~l~g~ip~~l---~~l~~l~~~~n~~~~~~~ 186 (595)
++|++++..|..+ .+++.+++++|++.|.|+
T Consensus 502 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 502 ASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 7777775444333 445666777777766654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=6.3e-12 Score=139.01 Aligned_cols=109 Identities=27% Similarity=0.316 Sum_probs=75.9
Q ss_pred CEEEEEcCCCCCCCC---CCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCcee
Q 007625 77 NVISLTLGSNGFSGK---ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 153 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~---~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l 153 (595)
+++.|+|++|.+++. .+..+..+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+.++++| .|
T Consensus 450 ~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L 528 (606)
T 3t6q_A 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL 528 (606)
T ss_dssp TCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EE
T ss_pred CCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EE
Confidence 566666666666542 22446666777777777777776667777777777777777777777777777777777 77
Q ss_pred cCCCCcCCccCchh---hhccccccccccccccCCC
Q 007625 154 DLSSNNLTGRIPMQ---LFSVATFNFTGTHLICGSS 186 (595)
Q Consensus 154 ~l~~N~l~g~ip~~---l~~l~~l~~~~n~~~~~~~ 186 (595)
+|++|++++..|.. +.+++.+++++||+.|.|+
T Consensus 529 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp ECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred ECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 77777777555543 3456778888888888764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=4.5e-12 Score=136.00 Aligned_cols=110 Identities=23% Similarity=0.329 Sum_probs=97.6
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+|++..+..|.++++|+.|+|++|.|++..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|+
T Consensus 225 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 304 (477)
T 2id5_A 225 NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304 (477)
T ss_dssp CCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECC
T ss_pred cccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECC
Confidence 68899999999995444679999999999999999998778889999999999999999998889999999999999999
Q ss_pred CCcCCccCchh----hhccccccccccccccCCCC
Q 007625 157 SNNLTGRIPMQ----LFSVATFNFTGTHLICGSSL 187 (595)
Q Consensus 157 ~N~l~g~ip~~----l~~l~~l~~~~n~~~~~~~~ 187 (595)
+|+|++ +|.. +.++..+++++|++.|+|..
T Consensus 305 ~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 305 GNQLTT-LEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp SSCCSC-CCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred CCcCce-eCHhHcCCCcccCEEEccCCCccCccch
Confidence 999994 5543 35788999999999999864
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.25 E-value=9.5e-12 Score=114.51 Aligned_cols=100 Identities=20% Similarity=0.236 Sum_probs=81.9
Q ss_pred CEEEEEcCCCCCCCCCCccccccC-CCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccc-cccCCCCceec
Q 007625 77 NVISLTLGSNGFSGKISPSITKLK-FLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKHLD 154 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~ 154 (595)
+++.|+|++|+++ .+|. +..+. +|++|+|++|.|++ + ..|+.+++|++|+|++|+|++ +|+. +..+++|+.|+
T Consensus 20 ~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 20 RDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELI 94 (176)
T ss_dssp SCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEE
T ss_pred CceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEEE
Confidence 7899999999998 4554 66665 99999999999995 4 678999999999999999994 5544 58999999999
Q ss_pred CCCCcCCccCch--hh---hccccccccccccc
Q 007625 155 LSSNNLTGRIPM--QL---FSVATFNFTGTHLI 182 (595)
Q Consensus 155 l~~N~l~g~ip~--~l---~~l~~l~~~~n~~~ 182 (595)
|++|+|+ .+|. .+ .++..+++++|+..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 9999996 6775 33 46778889998874
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.5e-12 Score=144.73 Aligned_cols=104 Identities=25% Similarity=0.365 Sum_probs=94.2
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+|+.|+|++|.|+ .+|..|++|++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+ .+|..|++|++|+.|+|
T Consensus 247 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 247 DFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 47999999999999 99999999999999999999999 89999999999999999999998 89999999999999999
Q ss_pred CCCcCCccCchhhhcc----ccccccccccc
Q 007625 156 SSNNLTGRIPMQLFSV----ATFNFTGTHLI 182 (595)
Q Consensus 156 ~~N~l~g~ip~~l~~l----~~l~~~~n~~~ 182 (595)
++|.|+|.+|..+..+ ..+++.+|.+.
T Consensus 324 ~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~ 354 (727)
T 4b8c_D 324 EGNPLEKQFLKILTEKSVTGLIFYLRDNRPE 354 (727)
T ss_dssp TTSCCCSHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred CCCccCCCChHHHhhcchhhhHHhhccCccc
Confidence 9999999999877543 23567777664
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.24 E-value=3.3e-12 Score=123.77 Aligned_cols=103 Identities=15% Similarity=0.191 Sum_probs=89.0
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCc-cCCCCCccccCCCcccEEEecc-ccccCccccccccCCCCcee
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDND-LSGTLPDFLGSMTHLQSLNLAN-NKFSGSIPATWSQLSNLKHL 153 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~-l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l 153 (595)
.+++.|+|++|++++..+..|.++++|++|+|++|. +++..+..|.++++|++|+|++ |+|++..+..|.++++|+.|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999997666789999999999999997 8855556899999999999999 99996666789999999999
Q ss_pred cCCCCcCCccCch--hhhccc---ccccccc
Q 007625 154 DLSSNNLTGRIPM--QLFSVA---TFNFTGT 179 (595)
Q Consensus 154 ~l~~N~l~g~ip~--~l~~l~---~l~~~~n 179 (595)
+|++|++++ +|. .+.+++ .+++++|
T Consensus 111 ~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N 140 (239)
T 2xwt_C 111 GIFNTGLKM-FPDLTKVYSTDIFFILEITDN 140 (239)
T ss_dssp EEEEECCCS-CCCCTTCCBCCSEEEEEEESC
T ss_pred eCCCCCCcc-ccccccccccccccEEECCCC
Confidence 999999995 885 344555 7888888
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.24 E-value=1e-11 Score=138.02 Aligned_cols=104 Identities=18% Similarity=0.322 Sum_probs=59.0
Q ss_pred CEEEEEcCCCCCCCCCCcccc--ccCCCCeEEccCCccCCCCCccccCCCcccEEEe------ccccccCccccccccCC
Q 007625 77 NVISLTLGSNGFSGKISPSIT--KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNL------ANNKFSGSIPATWSQLS 148 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~--~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l------~~N~l~g~~p~~~~~l~ 148 (595)
+++.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..++++++|++|+| ++|++.+.+|..+.+++
T Consensus 489 ~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~ 566 (636)
T 4eco_A 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566 (636)
T ss_dssp GCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred CccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence 4555566666555 4555554 55666666666666654 5555556666666655 34555555565565666
Q ss_pred CCceecCCCCcCCccCchhh-hcccccccccccccc
Q 007625 149 NLKHLDLSSNNLTGRIPMQL-FSVATFNFTGTHLIC 183 (595)
Q Consensus 149 ~L~~l~l~~N~l~g~ip~~l-~~l~~l~~~~n~~~~ 183 (595)
+|+.|+|++|+| +.||..+ .++..+++++|++.|
T Consensus 567 ~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 567 SLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNIS 601 (636)
T ss_dssp SCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCE
T ss_pred CCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcc
Confidence 666666666666 3555433 345555556655544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=113.75 Aligned_cols=90 Identities=22% Similarity=0.310 Sum_probs=80.6
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..+..+++|++|+|++|+|++..+..+.++++|+.|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 131 (177)
T 2o6r_A 52 TQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWL 131 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred ccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEe
Confidence 47999999999999766667899999999999999999777777899999999999999999555555788999999999
Q ss_pred CCCcCCccCc
Q 007625 156 SSNNLTGRIP 165 (595)
Q Consensus 156 ~~N~l~g~ip 165 (595)
++|.+++..|
T Consensus 132 ~~N~~~~~~~ 141 (177)
T 2o6r_A 132 HTNPWDCSCP 141 (177)
T ss_dssp CSSCBCCCHH
T ss_pred cCCCeeccCc
Confidence 9999998776
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-11 Score=137.03 Aligned_cols=106 Identities=19% Similarity=0.229 Sum_probs=79.3
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 33 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 112 (606)
T 3vq2_A 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112 (606)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECT
T ss_pred CcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEcc
Confidence 67788888888887666678888888888888888886667778888888888888888886667778888888888888
Q ss_pred CCcCCccCchh---hhccccccccccccc
Q 007625 157 SNNLTGRIPMQ---LFSVATFNFTGTHLI 182 (595)
Q Consensus 157 ~N~l~g~ip~~---l~~l~~l~~~~n~~~ 182 (595)
+|++++..|.. +.+++.|++++|...
T Consensus 113 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 141 (606)
T 3vq2_A 113 ETKLASLESFPIGQLITLKKLNVAHNFIH 141 (606)
T ss_dssp TSCCCCSSSSCCTTCTTCCEEECCSSCCC
T ss_pred CCccccccccccCCCCCCCEEeCCCCccc
Confidence 88877433333 345666777777653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.23 E-value=7.1e-12 Score=115.34 Aligned_cols=101 Identities=18% Similarity=0.220 Sum_probs=86.4
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCcccc--ccccCCCCceec
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA--TWSQLSNLKHLD 154 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~l~ 154 (595)
+++.|+|++|.|++. +.|.++++|++|+|++|.|++..|..++.+++|++|+|++|+|+ .+|. .+.++++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 799999999999965 67999999999999999999543444599999999999999997 7887 899999999999
Q ss_pred CCCCcCCccCchh----h---hcccccccccccc
Q 007625 155 LSSNNLTGRIPMQ----L---FSVATFNFTGTHL 181 (595)
Q Consensus 155 l~~N~l~g~ip~~----l---~~l~~l~~~~n~~ 181 (595)
|++|.++ .+|.. + .++..+++++|..
T Consensus 120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 9999998 67763 3 4567777777753
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=7.2e-12 Score=144.01 Aligned_cols=115 Identities=19% Similarity=0.188 Sum_probs=85.3
Q ss_pred CcceeEecCCCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCC-CccccCCCcccEEEeccccccCccccccc
Q 007625 67 SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL-PDFLGSMTHLQSLNLANNKFSGSIPATWS 145 (595)
Q Consensus 67 ~w~gv~c~~~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 145 (595)
.|..|.+...+++.|+|++|.|++..|..|.++++|++|+|++|.+.+.+ |..|++|++|++|+|++|+|++..|..|+
T Consensus 15 ~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~ 94 (844)
T 3j0a_A 15 NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94 (844)
T ss_dssp CSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred CCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence 67777774468888888888888777777888888888888887666666 66777778888888888877776777777
Q ss_pred cCCCCceecCCCCcCCccCchh-----hhcccccccccccc
Q 007625 146 QLSNLKHLDLSSNNLTGRIPMQ-----LFSVATFNFTGTHL 181 (595)
Q Consensus 146 ~l~~L~~l~l~~N~l~g~ip~~-----l~~l~~l~~~~n~~ 181 (595)
++++|++|+|++|.+++.+|.. +.+|+.|++++|..
T Consensus 95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l 135 (844)
T 3j0a_A 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135 (844)
T ss_dssp SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCC
T ss_pred CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcc
Confidence 7777777777777777666543 34556666666654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.5e-11 Score=115.05 Aligned_cols=90 Identities=24% Similarity=0.289 Sum_probs=81.6
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|.|++..+..|.+|++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 54 ~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 133 (193)
T 2wfh_A 54 KHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAI 133 (193)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEe
Confidence 48999999999999887888999999999999999999877888999999999999999999555556999999999999
Q ss_pred CCCcCCccCc
Q 007625 156 SSNNLTGRIP 165 (595)
Q Consensus 156 ~~N~l~g~ip 165 (595)
++|.+...-.
T Consensus 134 ~~N~~~C~c~ 143 (193)
T 2wfh_A 134 GANPLYCDCN 143 (193)
T ss_dssp CSSCEECSGG
T ss_pred CCCCeecCCc
Confidence 9999986443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-11 Score=122.12 Aligned_cols=105 Identities=24% Similarity=0.322 Sum_probs=80.5
Q ss_pred CCEEEEEcCCCC-CCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceec
Q 007625 76 GNVISLTLGSNG-FSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (595)
Q Consensus 76 ~~l~~l~l~~n~-l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (595)
.+++.|+|++|. +....|..|.++++|++|+|++|.+++..|..+.++++|++|+|++|++++..+..+.++++|+.|+
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 159 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence 368888888887 6655577788888888888888888877777788888888888888888865556678888888888
Q ss_pred CCCCcCCccCch-h---hhcccccccccccc
Q 007625 155 LSSNNLTGRIPM-Q---LFSVATFNFTGTHL 181 (595)
Q Consensus 155 l~~N~l~g~ip~-~---l~~l~~l~~~~n~~ 181 (595)
|++|+++ .+|. . +.+++.+++++|..
T Consensus 160 l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l 189 (285)
T 1ozn_A 160 LHGNRIS-SVPERAFRGLHSLDRLLLHQNRV 189 (285)
T ss_dssp CCSSCCC-EECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCccc-ccCHHHhcCccccCEEECCCCcc
Confidence 8888888 4443 2 34667777887764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.2e-11 Score=135.69 Aligned_cols=108 Identities=24% Similarity=0.357 Sum_probs=63.6
Q ss_pred CEEEEEcCCCCCCC--CCCccccccCCCCeEEccCCccCCCCCcc-ccCC----------------------CcccEEEe
Q 007625 77 NVISLTLGSNGFSG--KISPSITKLKFLASLELQDNDLSGTLPDF-LGSM----------------------THLQSLNL 131 (595)
Q Consensus 77 ~l~~l~l~~n~l~g--~~~~~~~~l~~L~~L~l~~n~l~g~~p~~-~~~l----------------------~~L~~L~l 131 (595)
+++.|+|++|++++ .+|..+.++++|++|+|++|.+++.+|.. +..+ ++|++|+|
T Consensus 378 ~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~~L~~L~L 457 (562)
T 3a79_B 378 RLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDL 457 (562)
T ss_dssp SCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCCTTCSEEEC
T ss_pred CCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhcCcCCEEEC
Confidence 45556666666554 22344555555555555555555434432 3333 45666666
Q ss_pred ccccccCccccccccCCCCceecCCCCcCCccCchh-h---hccccccccccccccCCC
Q 007625 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-L---FSVATFNFTGTHLICGSS 186 (595)
Q Consensus 132 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~-l---~~l~~l~~~~n~~~~~~~ 186 (595)
++|+|+ .+|..+.++++|+.|+|++|+|+ .+|.. + .+++.+++++|++.|+|+
T Consensus 458 ~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 458 HNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 666666 56666666777777777777777 56654 2 345666777777777654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.4e-11 Score=134.47 Aligned_cols=87 Identities=26% Similarity=0.332 Sum_probs=81.8
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCcc-ccccccCCCCceec
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI-PATWSQLSNLKHLD 154 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~l~ 154 (595)
.+++.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .|++|++|++|+|++|+|++.+ |..+++|++|+.|+
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 48999999999999 899999999999999999999996 88 8999999999999999999776 99999999999999
Q ss_pred CCCCcCCccCc
Q 007625 155 LSSNNLTGRIP 165 (595)
Q Consensus 155 l~~N~l~g~ip 165 (595)
|++|+|++..|
T Consensus 540 L~~N~l~~~~~ 550 (567)
T 1dce_A 540 LQGNSLCQEEG 550 (567)
T ss_dssp CTTSGGGGSSS
T ss_pred ecCCcCCCCcc
Confidence 99999996554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.1e-11 Score=134.40 Aligned_cols=87 Identities=29% Similarity=0.342 Sum_probs=47.6
Q ss_pred CEEEEEcCCCCCCC--CCCccccccCCCCeEEccCCccCCCCCcc-ccCCCcccEEEeccccccCccccccccCCCCcee
Q 007625 77 NVISLTLGSNGFSG--KISPSITKLKFLASLELQDNDLSGTLPDF-LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 153 (595)
Q Consensus 77 ~l~~l~l~~n~l~g--~~~~~~~~l~~L~~L~l~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l 153 (595)
+++.|+|++|++++ .+|..+.++++|++|+|++|.+++.+|.. +..+++|++|+|++|++++.+|..+. ++|+.|
T Consensus 349 ~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L 426 (520)
T 2z7x_B 349 ELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVL 426 (520)
T ss_dssp SCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEE
T ss_pred CCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEE
Confidence 56666666666665 44455666666666666666666545543 45555555555555555444444332 344444
Q ss_pred cCCCCcCCccCch
Q 007625 154 DLSSNNLTGRIPM 166 (595)
Q Consensus 154 ~l~~N~l~g~ip~ 166 (595)
+|++|+|+ .+|.
T Consensus 427 ~Ls~N~l~-~ip~ 438 (520)
T 2z7x_B 427 DLHSNKIK-SIPK 438 (520)
T ss_dssp ECCSSCCC-CCCG
T ss_pred ECCCCccc-ccch
Confidence 44444444 4443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=4.1e-11 Score=117.69 Aligned_cols=146 Identities=16% Similarity=0.134 Sum_probs=112.9
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEE
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 345 (595)
....+.|+....++.|+.+.||++.. ++..+++|+...... .....+.+|+.+++.+. +..+.++++++...+..++
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 33456788888888899999999986 468999999864211 12345788999999884 6678889999988888999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--------------------------------- 392 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------- 392 (595)
||||++|.++.+.+.. ......++.+++.+|+.||+..
T Consensus 88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999998766321 1123478889999999999810
Q ss_pred -----------------------CCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 393 -----------------------NPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 393 -----------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876566799999864
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.6e-11 Score=116.73 Aligned_cols=109 Identities=28% Similarity=0.393 Sum_probs=96.9
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|
T Consensus 64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 142 (229)
T 3e6j_A 64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEEC
T ss_pred cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEEC
Confidence 48999999999998655567899999999999999999766677899999999999999999 89999999999999999
Q ss_pred CCCcCCccCch----hhhccccccccccccccCCC
Q 007625 156 SSNNLTGRIPM----QLFSVATFNFTGTHLICGSS 186 (595)
Q Consensus 156 ~~N~l~g~ip~----~l~~l~~l~~~~n~~~~~~~ 186 (595)
++|+|+ .+|. .+.++..+++++|++.|.|+
T Consensus 143 ~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 143 DQNQLK-SIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCC-CCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCCcCC-ccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 999999 5553 34577889999999999874
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.21 E-value=5.1e-12 Score=131.83 Aligned_cols=101 Identities=20% Similarity=0.268 Sum_probs=77.3
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|++++. +.+.++++|++|+|++|.+++..|..|..+++|++|+|++|+++ .+|..+..+++|+.|+|+
T Consensus 227 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~ 303 (390)
T 3o6n_A 227 ELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 303 (390)
T ss_dssp SCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECC
T ss_pred cccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECC
Confidence 678888888888753 46788888888888888888777888888888888888888887 567677778888888888
Q ss_pred CCcCCccCchhh---hcccccccccccc
Q 007625 157 SNNLTGRIPMQL---FSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~~l---~~l~~l~~~~n~~ 181 (595)
+|+++ .+|..+ .+++.+++++|+.
T Consensus 304 ~n~l~-~~~~~~~~l~~L~~L~L~~N~i 330 (390)
T 3o6n_A 304 HNHLL-HVERNQPQFDRLENLYLDHNSI 330 (390)
T ss_dssp SSCCC-CCGGGHHHHTTCSEEECCSSCC
T ss_pred CCcce-ecCccccccCcCCEEECCCCcc
Confidence 88887 566543 4566777777765
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.3e-11 Score=136.61 Aligned_cols=116 Identities=17% Similarity=0.164 Sum_probs=101.4
Q ss_pred cceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccc
Q 007625 68 WSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136 (595)
Q Consensus 68 w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l 136 (595)
+..+.|.. ..++.|+|++|.|++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 56688853 3789999999999988888999999999999999999988899999999999999999999
Q ss_pred cCccccccccCCCCceecCCCCcCCccCch---hhhcccccccccccccc
Q 007625 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPM---QLFSVATFNFTGTHLIC 183 (595)
Q Consensus 137 ~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~---~l~~l~~l~~~~n~~~~ 183 (595)
++..|..|+++++|++|+|++|++++..|. .+.+++.+++++|....
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~ 143 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCC
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccc
Confidence 988899999999999999999999954343 34567888899987644
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.8e-11 Score=124.62 Aligned_cols=101 Identities=18% Similarity=0.308 Sum_probs=58.2
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+++ .+|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..+..+++|+.|+|+
T Consensus 172 ~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 248 (330)
T 1xku_A 172 KLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248 (330)
T ss_dssp TCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred CcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECC
Confidence 5566666666665 3444333 556666666666665555566666666666666666665444556666666666666
Q ss_pred CCcCCccCchhh---hcccccccccccc
Q 007625 157 SNNLTGRIPMQL---FSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~~l---~~l~~l~~~~n~~ 181 (595)
+|+|+ .+|..+ .++..+++++|+.
T Consensus 249 ~N~l~-~lp~~l~~l~~L~~L~l~~N~i 275 (330)
T 1xku_A 249 NNKLV-KVPGGLADHKYIQVVYLHNNNI 275 (330)
T ss_dssp SSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred CCcCc-cCChhhccCCCcCEEECCCCcC
Confidence 66666 555543 2344555565554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.6e-11 Score=116.13 Aligned_cols=111 Identities=23% Similarity=0.293 Sum_probs=96.2
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+.++++|+.|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 131 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRL 131 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEEC
Confidence 48999999999999666667899999999999999999666667899999999999999999766667899999999999
Q ss_pred CCCcCCccCch---hhhccccccccccccccCCC
Q 007625 156 SSNNLTGRIPM---QLFSVATFNFTGTHLICGSS 186 (595)
Q Consensus 156 ~~N~l~g~ip~---~l~~l~~l~~~~n~~~~~~~ 186 (595)
++|+|++..+. .+.++..+++++|++.|.++
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 99999954333 24578899999999998875
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.19 E-value=4.5e-12 Score=137.91 Aligned_cols=115 Identities=25% Similarity=0.398 Sum_probs=89.8
Q ss_pred CCCCCCCCCCCC----Cccee-EecCCCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEE
Q 007625 55 TDWNDHFVSPCF----SWSHV-TCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSL 129 (595)
Q Consensus 55 ~~w~~~~~~~c~----~w~gv-~c~~~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L 129 (595)
.+|..+ ..+|. .|.|+ .|..++++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|
T Consensus 34 ~~W~~~-~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L 105 (571)
T 3cvr_A 34 DKWEKQ-ALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYL 105 (571)
T ss_dssp HHHHTT-CCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEE
T ss_pred HHHhcc-CCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEE
Confidence 356442 34562 59999 7887899999999999996 777664 78999999999998 788 457888889
Q ss_pred EeccccccCccccccccCCCCceecCCCCcCCccCchhhhccccccccccccc
Q 007625 130 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLI 182 (595)
Q Consensus 130 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l~~l~~l~~~~n~~~ 182 (595)
+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|..+.+|..|++++|...
T Consensus 106 ~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~l~ 153 (571)
T 3cvr_A 106 DACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPELPALLEYINADNNQLT 153 (571)
T ss_dssp ECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS
T ss_pred EccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCCcCccccEEeCCCCccC
Confidence 999888885 777 655 88888888888885 7776667788888887654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=2.8e-11 Score=119.89 Aligned_cols=105 Identities=15% Similarity=0.244 Sum_probs=67.4
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..+.++++|++|+|+
T Consensus 53 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 132 (276)
T 2z62_A 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132 (276)
T ss_dssp TCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred CCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECc
Confidence 56677777777765555566677777777777777765555666677777777777777665444456666777777777
Q ss_pred CCcCCc-cCchhh---hcccccccccccc
Q 007625 157 SNNLTG-RIPMQL---FSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g-~ip~~l---~~l~~l~~~~n~~ 181 (595)
+|++++ .+|..+ .+++.+++++|..
T Consensus 133 ~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l 161 (276)
T 2z62_A 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (276)
T ss_dssp SSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCccceecCchhhccCCCCCEEECCCCCC
Confidence 777664 245443 3455566666644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=3.2e-11 Score=135.28 Aligned_cols=106 Identities=25% Similarity=0.286 Sum_probs=81.5
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|+++++|++|+|+
T Consensus 26 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~ 105 (680)
T 1ziw_A 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105 (680)
T ss_dssp TCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred CCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECC
Confidence 68888888888887666778888888888888888887778888888888888888888884433468888888888888
Q ss_pred CCcCCccCchh---hhccccccccccccc
Q 007625 157 SNNLTGRIPMQ---LFSVATFNFTGTHLI 182 (595)
Q Consensus 157 ~N~l~g~ip~~---l~~l~~l~~~~n~~~ 182 (595)
+|++++..|.. +.+++.+++++|...
T Consensus 106 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 134 (680)
T 1ziw_A 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLS 134 (680)
T ss_dssp SSCCCCCCSCTTTTCTTCCEEECCSSCCS
T ss_pred CCccCccChhHccccCCCCEEECCCCccc
Confidence 88887443343 345677777777653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=2.7e-11 Score=135.89 Aligned_cols=110 Identities=17% Similarity=0.240 Sum_probs=76.4
Q ss_pred CEEEEEcCCCCCCCCCC--------ccccccCCCCeEEccCCccCCCCCc-cccCCCcccEEEeccccccCccccccccC
Q 007625 77 NVISLTLGSNGFSGKIS--------PSITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPATWSQL 147 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~--------~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l 147 (595)
+++.|+|++|.+++..+ ..|.++++|++|+|++|+|+ .+|. .|.++++|+.|+|++|+|++..+..|.++
T Consensus 505 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l 583 (680)
T 1ziw_A 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQ 583 (680)
T ss_dssp TCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred ccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCC
Confidence 45555555555543211 12556666666666666666 4554 57888888888888888885555557788
Q ss_pred CCCceecCCCCcCCccCch----hhhccccccccccccccCCCC
Q 007625 148 SNLKHLDLSSNNLTGRIPM----QLFSVATFNFTGTHLICGSSL 187 (595)
Q Consensus 148 ~~L~~l~l~~N~l~g~ip~----~l~~l~~l~~~~n~~~~~~~~ 187 (595)
++|+.|+|++|+|++..|. .+.++..+++++|||.|+|+.
T Consensus 584 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 584 VSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred CCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 8888888888888865554 345788899999999999864
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.19 E-value=2.7e-11 Score=124.16 Aligned_cols=110 Identities=23% Similarity=0.181 Sum_probs=87.5
Q ss_pred CCEEEEEcCC-CCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceec
Q 007625 76 GNVISLTLGS-NGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (595)
Q Consensus 76 ~~l~~l~l~~-n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (595)
.+|+.|+|++ |.|++..+..|.+|++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++..|..+..++ |+.|+
T Consensus 31 ~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~ 109 (347)
T 2ifg_A 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELV 109 (347)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEE
T ss_pred CCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEE
Confidence 3799999996 999987778899999999999999999998899999999999999999999954444555555 99999
Q ss_pred CCCCcCCccCch-hhh---ccccccccccccccCCC
Q 007625 155 LSSNNLTGRIPM-QLF---SVATFNFTGTHLICGSS 186 (595)
Q Consensus 155 l~~N~l~g~ip~-~l~---~l~~l~~~~n~~~~~~~ 186 (595)
|++|.|...-.. .+. ......+..+...|..+
T Consensus 110 l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~ 145 (347)
T 2ifg_A 110 LSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ 145 (347)
T ss_dssp CCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred eeCCCccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence 999999854331 121 22334455667777654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.9e-11 Score=114.61 Aligned_cols=101 Identities=14% Similarity=0.218 Sum_probs=83.1
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+++ .+| .+..+++|++|+|++|.++ .+..+..+++|++|+|++|++++..|..++++++|++|+|+
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 6888999999888 666 6888899999999999765 34578889999999999999988788888899999999999
Q ss_pred CCcCCccCchhh---hcccccccccccc
Q 007625 157 SNNLTGRIPMQL---FSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~~l---~~l~~l~~~~n~~ 181 (595)
+|++++..|..+ .+++.|++++|..
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~ 148 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGA 148 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTB
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCC
Confidence 999987677654 4567788888873
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.9e-11 Score=127.53 Aligned_cols=105 Identities=17% Similarity=0.222 Sum_probs=86.1
Q ss_pred CCEEEEEcCCCCCCCCCCc-cccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceec
Q 007625 76 GNVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~-~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (595)
.+++.|++++|.+. .+|+ .+.++++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..++++++|++|+
T Consensus 45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 36778899999888 4554 478899999999999999876677889999999999999999977777788999999999
Q ss_pred CCCCcCCccCchh----hhccccccccccccc
Q 007625 155 LSSNNLTGRIPMQ----LFSVATFNFTGTHLI 182 (595)
Q Consensus 155 l~~N~l~g~ip~~----l~~l~~l~~~~n~~~ 182 (595)
|++|+++ .+|.. +.+++.+++++|...
T Consensus 124 L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~ 154 (390)
T 3o6n_A 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 154 (390)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCccC-cCCHHHhcCCCCCcEEECCCCccC
Confidence 9999998 67754 356788888888653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.18 E-value=8.3e-12 Score=142.19 Aligned_cols=106 Identities=25% Similarity=0.416 Sum_probs=96.9
Q ss_pred CCEEEEEcCCCCCCC-----------------CCCcccc--ccCCCCeEEccCCccCCCCCccccCCCcccEEEecccc-
Q 007625 76 GNVISLTLGSNGFSG-----------------KISPSIT--KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK- 135 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g-----------------~~~~~~~--~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~- 135 (595)
.+++.|+|++|.|+| .+|+.++ +|++|++|+|++|++.|.+|..|++|++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 589999999999998 4999988 99999999999999999999999999999999999998
Q ss_pred ccC-ccccccccCC-------CCceecCCCCcCCccCch--hh---hccccccccccccc
Q 007625 136 FSG-SIPATWSQLS-------NLKHLDLSSNNLTGRIPM--QL---FSVATFNFTGTHLI 182 (595)
Q Consensus 136 l~g-~~p~~~~~l~-------~L~~l~l~~N~l~g~ip~--~l---~~l~~l~~~~n~~~ 182 (595)
|+| .+|..+++++ +|+.|+|++|+|+ .+|. .+ .+|..|++++|...
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~ 586 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR 586 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc
Confidence 999 8999888776 9999999999999 9998 55 45678889999765
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.17 E-value=2.1e-11 Score=124.28 Aligned_cols=84 Identities=27% Similarity=0.314 Sum_probs=44.2
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|.+++..+..|.++++|+.|+|++|.+++..|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus 194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~ 272 (332)
T 2ft3_A 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272 (332)
T ss_dssp SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECC
T ss_pred CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECC
Confidence 4445555555555444445555555555555555555444445555555555555555555 455555555555555555
Q ss_pred CCcCC
Q 007625 157 SNNLT 161 (595)
Q Consensus 157 ~N~l~ 161 (595)
+|+|+
T Consensus 273 ~N~l~ 277 (332)
T 2ft3_A 273 TNNIT 277 (332)
T ss_dssp SSCCC
T ss_pred CCCCC
Confidence 55555
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=2.7e-11 Score=131.34 Aligned_cols=107 Identities=23% Similarity=0.260 Sum_probs=88.0
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCC--CCCccccCCCcccEEEeccccccCccccc-cccCCCCce
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG--TLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKH 152 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~ 152 (595)
.+++.|+|++|.+++.+|..+.++++|++|+|++|++++ .+|..++.+++|++|+|++|++++.+|.. +..+++|+.
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~ 403 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence 478888888888888888888888888888888888886 56677888888888888888888767765 778888888
Q ss_pred ecCCCCcCCccCchhh-hccccccccccccc
Q 007625 153 LDLSSNNLTGRIPMQL-FSVATFNFTGTHLI 182 (595)
Q Consensus 153 l~l~~N~l~g~ip~~l-~~l~~l~~~~n~~~ 182 (595)
|+|++|++++.+|..+ .++..+++++|...
T Consensus 404 L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 404 LNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434 (520)
T ss_dssp EECCSSCCCGGGGGSCCTTCCEEECCSSCCC
T ss_pred EECcCCCCCcchhhhhcccCCEEECCCCccc
Confidence 8888888888888777 47888888888664
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.5e-11 Score=124.10 Aligned_cols=105 Identities=21% Similarity=0.307 Sum_probs=84.7
Q ss_pred CCEEEEEcCCCCCCCC--CC--ccccccCCCCeEEccCCccCCCCCc----cccCCCcccEEEeccccccCccccccccC
Q 007625 76 GNVISLTLGSNGFSGK--IS--PSITKLKFLASLELQDNDLSGTLPD----FLGSMTHLQSLNLANNKFSGSIPATWSQL 147 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~--~~--~~~~~l~~L~~L~l~~n~l~g~~p~----~~~~l~~L~~L~l~~N~l~g~~p~~~~~l 147 (595)
.+++.|+|++|++.+. ++ ..++++++|++|+|++|+|+ .+|. .++++++|++|||++|+|++.+|..+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 4799999999998753 32 23478899999999999997 4554 25788999999999999998878888777
Q ss_pred ---CCCceecCCCCcCCccCchhh-hccccccccccccc
Q 007625 148 ---SNLKHLDLSSNNLTGRIPMQL-FSVATFNFTGTHLI 182 (595)
Q Consensus 148 ---~~L~~l~l~~N~l~g~ip~~l-~~l~~l~~~~n~~~ 182 (595)
++|++|+|++|+|+ .+|..+ .+++.|++++|...
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~ 285 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLN 285 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCC
T ss_pred cCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCC
Confidence 68999999999999 788765 47888899988765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=4.5e-11 Score=120.60 Aligned_cols=105 Identities=19% Similarity=0.161 Sum_probs=77.1
Q ss_pred CEEEEEcCCCCCCCCCCccc--cccCCCCeEEccCCccCCCCC----ccccCCCcccEEEeccccccCccccccccCCCC
Q 007625 77 NVISLTLGSNGFSGKISPSI--TKLKFLASLELQDNDLSGTLP----DFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 150 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~--~~l~~L~~L~l~~n~l~g~~p----~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 150 (595)
+++.|+|++|.+++.+|..+ .++++|++|+|++|.+++..| ..+..+++|++|+|++|++++..|..++++++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 47888888888888888777 778888888888888887655 344567788888888888877677777788888
Q ss_pred ceecCCCCcCCcc--Cc-----hhhhcccccccccccc
Q 007625 151 KHLDLSSNNLTGR--IP-----MQLFSVATFNFTGTHL 181 (595)
Q Consensus 151 ~~l~l~~N~l~g~--ip-----~~l~~l~~l~~~~n~~ 181 (595)
++|+|++|++.+. +| ..+.+++.|++++|..
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 209 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGM 209 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCC
Confidence 8888888877642 21 2345667777777754
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.15 E-value=6.3e-11 Score=130.75 Aligned_cols=107 Identities=18% Similarity=0.162 Sum_probs=84.6
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|.|++..|..|+++++|++|+|++|.|++..|..|+++++|++|+|++|+|++..+..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 37888888888888777778888888888888888888777777888888888888888888444444688888888888
Q ss_pred CCCcCCccCchhh---hccccccccccccc
Q 007625 156 SSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (595)
Q Consensus 156 ~~N~l~g~ip~~l---~~l~~l~~~~n~~~ 182 (595)
++|.|++..|..+ .+|..|++++|...
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence 8888886666544 45677788887653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=5.2e-11 Score=129.93 Aligned_cols=106 Identities=20% Similarity=0.244 Sum_probs=65.7
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccc------------------cCCCcccEEEeccccccC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL------------------GSMTHLQSLNLANNKFSG 138 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~------------------~~l~~L~~L~l~~N~l~g 138 (595)
+++.|+|++|+|+ .+|..+..+++|++|+|++|.|+ .+|..+ ..+++|++|+|++|+|+
T Consensus 388 ~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~- 464 (549)
T 2z81_A 388 NLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK- 464 (549)
T ss_dssp TCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-
T ss_pred CCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-
Confidence 5666666666666 55656666666666666666655 233221 25666677777777776
Q ss_pred ccccccccCCCCceecCCCCcCCccCchhh---hccccccccccccccCCC
Q 007625 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLICGSS 186 (595)
Q Consensus 139 ~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l---~~l~~l~~~~n~~~~~~~ 186 (595)
.+|. ...+++|+.|+|++|+|++.+|..+ .+++.+++++|++.|.|+
T Consensus 465 ~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 465 TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 5665 4567777777777777776555433 455667777777777654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.6e-11 Score=124.12 Aligned_cols=107 Identities=14% Similarity=0.184 Sum_probs=91.8
Q ss_pred CCEEEEEcCCCCCCCCCCcccccc-----CCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCc--ccccc--cc
Q 007625 76 GNVISLTLGSNGFSGKISPSITKL-----KFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS--IPATW--SQ 146 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l-----~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~~--~~ 146 (595)
.+++.|+|++|++++. |..++++ ++|++|+|++|+|++..|..|+++++|++|+|++|++.|. +|..+ .+
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence 4899999999999977 8888888 9999999999999988889999999999999999999876 45555 89
Q ss_pred CCCCceecCCCCcCCc--cCchhh----hcccccccccccccc
Q 007625 147 LSNLKHLDLSSNNLTG--RIPMQL----FSVATFNFTGTHLIC 183 (595)
Q Consensus 147 l~~L~~l~l~~N~l~g--~ip~~l----~~l~~l~~~~n~~~~ 183 (595)
+++|+.|+|++|+|++ .+|..+ .+++.|++++|....
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 242 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCS
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCc
Confidence 9999999999999983 344333 588999999997644
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.13 E-value=4.4e-11 Score=121.05 Aligned_cols=104 Identities=22% Similarity=0.188 Sum_probs=73.4
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCcccc-CCCcccEEEeccccccCccccccccCCCCceec
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG-SMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (595)
.+++.|+|++|++++..+..+..+++|++|+|++|.+++..|..+. .+++|++|+|++|+|+ .+|. ...+++|+.|+
T Consensus 120 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~-~~~l~~L~~L~ 197 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLD 197 (317)
T ss_dssp SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC-EEEC-CCCCTTCCEEE
T ss_pred CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc-cccc-ccccccCCEEE
Confidence 3678888888888876676788888888888888888866666653 6777888888887777 3343 33477777777
Q ss_pred CCCCcCCccCchhh---hccccccccccccc
Q 007625 155 LSSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (595)
Q Consensus 155 l~~N~l~g~ip~~l---~~l~~l~~~~n~~~ 182 (595)
|++|+|+ .+|..+ .+++.+++++|...
T Consensus 198 Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 198 LSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp CCSSCCC-EECGGGGGGTTCSEEECTTSCCC
T ss_pred CCCCcCC-cchhhhcccCcccEEECcCCccc
Confidence 7777777 455433 45566777777654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.12 E-value=5.4e-11 Score=130.30 Aligned_cols=107 Identities=23% Similarity=0.298 Sum_probs=94.8
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCC--CCCccccCCCcccEEEeccccccCccccc-cccCCCCce
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG--TLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKH 152 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~ 152 (595)
.+++.|+|++|.+++.+|..+.++++|++|+|++|++++ .+|..++++++|++|+|++|++++.+|.. +..+++|+.
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~ 432 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence 479999999999999899999999999999999999996 34567899999999999999999867765 788999999
Q ss_pred ecCCCCcCCccCchhh-hccccccccccccc
Q 007625 153 LDLSSNNLTGRIPMQL-FSVATFNFTGTHLI 182 (595)
Q Consensus 153 l~l~~N~l~g~ip~~l-~~l~~l~~~~n~~~ 182 (595)
|+|++|+|++.+|..+ .++..+++++|...
T Consensus 433 L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~ 463 (562)
T 3a79_B 433 LNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM 463 (562)
T ss_dssp EECCSSCCCGGGGSSCCTTCSEEECCSSCCC
T ss_pred EECCCCCCCcchhhhhcCcCCEEECCCCcCc
Confidence 9999999999888888 58999999999764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=1e-11 Score=127.74 Aligned_cols=108 Identities=16% Similarity=0.242 Sum_probs=62.6
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCcc-ccCCCcccEEEeccccccCc----------------
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDF-LGSMTHLQSLNLANNKFSGS---------------- 139 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~---------------- 139 (595)
+++.|+|++|++++..|..+.++++|++|+|++|.++ .+|.. +..+++|+.|+|++|++++.
T Consensus 175 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~ 253 (353)
T 2z80_A 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253 (353)
T ss_dssp EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCE
T ss_pred CCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccccccchhhc
Confidence 3444555555554444444555555555555555544 23322 22355566666666666542
Q ss_pred ---------------cccccccCCCCceecCCCCcCCccCchhh----hccccccccccccccCCC
Q 007625 140 ---------------IPATWSQLSNLKHLDLSSNNLTGRIPMQL----FSVATFNFTGTHLICGSS 186 (595)
Q Consensus 140 ---------------~p~~~~~l~~L~~l~l~~N~l~g~ip~~l----~~l~~l~~~~n~~~~~~~ 186 (595)
+|..+.++++|+.|+|++|+|+ .+|..+ .+++.+++++|++.|.|+
T Consensus 254 l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 254 FTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp EEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 3444567778888888888887 677543 456777788888877764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=1e-10 Score=114.39 Aligned_cols=128 Identities=14% Similarity=0.042 Sum_probs=96.4
Q ss_pred eeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCC--CccccceeecCCceEEEEEecccCcHhh
Q 007625 280 GQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGYCTTSSERILVYPFMQNLSVAY 357 (595)
Q Consensus 280 G~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~ 357 (595)
+.|..+.||++...+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++++....+..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 455669999998777888999997542 2245678999988886545 455888888777889999999998873
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 007625 358 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--------------------------------------------- 392 (595)
Q Consensus 358 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------------- 392 (595)
... .+ ...++.+++..|..||+..
T Consensus 104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 2356778888888888742
Q ss_pred ----------CCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 393 ----------NPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 393 ----------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
.+.++|+|++|.||+++++..+.|+|||.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999875
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.07 E-value=8.2e-11 Score=126.39 Aligned_cols=103 Identities=21% Similarity=0.180 Sum_probs=63.2
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCc----------------cccCCCcccEEEeccccccCcc
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD----------------FLGSMTHLQSLNLANNKFSGSI 140 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~----------------~~~~l~~L~~L~l~~N~l~g~~ 140 (595)
+++.|+|++|.+++.+| |..+++|++|+|++|.|++..+. ....+++|+.|+|++|+|++..
T Consensus 59 ~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~~ 136 (487)
T 3oja_A 59 KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLR 136 (487)
T ss_dssp TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCSGG
T ss_pred CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCCCC
Confidence 56666666666665443 66666666666655555421110 0112455666666666666666
Q ss_pred ccccccCCCCceecCCCCcCCccCchhh----hcccccccccccc
Q 007625 141 PATWSQLSNLKHLDLSSNNLTGRIPMQL----FSVATFNFTGTHL 181 (595)
Q Consensus 141 p~~~~~l~~L~~l~l~~N~l~g~ip~~l----~~l~~l~~~~n~~ 181 (595)
|..++++++|+.|+|++|.|++.+|..+ .++..|++++|..
T Consensus 137 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp GBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred chhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 6677777778888888888777666544 4567777777764
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.06 E-value=3.6e-12 Score=119.78 Aligned_cols=105 Identities=22% Similarity=0.266 Sum_probs=90.3
Q ss_pred CCCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceec
Q 007625 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (595)
Q Consensus 75 ~~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (595)
..+++.|+|++|++++ +| .+.++++|++|+|++|.|+ .+|..+..+++|++|+|++|+|++ +| .+.++++|+.|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 3589999999999996 77 8999999999999999999 789988889999999999999995 66 688999999999
Q ss_pred CCCCcCCccCch-----hhhccccccccccccccCC
Q 007625 155 LSSNNLTGRIPM-----QLFSVATFNFTGTHLICGS 185 (595)
Q Consensus 155 l~~N~l~g~ip~-----~l~~l~~l~~~~n~~~~~~ 185 (595)
|++|+++ .+|. .+.++..+++++|++.+.+
T Consensus 122 l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 122 MSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp ESEEECC-CHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred CCCCcCC-chhHHHHHhcCCCCCEEEecCCcccccc
Confidence 9999998 4443 3456788899999886653
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.8e-10 Score=126.09 Aligned_cols=104 Identities=15% Similarity=0.237 Sum_probs=48.6
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..++++++|++|+|+
T Consensus 53 ~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~ 132 (570)
T 2z63_A 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132 (570)
T ss_dssp SCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECC
T ss_pred CceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecC
Confidence 44444555544444334444445555555555555444334444555555555555555443222234555555555555
Q ss_pred CCcCCc-cCchhh---hccccccccccc
Q 007625 157 SNNLTG-RIPMQL---FSVATFNFTGTH 180 (595)
Q Consensus 157 ~N~l~g-~ip~~l---~~l~~l~~~~n~ 180 (595)
+|.+++ .+|..+ .+++.+++++|.
T Consensus 133 ~n~l~~~~lp~~~~~l~~L~~L~l~~n~ 160 (570)
T 2z63_A 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (570)
T ss_dssp SSCCCCCCCCGGGGGCTTCCEEECTTSC
T ss_pred CCccceecChhhhcccCCCCEEeCcCCc
Confidence 555543 244433 233444455543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.04 E-value=3.2e-10 Score=113.19 Aligned_cols=102 Identities=30% Similarity=0.414 Sum_probs=81.3
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|.+++ +| .+.++++|++|+|++|++++ + +.+..+++|++|+|++|++++. +.+.++++|+.|+|
T Consensus 90 ~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 163 (291)
T 1h6t_A 90 KNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 163 (291)
T ss_dssp TTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred CCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEc
Confidence 478999999999985 44 48899999999999999985 4 4688899999999999999854 56888999999999
Q ss_pred CCCcCCccCc-hhhhcccccccccccccc
Q 007625 156 SSNNLTGRIP-MQLFSVATFNFTGTHLIC 183 (595)
Q Consensus 156 ~~N~l~g~ip-~~l~~l~~l~~~~n~~~~ 183 (595)
++|++++..| ..+.++..|++++|....
T Consensus 164 ~~N~l~~~~~l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 164 EDNQISDIVPLAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSCCCB
T ss_pred cCCccccchhhcCCCccCEEECCCCcCCC
Confidence 9999985444 234567788888886643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=7.6e-10 Score=113.97 Aligned_cols=143 Identities=13% Similarity=0.165 Sum_probs=105.8
Q ss_pred cCCeeeeccceEEEEEEeCCCcEEEEEEec--cCCCchhHHHHHHHHHHHHhcC--CCCCccccceeecC---CceEEEE
Q 007625 275 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTS---SERILVY 347 (595)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 347 (595)
..+.|+.|.++.||+.... +..+++|+.. ..........+.+|..+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3667899999999999874 4678888765 3221223456788999999887 45577888888766 4478999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC----------------------------------- 392 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------- 392 (595)
||++|..+.+.. ...++...+..++.+++..|+.||+..
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999987764321 123678888999999999999999731
Q ss_pred --------------------CCCcEEcCCCCCCEEEcCCCc--EEEeecccccc
Q 007625 393 --------------------NPKIIHRDLKAANILLDDNFE--AVLCDFGLAKL 424 (595)
Q Consensus 393 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~~~~ 424 (595)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987753 68999998864
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.02 E-value=5e-11 Score=131.23 Aligned_cols=115 Identities=23% Similarity=0.460 Sum_probs=81.5
Q ss_pred CCCCCCCCCCCCCCcceeE--------ecCCCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCc
Q 007625 54 FTDWNDHFVSPCFSWSHVT--------CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTH 125 (595)
Q Consensus 54 l~~w~~~~~~~c~~w~gv~--------c~~~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~ 125 (595)
+.+|... .+||.|.|.. |...+++.|++++|+|+ .+|..+. ++|++|+|++|+|+ .+|. .+++
T Consensus 12 w~~W~~~--~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~ 82 (622)
T 3g06_A 12 WSAWRRA--APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPE 82 (622)
T ss_dssp HHHHHHT--CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred HHHHHhc--CCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence 4457543 4667886643 33346888888888888 7777665 78888888888887 5776 5677
Q ss_pred ccEEEeccccccCccccccccCCCCceecCCCCcCCccCchhhhccccccccccccc
Q 007625 126 LQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLI 182 (595)
Q Consensus 126 L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l~~l~~l~~~~n~~~ 182 (595)
|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|..+.++..|++++|...
T Consensus 83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~~l~~L~~L~L~~N~l~ 134 (622)
T 3g06_A 83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPALPSGLCKLWIFGNQLT 134 (622)
T ss_dssp CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCCCCTTCCEEECCSSCCS
T ss_pred CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCCCCCCcCEEECCCCCCC
Confidence 888888888887 5665 5677777777777777 46666666677777766543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.01 E-value=2e-10 Score=111.15 Aligned_cols=104 Identities=18% Similarity=0.288 Sum_probs=84.6
Q ss_pred CCEEEEEcCCCC-CCCCCCccccccCCCCeEEccC-CccCCCCCccccCCCcccEEEeccccccCccccccccCCCCc--
Q 007625 76 GNVISLTLGSNG-FSGKISPSITKLKFLASLELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK-- 151 (595)
Q Consensus 76 ~~l~~l~l~~n~-l~g~~~~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~-- 151 (595)
.+++.|+|++|+ +++..+..|.++++|++|+|++ |+|++..|..|.++++|++|+|++|++++ +|. +..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 478999999997 8755556899999999999998 99996666788999999999999999995 786 88888888
Q ss_pred -eecCCCC-cCCccCch-hh---hccc-cccccccccc
Q 007625 152 -HLDLSSN-NLTGRIPM-QL---FSVA-TFNFTGTHLI 182 (595)
Q Consensus 152 -~l~l~~N-~l~g~ip~-~l---~~l~-~l~~~~n~~~ 182 (595)
.|++++| +++ .+|. .+ .+++ .+++++|...
T Consensus 133 ~~L~l~~N~~l~-~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 133 FILEITDNPYMT-SIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEEEESCTTCC-EECTTTTTTTBSSEEEEECCSCCCC
T ss_pred cEEECCCCcchh-hcCcccccchhcceeEEEcCCCCCc
Confidence 9999999 888 4554 23 4566 7888888653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.00 E-value=6.5e-10 Score=109.23 Aligned_cols=101 Identities=28% Similarity=0.379 Sum_probs=78.6
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|+|++. ++ +.++++|++|+|++|+|++ +|.... ++|++|+|++|+|++ +| .+.++++|+.|+|
T Consensus 63 ~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 63 TNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 4788999999999854 44 8899999999999999984 665433 888899999998884 44 5888899999999
Q ss_pred CCCcCCccCch--hhhccccccccccccccC
Q 007625 156 SSNNLTGRIPM--QLFSVATFNFTGTHLICG 184 (595)
Q Consensus 156 ~~N~l~g~ip~--~l~~l~~l~~~~n~~~~~ 184 (595)
++|+|++ +|. .+.++..|++++|.....
T Consensus 136 s~N~i~~-~~~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 136 RNNKLKS-IVMLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp TTSCCCB-CGGGGGCTTCCEEECTTSCCCBC
T ss_pred CCCcCCC-ChHHccCCCCCEEECCCCcCcch
Confidence 9999884 552 345677888888876544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.00 E-value=7.2e-12 Score=117.69 Aligned_cols=102 Identities=21% Similarity=0.327 Sum_probs=87.9
Q ss_pred CEEEEEcCCCCCCCCCCc------cccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCC
Q 007625 77 NVISLTLGSNGFSGKISP------SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 150 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~------~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 150 (595)
+++.++|+.+.++|.+|. .+.++++|++|+|++|.|++ +| .+.++++|++|+|++|+|+ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 566666777777777766 89999999999999999995 88 8999999999999999999 899888889999
Q ss_pred ceecCCCCcCCccCch--hhhccccccccccccc
Q 007625 151 KHLDLSSNNLTGRIPM--QLFSVATFNFTGTHLI 182 (595)
Q Consensus 151 ~~l~l~~N~l~g~ip~--~l~~l~~l~~~~n~~~ 182 (595)
+.|+|++|+|++ +|. .+.++..+++++|...
T Consensus 96 ~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i~ 128 (198)
T 1ds9_A 96 EELWISYNQIAS-LSGIEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp SEEEEEEEECCC-HHHHHHHHHSSEEEESEEECC
T ss_pred CEEECcCCcCCc-CCccccCCCCCEEECCCCcCC
Confidence 999999999994 773 3457788999998753
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.00 E-value=4.5e-10 Score=113.08 Aligned_cols=102 Identities=23% Similarity=0.362 Sum_probs=84.2
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|++++ +++ +.++++|++|+|++|.+++ +|. ++.+++|++|+|++|++++ ++. +.++++|+.|+|
T Consensus 107 ~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 180 (308)
T 1h6u_A 107 QSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKA 180 (308)
T ss_dssp TTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEEC
Confidence 479999999999986 444 9999999999999999995 444 8899999999999999995 554 889999999999
Q ss_pred CCCcCCccCch--hhhccccccccccccccC
Q 007625 156 SSNNLTGRIPM--QLFSVATFNFTGTHLICG 184 (595)
Q Consensus 156 ~~N~l~g~ip~--~l~~l~~l~~~~n~~~~~ 184 (595)
++|++++ +|. .+.++..+++++|.....
T Consensus 181 ~~n~l~~-~~~l~~l~~L~~L~L~~N~l~~~ 210 (308)
T 1h6u_A 181 DDNKISD-ISPLASLPNLIEVHLKNNQISDV 210 (308)
T ss_dssp CSSCCCC-CGGGGGCTTCCEEECTTSCCCBC
T ss_pred CCCccCc-ChhhcCCCCCCEEEccCCccCcc
Confidence 9999984 553 456778888999876544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.00 E-value=4.5e-10 Score=114.96 Aligned_cols=104 Identities=27% Similarity=0.375 Sum_probs=81.1
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|++++. ++ +..+++|++|+|++|.+++ + +.+..+++|++|+|++|++++ +| .+..+++|+.|+|
T Consensus 221 ~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L 294 (347)
T 4fmz_A 221 TRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFL 294 (347)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEEC
T ss_pred CcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEEC
Confidence 4788899999998854 43 8888899999999998884 4 468888888999998888884 44 5788888888888
Q ss_pred CCCcCCccCchhh---hccccccccccccccCC
Q 007625 156 SSNNLTGRIPMQL---FSVATFNFTGTHLICGS 185 (595)
Q Consensus 156 ~~N~l~g~ip~~l---~~l~~l~~~~n~~~~~~ 185 (595)
++|++++..|..+ .+++.+++++|+.....
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 327 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR 327 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCG
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCcccccc
Confidence 8888887666544 45677888888765543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.98 E-value=3e-10 Score=116.57 Aligned_cols=101 Identities=19% Similarity=0.279 Sum_probs=84.7
Q ss_pred C-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCc-cccCCCcccE-EE
Q 007625 65 C-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQS-LN 130 (595)
Q Consensus 65 c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~-L~ 130 (595)
| |+|..|.|+. .+++.|+|++|+|+...+..|.+|++|++|+|++|++.+.+|. .|.+|++|+. ++
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 6 6899999974 2688999999999944445799999999999999999877765 5789998875 67
Q ss_pred eccccccCccccccccCCCCceecCCCCcCCccCch
Q 007625 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM 166 (595)
Q Consensus 131 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~ 166 (595)
+++|+|+...|..|.++++|++|++++|+|+ .+|.
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~ 121 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPD 121 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCS-SCCC
T ss_pred ccCCcccccCchhhhhccccccccccccccc-cCCc
Confidence 7889999767788999999999999999998 4553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.98 E-value=8.3e-10 Score=110.18 Aligned_cols=100 Identities=29% Similarity=0.399 Sum_probs=79.4
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|++++..+ +.++++|++|+|++|.+++ +| .+..+++|++|+|++|++++ + +.+.++++|+.|+|
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 478899999999985443 8889999999999999884 44 48889999999999999885 4 46888899999999
Q ss_pred CCCcCCccCch--hhhccccccccccccc
Q 007625 156 SSNNLTGRIPM--QLFSVATFNFTGTHLI 182 (595)
Q Consensus 156 ~~N~l~g~ip~--~l~~l~~l~~~~n~~~ 182 (595)
++|++++ ++. .+.++..|++++|...
T Consensus 142 ~~n~l~~-~~~l~~l~~L~~L~L~~N~l~ 169 (291)
T 1h6t_A 142 GNNKITD-ITVLSRLTKLDTLSLEDNQIS 169 (291)
T ss_dssp CSSCCCC-CGGGGGCTTCSEEECCSSCCC
T ss_pred cCCcCCc-chhhccCCCCCEEEccCCccc
Confidence 9999884 442 4466788888888653
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.7e-10 Score=116.63 Aligned_cols=99 Identities=23% Similarity=0.259 Sum_probs=83.8
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|++++..|..|.++++|++|+|++|.+++..| +..+++|++|+|++|+|++ +| .+++|+.|+++
T Consensus 35 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-l~----~~~~L~~L~l~ 107 (317)
T 3o53_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL----VGPSIETLHAA 107 (317)
T ss_dssp GCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-EE----ECTTCCEEECC
T ss_pred CCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-cc----CCCCcCEEECC
Confidence 78899999999998777889999999999999999986554 8899999999999999983 44 34889999999
Q ss_pred CCcCCccCchhhhccccccccccccc
Q 007625 157 SNNLTGRIPMQLFSVATFNFTGTHLI 182 (595)
Q Consensus 157 ~N~l~g~ip~~l~~l~~l~~~~n~~~ 182 (595)
+|++++..+..+.++..+++++|...
T Consensus 108 ~n~l~~~~~~~~~~L~~L~l~~N~l~ 133 (317)
T 3o53_A 108 NNNISRVSCSRGQGKKNIYLANNKIT 133 (317)
T ss_dssp SSCCSEEEECCCSSCEEEECCSSCCC
T ss_pred CCccCCcCccccCCCCEEECCCCCCC
Confidence 99998766677788888888888763
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.96 E-value=1e-09 Score=107.79 Aligned_cols=100 Identities=19% Similarity=0.294 Sum_probs=84.8
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|+++ .++ .+..+++|++|+|++|+|++ +|. +.++++|++|+|++|++++ +|... . ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEEC
T ss_pred CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEc
Confidence 48999999999998 566 79999999999999999995 555 9999999999999999994 66533 3 99999999
Q ss_pred CCCcCCccCch--hhhcccccccccccccc
Q 007625 156 SSNNLTGRIPM--QLFSVATFNFTGTHLIC 183 (595)
Q Consensus 156 ~~N~l~g~ip~--~l~~l~~l~~~~n~~~~ 183 (595)
++|+|++ +|. .+.++..|++++|....
T Consensus 114 ~~N~l~~-~~~l~~l~~L~~L~Ls~N~i~~ 142 (263)
T 1xeu_A 114 DNNELRD-TDSLIHLKNLEILSIRNNKLKS 142 (263)
T ss_dssp CSSCCSB-SGGGTTCTTCCEEECTTSCCCB
T ss_pred cCCccCC-ChhhcCcccccEEECCCCcCCC
Confidence 9999994 663 45678889999997643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.96 E-value=1e-09 Score=120.59 Aligned_cols=101 Identities=31% Similarity=0.432 Sum_probs=70.9
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+|+.|+|++|.|++ +| .+..|++|+.|+|++|.|++ + +.+..|++|+.|+|++|+|++. ..+..|++|+.|+|
T Consensus 87 ~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 160 (605)
T ss_dssp TTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEEC
T ss_pred CCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEEC
Confidence 467888888888874 33 57778888888888888774 3 3577777788888888777743 46777777777777
Q ss_pred CCCcCCccCc-hhhhccccccccccccc
Q 007625 156 SSNNLTGRIP-MQLFSVATFNFTGTHLI 182 (595)
Q Consensus 156 ~~N~l~g~ip-~~l~~l~~l~~~~n~~~ 182 (595)
++|+|++..| ..+.+|..|++++|++.
T Consensus 161 s~N~l~~~~~l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 161 EDNQISDIVPLAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred cCCcCCCchhhccCCCCCEEECcCCCCC
Confidence 7777775544 13345666777777553
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.95 E-value=9.3e-10 Score=119.68 Aligned_cols=95 Identities=24% Similarity=0.348 Sum_probs=75.7
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 36888889888888 677 457888888888888886 777 665 88888888888885 776 6788888888
Q ss_pred CCCcCCccCchhhhcccccccccccccc
Q 007625 156 SSNNLTGRIPMQLFSVATFNFTGTHLIC 183 (595)
Q Consensus 156 ~~N~l~g~ip~~l~~l~~l~~~~n~~~~ 183 (595)
++|+|++ +|..+.+|..|++++|.+..
T Consensus 148 s~N~l~~-lp~~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 148 DNNQLTM-LPELPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp CSSCCSC-CCCCCTTCCEEECCSSCCSC
T ss_pred CCCccCc-CCCcCCCcCEEECCCCCCCC
Confidence 8888884 78766778888888887543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.95 E-value=1.2e-09 Score=109.93 Aligned_cols=100 Identities=21% Similarity=0.392 Sum_probs=86.1
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|.+++ ++ .+.++++|++|+|++|.+++ +|. +..+++|++|+|++|++++ +|. +.++++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 158 (308)
T 1h6u_A 85 TKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSI 158 (308)
T ss_dssp CSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEEC
T ss_pred CCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEc
Confidence 489999999999995 44 69999999999999999995 554 9999999999999999995 444 899999999999
Q ss_pred CCCcCCccCch--hhhccccccccccccc
Q 007625 156 SSNNLTGRIPM--QLFSVATFNFTGTHLI 182 (595)
Q Consensus 156 ~~N~l~g~ip~--~l~~l~~l~~~~n~~~ 182 (595)
++|++++ +|. .+.++..|++++|...
T Consensus 159 ~~n~l~~-~~~l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 159 GNAQVSD-LTPLANLSKLTTLKADDNKIS 186 (308)
T ss_dssp CSSCCCC-CGGGTTCTTCCEEECCSSCCC
T ss_pred cCCcCCC-ChhhcCCCCCCEEECCCCccC
Confidence 9999994 553 4467788899998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.1e-09 Score=109.99 Aligned_cols=185 Identities=19% Similarity=0.195 Sum_probs=120.7
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCC--CccccceeecCC---ceEEEEEe
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKN--LLQLIGYCTTSS---ERILVYPF 349 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~ 349 (595)
.+.++.|.+..||+.. ..+++|+... ......+.+|..+++.+. +.. +.+++......+ ..++||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 5678999999999864 4688888542 234567899999998874 333 334444433332 34789999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------------------------------------
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ-------------------------------------- 391 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------- 391 (595)
++|.++..... ..++..++..++.+++..++.||+.
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988765332 1366777788888888888888861
Q ss_pred -----------------CCCCcEEcCCCCCCEEEcC--CCcEEEeeccccccccCcCcceeec--------------ccc
Q 007625 392 -----------------CNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVDAKLTHVTTQ--------------IRG 438 (595)
Q Consensus 392 -----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~~~~~~~~~~~~~~~--------------~~g 438 (595)
..+.++|+|++|.||++++ +..+.|+||+.+..-.... ..... ...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHH
Confidence 1135899999999999998 5567899999886532210 00000 000
Q ss_pred cccccC-ccccCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 007625 439 TMGHIA-PEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476 (595)
Q Consensus 439 t~~y~a-PE~~~~~~~~~~sDv~SlGvvl~elltg~~p~ 476 (595)
..++.. |+.... .....+.|+++.++|++.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 001111 222111 122368999999999999998664
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.89 E-value=2.5e-09 Score=117.44 Aligned_cols=102 Identities=29% Similarity=0.374 Sum_probs=78.7
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+|+.|+|++|+|++..| +.+|++|+.|+|++|.|++ +| .|..|++|+.|+|++|+|++ +| .+..|++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEEC
Confidence 478888888888886544 8888888888888888884 44 68888888888888888884 44 5888888888888
Q ss_pred CCCcCCccCch--hhhccccccccccccccC
Q 007625 156 SSNNLTGRIPM--QLFSVATFNFTGTHLICG 184 (595)
Q Consensus 156 ~~N~l~g~ip~--~l~~l~~l~~~~n~~~~~ 184 (595)
++|+|++ ++. .+.+|..|++++|.....
T Consensus 139 s~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 139 GNNKITD-ITVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp CSSCCCC-CGGGGSCTTCSEEECCSSCCCCC
T ss_pred CCCccCC-chhhcccCCCCEEECcCCcCCCc
Confidence 8888884 442 446677888888865433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.89 E-value=2.5e-09 Score=113.67 Aligned_cols=96 Identities=21% Similarity=0.344 Sum_probs=55.3
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|++++ +| +|+++++|++|++++|++++ +|..+ ++|++|+|++|++++ +| .++++++|+.|+++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 45555555555553 44 35666666666666666653 55432 355666666666653 44 46666666666666
Q ss_pred CCcCCccCchhhhcccccccccccc
Q 007625 157 SNNLTGRIPMQLFSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~~l~~l~~l~~~~n~~ 181 (595)
+|++++ +|....+++.+++++|..
T Consensus 204 ~N~l~~-l~~~~~~L~~L~l~~n~l 227 (454)
T 1jl5_A 204 NNSLKK-LPDLPLSLESIVAGNNIL 227 (454)
T ss_dssp SSCCSS-CCCCCTTCCEEECCSSCC
T ss_pred CCcCCc-CCCCcCcccEEECcCCcC
Confidence 666663 555445666666666644
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.9e-09 Score=115.04 Aligned_cols=98 Identities=26% Similarity=0.385 Sum_probs=57.6
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|.+++..+ +..+++|+.|+|++|++++..| ++.+++|+.|+|++|++++..| +..+++|+.|+++
T Consensus 266 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 339 (466)
T 1o6v_A 266 KLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339 (466)
T ss_dssp TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECC
T ss_pred CCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECC
Confidence 56677777777764332 6666666666666666664332 5666666666666666665444 5566666666666
Q ss_pred CCcCCccCch--hhhcccccccccccc
Q 007625 157 SNNLTGRIPM--QLFSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~--~l~~l~~l~~~~n~~ 181 (595)
+|++++ +|. .+.++..+++++|+.
T Consensus 340 ~n~l~~-~~~l~~l~~L~~L~l~~n~l 365 (466)
T 1o6v_A 340 NNKVSD-VSSLANLTNINWLSAGHNQI 365 (466)
T ss_dssp SSCCCC-CGGGTTCTTCCEEECCSSCC
T ss_pred CCccCC-chhhccCCCCCEEeCCCCcc
Confidence 666653 231 233445555555554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.88 E-value=2.7e-10 Score=118.54 Aligned_cols=86 Identities=22% Similarity=0.405 Sum_probs=42.2
Q ss_pred CEEEEEcCCCCCC-CCCC---ccccccCCCCeEEccCCccC--C---CCCccccCCCcccEEEecccccc----Cccccc
Q 007625 77 NVISLTLGSNGFS-GKIS---PSITKLKFLASLELQDNDLS--G---TLPDFLGSMTHLQSLNLANNKFS----GSIPAT 143 (595)
Q Consensus 77 ~l~~l~l~~n~l~-g~~~---~~~~~l~~L~~L~l~~n~l~--g---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~ 143 (595)
+++.|+|++|+++ +.++ ..+..+++|++|+|++|+|+ | .+|..+..+++|++|+|++|+|+ +.+|..
T Consensus 160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 4555555555554 2233 23444555555555555554 2 23334455555555555555553 344545
Q ss_pred cccCCCCceecCCCCcCCc
Q 007625 144 WSQLSNLKHLDLSSNNLTG 162 (595)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g 162 (595)
+.++++|+.|+|++|.|++
T Consensus 240 l~~~~~L~~L~L~~n~i~~ 258 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSA 258 (386)
T ss_dssp GGGCTTCCEEECTTCCCCH
T ss_pred HccCCCcCEEECCCCCCch
Confidence 5555555555555555543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.84 E-value=2.6e-10 Score=121.28 Aligned_cols=101 Identities=18% Similarity=0.149 Sum_probs=64.9
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcc-------------cEEEeccccccCcccc
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHL-------------QSLNLANNKFSGSIPA 142 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L-------------~~L~l~~N~l~g~~p~ 142 (595)
.+++.|++++|++ |.+|++|++|++|++|+|++|.++|.+|.+++++++| ++|++++|++++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 4789999999999 7999999999999999999999999999999998875 899999999884 554
Q ss_pred ccccCCCCceecCCCCcCCccCchhhhccccccccccccc
Q 007625 143 TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLI 182 (595)
Q Consensus 143 ~~~~l~~L~~l~l~~N~l~g~ip~~l~~l~~l~~~~n~~~ 182 (595)
. .++|+.|++++|++++ +|..+.+++.+++++|...
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~ 124 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLK 124 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCS
T ss_pred C---cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccC
Confidence 2 3678888888888885 8877777888888887654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.83 E-value=6e-09 Score=110.85 Aligned_cols=93 Identities=24% Similarity=0.251 Sum_probs=42.4
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+|++. | ++++++|++|+|++|.|++ +| ++++++|++|+|++|++++ +| ++++++|+.|+++
T Consensus 65 ~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~ 135 (457)
T 3bz5_A 65 GLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCA 135 (457)
T ss_dssp TCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECT
T ss_pred CCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECC
Confidence 444444444444432 2 4444445555555554443 22 4444555555555555443 32 4444555555555
Q ss_pred CCcCCccCc-hhhhcccccccccc
Q 007625 157 SNNLTGRIP-MQLFSVATFNFTGT 179 (595)
Q Consensus 157 ~N~l~g~ip-~~l~~l~~l~~~~n 179 (595)
+|+|++ +| ..+.+++.+++++|
T Consensus 136 ~N~l~~-l~l~~l~~L~~L~l~~n 158 (457)
T 3bz5_A 136 RNTLTE-IDVSHNTQLTELDCHLN 158 (457)
T ss_dssp TSCCSC-CCCTTCTTCCEEECTTC
T ss_pred CCccce-eccccCCcCCEEECCCC
Confidence 555543 22 22334444444444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.82 E-value=3.4e-09 Score=112.76 Aligned_cols=100 Identities=17% Similarity=0.183 Sum_probs=83.1
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCC-------
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLS------- 148 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~------- 148 (595)
.+++.|+|++|++++. .++.+++|++|+|++|+|++ +| ++.+++|++|+|++|+|++..+..+.+|+
T Consensus 191 ~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n 264 (457)
T 3bz5_A 191 KLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQT 264 (457)
T ss_dssp TTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTC
T ss_pred CCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCC
Confidence 4789999999999965 48999999999999999996 77 88999999999999999976666666665
Q ss_pred CCceecCCCCcCCccCch-hhhcccccccccccc
Q 007625 149 NLKHLDLSSNNLTGRIPM-QLFSVATFNFTGTHL 181 (595)
Q Consensus 149 ~L~~l~l~~N~l~g~ip~-~l~~l~~l~~~~n~~ 181 (595)
+|+.|++++|.+.|.+|. .+.+++.+++++|+.
T Consensus 265 ~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~ 298 (457)
T 3bz5_A 265 DLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQ 298 (457)
T ss_dssp CCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTT
T ss_pred CCCEEECCCCccCCcccccccccCCEEECCCCcc
Confidence 667888888888888884 347788888888864
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.82 E-value=6.4e-09 Score=106.27 Aligned_cols=99 Identities=22% Similarity=0.380 Sum_probs=71.5
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|++++|.+.+..+ +..+++|++|+|++|.+++ +|. +..+++|++|+|++|++++ + +.+..+++|+.|++
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNV 272 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred CccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence 367788888888875443 7778888888888888874 444 7788888888888888774 4 35777888888888
Q ss_pred CCCcCCccCch--hhhcccccccccccc
Q 007625 156 SSNNLTGRIPM--QLFSVATFNFTGTHL 181 (595)
Q Consensus 156 ~~N~l~g~ip~--~l~~l~~l~~~~n~~ 181 (595)
++|++++ +|. .+.+++.+++++|+.
T Consensus 273 ~~n~l~~-~~~~~~l~~L~~L~L~~n~l 299 (347)
T 4fmz_A 273 GSNQISD-ISVLNNLSQLNSLFLNNNQL 299 (347)
T ss_dssp CSSCCCC-CGGGGGCTTCSEEECCSSCC
T ss_pred cCCccCC-ChhhcCCCCCCEEECcCCcC
Confidence 8888873 452 345667777777765
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.81 E-value=6e-09 Score=111.22 Aligned_cols=98 Identities=28% Similarity=0.425 Sum_probs=49.1
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|++++ + +.+..+++|+.|+|++|.+++..| +..+++|+.|+|++|++++. |. +..+++|+.|+|+
T Consensus 222 ~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~ 295 (466)
T 1o6v_A 222 NLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLELN 295 (466)
T ss_dssp TCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEECC
T ss_pred CCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEEcC
Confidence 45556666665553 2 235555555555555555554332 55555555555555555532 22 4555555555555
Q ss_pred CCcCCccCc-hhhhccccccccccc
Q 007625 157 SNNLTGRIP-MQLFSVATFNFTGTH 180 (595)
Q Consensus 157 ~N~l~g~ip-~~l~~l~~l~~~~n~ 180 (595)
+|++++..| ..+.+++.+++++|.
T Consensus 296 ~n~l~~~~~~~~l~~L~~L~L~~n~ 320 (466)
T 1o6v_A 296 ENQLEDISPISNLKNLTYLTLYFNN 320 (466)
T ss_dssp SSCCSCCGGGGGCTTCSEEECCSSC
T ss_pred CCcccCchhhcCCCCCCEEECcCCc
Confidence 555553222 123344445555544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.80 E-value=9.3e-10 Score=113.47 Aligned_cols=105 Identities=25% Similarity=0.301 Sum_probs=69.6
Q ss_pred CEEEEEcCCCCCCCCCC----ccccccC-CCCeEEccCCccCCCCCccccCC-----CcccEEEeccccccCcccccccc
Q 007625 77 NVISLTLGSNGFSGKIS----PSITKLK-FLASLELQDNDLSGTLPDFLGSM-----THLQSLNLANNKFSGSIPATWSQ 146 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~----~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~ 146 (595)
+++.|+|++|.|++..+ ..|.+++ +|++|+|++|.|++..+..+..+ ++|++|+|++|++++..+..+..
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 47777777777775554 5566676 77777777777776666666665 77777777777777665554433
Q ss_pred C-----CCCceecCCCCcCCccCchhh--------hcccccccccccc
Q 007625 147 L-----SNLKHLDLSSNNLTGRIPMQL--------FSVATFNFTGTHL 181 (595)
Q Consensus 147 l-----~~L~~l~l~~N~l~g~ip~~l--------~~l~~l~~~~n~~ 181 (595)
. ++|+.|+|++|+|++..+..+ .+++.|++++|..
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 150 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL 150 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCG
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcC
Confidence 3 677777777777764443332 2566677777654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.80 E-value=5.1e-10 Score=113.94 Aligned_cols=102 Identities=19% Similarity=0.213 Sum_probs=58.0
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCC-CCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGT-LPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
+++.|++++|.+.+..+. +.++++|++|+|++|.+++. +|..+..+++|++|+|++|++++..|..++++++|++|+|
T Consensus 71 ~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L 149 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 149 (336)
T ss_dssp TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence 455566666666544433 44566666666666666544 5555666666666666666666556666666666666666
Q ss_pred CCC-cCCcc-Cch---hhhcccccccccc
Q 007625 156 SSN-NLTGR-IPM---QLFSVATFNFTGT 179 (595)
Q Consensus 156 ~~N-~l~g~-ip~---~l~~l~~l~~~~n 179 (595)
++| .+++. +|. .+.+++.|++++|
T Consensus 150 ~~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 178 (336)
T 2ast_B 150 SGCSGFSEFALQTLLSSCSRLDELNLSWC 178 (336)
T ss_dssp TTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCCCCCHHHHHHHHhcCCCCCEEcCCCC
Confidence 666 45542 333 2334555555554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.79 E-value=8.6e-10 Score=114.71 Aligned_cols=105 Identities=23% Similarity=0.321 Sum_probs=53.3
Q ss_pred CCEEEEEcCCCCCCC----CCCcccccc---------CCCCeEEccCCccC-CCCC---ccccCCCcccEEEecccccc-
Q 007625 76 GNVISLTLGSNGFSG----KISPSITKL---------KFLASLELQDNDLS-GTLP---DFLGSMTHLQSLNLANNKFS- 137 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g----~~~~~~~~l---------~~L~~L~l~~n~l~-g~~p---~~~~~l~~L~~L~l~~N~l~- 137 (595)
.+++.|+|++|.+++ .++..+..+ ++|++|+|++|+|+ +.+| ..+..+++|++|+|++|+|+
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~ 201 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCH
Confidence 355555555555542 233444444 55555555555555 3334 34445555555555555555
Q ss_pred -C---ccccccccCCCCceecCCCCcCC----ccCchhh---hccccccccccc
Q 007625 138 -G---SIPATWSQLSNLKHLDLSSNNLT----GRIPMQL---FSVATFNFTGTH 180 (595)
Q Consensus 138 -g---~~p~~~~~l~~L~~l~l~~N~l~----g~ip~~l---~~l~~l~~~~n~ 180 (595)
| .+|..+.++++|+.|+|++|.|+ +.+|..+ .+|..|++++|.
T Consensus 202 ~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~ 255 (386)
T 2ca6_A 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 255 (386)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCC
T ss_pred hHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCC
Confidence 2 23335555555555555555554 3444332 334455555554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.77 E-value=6.2e-09 Score=114.53 Aligned_cols=74 Identities=34% Similarity=0.457 Sum_probs=49.1
Q ss_pred CCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcCCccCchhhh---ccccccc
Q 007625 100 KFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNF 176 (595)
Q Consensus 100 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l~---~l~~l~~ 176 (595)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+. ++..+++
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 567777777777773 66 34567777777777777 5665 4567777777777777 6776543 3455667
Q ss_pred cccccc
Q 007625 177 TGTHLI 182 (595)
Q Consensus 177 ~~n~~~ 182 (595)
++|++.
T Consensus 292 ~~N~l~ 297 (622)
T 3g06_A 292 EGNPLS 297 (622)
T ss_dssp CSCCCC
T ss_pred cCCCCC
Confidence 777653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.76 E-value=1.4e-09 Score=110.68 Aligned_cols=113 Identities=19% Similarity=0.261 Sum_probs=85.7
Q ss_pred CCCCcceeEecCCCEEEEEcCCCCCCCCCCcccccc--CCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCc-c
Q 007625 64 PCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKL--KFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS-I 140 (595)
Q Consensus 64 ~c~~w~gv~c~~~~l~~l~l~~n~l~g~~~~~~~~l--~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~ 140 (595)
-|..|.++.|+...++.|+|++|.+. +..+..+ ++|+.|++++|.+++.+|. +.++++|++|+|++|.+++. +
T Consensus 35 vc~~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 35 VCKRWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp SCHHHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHH
Confidence 45578888776556778888888776 4557777 7888888888888866554 56788888888888888765 7
Q ss_pred ccccccCCCCceecCCCCcCCccCchhh---hccccccccccc
Q 007625 141 PATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTH 180 (595)
Q Consensus 141 p~~~~~l~~L~~l~l~~N~l~g~ip~~l---~~l~~l~~~~n~ 180 (595)
|..+.++++|++|+|++|.+++.+|..+ .+++.|++++|.
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~ 153 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCB
T ss_pred HHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCC
Confidence 7778888888888888888887776544 456777777774
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.67 E-value=6e-09 Score=107.32 Aligned_cols=102 Identities=21% Similarity=0.231 Sum_probs=88.0
Q ss_pred EEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCC----ccccCCC-cccEEEeccccccCccccccccC-----CC
Q 007625 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP----DFLGSMT-HLQSLNLANNKFSGSIPATWSQL-----SN 149 (595)
Q Consensus 80 ~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p----~~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l-----~~ 149 (595)
.+.|++|+++|.+|..+...++|++|+|++|.|++..+ ..+.+++ +|++|+|++|+|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999877777889999999999996666 7788899 99999999999998888888776 99
Q ss_pred CceecCCCCcCCccCchhh--------hcccccccccccc
Q 007625 150 LKHLDLSSNNLTGRIPMQL--------FSVATFNFTGTHL 181 (595)
Q Consensus 150 L~~l~l~~N~l~g~ip~~l--------~~l~~l~~~~n~~ 181 (595)
|+.|+|++|++++..+..+ .+++.|++++|..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 121 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcC
Confidence 9999999999997666432 4678899999875
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.61 E-value=7e-09 Score=101.11 Aligned_cols=67 Identities=24% Similarity=0.363 Sum_probs=57.5
Q ss_pred cccCCCCeEEccCCccCC--CCCccccCCCcccEEEeccccccCccccccccCC--CCceecCCCCcCCccCc
Q 007625 97 TKLKFLASLELQDNDLSG--TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLS--NLKHLDLSSNNLTGRIP 165 (595)
Q Consensus 97 ~~l~~L~~L~l~~n~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~--~L~~l~l~~N~l~g~ip 165 (595)
.++++|+.|+|++|+|++ .+|..+..+++|++|+|++|+|++. ..+..++ +|+.|+|++|.+++.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 468899999999999997 6678888999999999999999954 3455555 89999999999998887
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.51 E-value=9e-09 Score=109.46 Aligned_cols=106 Identities=18% Similarity=0.237 Sum_probs=82.3
Q ss_pred CCEEEEEcCCCCCCCCCCcccccc-----CCCCeEEccCCccCCC----CCccccCCCcccEEEeccccccCcccccccc
Q 007625 76 GNVISLTLGSNGFSGKISPSITKL-----KFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGSIPATWSQ 146 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l-----~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 146 (595)
.+++.|+|++|.+++..+..+... ++|++|+|++|.+++. +|..+..+++|++|+|++|++++..+..+..
T Consensus 284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 363 (461)
T 1z7x_W 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHH
Confidence 579999999999875544444433 6899999999998865 5677788899999999999988665555543
Q ss_pred -----CCCCceecCCCCcCCc----cCchhh---hcccccccccccc
Q 007625 147 -----LSNLKHLDLSSNNLTG----RIPMQL---FSVATFNFTGTHL 181 (595)
Q Consensus 147 -----l~~L~~l~l~~N~l~g----~ip~~l---~~l~~l~~~~n~~ 181 (595)
.++|+.|+|++|++++ .+|..+ .+++.+++++|+.
T Consensus 364 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i 410 (461)
T 1z7x_W 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCC
Confidence 6789999999999986 677654 5677888888875
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.46 E-value=9.7e-09 Score=109.22 Aligned_cols=106 Identities=19% Similarity=0.201 Sum_probs=69.0
Q ss_pred CCEEEEEcCCCCCCCCC-----CccccccCCCCeEEccCCccCCC----CCccccCCCcccEEEeccccccCcccccccc
Q 007625 76 GNVISLTLGSNGFSGKI-----SPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGSIPATWSQ 146 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~-----~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 146 (595)
.+++.|+|++|.+++.- +..+..+++|++|+|++|.+++. +|..+.++++|++|+|++|.+++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 47788888888776432 12223577888888888887743 6667777788888888888776554444433
Q ss_pred C-----CCCceecCCCCcCCcc----Cchhh---hcccccccccccc
Q 007625 147 L-----SNLKHLDLSSNNLTGR----IPMQL---FSVATFNFTGTHL 181 (595)
Q Consensus 147 l-----~~L~~l~l~~N~l~g~----ip~~l---~~l~~l~~~~n~~ 181 (595)
. ++|+.|+|++|.+++. +|..+ .+++.+++++|..
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i 353 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL 353 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBC
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcc
Confidence 2 5777777777777754 33332 4566677777743
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.45 E-value=1e-07 Score=92.89 Aligned_cols=77 Identities=25% Similarity=0.347 Sum_probs=66.0
Q ss_pred CCEEEEEcCCCCCCC--CCCccccccCCCCeEEccCCccCCCCCccccCCC--cccEEEeccccccCcccc-------cc
Q 007625 76 GNVISLTLGSNGFSG--KISPSITKLKFLASLELQDNDLSGTLPDFLGSMT--HLQSLNLANNKFSGSIPA-------TW 144 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g--~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~--~L~~L~l~~N~l~g~~p~-------~~ 144 (595)
.+++.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|+.|+|++|.+.+.+|. .+
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il 247 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIR 247 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHH
Confidence 489999999999998 5567788999999999999999964 4566666 999999999999988773 37
Q ss_pred ccCCCCceec
Q 007625 145 SQLSNLKHLD 154 (595)
Q Consensus 145 ~~l~~L~~l~ 154 (595)
..+++|+.||
T Consensus 248 ~~~P~L~~LD 257 (267)
T 3rw6_A 248 ERFPKLLRLD 257 (267)
T ss_dssp HHCTTCCEES
T ss_pred HHCcccCeEC
Confidence 7889999887
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.6e-07 Score=96.18 Aligned_cols=105 Identities=17% Similarity=0.204 Sum_probs=83.5
Q ss_pred eEecCCCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCC-ccccCCCcccEEEeccccccCcccc-ccccCC
Q 007625 71 VTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP-DFLGSMTHLQSLNLANNKFSGSIPA-TWSQLS 148 (595)
Q Consensus 71 v~c~~~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~ 148 (595)
..|.. ++++.++++|+ .+|..+ .++|++|+|++|+|+ .|| ..|.+|++|++|+|++|++.+.+|. .|.+++
T Consensus 7 C~C~~---~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~ 79 (350)
T 4ay9_X 7 CHCSN---RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79 (350)
T ss_dssp SEEET---TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCT
T ss_pred cEeeC---CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcch
Confidence 46754 35778999999 888877 378999999999999 565 5799999999999999999877875 578899
Q ss_pred CCc-eecCCCCcCCccCchh---hhccccccccccccc
Q 007625 149 NLK-HLDLSSNNLTGRIPMQ---LFSVATFNFTGTHLI 182 (595)
Q Consensus 149 ~L~-~l~l~~N~l~g~ip~~---l~~l~~l~~~~n~~~ 182 (595)
+|. .+.+++|+|++..|.. +.+|+.+++++|...
T Consensus 80 ~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~ 117 (350)
T 4ay9_X 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 117 (350)
T ss_dssp TCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCS
T ss_pred hhhhhhcccCCcccccCchhhhhccccccccccccccc
Confidence 876 4777889999433443 456788889988764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2.5e-06 Score=83.68 Aligned_cols=135 Identities=14% Similarity=0.114 Sum_probs=97.3
Q ss_pred Ceeeeccce-EEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCCceEEEEEecccC
Q 007625 277 NIIGQGGFG-KVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 277 ~~lG~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (595)
+.+..|..| .||+.... ++..+++|+-.. .....+.+|...++.+. +--+.++++++.+.+..++||+++++.
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 345556655 69988754 567799998643 34567888999988774 333667888888888999999999998
Q ss_pred cHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 007625 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC----------------------------------------- 392 (595)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------------- 392 (595)
++.+..... ......+..+++..|+.||...
T Consensus 106 ~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 106 TAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp EHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred cccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 876654321 1223455666677777777431
Q ss_pred --------------CCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 393 --------------NPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 393 --------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
.+.++|+|+.+.||++++++.+-|+||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1238999999999999988777799999875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.35 E-value=5.9e-08 Score=100.12 Aligned_cols=85 Identities=19% Similarity=0.253 Sum_probs=41.9
Q ss_pred CEEEEEcCCCCCCCCCCccc-----cccCCCCeEEccCCccCC----CCCccccCCCcccEEEeccccccCc----cccc
Q 007625 77 NVISLTLGSNGFSGKISPSI-----TKLKFLASLELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSGS----IPAT 143 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~-----~~l~~L~~L~l~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~ 143 (595)
+++.|+|++|+|+..-...+ ...++|++|+|++|.|+. .++..+..+++|++|+|++|+|++. ++..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 44555555555543222222 123455555555555542 1333344555566666666665532 2344
Q ss_pred cccCCCCceecCCCCcCC
Q 007625 144 WSQLSNLKHLDLSSNNLT 161 (595)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~ 161 (595)
+...++|+.|+|++|.|+
T Consensus 207 L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp GGGCSCCCEEECCSSCCC
T ss_pred HhcCCCcCeEECCCCCCC
Confidence 455555666666666655
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=4.4e-06 Score=83.63 Aligned_cols=136 Identities=19% Similarity=0.205 Sum_probs=94.1
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCC---CCccccceee-cCCceEEEEEecc
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK---NLLQLIGYCT-TSSERILVYPFMQ 351 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~ 351 (595)
.+.++.|....||+. |..+++|+-. .......+.+|..++..+.+. .+.+++.++. ..+..++||+|++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456888999999987 5678888743 234456789999999998753 2455566664 3455789999999
Q ss_pred cCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 007625 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ---------------------------------------- 391 (595)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------- 391 (595)
|.++...... .++......++.+++..|+.||+.
T Consensus 97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9877653211 134445555555555555555542
Q ss_pred -----------------CCCCcEEcCCCCCCEEEcC---CCc-EEEeecccccc
Q 007625 392 -----------------CNPKIIHRDLKAANILLDD---NFE-AVLCDFGLAKL 424 (595)
Q Consensus 392 -----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DfG~~~~ 424 (595)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 355 58999998764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.11 E-value=2.8e-07 Score=95.06 Aligned_cols=88 Identities=22% Similarity=0.270 Sum_probs=73.0
Q ss_pred CCEEEEEcCCCCCCC----CCCccccccCCCCeEEccCCccCCC----CCccccCCCcccEEEeccccccCc----cccc
Q 007625 76 GNVISLTLGSNGFSG----KISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IPAT 143 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g----~~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~ 143 (595)
.+++.|+|++|.|+. .++..+..+++|++|+|++|.|+.. ++..+..+++|+.|+|++|.|+.. ++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 479999999999974 3455568899999999999999742 466778889999999999999853 4555
Q ss_pred cccCCCCceecCCCCcCCcc
Q 007625 144 WSQLSNLKHLDLSSNNLTGR 163 (595)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g~ 163 (595)
+...++|++|+|++|.|+..
T Consensus 235 L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHCSSCCEEECTTSSCCHH
T ss_pred HHhCCCCCEEeccCCCCCHH
Confidence 66789999999999999854
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.11 E-value=4.6e-07 Score=83.66 Aligned_cols=106 Identities=17% Similarity=0.252 Sum_probs=77.9
Q ss_pred CCEEEEEcCCC-CCCCC----CCccccccCCCCeEEccCCccCCC----CCccccCCCcccEEEeccccccCc----ccc
Q 007625 76 GNVISLTLGSN-GFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IPA 142 (595)
Q Consensus 76 ~~l~~l~l~~n-~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~ 142 (595)
..++.|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|+|+.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 47889999998 88642 345567778999999999998732 445566678899999999999853 566
Q ss_pred ccccCCCCceecC--CCCcCCccCc----hhh---hcccccccccccc
Q 007625 143 TWSQLSNLKHLDL--SSNNLTGRIP----MQL---FSVATFNFTGTHL 181 (595)
Q Consensus 143 ~~~~l~~L~~l~l--~~N~l~g~ip----~~l---~~l~~l~~~~n~~ 181 (595)
.+...++|++|+| ++|.|+..-- ..+ .+++.|++++|..
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 7788889999999 8899874322 222 3567777777643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=6.1e-06 Score=84.39 Aligned_cols=82 Identities=6% Similarity=-0.040 Sum_probs=54.2
Q ss_pred CCee-eeccceEEEEEEeC-------CCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcC-C--CCCccccceeecC--
Q 007625 276 SNII-GQGGFGKVYKGVLS-------DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAI-H--KNLLQLIGYCTTS-- 340 (595)
Q Consensus 276 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 340 (595)
.+.| +.|..+.+|+.... ++..+++|+..... .......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999998764 26778898764321 0001235678888888774 2 3466777776554
Q ss_pred -CceEEEEEecccCcHhh
Q 007625 341 -SERILVYPFMQNLSVAY 357 (595)
Q Consensus 341 -~~~~lv~e~~~~gsL~~ 357 (595)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999999876543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.94 E-value=7.4e-06 Score=82.83 Aligned_cols=89 Identities=16% Similarity=0.215 Sum_probs=75.0
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCccc-EEEeccccccCccccccccCCCCceec
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQ-SLNLANNKFSGSIPATWSQLSNLKHLD 154 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (595)
.+++.|+|++|+++..-+..|.++++|+.|+|++| ++..-+..|.++++|+ .|+|.+ +++..-+.+|.+|++|+.|+
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 47999999999999444557999999999999998 7755566799999999 999998 77744457799999999999
Q ss_pred CCCCcCCccCchh
Q 007625 155 LSSNNLTGRIPMQ 167 (595)
Q Consensus 155 l~~N~l~g~ip~~ 167 (595)
+++|+++ .|+..
T Consensus 304 l~~n~i~-~I~~~ 315 (329)
T 3sb4_A 304 ATGDKIT-TLGDE 315 (329)
T ss_dssp ECSSCCC-EECTT
T ss_pred eCCCccC-ccchh
Confidence 9999998 67753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.94 E-value=5.9e-05 Score=76.32 Aligned_cols=141 Identities=18% Similarity=0.242 Sum_probs=78.6
Q ss_pred CeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCC--CCCccccc------eeecCCceEEEEE
Q 007625 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KNLLQLIG------YCTTSSERILVYP 348 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e 348 (595)
+.|+.|..+.||+....+| .+++|+... . ...+..|..++..+.. -.+.+++. +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR--P---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS--C---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC--C---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4466677899999987554 589998864 1 2233345555444421 12333332 1234566789999
Q ss_pred ecccCcHh--------------hhhcccCCC-----C-----CCCCHHHH------------------------------
Q 007625 349 FMQNLSVA--------------YRLRDLKPG-----E-----KGLDWPTR------------------------------ 374 (595)
Q Consensus 349 ~~~~gsL~--------------~~l~~~~~~-----~-----~~l~~~~~------------------------------ 374 (595)
|++|.++. ..+|..... . ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986432 112211110 0 01123211
Q ss_pred -HHHHHHHHHHHHHHhh----------cCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 375 -KRVAFGTAYGLEYLHE----------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 375 -~~i~~~ia~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
..+..++..++.+|+. ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666653 123589999999999999888889999999764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.86 E-value=2.1e-06 Score=79.16 Aligned_cols=86 Identities=17% Similarity=0.198 Sum_probs=71.0
Q ss_pred CCEEEEEcCCCCCCCC----CCccccccCCCCeEEccCCccCCC----CCccccCCCcccEEEe--ccccccCc----cc
Q 007625 76 GNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNL--ANNKFSGS----IP 141 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l--~~N~l~g~----~p 141 (595)
.+++.|+|++|.|... +...+...++|++|+|++|.|+.. +...+...++|++|+| ++|.|+.. +.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 4799999999999742 344566778999999999999843 5667888899999999 88999854 44
Q ss_pred cccccCCCCceecCCCCcCC
Q 007625 142 ATWSQLSNLKHLDLSSNNLT 161 (595)
Q Consensus 142 ~~~~~l~~L~~l~l~~N~l~ 161 (595)
..+...++|+.|+|++|.+.
T Consensus 145 ~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEeccCCCCC
Confidence 55667799999999999986
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.86 E-value=1.3e-06 Score=95.81 Aligned_cols=58 Identities=16% Similarity=0.118 Sum_probs=29.9
Q ss_pred CCcccEEEeccccccC-ccccccccCCCCceecCCCCcCCccC-ch---hhhccccccccccc
Q 007625 123 MTHLQSLNLANNKFSG-SIPATWSQLSNLKHLDLSSNNLTGRI-PM---QLFSVATFNFTGTH 180 (595)
Q Consensus 123 l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g~i-p~---~l~~l~~l~~~~n~ 180 (595)
+++|++|+|++|++++ .++..+..+++|+.|+|++|.|++.. +. .+.+++.|++++|+
T Consensus 462 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp CTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred CccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 5555555555555554 23334455566666666666654332 21 23445555555554
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=6.5e-05 Score=77.93 Aligned_cols=76 Identities=14% Similarity=0.147 Sum_probs=48.8
Q ss_pred CCeeeeccceEEEEEEeC-CCcEEEEEEeccCCC------chhHHHHHHHHHHHHhcCC--CCCc-cccceeecCCceEE
Q 007625 276 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS------PGGEAAFQREVHLISVAIH--KNLL-QLIGYCTTSSERIL 345 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~l 345 (595)
.+.||.|.++.||++... +++.+++|....... ......+..|.+++..+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567899999999999754 568899998653211 1123456778888887642 3333 44433 3456789
Q ss_pred EEEecccC
Q 007625 346 VYPFMQNL 353 (595)
Q Consensus 346 v~e~~~~g 353 (595)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.0001 Score=72.76 Aligned_cols=78 Identities=21% Similarity=0.257 Sum_probs=55.5
Q ss_pred CCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCC---CCccccceeecCCceEEEEE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK---NLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e 348 (595)
.....+.+|.|..+.||+.+..||+.|.+|+-.... ......|..|...|+.+.-. .+.+++++ +..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 445577899999999999999999999999865322 22334678899998887422 23344443 23478999
Q ss_pred ecccCc
Q 007625 349 FMQNLS 354 (595)
Q Consensus 349 ~~~~gs 354 (595)
|++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 997654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00016 Score=72.29 Aligned_cols=140 Identities=14% Similarity=0.195 Sum_probs=93.0
Q ss_pred cCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC---CCCCccccceeecCCceEEEEEecc
Q 007625 275 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTSSERILVYPFMQ 351 (595)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 351 (595)
..+.|+.|....+|+... ++..+++|+... .....+..|...++.+. ...+.+++.++...+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEG----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCc----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 356789999999999986 567888998653 23567889998888874 3557788888887788999999999
Q ss_pred cCcHh-----------hhhcccCC-CC-----------------CCCCHHHHH---HHHH----------------HHHH
Q 007625 352 NLSVA-----------YRLRDLKP-GE-----------------KGLDWPTRK---RVAF----------------GTAY 383 (595)
Q Consensus 352 ~gsL~-----------~~l~~~~~-~~-----------------~~l~~~~~~---~i~~----------------~ia~ 383 (595)
+..+. ..||.... .. -.-+|.... ++.. .+..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87542 12333221 00 012454322 1111 1111
Q ss_pred H-HHHHhh-cCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 384 G-LEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 384 ~-L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
. ...|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123322 2356899999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.69 E-value=8.5e-05 Score=77.73 Aligned_cols=78 Identities=12% Similarity=0.116 Sum_probs=48.3
Q ss_pred CCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcceeecc-cccccccCccccCCC---CCCccchhHHHHHHHHH
Q 007625 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-RGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLE 468 (595)
Q Consensus 393 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~sDv~SlGvvl~e 468 (595)
.+.++|+|+++.||+++.++ ++|+||+.+..-..... ..... .-...|.+|+..... ......++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34899999999999998876 99999998875432110 00000 012346666655321 11223456678888888
Q ss_pred HHhC
Q 007625 469 LVTG 472 (595)
Q Consensus 469 lltg 472 (595)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.65 E-value=3.3e-06 Score=92.58 Aligned_cols=103 Identities=9% Similarity=0.046 Sum_probs=47.1
Q ss_pred CEEEEEcCCCCCCCCCCcccc-ccCCCCeEEcc--C----CccCCC-----CCccccCCCcccEEEeccccccCcccccc
Q 007625 77 NVISLTLGSNGFSGKISPSIT-KLKFLASLELQ--D----NDLSGT-----LPDFLGSMTHLQSLNLANNKFSGSIPATW 144 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~-~l~~L~~L~l~--~----n~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 144 (595)
+++.|++..|++++.....+. .+++|+.|+|+ + |.+++. ++..+.++++|+.|+|++ ++++..+..+
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l 451 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYI 451 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHH
Confidence 455555555655544444443 35556666665 2 334311 111134445555555544 4443333333
Q ss_pred cc-CCCCceecCCCCcCCccCch----hhhccccccccccc
Q 007625 145 SQ-LSNLKHLDLSSNNLTGRIPM----QLFSVATFNFTGTH 180 (595)
Q Consensus 145 ~~-l~~L~~l~l~~N~l~g~ip~----~l~~l~~l~~~~n~ 180 (595)
.. +++|+.|+|++|.+++..+. .+.+|+.|++++|+
T Consensus 452 ~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~ 492 (594)
T 2p1m_B 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCP 492 (594)
T ss_dssp HHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCS
T ss_pred HHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCC
Confidence 33 45555555555555433222 12344455555444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.62 E-value=6.3e-06 Score=90.32 Aligned_cols=104 Identities=13% Similarity=0.110 Sum_probs=69.6
Q ss_pred CCEEEEEcCCCCCCCCCCcccc-ccCCCCeEEccCC-ccCCC-CCccccCCCcccEEEeccccccCccccccc----cCC
Q 007625 76 GNVISLTLGSNGFSGKISPSIT-KLKFLASLELQDN-DLSGT-LPDFLGSMTHLQSLNLANNKFSGSIPATWS----QLS 148 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~-~l~~L~~L~l~~n-~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~----~l~ 148 (595)
.+++.|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4788888888887766666665 6788888888887 45432 455555788888888888887765444433 566
Q ss_pred CCceecCCCCc--CCccCch----hhhcccccccccc
Q 007625 149 NLKHLDLSSNN--LTGRIPM----QLFSVATFNFTGT 179 (595)
Q Consensus 149 ~L~~l~l~~N~--l~g~ip~----~l~~l~~l~~~~n 179 (595)
+|+.|+|++|. ++..... .+.+++.|++++|
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 88888888886 2211111 2356677777766
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.46 E-value=4.8e-05 Score=83.26 Aligned_cols=81 Identities=15% Similarity=0.181 Sum_probs=55.1
Q ss_pred CCEEEEEcCCCCCCCC----CCccccccCCCCeEEccCCccC----CCCCccccCCCcccEEEeccccccCccccccccC
Q 007625 76 GNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLS----GTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQL 147 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~----~~~~~~~l~~L~~L~l~~n~l~----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l 147 (595)
.+++.|+|++|.+++. ++..+.++++|++|+|++|.++ +.++..+.++++|++|+|++|.+.+ +|..+.++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhh
Confidence 4677888888877655 4444566777788888877776 3344555667777888887777763 66666666
Q ss_pred CCCceecCCC
Q 007625 148 SNLKHLDLSS 157 (595)
Q Consensus 148 ~~L~~l~l~~ 157 (595)
++|+.|++++
T Consensus 243 ~~L~~L~l~~ 252 (592)
T 3ogk_B 243 ANLEEFCGGS 252 (592)
T ss_dssp TTCCEEEECB
T ss_pred hHHHhhcccc
Confidence 6666666654
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.43 E-value=3e-05 Score=79.23 Aligned_cols=54 Identities=19% Similarity=0.153 Sum_probs=24.5
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCcccc--CCCcccEEEec
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG--SMTHLQSLNLA 132 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~--~l~~L~~L~l~ 132 (595)
.+++.|+|++|.-. .+++ + .+++|+.|+|..+.++...-..+. .+++|++|+|+
T Consensus 172 P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp TTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred CCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 46777777665211 2222 2 245555555555544322222222 44555555543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.41 E-value=3.8e-05 Score=69.40 Aligned_cols=85 Identities=11% Similarity=0.128 Sum_probs=65.7
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCc-cCCCCCccccCC----CcccEEEeccc-cccCccccccccCCCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDND-LSGTLPDFLGSM----THLQSLNLANN-KFSGSIPATWSQLSNL 150 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~-l~g~~p~~~~~l----~~L~~L~l~~N-~l~g~~p~~~~~l~~L 150 (595)
+++.|||+++.++..-=..+.++++|+.|+|+++. |+..-=..|+.+ ++|++|+|+++ +++..-=..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 79999999999875544567899999999999985 664333345554 47999999997 4875544568889999
Q ss_pred ceecCCCCc-CC
Q 007625 151 KHLDLSSNN-LT 161 (595)
Q Consensus 151 ~~l~l~~N~-l~ 161 (595)
++|+|++.. ++
T Consensus 142 ~~L~L~~c~~It 153 (176)
T 3e4g_A 142 KYLFLSDLPGVK 153 (176)
T ss_dssp CEEEEESCTTCC
T ss_pred CEEECCCCCCCC
Confidence 999999875 44
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0073 Score=60.19 Aligned_cols=159 Identities=14% Similarity=0.124 Sum_probs=86.3
Q ss_pred cCHHHHHHHhcCCCc-----CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCC--Cccc
Q 007625 261 FSCRELQLATDNFSE-----SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQL 333 (595)
Q Consensus 261 ~~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l 333 (595)
++.+++......|.. .+.|+.|....+|+....+| .+++|+...... ...+..|+.++..+...+ +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcc
Confidence 445555555555654 23466788899999987655 688998764211 224456776666653222 2333
Q ss_pred cce------eecCCceEEEEEecccCcHhh--------------hhcccCCC-CC----CC---CHHHHHH---------
Q 007625 334 IGY------CTTSSERILVYPFMQNLSVAY--------------RLRDLKPG-EK----GL---DWPTRKR--------- 376 (595)
Q Consensus 334 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-~~----~l---~~~~~~~--------- 376 (595)
+.. ....+..+++++|++|..+.. .+|..... .. .. .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 122355689999998764321 12211100 00 01 1222110
Q ss_pred ---HHHHHHHHHHHHhhc----CCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 377 ---VAFGTAYGLEYLHEQ----CNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 377 ---i~~~ia~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
+...+...+++++.. ...+++|+|+++.||+++++..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555532 23479999999999999987666899999765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.16 E-value=7.2e-05 Score=76.41 Aligned_cols=106 Identities=20% Similarity=0.244 Sum_probs=75.3
Q ss_pred CCEEEEEcCCCCCCCCCCcccc--ccCCCCeEEccC--CccCCC-----CCccc--cCCCcccEEEeccccccCcccccc
Q 007625 76 GNVISLTLGSNGFSGKISPSIT--KLKFLASLELQD--NDLSGT-----LPDFL--GSMTHLQSLNLANNKFSGSIPATW 144 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~--~l~~L~~L~l~~--n~l~g~-----~p~~~--~~l~~L~~L~l~~N~l~g~~p~~~ 144 (595)
.+++.|+|..++++...-..+. ++++|+.|+|+. |...|. +...+ ..+++|++|+|++|.+++..+..+
T Consensus 193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l 272 (362)
T 2ra8_A 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272 (362)
T ss_dssp TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred CCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence 4799999998887644333444 789999999964 332222 11122 357999999999999986555444
Q ss_pred c---cCCCCceecCCCCcCCcc----Cch---hhhcccccccccccc
Q 007625 145 S---QLSNLKHLDLSSNNLTGR----IPM---QLFSVATFNFTGTHL 181 (595)
Q Consensus 145 ~---~l~~L~~l~l~~N~l~g~----ip~---~l~~l~~l~~~~n~~ 181 (595)
. .+++|++|+|+.|.|++. ++. .+.+|..|++++|..
T Consensus 273 a~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp HHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred HhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 3 588999999999999863 343 356788888888753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00069 Score=58.11 Aligned_cols=56 Identities=20% Similarity=0.381 Sum_probs=26.7
Q ss_pred EEEcCCCCCC-CCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEecccccc
Q 007625 80 SLTLGSNGFS-GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 137 (595)
Q Consensus 80 ~l~l~~n~l~-g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~ 137 (595)
.++.++++|+ ..+|..+. ++|+.|+|++|+|+..-+..|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555566654 23443222 24555555555555322333445555555555555443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0015 Score=64.78 Aligned_cols=71 Identities=7% Similarity=0.014 Sum_probs=43.9
Q ss_pred CCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCc-cccceeecCCceEEEEEec-ccC
Q 007625 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL-QLIGYCTTSSERILVYPFM-QNL 353 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~-~~g 353 (595)
.+.|+.|....+|+. ..+++|+...... ......+|..+++.+...++. +++++ ..+..+++++|+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 678899999999998 5688888753211 111234677777766433333 44433 344457899999 554
Q ss_pred cH
Q 007625 354 SV 355 (595)
Q Consensus 354 sL 355 (595)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.005 Score=61.60 Aligned_cols=142 Identities=13% Similarity=0.124 Sum_probs=80.3
Q ss_pred CeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCC--Cccccce-----eecCCceEEEEEe
Q 007625 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGY-----CTTSSERILVYPF 349 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~ 349 (595)
..++ |....||+....+|+.+++|+..... .....+..|..++..+.... +.+++.. ....+..+++|+|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 4566 88889999887777789999986321 13445667877777664222 3444433 1123455789999
Q ss_pred cccCcHhh--------------hhcccCCC-----CCCCCHHHH----HHH---------------HHHHHHHHHHHhhc
Q 007625 350 MQNLSVAY--------------RLRDLKPG-----EKGLDWPTR----KRV---------------AFGTAYGLEYLHEQ 391 (595)
Q Consensus 350 ~~~gsL~~--------------~l~~~~~~-----~~~l~~~~~----~~i---------------~~~ia~~L~~LH~~ 391 (595)
++|..+.. .+|..... ....++... ..+ ...+...++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98754320 12211100 011222211 000 11111223333221
Q ss_pred ----CCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 392 ----CNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 392 ----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
....++|+|+++.||+++ + .+.|+||+.+.
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 234689999999999999 4 89999998865
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00054 Score=68.94 Aligned_cols=77 Identities=13% Similarity=0.052 Sum_probs=66.0
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCC-eEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLA-SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~-~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
+++.|+|++| +...-+..|.++++|+ .|+|++ +++..-+..|.+|++|+.|+|++|+++..-+..|.++++|+.|+.
T Consensus 251 ~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 251 YLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 7999999998 7744456799999999 999999 787455689999999999999999999555557999999999874
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0011 Score=56.76 Aligned_cols=57 Identities=19% Similarity=0.302 Sum_probs=46.7
Q ss_pred CeEEccCCccC-CCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcCC
Q 007625 103 ASLELQDNDLS-GTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161 (595)
Q Consensus 103 ~~L~l~~n~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 161 (595)
..++.++++|+ ..+|..|. ++|++|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47899999997 46786543 46999999999999444456889999999999999886
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0019 Score=67.57 Aligned_cols=73 Identities=15% Similarity=0.160 Sum_probs=49.0
Q ss_pred CCeeeeccceEEEEEEeCC--------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCC-ccccceeecCCceEEE
Q 007625 276 SNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV 346 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 346 (595)
.+.|+.|....+|++...+ +..+++|+.... .....+..|..++..+...++ .++++.+.+ .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 4567888899999998753 578999987431 112445578888888754444 455554432 389
Q ss_pred EEecccCcH
Q 007625 347 YPFMQNLSV 355 (595)
Q Consensus 347 ~e~~~~gsL 355 (595)
++|++|.++
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0024 Score=64.20 Aligned_cols=32 Identities=34% Similarity=0.422 Sum_probs=27.5
Q ss_pred CCCcEEcCCCCCCEEEcCC----CcEEEeecccccc
Q 007625 393 NPKIIHRDLKAANILLDDN----FEAVLCDFGLAKL 424 (595)
Q Consensus 393 ~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~~~~ 424 (595)
.+.++|+|+.+.||+++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999874 6799999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0045 Score=63.25 Aligned_cols=73 Identities=11% Similarity=0.031 Sum_probs=43.0
Q ss_pred CCeeeeccceEEEEEEeCC---------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCC-ccccceeecCCceEE
Q 007625 276 SNIIGQGGFGKVYKGVLSD---------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERIL 345 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 345 (595)
.+.|+.|....+|+....+ +..+++|+..... ........|..++..+...++ .++++.. . -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 4567788889999998754 2688888764321 111123577777777753343 3555433 2 378
Q ss_pred EEEecccCc
Q 007625 346 VYPFMQNLS 354 (595)
Q Consensus 346 v~e~~~~gs 354 (595)
||+|++|.+
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.47 E-value=0.00077 Score=61.98 Aligned_cols=85 Identities=11% Similarity=0.198 Sum_probs=60.2
Q ss_pred CCCEEEEEcCCC-CCCC----CCCccccccCCCCeEEccCCccCC----CCCccccCCCcccEEEeccccccCc----cc
Q 007625 75 NGNVISLTLGSN-GFSG----KISPSITKLKFLASLELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSGS----IP 141 (595)
Q Consensus 75 ~~~l~~l~l~~n-~l~g----~~~~~~~~l~~L~~L~l~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p 141 (595)
+..++.|+|++| +|.. .+...+..-+.|+.|+|++|.|.. .|-..+..-+.|++|+|++|+|+.. +-
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 347888999885 6653 234456667889999999998872 2344455667899999999998743 33
Q ss_pred cccccCCCCceecCCCCc
Q 007625 142 ATWSQLSNLKHLDLSSNN 159 (595)
Q Consensus 142 ~~~~~l~~L~~l~l~~N~ 159 (595)
..+..-+.|+.|+|++|.
T Consensus 120 ~aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQR 137 (197)
T ss_dssp HHTTTTCCCSEEECCCCS
T ss_pred HHHhhCCceeEEECCCCc
Confidence 446566779999998763
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0095 Score=60.93 Aligned_cols=142 Identities=16% Similarity=0.199 Sum_probs=82.6
Q ss_pred CCeeeeccceEEEEEEeC--------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCC-ccccceeecCCceEEE
Q 007625 276 SNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV 346 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 346 (595)
.+.|..|-...+|+.... +++.|.+|+.... ......+.+|..+++.+...++ .++++++.+ .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 456777888999999864 2478999986321 1234566789998887753333 455555443 399
Q ss_pred EEecccCcHhhh-----------------hcccC-CCCCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 007625 347 YPFMQNLSVAYR-----------------LRDLK-PGEKGLD--WPTRKRVAFGTAY-------------------GLEY 387 (595)
Q Consensus 347 ~e~~~~gsL~~~-----------------l~~~~-~~~~~l~--~~~~~~i~~~ia~-------------------~L~~ 387 (595)
|||++|.++... +|... ....... +.+..++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998654311 12111 1111222 3455555444322 2333
Q ss_pred Hh----hc-CCCCcEEcCCCCCCEEEcCC----CcEEEeeccccc
Q 007625 388 LH----EQ-CNPKIIHRDLKAANILLDDN----FEAVLCDFGLAK 423 (595)
Q Consensus 388 LH----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~~~ 423 (595)
|. .. ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 32 21 23469999999999999876 789999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.015 Score=61.01 Aligned_cols=74 Identities=16% Similarity=0.121 Sum_probs=47.0
Q ss_pred CCeeeeccceEEEEEEeCC-CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCC-ccccceeecCCceEEEEEecccC
Q 007625 276 SNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILVYPFMQNL 353 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g 353 (595)
.+.|+.|-...+|++...+ +..+++|+..... .. .....+|..++..+...++ .++++++. + ..||+|++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 4578888899999999765 4788898874321 11 1112578888888865555 45665552 2 3599999875
Q ss_pred cH
Q 007625 354 SV 355 (595)
Q Consensus 354 sL 355 (595)
++
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.025 Score=56.92 Aligned_cols=31 Identities=23% Similarity=0.369 Sum_probs=27.5
Q ss_pred CCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 394 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987754
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0029 Score=65.50 Aligned_cols=60 Identities=10% Similarity=0.048 Sum_probs=25.6
Q ss_pred cccccCCCCeEEccCCccC-----CCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 95 SITKLKFLASLELQDNDLS-----GTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 95 ~~~~l~~L~~L~l~~n~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.|.++++|+.++|.+|.+. ..-+..|.+|++|+.++|. |+++-.-...|.+|++|+.|+|
T Consensus 266 aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~l 330 (401)
T 4fdw_A 266 AFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTI 330 (401)
T ss_dssp TTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEE
T ss_pred HhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEE
Confidence 3444444555544444432 1223344444455555444 2243122223444455555554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.31 E-value=0.017 Score=53.53 Aligned_cols=104 Identities=17% Similarity=0.102 Sum_probs=68.5
Q ss_pred cCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc
Q 007625 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (595)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 431 (595)
..+|.+.|..+ +.++++.++|.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 32 ~vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc--------
Confidence 34788888864 46899999999999999998776321111 1223456899999999998754 1110
Q ss_pred eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 007625 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA 475 (595)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p 475 (595)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123566888763 4557889999999999999875544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0059 Score=63.13 Aligned_cols=85 Identities=12% Similarity=0.144 Sum_probs=67.0
Q ss_pred CEEEEEcCCCCCC-----CCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCc
Q 007625 77 NVISLTLGSNGFS-----GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151 (595)
Q Consensus 77 ~l~~l~l~~n~l~-----g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 151 (595)
+|+.|+|.+|.+. ..-+..|.++++|+.++|. |+++..-...|.+|++|+.|+|.+| ++..-+.+|.++ +|+
T Consensus 272 ~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~ 348 (401)
T 4fdw_A 272 ELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIK 348 (401)
T ss_dssp TCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCC
T ss_pred CCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCC
Confidence 6888888887764 2334579999999999999 4577445678999999999999665 773445679999 999
Q ss_pred eecCCCCcCCccCc
Q 007625 152 HLDLSSNNLTGRIP 165 (595)
Q Consensus 152 ~l~l~~N~l~g~ip 165 (595)
.|++++|.+. .++
T Consensus 349 ~l~l~~n~~~-~l~ 361 (401)
T 4fdw_A 349 EVKVEGTTPP-QVF 361 (401)
T ss_dssp EEEECCSSCC-BCC
T ss_pred EEEEcCCCCc-ccc
Confidence 9999999887 444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.54 E-value=0.004 Score=56.06 Aligned_cols=87 Identities=9% Similarity=0.157 Sum_probs=60.9
Q ss_pred CCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEecccc-ccCccccccccC----CCCceecCCCCc-CCcc--
Q 007625 92 ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK-FSGSIPATWSQL----SNLKHLDLSSNN-LTGR-- 163 (595)
Q Consensus 92 ~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~l~l~~N~-l~g~-- 163 (595)
+|.....--+|+.|||+++.++..--..+.++++|++|+|+++. ++..-=..++.+ ++|++|+|+++. +|..
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 34433233579999999999886555667899999999999985 775444456654 479999999975 6621
Q ss_pred --Cchhhhcccccccccc
Q 007625 164 --IPMQLFSVATFNFTGT 179 (595)
Q Consensus 164 --ip~~l~~l~~l~~~~n 179 (595)
+ ..+.+|+.|++++-
T Consensus 133 ~~L-~~~~~L~~L~L~~c 149 (176)
T 3e4g_A 133 IAL-HHFRNLKYLFLSDL 149 (176)
T ss_dssp HHG-GGCTTCCEEEEESC
T ss_pred HHH-hcCCCCCEEECCCC
Confidence 1 13456666776653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.19 E-value=0.0046 Score=56.73 Aligned_cols=87 Identities=13% Similarity=0.133 Sum_probs=64.8
Q ss_pred CCCEEEEEcCCCCCCCC----CCccccccCCCCeEEccCCccCCC----CCccccCCCcccEEEeccc---cccC----c
Q 007625 75 NGNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANN---KFSG----S 139 (595)
Q Consensus 75 ~~~l~~l~l~~n~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N---~l~g----~ 139 (595)
+..|+.|+|++|+|... +...+..-+.|++|+|++|.|+.. +-..+..-+.|+.|+|++| .+.. .
T Consensus 69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ 148 (197)
T 1pgv_A 69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMD 148 (197)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHH
T ss_pred CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHH
Confidence 45899999999999743 334455678999999999999843 3345566678999999876 3442 2
Q ss_pred cccccccCCCCceecCCCCcCC
Q 007625 140 IPATWSQLSNLKHLDLSSNNLT 161 (595)
Q Consensus 140 ~p~~~~~l~~L~~l~l~~N~l~ 161 (595)
+-..+..-+.|+.|+++.|.+.
T Consensus 149 ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 149 MMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHhCCCcCeEeccCCCcc
Confidence 4455666788999999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.03 E-value=0.12 Score=53.53 Aligned_cols=141 Identities=12% Similarity=0.133 Sum_probs=82.7
Q ss_pred CCeeeeccceEEEEEEeCC--------CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCC-ccccceeecCCceEEE
Q 007625 276 SNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV 346 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 346 (595)
.+.+..|-...+|+....+ +..|++|+..... ....+..+|..+++.+...++ .++++.+ . -+.|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 4567778889999998753 5789999864321 111223578888877753333 3444432 2 3789
Q ss_pred EEecccCcHhh-----------------hhcccC------C---CCCCCCHHHHHHHHHHH-------------------
Q 007625 347 YPFMQNLSVAY-----------------RLRDLK------P---GEKGLDWPTRKRVAFGT------------------- 381 (595)
Q Consensus 347 ~e~~~~gsL~~-----------------~l~~~~------~---~~~~l~~~~~~~i~~~i------------------- 381 (595)
++|++|.++.. .+|... + ...+.-+.+..++..++
T Consensus 149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 228 (424)
T 3mes_A 149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI 228 (424)
T ss_dssp EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence 99999865321 011110 1 11222244444443322
Q ss_pred HHHHHHHhh---------------------cCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 382 AYGLEYLHE---------------------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 382 a~~L~~LH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
...+.+|.+ .....++|+|+.+.||+ +.++.+.++||..+.
T Consensus 229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 222333321 11236899999999999 778899999999875
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=93.57 E-value=0.063 Score=55.09 Aligned_cols=99 Identities=12% Similarity=0.277 Sum_probs=61.5
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
.++.+.+.++-.+ .-...|.+++.|+.+.+. +.++..-...|.++++|+.++|..| ++-.-..+|.+|.+|+.+.|.
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 4666766654332 334457778888888885 4455233456777888888888654 552233457778888888875
Q ss_pred CCcCCccCchhh----hccccccccccc
Q 007625 157 SNNLTGRIPMQL----FSVATFNFTGTH 180 (595)
Q Consensus 157 ~N~l~g~ip~~l----~~l~~l~~~~n~ 180 (595)
.| ++ .|+... .+|+.+.+.+|.
T Consensus 343 ~s-v~-~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 343 SS-VT-KIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp TT-CC-BCCGGGGTTCTTCCEEEESSCH
T ss_pred cc-cC-EEhHhHhhCCCCCCEEEECCce
Confidence 44 55 565432 346666676664
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=92.24 E-value=0.22 Score=50.96 Aligned_cols=68 Identities=19% Similarity=0.358 Sum_probs=46.8
Q ss_pred ccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccc-cccccCCCCceecCCCCcCCccCch
Q 007625 94 PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP-ATWSQLSNLKHLDLSSNNLTGRIPM 166 (595)
Q Consensus 94 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g~ip~ 166 (595)
..|.+++.|+.+.+.++..+ .-...|.++++|+.+.+. +.++ .|+ ..|.++.+|+.++|..| ++ .|..
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~ 327 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILD 327 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECT
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehH
Confidence 45777888888888766544 445567788888888885 4555 444 45778888888888654 44 4543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=92.13 E-value=0.25 Score=50.16 Aligned_cols=62 Identities=11% Similarity=0.157 Sum_probs=31.2
Q ss_pred cccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCC
Q 007625 95 SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSS 157 (595)
Q Consensus 95 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~ 157 (595)
.|.++.+|+.+.+..+ +...-...|.++++|+.+++.+|.++..-...|.++.+|+.++|.+
T Consensus 258 aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~ 319 (379)
T 4h09_A 258 LLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPT 319 (379)
T ss_dssp TTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCT
T ss_pred ccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCc
Confidence 3445555555555433 3312233455566666666666555522233455666666666543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=92.08 E-value=0.097 Score=53.68 Aligned_cols=80 Identities=15% Similarity=0.207 Sum_probs=50.1
Q ss_pred ccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCcc-ccccccCCCCceecCCCCcCCccCchhh----
Q 007625 94 PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI-PATWSQLSNLKHLDLSSNNLTGRIPMQL---- 168 (595)
Q Consensus 94 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~l~l~~N~l~g~ip~~l---- 168 (595)
..|..+.+|+.+.+.++ ++..-...|.++++|+.++|.++ ++ .| ..+|.++++|+.++|..| ++ .|+...
T Consensus 291 ~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C 365 (394)
T 4fs7_A 291 KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGC 365 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTC
T ss_pred ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCC
Confidence 34677778888887655 55233456777888888888644 55 44 445777888888887766 55 555422
Q ss_pred hccccccccc
Q 007625 169 FSVATFNFTG 178 (595)
Q Consensus 169 ~~l~~l~~~~ 178 (595)
.+|+.+.+..
T Consensus 366 ~~L~~i~lp~ 375 (394)
T 4fs7_A 366 INLKKVELPK 375 (394)
T ss_dssp TTCCEEEEEG
T ss_pred CCCCEEEECC
Confidence 2345555543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=91.90 E-value=0.19 Score=51.01 Aligned_cols=81 Identities=11% Similarity=0.155 Sum_probs=59.1
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccc-cccccCCCCceecC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP-ATWSQLSNLKHLDL 155 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~l~l 155 (595)
.++.+.+.. ++...-...|.++++|+.+++.++.++..-+..|.++++|+.++|..| ++ .|+ .+|.++++|+.+.+
T Consensus 264 ~l~~i~l~~-~i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 264 ALKTLNFYA-KVKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TCCEEEECC-CCSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCC
T ss_pred hhccccccc-cceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEE
Confidence 344455543 243222346889999999999999998444678999999999999765 66 454 56999999999987
Q ss_pred CCCcCC
Q 007625 156 SSNNLT 161 (595)
Q Consensus 156 ~~N~l~ 161 (595)
..| ++
T Consensus 341 p~~-v~ 345 (379)
T 4h09_A 341 PKS-IT 345 (379)
T ss_dssp CTT-CC
T ss_pred CCc-cC
Confidence 544 44
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.07 E-value=0.2 Score=51.58 Aligned_cols=28 Identities=32% Similarity=0.539 Sum_probs=24.2
Q ss_pred cEEcCCCCCCEEE------cCCCcEEEeeccccc
Q 007625 396 IIHRDLKAANILL------DDNFEAVLCDFGLAK 423 (595)
Q Consensus 396 ivH~Dlkp~NIll------~~~~~~kl~DfG~~~ 423 (595)
++|+|+.+.||++ +++..++++||.++.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456779999999875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.69 E-value=0.98 Score=41.58 Aligned_cols=116 Identities=11% Similarity=0.076 Sum_probs=77.3
Q ss_pred CCCCCccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCC
Q 007625 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (595)
Q Consensus 326 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 405 (595)
.||+.++. ..-.+.+...+.|+.-+.+.-...++ ..+...+++++.+|+....+++.. +|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 57887765 34455555555555444332222233 367889999999999888666654 788999999
Q ss_pred EEEcCCCcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 007625 406 ILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477 (595)
Q Consensus 406 Ill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~ 477 (595)
++++.++.+++.-.|+-..+ +|. ..++..=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999776654322 222 12222334457788899999987764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=88.22 E-value=0.35 Score=49.45 Aligned_cols=79 Identities=14% Similarity=0.102 Sum_probs=61.0
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.+.+.++ +...-..+|.++++|+.++|.++ ++..-...|.++++|+.++|..| ++-.-..+|.++++|+.+++.
T Consensus 298 ~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 298 SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp TCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred cccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 6888888764 55333457999999999999755 76334678999999999999877 773334579999999999886
Q ss_pred CC
Q 007625 157 SN 158 (595)
Q Consensus 157 ~N 158 (595)
.|
T Consensus 375 ~~ 376 (394)
T 4fs7_A 375 KR 376 (394)
T ss_dssp GG
T ss_pred CC
Confidence 54
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.05 E-value=2 Score=39.72 Aligned_cols=115 Identities=13% Similarity=0.142 Sum_probs=74.9
Q ss_pred CCCCCccccceeecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCcEEcCCCCC
Q 007625 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE-YLHEQCNPKIIHRDLKAA 404 (595)
Q Consensus 326 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~Dlkp~ 404 (595)
.||++ -...-.+++...+.|+.-+++.-...++ .++...+++++.+++.... +++. -+|--++|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 2334455666666666654443333333 3678899999999888766 5554 478889999
Q ss_pred CEEEcCCCcEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 007625 405 NILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477 (595)
Q Consensus 405 NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~ 477 (595)
|++++.++.+++.-.|+-.. ++|.-+ ++.-=.-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTT------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCccc------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999987776432 233221 121223357778888888876653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 595 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-62
Identities = 74/282 (26%), Positives = 127/282 (45%), Gaps = 26/282 (9%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 329
+ IG G FG VYKG VAVK L +P AF+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+L +GY T + + +V + + S+ + L ++ + +A TA G++YLH
Sbjct: 66 ILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLH 121
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYL 448
+ IIHRDLK+ NI L ++ + DFGLA + +H Q+ G++ +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 449 STGKS---SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505
S ++DV+ +GI L EL+TGQ ++ + + L+ +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS----NINNRDQIIFMVGRGYLSPDLSKV 234
Query: 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
S + M ++ C + ++RP Q++ ++
Sbjct: 235 --------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 4e-62
Identities = 74/277 (26%), Positives = 126/277 (45%), Gaps = 24/277 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+ +G G FG+V+ G + +TKVAVK L+ AF E +L+ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRL 70
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
++L T ++ +M+N S+ L+ P L +A A G+ ++ E
Sbjct: 71 VRLYAVVT-QEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 450
+ IHRDL+AANIL+ D + DFGLA+L++ + + APE ++
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 451 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510
G + K+DV+ +GI L E+VT R E ++ ++ + R R ++ +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQNLERGYRMVRPDNCPEE-- 238
Query: 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ Q+ LC + PEDRP + +L+
Sbjct: 239 ----------LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-60
Identities = 71/284 (25%), Positives = 123/284 (43%), Gaps = 28/284 (9%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+ IG G FG V+ G + KVA+K +++ E F E ++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKL 62
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGLEYLH 389
+QL G C + LV+ FM++ L D ++GL T + G+ YL
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
E C +IHRDL A N L+ +N + DFG+ + V +T + + +PE S
Sbjct: 119 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 450 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509
+ S K+DV+ +G+ + E+ + + +R E +++ I R +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVEDISTGFRLYKPRLASTH- 230
Query: 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE 553
+ Q+ C + PEDRP +++++ L ++AE
Sbjct: 231 -----------VYQIMNHCWKERPEDRPAFSRLLRQL--AEIAE 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-60
Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 24/277 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
++ +GQG FG+V+ G + T+VA+K L+ AF +E ++ H+ L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKL 74
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
+QL + +V +M S K L P +A A G+ Y+
Sbjct: 75 VQLYAVVSEE-PIYIVTEYMSKGS--LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 450
+HRDL+AANIL+ +N + DFGLA+L++ + + APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 451 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510
G+ + K+DV+ +GI L EL T R + E +LD + + R + +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPES-- 242
Query: 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + C + PE+RP + L+
Sbjct: 243 ----------LHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (506), Expect = 1e-59
Identities = 72/304 (23%), Positives = 126/304 (41%), Gaps = 39/304 (12%)
Query: 261 FSCRELQLATDNFSES---------NIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYY 307
F+ + A F++ +IG G FG+V G L K VA+K L+ Y
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 308 SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK 367
+ F E ++ H N++ L G T S+ +++ FM+N S+ LR +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123
Query: 368 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427
+ G A G++YL + +HRDL A NIL++ N + DFGL++ ++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 428 KLTHVTT----QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 483
+ T + + APE + K + +DV+ YGI + E+++ + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-YWDMTN 239
Query: 484 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 543
++ +++ I + R D + Q+ L C Q RP Q+V
Sbjct: 240 QD---VINAIEQDYRLPPPMDCPSA------------LHQLMLDCWQKDRNHRPKFGQIV 284
Query: 544 KMLQ 547
L
Sbjct: 285 NTLD 288
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (503), Expect = 2e-59
Identities = 71/310 (22%), Positives = 123/310 (39%), Gaps = 46/310 (14%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 318
L+ +N IG+G FG+V++ T VAVK L++ S +A FQRE
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 319 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK--------------- 363
L++ + N+++L+G C L++ +M + LR +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 364 -----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418
PG L + +A A G+ YL E+ K +HRDL N L+ +N + D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 183
Query: 419 FGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477
FGL++ + A + + PE + + + ++DV+ YG+ L E+ +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 478 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 537
+ EE + + D N+ + + LC P DRP
Sbjct: 244 YGMAHEE----------------VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP 287
Query: 538 PMAQVVKMLQ 547
+ ++LQ
Sbjct: 288 SFCSIHRILQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-59
Identities = 65/327 (19%), Positives = 120/327 (36%), Gaps = 47/327 (14%)
Query: 266 LQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV 324
++L D+F + + +G G G V+K +A K + P RE+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 325 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 384
++ G + E + M S L + + +V+ G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGS----LDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
L YL E+ KI+HRD+K +NIL++ E LCDFG++ + + GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMS 171
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504
PE L S ++D++ G++L+E+ G+ I +E E +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 505 IVDRNLNTYDSKEVETMVQVALL--------------------------CTQSTPEDRPP 538
R L++Y M LL C P +R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 539 MAQVVKMLQGEDLAERW---AEWEELE 562
+ Q+ + + ++ EE++
Sbjct: 292 LKQL--------MVHAFIKRSDAEEVD 310
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-59
Identities = 70/289 (24%), Positives = 128/289 (44%), Gaps = 29/289 (10%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNT-----KVAVKRLQDYYSPGGEAAFQREVHL 321
++ + +IG G FG+VYKG+L ++ VA+K L+ Y+ F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 381
+ H N+++L G + +++ +M+N ++ LR+ + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGT 439
A G++YL N +HRDL A NIL++ N + DFGL++++ D + T+ T+ +
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499
+ APE +S K + +DV+ +GI + E++T + E ++ I R
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----VMKAINDGFRL 232
Query: 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548
D + Q+ + C Q RP A +V +L
Sbjct: 233 PTPMDCPSA------------IYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-58
Identities = 58/277 (20%), Positives = 108/277 (38%), Gaps = 24/277 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+ + +G G FG V G VA+K +++ E F E ++ H+ L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKL 61
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
+QL G CT ++ +M N + L L+ + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 450
+ +HRDL A N L++D + DFGL++ V + + + PE L
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 451 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 510
K S K+D++ +G+ + E+ + + + R E +HI + LR R + ++
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSE---TAEHIAQGLRLYRPHLASEK-- 229
Query: 511 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + C ++RP ++ +
Sbjct: 230 ----------VYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 9e-58
Identities = 64/290 (22%), Positives = 121/290 (41%), Gaps = 29/290 (10%)
Query: 264 RELQLATDNFSESNI-IGQGGFGKVYKGVL---SDNTKVAVKRLQDYYSPGGEAAFQREV 319
++L L DN ++I +G G FG V +GV VA+K L+ RE
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 320 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 379
++ + +++LIG C +LV + L + + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLH 116
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIR 437
+ G++YL E+ +HRDL A N+LL + A + DFGL+K + D + +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 438 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 497
+ APE ++ K S ++DV+ YG+T+ E ++ + + +++ E ++ I +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPE---VMAFIEQGK 229
Query: 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
R + + + + C EDRP V + ++
Sbjct: 230 RMECPPECPPE------------LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-56
Identities = 78/285 (27%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIH 327
+F+E +IG+G FG VY G L DN AVK L G + F E ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 328 KNLLQLIGYCT-TSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGL 385
N+L L+G C + ++V P+M++ LR+ E A G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGD----LRNFIRNETHNPTVKDLIGFGLQVAKGM 143
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTHVTTQIRGTMGH 442
+ K +HRDL A N +LD+ F + DFGLA+ + + H T + +
Sbjct: 144 ---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502
+A E L T K + K+DV+ +G+ L EL+T DV D LL+ RL
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-------PDVNTFDITVYLLQGRRL 253
Query: 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + +V L C E RP +++V +
Sbjct: 254 LQ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (480), Expect = 3e-56
Identities = 71/306 (23%), Positives = 134/306 (43%), Gaps = 26/306 (8%)
Query: 259 RRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQR 317
+ + ++ + + + +G G +G+VY+GV + VAVK L++ F +
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK 62
Query: 318 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 377
E ++ H NL+QL+G CT ++ FM ++ LR+ E + +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYM 120
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
A + +EYL + IHRDL A N L+ +N + DFGL++L+ +
Sbjct: 121 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 438 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 497
+ APE L+ K S K+DV+ +G+ L E+ T + + + + + K
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKDY 233
Query: 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAE 557
R +R ++ + ++ C Q P DRP A++ + E + + +
Sbjct: 234 RMERPEGCPEK------------VYELMRACWQWNPSDRPSFAEIHQAF--ETMFQESSI 279
Query: 558 WEELEE 563
+E+E+
Sbjct: 280 SDEVEK 285
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-56
Identities = 63/291 (21%), Positives = 114/291 (39%), Gaps = 30/291 (10%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
IG+G FG+V++G +VAVK + E++ + H+N+L I
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 339 ----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-- 392
T ++ LV + ++ S+ L + ++A TA GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 393 ---NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK---LTHVTTQIRGTMGHIAPE 446
P I HRDLK+ NIL+ N + D GLA D+ + GT ++APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 447 YLST------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE--EDVLLLDHIRKLLR 498
L +S ++ D++ G+ E+ + D++ D + +R
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 499 EDRLNDIVDRNL--NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + N+ + + M ++ C + R ++ K L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 8e-56
Identities = 66/278 (23%), Positives = 108/278 (38%), Gaps = 30/278 (10%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
IG+G FG V G KVAVK +++ AF E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 62
Query: 331 LQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+QL+G + +V +M S+ LR G L + + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
+HRDL A N+L+ ++ A + DFGL K + + + APE L
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALR 173
Query: 450 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509
K S K+DV+ +GI L E+ + R ++ ++ + K + D +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGYKMDAPDGCPPA- 228
Query: 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ +V C RP Q+ + L+
Sbjct: 229 -----------VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-55
Identities = 67/301 (22%), Positives = 115/301 (38%), Gaps = 40/301 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS- 323
+ S +G G FGKV + VAVK L+ A E+ ++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD--------------LKPGEKGL 369
+ H N++ L+G CT +++ + + LR ++ E L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 370 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
D ++ A G+ +L + IHRDL A NILL +CDFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 430 TH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
+ V R + +APE + + ++DV+ YGI L EL + + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 489 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548
I++ R M + C + P RP Q+V++++
Sbjct: 257 FYKMIKEGFRML------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 549 E 549
+
Sbjct: 305 Q 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-55
Identities = 65/306 (21%), Positives = 117/306 (38%), Gaps = 45/306 (14%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK------VAVKRLQDYYSPGGEAAFQREVHLIS- 323
+N ++G G FGKV +K VAVK L++ A E+ +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------------- 364
+ H+N++ L+G CT S L++ + + LR +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 365 GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424
L + A+ A G+E+L + +HRDL A N+L+ +CDFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 425 VDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 483
+ + +V R + +APE L G + K+DV+ YGI L E+ + + +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 272
Query: 484 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 543
+ + I+ + D+ + + + C RP +
Sbjct: 273 DAN--FYKLIQNGFKMDQPFYATEE------------IYIIMQSCWAFDSRKRPSFPNLT 318
Query: 544 KMLQGE 549
L +
Sbjct: 319 SFLGCQ 324
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-55
Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 37/293 (12%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLIS-VAI 326
++ ++IG+G FG+V K + + A+KR+++Y S F E+ ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE------------KGLDWPTR 374
H N++ L+G C L + + ++ LR + E L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 375 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 434
A A G++YL + + IHRDL A NIL+ +N+ A + DFGL++ + + T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494
R + +A E L+ + +DV+ YG+ L E+V+ E L + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLP 240
Query: 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ R ++ + D + + C + P +RP AQ++ L
Sbjct: 241 QGYRLEKPLNCDDE------------VYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-54
Identities = 55/280 (19%), Positives = 106/280 (37%), Gaps = 24/280 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+++ IG G +G+ K SD + K L + + EV+L+ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 329 NLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
N+++ + L V + + +A + + LD RV L+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 387 YLHEQ--CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
H + ++HRDLK AN+ LD L DFGLA++++ T GT +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMS 182
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504
PE ++ +EK+D++ G L EL F+ ++E
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKE---------------LAGK 225
Query: 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
I + + + + ++ RP + ++++
Sbjct: 226 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 4e-54
Identities = 57/275 (20%), Positives = 107/275 (38%), Gaps = 31/275 (11%)
Query: 277 NIIGQGGFGKVYKGVLSD-NTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLI 334
IG+G F VYKG+ ++ +VA LQD + F+ E ++ H N+++
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 335 GYCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
++ + +LV M + + L+ K + + GL++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGT----LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 391 QCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
+ P IIHRDLK NI + + D GLA L + GT +APE
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186
Query: 450 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509
K E DV+ +G+ +LE+ T + E + + + ++ + +
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
+ ++ C + ++R + ++
Sbjct: 242 V-----------KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-53
Identities = 56/277 (20%), Positives = 107/277 (38%), Gaps = 25/277 (9%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+++ +G+G +G+V V VAVK + + ++E+ + + H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+++ G+ + + L + + R+ + G+ P +R G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA-KLTHVTTQIRGTMGHIAPEYL 448
I HRD+K N+LLD+ + DFGLA + + ++ GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 449 STGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507
+ +E DV+ GI L ++ G+ D + D K + I
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKI-- 232
Query: 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
++ P R + + K
Sbjct: 233 -------DSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-53
Identities = 64/279 (22%), Positives = 109/279 (39%), Gaps = 30/279 (10%)
Query: 275 ESNIIGQGGFGKVYKGVLSD---NTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL 330
E +G G FG V KG VAVK L+ + P + E +++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
+++IG C S +LV + L + + + + G++YL E
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGP----LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYL 448
+HRDL A N+LL A + DFGL+K + A + Q + + APE +
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508
+ K S K+DV+ +G+ + E + + + ++ E + + K R
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSE---VTAMLEKGERMGCPAGCPRE 238
Query: 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
M + LC E+RP A V L+
Sbjct: 239 ------------MYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 3e-52
Identities = 63/277 (22%), Positives = 108/277 (38%), Gaps = 31/277 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 327
++F +G+G FG VY +A+K L G E +REV + S H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
N+L+L GY ++ L+ + +V L+ L D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
H + ++IHRD+K N+LL E + DFG + + + GT+ ++ PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507
+ EK D++ G+ E + G+ + + +E I ++ E D V
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKRISRV--EFTFPDFVT 228
Query: 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
E + + P RP + +V++
Sbjct: 229 -----------EGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-51
Identities = 63/298 (21%), Positives = 128/298 (42%), Gaps = 32/298 (10%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 318
E ++A + + S +GQG FG VY+GV T+VA+K + + S F E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 319 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG------LDWP 372
++ ++++L+G + +++ M + LR L+P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTH 431
++A A G+ YL+ K +HRDL A N ++ ++F + DFG+ + + +
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 491
+ + ++PE L G + +DV+ +G+ L E+ T + L E+ +L
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQ---VLR 246
Query: 492 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549
+ + D+ ++ D + ++ +C Q P+ RP +++ ++ E
Sbjct: 247 FVMEGGLLDKPDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-50
Identities = 57/283 (20%), Positives = 116/283 (40%), Gaps = 29/283 (10%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVA 325
F + ++G G FG VYKG+ VA+K L++ SP E ++++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
+ ++ +L+G C TS+ +++ L ++ + + A G+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA-KLTHVTTQIRGTMGHIA 444
YL ++ +++HRDL A N+L+ + DFGLAKL+ A + + + + +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504
E + + ++DV+ YG+T+ EL+T + + E + + K R +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASE---ISSILEKGERLPQPPI 237
Query: 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + + C + RP +++
Sbjct: 238 CTID------------VYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 6e-50
Identities = 72/281 (25%), Positives = 101/281 (35%), Gaps = 34/281 (12%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAI 326
FS+ IG G FG VY + ++ VA+K++ S +EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H N +Q G LV + + KP L V G GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
YLH +IHRD+KA NILL + L DFG A ++ GT +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPE 181
Query: 447 YLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503
+ G+ K DV+ GIT +EL + L + L HI + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNESPALQS 236
Query: 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
E C Q P+DRP ++K
Sbjct: 237 GHWS-----------EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-49
Identities = 73/286 (25%), Positives = 107/286 (37%), Gaps = 32/286 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRL--QDYYSPGGEAAFQREVHLISV 324
+ +G G FG V +G + VAVK L P F REV+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 325 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAY 383
H+NL++L G T ++ V S L D +G T R A A
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH--VTTQIRGTMG 441
G+ YL + IHRDL A N+LL + DFGL + + H + +
Sbjct: 123 GMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501
APE L T S +D + +G+TL E+ T + + L + +L ++ R R
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQ--ILHKIDKEGERLPR 236
Query: 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
D + V + C PEDRP + L
Sbjct: 237 PEDCPQD------------IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-48
Identities = 54/282 (19%), Positives = 109/282 (38%), Gaps = 29/282 (10%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAI 326
+ IG+G FG V++G+ VA+K ++ S F +E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGL 385
H ++++LIG T + ++ LR K LD + A+ + L
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 445
YL + + +HRD+ A N+L+ N L DFGL++ ++ + ++ + + +AP
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505
E ++ + + +DV+ +G+ + E++ + ++ I R +
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGERLPMPPNC 234
Query: 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
T+ + C P RP ++ L
Sbjct: 235 ------------PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 9e-48
Identities = 63/281 (22%), Positives = 111/281 (39%), Gaps = 29/281 (10%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
D + +G G FGKVYK + A K + D S + E+ +++ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-DTKSEEELEDYMVEIDILASCDHP 69
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N+++L+ + ++ F +V + +L+ + L + V T L YL
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYL 126
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H+ KIIHRDLKA NIL + + L DFG++ + + GT +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVV 182
Query: 449 STGKS-----SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503
S K DV+ GITL+E+ + L + K+ + +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMR------VLLKIAKSEPPT 234
Query: 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
S + ++ C + + R +Q+++
Sbjct: 235 LAQPSRW----SSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-47
Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 41/299 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLI 322
D +G+G FG+V + TKVAVK L+ + + E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 323 S-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------EKGL 369
+ HKN++ L+G CT ++ + ++ L+ +P E+ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 370 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
A+ A G+EYL K IHRDL A N+L+ ++ + DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 430 THVTTQ-IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
+ T R + +APE L + ++DV+ +G+ L E+ T + EE
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245
Query: 489 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
L +++ R D+ ++ + + + C + P RP Q+V+ L
Sbjct: 246 LFKLLKEGHRMDKPSNCTNE------------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 7e-47
Identities = 70/298 (23%), Positives = 123/298 (41%), Gaps = 39/298 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGV------LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV 324
D +G+G FG+V + + VAVK L++ + A E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 325 AIH-KNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKP------------GEKGLD 370
H N++ L+G CT + ++ F + +++ LR + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 371 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+F A G+E+L + K IHRDL A NILL + +CDFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 431 HV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489
+V R + +APE + + ++DV+ +G+ L E+ + + V +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-------PGVKI 242
Query: 490 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+ + L+E D Y + E M Q L C P RP +++V+ L
Sbjct: 243 DEEFCRRLKEGTRMRAPD-----YTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-45
Identities = 52/276 (18%), Positives = 108/276 (39%), Gaps = 26/276 (9%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
++ IGQG G VY + ++ +VA++++ + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ + E +V ++ S+ + E +D V LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFL 132
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H ++IHRD+K+ NILL + L DFG + + + +T + GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508
+ K D++ GI +E++ G+ ++ + +L ++L
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL------ 242
Query: 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
S + C E R ++++
Sbjct: 243 ------SAIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-43
Identities = 60/300 (20%), Positives = 107/300 (35%), Gaps = 34/300 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 327
++F I+G+G F V L+ + + A+K L + RE ++S H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
++L + + +N L D + LEY
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPE 446
LH + IIHRDLK NILL+++ + DFG AK++ + GT +++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506
L+ + + +D++ G + +LV G + L+ I KL
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKIIKL---------- 225
Query: 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERW---AEWEELEE 563
+ + + +V+ R ++ G A + WE L +
Sbjct: 226 EYDFPEKFFPKARDLVE---KLLVLDATKRLGCEEMEGY--GPLKAHPFFESVTWENLHQ 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 155 bits (392), Expect = 7e-43
Identities = 56/277 (20%), Positives = 104/277 (37%), Gaps = 26/277 (9%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
D++ +G G FG V++ + A K + + ++E+ +SV H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPT 84
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
L+ L +E +++Y FM + ++ D + GL ++H
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH 141
Query: 390 EQCNPKIIHRDLKAANILL--DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
E +H DLK NI+ + E L DFGL +D K + T GT APE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEV 196
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507
TD++ G+ L++G E D L +++ +D
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSP-----FGGENDDETLRNVKSCDWN------MD 245
Query: 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
+ + S++ + ++ + P R + Q ++
Sbjct: 246 DSAFSGISEDGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 147 bits (373), Expect = 6e-41
Identities = 58/290 (20%), Positives = 110/290 (37%), Gaps = 39/290 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--------QDYYSPGGEAAFQREVHL 321
+N+ I+G+G V + + + AVK + A +EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 322 IS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
+ V+ H N++QL T++ LV+ M+ + L + + L +++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRA 118
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
+ LH+ I+HRDLK NILLDD+ L DFG + +D ++ GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTP 173
Query: 441 GHIAPEYLSTG------KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494
++APE + ++ D++ G+ + L+ G + +L+L I
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQMLMLRMIM 228
Query: 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
+ + S V+ +V P+ R + +
Sbjct: 229 S--GNYQFGSPEWDDY----SDTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 7e-41
Identities = 62/310 (20%), Positives = 125/310 (40%), Gaps = 29/310 (9%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLI 322
++ + D + +++G G F +V VA+K + G E + + E+ ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 323 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
H N++ L + L+ + + R+ + R+ F
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVL 117
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 439
++YLH+ I+HRDLK N+L D++ + ++ DFGL+K+ D V + GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGT 172
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499
G++APE L+ S+ D + G+ L+ G +E D L + I K E
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----FYDENDAKLFEQILK--AE 225
Query: 500 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM--LQGEDLAERWAE 557
+ ++ S + ++ + PE R Q ++ + G+ ++
Sbjct: 226 YEFDSPYWDDI----SDSAKDFIR---HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIH 278
Query: 558 WEELEEVRQQ 567
E++++
Sbjct: 279 QSVSEQIKKN 288
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (377), Expect = 8e-41
Identities = 50/277 (18%), Positives = 99/277 (35%), Gaps = 26/277 (9%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
D + +G G FG V++ V + K + P + + E+ +++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPK 87
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
L+ L E +L+ F+ + R+ + GL+++H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH 144
Query: 390 EQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
E I+H D+K NI+ + + DFGLA ++ + T APE
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEI 199
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507
+ TD++ G+ L++G F+ ++ E + + ED + +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDEDAFSSV-- 255
Query: 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
S E + ++ Q P R + ++
Sbjct: 256 -------SPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 1e-40
Identities = 61/288 (21%), Positives = 116/288 (40%), Gaps = 23/288 (7%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 329
+ + IG+G +G VYK + A+K+++ + G + RE+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+++L T +LV+ + + L E GL+ T K G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
++ +++HRDLK N+L++ E + DFGLA+ + T +I +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 450 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV--- 506
+ K S D++ G E+V G F + E + ++ + I ++
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPL--FPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 507 --DRNLNTYDSKEVETMVQ------VALL--CTQSTPEDRPPMAQVVK 544
D N Y+ E+ ++ + LL + P R Q ++
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 66/305 (21%), Positives = 115/305 (37%), Gaps = 36/305 (11%)
Query: 262 SCRELQLATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRL-QDYYSPGGEAAFQRE 318
CR A + IG+G +GKV+K + + VA+KR+ G + RE
Sbjct: 2 LCR----ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 57
Query: 319 VHL---ISVAIHKNLLQLIGYCTTSS--ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
V + + H N+++L CT S + +++ K E G+ T
Sbjct: 58 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 117
Query: 374 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433
K + F GL++LH +++HRDLK NIL+ + + L DFGLA++ ++
Sbjct: 118 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 172
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 493
T + T+ + APE L + D++ G E+ + DV L I
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL-----FRGSSDVDQLGKI 227
Query: 494 RKLLR--------------EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 539
++ + + + + + E + L C P R
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
Query: 540 AQVVK 544
+
Sbjct: 288 YSALS 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 147 bits (372), Expect = 6e-40
Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 32/278 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRL--QDYYSPGGEAAFQREVHLISV--- 324
++FS IIG+GGFG+VY +D A+K L + GE E ++S+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 325 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 384
++ + T + + M + Y L + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
LE++H + +++RDLK ANILLD++ + D GLA K H + GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173
Query: 445 PEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503
PE L G + D F G L +L+ G + +++ ++ + + D
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF- 232
Query: 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 541
S E+ ++++ Q R
Sbjct: 233 -----------SPELRSLLE---GLLQRDVNRRLGCLG 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 1e-39
Identities = 58/287 (20%), Positives = 103/287 (35%), Gaps = 19/287 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+NF + IG+G +G VYK VA+K+++ D + G + RE+ L+ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N+++L+ T ++ LV+ F+ + G+ P K F GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFC 118
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H ++HRDLK N+L++ L DFGLA+ + T ++ L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAID-----------FSRLEEEEDVLLLDHIRKLL 497
S D++ G E+VT + F L ++V+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 498 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
+ ++ + E + P R +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 143 bits (362), Expect = 2e-39
Identities = 57/284 (20%), Positives = 109/284 (38%), Gaps = 30/284 (10%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAI 326
+D + I+G GG +V+ L + VAVK L P F+RE +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 327 HKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
H ++ + + +V ++ +++ + P + V
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 440
L + H+ IIHRD+K ANI++ + DFG+A+ + V T + GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500
+++PE ++DV+ G L E++TG+ + + H+R+
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----GDSPVSVAYQHVRE----- 229
Query: 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
+ I + S +++ +V PE+R A ++
Sbjct: 230 --DPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMR 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-39
Identities = 75/324 (23%), Positives = 124/324 (38%), Gaps = 41/324 (12%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAI- 326
++F ++G+G FGKV+ N A+K L E ++S+A
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H L + T V ++ + Y ++ D A GL+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
+LH + I++RDLK NILLD + + DFG+ K T GT +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 173
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506
L K + D + +G+ L E++ GQ F +EEE L IR
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEE---LFHSIRM----------D 218
Query: 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM---LQGEDLAERWAEWEELEE 563
+ + KE + ++ PE R + ++ + + WEELE
Sbjct: 219 NPFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDIRQHPLFREIN-------WEELER 268
Query: 564 VRQQEVSLLPHQFAWGEDSSIDQE 587
++ + P + + S+ D+E
Sbjct: 269 -KEIDPPFRPKVKSPFDCSNFDKE 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (363), Expect = 4e-39
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 327
+F +G G FG+V+ + A+K L + E ++S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
++++ G + + ++ +++ L L + P K A LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LH + II+RDLK NILLD N + DFG AK V VT + GT +IAPE
Sbjct: 120 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEV 172
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQR 474
+ST ++ D + +GI + E++ G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 4e-39
Identities = 53/326 (16%), Positives = 118/326 (36%), Gaps = 36/326 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+ + + +G+G FG V++ V S K ++ + ++E+ ++++A H+N
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRN 62
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+L L + E ++++ F+ L + R+ L+ L++LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLH 119
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
I H D++ NI+ + + +FG A+ + + + APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEV 174
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507
S TD++ G + L++G F ++ + + + E+ +I
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEAFKEI-- 230
Query: 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQ 567
S E V + R ++ L W + +++E V +
Sbjct: 231 -------SIEAMDFVD---RLLVKERKSRMTASEA--------LQHPWLK-QKIERVSTK 271
Query: 568 EVSLLPHQFAWGEDSSIDQEAIQLSN 593
+ L H+ + D + +
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAA 297
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 8e-39
Identities = 50/294 (17%), Positives = 93/294 (31%), Gaps = 32/294 (10%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 323
EL++ + + IG G FG +Y G ++ +VA+K E +
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYK 57
Query: 324 VAIHKNLLQLIGYCTTSSER-ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
+ + I +C + ++V + + T +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMI 113
Query: 383 YGLEYLHEQCNPKIIHRDLKAANIL---LDDNFEAVLCDFGLAKLVDAKLTHV------T 433
+EY+H + IHRD+K N L + DFGLAK TH
Sbjct: 114 SRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 493
+ GT + + + S + D+ G L+ G + +
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
Query: 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547
+K+ L E T + C +D+P + + ++ +
Sbjct: 231 KKM-------STPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 53/295 (17%), Positives = 110/295 (37%), Gaps = 27/295 (9%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
++ + IG+G +G V + +VA+K++ + RE+ ++ H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ + + + ++ + L L + L + GL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYI 125
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 446
H ++HRDLK +N+LL+ + +CDFGLA++ D H T+ T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 447 YLSTG-KSSEKTDVFGYGITLLELVTGQ----------------RAIDFSRLEEEEDVLL 489
+ ++ D++ G L E+++ + + E+ ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 490 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
L LL N + L + ++ P R + Q +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (351), Expect = 9e-38
Identities = 44/288 (15%), Positives = 93/288 (32%), Gaps = 33/288 (11%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG+G FG +++G L +N +VA+K + E + + + Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
++ + S+ L + T A ++ +HE+ ++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 398 HRDLKAANILLDDNFEAV-----LCDFGLAKLVDAKLTHV------TTQIRGTMGHIAPE 446
+RD+K N L+ + DFG+ K +T + GT +++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506
+ S + D+ G + + G + L+ + + I + + L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSL--PWQGLKAATNKQKYERIGEKKQSTPL---- 237
Query: 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 554
R L +E + + P + + + ER
Sbjct: 238 -RELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF--SKVLER 279
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 70/285 (24%), Positives = 108/285 (37%), Gaps = 24/285 (8%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRL----QDYYSPGGEAAFQREVHLISVAIHKNLL 331
+ +G+G F VYK + N VA+K++ + G RE+ L+ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L+ S LV+ FM+ +K L K T GLEYLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
I+HRDLK N+LLD+N L DFGLAK + T Q+ T + APE L
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 452 KS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL----------LDHIRKLLRED 500
+ D++ G L EL+ + ++ + + L
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545
L+ S + ++ + P R Q +KM
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-37
Identities = 66/298 (22%), Positives = 107/298 (35%), Gaps = 39/298 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+++++ +IG G FG VY+ L VA+K++ + RE+ ++ H N
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCN 74
Query: 330 LLQLIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
+++L + +S E+ LV ++ R ++ L K +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442
L Y+H I HRD+K N+LLD D LCDFG AK + + I
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYR 189
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502
+ DV+ G L EL+ GQ F + L I K+L
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVD---QLVEIIKVLGTPTR 244
Query: 503 NDIVDRNLNTYDSKEVETMVQ--------------VALL--CTQSTPEDRPPMAQVVK 544
I + N N + K + +AL + TP R +
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-36
Identities = 56/284 (19%), Positives = 97/284 (34%), Gaps = 33/284 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISV 324
D + +G G F V K S + A K R + +REV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 325 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 384
H N++ L ++ IL+ + L D ++ L G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
+ YLH I H DLK NI+L D + DFGLA +D + I GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTP 180
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500
+APE ++ + D++ G+ L++G +E L ++ + E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSAVNYEF 235
Query: 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
+ S + ++ P+ R + ++
Sbjct: 236 E------DEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 5e-36
Identities = 52/276 (18%), Positives = 103/276 (37%), Gaps = 32/276 (11%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIG 335
++G G GKV + K A+K LQD +REV L A ++++++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVD 72
Query: 336 YCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
++V + + R++ G++ + ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 392 CNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
I HRD+K N+L L DFG AK + + T T ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508
K + D++ G+ + L+ G + + ++ +R +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQYE--FPN 238
Query: 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
+ S+EV+ +++ ++ P R + + +
Sbjct: 239 PEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 1e-35
Identities = 56/277 (20%), Positives = 98/277 (35%), Gaps = 43/277 (15%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRL-----QDYYSPGGEAAFQREVHLIS--VAIHKN 329
++G GGFG VY G+ +SDN VA+K + D+ EV L+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+++L+ + +L+ + + L D L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 390 EQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
++HRD+K NIL+D + E L DFG L+ V T GT + PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 181
Query: 449 STGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507
+ V+ GI L ++V G + V + + ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ-----HLIR 236
Query: 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
C P DRP ++
Sbjct: 237 W-------------------CLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-34
Identities = 56/289 (19%), Positives = 107/289 (37%), Gaps = 23/289 (7%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+ + IG+G +G V+K + VA+KR++ D G ++ RE+ L+ HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N+++L + + LV+ F + LD K F GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H + ++HRDLK N+L++ N E L +FGLA+ + + ++
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD- 507
S D++ G EL R + F + ++ + + + E++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 508 ------------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
+L K T + + P R + ++
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-33
Identities = 45/207 (21%), Positives = 80/207 (38%), Gaps = 11/207 (5%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 327
++F ++G+G FGKV + A+K L + + A E ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
L L T V + + + L + T +R F A +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSA 117
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
L + +++RD+K N++LD + + DFGL K + GT ++APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQR 474
L D +G G+ + E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (314), Expect = 3e-32
Identities = 61/331 (18%), Positives = 116/331 (35%), Gaps = 42/331 (12%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 327
D F +G G FG+V A+K L Q E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
L++L +S +V ++ + P + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAG----GEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LH +I+RDLK N+L+D + DFG AK ++ T + GT +APE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEI 209
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507
+ + ++ D + G+ + E+ G ++ + + + I
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP-----FFADQPIQIYEKIVS----------GK 254
Query: 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERW---AEWEELEEV 564
++ S +++ +++ Q R K + +W +W + +
Sbjct: 255 VRFPSHFSSDLKDLLR---NLLQVDLTKRFGNL---KNGVNDIKNHKWFATTDWIAIYQ- 307
Query: 565 RQQEVSLLPHQFAWGEDSSID---QEAIQLS 592
R+ E +P G+ S+ D +E I++S
Sbjct: 308 RKVEAPFIPKFKGPGDTSNFDDYEEEEIRVS 338
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 5e-32
Identities = 67/310 (21%), Positives = 109/310 (35%), Gaps = 39/310 (12%)
Query: 263 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVH 320
C E+ + + IGQG FG+V+K KVA+K++ + G RE+
Sbjct: 6 CDEV----SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 321 LISVAIHKNLLQLIGYCTTSSERI--------LVYPFMQNLSVAYRLRDLKPGEKGLDWP 372
++ + H+N++ LI C T + LV+ F ++ L
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLS 117
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-- 430
KRV L L+ KI+HRD+KAAN+L+ + L DFGLA+
Sbjct: 118 EIKRVMQML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 431 -HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ------------RAI 476
+ T T+ + PE L + D++G G + E+ T I
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 477 DFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALL--CTQSTPE 534
+V +L + L R + V + L+ P
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 535 DRPPMAQVVK 544
R +
Sbjct: 295 QRIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-32
Identities = 51/289 (17%), Positives = 103/289 (35%), Gaps = 21/289 (7%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 328
+ + +G G +G V V KVA+K+L + + S RE+ L+ H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ L+ T F + + L + + + GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H HRDLK N+ ++++ E + DFGLA+ D+++ T + L
Sbjct: 138 HAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVIL 191
Query: 449 STGKSSEKTDVFGYGITLLELVTG-------------QRAIDFSRLEEEEDVLLLDHIRK 495
+ + ++ D++ G + E++TG + + + E V L
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 496 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544
L ++ ++ + + V + E R + +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (289), Expect = 5e-29
Identities = 48/250 (19%), Positives = 97/250 (38%), Gaps = 22/250 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHK 328
D++ +G+G + +V++ + +++N KV VK L P + +RE+ ++ +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGP 90
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ L R F D K + L + + L+Y
Sbjct: 91 NIITLADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTLTDYDIRFYMYEILKALDYC 145
Query: 389 HEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE- 446
H I+HRD+K N+++D ++ + L D+GLA+ + + PE
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506
+ D++ G L ++ + ++ L I K+L + L D +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFF----HGHDNYDQLVRIAKVLGTEDLYDYI 256
Query: 507 DRNLNTYDSK 516
D+ D +
Sbjct: 257 DKYNIELDPR 266
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 43/206 (20%), Positives = 85/206 (41%), Gaps = 8/206 (3%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIH 327
+ + + +G G +G V +VAVK+L + + S RE+ L+ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
+N++ L+ T + + + + L + + + GL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
+H HRDLK +N+ ++++ E + DFGLA+ D +T +
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 190
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQ 473
L+ ++ D++ G + EL+TG+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 1e-27
Identities = 57/281 (20%), Positives = 97/281 (34%), Gaps = 31/281 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRL---QDYYSPGGEAAFQREVHLIS 323
+NF ++G G +GKV+ A+K L + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 324 VAIHK-NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
L+ L T ++ L+ ++ + L + T V
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHEVQIYVG 136
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442
+ L II+RD+K NILLD N VL DFGL+K A T GT+ +
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 443 IAPEYLSTGKS--SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500
+AP+ + G S + D + G+ + EL+TG F+ E+ +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEPP 254
Query: 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 541
++ S + ++Q P+ R
Sbjct: 255 YPQEM---------SALAKDLIQ---RLLMKDPKKRLGCGP 283
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (276), Expect = 3e-27
Identities = 48/235 (20%), Positives = 89/235 (37%), Gaps = 21/235 (8%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-----------VAI 326
+G G F V+ + +NT VA+K ++ A + E+ L+
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGL 385
++L+L+ + + + + L +K E K+++ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 386 EYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGHI 443
+Y+H +C IIH D+K N+L++ + L +A L +A T +
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498
+PE L D++ + EL+TG F E DHI +++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIE 249
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 5e-27
Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 12/207 (5%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 328
+ IG G G V + VA+K+L + + + RE+ L+ HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 329 NLLQLIGYCTTSS--ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
N++ L+ T E + L A + ++ LD + + G++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
+LH IHRDLK +NI++ + + DFGLA+ + + T T + APE
Sbjct: 134 HLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPE 188
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ E D++ G + E+V +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 3e-20
Identities = 20/159 (12%), Positives = 42/159 (26%), Gaps = 20/159 (12%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVK---------RLQDYYSPGGEAAFQREVHLISVAIH 327
++G+G V+ + VK + G+ F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
+ L +L G + + + V +
Sbjct: 66 RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
+ + I+H DL N+L+ + + DF + V
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVG 153
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 70.4 bits (171), Expect = 1e-13
Identities = 26/157 (16%), Positives = 52/157 (33%), Gaps = 10/157 (6%)
Query: 2 FGALHKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHF 61
+L L + + L+ E + + + T + N++
Sbjct: 237 LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN- 295
Query: 62 VSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG 121
N+ LTL N S ++ L L L +N +S L
Sbjct: 296 ---QLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLA 348
Query: 122 SMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158
++T++ L+ +N+ S P + L+ + L L+
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.0 bits (157), Expect = 8e-12
Identities = 23/69 (33%), Positives = 35/69 (50%), Gaps = 4/69 (5%)
Query: 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158
LK L L L N++S P + S+T LQ L ANNK S ++ + L+N+ L N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 159 NLTGRIPMQ 167
++ P+
Sbjct: 362 QISDLTPLA 370
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 6e-08
Identities = 34/136 (25%), Positives = 49/136 (36%), Gaps = 6/136 (4%)
Query: 57 WNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL 116
S S V + N+ SL +N S I L L L N L
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD-- 233
Query: 117 PDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNF 176
L S+T+L L+LANN+ S P S L+ L L L +N ++ P+ + T
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
Query: 177 TGTHLICGSSLEQPCM 192
+ + S
Sbjct: 292 LNENQLEDISPISNLK 307
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 33/138 (23%), Positives = 49/138 (35%), Gaps = 25/138 (18%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
N+ L+L N ++ L L L+L +N +S P L +T L L L
Sbjct: 216 GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271
Query: 133 NNKFSGSIP--------------------ATWSQLSNLKHLDLSSNNLTGRIPM-QLFSV 171
N+ S P + S L NL +L L NN++ P+ L +
Sbjct: 272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKL 331
Query: 172 ATFNFTGTHLICGSSLEQ 189
F + SSL
Sbjct: 332 QRLFFANNKVSDVSSLAN 349
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 3e-05
Identities = 14/69 (20%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158
L L +++ T+ + + +L SI L+NL ++ S+N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGV-EYLNNLTQINFSNN 76
Query: 159 NLTGRIPMQ 167
LT P++
Sbjct: 77 QLTDITPLK 85
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 3e-13
Identities = 23/115 (20%), Positives = 38/115 (33%), Gaps = 1/115 (0%)
Query: 51 HGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDN 110
+ D + + V + + + K L L+L++N
Sbjct: 195 ANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN 254
Query: 111 DLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+ GTLP L + L SLN++ N G IP L ++N P
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.5 bits (158), Expect = 3e-12
Identities = 24/71 (33%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 123 MTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP--MQLFSVATFNFTGTH 180
+L L+L NN+ G++P +QL L L++S NNL G IP L +
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 181 LICGSSLEQPC 191
+CGS L C
Sbjct: 303 CLCGSPLP-AC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.8 bits (125), Expect = 5e-08
Identities = 24/128 (18%), Positives = 48/128 (37%), Gaps = 26/128 (20%)
Query: 36 EGEALIEVLKALNDTHGQFTDWNDHFVSPC-FSWSHVTCRNGNVISLTLGSNGFSGKISP 94
+ +AL+++ K L + + W C +W V C
Sbjct: 7 DKQALLQIKKDLGN-PTTLSSWLPT-TDCCNRTWLGVLCDTD------------------ 46
Query: 95 SITKLKFLASLELQDNDLSG--TLPDFLGSMTHLQSLNLANN-KFSGSIPATWSQLSNLK 151
T+ + +L+L +L +P L ++ +L L + G IP ++L+ L
Sbjct: 47 --TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 152 HLDLSSNN 159
+L ++ N
Sbjct: 105 YLYITHTN 112
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.4 bits (137), Expect = 1e-09
Identities = 23/101 (22%), Positives = 38/101 (37%), Gaps = 14/101 (13%)
Query: 63 SPCF-SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG 121
C V C + + + + P L+LQ+N ++
Sbjct: 6 FRCQCHLRVVQCSDLGLEKVPKD-------LPPDTA------LLDLQNNKITEIKDGDFK 52
Query: 122 SMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 162
++ +L +L L NNK S P ++ L L+ L LS N L
Sbjct: 53 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE 93
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 34/182 (18%), Positives = 59/182 (32%), Gaps = 12/182 (6%)
Query: 10 PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWS 69
P + L + N R+ G + V++ + N F
Sbjct: 95 PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 154
Query: 70 HVTCRNG----------NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDF 119
++ L L N + + S+ L LA L L N +S
Sbjct: 155 IRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 214
Query: 120 LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGT 179
L + HL+ L+L NNK +P + ++ + L +NN++ I F +N
Sbjct: 215 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA-IGSNDFCPPGYNTKKA 272
Query: 180 HL 181
Sbjct: 273 SY 274
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.9 bits (102), Expect = 3e-05
Identities = 25/122 (20%), Positives = 50/122 (40%), Gaps = 3/122 (2%)
Query: 41 IEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLK 100
++ L Q +++ ++ V+ L SG + + +K
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 101 FLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNL 160
L+ + + D +++ T+P G L L+L NK + A+ L+NL L LS N++
Sbjct: 151 KLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 161 TG 162
+
Sbjct: 208 SA 209
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 12/45 (26%), Positives = 18/45 (40%)
Query: 124 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
L+L NNK + + L NL L L +N ++ P
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 37.3 bits (85), Expect = 0.004
Identities = 21/117 (17%), Positives = 35/117 (29%), Gaps = 24/117 (20%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNL----- 131
N+ +L L +N S + L L L L N L ++ L+
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
Query: 132 ------------------ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
K SG + + L ++ ++ N+T IP L
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP 171
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (133), Expect = 6e-09
Identities = 15/74 (20%), Positives = 27/74 (36%), Gaps = 5/74 (6%)
Query: 102 LASLELQDNDLSGT-LPDFLGSMTHLQSLNLANNKFSG----SIPATWSQLSNLKHLDLS 156
+ SL++Q +LS + L + Q + L + + I + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 157 SNNLTGRIPMQLFS 170
SN L +
Sbjct: 64 SNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 2e-07
Identities = 23/135 (17%), Positives = 45/135 (33%), Gaps = 14/135 (10%)
Query: 48 NDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKF-----L 102
+ + C +S V +N ++ L + +N + + L
Sbjct: 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 371
Query: 103 ASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGSIPATWSQ-----LSNLKHL 153
L L D D+S + L L + L+ L+L+NN + + L+ L
Sbjct: 372 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQL 431
Query: 154 DLSSNNLTGRIPMQL 168
L + + +L
Sbjct: 432 VLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 7e-07
Identities = 15/93 (16%), Positives = 30/93 (32%), Gaps = 10/93 (10%)
Query: 77 NVISLTLGSNGFSGK-ISPSITKLKFLASLELQDNDLSG----TLPDFLGSMTHLQSLNL 131
++ SL + S + + L+ + L D L+ + L L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 132 ANNKFSGSIP-----ATWSQLSNLKHLDLSSNN 159
+N+ + ++ L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 3e-05
Identities = 21/125 (16%), Positives = 37/125 (29%), Gaps = 4/125 (3%)
Query: 57 WNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL 116
+ + S+ S +++ L+D +
Sbjct: 302 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 361
Query: 117 PDFLGSMTHLQSLNLANNKFSG----SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVA 172
+ L+ L LA+ S S+ AT +L+ LDLS+N L +QL
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 173 TFNFT 177
Sbjct: 422 RQPGC 426
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 2e-04
Identities = 11/57 (19%), Positives = 19/57 (33%), Gaps = 1/57 (1%)
Query: 126 LQSLNLANNKFSGS-IPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181
+QSL++ + S + L + + L LT + S N L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 5e-08
Identities = 23/124 (18%), Positives = 37/124 (29%), Gaps = 9/124 (7%)
Query: 48 NDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLEL 107
D + ++ ++ + N S +I L L +
Sbjct: 232 RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNV 291
Query: 108 QDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 167
+N L LP L+ L + N + +P NLK L + N L P
Sbjct: 292 SNNKLI-ELPALPPR---LERLIASFNHLA-EVP---ELPQNLKQLHVEYNPLRE-FPDI 342
Query: 168 LFSV 171
SV
Sbjct: 343 PESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 19/61 (31%), Positives = 29/61 (47%), Gaps = 8/61 (13%)
Query: 102 LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
LEL + LS +LP+ HL+SL + N + +P +LK L + +NNL
Sbjct: 40 AHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELP---ELPQSLKSLLVDNNNLK 91
Query: 162 G 162
Sbjct: 92 A 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.1 bits (84), Expect = 0.004
Identities = 15/60 (25%), Positives = 23/60 (38%), Gaps = 5/60 (8%)
Query: 124 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLIC 183
L L N S S+P +L+ L S N+LT +P S+ + +L
Sbjct: 38 RQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.9 bits (112), Expect = 6e-07
Identities = 28/144 (19%), Positives = 46/144 (31%), Gaps = 1/144 (0%)
Query: 48 NDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLEL 107
+ ++ L LG N + L L +L L
Sbjct: 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109
Query: 108 QDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 167
DN +S +P + L SLNLA+N F+ + W L+ L+ P +
Sbjct: 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSK 168
Query: 168 LFSVATFNFTGTHLICGSSLEQPC 191
+ V + + C S + C
Sbjct: 169 VRDVQIKDLPHSEFKCSSENSEGC 192
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 2e-06
Identities = 19/104 (18%), Positives = 31/104 (29%), Gaps = 24/104 (23%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG------------------- 121
L L + + + +L + L+L N L P
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 122 --SMTHLQSLNLANNKF-SGSIPATWSQLSNLKHLDLSSNNLTG 162
++ LQ L L NN+ + L L+L N+L
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (108), Expect = 5e-06
Identities = 13/65 (20%), Positives = 23/65 (35%), Gaps = 3/65 (4%)
Query: 95 SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154
++K+ + +L+ LP L L+L+ N AT + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 155 LSSNN 159
L
Sbjct: 62 LDRAE 66
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 6e-06
Identities = 16/48 (33%), Positives = 25/48 (52%), Gaps = 4/48 (8%)
Query: 109 DNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156
DN +S P L S+ +L ++L NN+ S P + SNL + L+
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 13/51 (25%), Positives = 24/51 (47%), Gaps = 2/51 (3%)
Query: 117 PDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 167
L +++ L +L +NK S P + L NL + L +N ++ P+
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA 214
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 7e-04
Identities = 15/83 (18%), Positives = 27/83 (32%), Gaps = 4/83 (4%)
Query: 51 HGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDN 110
G + S + +L N S + L L + L++N
Sbjct: 148 AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNN 205
Query: 111 DLSGTLPDFLGSMTHLQSLNLAN 133
+S P L + ++L + L N
Sbjct: 206 QISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 10/62 (16%), Positives = 25/62 (40%), Gaps = 4/62 (6%)
Query: 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158
L + ++++ T+ + + +L+ + +I L+NL L+L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 159 NL 160
+
Sbjct: 74 QI 75
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (106), Expect = 7e-06
Identities = 24/115 (20%), Positives = 39/115 (33%), Gaps = 2/115 (1%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
GN+ L L N S + L L L L N ++ P + L +L L
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS--VATFNFTGTHLICGS 185
N S + L L++L L+ N + + F + + + C
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 4/77 (5%)
Query: 86 NGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWS 145
N S + ++ L+ L L L DN LQ ++++ S+P
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPCSLPQ--- 266
Query: 146 QLSNLKHLDLSSNNLTG 162
+L+ L++N+L G
Sbjct: 267 RLAGRDLKRLAANDLQG 283
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 1e-05
Identities = 15/133 (11%), Positives = 33/133 (24%), Gaps = 2/133 (1%)
Query: 111 DLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+L + + + L+L K I + L +D S N + L
Sbjct: 6 ELIEQAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLR 63
Query: 171 VATFNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACR 230
+ IC + + L + + L+ +
Sbjct: 64 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123
Query: 231 YQKLRKLKHDVFF 243
+ + V +
Sbjct: 124 VTNKKHYRLYVIY 136
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 13/66 (19%), Positives = 22/66 (33%), Gaps = 11/66 (16%)
Query: 107 LQDNDLSGTLPDFLGSM------THLQSLNLANNKFSGSIP-----ATWSQLSNLKHLDL 155
L D LS + LQ+L L N+ ++ +L L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 156 SSNNLT 161
+ N +
Sbjct: 310 NGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 4e-04
Identities = 10/93 (10%), Positives = 28/93 (30%), Gaps = 11/93 (11%)
Query: 102 LASLELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSG----SIPATWSQLSNLKHL 153
+ L+ + ++ ++ L ++ + L+ N + + +L+
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 154 DLSSN---NLTGRIPMQLFSVATFNFTGTHLIC 183
+ S + IP L + L
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHT 97
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 15/38 (39%), Positives = 21/38 (55%), Gaps = 2/38 (5%)
Query: 120 LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSS 157
L +T LQ+L L+ N S + A + L NL L+L S
Sbjct: 174 LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 6e-04
Identities = 11/87 (12%), Positives = 25/87 (28%), Gaps = 4/87 (4%)
Query: 97 TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156
L+ ++ + + + + N+ L N+ L L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 157 SNNLTGRIPMQLFSVATFNFTGTHLIC 183
N LT P+ + F + +
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVK 103
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 2e-04
Identities = 15/115 (13%), Positives = 32/115 (27%), Gaps = 3/115 (2%)
Query: 51 HGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDN 110
D D+ + + + L L NG + + + +N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 111 DLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+L D + L+++ + L L+ NL ++P
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 6e-04
Identities = 18/93 (19%), Positives = 34/93 (36%), Gaps = 3/93 (3%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGT--LPDFLGSMTHLQSLNLA 132
+ L S+ + + + L SL L +N L + + +L+ LNL+
Sbjct: 41 QNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLS 99
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
N+ + L+ L L N+L+
Sbjct: 100 GNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 12/64 (18%), Positives = 26/64 (40%), Gaps = 5/64 (7%)
Query: 111 DLSGT--LPDFLGSMT--HLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM 166
DL+G PD G + + + + + +S ++H+DLS++ +
Sbjct: 6 DLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLH 64
Query: 167 QLFS 170
+ S
Sbjct: 65 GILS 68
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 17/121 (14%), Positives = 34/121 (28%), Gaps = 4/121 (3%)
Query: 51 HGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQD- 109
+ + V V S +L +L L L
Sbjct: 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210
Query: 110 NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
D+ LG + L++L + G++ L HL ++ ++ T +
Sbjct: 211 YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINCSHFTTIARPTIG 267
Query: 170 S 170
+
Sbjct: 268 N 268
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 595 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.66 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.43 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.38 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.36 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.35 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.31 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.25 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.23 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.19 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.05 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.96 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.88 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.79 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.69 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.68 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.67 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.67 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.65 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.58 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.52 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.49 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.19 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.17 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.11 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.02 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.85 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.79 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.66 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.59 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.48 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.48 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.3 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.12 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.81 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.48 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.61 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.22 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.37 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=412.18 Aligned_cols=261 Identities=29% Similarity=0.445 Sum_probs=205.9
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
++..++|++.+.||+|+||+||+|+++ ..||||+++.. ........|.+|++++++++||||+++++++.. +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 345678999999999999999999864 36999999743 345567889999999999999999999998754 56899
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++|+|.+++... ...+++..+..++.|+|.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 v~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 99999999999999753 34699999999999999999999999 9999999999999999999999999999876
Q ss_pred cCcCc-ceeecccccccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 426 DAKLT-HVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 426 ~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .....+.....
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~~--- 227 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRGYL--- 227 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHHTSC---
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH----HHHHHHhcCCC---
Confidence 54322 23345679999999999864 357999999999999999999999997543221 11111111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 502 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 502 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.+.+...+...+.++.+++.+||+.||++||||.||+++|+.
T Consensus 228 -----~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 228 -----SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp -----CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111111233345678899999999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=406.86 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=200.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
.++|+..+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++||||++++|++..++..++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 3578889999999999999999988899999999753 23457899999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++|+|.+++... ...+++..+..++.|+|.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999998753 35689999999999999999999999 99999999999999999999999999998776554
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhC-CCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg-~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
........||+.|+|||++.+..++.++|||||||++|||+|+ ++|+...... .+...+....+
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----~~~~~i~~~~~---------- 220 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTGFR---------- 220 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----HHHHHHHHTCC----------
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHhcCC----------
Confidence 4444456789999999999999999999999999999999996 4444432221 12222221111
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+...+.++.+++.+||+.||++||||+||+++|+++
T Consensus 221 --~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 221 --LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 011223346788999999999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=410.72 Aligned_cols=258 Identities=28% Similarity=0.414 Sum_probs=210.7
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
++..++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||++++++.+ +..++|
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 34567888999999999999999999888999999997432 345789999999999999999999998754 567999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence 99999999999876432 24589999999999999999999999 99999999999999999999999999999876
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
...........||+.|+|||++.+..++.++|||||||++|||+||..|+....... .....+. ...+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~----~~~~~i~---~~~~----- 228 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQNLE---RGYR----- 228 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHHH---TTCC-----
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH----HHHHHHH---hcCC-----
Confidence 554444455678999999999998999999999999999999999766554322111 1112221 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+...+.++.+++.+||+.||++||||.||++.|++
T Consensus 229 ----~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 01122344578899999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=397.53 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=215.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
.++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|++.+++..++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 36899999999999999999999888899999997532 3457899999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++|++..++... ...+++..+.+++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999987653 34689999999999999999999999 99999999999999999999999999998776554
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 508 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (595)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +...+. ...+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-----~~~~i~---~~~~------- 219 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHIA---QGLR------- 219 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----HHHHHH---TTCC-------
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-----HHHHHH---hCCC-------
Confidence 444445678999999999999999999999999999999998 899997654321 111121 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 509 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 509 ~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+...+.++.+++.+||+.||++|||++||++.|.+
T Consensus 220 --~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 --LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11122334678899999999999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=406.80 Aligned_cols=256 Identities=21% Similarity=0.298 Sum_probs=198.4
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeec--CCceEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILV 346 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 346 (595)
++|++.+.||+|+||+||+|+.+ +|+.||+|++... ..+...+.+.+|++++++++||||+++++++.+ ++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999964 7899999998743 345556789999999999999999999999865 4567899
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
|||+++|+|.+++.........+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765444567999999999999999999999861 12499999999999999999999999999997
Q ss_pred ccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ +...+. ...
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-----~~~~i~----~~~--- 230 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGKIR----EGK--- 230 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHH----HTC---
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-----HHHHHH----cCC---
Confidence 754322 2345679999999999999999999999999999999999999997644321 111111 111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 231 -----~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 -----FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11122334467889999999999999999999965
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=403.42 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=203.4
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|++.+.||+|+||+||+|+.. +|+.||||++.........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999974 78999999997544444456789999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++|+|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999874 45699999999999999999999999 99999999999999999999999999999765432
Q ss_pred c-ceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 430 T-HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 430 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
. .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||......... .... . .....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---~~~~-~---~~~~~----- 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---YSDW-K---EKKTY----- 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH---HHHH-H---TTCTT-----
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH---HHHH-h---cCCCC-----
Confidence 2 23345679999999999988776 57899999999999999999999764432111 1111 0 11000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.......+.++.+++.+||+.||++|||++|+++
T Consensus 226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011223457778999999999999999999954
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-51 Score=411.07 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=217.8
Q ss_pred HHHHHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 265 ELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
++++..++|++.+.||+|+||+||+|++. +++.||||+++.. ....++|.+|++++++++|||||++++++.+++..
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 34456678999999999999999999975 5889999998743 23467899999999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 99999999999999997532 45799999999999999999999999 99999999999999999999999999999
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
..............|++.|+|||++.+..++.++|||||||++|||++|..|+....... .+.+.+. .+.
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~----~~~~~i~----~~~-- 233 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLE----KDY-- 233 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHH----TTC--
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH----HHHHHHh----cCC--
Confidence 876655555555668999999999999999999999999999999999877664322211 1112111 110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 550 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 550 (595)
....+...+.++.+++.+||+.||++|||+.||++.|+...
T Consensus 234 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01122334567889999999999999999999999997653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-50 Score=407.45 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=201.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CC---cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
.++|++.++||+|+||+||+|+++ ++ ..||||++.........+.|.+|++++++++|||||++++++..++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 356777899999999999999964 23 35899998766666777889999999999999999999999999999999
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++|+|.+++... ...+++.++..++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 105 v~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999988752 34699999999999999999999999 9999999999999999999999999999877
Q ss_pred cCcCcce----eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 426 DAKLTHV----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 426 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
....... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+. ...
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-----~~~~~i~---~~~ 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----DVINAIE---QDY 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHH---TTC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-----HHHHHHH---cCC
Confidence 5432221 122457999999999999999999999999999999998 89999754321 1222221 111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
+ ...+...+.++.+++.+||+.||++||||.||++.|+.
T Consensus 251 ~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 251 R---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred C---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 11223345678899999999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=397.38 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=207.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+|+.+ +++.||+|++... ........+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57899999999999999999975 6899999998632 12334677899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999986 34689999999999999999999999 999999999999999999999999999986654
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+ . ........
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~---~~~i~~~~------- 220 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----T---YKRISRVE------- 220 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H---HHHHHTTC-------
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-----H---HHHHHcCC-------
Confidence 32 334679999999999999999999999999999999999999997644321 1 11111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. ..+...+.++.+++.+||+.||++|||++|+++
T Consensus 221 ~---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 F---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0 112233467888999999999999999999965
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=399.75 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=209.7
Q ss_pred hcCCCcCCe-eeeccceEEEEEEeC---CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 270 TDNFSESNI-IGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 270 ~~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
.++|.+.+. ||+|+||+||+|.++ ++..||||+++........+.|.+|++++++++|||||++++++.+ +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 345666674 999999999999853 3557999999876666677899999999999999999999999865 56899
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
||||+++|+|.+++... ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+
T Consensus 86 vmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 99999999999987642 35699999999999999999999999 9999999999999999999999999999977
Q ss_pred cCcCcce--eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 426 DAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 426 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
....... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +...+. ...+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-----~~~~i~---~~~~- 230 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIE---QGKR- 230 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----HHHHHH---TTCC-
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-----HHHHHH---cCCC-
Confidence 6543322 234568999999999999999999999999999999998 899997543221 222221 1111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...++..+.++.+++.+||+.||++||||.+|++.|+.
T Consensus 231 --------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11233445678899999999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=401.53 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=203.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCC-----cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (595)
.+.|+..++||+|+||+||+|.+++. ..||||+++....+.....|.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688899999999999999996532 3699999986666666778999999999999999999999999999999
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
+||||+.++++.+.+... ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999887753 35699999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCcc--eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 425 VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 425 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
....... ......||+.|+|||++.+..++.++|||||||++|||+||..|+....... .+...+. .+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~----~~~~~i~----~~~- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EVMKAIN----DGF- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHH----TTC-
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH----HHHHHHh----ccC-
Confidence 6543222 2234568999999999999999999999999999999999766654322111 1122221 110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
....+...+.++.+++.+||+.||++||||.||++.|+.
T Consensus 231 -------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 231 -------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp -------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 111223345678899999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=412.95 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=209.2
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
+..++|++.+.||+|+||+||+|+.. +|+.||+|+++....+.....+.+|+.++++++|||||++++++.+++..++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999964 78999999997655556678899999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
|||+++|+|.+++.+ ...+++..+..++.|++.||.|||+ + +|+||||||+|||+++++.+||+|||+|+..
T Consensus 83 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999986 3468999999999999999999996 5 8999999999999999999999999999876
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHh--------
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL-------- 497 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~-------- 497 (595)
.... .....||+.|+|||++.+.+++.++||||+||++|||++|+.||.....................
T Consensus 156 ~~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 156 IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred CCCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 4322 23467999999999999999999999999999999999999999765432211100000000000
Q ss_pred ---------cc----cccc----ccccccCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 498 ---------RE----DRLN----DIVDRNLNTY-DSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 498 ---------~~----~~~~----~~~d~~l~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.. .... .+.....+.. ....+.++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 0000 0000000000 0112457888999999999999999999976
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=396.48 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=207.2
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4799999999999999999995 479999999986432 23457789999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++|+|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999988764 3589999999999999999999999 99999999999999999999999999998775433
Q ss_pred cceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... .+.... ......
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~~~----~~~~~~------ 235 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLIA----TNGTPE------ 235 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHH----HHCSCC------
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH----HHHHHH----hCCCCC------
Confidence 2 2344569999999999999999999999999999999999999997544221 111111 111100
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
...+...+.++.+++.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112334567889999999999999999999964
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=393.45 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=200.3
Q ss_pred CeeeeccceEEEEEEeC---CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEeccc
Q 007625 277 NIIGQGGFGKVYKGVLS---DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (595)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (595)
++||+|+||+||+|.++ .++.||||+++.. ..+...+.|.+|++++++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999853 3568999999743 334456789999999999999999999999865 467899999999
Q ss_pred CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCcce
Q 007625 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (595)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 432 (595)
|+|.++++. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999886 45699999999999999999999999 99999999999999999999999999998765443322
Q ss_pred --eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccccc
Q 007625 433 --TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 509 (595)
Q Consensus 433 --~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (595)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +...+. ...+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-----~~~~i~---~~~~-------- 228 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLE---KGER-------- 228 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHH---TTCC--------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-----HHHHHH---cCCC--------
Confidence 234568999999999999999999999999999999998 899997543211 122221 1111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 510 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 510 l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus 229 -~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11223345678899999999999999999999998865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=407.69 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=209.3
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCC-C-----cEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecC
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSD-N-----TKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 340 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 340 (595)
+..++|++.++||+|+||+||+|++.. + ..||+|++...........+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 455789999999999999999999632 2 369999987655555667899999999998 899999999999999
Q ss_pred CceEEEEEecccCcHhhhhcccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCC
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKP-------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 401 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 401 (595)
+..++||||+++|+|.++++.... ....+++..++.++.|++.||+|||++ +|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999975432 123589999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 007625 402 KAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (595)
Q Consensus 402 kp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~ 479 (595)
||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876554333 2334568999999999999999999999999999999998 89999754
Q ss_pred chhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 007625 480 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 547 (595)
Q Consensus 480 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 547 (595)
.... .+...+. .+. . ...+...+.++.+++.+||+.||++|||++||+++|.
T Consensus 271 ~~~~----~~~~~~~----~~~-----~---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDA----NFYKLIQ----NGF-----K---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSH----HHHHHHH----TTC-----C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHH----HHHHHHh----cCC-----C---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3321 1222221 110 0 1122334567889999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=399.13 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=204.7
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
+..++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||++++++. .+..++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 3457899999999999999999999888899999996432 34578999999999999999999999985 45689999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|..++.... ...++|.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 91 Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 91 EYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999999998887532 34699999999999999999999999 999999999999999999999999999987755
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
..........||+.|+|||++.+..++.++|||||||++|||+||..|+...... ......+.. ..+
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----~~~~~~i~~---~~~------ 232 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER---GYR------ 232 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHT---TCC------
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----HHHHHHHHh---cCC------
Confidence 4444444566899999999999999999999999999999999977665433221 112222221 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
...+...+.++.+++.+||+.||++||++++|+++|+..
T Consensus 233 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 233 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred ---CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 012233446788999999999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-49 Score=399.84 Aligned_cols=267 Identities=26% Similarity=0.403 Sum_probs=217.9
Q ss_pred HHHHHHHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccce
Q 007625 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336 (595)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 336 (595)
+.+++...++|++.+.||+|+||+||+|+++ +++.||||+++..........|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3455667789999999999999999999863 4578999999866666667889999999999999999999999
Q ss_pred eecCCceEEEEEecccCcHhhhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 007625 337 CTTSSERILVYPFMQNLSVAYRLRDLKP--------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396 (595)
Q Consensus 337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 396 (595)
+...+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999874321 124589999999999999999999999 99
Q ss_pred EEcCCCCCCEEEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCC-C
Q 007625 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-R 474 (595)
Q Consensus 397 vH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~-~ 474 (595)
+||||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999999876543322 334466899999999999999999999999999999999996 5
Q ss_pred CCCCCchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 475 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 475 p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
||......+ ....+. .+. ....+...+.++.+++.+||+.||++||||.||+++|+.+
T Consensus 242 p~~~~~~~e-----~~~~v~----~~~--------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAHEE-----VIYYVR----DGN--------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCHHH-----HHHHHH----TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCHHH-----HHHHHH----cCC--------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 666443221 112221 111 1112333446788999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=396.42 Aligned_cols=251 Identities=25% Similarity=0.311 Sum_probs=205.9
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
+.|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 56899999999999999999964 7899999998743 344567889999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+++|+|.+++.+. ...+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999987753 34699999999999999999999999 99999999999999999999999999997654321
Q ss_pred cceeecccccccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
.......||+.|+|||++. +..++.++|||||||++|||+||+.||......+ ....+. .... .
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-----~~~~i~---~~~~-~- 233 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----VLLKIA---KSEP-P- 233 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----HHHHHH---HSCC-C-
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-----HHHHHH---cCCC-C-
Confidence 1223456999999999984 4568999999999999999999999997644321 111111 1110 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 234 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 -----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112334567889999999999999999999965
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=385.64 Aligned_cols=247 Identities=23% Similarity=0.360 Sum_probs=196.6
Q ss_pred CcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeec----CCceEEEE
Q 007625 274 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVY 347 (595)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 347 (595)
+..+.||+|+||+||+|+.. ++..||+|++... ......+.|.+|++++++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999965 6889999998743 344556789999999999999999999999864 34578999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc-CCCcEEEeecccccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~~~~~~ 426 (595)
||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +++|+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999986 34689999999999999999999998 11299999999999996 57899999999998654
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.. ......||+.|+|||++.+ +++.++|||||||++|||+||+.||....... .+...+ . .+.....+
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~----~~~~~i---~-~~~~~~~~ 234 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIYRRV---T-SGVKPASF 234 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHHHHH---T-TTCCCGGG
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH----HHHHHH---H-cCCCCccc
Confidence 32 2345679999999999865 59999999999999999999999997433211 111111 1 11111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
+ .....++.+++.+||+.||++|||++|+++
T Consensus 235 ~-------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 D-------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G-------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 112346788999999999999999999965
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=394.39 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=201.3
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCC----CcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
+..++|++.+.||+|+||+||+|++.. +..||||+++..........|.+|++++++++||||+++++++. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345789999999999999999998642 35689999876666666788999999999999999999999986 4678
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++|++.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 83 ~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 9999999999999887652 34689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
..............||+.|+|||++.+..++.++|||||||++|||+| |..||......+ +...+.. ...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-----~~~~i~~---~~~- 227 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIEN---GER- 227 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHHHHT---TCC-
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-----HHHHHHc---CCC-
Confidence 776544444455668999999999999999999999999999999998 889987654321 2222221 111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus 228 --------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 228 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11233345678899999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=395.50 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=205.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+|+.. +|+.||||++... ........+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999974 7899999998632 12344577999999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999998876 34699999999999999999999999 999999999999999999999999999997754
Q ss_pred cCc-ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 428 KLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 428 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||....... +. ...... ..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----~~---~~i~~~-~~---- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-----IF---QKIIKL-EY---- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH---HHHHTT-CC----
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-----HH---HHHHcC-CC----
Confidence 322 23345679999999999999999999999999999999999999998644321 11 111111 10
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.++...+.++.+++.+||+.||++|||++|+++
T Consensus 228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112233457889999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-49 Score=396.30 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=192.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.+.|++.+.||+|+||+||+|+.+ +++.||||++...........+.+|+.++++++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999965 6899999999754444455678899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc---CCCcEEEeeccccccc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAKLV 425 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~~~~~ 425 (595)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999975 45699999999999999999999999 999999999999994 5789999999999876
Q ss_pred cCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccc
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 505 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (595)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+. ... . .
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----~~~~i~---~~~-~-~- 227 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-----LFEQIL---KAE-Y-E- 227 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHH---TTC-C-C-
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-----HHHHHh---ccC-C-C-
Confidence 5432 2334569999999999999999999999999999999999999997644321 111111 111 0 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
++. ......+.++.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FDS---PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCT---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCC---ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000 1122344678899999999999999999999884
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-48 Score=391.71 Aligned_cols=246 Identities=27% Similarity=0.352 Sum_probs=202.1
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
+.|+..+.||+|+||+||+|+. .+++.||||++.... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3588899999999999999996 478899999987432 2334567999999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|++..++.. ...+++.++..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999998766654 35699999999999999999999999 999999999999999999999999999986543
Q ss_pred cCcceeecccccccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 504 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (595)
. ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ......... ...
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--------~~~~i~~~~-~~~ 233 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNE-SPA 233 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSC-CCC
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCC-CCC
Confidence 2 33569999999999864 458999999999999999999999997543211 111111111 111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 505 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 505 ~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. .+...+.++.+++.+||+.||++|||+.|+++
T Consensus 234 ~-------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 L-------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C-------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 11223457889999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=390.34 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=203.5
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCc----EEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (595)
++|++.++||+|+||+||+|++. +|+ +||+|+++...+....+.|.+|++++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999964 443 58999987656666778999999999999999999999999864 5678
Q ss_pred EEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccc
Q 007625 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (595)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 425 (595)
+++|+.+|+|.+.+... ...+++..++.++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999999888753 45699999999999999999999999 9999999999999999999999999999977
Q ss_pred cCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccc
Q 007625 426 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 503 (595)
Q Consensus 426 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (595)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |..||......+ +...+... .+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-----~~~~i~~~---~~-- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEKG---ER-- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-----HHHHHHHT---CC--
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHcC---CC--
Confidence 544332 2334568999999999999999999999999999999999 788887544321 22222211 11
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 504 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 504 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
...++..+.++.+++.+||+.||++|||+.||++.|+.
T Consensus 232 -------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 232 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp -------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 11233445678899999999999999999999999865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-47 Score=391.52 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=208.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
-++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 358999999999999999999964 7899999999643 33456788999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc--CCCcEEEeecccccccc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~~~~~~ 426 (595)
|+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++...
T Consensus 104 ~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 104 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 99999999998642 34699999999999999999999999 999999999999996 45789999999998775
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ....+.. ... . .
T Consensus 178 ~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~~---~~~-~--~ 244 (350)
T d1koaa2 178 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-----TLRNVKS---CDW-N--M 244 (350)
T ss_dssp TTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH---TCC-C--S
T ss_pred ccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-----HHHHHHh---CCC-C--C
Confidence 433 2344569999999999999999999999999999999999999997654321 1111111 110 0 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
+. ......+.++.+++.+||+.||++|||+.|++++
T Consensus 245 ~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DD---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CC---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred Cc---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0112234577889999999999999999999885
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=379.66 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=206.6
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC-----CchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... .....+.+.+|++++++++||||+++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46899999999999999999996 479999999986432 123467899999999999999999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC----cEEEeec
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF 419 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 419 (595)
++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 999999999999999976 34699999999999999999999999 999999999999998776 4999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ....+. ..
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----~~~~i~---~~ 231 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVS---AV 231 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---TT
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-----HHHHHH---hc
Confidence 9998765432 2334568999999999999999999999999999999999999998644321 111111 11
Q ss_pred c-cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 500 D-RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 500 ~-~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. ..... .+...+.++.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 NYEFEDE-------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCCCHH-------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCch-------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000 01123457788999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=383.04 Aligned_cols=250 Identities=26% Similarity=0.340 Sum_probs=198.5
Q ss_pred hcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec-CCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 348 (595)
.++|++.+.||+|+||.||+|++ .|+.||||+++.. ...+.|.+|++++++++||||++++|++.+ .+..++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 45678899999999999999998 5789999999642 345779999999999999999999999865 456899999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+++|+|.+++.... ...+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999997532 23589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
.....+|..|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+.. +.
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----~~~~~i~~----~~------ 217 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVEK----GY------ 217 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHHHTT----TC------
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHc----CC------
Confidence 223457899999999999999999999999999999998 67777654322 12222221 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
....+.....++.+++.+||+.||.+||||.||+++|+..
T Consensus 218 --~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 218 --KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1112333446788999999999999999999999999764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=389.10 Aligned_cols=270 Identities=24% Similarity=0.360 Sum_probs=205.9
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccc
Q 007625 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQL 333 (595)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 333 (595)
+..+.+++..++|++.+.||+|+||.||+|++. +++.||||+++..........+.+|...+.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 344566667788999999999999999999853 34689999998666666677888888888877 68999999
Q ss_pred cceeecC-CceEEEEEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcC
Q 007625 334 IGYCTTS-SERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 400 (595)
Q Consensus 334 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 400 (595)
++++... ...++||||+++|+|.++++.... ....+++.+++.++.||+.||+|||++ +|+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence 9988665 467999999999999999975321 124589999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCC-CCCCC
Q 007625 401 LKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-RAIDF 478 (595)
Q Consensus 401 lkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~-~p~~~ 478 (595)
|||+|||+++++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 234467999999999999999999999999999999999975 56764
Q ss_pred CchhhhhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 479 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 479 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..... .+...+.. +.. ...+...+.++.+++.+||+.||++|||+.||+++|+..
T Consensus 240 ~~~~~----~~~~~~~~----~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 240 VKIDE----EFCRRLKE----GTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCCSH----HHHHHHHH----TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHH----HHHHHHhc----CCC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 33211 11122221 111 112233445788999999999999999999999999763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=389.82 Aligned_cols=265 Identities=23% Similarity=0.369 Sum_probs=217.2
Q ss_pred HHHHHhcCCCcCCeeeeccceEEEEEEeC------CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceee
Q 007625 265 ELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338 (595)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 338 (595)
++++..++|++.+.||+|+||+||+|.+. ++..||||+++..........|.+|++++++++||||+++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34556688999999999999999999863 357899999986666666678999999999999999999999999
Q ss_pred cCCceEEEEEecccCcHhhhhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC
Q 007625 339 TSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (595)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 412 (595)
..+..++||||+++|+|.+++.... .....+++..+..++.|+|.||.|||++ +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 9999999999999999999887421 2234579999999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccCcCcce-eecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCC-CCCCCCchhhhhhhhHH
Q 007625 413 EAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-RAIDFSRLEEEEDVLLL 490 (595)
Q Consensus 413 ~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~-~p~~~~~~~~~~~~~l~ 490 (595)
++||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||. .||......
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-------- 242 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------- 242 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--------
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 99999999998775443322 23346899999999999999999999999999999999985 666543321
Q ss_pred HHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 491 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 491 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
+......... ....+...+..+.+++.+||+.+|++||||+||+++|++.
T Consensus 243 ~~~~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 243 QVLRFVMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHhCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1122111111 1112233446799999999999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-47 Score=389.94 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=208.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 45799999999999999999996 479999999987532 3445678899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc--CCCcEEEeecccccccc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~~~~~~ 426 (595)
|+++|+|.+.+... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++...
T Consensus 107 ~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999998877642 34699999999999999999999999 999999999999998 67899999999999876
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+.. .. .. +
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----~~~~i~~---~~-~~--~ 247 (352)
T d1koba_ 181 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-----TLQNVKR---CD-WE--F 247 (352)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHH---CC-CC--C
T ss_pred CCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh---CC-CC--C
Confidence 532 2344568999999999999999999999999999999999999997644321 1111111 11 00 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. ......+.++.+++.+||+.||.+|||+.|++++
T Consensus 248 ~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DE---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CS---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Cc---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 1122344678899999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=387.14 Aligned_cols=249 Identities=21% Similarity=0.262 Sum_probs=207.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (595)
-++|++.+.||+|+||+||+|+. .+|+.||+|+++... .......+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46799999999999999999996 479999999996421 233467789999999999999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999886 34689999999999999999999999 99999999999999999999999999998654
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... +...+. . ..
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~~~~i~---~-~~----- 221 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELIL---M-EE----- 221 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---H-CC-----
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-----HHHHHh---c-CC-----
Confidence 332 22345679999999999999999999999999999999999999998654321 111111 1 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 544 (595)
..++...+.++.+++.+||+.||.+||+ ++|+++
T Consensus 222 ----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1122334457788999999999999995 777755
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=381.83 Aligned_cols=252 Identities=28% Similarity=0.399 Sum_probs=203.4
Q ss_pred CCeeeeccceEEEEEEeCCC----cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeec-CCceEEEEEec
Q 007625 276 SNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILVYPFM 350 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 350 (595)
.++||+|+||+||+|++.++ ..||||+++.........+|.+|++++++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 56899999999999996432 35899999766666777899999999999999999999999865 45789999999
Q ss_pred ccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcCc
Q 007625 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (595)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 430 (595)
++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999998753 34578899999999999999999999 999999999999999999999999999987654322
Q ss_pred c---eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 431 H---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 431 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
. ......||+.|+|||++.+..++.++||||||+++|||+||+.||...... ......+. ...+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----~~~~~~i~---~g~~~----- 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDITVYLL---QGRRL----- 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHH---TTCCC-----
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH----HHHHHHHH---cCCCC-----
Confidence 2 223356899999999999999999999999999999999988887643211 11111111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
..+.....++.+++.+||+.||++||+|.||+++|+.+
T Consensus 254 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11223346788999999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-47 Score=382.55 Aligned_cols=246 Identities=25% Similarity=0.312 Sum_probs=206.2
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ......+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5689999999999999999996 46999999998632 12334678899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+++|++...+.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998886 45688999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+ . ........
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~---~~~i~~~~------- 217 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----T---YEKILNAE------- 217 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H---HHHHHHCC-------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-----H---HHHHHcCC-------
Confidence 3 234679999999999999999999999999999999999999998644321 1 11111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 545 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 545 (595)
..+++..+.++.+++.+|++.||.+|| |++|++++
T Consensus 218 ---~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 ---LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 011223345788899999999999996 89998654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=384.15 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=204.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCc--EEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeecCCceEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (595)
++|++.++||+|+||+||+|+++ +|. .||||+++........+.|.+|++++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888999999999999999965 444 47888887655555677899999999998 799999999999999999999
Q ss_pred EEecccCcHhhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcE
Q 007625 347 YPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 414 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 414 (595)
|||+++|+|.++++... .....+++..+.+++.|||.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997531 2245799999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCC-CCCCCchhhhhhhhHHHHH
Q 007625 415 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR-AIDFSRLEEEEDVLLLDHI 493 (595)
Q Consensus 415 kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~-p~~~~~~~~~~~~~l~~~~ 493 (595)
||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||......+ ..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--------~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LY 236 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HH
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--------HH
Confidence 9999999986543222 223458999999999999999999999999999999999765 565433211 11
Q ss_pred HHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 494 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 494 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.......+ ...+...+.++.+++.+||+.||++||||+||++.|+.
T Consensus 237 ~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 237 EKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp HHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111111 11233345688899999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=383.07 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=214.8
Q ss_pred HHHhcCCCcCCeeeeccceEEEEEEe------CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeec
Q 007625 267 QLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (595)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 339 (595)
++..++|++.++||+|+||.||+|++ .+++.||||+++..........|.+|+.+++++ +|||||++++++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 34557889999999999999999985 346789999998666666777899999999999 69999999999999
Q ss_pred CCceEEEEEecccCcHhhhhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCC
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKP--------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 405 (595)
.+..++||||+++|+|.++++.... ....+++..+..++.||+.||+|||++ +++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 9999999999999999999975432 234689999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCC-CCCCCCchhh
Q 007625 406 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-RAIDFSRLEE 483 (595)
Q Consensus 406 Ill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~-~p~~~~~~~~ 483 (595)
|+++.++.+|++|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+|+. +|+......+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999977654333 334467899999999999999999999999999999999954 4454332211
Q ss_pred hhhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 484 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.+...+....+ ...+...+.++.+++.+||+.||++||||.||+++|++
T Consensus 256 ----~~~~~i~~~~~------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 256 ----KFYKMIKEGFR------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp ----HHHHHHHHTCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----HHHHHHhcCCC------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 12222221111 01122344678899999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=381.14 Aligned_cols=262 Identities=27% Similarity=0.381 Sum_probs=210.2
Q ss_pred HHhcCCCcCCeeeeccceEEEEEEeCC--------CcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceee
Q 007625 268 LATDNFSESNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (595)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 338 (595)
+..++|++.+.||+|+||.||+|+... +..||||+++.........++.+|...+.++ +||||+++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 455788999999999999999998522 3479999998766666778899999999888 7999999999999
Q ss_pred cCCceEEEEEecccCcHhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCE
Q 007625 339 TSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (595)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 406 (595)
+++..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999975432 135689999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCcCcc-eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhh
Q 007625 407 LLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 484 (595)
Q Consensus 407 ll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~ 484 (595)
|++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+| |..||......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-- 244 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 244 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence 9999999999999999977554322 2344668999999999999999999999999999999998 68888654331
Q ss_pred hhhhHHHHHHHHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 007625 485 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 549 (595)
Q Consensus 485 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 549 (595)
.+...+. .+.. ...+...+.++.+++.+||+.||++|||+.||++.|+.+
T Consensus 245 ---~~~~~i~----~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 ---ELFKLLK----EGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHHHH----TTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHH----cCCC--------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1122221 1110 111223345788999999999999999999999999763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-46 Score=372.29 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=201.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCc----
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE---- 342 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 342 (595)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... .......|.+|+++++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 479999999997432 33455689999999999999999999999876543
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++||||+++++|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 7899999999999998876 34699999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCcCc--ceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 423 KLVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 423 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~~~~~~ 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VAYQHVRED 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH--------HHHHHHhcC
Confidence 76543322 23345679999999999999999999999999999999999999998644321 111111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhc
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-PMAQVVKMLQG 548 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~ 548 (595)
.... . ......+.++.+++.+|++.||++|| |++++++.|..
T Consensus 231 ~~~~---~---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIPP---S---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCCG---G---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCC---c---hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1100 0 01122345788899999999999999 89999887754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=378.72 Aligned_cols=256 Identities=28% Similarity=0.370 Sum_probs=197.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC--CC--cEEEEEEeccCC--CchhHHHHHHHHHHHHhcCCCCCccccceeecCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS--DN--TKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
.++|++.+.||+|+||+||+|++. ++ ..||||+++... .....+.|.+|++++++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 356888999999999999999853 22 368999986432 33456789999999999999999999999975 467
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++|++.+.+... ...+++..+..++.|+|.||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 8999999999999888753 24599999999999999999999999 99999999999999999999999999999
Q ss_pred cccCcCcce--eecccccccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 424 LVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 424 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
......... .....||..|+|||++.+..++.++|||||||++|||+| |+.||......+ . .....+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-----~---~~~i~~~~ 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----I---LHKIDKEG 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----H---HHHHHTSC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-----H---HHHHHhCC
Confidence 875543332 234567889999999999999999999999999999998 899997544321 1 12221221
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
... ..+...+.++.+++.+||+.||++||||.||++.|++
T Consensus 232 ~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 ERL--------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 110 1122334578899999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=376.77 Aligned_cols=266 Identities=23% Similarity=0.305 Sum_probs=200.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC----ceEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERILV 346 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 346 (595)
.+|...+.||+|+||+||+|++ +|+.||||+++.. ......++.|+..+.+++||||+++++++.+.+ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~--~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc--chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 4567788999999999999997 6899999998642 122233344555667789999999999997654 57899
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-----NPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
|||+++|+|.+++++ ..++|..+..++.|+|.||+|+|+.. ..+|+||||||+|||+++++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999985 35899999999999999999999731 23899999999999999999999999999
Q ss_pred cccccCcCcc---eeecccccccccCccccCCCC------CCccchhHHHHHHHHHHHhCCCCCCCCchhhhh------h
Q 007625 422 AKLVDAKLTH---VTTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE------D 486 (595)
Q Consensus 422 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~------~ 486 (595)
++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9877543322 223467999999999987543 577899999999999999999887542211110 0
Q ss_pred hhHHHHHHHHhccccccccccccCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 487 VLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 487 ~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.............+. +.+.++. ...+....+.+++.+||+.||++|||+.||++.|+.
T Consensus 235 ~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 011112222222111 1222221 133466779999999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-46 Score=384.59 Aligned_cols=245 Identities=21% Similarity=0.263 Sum_probs=205.7
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC--CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (595)
++|++.+.||+|+||+||+|+.+ +|+.||||++... ........+.+|+++++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999964 7999999998632 12234567899999999999999999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccC
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 427 (595)
||+.+|+|..++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999999763 4689999999999999999999999 999999999999999999999999999987754
Q ss_pred cCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc
Q 007625 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 507 (595)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (595)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+.. ..
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~i~~----~~------ 254 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----IYEKIVS----GK------ 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----CC------
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-----HHHHHhc----CC------
Confidence 3 234569999999999999999999999999999999999999997643211 1111111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007625 508 RNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVK 544 (595)
Q Consensus 508 ~~l~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 544 (595)
...+...+.++.+++.+||+.||.+|+ |++|+++
T Consensus 255 ---~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 ---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 011223446788999999999999994 8888865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.9e-46 Score=369.37 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=204.7
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCC--------chhHHHHHHHHHHHHhcC-CCCCccccceeecC
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS--------PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTS 340 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 340 (595)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ......+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999996 4789999999864321 112346889999999997 99999999999999
Q ss_pred CceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecc
Q 007625 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (595)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 420 (595)
+..++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999975 34699999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcCcceeecccccccccCccccC------CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHH
Q 007625 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLS------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 494 (595)
Q Consensus 421 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~ 494 (595)
+++...... ......||+.|+|||++. ...++.++||||+||++|||+||+.||....... ....+.
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-----~~~~i~ 228 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-----MLRMIM 228 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-----HHHHHH
Confidence 999775532 234467999999999985 3457889999999999999999999998654321 111111
Q ss_pred HHhccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 495 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 495 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. +... ... ......+.++.+++.+||+.||++|||+.||++
T Consensus 229 ---~-~~~~-~~~----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 ---S-GNYQ-FGS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ---H-TCCC-CCT----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---h-CCCC-CCC----cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 1110 000 012234467889999999999999999999854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.4e-46 Score=384.20 Aligned_cols=250 Identities=24% Similarity=0.264 Sum_probs=199.7
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHH---HHHHHHhcCCCCCccccceeecCCce
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQR---EVHLISVAIHKNLLQLIGYCTTSSER 343 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~ 343 (595)
-++|++.++||+|+||+||+|+.. +|+.||||++.... .......+.+ |+++++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999965 79999999985321 1122233344 46677778899999999999999999
Q ss_pred EEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999986 34688999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccc
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 502 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (595)
...... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ....... ...
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~-~~~-- 224 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMT-LTM-- 224 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHHHS-SSC--
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhc-ccC--
Confidence 765432 234569999999999875 5689999999999999999999999986443211 1111111 000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007625 503 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 544 (595)
Q Consensus 503 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 544 (595)
....+...+.++.+++.+||+.||++||| ++|+++
T Consensus 225 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01112233457889999999999999999 677765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=374.70 Aligned_cols=252 Identities=16% Similarity=0.236 Sum_probs=205.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
.++|++.+.||+|+||+||+|... +++.||+|+++.. ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 468999999999999999999975 6889999999643 2345678899999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCC--CcEEEeecccccccc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN--FEAVLCDFGLAKLVD 426 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG~~~~~~ 426 (595)
|+++|+|.+++... ...+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999999752 24689999999999999999999999 99999999999999854 589999999998765
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
... ......||+.|+|||...+..++.++||||+||++|||++|+.||....... . ......... . +.
T Consensus 156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-----~---~~~i~~~~~-~-~~ 223 (321)
T d1tkia_ 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----I---IENIMNAEY-T-FD 223 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H---HHHHHHTCC-C-CC
T ss_pred cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-----H---HHHHHhCCC-C-CC
Confidence 432 2334568999999999999999999999999999999999999998654321 1 111111110 0 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
... ....+.++.+++.+|++.||++|||+.|++++
T Consensus 224 ~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 224 EEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 01124567899999999999999999999873
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=379.75 Aligned_cols=248 Identities=25% Similarity=0.343 Sum_probs=203.1
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCC--CchhHHHHHHHHHHHH-hcCCCCCccccceeecCCceEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTTSSERILV 346 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 346 (595)
++|++.+.||+|+||+||+|+.. +++.||||+++... .......+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999964 78999999996321 2233455667776655 68999999999999999999999
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 426 (595)
|||+++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999986 34589999999999999999999999 99999999999999999999999999998665
Q ss_pred CcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccccccccc
Q 007625 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 506 (595)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (595)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+..... +...+.. ..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-----~~~~i~~----~~----- 219 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----LFHSIRM----DN----- 219 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----CC-----
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-----HHHHHHc----CC-----
Confidence 4322 2344679999999999999999999999999999999999999998654321 1111111 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 007625 507 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA-QVVK 544 (595)
Q Consensus 507 d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 544 (595)
+ .++...+.++.+++.+||+.||++||++. |+++
T Consensus 220 -~---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 -P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -C---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 11223346788999999999999999985 6643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=375.13 Aligned_cols=257 Identities=27% Similarity=0.270 Sum_probs=197.1
Q ss_pred cCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCc----hhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 275 ESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
..++||+|+||+||+|+.. +|+.||||+++..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3678999999999999964 6999999998643211 1234688999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+.++++...... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 999877766543 45688999999999999999999999 99999999999999999999999999998765433
Q ss_pred cceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccccccccc-
Q 007625 430 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD- 507 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d- 507 (595)
.. .....||+.|+|||++.+. .++.++|||||||++|||+||+.||......+ ....+.............+
T Consensus 155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-----~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-----QLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHHCCCCTTTSSST
T ss_pred cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-----HHHHHHHhcCCCChhhccch
Confidence 22 2345689999999998654 57999999999999999999999997654322 1122222111110000000
Q ss_pred ---------ccCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 508 ---------RNLNTYD-----SKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 508 ---------~~l~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
......+ +....++.+++.+|++.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0011111 123467889999999999999999999965
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=371.84 Aligned_cols=264 Identities=24% Similarity=0.309 Sum_probs=201.0
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
|+|++.+.||+|+||+||+|+. .+|+.||||+++... .......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999996 579999999996432 23345788999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
|+.++.+...... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9986544433332 245699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc--ccccccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--EDRLNDI 505 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~--~~~~~~~ 505 (595)
.. ......||+.|+|||.+.... ++.++||||+||++|||++|+.||...+.... +......... +......
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ----LFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTG
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH----HHHHHHhcCCCchhhcccc
Confidence 22 233456999999999977665 58899999999999999999999986543221 1111111100 0000000
Q ss_pred cc-----ccCCC--------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 506 VD-----RNLNT--------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 506 ~d-----~~l~~--------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. ..... .......++.+++.+|++.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 00000 011234678889999999999999999999764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=377.18 Aligned_cols=252 Identities=21% Similarity=0.252 Sum_probs=198.5
Q ss_pred hcCCCcCC-eeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhc-CCCCCccccceeec----CCc
Q 007625 270 TDNFSESN-IIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT----SSE 342 (595)
Q Consensus 270 ~~~~~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 342 (595)
.++|++.. +||+|+||+||+|+. .+++.||||+++. ...+.+|+.++.++ +||||+++++++.+ ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 35788764 699999999999996 5789999999864 24567899887654 89999999998865 356
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC---CCcEEEeec
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDF 419 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 419 (595)
.++|||||++|+|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+|||+++ ++.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 799999999999999997532 35799999999999999999999999 9999999999999985 567999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 499 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 499 (595)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ...+......
T Consensus 159 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-----~~~~~~~i~~ 231 (335)
T d2ozaa1 159 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGMKTRIRM 231 (335)
T ss_dssp TTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCS
T ss_pred ceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-----HHHHHHHHhc
Confidence 9998765432 23445799999999999999999999999999999999999999975432111 1111111100
Q ss_pred ccccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 DRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 ~~~~~~~d~~l~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. ..++. .....+.++.+++.+|++.||++|||+.|++++
T Consensus 232 ~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 232 GQ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CS------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 00111 113345678999999999999999999999873
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-45 Score=367.96 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=202.7
Q ss_pred cCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCC-CchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEEe
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (595)
++|++.++||+|+||+||+|+.++|+.||||+++... .......+.+|+.++++++||||+++++++..++..+++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999899999999996432 333457899999999999999999999999999999999999
Q ss_pred cccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCcC
Q 007625 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (595)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 429 (595)
+.++.+...... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 998777666554 45799999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc---cccccc
Q 007625 430 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLNDI 505 (595)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~~ 505 (595)
. ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||........ + ..+...... ..+...
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~----~-~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ----L-MRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----H-HHHHHHHCCCCTTTSTTG
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH----H-HHHHHhhCCCChhhccch
Confidence 2 22334589999999998754 569999999999999999999999986543211 1 111111110 000000
Q ss_pred c-----cccC--------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 506 V-----DRNL--------NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 506 ~-----d~~l--------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. +... .........++.+++.+|++.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000 0112233467889999999999999999999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=368.22 Aligned_cols=242 Identities=23% Similarity=0.364 Sum_probs=196.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCC-C-c---hhHHHHHHHHHHHHhcC--CCCCccccceeecCC
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-S-P---GGEAAFQREVHLISVAI--HKNLLQLIGYCTTSS 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~-~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 341 (595)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... . . .....+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999996 478999999986321 1 1 11234678999999986 899999999999999
Q ss_pred ceEEEEEeccc-CcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-CCcEEEeec
Q 007625 342 ERILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDF 419 (595)
Q Consensus 342 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df 419 (595)
..++||||+.+ +++.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999975 577777765 34699999999999999999999999 9999999999999985 479999999
Q ss_pred cccccccCcCcceeecccccccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 420 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
|+++..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||..... +. +
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------i~---~ 218 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------II---R 218 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HH---H
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----------Hh---h
Confidence 999865433 2334679999999999987665 5778999999999999999999974211 00 0
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. . .++...+.++.+++.+||+.||++|||++|++++
T Consensus 219 ~~---~-------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 GQ---V-------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CC---C-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc---c-------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 0 0112234578889999999999999999999763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=368.86 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=198.2
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CC-CcEEEEEEeccC-CCchhHHHHHHHHHHHHhc---CCCCCccccceeec----
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SD-NTKVAVKRLQDY-YSPGGEAAFQREVHLISVA---IHKNLLQLIGYCTT---- 339 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 339 (595)
.++|++.+.||+|+||+||+|+. ++ ++.||||+++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999996 34 567999998632 2222333456777776655 79999999998853
Q ss_pred -CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEee
Q 007625 340 -SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (595)
Q Consensus 340 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 418 (595)
....+++|||+.++.+...... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 3467899999998877655443 245689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 419 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
||+++...... ......||+.|+|||++.+..++.++||||+||++|||+||+.||......+. ...+.....
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-----~~~i~~~~~ 232 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-----LGKILDVIG 232 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHHHC
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-----HHHHHHhhC
Confidence 99988654332 23456799999999999999999999999999999999999999986543221 111111111
Q ss_pred cc---ccc-----------ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 499 ED---RLN-----------DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 499 ~~---~~~-----------~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. .+. .................+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000 000001111223344677889999999999999999999653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=355.80 Aligned_cols=264 Identities=23% Similarity=0.275 Sum_probs=197.8
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeec--------
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-------- 339 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 339 (595)
.++|++.+.||+|+||+||+|+. .+|+.||||++... ........+.+|++++++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999996 47999999998632 334455778999999999999999999998755
Q ss_pred CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeec
Q 007625 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (595)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 419 (595)
....++||||+.++.+...... ...++...++.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 3457899999998776655443 45689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCcCcc---eeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHH
Q 007625 420 GLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 495 (595)
Q Consensus 420 G~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~ 495 (595)
|+++........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ....+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-----~~~~i~~ 236 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-----QLALISQ 236 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-----HHHHHHH
Confidence 999876543221 22335699999999998765 68999999999999999999999997644321 1111211
Q ss_pred Hhcc---ccccccccc---------cCCCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 496 LLRE---DRLNDIVDR---------NLNTYDS-------KEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 496 ~~~~---~~~~~~~d~---------~l~~~~~-------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.... ......... ....... ....++.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1111 000000000 0000001 113456789999999999999999999753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-43 Score=358.10 Aligned_cols=263 Identities=19% Similarity=0.308 Sum_probs=200.0
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecCC----ceE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERI 344 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 344 (595)
+++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+|++++++++|||++++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999996 5899999999976555566678999999999999999999999986653 345
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 424 (595)
++++|+.+|+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 66677889999999974 3589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCcCcc--eeecccccccccCccccC-CCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 425 VDAKLTH--VTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 425 ~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
....... ......||+.|+|||++. +..++.++||||+||++|||++|+.||.......... ..........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~-----~~~~~~~~~~ 233 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN-----HILGILGSPS 233 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----HHHHHHCSCC
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH-----HHhhhccCCC
Confidence 6543222 234456999999999985 4567899999999999999999999998654322111 1100000000
Q ss_pred cc-----------c-c-ccccCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 502 LN-----------D-I-VDRNLNTY-----DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 502 ~~-----------~-~-~d~~l~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.. . . ..+..... .+....++.+++.+|++.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0 0 00000000 11223467899999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=360.51 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=195.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCC------
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 341 (595)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.. ......+.+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999964 6999999999743 34445678899999999999999999999997654
Q ss_pred ceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccc
Q 007625 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (595)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 421 (595)
..++||||+ +.+|....+. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 569999999 5577776653 4599999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcCcceeecccccccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcc-
Q 007625 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE- 499 (595)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~- 499 (595)
++..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......... ..........
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~----~~~~~~~~~~~ 239 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL----KEIMKVTGTPP 239 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHHHCCCC
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH----HHHHhccCCCc
Confidence 9876543 2345689999999998764 5689999999999999999999999865432111 1111000000
Q ss_pred ----------------ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 500 ----------------DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 500 ----------------~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
..........+.........++.+++.+|+..||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000011111122334567889999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=351.10 Aligned_cols=262 Identities=24% Similarity=0.292 Sum_probs=206.0
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecCCceEEEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (595)
++|++.+.||+|+||+||+|+. .+++.||||+++.. ........+.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999996 47899999999743 334556889999999999999999999999999999999999
Q ss_pred ecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeeccccccccCc
Q 007625 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (595)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 428 (595)
++.++++..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999998887764 45689999999999999999999999 9999999999999999999999999999877544
Q ss_pred CcceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc---cccc
Q 007625 429 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RLND 504 (595)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~ 504 (595)
... .....+++.|+|||++.+.. ++.++||||+||++|||++|+.||........ ....+....... ....
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD----QLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH----HHHHHHHHHCCCCTTTCTT
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH----HHHHHHhhcCCCChhhhhh
Confidence 322 23345788999999987665 68999999999999999999999754332111 111121111110 0000
Q ss_pred ---cc----------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 505 ---IV----------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 505 ---~~----------d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.. ..............+.+++.+|++.||++|||++||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00111122334567788999999999999999999954
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=357.30 Aligned_cols=253 Identities=22% Similarity=0.279 Sum_probs=203.8
Q ss_pred cCCCcCCeeeeccceEEEEEEe----CCCcEEEEEEeccCC---CchhHHHHHHHHHHHHhcCC-CCCccccceeecCCc
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSE 342 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 342 (595)
++|++.+.||+|+||+||+|+. .+|+.||||+++... .......+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999985 258899999986321 22334667899999999976 899999999999999
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.+++|||+.+|+|.+++... ..++......++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999863 3578899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhccc
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 500 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 500 (595)
+.+............|++.|+|||.+.+. .++.++|||||||++|||+||+.||........... ........
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~----i~~~~~~~- 251 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE----ISRRILKS- 251 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH----HHHHHHHC-
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHHhcccC-
Confidence 87765544445556799999999998754 468899999999999999999999976543322211 11111110
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007625 501 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 544 (595)
Q Consensus 501 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 544 (595)
....+...+.++.+++.+|++.||++||| ++|+++
T Consensus 252 ---------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 01123345578889999999999999995 778754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=356.93 Aligned_cols=263 Identities=22% Similarity=0.278 Sum_probs=193.7
Q ss_pred CCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCccccceeecC------CceE
Q 007625 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SERI 344 (595)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 344 (595)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|++++++++||||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5778899999999999999974 799999999974321 224799999999999999999998543 2468
Q ss_pred EEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC-cEEEeeccccc
Q 007625 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAK 423 (595)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~ 423 (595)
+||||++++.+....+ .......+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 9999998764444333 222356799999999999999999999999 999999999999999775 89999999998
Q ss_pred cccCcCcceeecccccccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhH-------HHHHHH
Q 007625 424 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL-------LDHIRK 495 (595)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l-------~~~~~~ 495 (595)
....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||............. .+....
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 7654322 234568999999998765 568999999999999999999999997654322111000 000111
Q ss_pred Hhcc---ccccccccccC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 496 LLRE---DRLNDIVDRNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 496 ~~~~---~~~~~~~d~~l-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
.... ........... .........++.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000000000 00122345578899999999999999999999753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-42 Score=349.33 Aligned_cols=259 Identities=17% Similarity=0.201 Sum_probs=195.9
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCcccc-ceeecCCceEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI-GYCTTSSERILVY 347 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-~~~~~~~~~~lv~ 347 (595)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+..|+++++.++|+|++..+ ++....+..++||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 35799999999999999999996 4689999999864322 23578899999999877766555 4556677888999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEc---CCCcEEEeecccccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAKL 424 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~~~~ 424 (595)
||+. +++...+... ...+++.++..++.|++.||+|||++ +|+||||||+|||++ .+..++|+|||+++.
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 83 ELLG-PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp ECCC-CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEcC-Cchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 9985 5666555532 35699999999999999999999999 999999999999986 355799999999997
Q ss_pred ccCcCcc------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhc
Q 007625 425 VDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 498 (595)
Q Consensus 425 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 498 (595)
....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~~~~~~~ 234 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMS 234 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHHhhcccCC
Confidence 7543221 2234579999999999999999999999999999999999999997644322111 11111111100
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 499 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 499 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
. .... .....+.++.+++..||+.+|++||++.++.+.|++
T Consensus 235 ~-~~~~--------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 235 T-PIEV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp S-CHHH--------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred C-ChhH--------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0 0000 011233578889999999999999999999888765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-42 Score=351.01 Aligned_cols=258 Identities=19% Similarity=0.263 Sum_probs=196.8
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecC--CceEEE
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTS--SERILV 346 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 346 (595)
++|++.++||+|+||+||+|+. .+|+.||||+++. ...+.+.+|+++++.+. ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 5799999999999999999996 4789999999864 23567889999999995 99999999998744 568899
Q ss_pred EEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCC-cEEEeeccccccc
Q 007625 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLV 425 (595)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~~ 425 (595)
|||+.+++|.... +.+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 9999999987653 2489999999999999999999999 999999999999998654 6999999999876
Q ss_pred cCcCcceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHH---------HHH
Q 007625 426 DAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH---------IRK 495 (595)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~---------~~~ 495 (595)
.... ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||................ ...
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 5432 233456899999999987654 7999999999999999999999997654322211111111 100
Q ss_pred Hhcc--ccccccccc--------cCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 496 LLRE--DRLNDIVDR--------NLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 496 ~~~~--~~~~~~~d~--------~l~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
.... ......... ... ........++.+++.+|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000000 000 011223457889999999999999999999965
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-41 Score=340.87 Aligned_cols=259 Identities=15% Similarity=0.204 Sum_probs=203.3
Q ss_pred hcCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCC-CCCccccceeecCCceEEEE
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSERILVY 347 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 347 (595)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+|++.++.+.| +|++.+++++......++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 468999999999999999999964 789999999864322 2346788889998875 89999999999999999999
Q ss_pred EecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcC-----CCcEEEeecccc
Q 007625 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-----NFEAVLCDFGLA 422 (595)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfG~~ 422 (595)
||+ +++|.+.+... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 81 e~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 998 68998888753 34689999999999999999999999 9999999999999974 578999999999
Q ss_pred ccccCcCcc------eeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHH
Q 007625 423 KLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 496 (595)
Q Consensus 423 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 496 (595)
+........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~--~~~~i~~~ 231 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYERIGEK 231 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH--HHHHHHhc
Confidence 876543211 2234579999999999999999999999999999999999999998644322211 11111111
Q ss_pred hccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 007625 497 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 548 (595)
Q Consensus 497 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 548 (595)
.......++ ....+.++.+++..|++.+|++||+++.+.+.|++
T Consensus 232 ~~~~~~~~l--------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 232 KQSTPLREL--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHSCHHHH--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred cCCCChHHh--------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111101111 11123568888899999999999999998887755
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=354.52 Aligned_cols=263 Identities=20% Similarity=0.267 Sum_probs=192.0
Q ss_pred cCCCcCCeeeeccceEEEEEEeC-CCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC------Cc
Q 007625 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SE 342 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 342 (595)
++|++.++||+|+||+||+|+.. +|+.||||++... .+......+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999965 6999999999743 3344556789999999999999999999998643 57
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.++||||+.++.+. .+. ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++.++++|||++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 79999999775544 332 3489999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHH-----------
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD----------- 491 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~----------- 491 (595)
+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+...........
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 8665432 233456899999999999999999999999999999999999999765432211110000
Q ss_pred ---HHHHHhccc------cccccccccC-CC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007625 492 ---HIRKLLRED------RLNDIVDRNL-NT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 545 (595)
Q Consensus 492 ---~~~~~~~~~------~~~~~~d~~l-~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 545 (595)
......... .....+.... .. .......++.+++.+|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 0000111111 11 123456788999999999999999999999643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=350.14 Aligned_cols=258 Identities=21% Similarity=0.281 Sum_probs=196.4
Q ss_pred hcCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccC-CCchhHHHHHHHHHHHHhcCCCCCccccceeecC-----Cc
Q 007625 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE 342 (595)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 342 (595)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.. .+......+.+|++++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999996 47999999999743 3344556789999999999999999999988643 34
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEEeecccc
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 422 (595)
.+++++|+.+|+|.+++.. ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 5777888899999998863 4599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCcCcceeecccccccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCCchhhhhhhhHHHHHHHHhcccc
Q 007625 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 501 (595)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 501 (595)
...... .....||+.|+|||...+.. ++.++||||+||++|+|++|+.||...+...... .+........
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~-----~i~~~~~~~~ 239 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK-----LILRLVGTPG 239 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----HHHHHHCCCC
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH-----HHHHhcCCCC
Confidence 765432 23456899999999876654 6899999999999999999999998654322111 1111100000
Q ss_pred c-----------ccccc--ccCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007625 502 L-----------NDIVD--RNLNTY-----DSKEVETMVQVALLCTQSTPEDRPPMAQVVK 544 (595)
Q Consensus 502 ~-----------~~~~d--~~l~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 544 (595)
. ..... ...... ......++.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 00000 000000 1123456788999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-37 Score=315.55 Aligned_cols=264 Identities=20% Similarity=0.231 Sum_probs=190.3
Q ss_pred cCCCcCCeeeeccceEEEEEEe-CCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-----------CCCCccccceee
Q 007625 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----------HKNLLQLIGYCT 338 (595)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 338 (595)
++|+++++||+|+||+||+|+. .+|+.||||+++.. ......+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 4599999999999999999996 47999999999642 234567788998888775 578999998875
Q ss_pred c--CCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCEEEcCCC---
Q 007625 339 T--SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNF--- 412 (595)
Q Consensus 339 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~--- 412 (595)
. ....+++++++..+.......... ....+++..++.++.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 4 345667777765554333332222 24578999999999999999999998 5 899999999999998664
Q ss_pred ---cEEEeeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCCchhhh--hhh
Q 007625 413 ---EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE--EDV 487 (595)
Q Consensus 413 ---~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~p~~~~~~~~~--~~~ 487 (595)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||........ ...
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 3999999999865432 2345689999999999999999999999999999999999999975432111 011
Q ss_pred hHHHHHHHH-------hcc-cccccccc--------------------ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007625 488 LLLDHIRKL-------LRE-DRLNDIVD--------------------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 539 (595)
Q Consensus 488 ~l~~~~~~~-------~~~-~~~~~~~d--------------------~~l~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 539 (595)
.+...+... ... ......++ ............++.+++.+|++.||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 111111100 000 00000000 00112456778899999999999999999999
Q ss_pred HHHHH
Q 007625 540 AQVVK 544 (595)
Q Consensus 540 ~evl~ 544 (595)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99964
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.89 E-value=1.1e-23 Score=211.69 Aligned_cols=149 Identities=28% Similarity=0.503 Sum_probs=133.1
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCCCCCCCCCC--CcceeEecC----CCEEEEEcCCCCCCC--CCCccccccCCC
Q 007625 31 REPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCF--SWSHVTCRN----GNVISLTLGSNGFSG--KISPSITKLKFL 102 (595)
Q Consensus 31 ~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~--~w~gv~c~~----~~l~~l~l~~n~l~g--~~~~~~~~l~~L 102 (595)
.|.+.|++||++||+++.++. .+.+|..+ ++|| .|.||+|+. .+|+.|+|++|+++| .+|++|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~--~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCC--CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 488999999999999999875 68999864 4566 599999985 279999999999998 578999999999
Q ss_pred CeEEccC-CccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcCCccCchhhhcc---ccccccc
Q 007625 103 ASLELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSV---ATFNFTG 178 (595)
Q Consensus 103 ~~L~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l~~l---~~l~~~~ 178 (595)
++|+|++ |+++|.+|.+|++|++|++|+|++|+|++..|..+.++.+|+.+++++|++.+.+|..+.++ ..+++++
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~ 158 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccc
Confidence 9999997 89999999999999999999999999999999999999999999999999999999877654 5677788
Q ss_pred cccc
Q 007625 179 THLI 182 (595)
Q Consensus 179 n~~~ 182 (595)
|...
T Consensus 159 n~l~ 162 (313)
T d1ogqa_ 159 NRIS 162 (313)
T ss_dssp SCCE
T ss_pred cccc
Confidence 7653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=3e-23 Score=192.74 Aligned_cols=170 Identities=11% Similarity=0.057 Sum_probs=120.7
Q ss_pred CcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCC-----------------chhHHHHHHHHHHHHhcCCCCCccccce
Q 007625 274 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS-----------------PGGEAAFQREVHLISVAIHKNLLQLIGY 336 (595)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----------------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 336 (595)
.+++.||+|+||+||+|+..+|+.||||+++.... ......+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999988999999998753211 0112345668888999999999887654
Q ss_pred eecCCceEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcEEcCCCCCCEEEcCCCcEEE
Q 007625 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 416 (595)
Q Consensus 337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 416 (595)
. ..+++|||+++..+.. ++......++.|++.+++|||+. +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2479999998765432 23334568999999999999999 99999999999999966 5899
Q ss_pred eeccccccccCcCcceeecccccccccCccccCCCCCCccchhHHHHHHH
Q 007625 417 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITL 466 (595)
Q Consensus 417 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl 466 (595)
+|||.+.....+....... ..... -.|. ...+|+.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~~~l~--rd~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILE--RDVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHHHH--HHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHH--HHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 9999997664332111000 00000 0111 135678899999975433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.66 E-value=7.3e-17 Score=149.11 Aligned_cols=125 Identities=26% Similarity=0.396 Sum_probs=108.3
Q ss_pred CCCC-CCcceeEecC-----------CCEEEEEcCCCCCCCCC-CccccccCCCCeEEccCCccCCCCCccccCCCcccE
Q 007625 62 VSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKI-SPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128 (595)
Q Consensus 62 ~~~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~-~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~ 128 (595)
+..| |.|..|.|+. .+++.|+|++|.|++.+ +..|.++++|+.|+|++|.+.+..+..+..+++|++
T Consensus 3 P~~C~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~ 82 (192)
T d1w8aa_ 3 PAMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQE 82 (192)
T ss_dssp CTTSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CCCCEEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccce
Confidence 3456 6899999974 26889999999998756 456899999999999999999889999999999999
Q ss_pred EEeccccccCccccccccCCCCceecCCCCcCCccCch----hhhccccccccccccccCCCC
Q 007625 129 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM----QLFSVATFNFTGTHLICGSSL 187 (595)
Q Consensus 129 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~----~l~~l~~l~~~~n~~~~~~~~ 187 (595)
|+|++|+|++..|..|.++++|++|+|++|+|+ .+|. .+.++..+++++|++.|.+..
T Consensus 83 L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~~~ 144 (192)
T d1w8aa_ 83 LQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp EECCSCCCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred eeeccccccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCcccccccccccccccccch
Confidence 999999999767778999999999999999999 5654 345678999999999988643
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.51 E-value=5.5e-15 Score=147.22 Aligned_cols=113 Identities=31% Similarity=0.462 Sum_probs=101.8
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
....++++++.+.|.+|..+..+++|+.|++++|.+++.+| .++.+++|++|+|++|+|+|.+|..|++|++|++|+|+
T Consensus 198 ~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls 276 (313)
T d1ogqa_ 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276 (313)
T ss_dssp CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECc
Confidence 34468888888888999999999999999999999998765 68999999999999999999999999999999999999
Q ss_pred CCcCCccCch--hhhccccccccccccccCCCCCCCC
Q 007625 157 SNNLTGRIPM--QLFSVATFNFTGTHLICGSSLEQPC 191 (595)
Q Consensus 157 ~N~l~g~ip~--~l~~l~~l~~~~n~~~~~~~~~~~c 191 (595)
+|+|+|.||. .+.++..+++++|+.+||.|++ .|
T Consensus 277 ~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 277 FNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp SSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 9999999996 3677888999999999998874 55
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=4.9e-14 Score=119.70 Aligned_cols=99 Identities=22% Similarity=0.366 Sum_probs=85.9
Q ss_pred EEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCc
Q 007625 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNN 159 (595)
Q Consensus 80 ~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~ 159 (595)
.|+|++|+|+ .++ .+..+++|++|+|++|.|+ .+|+.++.+++|++|++++|+|+ .+| .+.++++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 6899999998 665 4999999999999999999 78999999999999999999999 566 48999999999999999
Q ss_pred CCccCch--h---hhccccccccccccccC
Q 007625 160 LTGRIPM--Q---LFSVATFNFTGTHLICG 184 (595)
Q Consensus 160 l~g~ip~--~---l~~l~~l~~~~n~~~~~ 184 (595)
|+ .+|. . +.++..+++++|+....
T Consensus 77 i~-~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 77 LQ-QSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CC-SSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred cC-CCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 98 5552 3 35678899999987544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=7.4e-14 Score=123.72 Aligned_cols=104 Identities=18% Similarity=0.257 Sum_probs=86.6
Q ss_pred EcCCCCCCCCCCccccccCCCCeEEccCC-ccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcC
Q 007625 82 TLGSNGFSGKISPSITKLKFLASLELQDN-DLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNL 160 (595)
Q Consensus 82 ~l~~n~l~g~~~~~~~~l~~L~~L~l~~n-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l 160 (595)
+.+++++. .+|..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+..-|..|..+++|++|+|++|+|
T Consensus 14 ~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l 92 (156)
T d2ifga3 14 RCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92 (156)
T ss_dssp ECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCC
T ss_pred EecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCC
Confidence 33456665 56778899999999999876 58854456799999999999999999966677899999999999999999
Q ss_pred CccCchhhh---ccccccccccccccCCCC
Q 007625 161 TGRIPMQLF---SVATFNFTGTHLICGSSL 187 (595)
Q Consensus 161 ~g~ip~~l~---~l~~l~~~~n~~~~~~~~ 187 (595)
+ .+|...+ ++..+++++||+.|+|.+
T Consensus 93 ~-~l~~~~~~~~~l~~L~L~~Np~~C~C~~ 121 (156)
T d2ifga3 93 E-SLSWKTVQGLSLQELVLSGNPLHCSCAL 121 (156)
T ss_dssp S-CCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred c-ccChhhhccccccccccCCCcccCCchH
Confidence 9 8887543 578899999999998854
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.38 E-value=5.4e-13 Score=122.56 Aligned_cols=111 Identities=21% Similarity=0.368 Sum_probs=94.2
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|.+.+..+..+..+++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|..+++|++|+|
T Consensus 54 ~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L 133 (192)
T d1w8aa_ 54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133 (192)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEEC
T ss_pred ceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccc
Confidence 48999999999999888899999999999999999999777778999999999999999999777778999999999999
Q ss_pred CCCcCCccCchhh--hccccccccccccccCCC
Q 007625 156 SSNNLTGRIPMQL--FSVATFNFTGTHLICGSS 186 (595)
Q Consensus 156 ~~N~l~g~ip~~l--~~l~~l~~~~n~~~~~~~ 186 (595)
++|.+.+..+... ..+..+.+.+|...|..|
T Consensus 134 ~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 134 ASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp TTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 9999986544321 234556666777666543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=6.6e-13 Score=128.65 Aligned_cols=110 Identities=25% Similarity=0.346 Sum_probs=85.8
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|.+.+..+..+..+.+|+.|++++|.+++..|..+..+++|+.|++++|+|++..+..|..+++|++|+|+
T Consensus 101 ~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls 180 (266)
T d1p9ag_ 101 ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180 (266)
T ss_dssp TCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECC
T ss_pred ccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecc
Confidence 45555555555554445555666666667777777775555667789999999999999997777789999999999999
Q ss_pred CCcCCccCchhhh---ccccccccccccccCCCC
Q 007625 157 SNNLTGRIPMQLF---SVATFNFTGTHLICGSSL 187 (595)
Q Consensus 157 ~N~l~g~ip~~l~---~l~~l~~~~n~~~~~~~~ 187 (595)
+|+|+ .+|..++ +++.++++||||.|+|..
T Consensus 181 ~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp SSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred cCCCc-ccChhHCCCCCCCEEEecCCCCCCCcch
Confidence 99999 9998765 567889999999999854
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=4.5e-13 Score=131.17 Aligned_cols=112 Identities=21% Similarity=0.257 Sum_probs=99.6
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
..++.+++++|.|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|++++|++++..|..|.++++|++|++
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l 208 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccc
Confidence 37899999999999766778999999999999999999877889999999999999999999888999999999999999
Q ss_pred CCCcCCccCchhh---hccccccccccccccCCCC
Q 007625 156 SSNNLTGRIPMQL---FSVATFNFTGTHLICGSSL 187 (595)
Q Consensus 156 ~~N~l~g~ip~~l---~~l~~l~~~~n~~~~~~~~ 187 (595)
++|++++..|..+ .+++.+++++|++.|+|+.
T Consensus 209 ~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred cccccccccccccccccccCEEEecCCCCCCCccc
Confidence 9999996555444 5578999999999998753
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=1.3e-12 Score=116.38 Aligned_cols=101 Identities=20% Similarity=0.226 Sum_probs=86.3
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCcccc-ccccCCCCceecC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDL 155 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~l 155 (595)
+++.|+|++|+|+ .++..+..+++|+.|+|++|.|+ .++ .|..+++|++|+|++|+++ .+|+ .+..+++|+.|+|
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELIL 94 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEEC
T ss_pred cCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCcccccccccccccee
Confidence 6899999999999 66777788999999999999999 675 5899999999999999999 5554 4578999999999
Q ss_pred CCCcCCccCch-----hhhccccccccccccc
Q 007625 156 SSNNLTGRIPM-----QLFSVATFNFTGTHLI 182 (595)
Q Consensus 156 ~~N~l~g~ip~-----~l~~l~~l~~~~n~~~ 182 (595)
++|+|+ .++. .+.++..+++++|+..
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccccc-ccccccccccccccchhhcCCCccc
Confidence 999998 5553 3467788899999863
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.25 E-value=5.4e-12 Score=106.76 Aligned_cols=82 Identities=27% Similarity=0.376 Sum_probs=74.7
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccc--cccccCCCCcee
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP--ATWSQLSNLKHL 153 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~l 153 (595)
.+++.|+|++|.|+ .+|+.++.+++|+.|++++|.|+ .+| .+.++++|++|++++|+|+ .+| ..+..+++|+.|
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLL 95 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccC-CCCCchhhcCCCCCCEE
Confidence 37999999999998 78888999999999999999999 566 5999999999999999998 444 468999999999
Q ss_pred cCCCCcCC
Q 007625 154 DLSSNNLT 161 (595)
Q Consensus 154 ~l~~N~l~ 161 (595)
++++|+++
T Consensus 96 ~l~~N~i~ 103 (124)
T d1dcea3 96 NLQGNSLC 103 (124)
T ss_dssp ECTTSGGG
T ss_pred ECCCCcCC
Confidence 99999998
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=8.2e-12 Score=110.23 Aligned_cols=95 Identities=24% Similarity=0.228 Sum_probs=81.2
Q ss_pred CCcceeEecC-------------CCEEEEEcCCCC-CCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEe
Q 007625 66 FSWSHVTCRN-------------GNVISLTLGSNG-FSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNL 131 (595)
Q Consensus 66 ~~w~gv~c~~-------------~~l~~l~l~~n~-l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l 131 (595)
+.+.+|.|.. .+++.|+|++|+ |+..-+..|.+|++|+.|+|++|+|+...|..|..+++|++|+|
T Consensus 8 ~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 4688899963 378899998765 88555567999999999999999999766888999999999999
Q ss_pred ccccccCccccccccCCCCceecCCCCcCC
Q 007625 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161 (595)
Q Consensus 132 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 161 (595)
++|+|+ .+|..+....+|+.|+|++|.+.
T Consensus 88 s~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 88 SFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cCCCCc-ccChhhhccccccccccCCCccc
Confidence 999999 77777666668999999999996
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.19 E-value=1.1e-11 Score=122.24 Aligned_cols=107 Identities=23% Similarity=0.262 Sum_probs=93.8
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|++++|.+++..+..|.+++.+++|++++|.+++..|..+.++++|++|+|++|+|+ .+|+.|.++++|++|+|
T Consensus 171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L 249 (305)
T d1xkua_ 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249 (305)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEEC
Confidence 37889999999999888889999999999999999999877889999999999999999998 78999999999999999
Q ss_pred CCCcCCccCchh----------hhccccccccccccccC
Q 007625 156 SSNNLTGRIPMQ----------LFSVATFNFTGTHLICG 184 (595)
Q Consensus 156 ~~N~l~g~ip~~----------l~~l~~l~~~~n~~~~~ 184 (595)
++|+|+ .|+.. ..++..+++++|++.+.
T Consensus 250 s~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 250 HNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred CCCccC-ccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 999998 67642 24567888999998654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.05 E-value=6e-11 Score=105.23 Aligned_cols=90 Identities=18% Similarity=0.220 Sum_probs=76.3
Q ss_pred ecCCCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccc--cccccCCCC
Q 007625 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP--ATWSQLSNL 150 (595)
Q Consensus 73 c~~~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L 150 (595)
+...+++.|+|++|.|+ .++ .|..+++|++|+|++|+|+...+..+..+++|++|+|++|+|+ .++ ..+..+++|
T Consensus 38 ~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L 114 (162)
T d1a9na_ 38 ATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSL 114 (162)
T ss_dssp GGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTC
T ss_pred cccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-cccccccccccccc
Confidence 44458999999999999 564 5999999999999999999544445678999999999999998 555 368899999
Q ss_pred ceecCCCCcCCccCch
Q 007625 151 KHLDLSSNNLTGRIPM 166 (595)
Q Consensus 151 ~~l~l~~N~l~g~ip~ 166 (595)
++|++++|.++ ..|.
T Consensus 115 ~~L~l~~N~i~-~~~~ 129 (162)
T d1a9na_ 115 TYLCILRNPVT-NKKH 129 (162)
T ss_dssp CEEECCSSGGG-GSTT
T ss_pred chhhcCCCccc-cccc
Confidence 99999999998 5663
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.96 E-value=5.9e-10 Score=109.57 Aligned_cols=89 Identities=29% Similarity=0.473 Sum_probs=45.9
Q ss_pred CCCC-CCcceeEecCCCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCC-ccccCCCcccEEEeccccccCc
Q 007625 62 VSPC-FSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP-DFLGSMTHLQSLNLANNKFSGS 139 (595)
Q Consensus 62 ~~~c-~~w~gv~c~~~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~ 139 (595)
+..| |.|.+|.|+. ++|+ .+|+.+. ++|++|+|++|+|+ .+| ..|.++++|++|++++|.+...
T Consensus 5 p~~c~c~~~~~~C~~----------~~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i 70 (305)
T d1xkua_ 5 PFRCQCHLRVVQCSD----------LGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKI 70 (305)
T ss_dssp CTTCEEETTEEECTT----------SCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCB
T ss_pred CCCCEecCCEEEecC----------CCCC-ccCCCCC--CCCCEEECcCCcCC-CcChhHhhcccccccccccccccccc
Confidence 4456 6899999974 2333 3444332 34555555555555 233 2445555555555555555533
Q ss_pred cccccccCCCCceecCCCCcCCccCc
Q 007625 140 IPATWSQLSNLKHLDLSSNNLTGRIP 165 (595)
Q Consensus 140 ~p~~~~~l~~L~~l~l~~N~l~g~ip 165 (595)
.|..|.++++|+.|++++|+|+ .+|
T Consensus 71 ~~~~f~~l~~L~~L~l~~n~l~-~l~ 95 (305)
T d1xkua_ 71 SPGAFAPLVKLERLYLSKNQLK-ELP 95 (305)
T ss_dssp CTTTTTTCTTCCEEECCSSCCS-BCC
T ss_pred chhhhhCCCccCEecccCCccC-cCc
Confidence 3444555555555555555555 344
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.95 E-value=1.1e-11 Score=114.04 Aligned_cols=102 Identities=25% Similarity=0.310 Sum_probs=87.2
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|+|+ .++ .|.+|++|+.|+|++|.|+ .+|..+..+++|+.|++++|+|+ .++ .+.++++|+.|+|
T Consensus 48 ~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred cccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 48999999999998 565 5999999999999999998 78887777889999999999999 555 4889999999999
Q ss_pred CCCcCCccCch-----hhhcccccccccccccc
Q 007625 156 SSNNLTGRIPM-----QLFSVATFNFTGTHLIC 183 (595)
Q Consensus 156 ~~N~l~g~ip~-----~l~~l~~l~~~~n~~~~ 183 (595)
++|+|+ .++. .+.+++.+++++|+...
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccchhc-cccccccccCCCccceeecCCCcccc
Confidence 999998 5542 45678889999998643
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=8.2e-10 Score=107.39 Aligned_cols=107 Identities=24% Similarity=0.253 Sum_probs=85.0
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|++.+..+..+..+++|+.+++++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 37888888888888666677888888888888888888655677888888888888888888666777888888888888
Q ss_pred CCCcCCccCchhh---hccccccccccccc
Q 007625 156 SSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (595)
Q Consensus 156 ~~N~l~g~ip~~l---~~l~~l~~~~n~~~ 182 (595)
++|++++..|..+ .++..+++++|...
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~ 214 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred hhccccccChhHhhhhhhcccccccccccc
Confidence 8888887667655 35667778877653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.88 E-value=2.1e-09 Score=103.36 Aligned_cols=82 Identities=24% Similarity=0.361 Sum_probs=49.1
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|+|++|+|+ .+|. ++.+++|++|+|++|+++ .+|..+.++++|+.|++++|.+.+..+..+..+.+|+.|+++
T Consensus 56 ~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~ 132 (266)
T d1p9ag_ 56 RLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132 (266)
T ss_dssp TCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECT
T ss_pred ccccccccccccc-cccc-cccccccccccccccccc-ccccccccccccccccccccccceeecccccccccccccccc
Confidence 5667777777766 4442 456666777777777666 345566666666666666666654444444455555555555
Q ss_pred CCcCC
Q 007625 157 SNNLT 161 (595)
Q Consensus 157 ~N~l~ 161 (595)
+|.++
T Consensus 133 ~n~l~ 137 (266)
T d1p9ag_ 133 GNELK 137 (266)
T ss_dssp TSCCC
T ss_pred ccccc
Confidence 55554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.79 E-value=6.2e-09 Score=95.31 Aligned_cols=99 Identities=23% Similarity=0.405 Sum_probs=68.1
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
+++.|++++|+++ .++ .+..+++|++|+|++|+|++ +++ ++++++|++|++++|.+. .+| .+.++++|+.|+++
T Consensus 41 ~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 41 QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLF 114 (199)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-cccccccccccccc
Confidence 6777788877777 343 47777788888888887774 333 777788888888887776 455 36777778888887
Q ss_pred CCcCCccCc-hhhhcccccccccccc
Q 007625 157 SNNLTGRIP-MQLFSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip-~~l~~l~~l~~~~n~~ 181 (595)
+|.+....+ ..+.++..+++++|..
T Consensus 115 ~~~~~~~~~~~~l~~L~~L~l~~n~l 140 (199)
T d2omxa2 115 NNQITDIDPLKNLTNLNRLELSSNTI 140 (199)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSSCC
T ss_pred ccccccccccchhhhhHHhhhhhhhh
Confidence 777763222 2345666777777654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.73 E-value=6.7e-09 Score=104.88 Aligned_cols=99 Identities=29% Similarity=0.433 Sum_probs=60.2
Q ss_pred CEEEEEcCCCCCCCCCC--------------------ccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccc
Q 007625 77 NVISLTLGSNGFSGKIS--------------------PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~--------------------~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l 136 (595)
+++.|++++|.+++..+ ..+..+++|+.|+|++|++++ ++ .+..+++|+.|+|++|+|
T Consensus 264 ~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l 341 (384)
T d2omza2 264 KLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKV 341 (384)
T ss_dssp TCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCC
T ss_pred cCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCC
Confidence 56677777766664321 235556666677777777664 33 266677777777777776
Q ss_pred cCccccccccCCCCceecCCCCcCCccCc-hhhhcccccccccc
Q 007625 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP-MQLFSVATFNFTGT 179 (595)
Q Consensus 137 ~g~~p~~~~~l~~L~~l~l~~N~l~g~ip-~~l~~l~~l~~~~n 179 (595)
+ .+| .+.++++|++|+|++|+|++-.| ..+.+|+.|++++|
T Consensus 342 ~-~l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 342 S-DVS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp C-CCG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred C-CCh-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 6 344 46667777777777777764333 23445566666655
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.71 E-value=1.4e-08 Score=92.86 Aligned_cols=99 Identities=27% Similarity=0.507 Sum_probs=79.1
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|++++. ++ ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+.. ++ .+.++++|+.|++
T Consensus 62 ~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~~-~~~~l~~L~~L~l 135 (199)
T d2omxa2 62 NNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-ID-PLKNLTNLNRLEL 135 (199)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEEC
T ss_pred CCcCcCccccccccCc-cc-ccCCcccccccccccccc-ccc-cccccccccccccccccccc-cc-ccchhhhhHHhhh
Confidence 4899999999999954 33 999999999999999988 565 48899999999999998874 33 4778899999999
Q ss_pred CCCcCCccCch--hhhcccccccccccc
Q 007625 156 SSNNLTGRIPM--QLFSVATFNFTGTHL 181 (595)
Q Consensus 156 ~~N~l~g~ip~--~l~~l~~l~~~~n~~ 181 (595)
++|++. .+|. .+.++..+++.+|..
T Consensus 136 ~~n~l~-~~~~l~~~~~L~~L~l~~n~l 162 (199)
T d2omxa2 136 SSNTIS-DISALSGLTSLQQLNFSSNQV 162 (199)
T ss_dssp CSSCCC-CCGGGTTCTTCSEEECCSSCC
T ss_pred hhhhhc-ccccccccccccccccccccc
Confidence 999987 5552 345667777777754
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.69 E-value=1.8e-08 Score=93.06 Aligned_cols=79 Identities=23% Similarity=0.352 Sum_probs=44.9
Q ss_pred CEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCC
Q 007625 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (595)
.++.|++++|.++. ++ .+..+++|++|+|++|.|++ ++ .++.|++|++|++++|+|+ .+| .+.++++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccc
Confidence 45566666666653 22 25556666666666666653 33 2455666666666666665 344 35556666666666
Q ss_pred CCcCC
Q 007625 157 SNNLT 161 (595)
Q Consensus 157 ~N~l~ 161 (595)
+|.+.
T Consensus 121 ~~~~~ 125 (210)
T d1h6ta2 121 HNGIS 125 (210)
T ss_dssp TSCCC
T ss_pred ccccc
Confidence 66654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.68 E-value=5.1e-10 Score=102.63 Aligned_cols=87 Identities=21% Similarity=0.331 Sum_probs=75.8
Q ss_pred CCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcCCccCch--hh
Q 007625 91 KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM--QL 168 (595)
Q Consensus 91 ~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~--~l 168 (595)
.+|.++..|++|++|+|++|+|+ .++ .|.+|++|++|+|++|+|+ .+|.....+++|+.|++++|+|+ .++. .+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~~~~~l 114 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSGIEKL 114 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHHHHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-cccccccc
Confidence 56678999999999999999999 676 5999999999999999998 78876677789999999999999 5653 45
Q ss_pred hcccccccccccc
Q 007625 169 FSVATFNFTGTHL 181 (595)
Q Consensus 169 ~~l~~l~~~~n~~ 181 (595)
.+++.+++++|..
T Consensus 115 ~~L~~L~L~~N~i 127 (198)
T d1m9la_ 115 VNLRVLYMSNNKI 127 (198)
T ss_dssp HHSSEEEESEEEC
T ss_pred ccccccccccchh
Confidence 6788999999865
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.67 E-value=9.2e-09 Score=103.84 Aligned_cols=78 Identities=26% Similarity=0.354 Sum_probs=69.3
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|++++.. .+..+++|++|+|++|+|+ .+| .|++|++|++|+|++|+|++..| +.+|++|+.|+|
T Consensus 307 ~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L 380 (384)
T d2omza2 307 KNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380 (384)
T ss_dssp TTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEEC
T ss_pred cccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeC
Confidence 47889999999999653 3899999999999999999 465 69999999999999999996554 899999999999
Q ss_pred CCCc
Q 007625 156 SSNN 159 (595)
Q Consensus 156 ~~N~ 159 (595)
++|.
T Consensus 381 ~~Na 384 (384)
T d2omza2 381 NDQA 384 (384)
T ss_dssp CCEE
T ss_pred CCCc
Confidence 9983
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.67 E-value=7.9e-09 Score=97.53 Aligned_cols=98 Identities=19% Similarity=0.316 Sum_probs=76.9
Q ss_pred CC-CCcceeEecC-----------CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCC-ccccCCCcccEEE
Q 007625 64 PC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP-DFLGSMTHLQSLN 130 (595)
Q Consensus 64 ~c-~~w~gv~c~~-----------~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p-~~~~~l~~L~~L~ 130 (595)
+| |.+..|.|.. .++++|+|++|.|+...+..|.++++|++|+|++|.+...+| ..|.++++++.|+
T Consensus 5 ~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~ 84 (242)
T d1xwdc1 5 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 84 (242)
T ss_dssp SEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred cCCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccc
Confidence 45 5888899963 268889999999884444468889999999999998876554 4678888888888
Q ss_pred ec-cccccCccccccccCCCCceecCCCCcCC
Q 007625 131 LA-NNKFSGSIPATWSQLSNLKHLDLSSNNLT 161 (595)
Q Consensus 131 l~-~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 161 (595)
+. .|++....+..|.++++|+.|++++|.+.
T Consensus 85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp EECCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred ccccccccccccccccccccccccccchhhhc
Confidence 75 46777667777888999999999999887
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.65 E-value=2.5e-08 Score=91.98 Aligned_cols=100 Identities=29% Similarity=0.392 Sum_probs=77.8
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|.|++ ++ .+++|++|++|++++|+|+ .+| .+..+++|+.|++++|.+. .++ .+.++++|+.+++
T Consensus 68 ~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccccccccc-ccc-ccccccccccccc
Confidence 479999999999985 44 3788999999999999998 466 5888999999999999887 444 4777888888888
Q ss_pred CCCcCCccCc-hhhhcccccccccccc
Q 007625 156 SSNNLTGRIP-MQLFSVATFNFTGTHL 181 (595)
Q Consensus 156 ~~N~l~g~ip-~~l~~l~~l~~~~n~~ 181 (595)
++|.+++..+ ..+.+++.+++++|..
T Consensus 142 ~~n~l~~~~~~~~l~~L~~l~l~~n~l 168 (210)
T d1h6ta2 142 GNNKITDITVLSRLTKLDTLSLEDNQI 168 (210)
T ss_dssp CSSCCCCCGGGGGCTTCSEEECCSSCC
T ss_pred ccccccccccccccccccccccccccc
Confidence 8888874221 2455677777777754
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.58 E-value=3.7e-08 Score=91.95 Aligned_cols=65 Identities=26% Similarity=0.439 Sum_probs=40.0
Q ss_pred ccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcCCccCc
Q 007625 96 ITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165 (595)
Q Consensus 96 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 165 (595)
+.+.++|+.|++++|.+++ ++ .++++++|+.|+|++|+++ .+|+ +.++++|++|+|++|+|+ .+|
T Consensus 147 ~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt-~i~ 211 (227)
T d1h6ua2 147 LAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVS 211 (227)
T ss_dssp GGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCC-BCG
T ss_pred hcccccccccccccccccc-ch-hhcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCcCC-CCc
Confidence 4556666666666666653 22 2666666666666666666 3442 666666666666666666 444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.52 E-value=3.6e-08 Score=92.04 Aligned_cols=76 Identities=28% Similarity=0.425 Sum_probs=66.1
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|++++|.+.+.. .+.++++|+.|+|++|++++ +|. +.++++|++|+|++|+|+ .+|+ ++++++|+.|+|
T Consensus 151 ~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~~L~~L~l 224 (227)
T d1h6ua2 151 TNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTL 224 (227)
T ss_dssp TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCC-BCGG-GTTCTTCCEEEE
T ss_pred cccccccccccccccch--hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCC-CCcc-cccCCCCCEEEe
Confidence 47999999999998543 38999999999999999994 554 899999999999999999 5663 899999999999
Q ss_pred CC
Q 007625 156 SS 157 (595)
Q Consensus 156 ~~ 157 (595)
++
T Consensus 225 sn 226 (227)
T d1h6ua2 225 TN 226 (227)
T ss_dssp EE
T ss_pred eC
Confidence 74
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.49 E-value=9e-08 Score=94.92 Aligned_cols=93 Identities=25% Similarity=0.331 Sum_probs=60.5
Q ss_pred CCEEEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecC
Q 007625 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (595)
.+++.|+|++|+|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 35777888888877 56653 457777888888887 677654 45677777777776 44421 135777777
Q ss_pred CCCcCCccCch--hhhcccccccccccc
Q 007625 156 SSNNLTGRIPM--QLFSVATFNFTGTHL 181 (595)
Q Consensus 156 ~~N~l~g~ip~--~l~~l~~l~~~~n~~ 181 (595)
++|.++ .+|. .+.+++.+++.+|..
T Consensus 106 ~~n~l~-~lp~~~~l~~L~~L~l~~~~~ 132 (353)
T d1jl5a_ 106 SNNQLE-KLPELQNSSFLKIIDVDNNSL 132 (353)
T ss_dssp CSSCCS-SCCCCTTCTTCCEEECCSSCC
T ss_pred cccccc-cccchhhhccceeeccccccc
Confidence 777777 5663 234556666666554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=1.5e-06 Score=82.35 Aligned_cols=149 Identities=17% Similarity=0.145 Sum_probs=100.0
Q ss_pred HHHHHHhcCCCcCCeeeeccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcC-CCCCccccceeecCCc
Q 007625 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSE 342 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 342 (595)
.++....+.|+..+..+.++.+.||+... +++.+.+|+..... ......+.+|...+..+. +--+.+++.+...++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 45555556777666554455678998875 56677888875321 122334677888877664 3335677788888888
Q ss_pred eEEEEEecccCcHhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------
Q 007625 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------------------------------ 392 (595)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------ 392 (595)
.++||+++++.++....... . ....++.+++..++.||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 89999999998876544321 1 12334556666666666431
Q ss_pred --------------------------CCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 393 --------------------------NPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 393 --------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
.+.++|+|+.|.||++++++.+-|.||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1238999999999999987667799999875
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.19 E-value=5.3e-08 Score=85.74 Aligned_cols=68 Identities=25% Similarity=0.275 Sum_probs=40.4
Q ss_pred ccccCCCCeEEccCCccCCC--CCccccCCCcccEEEeccccccCcccc-ccccCCCCceecCCCCcCCccC
Q 007625 96 ITKLKFLASLELQDNDLSGT--LPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRI 164 (595)
Q Consensus 96 ~~~l~~L~~L~l~~n~l~g~--~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~i 164 (595)
+.++++|++|+|++|+|+.. ++..+..+++|+.|||++|+|+ .+++ ...+...|+.|+|++|.++...
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCc
Confidence 34566777777777777632 2334556677777777777776 4443 2223345677777777776433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.17 E-value=1.3e-06 Score=86.10 Aligned_cols=68 Identities=28% Similarity=0.361 Sum_probs=40.7
Q ss_pred cCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCccccccccCCCCceecCCCCcCCccCchhhhcccccc
Q 007625 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN 175 (595)
Q Consensus 99 l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~l~~l~~l~ 175 (595)
+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|....++..|.
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~~L~~L~ 350 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDLR 350 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCTTCCEEE
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccccccCeeE
Confidence 456667777777666 56643 456666677777766 56642 345666677777766 5664444444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.11 E-value=1.7e-06 Score=80.87 Aligned_cols=100 Identities=16% Similarity=0.207 Sum_probs=78.6
Q ss_pred EEEEcCCCCCCCCCCccccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCcccc-ccccCCCCceecCC-
Q 007625 79 ISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLS- 156 (595)
Q Consensus 79 ~~l~l~~n~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~l~- 156 (595)
+.++.++++++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+|. .|.+++.++.|++.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 46788888998 8887664 6899999999999943445689999999999999999876654 58889999999875
Q ss_pred CCcCCccCchh---hhcccccccccccc
Q 007625 157 SNNLTGRIPMQ---LFSVATFNFTGTHL 181 (595)
Q Consensus 157 ~N~l~g~ip~~---l~~l~~l~~~~n~~ 181 (595)
.|++....|.. +.+++.+++.+|..
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l 115 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGI 115 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCC
T ss_pred cccccccccccccccccccccccchhhh
Confidence 57787444443 35677888888754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=6.1e-06 Score=77.63 Aligned_cols=130 Identities=15% Similarity=0.036 Sum_probs=84.5
Q ss_pred eeeeccc-eEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCC--CCCccccceeecCCceEEEEEecccCc
Q 007625 278 IIGQGGF-GKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSSERILVYPFMQNLS 354 (595)
Q Consensus 278 ~lG~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (595)
.+..|.. +.||+...+++..+.+|.-.... ...+..|...++.+.. -.+.+++.+..+++..++||++++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3445553 68999998888889999865322 2345677777776643 335667777788888899999998765
Q ss_pred HhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------------
Q 007625 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-------------------------------------------- 390 (595)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-------------------------------------------- 390 (595)
+.... ... ...+.+++..|+-||+
T Consensus 93 ~~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 93 LLSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TTTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred ccccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 43211 110 1122233333334432
Q ss_pred -------c----CCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 391 -------Q----CNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 391 -------~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
. ..+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 01248999999999999988667899999865
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.02 E-value=6e-07 Score=78.72 Aligned_cols=87 Identities=23% Similarity=0.240 Sum_probs=61.0
Q ss_pred cccccCCCCeEEccCCccCCCCCccccCCCcccEEEeccccccCc--cccccccCCCCceecCCCCcCCccCch----hh
Q 007625 95 SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS--IPATWSQLSNLKHLDLSSNNLTGRIPM----QL 168 (595)
Q Consensus 95 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~l~l~~N~l~g~ip~----~l 168 (595)
.+..+..+..|++.+|... .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+ .++. ..
T Consensus 37 ~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~ 114 (162)
T d1koha1 37 DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKG 114 (162)
T ss_dssp TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTT
T ss_pred hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhc
Confidence 3555556666666666554 4555556788899999999988842 3445678888999999999988 5654 22
Q ss_pred hcccccccccccccc
Q 007625 169 FSVATFNFTGTHLIC 183 (595)
Q Consensus 169 ~~l~~l~~~~n~~~~ 183 (595)
.++..++++|||..+
T Consensus 115 ~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 115 LKLEELWLDGNSLSD 129 (162)
T ss_dssp CCCSSCCCTTSTTSS
T ss_pred cccceeecCCCCcCc
Confidence 456778888888744
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=7.5e-07 Score=91.27 Aligned_cols=105 Identities=19% Similarity=0.275 Sum_probs=75.2
Q ss_pred CEEEEEcCCCCCCCCC-CccccccCCCCeEEccCCccCC----CCCccccCCCcccEEEeccccccCc----ccccccc-
Q 007625 77 NVISLTLGSNGFSGKI-SPSITKLKFLASLELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSGS----IPATWSQ- 146 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~-~~~~~~l~~L~~L~l~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~- 146 (595)
+|+.||+++|++++.- ..-+..+++|+.|+|++|.|+- .++..+..+++|+.|||++|+|+.. +...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6889999999998532 3346678899999999998872 3456678889999999999988632 2333332
Q ss_pred CCCCceecCCCCcCCcc----Cchh---hhcccccccccccc
Q 007625 147 LSNLKHLDLSSNNLTGR----IPMQ---LFSVATFNFTGTHL 181 (595)
Q Consensus 147 l~~L~~l~l~~N~l~g~----ip~~---l~~l~~l~~~~n~~ 181 (595)
..+|+.|+|++|+++.. ++.. ..+++.+++++|+.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i 124 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL 124 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccc
Confidence 34799999999998743 2332 34577888888864
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.79 E-value=1.8e-06 Score=85.42 Aligned_cols=106 Identities=20% Similarity=0.259 Sum_probs=68.2
Q ss_pred CCEEEEEcCCCCCCCC-----CCccccccCCCCeEEccCCccCCC----CCccccCCCcccEEEeccccccCccc----c
Q 007625 76 GNVISLTLGSNGFSGK-----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGSIP----A 142 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~-----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p----~ 142 (595)
..++.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.-. .
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 4677888888877631 334566777888888888877522 44556677888888888888775422 2
Q ss_pred cccc--CCCCceecCCCCcCCcc----Cch----hhhcccccccccccc
Q 007625 143 TWSQ--LSNLKHLDLSSNNLTGR----IPM----QLFSVATFNFTGTHL 181 (595)
Q Consensus 143 ~~~~--l~~L~~l~l~~N~l~g~----ip~----~l~~l~~l~~~~n~~ 181 (595)
.+.. .++|+.|+|++|+|+.. +.. ...+++.+++++|.+
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 2322 35678888888887632 111 234567777777765
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.66 E-value=2.6e-06 Score=87.11 Aligned_cols=86 Identities=31% Similarity=0.373 Sum_probs=50.9
Q ss_pred CEEEEEcCCCCCCCCCCc----cccccCCCCeEEccCCccCCC----CCcccc-CCCcccEEEeccccccCc----cccc
Q 007625 77 NVISLTLGSNGFSGKISP----SITKLKFLASLELQDNDLSGT----LPDFLG-SMTHLQSLNLANNKFSGS----IPAT 143 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~~~~----~~~~l~~L~~L~l~~n~l~g~----~p~~~~-~l~~L~~L~l~~N~l~g~----~p~~ 143 (595)
.++.++++++.++..-.. .+....+|++|+|++|.|+.. ++..+. ..+.|++|+|++|+|+.. ++..
T Consensus 313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 392 (460)
T d1z7xw1 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 392 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred ccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHH
Confidence 466666666666543222 233445677777777776532 333333 355677777777777632 4445
Q ss_pred cccCCCCceecCCCCcCCc
Q 007625 144 WSQLSNLKHLDLSSNNLTG 162 (595)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g 162 (595)
+..+++|++|+|++|+|+.
T Consensus 393 l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 393 LLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHCCCCCEEECCSSSCCH
T ss_pred HhcCCCCCEEECCCCcCCH
Confidence 5666777777777777764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.59 E-value=1.5e-05 Score=76.35 Aligned_cols=60 Identities=20% Similarity=0.166 Sum_probs=26.0
Q ss_pred cCCCCeEEccCC-ccCCCCCccccCCCcccEEEecc-ccccCccccccccCCCCceecCCCC
Q 007625 99 LKFLASLELQDN-DLSGTLPDFLGSMTHLQSLNLAN-NKFSGSIPATWSQLSNLKHLDLSSN 158 (595)
Q Consensus 99 l~~L~~L~l~~n-~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N 158 (595)
+++|++|+|++| .+++..+..+.++++|++|+|++ +.+++.....++++++|+.|+++++
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 344444444442 23433444444444444444444 2344333334444444444444444
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.48 E-value=0.00015 Score=72.66 Aligned_cols=77 Identities=14% Similarity=0.131 Sum_probs=46.8
Q ss_pred CCeeeeccceEEEEEEeC-CCcEEEEEEeccC------CCchhHHHHHHHHHHHHhcC-C--CCCccccceeecCCceEE
Q 007625 276 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY------YSPGGEAAFQREVHLISVAI-H--KNLLQLIGYCTTSSERIL 345 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~------~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 345 (595)
.+.||.|....||++... +++.|+||.-... ..+........|.+.++.+. + ..+.+++. .+++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence 457899999999999865 4678999964321 11112233456777776552 2 23444443 34566789
Q ss_pred EEEecccCc
Q 007625 346 VYPFMQNLS 354 (595)
Q Consensus 346 v~e~~~~gs 354 (595)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.48 E-value=8.3e-06 Score=80.50 Aligned_cols=86 Identities=20% Similarity=0.318 Sum_probs=54.4
Q ss_pred CEEEEEcCCCCCCCC----CCccccccCCCCeEEccCCccCCC-----CCccccCCCcccEEEeccccccCc----cccc
Q 007625 77 NVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSGT-----LPDFLGSMTHLQSLNLANNKFSGS----IPAT 143 (595)
Q Consensus 77 ~l~~l~l~~n~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~ 143 (595)
.++.|++++|.++.. +...+...+.|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 455666666665421 223355567777788877777631 334456677777888877777532 4445
Q ss_pred cccCCCCceecCCCCcCCc
Q 007625 144 WSQLSNLKHLDLSSNNLTG 162 (595)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g 162 (595)
+..+++|+.|+|++|.|++
T Consensus 239 l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp GGGCTTCCEEECTTCCCCH
T ss_pred ccccccchhhhhhcCccCc
Confidence 6677777788888877764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.30 E-value=0.00011 Score=70.10 Aligned_cols=98 Identities=16% Similarity=0.194 Sum_probs=71.7
Q ss_pred CCEEEEEcCCC-CCCCCCCccccccCCCCeEEccC-CccCCCCCccccCCCcccEEEeccccccCccccccccCCCCcee
Q 007625 76 GNVISLTLGSN-GFSGKISPSITKLKFLASLELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 153 (595)
Q Consensus 76 ~~l~~l~l~~n-~l~g~~~~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l 153 (595)
.+++.|+|+++ .+++.....+.++++|++|+|++ +.++......++++++|+.|+++++--.+.++.-...+++ |
T Consensus 175 ~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~---L 251 (284)
T d2astb2 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---L 251 (284)
T ss_dssp TTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTT---S
T ss_pred ccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCcc---c
Confidence 47999999985 57877778899999999999999 5788777788999999999999887222223322233444 5
Q ss_pred cCCCCcCCccCchhhhccccccc
Q 007625 154 DLSSNNLTGRIPMQLFSVATFNF 176 (595)
Q Consensus 154 ~l~~N~l~g~ip~~l~~l~~l~~ 176 (595)
.+..+.+++..++.+++-....+
T Consensus 252 ~i~~~~ls~~~~~~~~~~~~~~i 274 (284)
T d2astb2 252 QINCSHFTTIARPTIGNKKNQEI 274 (284)
T ss_dssp EESCCCSCCTTCSSCSSTTCCCB
T ss_pred cccCccCCCCCCCccCccccchh
Confidence 56788888666666655443333
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.15 E-value=5.5e-05 Score=66.07 Aligned_cols=86 Identities=10% Similarity=0.191 Sum_probs=62.4
Q ss_pred CCEEEEEcCCC-CCCCC----CCccccccCCCCeEEccCCccCC----CCCccccCCCcccEEEeccccccCc----ccc
Q 007625 76 GNVISLTLGSN-GFSGK----ISPSITKLKFLASLELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSGS----IPA 142 (595)
Q Consensus 76 ~~l~~l~l~~n-~l~g~----~~~~~~~l~~L~~L~l~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~ 142 (595)
..++.|+|+++ .++.. +-..+...++|++|+|++|.+.. .+...+...+.|+.|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 37889999874 45422 23356677889999999998863 2334455678899999999998743 233
Q ss_pred ccccCCCCceecCCCCcCC
Q 007625 143 TWSQLSNLKHLDLSSNNLT 161 (595)
Q Consensus 143 ~~~~l~~L~~l~l~~N~l~ 161 (595)
.+...++|+.|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 5677788999999998776
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.12 E-value=0.00091 Score=64.79 Aligned_cols=136 Identities=14% Similarity=0.102 Sum_probs=77.0
Q ss_pred ceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCc--cccc-----eeecCCceEEEEEecccCcHh
Q 007625 284 FGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL--QLIG-----YCTTSSERILVYPFMQNLSVA 356 (595)
Q Consensus 284 ~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~~-----~~~~~~~~~lv~e~~~~gsL~ 356 (595)
-..||+++.++|..|++|+.+... ...+++..|...+..+....+. ..+. .....+..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 468999999999999999986533 2356677888887776432221 1111 223345667889998764321
Q ss_pred --------------hhhcc----cCC-CCCCCCHH-------------------HHHHHHHHHHHHHHHHhh----cCCC
Q 007625 357 --------------YRLRD----LKP-GEKGLDWP-------------------TRKRVAFGTAYGLEYLHE----QCNP 394 (595)
Q Consensus 357 --------------~~l~~----~~~-~~~~l~~~-------------------~~~~i~~~ia~~L~~LH~----~~~~ 394 (595)
..++. ... .....++. ....+...+...++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 11111 000 01111111 111122222233333322 2244
Q ss_pred CcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 395 KIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 395 ~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
+++|+|+.+.|||++++ ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC--ceEEechhcc
Confidence 78999999999999754 4589999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.81 E-value=0.0067 Score=57.95 Aligned_cols=159 Identities=13% Similarity=0.070 Sum_probs=81.6
Q ss_pred cCHHHHHHHhcCCCcCCeee-----eccceEEEEEEeCCCcEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCC-----C
Q 007625 261 FSCRELQLATDNFSESNIIG-----QGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN-----L 330 (595)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG-----~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n-----i 330 (595)
++.+|++....+|.+++... .|--.+.|+...++| .+++|+.....+. .++..|++++..+...+ .
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH---HHHHHHHHHHHhhhhcccccccc
Confidence 56678888888888766543 455578899998665 5899987543222 33445566665553222 1
Q ss_pred ccccc---eeecCCceEEEEEecccCcHh--------------hhhcccCCC---C--CCCCH-----------------
Q 007625 331 LQLIG---YCTTSSERILVYPFMQNLSVA--------------YRLRDLKPG---E--KGLDW----------------- 371 (595)
Q Consensus 331 v~l~~---~~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~~~---~--~~l~~----------------- 371 (595)
+...+ +.........++.+..+.... ..++..... . .....
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11110 112233455666666553221 111100000 0 00000
Q ss_pred -HHHHHHHHHHHHHHHHHhh-cCCCCcEEcCCCCCCEEEcCCCcEEEeeccccc
Q 007625 372 -PTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (595)
Q Consensus 372 -~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 423 (595)
......+......+...+. ..+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011112222222222221 123479999999999999998777899999875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.48 E-value=0.0004 Score=60.28 Aligned_cols=86 Identities=14% Similarity=0.113 Sum_probs=65.1
Q ss_pred CCEEEEEcCCCCCCCC----CCccccccCCCCeEEccCCccCCC----CCccccCCCcccEEEeccccccCc-------c
Q 007625 76 GNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS-------I 140 (595)
Q Consensus 76 ~~l~~l~l~~n~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~-------~ 140 (595)
..++.|+|++|.+... +...+...+.|+.|+|++|.|+.. +-..+...++|++|+|++|.+... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 5799999999998742 334456678999999999999843 233566778999999999976521 3
Q ss_pred ccccccCCCCceecCCCCcCC
Q 007625 141 PATWSQLSNLKHLDLSSNNLT 161 (595)
Q Consensus 141 p~~~~~l~~L~~l~l~~N~l~ 161 (595)
...+..-++|+.|+++.+...
T Consensus 124 ~~~L~~n~sL~~l~l~~~~~~ 144 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFASME 144 (167)
T ss_dssp HHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHhCCCccEeeCcCCCch
Confidence 445667789999999887543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.61 E-value=0.025 Score=55.75 Aligned_cols=73 Identities=15% Similarity=0.161 Sum_probs=48.3
Q ss_pred CCeeeeccceEEEEEEeCCC--------cEEEEEEeccCCCchhHHHHHHHHHHHHhcCCCCCc-cccceeecCCceEEE
Q 007625 276 SNIIGQGGFGKVYKGVLSDN--------TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL-QLIGYCTTSSERILV 346 (595)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv 346 (595)
.+.|+.|-.-.+|++..+++ +.|.+++.-. . .......+|..+++.+.-.++. ++++++.+ ..|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 46788888999999986543 4566666542 1 2234556888888887544444 66666542 689
Q ss_pred EEecccCcH
Q 007625 347 YPFMQNLSV 355 (595)
Q Consensus 347 ~e~~~~gsL 355 (595)
++|+++.++
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.22 E-value=0.0023 Score=55.08 Aligned_cols=86 Identities=17% Similarity=0.254 Sum_probs=54.1
Q ss_pred CCEEEEEcCC-CCCCCC----CCccccccCCCCeEEccCCccCCC----CCccccCCCcccEEEeccccccCc----ccc
Q 007625 76 GNVISLTLGS-NGFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IPA 142 (595)
Q Consensus 76 ~~l~~l~l~~-n~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~ 142 (595)
..++.|+|++ +.++.. +-..+...++|++|+|++|.++.. +-..+...++|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 3677788876 445421 223456677888888888877633 223445667888888888887633 334
Q ss_pred ccccCCCCce--ecCCCCcCC
Q 007625 143 TWSQLSNLKH--LDLSSNNLT 161 (595)
Q Consensus 143 ~~~~l~~L~~--l~l~~N~l~ 161 (595)
.+...++|+. |++++|.+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCccccEEeeccCCCcCc
Confidence 5666777775 444566664
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.37 E-value=0.0029 Score=54.41 Aligned_cols=87 Identities=18% Similarity=0.208 Sum_probs=65.9
Q ss_pred CCCEEEEEcCCCCCCCC----CCccccccCCCCeEEccCCccCCC----CCccccCCCcccEEEe--ccccccC----cc
Q 007625 75 NGNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNL--ANNKFSG----SI 140 (595)
Q Consensus 75 ~~~l~~l~l~~n~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l--~~N~l~g----~~ 140 (595)
..+++.|+|++|.++.. +...+...++|+.|++++|.++.. +-..+...++|+.++| ++|.+.. .+
T Consensus 45 n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~L 124 (166)
T d1io0a_ 45 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 124 (166)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHH
Confidence 35799999999998753 234567789999999999998733 3356777889987655 5677763 35
Q ss_pred ccccccCCCCceecCCCCcCC
Q 007625 141 PATWSQLSNLKHLDLSSNNLT 161 (595)
Q Consensus 141 p~~~~~l~~L~~l~l~~N~l~ 161 (595)
...+.+.++|+.|+++.|...
T Consensus 125 a~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 125 ANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEeCcCCCCc
Confidence 566778999999999887654
|